
<html lang="en"     class="pb-page"  data-request-id="dd584a04-fef6-499e-9482-ba4413c7d539"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2021.64.issue-3;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.0c01887"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer’s Disease Therapy" /></meta><meta name="dc.Creator" content="Aurélien  Beato" /></meta><meta name="dc.Creator" content="Anthonin  Gori" /></meta><meta name="dc.Creator" content="Benjamin  Boucherle" /></meta><meta name="dc.Creator" content="Marine  Peuchmaur" /></meta><meta name="dc.Creator" content="Romain  Haudecoeur" /></meta><meta name="dc.Description" content="The natural β-carboline alkaloids display similarities with neurotransmitters that can be favorably exploited to design bioactive and bioavailable drugs for Alzheimer’s disease (AD) therapy. Severa..." /></meta><meta name="Description" content="The natural β-carboline alkaloids display similarities with neurotransmitters that can be favorably exploited to design bioactive and bioavailable drugs for Alzheimer’s disease (AD) therapy. Severa..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 2, 2021" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c01887" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01887" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c01887" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c01887" /></link>
        
    
    

<title>β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer’s Disease Therapy | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c01887" /></meta><meta property="og:title" content="β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer’s Disease Therapy" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0029.jpeg" /></meta><meta property="og:description" content="The natural β-carboline alkaloids display similarities with neurotransmitters that can be favorably exploited to design bioactive and bioavailable drugs for Alzheimer’s disease (AD) therapy. Several AD targets are currently and intensively being investigated, divided in different hypotheses: mainly the cholinergic, the amyloid β (Aβ), and the Tau hypotheses. To date, only symptomatic treatments are available involving acetylcholinesterase and NMDA inhibitors. On the basis of plethoric single-target structure–activity relationship studies, the β-carboline scaffold was identified as a powerful tool for fostering activity and molecular interactions with a wide range of AD-related targets. This knowledge can undoubtedly be used to design multitarget-directed ligands, a highly relevant strategy preferred in the context of multifactorial pathology with intricate etiology such as AD. In this review, we first individually discuss the AD targets of the β-carbolines, and then we focus on the multitarget strategies dedicated to the deliberate design of new efficient scaffolds." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c01887"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c01887">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c01887&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c01887&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c01887&amp;href=/doi/10.1021/acs.jmedchem.0c01887" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 3</span><span class="cit-fg-pageRange">, 1392-1422</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/3" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c01782" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.0c00382" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer’s Disease Therapy</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Aurélien Beato</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Aurélien Beato</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Grenoble Alpes, CNRS, DPM, 38000 Grenoble, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Aur%C3%A9lien++Beato">Aurélien Beato</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anthonin Gori</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anthonin Gori</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Grenoble Alpes, CNRS, DPM, 38000 Grenoble, France</div><div class="loa-info-affiliations-info">CHANEL Parfums Beauté, F-93500 Pantin, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anthonin++Gori">Anthonin Gori</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Benjamin Boucherle</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Benjamin Boucherle</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Grenoble Alpes, CNRS, DPM, 38000 Grenoble, France</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Benjamin++Boucherle">Benjamin Boucherle</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marine Peuchmaur</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marine Peuchmaur</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Grenoble Alpes, CNRS, DPM, 38000 Grenoble, France</div></div><span class="conrtib-corresp"><strong>*</strong><a href="/cdn-cgi/l/email-protection#f5b894879c9b90dba59080969d98948087b5809b9c83d89287909b9a979990d89499859086db9387"><span class="__cf_email__" data-cfemail="eba68a9982858ec5bb8e9e8883868a9e99ab9e85829dc68c998e858489878ec68a879b8e98c58d99">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marine++Peuchmaur">Marine Peuchmaur</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8926-1922" title="Orcid link">http://orcid.org/0000-0002-8926-1922</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Romain Haudecoeur</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Romain Haudecoeur</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Univ. Grenoble Alpes, CNRS, DPM, 38000 Grenoble, France</div></div><span class="conrtib-corresp"><strong>*</strong><a href="/cdn-cgi/l/email-protection#d98bb6b4b8b0b7f791b8acbdbcbab6bcacab99acb7b0aff4beabbcb7b6bbb5bcf4b8b5a9bcaaf7bfab"><span class="__cf_email__" data-cfemail="fba994969a9295d5b39a8e9f9e98949e8e89bb8e95928dd69c899e959499979ed69a978b9e88d59d89">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Romain++Haudecoeur">Romain Haudecoeur</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6271-4717" title="Orcid link">http://orcid.org/0000-0002-6271-4717</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01887&amp;href=/doi/10.1021%2Facs.jmedchem.0c01887" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 3</span><span class="cit-pageRange">, 1392–1422</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 2, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>31 October 2020</li><li><span class="item_label"><b>Published</b> online</span>2 February 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 February 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c01887" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01887</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D1392%26pageCount%3D31%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DAur%25C3%25A9lien%2BBeato%252C%2BAnthonin%2BGori%252C%2BBenjamin%2BBoucherle%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D3%26contentID%3Dacs.jmedchem.0c01887%26title%3D%25CE%25B2-Carboline%2Bas%2Ba%2BPrivileged%2BScaffold%2Bfor%2BMultitarget%2BStrategies%2Bin%2BAlzheimer%25E2%2580%2599s%2BDisease%2BTherapy%26numPages%3D31%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D1422%26publicationDate%3DFebruary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c01887"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1281</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">2</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c01887" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;β-Carboline as a Privileged Scaffold for Multitarget Strategies in Alzheimer’s Disease Therapy&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Aurélien&quot;,&quot;last_name&quot;:&quot;Beato&quot;},{&quot;first_name&quot;:&quot;Anthonin&quot;,&quot;last_name&quot;:&quot;Gori&quot;},{&quot;first_name&quot;:&quot;Benjamin&quot;,&quot;last_name&quot;:&quot;Boucherle&quot;},{&quot;first_name&quot;:&quot;Marine&quot;,&quot;last_name&quot;:&quot;Peuchmaur&quot;},{&quot;first_name&quot;:&quot;Romain&quot;,&quot;last_name&quot;:&quot;Haudecoeur&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;02&quot;,&quot;issue&quot;:&quot;3&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;1392-1422&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c01887&quot;},&quot;abstract&quot;:&quot;The natural β-carboline alkaloids display similarities with neurotransmitters that can be favorably exploited to design bioactive and bioavailable drugs for Alzheimer’s disease (AD) therapy. Several AD targets are currently and intensively being investigated, divided in different hypotheses: mainly the cholinergic, the amyloid β (Aβ), and the Tau hypotheses. To date, only symptomatic treatments are available involving acetylcholinesterase and NMDA inhibitors. On the basis of plethoric single-target structure–activity relationship studies, the β-carboline scaffold was identified as a powerful tool for fostering activity and molecular interactions with a wide range of AD-related targets. This knowledge can undoubtedly be used to design multitarget-directed ligands, a highly relevant strategy preferred in the context of multifactorial pathology with intricate etiology such as AD. In this review, we first individually discuss the AD targets of the β-carbolines, and then we focus on the multitarget strategies dedi&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01887&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01887" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01887&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01887" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c01887&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01887" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c01887&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c01887&amp;href=/doi/10.1021/acs.jmedchem.0c01887" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c01887" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c01887" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (8 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c01887%26sid%3Dliteratum%253Aachs%26pmid%3D33528252%26genre%3Darticle%26aulast%3DBeato%26date%3D2021%26atitle%3D%25CE%25B2-Carboline%2Bas%2Ba%2BPrivileged%2BScaffold%2Bfor%2BMultitarget%2BStrategies%2Bin%2BAlzheimer%25E2%2580%2599s%2BDisease%2BTherapy%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D3%26spage%3D1392%26epage%3D1422%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291788" title="Reaction products">Reaction products</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292201" title="Scaffolds">Scaffolds</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/3" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/jmcmar.2021.64.issue-3/20210211/jmcmar.2021.64.issue-3.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0029.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The natural β-carboline alkaloids display similarities with neurotransmitters that can be favorably exploited to design bioactive and bioavailable drugs for Alzheimer’s disease (AD) therapy. Several AD targets are currently and intensively being investigated, divided in different hypotheses: mainly the cholinergic, the amyloid β (Aβ), and the Tau hypotheses. To date, only symptomatic treatments are available involving acetylcholinesterase and NMDA inhibitors. On the basis of plethoric single-target structure–activity relationship studies, the β-carboline scaffold was identified as a powerful tool for fostering activity and molecular interactions with a wide range of AD-related targets. This knowledge can undoubtedly be used to design multitarget-directed ligands, a highly relevant strategy preferred in the context of multifactorial pathology with intricate etiology such as AD. In this review, we first individually discuss the AD targets of the β-carbolines, and then we focus on the multitarget strategies dedicated to the deliberate design of new efficient scaffolds.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70873" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70873" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The β-carboline alkaloids represent a large group of natural and synthetic heterocyclic amines derived from tryptophan.<a onclick="showRef(event, 'ref1 ref2'); return false;" href="javascript:void(0);" class="ref ref1 ref2">(1,2)</a> Probably the most well-studied compounds of this group, harmine <b>1</b> and harmaline <b>2</b>, were originally isolated in the 1840s from the seeds of <i>Peganum harmala</i> L. (Syrian rue), a traditional plant used for various purposes such as an emmenagogue or abortifacient.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Since their discovery, numerous β-carboline alkaloids have been identified, highlighting the wide distribution of this family mainly in plants but also in animal tissues. These natural products encompass simple β-carbolines and more complex derivatives, such as indoloquinolizidines (e.g., reserpine, mitragynine, yohimbine) and strictosidine- or manzamine-related alkaloids (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The β-carboline core is composed of a tricyclic pyrido[3,4-<i>b</i>]indole ring structure, declined in several saturation states: β-carbolines for the unsaturated, fully aromatic scaffold (e.g., harmine <b>1</b>), dihydro-β-carbolines (e.g., harmaline <b>2</b>), and tetrahydro-β-carbolines or tryptolines (e.g., tetrahydroharmine <b>3</b>) for versions with a partially or completely reduced pyridine ring (the scaffolds are displayed in red, purple, and blue, respectively, throughout the review). As such, its structure is reminiscent of human tryptamine-based neurotransmitters, i.e., serotonin and melatonin, and this analogy, together with the enhanced rigidity conferred by an additional ring, has been exploited for the design of bioactive compounds for modulating several central nervous system (CNS) targets. Thus, among their broad spectrum of recorded biological activities (e.g., antimicrobial, antitumor, antiviral, antiparasitic properties), synthetic and natural β-carbolines were most often associated with psychopharmacological effects, interacting with a variety of benzodiazepine, serotonin, imidazoline, and dopamine receptors, as well as inhibiting brain enzymes. Especially, some β-carbolines were reported as best-in-class inhibitors for several biomolecular targets involved in Alzheimer’s disease (AD) or suspected to play a role.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Numbering of the β-carboline scaffold. Structure of representative β-carbolines in various oxidation states (<b>1</b>–<b>3</b>) and derivatives from natural sources (<b>4</b>–<b>7</b>) and drug discovery (<b>8</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">AD is a chronic neurodegenerative disorder first described by the neuropathologist Alois Alzheimer in 1907, leading to a significant number of deaths. Although mainly occurring in elderly populations, the familial AD can affect younger patients. Clinically, the main cognitive symptoms of AD are progressive short-term memory impairment, disturbances of orientation, or neuropsychological disorders (e.g., aphasia, agnosia, apraxis). While the pathogenesis of AD is still unclear, due to the complex and multifactorial nature of the disease, several hypotheses have been advanced based on pathological or behavioral changes in AD patients.<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4−6)</a> Besides the three main hypotheses, namely, the cholinergic, amyloid-β (Aβ), and tau protein hypotheses that are regarded as the leading pathological pathways of AD, various other targets have emerged, some of them being interrelated. The cholinergic hypothesis was the first and most studied theory of the disease<a onclick="showRef(event, 'ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref4 ref5 ref6">(4−6)</a> and has led to four out of five anti-AD drugs currently on the market (donepezil, rivastigmine, galantamine, and tacrine which are acetylcholinesterase (AChE) inhibitors), the fifth being memantine, a <i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate receptor (NMDA) inhibitor. This hypothesis is based on the utmost role of the neurotransmitter acetylcholine, its decrease being associated with dementia symptoms. Understandably, research has focused on inhibitors of cholinesterases, serine hydrolase enzymes that can be subdivided into AChE and butyrylcholinesterase (BuChE). The Aβ cascade hypothesis is related to the neurotoxicity and acceleration of the neuronal cell death consecutively to the accumulation of insoluble amyloid plaques.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> These aggregates of Aβ peptides result from the cleavage of the amyloid precursor protein (APP), a transmembrane protein located in neural synapses, by two secretase enzymes, the β-site APP cleaving enzyme 1 (BACE1, or β-secretase) and the γ-secretase. Under the normal nonamyloid pathway, APP is sequentially cleaved by α- and γ-secretases leading to soluble and nontoxic APP derivatives. Conversely, β- and γ-secretases cleavage produces among other products an Aβ<sub>42</sub> monomer derivative (the most neurotoxic form of Aβ) known to accumulate in the extracellular environment, ending in amyloid plaques formation and local inflammatory response. The tau hypothesis pinpoints the hyperphosphorylation of tau protein as one of the main pathological pathways of AD.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> This hyperphosphorylation process is a consequence of both the overactivation of kinases<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> (e.g., mitogen-activated protein kinase (MAPK), cyclin-dependent kinase-5 (CDK-5), glycogen synthase kinase-3β (GSK-3β) or dual specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A)) and the inactivation of protein phosphatase or protein tyrosine phosphatase-A. Apart from these three main theories, AD is also related to other pathological hypotheses<a onclick="showRef(event, 'ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref5 ref6">(5,6)</a> such as the oxidative stress associated with the search of monoamine oxidases (MAO-A and B) inhibitors or metal chelators, and the excitotoxic theory involving for instance phosphodiesterases (PDE), NMDA, and gamma-aminobutyric acid (GABA) receptors.</div><div class="NLM_p">As the pathogenic mechanisms of AD are thus nebulous and multifactorial, with intricate etiology, current drug discovery research is moving to multitarget strategies with a view to affect several nodes of the complex neurodegenerative network simultaneously. Different approaches have been described to alter the function of several targets at once, among them the multitarget-directed ligands (MTDL) aimed at hybridize pharmacophoric moieties mostly already known as bioactive molecules.<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7−9)</a> In this line, the tacrine and donepezil scaffolds inspired the design of numerous MTDL. The unique place of natural compounds, such as resveratrol or coumarin, in this strategy has also been repeatedly emphasized.</div><div class="NLM_p">Similarly, the β-carboline scaffold is at the forefront of the targeting of the myriad of biomolecules involved in AD. Harmine (<b>1</b>) is a reference inhibitor of MAO-A and tau-phosphorylation kinase DYRK1A. Tadalafil (<b>8</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) has been marketed in 2003 as an excellent (and selective) antiphosphodiesterase-5 (PDE5) agent. Extended β-carbolines were identified as single-digit nanomolar AChE and histone deacetylase (HDAC) inhibitors, and GABA<sub>A</sub> receptor modulators. Therefore, with the emergence of multitarget strategies against AD, the β-carboline scaffold is naturally well-positioned to become a dedicated platform able to concurrently reach a variety of neurological biomolecules and processes.</div><div class="NLM_p last">Thus, we present herein an overview of the β-carboline derivatives (with associated structure–activity relationship (SAR) studies) that have been reported for their ability to inhibit or interfere with the main hypotheses, processes, and targets in the frame of AD, namely, ChE, BACE1, Aβ fibrillation, tau phosphorylation kinases, MAO, PDE5, glutamate, NMDA, GABA<sub>A</sub>, and 5-hydroxytryptamine (5-HT) receptors, and finally HDAC. After a successive discussion of these targets in individual sections, the last part of the review focuses on multitarget strategies using a β-carboline scaffold deliberately designed for reaching several targets at once and provides a critical overall analysis of the field together with perspectives for future works.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Acetyl- and Butyrylcholinesterase (AChE/BuChE) Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_77218" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_77218" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Acetylcholine, a major neurotransmitter in the CNS, plays a crucial role in the neurological regulation of various functions (e.g., learning, memory, cognition). In AD, its depletion is associated with cognitive deficits, arousing the cholinergic hypothesis in the physiopathology of AD and thus the search for inhibitors of its degrading enzymes, AChE and BuChE. Indeed, some approved drugs (e.g., donepezil and rivastigmin) were put on the market; however, the clinical benefits of these treatments are still low, merely alleviating some of the major symptoms of AD. AChE and BuChE are both present in the brain with different specificities and expression activities. A selective inhibition of AChE is more crucial in the early stage, while BuChE inhibition may be critical in the mid to later stages of the pathogenesis. Nevertheless, AChE, whose natural substrate is acetylcholine, remains a primary target; however, BuChE was recently recognized as a new advanced target to treat AD. BuChE is a nonspecific cholinesterase able to hydrolyze various types of natural or toxic esters. Both enzymes are serine hydrolases with a catalytic active site (CAS) located at the bottom of a 20 Å gorge, less restrictive in the case of BuChE, compared to AChE, and a peripheral anionic site (PAS) at the entry of that gorge.</div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Simple β-Carbolines and Reduced Analogues</h3><div class="NLM_p">If the β-carboline scaffold by itself clearly appeared as unable to efficiently bind both AChE and BuChE (IC<sub>50</sub> > 40 μM for <b>9a</b>),<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> the insertion of simple substituents at various positions only led to moderately active analogues at the micromolar range against both enzymes.<a onclick="showRef(event, 'ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12 ref13 ref14 ref15 ref16 ref17 ref18 ref19 ref20 ref21 ref22">(10−22)</a> Indeed, while the introduction of polar groups at position 1 was slightly beneficial in some cases, especially compared with methyl analogues (IC<sub>50</sub> = 4.0 μM for <b>10</b> vs. >10 μM for <b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), the 9-substituted β-carbolines looked more promising. In particular, the 9-propargyl moiety produced the best results, regardless of other positions status: despite 1-methyl, 7-methoxy substitutions, harmine-related compound <b>11</b> shared with its naked analogue the same AChE inhibition potency (IC<sub>50</sub> = 2.0 and 1.9 μM, respectively). However, the introduction of extended or polar substituents at position 9 of compound <b>11</b> gave lower activities in all cases. If isoxazoline derivatives were associated with a 10-fold drop of inhibition potency (IC<sub>50</sub> = 11 μM for the most active analogue <b>12</b>),<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> a large series of triazoles and hydrazides were found completely inactive against AChE (IC<sub>50</sub> > 100 μM).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> Natural β-carbolines bearing a 9-methoxy group were also marginally active.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Globally, the functionalization of positions 1 and 7 only provided a limited impact (e.g., IC<sub>50</sub> > 10 μM for <b>1</b>, <b>9a</b>, and <b>9b</b>). Attempts to explore substitutions at positions 3, 4, and 6 failed, as the resulting derivatives were found even less potent than their parent compounds. Partial or total reduction of the pyridine ring afforded comparable results. The dihydro-β-carboline <b>2</b> especially showed similar inhibition values than its fully oxidized counterpart <b>1</b>,<a onclick="showRef(event, 'ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref14 ref15">(14,15)</a> while 1-hydroxydihydro-β-carboline was mostly inactive.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Regarding tetrahydro-β-carbolines, no activity improvement was recorded as well (e.g., IC<sub>50</sub> > 10 μM for <b>1</b> and <b>3</b>, as well as for <b>9a</b> and its reduced counterpart),<a onclick="showRef(event, 'ref14 ref21'); return false;" href="javascript:void(0);" class="ref ref14 ref21">(14,21)</a> except for enantiopure compound <b>13</b> (IC<sub>50</sub> = 2.5 μM) and for the only 8-substituted analogue, <b>14</b>, that reached an IC<sub>50</sub> of 2.0 μM,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> making position 8 of β-carbolines a potentially valuable subject for further studies. Examining basic interactions between simple β-carbolines and the active site of AChE provided elements of interest. For example, the planar structure of harmane (<b>9b</b>) was found in docking experiments to mainly interact with aromatic residues of the CAS of AChE, especially, Trp84 and Phe330.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> A hydrogen bond would also occur between the indole NH and His440, and overall the interaction pattern reported appeared as quite similar to tacrine (a well-known planar inhibitor) interactions. Globally, the piecemeal BuChE inhibition results gave similar trends than for AChE, disregarding a few exceptions. Several 1-substituted compounds, inactive against AChE, were though tested on BuChE, and if compound <b>15</b>, for example, revealed a promising activity (IC<sub>50</sub> = 1.3 μM), submicromolar 1-naphthyl analogue <b>16</b> constituted a real breakthrough in the quest for efficient BuChE inhibitors (IC<sub>50</sub> = 0.22 μM).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Docking studies showed that <b>16</b> seemed to bind in a similar fashion than donepezil, a well-known cholinesterase inhibitor. In particular, the position of <b>16</b> allowed the formation of a key hydrogen bond between the indole NH and the OH group of Ser198, as well as π–π stacking interactions with Trp231 and His438.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Selected structures and IC<sub>50</sub> of simple substituted β-carbolines as AChE and/or BuChE inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> β-Carboliniums and R<sup>2</sup> Substituent Refinement: Toward Nanomolar Range Derivatives</h3><div class="NLM_p">Differences are classically observed in terms of anticholinesterase activity between neutral compounds and corresponding ammonium salts. It was often suggested that they could be related to a choline mimic effect, and then several authors focused on developing β-carboliniums for improving β-carboline scaffold affinity. At first glance, the substitution of the pyridine ring at position 2 by a methyl group appeared to yield mixed results for the corresponding pyridiniums. Indeed, if some improvements of activity were recorded, sometimes 10-fold (e.g., IC<sub>50</sub> > 40 μM for <b>9a</b> vs. around 5 μM for <b>17</b>), in other cases the IC<sub>50</sub> values remained very similar.<a onclick="showRef(event, 'ref10 ref27'); return false;" href="javascript:void(0);" class="ref ref10 ref27">(10,27)</a> However, when replacing the methyl group by bulkier substituents, more potent compounds were identified, with sub-micromolar potency. For example, 2-propylated counterpart of <b>17</b> reached an IC<sub>50</sub> value of 0.85 μM, vs. 4.1–6.7 μM for <b>17</b> itself.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> If the ester derivative <b>18</b> eventually showed the best activity among simple substituents at position 2 (IC<sub>50</sub> = 0.25 μM),<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> the phenyl analogues were also very potent (IC<sub>50</sub> = 0.42–0.76 μM, 0.54 μM for <b>19</b>, and 0.42 μM for <b>20</b>),<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> especially considering the possibilities of further fine-tuned modifications of the phenyl ring. Indeed, Zhou et al. generated very recently a systematic catalogue of compounds with various phenyl substitutions in order to determine the most favorable substituent at position 2 of the β-carbolinium scaffold.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Among the groups (fluoro, chloro, bromo, iodo, methyl, hydroxyl, methoxy, cyano, etc.) and positions (<i>ortho</i>, <i>meta</i>, <i>para</i>, etc.) evaluated, a few molecules led to inhibition values under 0.30 μM. Compounds <b>21a</b> and <b>21b</b> (IC<sub>50</sub> = 0.29 μM and 0.24 μM respectively) especially shed light on the potential beneficial role of a <i>para</i> substitution, probably through a steric favorable effect, a feature confirmed by several other comparisons (e.g., IC<sub>50</sub> = 0.56 μM for <b>21c</b> vs. > 9 μM for <i>ortho</i> and <i>meta</i> analogues, 0.43 μM for <b>21d</b> vs. >10 μM for <i>ortho</i> and <i>meta</i> analogues) and by molecular docking of <b>21a</b>, <b>21e</b> and their respective <i>meta</i> isomers, that showed inappropriate sterical clash with residue Asn87 in the case of <i>meta</i> substituents. A disubstituted analogue, <b>22</b>, displayed the best value, almost reaching the two-digits nanomolar range (IC<sub>50</sub> = 0.11 μM). It is worth noting that the aforementioned molecules exhibited a remarkable selectivity between AChE and BuChE, unlike the other compounds described so far. Inhibition values against BuChE were systematically around 100 times higher than against AChE (e.g., IC<sub>50</sub> = 32–60 μM for <b>21a</b>–<b>e</b> against BuChE), with a 390-fold difference as the maximum, in the case of a 4′-bromo-2′-fluoro derivative (IC<sub>50</sub> = 0.30 μM against AChE vs. 116 μM against BuChE).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Finally, the partial reduction of the pyridine moiety exerted a global detrimental effect on anti-AChE activity (e.g., IC<sub>50</sub> = 1.5–6.8 μM for <b>23a</b>–<b>c</b> vs. 0.24–0.43 μM for <b>21a</b>, <b>21b</b> and <b>21d</b>). A 100-fold drop was even measured when reducing compound <b>22</b> into the 3,4-dihydro counterpart <b>24</b> (IC<sub>50</sub> = 0.11 μM and >10 μM respectively). This phenomenon could be explained by the predicted binding modes of compounds <b>21a</b>, <b>21e</b>, and <b>23a</b> in the AChE active sites. In docking experiments, the aromatic core of the β-carbolines was found to be embedded in a group of aromatic residues, such as Trp86, Tyr337, Trp439, and Tyr449. Thus, when partially reducing the pyridine ring, a crucial π–π interaction between this group and the indole ring of Trp86 could be lost, jeopardizing the global affinity of the compounds.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a><named-content content-type="anchor" rid="fig3" type="simple"></named-content></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Selected structures and IC<sub>50</sub> of β-carboliniums as AChE and/or BuChE inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Extended β-Carbolines and Indoquinolizidines: From Active Natural Products to Lead Molecules</h3><div class="NLM_p">Numerous extensions of the β-carboline scaffold were provided by nature, and especially molecules with an additional fused six-membered ring, namely, indoloquinolizidines. Phytochemistry works around these compounds sometimes gave the opportunity to retrieve sporadic data about their AChE and/or BuChE inhibition potency. Overall, most of these compounds were found active only at concentrations >10 μM, but a couple of structural elements were able to decrease the IC<sub>50</sub> values. Once again, the introduction of a positive charge at the nitrogen atom of the quinolizidine part of these molecules gave interesting results: the quinolizidinium salt <b>25</b> was 30 times more potent against AChE than the neutral counterpart (IC<sub>50</sub> = 4.1 μM and 121 μM respectively, <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Surprisingly, limited modifications of <b>25</b> also led to more active derivatives: the reduction of ethylenyl group or the introduction of a hydroxyl group yielded analogues with IC<sub>50</sub> values of 5.2 μM and 10 μM, respectively.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Globally, the glycosylated analogue <b>26</b> displayed the best potential in this series but eventually remained in the micromolar range (IC<sub>50</sub> = 1.9 μM).<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> The other disparate compounds did not succeed to improve anti-AChE and anti-BuChE activity, including complex imbricated polycyclic and/or positively charged derivatives.<a onclick="showRef(event, 'ref19 ref29 ref33 ref34 ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref19 ref29 ref33 ref34 ref35 ref36">(19,29,33−36)</a> The presence of a fifth fused six-membered ring, common in natural products, appeared as beneficial for anti-AChE and anti-BuChE activities, as witnessed by the good AChE and BuChE inhibition properties of reserpine <b>4</b> (IC<sub>50</sub> = 1.7 μM and 2.8 μM, respectively, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> Even little substituted analogues reached decent micromolar-range inhibition of BuChE (but not AChE), such as compound <b>27</b> (IC<sub>50</sub> = 1.0 μM).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Especially, in docking experiments <b>27</b> was found to fit deep in the bottom gorge of BuChE, establishing hydrogen bonds with residues Ser198 and His438, and an anchoring π–π stacking with Trp84 at the choline binding site.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Contrariwise, when considering cationic derivatives low micromolar or submicromolar activities against AChE were recorded (e.g., IC<sub>50</sub> = 0.78 μM and 1.5 μM for <b>28</b> and <b>29</b>, respectively).<a onclick="showRef(event, 'ref10 ref38'); return false;" href="javascript:void(0);" class="ref ref10 ref38">(10,38)</a> Compound <b>29</b> was predicted to bind in the hydrophobic pocket of the PAS, formed by Phe330, Phe331, Tyr334, Tyr121, with a main π–π interaction between the terminal aromatic ring of <b>30</b> and Trp279, mostly matching the donepezil interaction pattern.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a> The presence of an additional nitrogen atom at position 14, which was associated with the natural evodiamine subclass of β-carbolines, gave rise to an increased potency in terms of BuChE inhibition, while improving the BuChE vs. AChE selectivity of these agents. Indeed, compounds <b>30</b> and <b>31</b> concomitantly achieved a sub-micromolar range potency (IC<sub>50</sub> = 0.5 μM and 0.88 μM respectively against BuChE) and a 4–7-fold better IC<sub>50</sub> against BuChE vs. AChE (IC<sub>50</sub> = 3.4 μM and 3.0 μM respectively against AChE).<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> Extended substitution at position 3 was thus investigated using a carbamate linker and either 5-oxo or 5-deoxo versions of the evodiamine scaffold. Among the 12 analogues reported, all compounds were barely inactive against AChE, especially the 5-oxo derivatives, but some derivatives emerged as good inhibitors of BuChE (IC<sub>50</sub> = 1.0–4.0 μM). More strikingly, compound <b>32</b> revealed a very high potential against BuChE, showing an IC<sub>50</sub> of 77 nM, the best value found among β-carboline derivatives to date, together with an exquisite BuChE vs. AChE selectivity index of more than 130.<a onclick="showRef(event, 'ref41'); return false;" href="javascript:void(0);" class="ref ref41">(41)</a> Finally, the impact of position 3 substitution was further scrutinized using a partially or completely oxidized evodiamine scaffold, without the 14-methyl group (i.e., rutaecarpine scaffold). All the compounds tested, bearing an amido bridge linked to various secondary amines, reached sub-micromolar potency.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Especially, compounds <b>33</b> and <b>34</b> were associated with IC<sub>50</sub> of 29 nM and 10 nM against AChE, while being very selective (IC<sub>50</sub> = 0.84 μM and 5.4 μM against BuChE, respectively), a property rationalized by molecular docking.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Selected structures and IC<sub>50</sub> of natural or bioinspired extended β-carbolines as AChE and/or BuChE inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Aβ Peptide Production and Fibrillation Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80080" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80080" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">One of the main hallmarks of AD is the accumulation of neurotoxic aggregates of Aβ peptides that could be self-induced or promoted by AChE and finally deposit in the form of amyloid plaques, with various consequences such as the imbalance of intracellular Ca<sup>2+</sup> levels leading to apoptosis or neuronal inflammatory response. The Aβ peptides result from the sequential cleavage of APP by β-site APP cleaving enzyme 1 (BACE1), the initial key enzyme in the amyloidogenic metabolic pathway, and γ-secretase. BACE1 is thus considered as a very interesting target for the development of new drugs for AD treatment. Many forms of Aβ have been previously described such as monomers, soluble oligomers, and fibrils with different levels of toxicity. During the aggregation process, Aβ fibrils entrap electrochemically active metal ions, mainly Cu and Zn ions, that can generate reactive oxygen species (ROS). Metal-ion chelators are therefore another research focus within the context of the Aβ cascade hypothesis to reduce the aggregation of Aβ fibrils and thus the generation of ROS. Accordingly, Aβ aggregation and BACE1 inhibitors, metal chelation, and radical scavenging are all attractive approaches that can be independently or simultaneously targeted to disrupt the formation of amyloid peptides and/or plaques.</div><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Structual Elements for BACE1 Inhibition</h3><div class="NLM_p">Regarding β-carbolines, after virtual screening studies of the Thai medicinal database, the natural product ochrolifuanine E <b>35</b> was identified as a BACE1 inhibitor with good predicted pharmacokinetic properties, including blood–brain barrier (BBB) crossing level, but a quite high toxicity.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> In line with docking studies, (<i>S</i>)-3-(azidomethyl)-2,3,4,9-tetrahydro-1<i>H</i>-pyrido[3,4-<i>b</i>]indole was chemically modulated, and, among the 22 synthesized compounds, <b>36</b> showed the most potent inhibitory activity on BACE1 (IC<sub>50</sub> = 1.5 μM, <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The binding mode of <b>36</b> highlighted hydrogen bonding interactions between the two polar hydrogen of the β-carboline core and residues Asp32 and Asp228 of BACE1. The introduction of more polar, bulkier, or halogenated substituents generally led to less active compounds.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Selected structures and IC<sub>50</sub> of β-carbolines as BACE1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Inhibition of Aβ Fibrillation and/or Oligomerization</h3><div class="NLM_p">Among others, compounds <b>16</b> (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) and <b>37</b>, which are BuChE inhibitors, were evaluated at 100 μM for their ability to prevent the formation of Aβ fibrils and soluble Aβ oligomers, described as the more neurotoxic form of Aβ peptides (39% and 58% respectively for <b>16</b>, 34% and 82% for <b>37</b>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Unlike previous studies suggesting that a compound is either a fibril or an oligomer inhibitor, compound <b>16</b> is able to inhibit both forms. Some other natural β-carbolines, mainly vinpocetine and reserpine <b>4</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), have been reported in piecemeal studies to have neuroprotective effects linked to Aβ aggregation and/or toxicity.<a onclick="showRef(event, 'ref37 ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref37 ref44 ref45">(37,44,45)</a> After identification of the marine fascaplysin <b>29</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) as an Aβ fibrillization inhibitor, the synthetic 9-methyl derivative <b>38</b>, originally designed as an AChE inhibitor, was recognized as a more potent analogue able to directly interact with Aβ through ionic interactions with the negatively charged residues of Aβ. Finally, 9-methylfascaplysin not only inhibited the formation of Aβ fibrillization but also prevented the formation of Aβ oligomers <i>in vitro</i>.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Natural β-carbolines isolated from <i>Picrasma quassioides</i> were also evaluated for their inhibitory effect on Aβ<sub>42</sub> aggregation, and the most active compound <b>39b</b>, a racemic bis-β-carboline, showed an IC<sub>50</sub> value of 10 μM, whereas the <i>N</i>-unsubstituted analogue <b>39a</b> and other isolated monomeric β-carbolines were inactive or marginally active.<a onclick="showRef(event, 'ref23 ref47'); return false;" href="javascript:void(0);" class="ref ref23 ref47">(23,47)</a><named-content content-type="anchor" rid="fig6" type="simple"></named-content></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Selected structures, IC<sub>50</sub> and aggregation inhibition percentages of β-carbolines as Aβ aggregation inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Tau Phosphorylation Kinases Inhibitors (GSK-3β, DYRK1A, CDK5, CK1/2, CLK1)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20170" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20170" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Tau is a hydrophilic microtubule-associated protein that plays an important role in the assembly and stability of microtubules and, therefore, in the normal brain function. In AD, tau is abnormally hyperphosphorylated, resulting in conformational changes and ultimately in the formation of neurofibrillary tangles (NFTs), highly disruptive and toxic intracellular aggregates that deposit in the brain, leading to neuronal dysfunction and death. To prevent the formation of NFTs, considered as the second main marker of Alzheimer’s disease, kinase inhibitors were identified or designed. Thus, several studies were dedicated to the inhibition of tau phosphorylation kinases, which mostly belong to the CMGC kinase group, namely, GSK-3β, DYRK1A, CDK5, casein kinases 1 and 2 (CK1/2), and dual specificity protein kinase (CLK1), among other minor contributions.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a> Especially, harmine <b>1</b> was found as one of the most active inhibitors of DYRK1A (IC<sub>50</sub> = 22–130 nM, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), while analogues norharmane <b>9a</b> and harmane <b>9b</b> were mostly inactive (IC<sub>50</sub> > 1.8 μM, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref49 ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57">(49−57)</a> However, upon fixing a hydroxy or methoxy group at position 7, some room at position 9 seems to be available for receiving substituents of various sizes, as witnessed by the good potencies of compounds <b>40</b> and <b>41a</b>–<b>c</b> (IC<sub>50</sub> = 35–59 nM), <b>41d</b> being the most promising member of the series (IC<sub>50</sub> = 25 nM, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref49 ref57 ref58 ref59 ref60 ref61'); return false;" href="javascript:void(0);" class="ref ref49 ref57 ref58 ref59 ref60 ref61">(49,57−61)</a> Only the presence of a 9-carboxylic acid moiety compromised significantly the activity (IC<sub>50</sub> = 1.1 μM). Further variations at position 7 revealed a general drop of activity upon methoxy replacement, except for the methyl ester <b>42a</b> (IC<sub>50</sub> = 27 nM, vs. 2.0–9.8 μM for <b>42b</b>–<b>d</b>). Position 1 was finally modulated by the introduction of substituents of various sizes, with only little impact on the anti-DYRK1A effect (IC<sub>50</sub> = 56–110 nM for <b>43a</b>–<b>c</b>). Contrariwise, the partial reduction of harmine has proved to be unsuccessful (<b>2</b>, IC<sub>50</sub> = 4.6–9.0 μM).<a onclick="showRef(event, 'ref49 ref50'); return false;" href="javascript:void(0);" class="ref ref49 ref50">(49,50)</a> Some of these elements were rationalized by the publication of three crystal structures of β-carboline–DYRK1A complexes with compounds <b>1</b>, <b>41d</b>, and <b>44</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ANR">3ANR</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UWY">6UWY</a>, and <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YU2">4YU2</a>, respectively, <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>A–C).<a onclick="showRef(event, 'ref61 ref62 ref63'); return false;" href="javascript:void(0);" class="ref ref61 ref62 ref63">(61−63)</a> The harmine <b>1</b> flat structure was found encased in the catalytic site between several hydrophobic residues, such as Ala186, Val173, Phe238, Val306, Leu294, and Leu241, establishing hydrogen bond anchors with the main chain of Leu241 and with the side chain amino group of Lys188. As observed previously, free space occurred around position 9 of harmine <b>1</b>, and the structures of <b>41d</b>–DYRK1A and <b>44</b>–DYRK1A complexes confirmed the possibility of introducing bulky groups without causing major steric clashes. The hydrogen bond set up by the 7-methoxy group could explain the inability of naked counterparts <b>9a</b> and <b>9b</b> to exert any significant effect against the enzyme. Interestingly, harmine <b>1</b> was described as partially kinase-selective (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref49 ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57 ref64 ref65'); return false;" href="javascript:void(0);" class="ref ref49 ref50 ref51 ref52 ref53 ref54 ref55 ref56 ref57 ref64 ref65">(49−57,64,65)</a> Especially, when considering Alzheimer’s disease-related kinases, it was found active against DYRK1A and CLK1 (IC<sub>50</sub> = 22–350 nM and 26–220 nM respectively), but not against CDK5 and CK1/2 (IC<sub>50</sub> > 1.5 μM). Its activity against GSK-3β, on the other hand, was discordant from study to study (IC<sub>50</sub> = 0.35–10 μM). Another β-carboline-based series of pyrrolo[3′,4’:5,6]indolizino[8,7-<i>b</i>]indole-1,3(2<i>H</i>,8<i>H</i>)-diones, derived from the natural alkaloid granulatimide, was tested against these same five kinases.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Among them, the 7-hydroxy derivative <b>45</b> was of particular interest, as it afforded sub-micromolar values for both CLK1, DYRK1A, and GSK-3β (IC<sub>50</sub> = 0.26 μM, 0.20 μM, and 0.42 μM respectively). Other β-carbolines have been developed as dedicated inhibitors of GSK-3β and CDK5, but with poor outputs. However, compound <b>46</b> was recently associated with interesting CLK1 inhibition properties (<i>K</i><sub>i</sub> = 0.14 μM) and with exquisite kinase selectivity (IC<sub>50</sub> > 10 μM against a range of ∼50 kinases), making it an excellent candidate in the AD context. The crystal structure of a <b>46</b>–CLK1 complex (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YTG">6YTG</a>, <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>D) revealed a noncanonical binding mode in the active site and the formation of multiple hydrogen bonds between the spiro piperidine moiety, the nitrile group, and residues Lys191, Asp325, and possibly Asn293. In addition, an unusual halogen bond was seen between the 7-chloro group of <b>46</b> and residue Glu242. A series of manzamine A (<b>7</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) derivatives have also been provided as potential inhibitors of GSK-3β.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> Regardless of the modifications made at the indole ring (introduction of hydroxy, ethoxy, or arylsulfonyl groups) or at the macrocyclic part (dehydration, insertion of a carbonyl group), the recorded levels of activity remained in all cases marginal (IC<sub>50</sub> = 5.4–25 μM), the best inhibitor being <b>47</b> (IC<sub>50</sub> = 4.8 μM). Finally, a series of β-carbolines was designed and evaluated against CDK5. The inhibition results remained very modest and did not deliver values below 5 μM (IC<sub>50</sub> = 5.0 μM for <b>48</b>).<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a></div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Selected structures and IC<sub>50</sub> (or <i>K</i><sub>i</sub> where indicated) of β-carbolines as inhibitors of tau phosphorylation kinases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Crystal structure of <b>1</b> (in green) bound to DYRK1A (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ANR">3ANR</a>). (B) Crystal structure of <b>41d</b> (in mauve) bound to DYRK1A (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UWY">6UWY</a>). (C) Crystal structure of <b>44</b> (in blue) bound to DYRK1A (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YU2">4YU2</a>). (D) Crystal structure of <b>46</b> (in pink) bound to CLK1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YTG">6YTG</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. IC<sub>50</sub> Values Obtained for Harmine (1) Against a Panel of Kinases<a class="ref internalNav" href="#tbl1-fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th><th class="colsep0 rowsep0" align="center">kinase</th><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK1</td><td class="colsep0 rowsep0" align="left">17–18</td><td class="colsep0 rowsep0" align="left">DYRK2</td><td class="colsep0 rowsep0" align="left">0.12–3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK2</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">DYRK3</td><td class="colsep0 rowsep0" align="left">0.21–0.80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>CDK5</b></td><td class="colsep0 rowsep0" align="left">8.0–21</td><td class="colsep0 rowsep0" align="left">DYRK4</td><td class="colsep0 rowsep0" align="left">9.5–80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK7</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">ERK2</td><td class="colsep0 rowsep0" align="left">>30</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CDK9</td><td class="colsep0 rowsep0" align="left">0.72</td><td class="colsep0 rowsep0" align="left">FYN</td><td class="colsep0 rowsep0" align="left">>250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>CK1</b></td><td class="colsep0 rowsep0" align="left">1.5–1.8</td><td class="colsep0 rowsep0" align="left"><b>GSK-3β</b></td><td class="colsep0 rowsep0" align="left">0.35–10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>CK2</b></td><td class="colsep0 rowsep0" align="left">>40</td><td class="colsep0 rowsep0" align="left">LCK</td><td class="colsep0 rowsep0" align="left">>250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>CLK1</b></td><td class="colsep0 rowsep0" align="left">0.026–0.22</td><td class="colsep0 rowsep0" align="left">LYN</td><td class="colsep0 rowsep0" align="left">>250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CLK2</td><td class="colsep0 rowsep0" align="left">0.12–0.28</td><td class="colsep0 rowsep0" align="left">MNB</td><td class="colsep0 rowsep0" align="left">0.15</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CLK3</td><td class="colsep0 rowsep0" align="left">3.0–10</td><td class="colsep0 rowsep0" align="left">PIM1</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">CLK4</td><td class="colsep0 rowsep0" align="left">0.024–0.050</td><td class="colsep0 rowsep0" align="left">PIM3</td><td class="colsep0 rowsep0" align="left">4.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>DYRK1A</b></td><td class="colsep0 rowsep0" align="left">0.022–0.35</td><td class="colsep0 rowsep0" align="left">PKA</td><td class="colsep0 rowsep0" align="left">>250</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">DYRK1B</td><td class="colsep0 rowsep0" align="left">0.028–0.26</td><td class="colsep0 rowsep0" align="left">PKC</td><td class="colsep0 rowsep0" align="left">>250</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-tbl1-fn1"><div class="footnote" id="tbl1-fn1"><sup><sup>a</sup></sup><p class="last">In bold are the main AD-related kinases.</p></div></div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i12">Monoamine Oxidases (MAO-A/B) Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32542" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32542" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">MAO, which are mitochondrial-associated enzymes, selectively catalyze the degradation of various monoamines including oxidation of amine neurotransmitters such as 5-HT, dopamine, norepinephrine, or epinephrine. Studies have recently reported high levels of MAO activity in AD patients, and promising results were achieved using MAO inhibitors to improve cognitive ability. Indeed, in AD, activated MAO participate in the neurodegenerative processes both through the increase of hydrogen peroxide and thus oxidative stress and via indirect production of amyloid β peptide in neurons, via the γ-secretase. Selective MAO-B inhibitors are preferred to avoid antidepressant effects and hypersensitive reactions mediated by the inhibition of MAO-A. Selective MAO-A inhibitors are more classically used to treat depression and anxiety by providing emotional stability, while MAO-B inhibitors are used in the treatment of neurological disease to decrease the production of neurotoxic compounds to enhance the neuronal survival.</div><div class="NLM_p">Harmane (<b>9b</b>, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>) and other β-carbolines are well-known as MAO inhibitors, as they constitute natural key ingredients responsible for the lower MAO activity observed in smokers and coffee consumers, resulting in a neuroprotective effect widely documented.<a onclick="showRef(event, 'ref69 ref70'); return false;" href="javascript:void(0);" class="ref ref69 ref70">(69,70)</a> Indeed, <b>9b</b> was associated in several studies with a sub-micromolar MAO-A inhibition potential (IC<sub>50</sub> = 29–340 nM).<a onclick="showRef(event, 'ref33 ref70 ref71 ref72 ref73'); return false;" href="javascript:void(0);" class="ref ref33 ref70 ref71 ref72 ref73">(33,70−73)</a> The analogous harmine (<b>1</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) was even more potent, showing single-digit nanomolar inhibition values (IC<sub>50</sub> = 1.0–5.3 nM), and more efficacy, although still moderate, against MAO-B.<a onclick="showRef(event, 'ref60 ref72 ref73 ref74 ref75'); return false;" href="javascript:void(0);" class="ref ref60 ref72 ref73 ref74 ref75">(60,72−75)</a> As a high-resolution structure of a <b>1</b>–MAO-A complex was elucidated by crystallography (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z5X">2Z5X</a>), the structural elements that rule the high inhibition potency are well-known (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>A).<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> Harmine is located at the active site, interacting with residues Tyr69, Asn181, Phe208, Val210, Gln215, Cys323, Ile325, Ile335, Leu337, Phe352, Tyr407, and Tyr444, and with the cofactor flavin adenine dinucleotide (FAD). A reported π–π interaction between Gln215 and the five-membered ring of harmine (3.4 Å), together with a water-bridged hydrogen bond network involving the two nitrogen atoms of the β-carboline structure and Tyr69, Asn181, and Gln215 seems to be an important component of the interaction pattern. An overlay of the complex with a MAO-B structure (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OJ9">1OJ9</a>)<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> reveals a major steric clash, as Ile335 is replaced by Tyr326 (black arrow in <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>B), and Asn181 becomes Cys172 that no longer allows the formation of a water-bridged hydrogen bond. These elements could explain the significant drop in harmine activity when considering MAO-B inhibition. Unsurprisingly, most of the anti-MAO-A modulation efforts were thus achieved based on the harmine structure. Introducing various substituents at position 9 always resulted in a loss of anti-MAO-A activity, and the potency even weakened as the substituent size increased (IC<sub>50</sub> = 11 nM for <b>40</b> vs. 0.74 μM and >10 μM for isopropyl and benzyl analogues).<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> If attempts to replace the 7-methoxy group by carbon-based substituents mostly failed (even if <b>42c</b> and <b>42d</b> still reached decent inhibition values, IC<sub>50</sub> = 40 nM and 30 nM respectively, <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>), the introduction of other 7-alkoxy groups provided derivatives with MAO-A inhibition similar to the parent compound (IC<sub>50</sub> < 5.0 nM for <b>49a</b>–<b>49e</b>).<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> In addition, compound <b>49d</b> was notably able to inhibit MAO-B activity 100 times more efficiently than harmine (IC<sub>50</sub> = 0.22 μM vs. 20 μM). At the other side of harmine, the diversification of position 1 was unsuccessful, IC<sub>50</sub> values against MAO-A systematically rising above 1 μM.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> All these observations are consistent with the crystal structure of MAO-A, since position 7 clearly appears as the most tolerant to steric hindrance and especially carbon chains, while positions 1 and 9 are already in close contact with adjacent residues. These elements were confirmed by the limited potential of 9-substituted 7-triazolylmethoxy derivatives reported recently.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a> In all cases, as expected, the functionalization of position 9, with phenylpropyl, propyl, butyl, or isobutyl groups, led to derivatives with IC<sub>50</sub> values against MAO-A of at least 0.43 μM (IC<sub>50</sub> = 0.43 μM for <b>50b</b>), with sometimes interesting action on MAO-B however (e.g., IC<sub>50</sub> = 0.26 μM for <b>50a</b>). The partial reduction of harmine <b>1</b>, leading to 3,4-dihydro analogue <b>2</b>, afforded retained MAO-A inhibition potency (IC<sub>50</sub> = 2.5–8.0 nM).<a onclick="showRef(event, 'ref72 ref73 ref74 ref79'); return false;" href="javascript:void(0);" class="ref ref72 ref73 ref74 ref79">(72−74,79)</a> Total reduction of the pyridine ring to give compound <b>3</b>, as well as reduction of differently substituted β-carbolines (1-H, 7-OMe, 6-OH, 7-OH), inexorably produced less active molecules, with no specific action on MAO-B as well.<a onclick="showRef(event, 'ref72 ref73 ref80 ref81 ref82'); return false;" href="javascript:void(0);" class="ref ref72 ref73 ref80 ref81 ref82">(72,73,80−82)</a> Methyl-pyridinium derivatives of harmine and harmaline were also significantly less active on MAO-A (<i>K</i><sub>i</sub> = 69 nM for <b>51</b> vs. IC<sub>50</sub> = 1.0–5.3 nM for <b>1</b>, and <i>K</i><sub>i</sub> = 140 nM for <b>52</b> vs. IC<sub>50</sub> = 2.5–8.0 nM for <b>2</b>), as were all the other 2-methyl cationic analogues.<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a> Finally, several natural derivatives with more complex structures were tested against MAO-A and MAO-B, but with only limited success.<a onclick="showRef(event, 'ref33 ref74'); return false;" href="javascript:void(0);" class="ref ref33 ref74">(33,74)</a> If compounds <b>53</b> and <b>54</b> reached IC<sub>50</sub> of 0.87 μM and 0.85 μM against MAO-A, the other molecules only yielded values above 1 μM.<named-content content-type="anchor" rid="fig9" type="simple"></named-content><named-content content-type="anchor" rid="fig10" type="simple"></named-content></div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Selected structures and IC<sub>50</sub> (or <i>K</i><sub>i</sub> where indicated) of β-carbolines as MAO-A/B inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (A) Crystal structure of <b>1</b> (in green) bound to MAO-A (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z5X">2Z5X</a>). (B) Overlay of crystal structures of <b>1</b> (in green) bound to MAO-A (in gold, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z5X">2Z5X</a>) and of MAO-B (in silver, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OJ9">1OJ9</a>). In orange, the FAD cofactor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i13">Phosphodiesterase Type 5 (PDE5) Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32602" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32602" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Considering the failing development of effective treatments for AD, a focus on other promising strategies highlighted new targets such as PDE. The classification of these enzymes in 11 families, each comprising multiple isoforms and splice variants, mainly relies on their substrate specificity: cyclic adenosine monophosphate (cAMP) and/or cyclic guanosine monophosphate (cGMP). These second messengers, respectively arising from ATP or GTP, are important elements in intraneuronal signal transduction cascades. By elevating cyclic nucleotide levels, PDE inhibitors promote gene transcription via the activation of the cAMP response element-binding (CREB), that regulates in turn the expression of genes involved in long-term memory formation.<a onclick="showRef(event, 'ref84 ref85'); return false;" href="javascript:void(0);" class="ref ref84 ref85">(84,85)</a> Indeed, the natural β-carboline vinpocetine inhibits PDE1 and shows beneficial effects on memory function in rats.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> To the best of our knowledge, vinpocetine is the only β-carboline described to inhibit PDE1, a dual substrate enzyme able to hydrolyze both cAMP and cGMP. There are few studies of β-carboline on PDE targets other than PDE5. Some β-carbolines inhibiting PDE4 were identified,<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a> but, so far, preclinical studies led on PDE4 inhibitors were hampered by aversive side effects, mainly emesis, because of the lack of selectivity on the four different gene products (PDE4A–D).<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a> On the other hand, several FDA-approved drugs, including the β-carboline tadalafil, inhibit PDE5, a cGMP-specific enzyme, for the treatment of male erectile dysfunction. Incidentally, clinical studies have revealed the potential of these inhibitors to enhance memory and cognitive functions strengthening the relevance of this target.<a onclick="showRef(event, 'ref88'); return false;" href="javascript:void(0);" class="ref ref88">(88)</a></div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 1-Aryl Dihydro-β-carbolines and Influence of the R<sup>2</sup> Substituent</h3><div class="NLM_p">Several series of simple reduced tricyclic 1-aryl β-carbolines without substitution of the nitrogen at position 2 were evaluated.<a onclick="showRef(event, 'ref89 ref90 ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref89 ref90 ref91 ref92">(89−92)</a> These compounds were mostly inactive or active at the micromolar range. Especially, the substitution of the 1-aryl group showed a limited impact on PDE5 inhibition potency: considering derivatives with 1<i>R</i>,3<i>S</i> configuration, the replacement of the 4′-bromophenyl group of <b>55</b> (IC<sub>50</sub> = 3.1 μM, <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>) with 4′-bromo or 2′,4′-dimethoxy analogues provided activities in a similar order of magnitude (IC<sub>50</sub> = 4.2 μM, and 6.4 μM, respectively). However, the absolute configuration of carbon 1 was more discriminating, as only 1<i>R</i>,3<i>S</i> and 1<i>R</i>,3<i>R</i> β-carbolines were found active. The importance of a <i>R</i> configuration at carbon 1 was illustrated by the evaluation of the four diastereoisomers of the 1-(2-bromo)aryl analogues, leading to an activity in the case of <b>55</b> and its 1<i>R</i>,3<i>R</i> counterpart (IC<sub>50</sub> = 3.1 μM and 5.6 μM respectively), whereas no activity was recorded for the two remaining stereoisomers. The same trend was observed for 1-aryl derivatives bearing different phenyl substituents. The thiophenyl analogue was found inactive however.<a onclick="showRef(event, 'ref93'); return false;" href="javascript:void(0);" class="ref ref93">(93)</a> If the substitution of position 2 by a chloroacetyl moiety did generally not improve the potency of the naked analogues (e.g., IC<sub>50</sub> = 2.7 μM for compound <b>56</b>), the introduction of more complex groups at this position produced two main series of more valuable derivatives. In the first series, phenyl-furoyl β-carbolines were evaluated as racemic mixtures, with a 3,4-methylenedioxyphenyl group as the 1-substituent, and all compounds showed anti-PDE5 activity at a sub-micromolar range.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> One compound especially yielded a <i>K</i><sub>i</sub> value below 100 nM (<i>K</i><sub>i</sub> = 78 nM for <b>57a</b>). A further expansion of substituents of the phenyl-furoyl group provided beneficial effects, when compared with shorter analogues, e.g., <b>57c</b> vs. <b>57b</b> (<i>K</i><sub>i</sub> = 64 nM vs. 120 nM), or <b>58b</b> vs. <b>58a</b> (<i>K</i><sub>i</sub> = 51 nM vs. 180 nM). The introduction of a piperidyl substituent at the phenyl-furoyl group and the simultaneous replacement of an oxygen atom from the 3,4-methylenedioxy moiety by a carbon provided compound <b>59</b>, which showed the best activity of the series (IC<sub>50</sub> = 8 nM). On the other hand, the reduction of the amido linker was found detrimental. It is worth noting that the evaluation of separated enantiomers of a representative compound confirmed that only the 1<i>R</i> configuration enabled PDE5 inhibition, as the 1<i>R</i> derivative <b>60</b> was found at least 150 times more active than the 1<i>S</i> analogue (IC<sub>50</sub> = 67 nM and >10 μM respectively). Similar results were obtained from the second series, using a pyrimidine ring as a linker between the β-carbolines and the remote phenyl groups, at position 2 (e.g., <i>K</i><sub>i</sub> = 63 nM for compound <b>61</b>).<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a> Again, the removal of an oxygen atom from the 3,4-methylenedioxyphenyl group at position 1 led to the most active derivative <b>62</b>, a dipyridine analogue with a <i>K</i><sub>i</sub> of 4 nM. As the compound was tested as a racemic mixture, it could be supposed that the actual potency of the 1<i>R</i> enantiomer is even higher. Among the other modifications tested, the introduction of a carbonyl group at position 4 of the β-carboline scaffold afforded a beneficial result (<i>K</i><sub>i</sub> = 9 nM for <b>63</b> vs. 63 nM for <b>61</b>), while its reduction in the hydroxy counterpart was unfavorable (<i>K</i><sub>i</sub> > 100 nM). A replacement of the 3,4-methylenedioxyphenyl group by a 3,4-dimethoxyphenyl substituent also led to a critical drop of anti-PDE5 activity. Interestingly, the alternative use of the rutaecarpine scaffold for anti-PDE5 activity also produces one compound with IC<sub>50</sub> below 100 nM, compound <b>64</b> (IC<sub>50</sub> = 86 nM), while all other derivatives were found less active.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Selected structures and IC<sub>50</sub> (or <i>K</i><sub>i</sub> where indicated) of 1-aryl dihydro-β-carbolines as PDE5 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> β-Carbolines with a Fused Hydantoin Ring</h3><div class="NLM_p">Starting from the β-carboline scaffold itself, GlaxoSmithKline performed a substructure search in their internal database to find more potent PDE5 inhibitors, and a fused β-carboline–hydantoin analogue was identified as promising, with a good recorded selectivity.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> Thus, they sought to produce numerous derivatives associated with different modulation points. First, from a stereochemistry point of view, a high number of fused β-carboline–hydantoin racemic mixtures did not allow an easy discrimination between <i>trans</i> and <i>cis</i> forms, showing similar good activities in almost all cases (e.g., IC<sub>50</sub> = 10 nM for <i>cis</i>-<b>65a</b> vs. 7 nM for <i>trans</i>-<b>65a</b>, 8 nM for <i>cis</i>-<b>65b</b> vs. 5 nM for <i>trans</i>-<b>65b</b>, 7 nM for <i>cis</i>-<b>65c</b> vs. 3 nM for <i>trans</i>-<b>65c</b>, <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>). Contrariwise, as already observed in the 1-aryl β-carboline series, the <i>R</i> configuration (corresponding to the <i>S</i> configuration for sulfur-containing compound <b>68</b>) of carbon 5, which is the counterpart of carbon 1 in the previous series, appeared as a determinant feature for reaching maximum potency (e.g., IC<sub>50</sub> = 330 nM for <b>66</b> vs. no activity for the 5-<i>S</i> isomer, 38 nM for <b>67</b> vs. 640 nM for the 5-<i>S</i> isomer, 170 nM for <b>68</b> vs. no activity for the 5-<i>R</i> isomer).<a onclick="showRef(event, 'ref90 ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref90 ref92 ref93">(90,92,93)</a> In addition, the <i>S</i> configuration at position 11 often promoted anti-PDE5 activity (e.g., IC<sub>50</sub> = 0.33 μM for <b>66</b> vs. 1.1 μM for the 11-<i>R</i> isomer, 38 nM for <b>67</b> vs. 290 nM for the 11-<i>R</i> isomer), but with some discordant data (e.g., IC<sub>50</sub> = 0.17 μM for <b>68</b> vs. 0.47 μM for the 11-<i>S</i> isomer). As a result, 5<i>R</i>,11<i>S</i> analogues often unveiled the most promising profile for building further fine-tuned iterations. Indeed, modulation efforts at various positions while fixing the absolute configurations afforded the best IC<sub>50</sub> values among tested enantiopure derivatives (IC<sub>50</sub> = 51 nM for <b>69a</b> and 40 nM for <b>69b</b>).<a onclick="showRef(event, 'ref89 ref90 ref91 ref92 ref97'); return false;" href="javascript:void(0);" class="ref ref89 ref90 ref91 ref92 ref97">(89−92,97)</a> Regarding the influence of substituents, if the presence of a 4-methoxyphenyl moiety at position 5 was found beneficial overall (IC<sub>50</sub> = 5–8 nM for <b>65b</b>, vs. >20 nM for analogues with chloro or cyano substituents, or with alternative heterocyclic rings), variations of the hydantoin <i>N</i>-substituent did not exert a crucial impact. Indeed, ethyl, butyl, and even bulkier benzyl, cyclohexyl, and ethylpyridine groups provided single-digit nanomolar activities (IC<sub>50</sub> < 10 nM for <b>65a</b>–<b>c</b>, among other analogues). Further modulations at these two positions failed to yield derivatives with similar properties. Especially, dimethoxyphenyl, chlorophenyl, bromophenyl, and bromothiophenyl groups introduced at position 5 of various β-carboline–hydantoin stereoisomers (with various <i>N</i>-substituents, e.g., ethyl, butyl, chlorophenyl) only generated compounds with IC<sub>50</sub> > 38 nM. However, it is worth noting that the best molecules of the series were 5-(bromophenyl) derivatives (<b>67</b>, <b>69a</b>, <b>69b</b>). Replacing the hydantoin ring by an analogous 2-thioxoimidazolidin-4-one was overall detrimental, even if compound <b>70</b> eventually reached the submicromolar range (IC<sub>50</sub> = 0.56 μM). Interestingly, only one analogue with 3,4-methylenedioxyphenyl substitution at position 5 was tested.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Despite the partial reduction of their hydantoin scaffold, compounds <b>71</b> and <b>72</b> revealed a shared promising IC<sub>50</sub> of 60 nM. However, the complete reduction of the hydantoin carbonyl groups yielded a completely inactive compound.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Selected structures and IC<sub>50</sub> of β-carbolines with a fused hydantoin ring or analogue as PDE5 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec6_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> β-Carbolines with a Fused Piperazinedione Ring</h3><div class="NLM_p">The expansion of previous β-carboline–hydantoincompounds into piperazinedione analogues gave engaging results. First, the evaluation of pairs of <i>cis</i> and <i>trans</i> racemic mixtures (e.g., IC<sub>50</sub> = 5 nM vs. 140 nM for <i>cis</i>- and <i>trans</i>-<b>73b</b>, respectively, <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>) first revealed a general trend, showcasing the <i>cis</i> configuration as the most favorable.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Thus, further preliminary studies investigated the substitution of nitrogen 2 of <i>cis</i> β-carboline–piperazinedione derivatives and succeeded to identify racemic, one-digit nanomolar inhibitors of PDE5, such as <i>cis</i> versions of <b>73a</b>–<b>d</b>, a result highlighting the considerable steric tolerance at this position (IC<sub>50</sub> = 5 nM for cyclohexyl <b>73c</b> and 3 nM for benzyl <b>73d</b>). All these molecules were associated with the presence of a 3,4-methylenedioxyphenyl group at position 6, which appeared as more advantageous than the 4-methoxyphenyl alternative. Further variations at positions 2 and 6 were performed, including independent analysis of each isolated enantiomer. It seemed that the 6<i>R</i>,12a<i>R</i> configuration issued the best results overall, followed by the isomer 6<i>R</i>,12a<i>S</i> (e.g., IC<sub>50</sub> = 3 nM for <b>74</b> vs. 1200 nM for the 12a<i>S</i> isomer, 10 nM for <b>75</b> vs. 9 nM for the 12a<i>R</i> isomer).<a onclick="showRef(event, 'ref92 ref97'); return false;" href="javascript:void(0);" class="ref ref92 ref97">(92,97)</a> By contrast, a <i>S</i> configuration at position 6 caused a dramatic loss of activity in each case, with IC<sub>50</sub> above 1.0 μM. This work led to the discovery of compound <b>8</b> which is known as tadalafil (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), a drug that was marketed as a PDE5 inhibitor in 2003.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> Tadalafil presented an exquisite PDE5 vs. PDE1–4 selectivity, and a far higher selectivity vs. PDE6 than sildenafil, the molecule mainly used as medicine for PDE5 inhibition. It also had excellent pharmacokinetic properties together with a high metabolic stability, leading to a good <i>in vivo</i> activity. From a structural point of view, the cocrystallization of PDE5 with tadalafil <b>8</b> (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UDU">1UDU</a>, <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>) allowed crucial data to be retrieved about molecular interactions.<a onclick="showRef(event, 'ref99 ref100'); return false;" href="javascript:void(0);" class="ref ref99 ref100">(99,100)</a> Especially, the pyridine ring is located between Phe820 and Val782, forming a typical P clamp system and an important hydrogen bond with Gln817 side chain. In addition, the flat tetracyclic core of tadalafil is maintained through hydrophobic interactions with Ile768, Ile778, Phe786, Leu804, and Phe820. On the other hand, the 3,4-methylenedioxyphenyl moiety occupies a pocket made of Ala783, Phe786, Phe787, Leu804, Ile813, and Met816. Interestingly, when considering the structure of PDE4 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WCU">4WCU</a>),<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> the presence of the 3,4-methylenedioxyphenyl group causes a steric clash with M411, potentially explaining the PDE5/PDE4 selectivity observed (IC<sub>50</sub> = 5 nM for PDE5 vs. > 10 μM for PDE4, a beneficial ratio given the clinical safety issues raised by PDE4 inhibitors). Finally, the amido <i>N</i>-methyl group is located in a very open area, without any close residue. The possibility of introducing more complexity at this position was thus further evaluated. Overall, among the <i>R,R</i> enantiomers tested, only a few showed IC<sub>50</sub> values similar to those mentioned above.<a onclick="showRef(event, 'ref90 ref92 ref97 ref98'); return false;" href="javascript:void(0);" class="ref ref90 ref92 ref97 ref98">(90,92,97,98)</a> Other studies focused exclusively on 3,4-methylenedioxyphenyl analogues. Interestingly, the tolerance for <i>N</i>-substitution was lesser in this context, and small, aliphatic moieties were found more promising for anti-PDE5 activity than aromatic or extended groups (e.g., IC<sub>50</sub> = 16 nM for <b>76</b> vs. 5 nM for <b>8</b>).<a onclick="showRef(event, 'ref98 ref102 ref103'); return false;" href="javascript:void(0);" class="ref ref98 ref102 ref103">(98,102,103)</a> In addition, the introduction of polar groups, such as OH or NH<sub>2</sub>, was detrimental, compared to hydrophobic equivalents.<a onclick="showRef(event, 'ref104'); return false;" href="javascript:void(0);" class="ref ref104">(104)</a> Finally, 6-(3,4-methylenedioxyphenyl) compounds bearing (<i>R</i>)-pyrrolidine-type substituents at the amido position of the piperazinedione ring were developed as the most potent β-carboline-based PDE5 inhibitors to date. Indeed, these pyrrolidine moieties substituted by various aromatic groups (e.g., pyridine, benzyl, imidazole) were able to bring IC<sub>50</sub> to very low nanomolar or sub-nanomolar values (IC<sub>50</sub> = 0.8–2.0 nM for <b>77a</b>, <b>77b</b>, <b>78a</b>, and <b>78b</b>).<a onclick="showRef(event, 'ref103 ref105'); return false;" href="javascript:void(0);" class="ref ref103 ref105">(103,105)</a></div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Selected structures and IC<sub>50</sub> of β-carbolines with a fused piperazinedione ring as PDE5 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. (A) Crystal structure of <b>8</b> (in orange) bound to PDE5 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UDU">1UDU</a>). (B) Overlay of crystal structures of <b>8</b> (in orange) bound to PDE5 (in gold, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UDU">1UDU</a>) and of PDE4 (in silver, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WCU">4WCU</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i17">Glutamate Receptors Binders (NMDA, mGluR)</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45525" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45525" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Glutamate, the primary excitatory neurotransmitter present in the CNS, is implicated in several key brain functions such as learning and memory. Glutamate can bind to two families of receptors: the ionotropic glutamate receptors, mainly NMDA receptors, voltage-dependent channels permeable to Ca<sup>2+</sup> that mediate excitatory neurotransmission, and the metabotropic receptors (mGluRs) belonging to the G-protein coupled receptors family and known for their neuroprotection properties. In AD, the overactivation of NMDA receptors through excessive binding of glutamate causes a large influx of Ca<sup>2+</sup> that leads to excitotoxicity, ultimately ending in neuronal degeneration. NMDA antagonists, such as the FDA-approved drug memantine, have demonstrated their neuroprotective role by attenuating incidents of excitotoxicity and thus neuronal death, delivering an efficient symptomatic treatment for AD. The heterooligomeric NMDA receptors comprise at least two types of subunits: NR1 and NR2, the latter occurring in four distinct subtypes (NR2A–D).</div><div id="sec7_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Inhibition of NMDA Receptors</h3><div class="NLM_p">β-Carbolines were first identified as potent and selective inhibitors of the NMDA receptor NR2B through a SAR study after rigidification of the primarily identified active skeleton.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> The activity of this series on NR1/2B subtype appeared to be strongly dependent on the presence of a phenolic hydroxyl group, whether at the A- or B-ring (e.g., IC<sub>50</sub> = 50 nM for <b>79</b> vs. 3.3 μM for the naked analogue, <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>), and its position relative to the basic nitrogen atom of the piperidine ring, the three main active compounds (IC<sub>50</sub> = 50 nM for <b>79</b>, 87 nM for <b>80</b>, and 140 nM for <b>81</b>) showing similar distances between these two moieties (7.8–8.8 Å). While <i>N</i><sup>2</sup>- or <i>N</i><sup>9</sup>-monosubstituted compounds were generally inactive on NMDA, compound <b>82</b> yielded IC<sub>50</sub> values of 27–28 μM against NR1/2A and NR1/2B, whereas the <i>R</i> enantiomer showed no activity.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> Both enantiomers of the phenyl analogues, with removed methylene links, were also inactive. Indeed, the “V”-like shape of compound <b>82</b> seems to foster interactions with the receptor, as corroborated by docking experiments. The two wings of the ‘V’ are formed by the tetrahydro-β-carboline core and the benzyl group, which interact in a similar manner than memantine or dizocilpine, i.e., with hydrophobic residues Val640, Leu643, and Ala644 (NR2A) or Met641, Val644, and Ala645 (NR1). Another rigidification strategy leading to β-carbolines was initiated after the identification of hit compounds presenting a biological activity on NMDA receptor and displaying both bicyclic lactam and indole moieties.<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> The study focused on nine β-carbolines, varying over their stereochemistry, substitution pattern and lactam-ring size, but the best obtained activity (compound <b>83</b>, IC<sub>50</sub> = 30 μM) remained modest.</div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Selected structures and IC<sub>50</sub> of β-carbolines as glutamate receptors binders.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec7_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Inhibition of mGluR Receptors</h3><div class="NLM_p last">While the specific involvement of mGluRs in AD pathogenesis is imprecise, their significant role is ascertained by their implication in the modulation of MAPK, directly implicated in the disease process. mGluRs are subdivided into three groups, mGluR1 belonging to group I mGluRs. Since the early 2000s, many reports have shown the neuroprotective effects of the mGluRs modulation, whether by the use of group II mGluR agonists or by group I mGluR antagonists.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Notably, β-carbolines designed from previously identified potent and selective pyrroles were evaluated as mGluR1 antagonists.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> The SAR study highlighted three main parameters responsible for the improvement of their <i>in vitro</i> potency: (1) a H-bond acceptor and/or donor on the unsubstituted lactam ring, (2) a H-bond acceptor group at R<sup>6</sup> and (3) a bulky and lipophilic substituent on the indole ring part and more conveniently at position 6. Structures complying with these criteria exhibited the best activities, and among them <b>84</b>, <b>85</b> (IC<sub>50</sub> = 71 nM for both) and <b>86a</b> (IC<sub>50</sub> = 100 nM) were the most promising. For these compounds, <i>in vivo</i> pharmacokinetic properties were evaluated on rats, showing oral bioavailability ranging of 9–12% and a maximum exposure in plasma of 37–145 ng/mL. Nevertheless, the most balanced mGluR1 antagonist regarding both <i>in vitro</i> activity and pharmacokinetic profile is compound <b>86b</b> (IC<sub>50</sub> = 170 nM), which is in addition associated with a suitable level of brain penetration.</div></div></div><div id="sec8" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">γ-Aminobutyric Acid Receptors (GABA<sub>A</sub>) Ligands</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47438" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47438" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">While cholinergic and glutamatergic dysfunctions are well-known to be disrupted in AD, the increase or decrease GABA levels in AD patient brains has long been discussed. However, despite some initial controversy, the primary inhibitory neurotransmitter GABA, involved in the maintenance of the excitatory/inhibitory balance in the brain, is undoubtedly implicated in AD pathology.<a onclick="showRef(event, 'ref111 ref112 ref113'); return false;" href="javascript:void(0);" class="ref ref111 ref112 ref113">(111−113)</a> Indeed, cognitive deficits were related to the dysfunction of presynaptic GABA that acts on GABA<sub>A</sub> receptors, widely located in the CNS. The increased GABAergic neurotransmission could be circumvented with an agonism at GABA<sub>A</sub> receptors, thus preventing the neuronal death and the formation of β-amyloid fibrils.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a></div><div id="sec8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Affinity of β-Carbolines and Influence of the R<sup>3</sup> and R<sup>4</sup> Substituents on Efficacy</h3><div class="NLM_p">The affinity of β-carbolines for the benzodiazepine binding site of GABA<sub>A</sub> receptor was initially discovered in the early 1980s. Even elementary β-carbolines with very low substitution levels achieved to fairly interact with GABA<sub>A</sub> receptor in a ubiquitously used [<sup>3</sup>H]ligand binding inhibition test (usually classical benzodiazepines were employed, such as diazepam, flunitrazepam or flumanezil). This is especially the case with norharmane <b>9a</b> and harmane <b>9b</b> (IC<sub>50</sub> = 1.6–8.2 μM and 7.2–25 μM, respectively, <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>), while further substitutions and partial or complete saturation of the pyridine ring led to an activity drop (e.g., IC<sub>50</sub> > 100 μM for <b>1</b>–<b>3</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>).<a onclick="showRef(event, 'ref115 ref116 ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref115 ref116 ref117 ref118">(115−118)</a> In contrast, the introduction of an ester group at position 3 produced compounds with far better affinities, in the nanomolar range. β-CCM <b>87b</b>, β-CCE <b>87c</b> together with higher homologues <b>87d</b> and <b>87e</b> thus shared similar IC<sub>50</sub> values of 1–10 nM, and seemingly constitute the optimal steric hindrance window, as both the carboxylic acid <b>87a</b> and the CH<sub>2</sub><i>t</i>-Bu <b>87f</b> analogues were less active (IC<sub>50</sub> = 31–33 μM and 0.75 μM, respectively, <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>).<a onclick="showRef(event, 'ref115 ref117 ref119 ref120 ref121 ref122 ref123 ref124 ref125'); return false;" href="javascript:void(0);" class="ref ref115 ref117 ref119 ref120 ref121 ref122 ref123 ref124 ref125">(115,117,119−125)</a> Interestingly, concomitant substitution of the positions 5 or 6 did not appear to be detrimental in this context, and several derivatives bearing various groups, such as OH, O<i>i</i>-Pr, NHBn or OBn, managed to retain the same level of affinity (e.g., IC<sub>50</sub> = 4 nM for <b>88a</b>, 10 nM for <b>88b</b>, vs. 1–19 nM for <b>87b</b>).<a onclick="showRef(event, 'ref124 ref126 ref127'); return false;" href="javascript:void(0);" class="ref ref124 ref126 ref127">(124,126,127)</a> Similarly, when introducing a methoxymethyl substituent at position 3, the affinity values remained in the low nanomolar (e.g., IC<sub>50</sub> < 10 nM for <b>89a</b>, <b>89d</b>, ZK-93423 <b>89e</b>, and abecarnil <b>90</b>) or subnanomolar ranges (e.g., IC<sub>50</sub> = 0.9 nM for <b>89b</b>, 0.5–1 nM for <b>89c</b>, 0.2–2 nM for <b>91</b>),<a onclick="showRef(event, 'ref127 ref128 ref129 ref130'); return false;" href="javascript:void(0);" class="ref ref127 ref128 ref129 ref130">(127−130)</a> even if the best values were yielded by 3-methyl analogue <b>92</b> (IC<sub>50</sub> = 0.4–0.7 nM).<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> However, the presence of a substituent at position 9 dramatically compromised the affinity for GABA<sub>A</sub> receptor (IC<sub>50</sub> > 0.29 μM for 9-methyl counterparts of <b>87b</b>, <b>89d</b>, and <b>89e</b>; > 5.0 μM for other derivatives).<a onclick="showRef(event, 'ref115 ref117 ref127 ref128'); return false;" href="javascript:void(0);" class="ref ref115 ref117 ref127 ref128">(115,117,127,128)</a> A few other chemical groups led to similar affinity upon further pharmacomodulation at position 3. Among them, the propyl ketone <b>87g</b>, nitrile <b>87h</b>, isothiocyanate <b>87i</b> and propoxy <b>87j</b> yielded the best results (IC<sub>50</sub> < 11 nM).<a onclick="showRef(event, 'ref117 ref118 ref119 ref120'); return false;" href="javascript:void(0);" class="ref ref117 ref118 ref119 ref120">(117−120)</a> Reduced versions of β-CCM <b>87b</b> and β-CCE <b>87c</b> showed far weaker activities (IC<sub>50</sub> = 6.0 μM).<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> In addition, the early discovery of β-carboline-based agonists and antagonists prompted research groups to establish enlightening structure-efficacy relationships. One striking feature was the shift of the β-carboline 3-esters efficacy along an inverse agonist–agonist continuum, as the carbon chain of the ester became bulkier (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>). Indeed, <b>87b</b> and <b>87c</b> behave as inverse agonists, <b>87d</b> and <b>87e</b> as antagonists and higher homologues showed anticonvulsant effects against leptazol-induced seizures, consistent with an agonist action.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a> Several other derivatives with more intrinsic efficacy were identified that fell into one or the other of these categories. Thus, compound <b>89e</b> appeared as a full agonist of GABA<sub>A</sub> receptor, whereas <b>91</b> was identified as a partial agonist, and <b>87h</b>, <b>87j</b>, or <b>92</b> were acknowledged to be antagonists. In the other hand, very close analogues were seen as inverse agonists, such as <b>87g</b> or less active3-methoxy and 3-ethoxy derivatives.<a onclick="showRef(event, 'ref120 ref121 ref122 ref123 ref124 ref125 ref126 ref127 ref128 ref129 ref130 ref131 ref132 ref133 ref134'); return false;" href="javascript:void(0);" class="ref ref120 ref121 ref122 ref123 ref124 ref125 ref126 ref127 ref128 ref129 ref130 ref131 ref132 ref133 ref134">(120−134)</a> While lacking an apparent rationale, this variability in terms of efficacy should derive from changes in molecular interactions, whose complete understanding is scrambled by the absence of accurate structural data and by the diversity of GABA<sub>A</sub> receptor subtypes.</div><figure id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Selected structures and IC<sub>50</sub> of 3- and 4-substituted β-carbolines as GABA<sub>A</sub> ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. GABA<sub>A</sub> efficacy continuum of β-carbolines 3-esters as a function of the ester chain length.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec8_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Receptor Subtypes Selectivity and Additional Combinations of Substituents</h3><div class="NLM_p">The GABA<sub>A</sub> receptor complex displays high molecular diversity and is made from a combination of various subunits. At least 15 different subunits have been identified and could explain the diversity of pharmacological effects observed in the presence of ligands.<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> In an initial pharmacophoric model, two hydrogen bond donating sites were suggested, termed H<sub>1</sub> and H<sub>2</sub>. Especially, H<sub>2</sub> was thought to correspond to the position 4 of β-carbolines, where the presence of an oxygen atom appeared as beneficial. In addition, the occupation of a lipophilic area at this site seemed to contribute to an agonist activity, as testified by 4-methoxymethyl derivatives <b>89e</b> and <b>91</b>. The evaluation of β-carbolines against specific receptor subtypes was a step further toward rationalization at the molecular level. The affinities of some of the best β-carbolines discovered previously for GABA<sub>A</sub> receptor subtypes α<sub>1</sub>β<sub>3</sub>γ<sub>2</sub>, α<sub>2</sub>β<sub>3</sub>γ<sub>2</sub>, α<sub>3</sub>β<sub>3</sub>γ<sub>2</sub>, α<sub>4</sub>β<sub>3</sub>γ<sub>2</sub>, α<sub>5</sub>β<sub>3</sub>γ<sub>2</sub>, and α<sub>6</sub>β<sub>3</sub>γ<sub>2</sub> (shortened respectively as α<sub>1</sub>, α<sub>2</sub>, α<sub>3</sub>, α<sub>4</sub>, α<sub>5</sub>, and α<sub>6</sub> subtypes) were thus assessed. First, all β-carbolines were found far less active against the subtypes α<sub>4</sub> and α<sub>6</sub> (<i>K</i><sub>i</sub> > 1.0 μM in almost all cases), while the remaining four subtypes afforded very low nanomolar <i>K</i><sub>i</sub> values (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Interestingly, if globally compounds devoid of 4-substitution showed some selectivity for α<sub>1</sub> (e.g., <b>87b</b>, <b>87e</b>, <b>87g</b>, <b>87j</b>, <b>88b</b>), 4-methoxymethyl analogues did not discriminate between α<sub>1</sub>, α<sub>2</sub>, α<sub>3</sub>, and α<sub>5</sub> subtypes (e.g., <b>89a</b>, <b>89d</b>, <b>89e</b>, <b>90</b>).<a onclick="showRef(event, 'ref128 ref135 ref136 ref137 ref138 ref139'); return false;" href="javascript:void(0);" class="ref ref128 ref135 ref136 ref137 ref138 ref139">(128,135−139)</a> The residue His105, which is present in subunits α<sub>1</sub>,α<sub>2</sub>, α<sub>3</sub>, and α<sub>5</sub>, and replaced by an arginine in α<sub>4</sub> and α<sub>6</sub>, was proposed to play a central role in this selectivity. Indeed, the affinity values of compounds <b>87b</b>, <b>87c</b>, and <b>90</b> for subtype α<sub>5</sub> dropped significantly upon mutation of His105 into Arg105 (<i>K</i><sub>i</sub> = 4.4 μM, 1.9 μM, and 6.2 μM respectively, vs. 44–68 nM, 27–110 nM, and 5–8 nM respectively for the wild type).<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> Further works were undertaken for exploring the selectivity profile of β-carbolines, especially by combining a favorable 3-substituent with diverse groups at positions 6 and 7. Hence, the production of 6,7-dimethoxy analogues afforded surprising pan-subtype inhibitors <b>93a</b> and <b>93b</b>, which are quite unique in their ability to bind efficiently to α<sub>6</sub> (<i>K</i><sub>i</sub> = 130 nM and 75 nM respectively, <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig18" id="" class=" internalNav">18</a></a>).<a onclick="showRef(event, 'ref128 ref135'); return false;" href="javascript:void(0);" class="ref ref128 ref135">(128,135)</a> Introducing other substituents at these positions, such as nitro, isothiocyanate, or ethynyl, provided additional compounds of interest (e.g., <b>94</b>, <b>95</b>, <b>96</b>), but with a more classical selectivity profile, except for <b>96</b>. The derivatization at position 6 using aryl or heteroaryl moieties, including phenyl, naphthyl, furyl, and thiophenyl mostly failed to significantly improve both affinity and selectivity, while a phenyl ester group at position 3 was associated with enhanced α<sub>1</sub> selectivity (e.g., for <b>97</b>, IC<sub>50</sub> = 34 nM against α<sub>1</sub> vs. > 1.0 μM against α<sub>2–6</sub>).<a onclick="showRef(event, 'ref135 ref138'); return false;" href="javascript:void(0);" class="ref ref135 ref138">(135,138)</a> Finally, derivative <b>98</b> was the only reported example of an active <i>N</i><sup><i>2</i></sup>-substituted β-carboline, revealing especially a good affinity for α<sub>1</sub> and α<sub>2</sub> subtypes (<i>K</i><sub>i</sub> = 7 nM and 12 nM respectively).<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a></div><figure id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Selected structures of second-generation β-carbolines as GABA<sub>A</sub> ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. <i>K</i><sub>i</sub> Values Obtained for β-Carbolines Against a Panel of GABA<sub>A</sub> Subtypes</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Cd</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> α<sub>1</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> α<sub>2</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> α<sub>3</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> α<sub>4</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> α<sub>5</sub> (nM)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>i</sub> α<sub>6</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>87b</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">7</td><td class="colsep0 rowsep0" align="left">72</td><td class="colsep0 rowsep0" align="left">1000–1300</td><td class="colsep0 rowsep0" align="left">44–68</td><td class="colsep0 rowsep0" align="left">4400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>87c</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">1000</td><td class="colsep0 rowsep0" align="left">27–110</td><td class="colsep0 rowsep0" align="left">2700–3100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>87e</b></td><td class="colsep0 rowsep0" align="left">0.7</td><td class="colsep0 rowsep0" align="left">15</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">1000–3000</td><td class="colsep0 rowsep0" align="left">110</td><td class="colsep0 rowsep0" align="left">>5000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>87g</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1000</td><td class="colsep0 rowsep0" align="left">>3000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>87j</b></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">52</td><td class="colsep0 rowsep0" align="left">69</td><td class="colsep0 rowsep0" align="left">1000</td><td class="colsep0 rowsep0" align="left">590</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>88b</b></td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">49</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">480</td><td class="colsep0 rowsep0" align="left">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>89a</b></td><td class="colsep0 rowsep0" align="left">0.6</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">1200</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>89b</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">3000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>89c</b></td><td class="colsep0 rowsep0" align="left">0.1</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">480</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>89d</b></td><td class="colsep0 rowsep0" align="left">0.5</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">1300</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>89e</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>90</b></td><td class="colsep0 rowsep0" align="left">1–12</td><td class="colsep0 rowsep0" align="left">2–15</td><td class="colsep0 rowsep0" align="left">4–8</td><td class="colsep0 rowsep0" align="left">1200–2000</td><td class="colsep0 rowsep0" align="left">5–8</td><td class="colsep0 rowsep0" align="left">6400–10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>93a</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">130</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>93b</b></td><td class="colsep0 rowsep0" align="left">6</td><td class="colsep0 rowsep0" align="left">19</td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">75</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>96</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">110</td><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">2000</td><td class="colsep0 rowsep0" align="left">210</td><td class="colsep0 rowsep0" align="left">2000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>97</b></td><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left">1000</td><td class="colsep0 rowsep0" align="left">1000</td><td class="colsep0 rowsep0" align="left">1000</td><td class="colsep0 rowsep0" align="left">1000</td><td class="colsep0 rowsep0" align="left">3000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>99a</b></td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">40</td><td class="colsep0 rowsep0" align="left">>1000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>99b</b></td><td class="colsep0 rowsep0" align="left">4</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">210</td><td class="colsep0 rowsep0" align="left">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>99c</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">11</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">230</td><td class="colsep0 rowsep0" align="left">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>101</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">12</td><td class="colsep0 rowsep0" align="left">16</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">200</td><td class="colsep0 rowsep0" align="left">>10000</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>102</b></td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="left">24</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">240</td><td class="colsep0 rowsep0" align="left">>10000</td></tr></tbody></table></div></div></div><div id="sec8_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Pyridodiindoles and Other Fused Ring Systems</h3><div class="NLM_p">Beyond the introduction of simple substituents in the β-carboline scaffold, derivatives including additional fused rings were developed. Especially, pyridodiindoles were conceived as a very rigid and planar platform made of five fused aromatic rings, based on a β-carboline core. Interestingly, the naked pyridodiindole <b>99a</b> was found as the most active representative of this new class of GABA<sub>A</sub> ligand (IC<sub>50</sub> = 4 nM), while appending various substituents consistently led to weaker activity records (<a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig19" id="" class=" internalNav">19</a></a>).<a onclick="showRef(event, 'ref118 ref119 ref141'); return false;" href="javascript:void(0);" class="ref ref118 ref119 ref141">(118,119,141)</a> However, if the introduction of 2′- and 3′-substituents was really prejudicial, similar substitutions at positions 4′ and 5′ afforded compounds with some retained affinity, as illustrated by the chloro analogues (IC<sub>50</sub> = 10 nM and 80 nM for <b>99b</b> and the 5′-chloro analogue of <b>99a</b>, respectively, vs. 0.72 μM and 2.2 μM for 2′- and 3′-chloro analogues of <b>99a</b>, respectively). In particular, at position 4′ there seems to be some room for a substituent, regardless of its chemical nature (halogens of various sizes, methoxy, hydroxy, with IC<sub>50</sub> < 0.019 μM for <b>99b</b> and <b>99c</b>) but with limitations in terms of steric hindrance (IC<sub>50</sub> > 4.0 μM for the benzyl analogue <b>99d</b>). As previously observed with simple β-carbolines, the substitution of the <i>N</i><sup>9</sup> with a methyl group led to a substantially decreased activity, while functionalization of the position 6 gave valuable compounds. Especially, by adding nitro or bromo groups, IC<sub>50</sub> values were obtained that remained similar to the naked parent <b>99a</b> (IC<sub>50</sub> = 4 nM for <b>100a</b> and 6 nM for <b>100b</b>). Finally, when exploring the impact of substituting the indole NH position and position 1 of the β-carboline, detrimental effects were seen in each case. A closer look to the subtype-related potency distribution showed selectivity profiles very similar to those observed with simpler β-carbolines (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>).<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> However, the affinity for subtype α<sub>5</sub> was significantly lower in all cases (e.g., <i>K</i><sub>i</sub> = 40 nM against α<sub>5</sub> vs. 1 nM against α<sub>1–3</sub> for <b>99a</b>; <i>K</i><sub>i</sub> = 230 nM against α<sub>5</sub> vs. < 12 nM against α<sub>1–3</sub> for <b>99d</b>). The insertion of an extra intracyclic nitrogen atom at the indole part of <b>99a</b> induced a loss of activity, irrespectively of its position.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> If compounds <b>101</b> and <b>102</b> managed to keep a similar activity range against α<sub>1</sub>, their action against the other subtypes dropped significantly. Other nitrogen positions afforded even less potent compounds against all subtypes. Conversely, the conversion of the β-carboline core into the carbazole counterpart by replacing the nitrogen atom at position 2 by a CH moiety strongly weakened the activity (IC<sub>50</sub> = 1.9–2.0 μM vs. 4 nM for <b>99a</b>), highlighting the crucial importance of the carboline skeleton.<a onclick="showRef(event, 'ref118 ref119'); return false;" href="javascript:void(0);" class="ref ref118 ref119">(118,119)</a> Finally, other classes of heterocyclic-fused β-carbolines were developed, i.e., oxazolo[4,5-<i>g</i>]-β-carbolines and pyrazino[2,3-<i>g</i>]-β-carbolines.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> These molecules, incorporating a classical 4-methoxymethyl group, were found highly potent, hitting the subnanomolar range (IC<sub>50</sub> = 0.8–0.9 nM for <b>103</b>–<b>106</b>) regardless of the structural features embedded (isopropyl ester group or isoxazole ring at position 3, oxazolo or pyrazino groups at positions 5 and 6).</div><figure id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0019.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Selected structures and IC<sub>50</sub> (or <i>K</i><sub>i</sub> where indicated) of fused β-carboline-based aromatic derivatives as GABA<sub>A</sub> ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec9" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">5-Hydroxytryptamine (5-HT) Receptors Binders</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78267" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78267" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The implications of the serotonergic system, and therefore its neurotransmitter 5-HT, in Alzheimer’s disease are diverse and complex, especially due to multiple interactions with other neurotransmitters such as acetylcholine, glutamate, or GABA. Serotonin is a monoamine neurotransmitter acting on 14 pre- and postsynaptic subtypes of receptors divided in seven families (5-HT<sub>1</sub> to 5-HT<sub>7</sub>) and mainly located in brain areas involved in particular in learning and memory. Among them, subtypes 1, 3, 4, 6, and 7 are of particular interest in the AD context. 5-HT<sub>4</sub> and 5-HT<sub>7</sub> receptor agonists as well as 5-HT<sub>1</sub>, 5-HT<sub>3</sub>, and 5-HT<sub>6</sub> antagonists have shown pro-cognitive effects in animal studies or clinical trials.<a onclick="showRef(event, 'ref114 ref142 ref143'); return false;" href="javascript:void(0);" class="ref ref114 ref142 ref143">(114,142,143)</a></div><div id="sec9_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Tetrahydro-β-carbolines and R<sup>1</sup>/R<sup>9</sup> Substituents Exploration</h3><div class="NLM_p">If tetrahydro-β-carbolines of classical structures, such as <b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), showed only weak activities against 5-HT receptors, improvements were observed upon methoxy or bromo position shifts (e.g., <i>K</i><sub>i</sub> < 0.18 μM for <b>107a</b> and <b>107b</b> against 5-HT<sub>2A</sub> and 5-HT<sub>2C</sub> vs. >10 μM for <b>3</b>).<a onclick="showRef(event, 'ref144 ref145 ref146 ref147'); return false;" href="javascript:void(0);" class="ref ref144 ref145 ref146 ref147">(144−147)</a> Especially, 8-bromo-tetrahydro-β-carboline provided the only inhibition constants below 100 nM, against 5-HT<sub>2A</sub> and 5-HT<sub>2C</sub>, while the 6- and 7-methoxy derivatives, mostly inactive against subtypes 1A, 2A, and 2C, showed interesting levels of activity against 5-HT<sub>2B</sub> (<i>K</i><sub>i</sub> > 1.0 μM vs. 0.16 μM and 0.39 μM, respectively). The 1-methyl-8-methoxy tetrahydro-β-carboline reached a <i>K</i><sub>i</sub> value of 0.45 μM against 5-HT<sub>1A</sub>, while all other tested molecules remained at the micromolar range. Hence, some selectivity was clearly observed upon substituent modifications, allowing the tetrahydro-β-carbolines to preferentially inhibit either subtypes 1A, 2A, 2B, or 2C, depending of the position and nature of the chemical groups introduced. In addition, the introduction of benzyl groups at position 1 led to 5-HT<sub>2B</sub> inhibitors with far better affinities, sometimes in the low subnanomolar range. Especially, 3′,4′-dimethoxy derivatives <b>108a</b>–<b>108d</b>, <b>109</b>, <b>110a</b>–<b>b</b>, and <b>111a</b>–<b>b</b> were found to inhibit 5-HT<sub>2B</sub> with <i>K</i><sub>B</sub> values below 0.3 nM, while concomitantly targeting the 2A and 2C subtypes, with a weaker potency however.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> The best value was recovered from <b>112</b>, which exhibited a <i>K</i><sub>B</sub> of 80 pM, and a good selectivity for 5-HT<sub>2B</sub> vs. 5-HT<sub>2A</sub> and 5-HT<sub>2C</sub> (∼100-fold). Interestingly, the substitution pattern of the β-carboline core affected only marginally the 5-HT<sub>2B</sub> inhibition activities observed, considering either the position (e.g., <i>K</i><sub>B</sub> = 80–500 pM for the various methyl derivatives <b>108a</b>, <b>109</b>, <b>110a</b> and <b>112</b>) or the nature (e.g., <i>K</i><sub>B</sub> = 100–700 pM for 6-substituted compounds <b>108a</b>–<b>d</b>) of the substituents. Contrariwise, the length of the methylene linker appeared as a crucial feature, as both the lower and the higher homologues led to significantly reduced action. Shifting the 3′,4′-dimethoxybenzyl group to position 2 was also unsuccessful. However, the introduction of naphthyl moieties in place of the 3′,4′-dimethoxyphenyl part of the molecule afforded results in a similar range of affinity (<i>K</i><sub>B</sub> = 400 pM for <b>113</b>). The natural indoloquinolizidine yohimbine (<b>5</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which was found as a potent ligand of 5-HT receptors (<i>K</i><sub>i</sub> = 25–160 nM against 1A, 1B and 1D subtypes, > 1.0 μM against 2A and 2C), confirmed the steric tolerance and activity potential of bulky groups at positions 1 and 2 of the scaffold.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> Finally, the substitution of both nitrogen atoms of the tetrahydro-β-carboline scaffold resulted to nanomolar inhibition values, with a modest 1A over 2A selectivity. Methoxyphenyl groups linked by various alkylpiperazyl chains at position 9, together with ketones introduced at position 2, led to <i>K</i><sub>i</sub> values of 20–59 nM against 5-HT<sub>1A</sub> (a more relevant subtype in the AD context) and 44–340 nM against 5-HT<sub>2A</sub>, with a very little influence of the structure variations (e.g., <i>K</i><sub>i</sub> = 20 nM and 44 nM for <b>114</b> against 1A and 2A subtypes, respectively).<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a><named-content content-type="anchor" rid="fig20" type="simple"></named-content></div><figure id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0020.jpeg" id="gr20" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Selected structures and <i>K</i><sub>i</sub> of tetrahydro-β-carbolines as ligands of various subtypes of 5-HT receptors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec9_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Dihydro- and Fully Aromatic Derivatives</h3><div class="NLM_p">On the other hand, when considering the 3,4-dihydro counterparts of the reduced β-carbolines, various effects were observed. The insertion of the double bond led either to a significant improvement of the potency (e.g., <i>K</i><sub>i</sub> = 0.92 μM vs. > 10 μM against 5-HT<sub>2C</sub> for <b>115a</b> and its tetrahydro analogue, respectively, <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig21" id="" class=" internalNav">21</a></a>), to a mere conservation of the efficiency, or to an activity drop (e.g., <i>K</i><sub>i</sub> = 0.13 μM vs. 0.47 μM against 5-HT<sub>2A</sub> for <b>107a</b> and its oxidized version, respectively).<a onclick="showRef(event, 'ref144 ref145 ref146'); return false;" href="javascript:void(0);" class="ref ref144 ref145 ref146">(144−146)</a> However, compounds <b>116a</b> and <b>116b</b> were the only to reach inhibition values below 100 nM (<i>K</i><sub>i</sub> = 69 nM and 75 nM against 5-HT<sub>2C</sub>, respectively). A more systematic exploration of 5-HT receptor subtypes provided additional data for representative dihydro-β-carbolines <b>2</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), <b>115a</b>, and <b>115b</b> (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).<a onclick="showRef(event, 'ref146 ref147'); return false;" href="javascript:void(0);" class="ref ref146 ref147">(146,147)</a> Similar selectivity profiles were seen for both compounds, targeting preferentially subtypes 2B and 7, and to a lesser extent 1A, 2A, 2C, and 6. Compound <b>115b</b> showed in addition a good potency against 5-HT<sub>5A</sub> (<i>K</i><sub>i</sub> = 0.85 μM). Further oxidation of the β-carboline pyridine ring afforded completely unsaturated analogues. Once again, the insertion of an additional double bond yielded mixed results: if some derivatives were definitely more active against 5-HT<sub>2A</sub> (e.g., <i>K</i><sub>i</sub> = 0.15–0.40 μM for <b>1</b> and <b>9b</b>, vs. 0.99–7.8 μM for <b>2</b> and <b>115b</b>), some others were less potent than their dihydro parent (e.g., <i>K</i><sub>i</sub> = 4.2–5.6 μM for <b>115a</b> vs. > 10 μM for the fully aromatic analogue).<a onclick="showRef(event, 'ref144 ref145 ref151'); return false;" href="javascript:void(0);" class="ref ref144 ref145 ref151">(144,145,151)</a> There were less variations when considering the 1A and 2C subtypes however. Unlike the tetrahydro-β-carboline series, the activity of fully aromatic analogues against 5-HT<sub>2B</sub> was hardly the best among 5-HT subtypes, often exceeded by the anti-5-HT<sub>2A</sub> potency (e.g., 1.4 μM vs. 0.69 μM for <b>117</b> and 1.5 μM vs. 0.56 μM for <b>118</b>). The introduction of heteroaromatic groups at position 1 partially restored a selectivity profile reminiscent of the tetrahydro-β-carbolines, with moderate activities however.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Among the evaluated scaffolds, the indole afforded the best results, with for example compounds <b>119a</b> (<i>K</i><sub>i</sub> = 0.25–0.90 μM against 5-HT<sub>2A-C</sub>), <b>119b</b> (<i>K</i><sub>i</sub> = 0.17–0.20 μM against 5-HT<sub>2B–C</sub>), and <b>120</b> (<i>K</i><sub>i</sub> = 0.10–0.81 μM against 5-HT<sub>2A-C</sub>). However, these molecules were not tested against more AD-relevant 5-HT receptor subtypes.</div><figure id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0021.jpeg" id="gr21" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Selected structures and <i>K</i><sub>i</sub> of dihydro- and fully aromatic β-carbolines as ligands of 5-HT receptors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. <i>K</i><sub>i</sub> Values Obtained for β-Carbolines Against a Panel of 5-HT Receptor Subtypes</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Cd</th><th class="colsep0 rowsep0" align="center">1A<i>K</i><sub>i</sub> (μM)</th><th class="colsep0 rowsep0" align="center">1B<i>K</i><sub>i</sub> (μM)</th><th class="colsep0 rowsep0" align="center">1D<i>K</i><sub>i</sub> (μM)</th><th class="colsep0 rowsep0" align="center">2A<i>K</i><sub>i</sub> (μM)</th><th class="colsep0 rowsep0" align="center">2C<i>K</i><sub>i</sub> (μM)</th><th class="colsep0 rowsep0" align="center">3<i>K</i><sub>i</sub> (μM)</th><th class="colsep0 rowsep0" align="center">5A<i>K</i><sub>i</sub> (μM)</th><th class="colsep0 rowsep0" align="center">6<i>K</i><sub>i</sub> (μM)</th><th class="colsep0 rowsep0" align="center">7<i>K</i><sub>i</sub> (μM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">5.0–7.8</td><td class="colsep0 rowsep0" align="left">9.4</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">5.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>115a</b></td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">4.2–5.6</td><td class="colsep0 rowsep0" align="left">0.92</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>115b</b></td><td class="colsep0 rowsep0" align="left">1.7–3.4</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">0.99–1.2</td><td class="colsep0 rowsep0" align="left">1.9</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">0.85</td><td class="colsep0 rowsep0" align="left">1.5</td><td class="colsep0 rowsep0" align="left">0.28</td></tr></tbody></table></div></div></div></div><div id="sec10" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i29">Histone Deacetylase (HDAC) Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_64440" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_64440" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Epigenetic regulation of gene expression via histone modification is a recent field explored in the understanding of AD. HDAC and histone acetyltransferases play an important role in the acetylation balance of histone for which abnormalities were observed in the pathology of AD. If the targeting of HDAC was clearly associated with neuroprotective properties in AD models, their action and the precise role of each isozyme are still unknown. Nevertheless, it is now largely accepted that HDAC inhibitors may impact proteins involved in AD, such as Aβ, GSK-3β, or tau. To date, several approaches aim at developing pan-HDAC inhibitors, but with expected collateral effects, as some isozymes play important and diverse neurologic functions. On the other hand, class I HDACs and HDAC6 (class IIb) have notably been proposed as targets of interest for AD treatments.<a onclick="showRef(event, 'ref152 ref153'); return false;" href="javascript:void(0);" class="ref ref152 ref153">(152,153)</a> As a consequence, literature around β-carboline HDAC inhibitors is still piecemeal. However, the presence of a zinc-chelating hydroxamic acid unit, reminiscently of the structure of SAHA (suberanilohydroxamic acid, or vorinostat, a drug marketed as antineoplastic agent through HDAC inhibition), is a feature shared by all reported β-carboline-based inhibitors. First, introducing the hydroxamic acid function at position 3 of the β-carboline scaffold provided a range of inhibitors.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Exploring the chain length of amido-linked derivatives showed that longer arms were favorable, especially when three methylene carbons or more are present (IC<sub>50</sub> = 1.4–1.8 μM for <b>121c</b>–<b>e</b> vs. > 3.2 μM for <b>121a</b> and <b>121b</b>, <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig22" id="" class=" internalNav">22</a></a>). Thus, several analogous linear derivatives were tested, with amido or urea links, and led to sub-micromolar potency (e.g., IC<sub>50</sub> = 270 nM for <b>122</b>).<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Considering individual HDAC isozymes, these molecules were found more active against HDAC1 and HDAC6 than against HDAC8, but with a small gap (e.g., IC<sub>50</sub> = 26 nM against HDAC1 and 34 nM against HDAC6 vs. 160 nM against HDAC8, for <b>122</b>). Again, compounds bearing shorter carbon chains showed less potential. The introduction of an aromatic link between the hydroxamic acid group and the β-carboline scaffold provided analogues with improved action on HDAC1 (e.g., IC<sub>50</sub> = 9.3 nM for <b>123a</b> vs. 26 nM for <b>122</b>). The modulation of position 1 produced even better activities, reaching the single-digit nanomolar and subnanomolar ranges against HDAC1, HDAC3, and HDAC6, while exerting low action on HDAC8 (e.g., for <b>123b</b>, IC<sub>50</sub> = 4.7 nM against HDAC1, 0.4 nM against HDAC3 and 0.9 nM against HDAC6 vs. 880 nM against HDAC8, a 200–2000-fold difference). The insertion of a <i>N</i>-substituted amido linker provided various results against nuclear HeLa HDACs, the presence of a 1-(4-methoxy)phenyl group being more favorable than the 1-methyl and unsubstituted counterparts (e.g., IC<sub>50</sub> = 960 nM for <b>124a</b> and340 nM for <b>124b</b>).<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> The <i>N</i>-substituent was further explored and the presence of terminal amino groups yielded the best inhibition values (IC<sub>50</sub> = 92 nM for <b>124d</b> and 120 nM for <b>124e</b>).<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> It is worth noting that the evaluation of compound <b>124c</b> against a series of HDAC isozymes confirmed the potency of these compounds against HDAC1 and HDAC6 (IC<sub>50</sub> = 4.1 nM and 2.6 nM respectively) and their inactivity against HDAC8 (IC<sub>50</sub> > 1.0 μM), but this time also against HDAC2 and HDAC4 (IC<sub>50</sub> > 1.0 μM). Alternatively, β-carbolines bearing the hydroxamic acid moiety at position 9 were investigated. A similar trend was observed regarding the potency of aromatic vs. aliphatic links (e.g., IC<sub>50</sub> = 1.4 nM for <b>125a</b> against HDAC6 vs. 550 nM for the analogue bearing a (CH<sub>2</sub>)<sub>5</sub> linker), but the most striking feature was the vastly improved HDAC6 vs. HDAC1 selectivity (e.g., for <b>125b</b>, IC<sub>50</sub> = 2.5 nM against HDAC6 vs. 9700 nM against HDAC1; for <b>125c</b>, IC<sub>50</sub> = 0.9 nM against HDAC6 vs. 4300 nM against HDAC1, an almost 5000-fold gap), which was inexistent with 3-substituted analogues.<a onclick="showRef(event, 'ref158 ref159'); return false;" href="javascript:void(0);" class="ref ref158 ref159">(158,159)</a> Tetracyclic derivatives shared a similar profile, with sometimes anti-HDAC6 inhibition values at the sub-nanomolar range (e.g., IC<sub>50</sub> = 0.9 nM for <b>126</b> and <i>K</i><sub>i</sub> = 0.7 nM for <b>127</b>), and overall conserved potency no matter the scaffold structure.<a onclick="showRef(event, 'ref160 ref161'); return false;" href="javascript:void(0);" class="ref ref160 ref161">(160,161)</a> This series was explored further and revealed fairly selective inhibition of HDAC6 among HDAC1, HDAC2, HDAC4, HDAC8, and HDAC10. Finally, indoloquinolizidine-based compounds showed a broader inhibition spectrum of HDACs, as <b>128</b> for example exhibited similar values for HDAC1, HDAC3 and HDAC6 (IC<sub>50</sub> = 24 nM, 71 nM, and 13 nM respectively).<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> Compound <b>130</b> was the only representative of a 2-substituted β-carboline–hydroxamic acid hybrid, with an interesting potency against HeLa HDACs (IC<sub>50</sub> = 44 nM).<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a></div><figure id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0022.jpeg" id="gr22" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Selected structures and IC<sub>50</sub> (or <i>K</i><sub>i</sub> where indicated) of β-carbolines as inhibitors of HDAC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">β-Carboline-Based Multitarget Strategies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55155" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55155" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As previously mentioned, due to the insufficient knowledge of the etiology of AD and its multifactorial nature, a change in the therapeutic paradigm appeared to be essential: the unsuccessful “one drug-one target” strategy is now increasingly overtaken by the design of MTDL. Indeed, positive results (additive or synergistic, i.e., even better than those obtained for each ligand separately) can be expected by simultaneously interacting on different targets known to be intricated in the complex network of several pathological AD-related events. The MTDL strategy is an alternative to the most classical multiple target approach that relies on the combination of at least two known drugs and can suffer many drawbacks. The attractive MTDL strategy can involve the hybridization of several pharmacophoric moieties, active on different targets, or the design of a molecule able to interact with multiple targets;<a onclick="showRef(event, 'ref7 ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref8 ref9">(7−9)</a> several natural products with these properties have notably been described and could benefit from further investigations in the frame of innovative anti-AD drug development. In this part, we will only focus on the first approach in which a deliberated chemical design is required. The second one, driven by multiple biological tests on isolated or synthesized molecules to specify their bioactive scope, has already been reviewed independently in the previous target-by-target parts. While the identity of the targets addressed in the MTDL strategies unsurprisingly matches those described above, the target pairs selection for undertaking a <i>de novo</i> design can represent a critical step of the process. In order to interfere at the initial phase of the disease, to slow down its evolution, or to optimally reverse AD progression, acting on the synaptic or neuronal loss would be helpful. In particular, the cholinergic neurons loss in AD patients is massive (almost 80%)<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> and lots of MTDL appropriately embed a scaffold targeting the cholinergic system. Furthermore, the preferred strategies were set up to interfere with both a symptomatic target (mainly receptors) and a disease-modifying target (such as Aβ, tau or neuroprotection), or at least with two different hypotheses of AD, as already mentioned.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> Based on these elements, four main MTDL strategies involving β-carbolines have been reported so far.</div><div id="sec11_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Targeting AChE/BuChE and Aβ Aggregation</h3><div class="NLM_p">Among MTDL, AChE/BuChE inhibitors represent the largest group, and it is naturally the case for β-carboline-including MTDL. Indeed, besides their catalytic activities, AChE and BuChE possess aggregation-promoting properties (Aβ fibrils and NFTs) involving their PAS. Therefore, in addition to their symptomatic effect, AChE/BuChE inhibitors targeting the PAS or dual-site inhibitors (acting on both CAS and PAS) could simultaneously decrease the rate of formation of Aβ fibrils and thus prevent the progression of AD. To evaluate this effect, Aβ antiaggregation properties have classically been evaluated through two procedures in order to discriminate between self-induced Aβ and/or AChE-induced Aβ aggregation inhibition. Moreover, several multifunctional AChE/BuChE inhibitors with Aβ antiaggregation properties feature additional activities (e.g., antioxidant, neuroprotective, metal chelation). Such a set of properties has often been tested for newly synthesized MTDL.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> Rutaecarpine, a natural product used in Chinese traditional medicine for diverse pharmacological activities, including neuroprotection, was used as a template in two independent research developments. First, a SAR analysis performed on a series of 3-aminoalkanamido-substituted 7,8-dehydrorutaecarpine, inspired from previously reported compounds such as <b>33</b> or <b>34</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>), showed some requirements to enhance the multitarget character of the series. Pyridinium substituents especially promoted a dual inhibitory potency against AChE (e.g., IC<sub>50</sub> = 0.8 nM and 0.6 nM for <b>130a</b> and <b>130b</b>, <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig23" id="" class=" internalNav">23</a></a>) and Aβ aggregation (e.g., 91–93% of inhibition of AChE-induced Aβ<sub>1–42</sub> aggregation at 25 μM for <b>130a</b> and <b>130b</b>); in return the positive charge seemed to compromise antioxidative activity.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> However, compound <b>130b</b> was associated with additional metal-chelating properties, of great interest in the frame of AD. Interestingly, the potency of these compounds was found to be variable against BuChE. Hence, if some analogues were able to interact efficiently with both enzymes, some others were very selective agents with an AChE vs. BuChE index up to ∼3000 (e.g., <b>130a</b>–<b>b</b>). These compounds seem to interact with the PAS of AChE, including hydrophobic contacts with Phe331, Phe330, Tyr334, Tyr121, or Phe290, but with a linker long enough for catching additional cation−π interactions with Trp84 and Tyr130 at the CAS of the enzyme, resulting in a global higher affinity. Second, rutaecarpine was also derivatized with sulfonamido-linked groups. Compound <b>131</b> was especially obtained as a selective inhibitor of BuChE (IC<sub>50</sub> = 3.6 μM), able to interact with both the CAS and PAS of BuChE (mainly through hydrogen bonding with Thr120 and contacts with Trp82, Gly115, Gly116, Gly121, Pro285, Ser287, or Tyr332), but unable to efficiently bind AChE (IC<sub>50</sub> > 100 μM), yielding a molecule with a similar scaffold than <b>130a</b>–<b>b</b> but with reverse selectivity.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> Besides its moderate self-induced Aβ aggregation inhibition properties (59% at 100 μM), <b>131</b> revealed suitable physicochemical properties and antioxidant activity, along with a selective chelation of biometal ion Cu<sup>2+</sup>. Unsurprisingly, hybrids of tacrine (a fragment known to bind to the CAS of AChE) and β-carboline (an aromatic moiety potentially able to interact with the PAS) behave as mixed-type ChE inhibitors (e.g., IC<sub>50</sub> = 32 nM and 41 nM against AChE and BuChE for <b>132</b>, IC<sub>50</sub> = 22 nM and 40 nM for <b>133</b>), as suggested by molecular modeling, with good inhibition of Aβ aggregation (e.g., 41% and 66% of inhibition of self-induced Aβ<sub>1–42</sub> aggregation at 20 μM for <b>132</b> and <b>133</b>).<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> In addition to its ability to cross the BBB, compound <b>133</b> also displayed good biometal-chelating abilities, a promising inhibition of Cu<sup>2+</sup>-induced Aβ aggregation, and moderate antioxidant properties. A similar biological profile was obtained from two distinct series of bivalent β-carbolines incorporating a hydrophilic spacer, designed for solubility purposes. In the first series, containing fully aromatic β-carboline dimers linked by nitrogen 9, compound <b>134</b> showed modest activity against AChE/BuChE with a slight selectivity for BuChE (IC<sub>50</sub> = 16 μM and 1.8 μM) and good Aβ aggregation inhibition properties (72% at 25 μM).<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> In the second series, which gathers tetrahydro-β-carboline dimers connected through nitrogen 2, compound <b>135</b> exhibited very similar potency (IC<sub>50</sub> = 18 μM and 1.7 μM against AChE and BuChE, and 83% of inhibition of Aβ aggregation at 25 μM), and exerted extra neuroprotective effect in several <i>in vitro</i> studies. But overall, the lack of stereocontrol and the subsequent probable coexistence of several stereoisomers of <b>135</b> and derivatives in mixture prevented any further analysis. In addition, cytotoxicity experiments demonstrated that compounds <b>134</b> and <b>135</b> are neurotoxic at 10 μM. To address the latter issue, β-carboline-cinnamic acid hybrids were designed based on the previously reported anti-AD properties of cinnamic acid derivatives. Compound <b>136</b> inhibited BuChE selectively (IC<sub>50</sub> = 21 μM vs. 1.3 μM against AChE and BuChE respectively), consistent with its predicted binding modes at BuChE active site, and with its significant inhibition of Aβ aggregation (72% at 20 μM).<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> Indeed, <b>136</b> could interlock in β-sheet, as observed in docking calculations. In addition, its profile includes neuroprotective effects and low neurotoxicity, and <i>in vivo</i> evaluations in AD model mice showed beneficial effects on several behavioral parameters such as restoration of learning and memory functions, without acute toxicity.</div><figure id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0023.jpeg" id="gr23" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Selected structures, IC<sub>50</sub>, and aggregation inhibition percentages of β-carbolines as multitarget agents, inhibitors of AChE/BuChE and Aβ aggregation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec11_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> Targeting BACE1 and Aβ Aggregation</h3><div class="NLM_p">The simultaneous targeting of BACE1 and Aβ aggregation allows disruption of both the production of Aβ and associated pathological events. Thus, starting from previous results obtained against individual targets, and following a multifunctional approach, researchers developed additional compounds designed to not only target BACE1 but also provide anti-Aβ aggregation, metal complexation and radical scavenging properties.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> Compound <b>137</b> (IC<sub>50</sub> > 50 μM against BACE1, IC<sub>50</sub> = 30 μM against Aβ aggregation, IC<sub>50</sub> = 43 μM for antioxidant activity, and 43% of metal chelating capability at 100 μM, <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig24" id="" class=" internalNav">24</a></a>) is representative of this multifunctional strategy: while retaining the tryptoline core with the two requisite NH groups for BACE1 interaction, it displays an additional phenolic structure playing a role in free radical scavenging but also improving Aβ binding with an evaluated optimal distance of 13–14 Å between the two aromatic moieties. In order to improve the poor inhibitory activity of this series against BACE1, the phenolic part was finally substituted by another more hydrophobic tryptoline moiety; however, the length between the terminal aromatic rings was maintained for the anti-Aβ-aggregation activity (IC<sub>50</sub> = 17 μM against BACE1, and 80% of Aβ aggregation inhibition at 100 μM for <b>138</b>).<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a><named-content content-type="anchor" rid="fig24" type="simple"></named-content></div><figure id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0024.jpeg" id="gr24" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Selected structures, IC<sub>50</sub> and aggregation inhibition percentages of β-carbolines as multitarget agents, inhibitors of BACE1 and Aβ aggregation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec11_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Targeting AChE and PDE5</h3><div class="NLM_p">While AChE and PDE5 are both involved in memory and cognition processes, the inhibition of these targets implies different and dissociable mechanisms.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> The design of innovative AChE/PDE5 dual inhibitors potentially producing a synergistic effect on AD thus appears as a relevant MTDL strategy. An initial focus on the repurposing and redeveloping of an existing marketed drug, tadalafil (<b>8</b>, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), a selective PDE5 inhibitor, was a potential starting point for designing dual inhibitors (IC<sub>50</sub> = 26 μM for <b>8</b>). Reminiscently of previous SAR results on anti-PDE5 tadalafil analogues (which denoted some tolerance at this position, <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>), the introduction of a donepezil-inspired benzylpiperidine fragment at position <i>N</i><sup>2</sup> resulted in an improvement of AChE inhibitory activity while maintaining a decent anti-PDE5 selective action. After the identification of the main important structural elements regarding each target independently (stereochemistry, nature of the substituent, alkyl chain length and bulkiness), the most active compounds (IC<sub>50</sub> = 36 nM and 32 nM against AChE, and IC<sub>50</sub> = 0.15 and 1.5 μM against PDE5 for <b>139</b> and <b>140</b> respectively, <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig25" id="" class=" internalNav">25</a></a>) were evaluated <i>in vivo</i> in an AD mouse model; the citrate salt of compound <b>140</b> was finally pointed as the most potent AChE/PDE5 dual-target anti-AD lead compound. Unsurprisingly, the predicted binding mode of <b>140</b> on PDE5 was very reminiscent of the tadalafil interaction pattern previously reported (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>), including the hydrogen bond with Gln817 and close contacts with Phe820, Val782 and Leu804. Regarding the AChE–<b>140</b> interaction pattern, docking simulations showed possible binding at both the CAS and PAS, the benzylpiperidine fragment being anchored at the bottom of the AChE gorge and interacting with Trp86 and Trp337. The same moiety in donepezil showed similar contacts.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> However, the poor water solubility of this compound restricted possible further development, mainly for oral bioavailability issues. Additional modifications achieved at various positions of the scaffold provided for example compounds <b>141</b> (IC<sub>50</sub> = 15 nM against AChE and 3.2 μM against PDE5) and <b>142</b> (IC<sub>50</sub> = 31 nM against AChE and 0.20 μM against PDE5) which fulfilled the expectations in terms of potency, selectivity and physicochemical properties (water solubility of 420 and 1400 μg/mL for citrate salts of <b>141</b> and <b>142</b>). Especially, an <i>in vivo</i> evaluation underlined the capacity of <b>141</b> to cross the BBB and to target both the cholinergic system and the cGMP signaling pathway. In a passageway water maze test performed on mice, <b>141</b> led to a reduced escape latency and improved the memory and cognitive functions in a similar way than the reference donepezil at 10 mg/kg. In addition, <b>141</b> exhibited an enhancement of central CREB protein phosphorylation, thereby potentially contributing to an amelioration of scopolamine-induced cognitive impairment in mice, and revealing a promising profile as an anti-AD, multitarget drug candidate.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a></div><figure id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0025.jpeg" id="gr25" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Selected structures and IC<sub>50</sub> of β-carbolines as multitarget agents, inhibitors of AChE and PDE5.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec11_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> Targeting AChE/BuChE and NMDA</h3><div class="NLM_p">The combination of donepezil, an AChE inhibitor, and memantine, the only marketed NMDA antagonist, is now a commonly used treatment for moderate to severe AD that has demonstrated beneficial effects. The development of new hybrids, that could alleviate AD symptoms, is thus one of the most promising MTDL strategies. Inspired by the bis-tacrine template that is far more potent on AChE than the monomeric analogue, homobivalent β-carbolines were designed with various length spacer. As for the tacrines, the optimal distance between the two pharmacophoric moieties is usually fixed at 7–9 carbons with loss of activity for shorter linkages and solubility issues for longer ones.<a onclick="showRef(event, 'ref28 ref176'); return false;" href="javascript:void(0);" class="ref ref28 ref176">(28,176)</a> By anchoring the linker either at <i>N</i><sup>2</sup> or <i>N</i><sup>9</sup> positions of the β-carboline scaffold, two series were developed and reported. The homodimers linked at the <i>N</i><sup>2</sup> position always kept some anti-ChE activities, often below 200 nM, while the potency against NMDA receptors varied. Especially, compound <b>143</b> reached decent ChE inhibition (IC<sub>50</sub> = 86 nM and 22 nM against AChE and BuChE, respectively, <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig26" id="" class=" internalNav">26</a></a>) and promising values against NMDA receptors (IC<sub>50</sub> = 2.6 μM and 1.8 μM against NR1/2A and NR1/2B, respectively), despite a longer 12-carbons linker, whereas tetrahydro-β-carboline analogues were globally less active. The other series produced molecules with much more variability in their AChE/BuChE and NMDA inhibition potencies: if the best AChE inhibitor <b>144</b> (IC<sub>50</sub> = 0.5 nM) was also the most active against NMDA (IC<sub>50</sub> = 1.4 μM and 2.9 μM, respectively), closely related analogues were found to be completely inactive against AChE (IC<sub>50</sub> > 10 μM) and NMDA (percentage of excitotoxicity at 25 μM around 100%). The activity of some compounds on MAO-A/B was also evaluated but yielded weak values. For reducing the molecular weight of the homobivalent β-carbolines in order to improve bioavailability while retaining both activities against AChE and NMDA, new β-carboline scaffolds were synthesized, but the results were underwhelming.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The best MTDL identified showed only weak activities compared to the homobivalent β-carbolines (IC<sub>50</sub> = 0.6 μM against AChE and BuChE, 35 μM and 5 μM against NR1/2A and NR1/2B, respectively, for compound <b>145</b>). Nevertheless, the SAR studies corroborated the higher potency of quaternary derivatives for NMDA activity and demonstrated that the incorporation of a propargyl moiety, known for its neuroprotective properties in selegiline and rasagiline, has no beneficial effect herein.</div><figure id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0026.jpeg" id="gr26" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Selected structures and IC<sub>50</sub> of β-carbolines as multitarget agents, inhibitors of AChE/BuChE and NMDA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec11_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> Targeting PDE5 and HDACs</h3><div class="NLM_p">Reminiscent of the respective works on PDE5 and HDAC inhibition, the development of dual inhibitors targeting both enzymes gathered the tadalafil scaffold and a linked zinc-chelating group. Especially, several mixtures of enantiomers bearing a hydroxamic acid head were examined.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> While these compounds partially lost the initial anti-PDE5 potency of tadalafil <b>8</b> and did not reach HDAC inhibition values similar to those obtained in HDAC-dedicated studies, in some cases sub-micromolar IC<sub>50</sub> values were yielded. Especially, compound <b>146</b> associated an IC<sub>50</sub> of 0.31 μM against PDE5 (a significant drop of activity compared to <b>8</b>, possibly due to the mixture of diastereoisomers tested) with values below 80 nM for HDAC1 and HDAC6 (<a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig27" id="" class=" internalNav">27</a></a>). While PDE5 inhibition was improved by implementing more flexible and/or shorter linkages between the tadalafil scaffold and the hydroxamic acid head, such modifications dramatically compromised anti-HDAC potency, regardless of the subtype (IC<sub>50</sub> = 0.12 μM and 0.14 μM against PDE5 for <b>147</b> and <b>148</b>, vs. 2.5 μM to >20 μM for HDACs subtypes 1, 2, and 6). Similarly, the development of <i>ortho</i>-aminoanilide analogues only afforded marginally active molecules (IC<sub>50</sub> > 2.0 μM against all tested targets).<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> However, a further focus on the activities of all isolated stereoisomers would shed light on the real potential of these structures. Besides, a series of isolated stereoisomers of slightly different structure was reported very recently.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> Interestingly, some compounds managed to efficiently bind to HDACs while incorporating short linkers, an observation that contradicts previously described results. Even a four-carbon derivative, compound <b>149a</b>, was able to inhibit both PDE5 (IC<sub>50</sub> = 12 nM) and HDAC (IC<sub>50</sub> = 131 nM) with decent activity levels; shorter one-, two-, and three-carbons analogues failed to efficiently bind HDAC, although their anti-PDE5 activities were exquisite (IC<sub>50</sub> = 2.0–20 nM for four molecules). Compound <b>149b</b> was even more promising (IC<sub>50</sub> = 7.0 nM and 61 nM against PDE5 and HDAC, respectively), but anti-PDE5 activity started to drop as the anti-HDAC effect increased with the introduction of a sixth carbon (e.g., IC<sub>50</sub> = 126 nM and 9.1 nM against PDE5 and HDAC, respectively, for compound <b>150</b>). The last molecule also showed some HDAC subtype selectivity, as if HDAC6 and HDAC8 were targeted with IC<sub>50</sub> values of 90–200 nM, HDAC1 was associated with far weaker activity (IC<sub>50</sub> = 1.65 μM). These results highlight the need for a balanced linker size and flexibility, as favorable elements for anti-PDE5 and anti-HDAC activities seem to be opposite.</div><figure id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0027.jpeg" id="gr27" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Selected structures and IC<sub>50</sub> of β-carbolines as multitarget agents, inhibitors of PDE5 and HDAC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec12" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">Conclusion and Prospects</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14653" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14653" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To date, only symptomatic treatments are available for countering the progression of AD, and the development of new compounds presents higher failure rates, compared to other diseases. Yet, the initial “one-target-one-compound” paradigm has produced a great number of molecules for addressing individual targets involved in the etiology of the disease. But AD is intrinsically multifactorial, and the complex interplay of the pathogenesis has dismissed most of the studies performed with blinkers. The emergence of widely chosen multitargeting compounds, able to concurrently tackle several pathogenetic pathways, is a promising tool to take them off. Apart from classical drug combination and coformulation, two main polypharmacological approaches have been of increasing importance in the past few years: the association of two or more ligands through an adequate linker; and the hybridization between several active skeletons, often fused or merged to provide compact molecules with optimal size. Both strategies rely on successful stories and FDA-approved drugs in various contexts. In the particular case of AD, some specific limitations appear however. First, the lack of appropriate animal models for AD is critical and makes it difficult to retrieve preclinical data. Second, the necessity of the BBB crossing is a sizable issue, hampering a full delivery of the biological activity for a wide range of compounds. However, the β-carboline scaffold has several assets. As a natural product family, it is attractive for CNS-targeting medicinal development: ∼84% of approved drugs for CNS diseases are natural or bioinspired products. Furthermore, since natural derivatives from coffee or tobacco, such as harmane or norharmane, are known to readily exert neurological actions, the BBB crossing could not be an intractable concern for β-carbolines. In addition, the scaffold presents a high structural analogy with native brain molecules, such as neurotransmitters 5-HT or melatonin, indicating a probable capacity to easily transit throughout the brain and to interact with several biomolecules and receptors of interest. Indeed, numerous studies have demonstrated the potential of β-carbolines to target AD-related biomolecules, feeding an impressive and ever-growing SAR meta-analysis. Through this Perspective, we have first tried to draw up the main lines target by target, summarized in <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig28" id="" class=" internalNav">28</a></a>. The scheme clearly shows that the β-carboline scaffold has been extensively exploited by medicinal chemists for the design of inhibitors of AD-related targets. Both rings have provided positive modifications, in almost every possible substitution positions. Additional fused rings have been added at several points, leading to highly modified analogues, often with very good activity records. While the SAR is overall very complex and hard to condense, several elements deserve to be highlighted. First, convergent favorable components are observed. The position 7 of the scaffold, when receiving an alkyl ether substituent, is able to foster the activity against DYRK1A, MAO, and GABA<sub>A</sub> to a lesser extent. Similar effects could be seen at position 2, where the substitution of the intracyclic nitrogen promotes NMDA, AChE and PDE5 inhibition simultaneously, or at position 1, where the presence of close aryl groups (0–1-carbon linker) is a crucial feature for PDE5 inhibition and 5-HT receptor binding. Second, sometimes the structural features required for the activity are not linked to a particular position, providing a flexibility that is precious for MTDL design. This is the case for HDAC targeting, needing the presence of a zinc-chelating head, such as an hydroxamic acid moiety, which can be placed at various positions without compromising the activity. The binding to NMDA receptors is also conditional on the global “V-like” shape of the compound, achievable through different molecular layouts starting from the initial rather linear skeleton. Finally, in some cases it appears to be possible to reach several targets by arranging independently several parts of the scaffold. As seen for example when examining the aforementioned crystal structures, at least a part of the molecule always points toward an open area, giving some latitude for modifying this position without triggering an activity loss. As such, it would be very engaging to see if the combination of a 5,6-fused heterocycle, for GABA<sub>A</sub> binding, with a β-carboline core extended at the opposite side with a hydantoin or a piperidine ring, for PDE5 inhibition (and for incidentally consolidating GABA<sub>A</sub> binding with the amido group thereby introduced at position 3) would deliver a retained activity against both targets—to take just one example. Overall, the meta-analysis performed herein could help researchers in the field to design new β-carbolines able to simultaneously or synergistically tackle multiple AD targets, while keeping a good ability to cross the BBB, for ultimately affording drug candidates of higher potential. By combining the targeting of disease-modifying pathways and symptomatic processes, the next-generation anti-AD agents represent a great promise for the future of AD treatments. The β-carboline platform would be a robust flagship for such an adventure.</div><figure id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0028.jpeg" id="gr28" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Overview of crucial (++), favorable (+) and unfavorable (−) elements of SAR regarding the effect of β-carbolines on the previously mentioned AD-related targets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.0c01887" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_31882" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_31882" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marine Peuchmaur</span> - <span class="hlFld-Affiliation affiliation">Univ.
Grenoble Alpes, CNRS, DPM, 38000 Grenoble, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-8926-1922" title="Orcid link">http://orcid.org/0000-0002-8926-1922</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#89c4e8fbe0e7eca7d9ecfceae1e4e8fcfbc9fce7e0ffa4eefbece7e6ebe5eca4e8e5f9ecfaa7effb"><span class="__cf_email__" data-cfemail="7d301c0f141318532d18081e15101c080f3d0813140b501a0f1813121f1118501c110d180e531b0f">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Romain Haudecoeur</span> - <span class="hlFld-Affiliation affiliation">Univ.
Grenoble Alpes, CNRS, DPM, 38000 Grenoble, France</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-6271-4717" title="Orcid link">http://orcid.org/0000-0002-6271-4717</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#91c3fefcf0f8ffbfd9f0e4f5f4f2fef4e4e3d1e4fff8e7bcf6e3f4fffef3fdf4bcf0fde1f4e2bff7e3"><span class="__cf_email__" data-cfemail="90c2fffdf1f9febed8f1e5f4f5f3fff5e5e2d0e5fef9e6bdf7e2f5fefff2fcf5bdf1fce0f5e3bef6e2">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Aurélien Beato</span> - <span class="hlFld-Affiliation affiliation">Univ.
Grenoble Alpes, CNRS, DPM, 38000 Grenoble, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anthonin Gori</span> - <span class="hlFld-Affiliation affiliation">Univ.
Grenoble Alpes, CNRS, DPM, 38000 Grenoble, France</span>; 
    <span class="hlFld-Affiliation affiliation">CHANEL
Parfums Beauté, F-93500 Pantin, France</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Benjamin Boucherle</span> - <span class="hlFld-Affiliation affiliation">Univ.
Grenoble Alpes, CNRS, DPM, 38000 Grenoble, France</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>A.B. and A.G. contributed equally to this work.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04525" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04525" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="29" class="article__inlineFigure"><h2 class="fig-label">Aurélien Beato</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=BIO-d7e5271-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Aurélien Beato</b> is a chemical engineer who graduated from Sigma Clermont (France) in 2019 and is currently doing his second year Ph.D. thesis in Organic Chemistry at the Department of Medicinal Chemistry of University Grenoble Alpes (France) under the supervision of Dr. Marine Peuchmaur and Dr. Benjamin Boucherle. He is working on the diversity-oriented chemical modification of natural extracts of plants.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="30" class="article__inlineFigure"><h2 class="fig-label">Anthonin Gori</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=BIO-d7e5276-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Anthonin Gori</b> obtained his Ph.D. in Organic Chemistry and Phytochemistry from University Grenoble Alpes (France) in 2020 under the supervision of Dr. Marine Peuchmaur and Dr. Benjamin Boucherle (CIFRE grant, CHANEL Parfums Beauté). He was hired as project leader at Clarins (France). His research studies are essentially focused on natural products and bioactive compounds from plants.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="31" class="article__inlineFigure"><h2 class="fig-label">Benjamin Boucherle</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=BIO-d7e5281-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Benjamin Boucherle</b> is a Pharm.D. recipient who graduated from the University of Grenoble (2005). He obtained his Ph.D. in Medicinal Chemistry in 2008 under the supervision of Prof. J.-L. Décout, working on CFTR modulators. After a postdoctoral position (2009–2011) focused on protein–protein interaction inhibitors in the Chemistry School of Clermont-Ferrand (France), he moved back to Grenoble for a medicinal chemistry project targeting cystic fibrosis (2012–2015). He is currently Lecturer in medicinal chemistry and pharmacognosy at the Faculty of Pharmacy at University Grenoble Alpes. His research studies are dedicated to the development of bioactive substances from chemical synthesis or natural products isolation.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="32" class="article__inlineFigure"><h2 class="fig-label">Marine Peuchmaur</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=BIO-d7e5286-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Marine Peuchmaur</b> is a chemical engineer who graduated from Ecole Nationale Supérieure de Chimie de Montpellier (France). She obtained her Ph.D. in 2007 in Chemical Biology from University Grenoble Alpes (France), under the supervision of Dr. Yung-Sing Wong. After two postdoctoral internships at the University of Montpellier (IBMM, France, 2007–2008) and at Trinity College (Dublin, Ireland, 2008–2009), she was hired in 2009 as a lecturer in organic chemistry at the Faculty of Pharmacy (University Grenoble Alpes). Her research work in the Department of Medicinal Chemistry focuses on both phytochemistry and organic synthesis for medicinal chemistry topics (design and synthesis of bioactive molecules or tools for biochemists). She received in 2015 the Accreditation to Supervise Research (HDR).</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="33" class="article__inlineFigure"><h2 class="fig-label">Romain Haudecoeur</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=BIO-d7e5291-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Romain Haudecoeur</b> obtained his Ph.D. in Chemical Biology from University Grenoble Alpes (France) in 2011, under the supervision of Prof. Ahcène Boumendjel. He joined the group of Dr. David Monchaud at the University of Burgundy (Dijon, France) as a postdoctoral associate in the same year. He was then appointed as Researcher in 2012 in the Department of Medicinal Chemistry of University Grenoble Alpes and received in 2020 the Accreditation to Supervise Research (HDR). His research work essentially focuses on the rational targeting of biological macromolecules, with the aim of developing new bioinspired, bioactive, and smart compounds for modulating the function of proteins such as tyrosinases, viral polymerases, and membrane ABC transporters.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i43">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47022" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47022" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The authors are grateful to ANR (“Agence Nationale de la Recherche”) for financial support through Labex ARCANE and CBH-EUR-GS (Grant ANR-17-EURE-0003). The authors thank the French MESR (“Ministère de l’Enseignement Supérieur, de la Recherche et de l’Innovation”) for the fellowship grant of A.B. and the company Chanel Parfums Beauté and the ANRT (“Association Nationale Recherche Technologie”) for the CIFRE (“Conventions Industrielles de Formation par la Recherche”) grant of A.G. (Grant 2017/0042).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">5-HT</td><td class="NLM_def"><p class="first last">5-hydroxytryptamine</p></td></tr><tr><td class="NLM_term">Aβ</td><td class="NLM_def"><p class="first last">amyloid-β</p></td></tr><tr><td class="NLM_term">AChE</td><td class="NLM_def"><p class="first last">acetylcholinesterase</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">BACE1</td><td class="NLM_def"><p class="first last">β-site APP cleaving enzyme 1</p></td></tr><tr><td class="NLM_term">BBB</td><td class="NLM_def"><p class="first last">blood-brain barrier</p></td></tr><tr><td class="NLM_term">BuChE</td><td class="NLM_def"><p class="first last">butyrylcholinesterase</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">CAS</td><td class="NLM_def"><p class="first last">catalytic active site</p></td></tr><tr><td class="NLM_term">CDK5</td><td class="NLM_def"><p class="first last">cyclin-dependent kinase 5</p></td></tr><tr><td class="NLM_term">cGMP</td><td class="NLM_def"><p class="first last">cyclic guanosine monophosphate</p></td></tr><tr><td class="NLM_term">ChE</td><td class="NLM_def"><p class="first last">cholinesterase</p></td></tr><tr><td class="NLM_term">CK1/2</td><td class="NLM_def"><p class="first last">casein kinase 1/2</p></td></tr><tr><td class="NLM_term">CLK1</td><td class="NLM_def"><p class="first last">dual specificity protein kinase</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">CREB</td><td class="NLM_def"><p class="first last">cAMP response element-binding</p></td></tr><tr><td class="NLM_term">DYRK1A</td><td class="NLM_def"><p class="first last">dual specificity tyrosine-phosphorylation-regulated kinase 1A</p></td></tr><tr><td class="NLM_term">FAD</td><td class="NLM_def"><p class="first last">flavin adenine dinucleotide</p></td></tr><tr><td class="NLM_term">FDA</td><td class="NLM_def"><p class="first last">Food and Drug Administration</p></td></tr><tr><td class="NLM_term">GABA</td><td class="NLM_def"><p class="first last">γ-aminobutyric acid</p></td></tr><tr><td class="NLM_term">GSK-3β</td><td class="NLM_def"><p class="first last">glycogen synthase kinase 3</p></td></tr><tr><td class="NLM_term">GTP</td><td class="NLM_def"><p class="first last">guanosine triphosphate</p></td></tr><tr><td class="NLM_term">HDAC</td><td class="NLM_def"><p class="first last">histone deacetylase</p></td></tr><tr><td class="NLM_term">NFTs</td><td class="NLM_def"><p class="first last">neurofibrillary tangles</p></td></tr><tr><td class="NLM_term">mGluR</td><td class="NLM_def"><p class="first last">glutamate metabotropic receptor</p></td></tr><tr><td class="NLM_term">NMDA</td><td class="NLM_def"><p class="first last"><i>N</i>-methyl-<span class="smallcaps smallerCapital">d</span>-aspartate</p></td></tr><tr><td class="NLM_term">NR</td><td class="NLM_def"><p class="first last">NMDA receptor subunits</p></td></tr><tr><td class="NLM_term">MAO</td><td class="NLM_def"><p class="first last">monoamine oxidase</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">MTDL</td><td class="NLM_def"><p class="first last">multitarget-directed ligand</p></td></tr><tr><td class="NLM_term">PAS</td><td class="NLM_def"><p class="first last">peripheral anionic site</p></td></tr><tr><td class="NLM_term">PDB</td><td class="NLM_def"><p class="first last">Protein Data Bank</p></td></tr><tr><td class="NLM_term">PDE</td><td class="NLM_def"><p class="first last">phosphodiesterase</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06520" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06520" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 179 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span> <span> </span><span class="NLM_article-title">β-Carboline alkaloids: biochemical and pharmacological functions</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">500</span>, <span class="refDoi"> DOI: 10.2174/092986707779940998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.2174%2F092986707779940998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=17305548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhs1yhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=479-500&author=R.+Caoauthor=W.+Pengauthor=Z.+Wangauthor=A.+Xu&title=%CE%B2-Carboline+alkaloids%3A+biochemical+and+pharmacological+functions&doi=10.2174%2F092986707779940998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">β-Carboline alkaloids: biochemical and pharmacological functions</span></div><div class="casAuthors">Cao, Rihui; Peng, Wenlie; Wang, Zihou; Xu, Anlong</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">479-500</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  β-Carboline alkaloids are a large group of natural and synthetic indole alkaloids with different degrees of aromaticity, some of which are widely distributed in nature, including various plants, foodstuffs, marine creatures, insects, mammalians as well as human tissues and body fluids.  These compds. are of great interest due to their diverse biol. activities.  Particularly, these compds. have been shown to intercalate into DNA, to inhibit CDK, Topoisomerase, and monoamine oxidase, and to interact with benzodiazepine receptors and 5-hydroxy serotonin receptors.  Furthermore, these chems. also demonstrated a broad spectrum of pharmacol. properties including sedative, anxiolytic, hypnotic, anticonvulsant, antitumor, antiviral, antiparasitic as well as antimicrobial activities.  In this review, we summarized the biochem. and pharmacol. functions of β-carboline alkaloids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrweya4vQLb5bVg90H21EOLACvtfcHk0lh3yhVElCOr8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhs1yhu78%253D&md5=5a5bb8fc6c45e4880249d1d6c3df3d27</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F092986707779940998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986707779940998%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DR.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DA.%26atitle%3D%25CE%25B2-Carboline%2520alkaloids%253A%2520biochemical%2520and%2520pharmacological%2520functions%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2007%26volume%3D14%26spage%3D479%26epage%3D500%26doi%3D10.2174%2F092986707779940998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">β-Carboline alkaloids monomers and dimers: occurrence, structural diversity, and biological activities</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">622</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.08.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2018.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=30125723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFOqsb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2018&pages=622-656&author=J.+Daiauthor=W.+Danauthor=U.+Schneiderauthor=J.+Wang&title=%CE%B2-Carboline+alkaloids+monomers+and+dimers%3A+occurrence%2C+structural+diversity%2C+and+biological+activities&doi=10.1016%2Fj.ejmech.2018.08.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">β-Carboline alkaloid monomers and dimers: Occurrence, structural diversity, and biological activities</span></div><div class="casAuthors">Dai, Jiangkun; Dan, Wenjia; Schneider, Uwe; Wang, Junru</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">622-656</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  β-Carboline alkaloids are a family of natural and synthetic products with great structural diversity and outstanding biol. activities.  This review covers critically important developments in the field of β-carbolines, predominantly over the past decade (2006-2017).  It is focused on both natural and synthetic monomers as well as dimers, and includes key information on occurrence, structural diversity, and biol. activities.  In cases where sufficient information is available, the structure-activity relation (SAR) and mechanism of their biol. activities are presented.  In addn., innovative syntheses of the β-carboline core and potential future directions are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocA6exouyLkLVg90H21EOLACvtfcHk0lh3yhVElCOr8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFOqsb7J&md5=920aa3e66da1ba5599847e3b35a698d3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.08.027%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DDan%26aufirst%3DW.%26aulast%3DSchneider%26aufirst%3DU.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3D%25CE%25B2-Carboline%2520alkaloids%2520monomers%2520and%2520dimers%253A%2520occurrence%252C%2520structural%2520diversity%252C%2520and%2520biological%2520activities%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D157%26spage%3D622%26epage%3D656%26doi%3D10.1016%2Fj.ejmech.2018.08.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nikam, T. D.</span>; <span class="NLM_string-name">Nitnaware, K. M.</span>; <span class="NLM_string-name">Ahire, M. L.</span></span> <span> </span><span class="NLM_article-title">Alkaloids Derived from Tryptophan: Harmine and Related Alkaloids</span>. In  <i>Natural Products</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramawat, K. G.</span>, <span class="NLM_string-name">Mérillon, J.-M.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin, Heidelberg</span>, <span class="NLM_year">2013</span>; pp  <span class="NLM_fpage">553</span>– <span class="NLM_lpage">574</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1007%2F978-3-642-22144-6_20" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=553-574&author=T.+D.+Nikam&author=K.+M.+Nitnaware&author=M.+L.+Ahireauthor=K.+G.+Ramawat&author=J.-M.+M%C3%A9rillon&title=Natural+Products"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-22144-6_20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-22144-6_20%26sid%3Dliteratum%253Aachs%26aulast%3DNikam%26aufirst%3DT.%2BD.%26atitle%3DAlkaloids%2520Derived%2520from%2520Tryptophan%253A%2520Harmine%2520and%2520Related%2520Alkaloids%26btitle%3DNatural%2520Products%26aulast%3DRamawat%26aufirst%3DK.%2BG.%26pub%3DSpringer%26date%3D2013%26spage%3D553%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abeysinghe, A. A. D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshapriya, R. D. U. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udawatte, C.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease; a review of the pathophysiological basis and therapeutic intervention</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">117996</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2020.117996</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.lfs.2020.117996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=32585249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlWnsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=2020&pages=117996&author=A.+A.+D.+T.+Abeysingheauthor=R.+D.+U.+S.+Deshapriyaauthor=C.+Udawatte&title=Alzheimer%E2%80%99s+disease%3B+a+review+of+the+pathophysiological+basis+and+therapeutic+intervention&doi=10.1016%2Fj.lfs.2020.117996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions</span></div><div class="casAuthors">Abeysinghe, A. A. D. T.; Deshapriya, R. D. U. S.; Udawatte, C.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">117996</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a neurodegenerative disorder and is identified as the most common cause for dementia.  Despite huge global economic burden and the impact on the close family of the patients, there is no definitive cure and thus, improved treatment methods are of need.  While memory and cognition are severely affected in AD, exact etiol. is yet unknown.  The β-Amyloid plaque formation and aggregation hypothesis is among the well-known hypotheses used to explain disease pathogenesis.  Currently there are five Food and Drug Administration (FDA) approved drugs as treatment options.  All these drugs are used for symptomatic treatment of AD.  Thus, disease modifying therapies which can directly address the pathol. changes in AD, are needed.  Such therapies could be designed based on inhibiting key steps of pathogenesis.  Currently there are novel AD drug candidates with various therapeutic mechanisms, undergoing different stages of drug development.  Extensive research is being done globally to broaden understanding of the exact mechanisms involved in AD and to develop therapeutic agents that can successfully hinder the occurrence and progression of the disease.  In this review, a comprehensive approach to understanding AD and suggestions to be considered in the development of therapeutics for it are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXyoafzRz7Z7Vg90H21EOLACvtfcHk0ljhfZhQHT1lHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlWnsrbM&md5=85aa42fe67fa61a4a40284a77f595077</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2020.117996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2020.117996%26sid%3Dliteratum%253Aachs%26aulast%3DAbeysinghe%26aufirst%3DA.%2BA.%2BD.%2BT.%26aulast%3DDeshapriya%26aufirst%3DR.%2BD.%2BU.%2BS.%26aulast%3DUdawatte%26aufirst%3DC.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253B%2520a%2520review%2520of%2520the%2520pathophysiological%2520basis%2520and%2520therapeutic%2520intervention%26jtitle%3DLife%2520Sci.%26date%3D2020%26volume%3D256%26spage%3D117996%26doi%3D10.1016%2Fj.lfs.2020.117996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohamed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, P. P. N.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: emerging trends in small molecule therapies</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4299</span>– <span class="NLM_lpage">4320</span>, <span class="refDoi"> DOI: 10.2174/092986711797200435</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.2174%2F092986711797200435" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=21861820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlSqsrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=4299-4320&author=T.+Mohamedauthor=P.+P.+N.+Rao&title=Alzheimer%E2%80%99s+disease%3A+emerging+trends+in+small+molecule+therapies&doi=10.2174%2F092986711797200435"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: emerging trends in small molecule therapies</span></div><div class="casAuthors">Mohamed, T.; Rao, P. P. N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">4299-4320</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a highly complex and rapidly progressive neurodegenerative disorder characterized by the systemic collapse of cognitive function and formation of dense amyloid plaques and neurofibrillary tangles.  AD pathol. is derived from the cholinergic, amyloid and tau hypotheses, resp.  Current pharmacotherapy with known anti-cholinesterases, such as Aricept and Exelon, only offer symptomatic relief without any disease-modifying effects.  It is now clear that in order to prevent the rapid progression of AD, new therapeutic treatments should target multiple AD pathways as opposed to the traditional "one drug, one target" approach.  This review will focus on the recent advances in medicinal chem. aimed at the development of small mol. therapies that target various AD pathol. routes such as the cholinesterases (AChE and BuChE), amyloidogenic secretases (β/γ - secretase), amyloid-β aggregation, tau phosphorylation and fibrillation and metal-ion redox/reactive oxygen species (ROS).  Some notable ring templates will be discussed along with their structure-activity relationship (SAR) data and their multiple modes of action.  These emerging trends signal a paradigm shift in anti-AD therapies aimed at the development of multifunctional small mols. as disease modifying agents (DMAs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7KOYLD281AbVg90H21EOLACvtfcHk0ljhfZhQHT1lHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlSqsrbO&md5=a8528d67ebe66b8e8f29079a37edb6e4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F092986711797200435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711797200435%26sid%3Dliteratum%253Aachs%26aulast%3DMohamed%26aufirst%3DT.%26aulast%3DRao%26aufirst%3DP.%2BP.%2BN.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520emerging%2520trends%2520in%2520small%2520molecule%2520therapies%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D4299%26epage%3D4320%26doi%3D10.2174%2F092986711797200435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, B.</span></span> <span> </span><span class="NLM_article-title">Progress in target drug molecules for Alzheimer’s disease</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.2174/1568026619666191203113745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.2174%2F1568026619666191203113745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=31797761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjs1Wrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2020&pages=4-36&author=J.+Xieauthor=R.+Liangauthor=Y.+Wangauthor=J.+Huangauthor=X.+Caoauthor=B.+Niu&title=Progress+in+target+drug+molecules+for+Alzheimer%E2%80%99s+disease&doi=10.2174%2F1568026619666191203113745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in Target Drug Molecules for Alzheimer's Disease</span></div><div class="casAuthors">Xie, Jiayang; Liang, Ruirui; Wang, Yajiang; Huang, Junyi; Cao, Xin; Niu, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-36</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a chronic neurodegenerative disease that 4 widespread in the elderly.  The etiol. of AD is complicated, and its pathogenesis is still unclear.  Although there are many researches on anti-AD drugs, they are limited to reverse relief symptoms and cannot treat diseases.  Therefore, the development of high-efficiency anti-AD drugs with no side effects has become an urgent need.  Based on the published literature, this paper summarizes the main targets of AD and their drugs, and focuses on the research and development progress of these drugs in recent years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-wKjH6SnEo7Vg90H21EOLACvtfcHk0ljhfZhQHT1lHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjs1Wrsbo%253D&md5=c287b0068f23a4c9a169fadf92759e11</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F1568026619666191203113745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026619666191203113745%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DNiu%26aufirst%3DB.%26atitle%3DProgress%2520in%2520target%2520drug%2520molecules%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2020%26volume%3D20%26spage%3D4%26epage%3D36%26doi%3D10.2174%2F1568026619666191203113745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">León, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer’s disease</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1002/med.20248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1002%2Fmed.20248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=21793014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=139-189&author=R.+Le%C3%B3nauthor=A.+G.+Garciaauthor=J.+Marco-Contelles&title=Recent+advances+in+the+multitarget-directed+ligands+approach+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fmed.20248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Leon, Rafael; Garcia, Antonio G.; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-189</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes an overwhelming health, social, economic, and political problem to nations.  Unless a new medicine capable to delay disease progression is found, the no. of cases will reach 107 million in 2050.  So far, the therapeutic paradigm one-compd.-one-target has failed.  This could be due to the multiple pathogenic mechanisms involved in AD including amyloid β (Aβ) aggregation to form plaques, τ hyperphosphorylation to disrupt microtubule to form neurofibrillary tangles, calcium imbalance, enhanced oxidative stress, impaired mitochondrial function, apoptotic neuronal death, and deterioration of synaptic transmission, particularly at cholinergic neurons.  Approx. 100 compds. are presently been investigated directed to single targets, namely inhibitors of β and γ secretase, vaccines or antibodies that clear Aβ, metal chelators to inhibit Aβ aggregation, blockers of glycogen synthase kinase 3β, enhancers of mitochondrial function, antioxidants, modulators of calcium-permeable channels such as voltage-dependent calcium channels, N-methyl-D-aspartate receptors for glutamate, or enhancers of cholinergic neurotransmission such as inhibitors of acetylcholinesterase or butyrylcholinesterase.  In view of this complex pathogenic mechanisms, and the successful treatment of chronic diseases such as HIV or cancer, with multiple drugs having complementary mechanisms of action, the concern is growing that AD could better be treated with a single compd. targeting two or more of the pathogenic mechanisms leading to neuronal death.  This review summarizes the current therapeutic strategies based on the paradigm one-compd.-various targets to treat AD.  A treatment that delays disease onset and/or progression by 5 years could halve the no. of people requiring institutionalization and/or dying from AD.  © 2011 Wiley Periodicals, Inc.  Med Res Rev.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YQ_Czzj5brVg90H21EOLACvtfcHk0ljM-qOACHpJdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL&md5=b08806a8a4ca71c35a3594338c881e74</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fmed.20248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20248%26sid%3Dliteratum%253Aachs%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520multitarget-directed%2520ligands%2520approach%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D139%26epage%3D189%26doi%3D10.1002%2Fmed.20248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guzior, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieckowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malawska, B.</span></span> <span> </span><span class="NLM_article-title">Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer’s disease</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">404</span>, <span class="refDoi"> DOI: 10.2174/0929867321666141106122628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.2174%2F0929867321666141106122628" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=373-404&author=N.+Guziorauthor=A.+Wieckowskaauthor=D.+Panekauthor=B.+Malawska&title=Recent+development+of+multifunctional+agents+as+potential+drug+candidates+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F0929867321666141106122628"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F0929867321666141106122628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666141106122628%26sid%3Dliteratum%253Aachs%26aulast%3DGuzior%26aufirst%3DN.%26aulast%3DWieckowska%26aufirst%3DA.%26aulast%3DPanek%26aufirst%3DD.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DRecent%2520development%2520of%2520multifunctional%2520agents%2520as%2520potential%2520drug%2520candidates%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D373%26epage%3D404%26doi%3D10.2174%2F0929867321666141106122628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maramai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benchekroun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabr, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yahiaoui, S.</span></span> <span> </span><span class="NLM_article-title">Multitarget therapeutic strategies for Alzheimer’s disease: review on emerging target combinations</span>. <i>BioMed Res. Int.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>2020</i></span>,  <span class="NLM_fpage">5120230</span>, <span class="refDoi"> DOI: 10.1155/2020/5120230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1155%2F2020%2F5120230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=32714977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADC%252BB38jnsVOgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2020&publication_year=2020&pages=5120230&author=S.+Maramaiauthor=M.+Benchekrounauthor=M.+T.+Gabrauthor=S.+Yahiaoui&title=Multitarget+therapeutic+strategies+for+Alzheimer%E2%80%99s+disease%3A+review+on+emerging+target+combinations&doi=10.1155%2F2020%2F5120230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target Combinations</span></div><div class="casAuthors">Maramai Samuele; Benchekroun Mohamed; Gabr Moustafa T; Yahiaoui Samir</div><div class="citationInfo"><span class="NLM_cas:title">BioMed research international</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">2020</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5120230</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neurodegenerative diseases represent nowadays one of the major health problems.  Despite the efforts made to unveil the mechanism leading to neurodegeneration, it is still not entirely clear what triggers this phenomenon and what allows its progression.  Nevertheless, it is accepted that neurodegeneration is a consequence of several detrimental processes, such as protein aggregation, oxidative stress, and neuroinflammation, finally resulting in the loss of neuronal functions.  Starting from these evidences, there has been a wide search for novel agents able to address more than a single event at the same time, the so-called multitarget-directed ligands (MTDLs).  These compounds originated from the combination of different pharmacophoric elements which endowed them with the ability to interfere with different enzymatic and/or receptor systems, or to exert neuroprotective effects by modulating proteins and metal homeostasis.  MTDLs have been the focus of the latest strategies to discover a new treatment for Alzheimer's disease (AD), which is considered the most common form of dementia characterized by neurodegeneration and cognitive dysfunctions.  This review is aimed at collecting the latest and most interesting target combinations for the treatment of AD, with a detailed discussion on new agents with favorable in vitro properties and on optimized structures that have already been assessed in vivo in animal models of dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTf-nmJ6xXlVC86Js-BCLiifW6udTcc2eZ9rui4AFzgs7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38jnsVOgtA%253D%253D&md5=ab46a4d0bdd352cadf2f0257ef40ac84</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1155%2F2020%2F5120230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2020%252F5120230%26sid%3Dliteratum%253Aachs%26aulast%3DMaramai%26aufirst%3DS.%26aulast%3DBenchekroun%26aufirst%3DM.%26aulast%3DGabr%26aufirst%3DM.%2BT.%26aulast%3DYahiaoui%26aufirst%3DS.%26atitle%3DMultitarget%2520therapeutic%2520strategies%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520review%2520on%2520emerging%2520target%2520combinations%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2020%26volume%3D2020%26spage%3D5120230%26doi%3D10.1155%2F2020%2F5120230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S.K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, R.</span></span> <span> </span><span class="NLM_article-title">Naturally occurring and synthetic β-carbolines as cholinesterase inhibitors</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">808</span>– <span class="NLM_lpage">810</span>, <span class="refDoi"> DOI: 10.1002/jps.2600610535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1002%2Fjps.2600610535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=5035798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaE38Xks12qurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1972&pages=808-810&author=S.+Ghosalauthor=S.K.+Bhattacharyaauthor=R.+Mehta&title=Naturally+occurring+and+synthetic+%CE%B2-carbolines+as+cholinesterase+inhibitors&doi=10.1002%2Fjps.2600610535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Naturally occurring and synthetic β-carbolines as cholinesterase inhibitors</span></div><div class="casAuthors">Ghosal, S.; Bhattacharya, S. K.; Mehta, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">808-10</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    </div><div class="casAbstract">The inhibitory activities of a no. of naturally occurring and synthetic aromatic and tetrahydro-β-carbolines toward true cholinesterases [9001-08-5] and pseudocholinesterases [9001-08-5] were detd.  Some quaternary aromatic β-carbolines such as 3-methylindolo[2,3-c]pyridinium (I) [17994-14-8] had .sim.1/6th the in vitro anticholinesterase activity of physostigmine [57-47-6].  The tertiary aromatic β-carbolines tested such as pyrido[3,4-b]indole [244-63-3] had only weak activity and the tetrahydro-β-carbolines tested were inactive.  Structure-activity relations involved in the anticholinesterase activity of β-carbolines were discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMZLz-6JyEnbVg90H21EOLACvtfcHk0lhDeXbkLK4Owg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38Xks12qurw%253D&md5=ad81c6748cc10db1d89be884ef6f10cc</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600610535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600610535%26sid%3Dliteratum%253Aachs%26aulast%3DGhosal%26aufirst%3DS.%26aulast%3DBhattacharya%26aufirst%3DS.K.%26aulast%3DMehta%26aufirst%3DR.%26atitle%3DNaturally%2520occurring%2520and%2520synthetic%2520%25CE%25B2-carbolines%2520as%2520cholinesterase%2520inhibitors%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1972%26volume%3D61%26spage%3D808%26epage%3D810%26doi%3D10.1002%2Fjps.2600610535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Otto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penzis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaube, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winckler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appenroth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleck, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tränkle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enzensperger, C.</span></span> <span> </span><span class="NLM_article-title">Beta and gamma carboline derivatives as potential anti-Alzheimer agents: a comparison</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.09.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2014.09.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=25240096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFOlsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=63-70&author=R.+Ottoauthor=R.+Penzisauthor=F.+Gaubeauthor=T.+Wincklerauthor=D.+Appenrothauthor=C.+Fleckauthor=C.+Tr%C3%A4nkleauthor=J.+Lehmannauthor=C.+Enzensperger&title=Beta+and+gamma+carboline+derivatives+as+potential+anti-Alzheimer+agents%3A+a+comparison&doi=10.1016%2Fj.ejmech.2014.09.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Beta and gamma carboline derivatives as potential anti-Alzheimer agents: A comparison</span></div><div class="casAuthors">Otto, Robert; Penzis, Robert; Gaube, Friedemann; Winckler, Thomas; Appenroth, Dorothea; Fleck, Christian; Traenkle, Christian; Lehmann, Jochen; Enzensperger, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-70</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Nine novel β- and γ-carboline derivs. bearing either methyl-, propargyl- or phenethyl-residues at the indole nitrogen were synthesized and tested as potential anti-Alzheimer drugs.  Antagonism of recombinantly expressed NMDA receptors, inhibition of cholinesterases, and radical scavenging properties were detd. for all compds.  Some were addnl. tested in vivo for their ability to reverse scopolamine-induced cognitive impairment in an 8-arm radial maze expt. with rats.  For the most promising candidates, the interaction with muscarinic M1 receptors was also investigated.  With this set of compds. assays the influence of the scaffold itself and the substituents can be investigated sep.  5-Methyl-γ-carboline (I) was the most potent (0.25 μmol/100 g b.w.) compd. in the in vivo test and might be a good starting point for the development of novel anti-Alzheimer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRwXrBRAcmgbVg90H21EOLACvtfcHk0lhDeXbkLK4Owg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFOlsLzM&md5=d12fd4e4f527b4fe894e9aa80dd361cc</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.09.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.09.048%26sid%3Dliteratum%253Aachs%26aulast%3DOtto%26aufirst%3DR.%26aulast%3DPenzis%26aufirst%3DR.%26aulast%3DGaube%26aufirst%3DF.%26aulast%3DWinckler%26aufirst%3DT.%26aulast%3DAppenroth%26aufirst%3DD.%26aulast%3DFleck%26aufirst%3DC.%26aulast%3DTr%25C3%25A4nkle%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DEnzensperger%26aufirst%3DC.%26atitle%3DBeta%2520and%2520gamma%2520carboline%2520derivatives%2520as%2520potential%2520anti-Alzheimer%2520agents%253A%2520a%2520comparison%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D87%26spage%3D63%26epage%3D70%26doi%3D10.1016%2Fj.ejmech.2014.09.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Filali, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouajila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Znati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bousejra-El
Garah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Jannet, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis of new isoxazoline derivatives from harmine and evaluation of their anti-Alzheimer, anti-cancer and anti-inflammatory activities</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">376</span>, <span class="refDoi"> DOI: 10.3109/14756366.2014.940932</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3109%2F14756366.2014.940932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=25068731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGlsbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2015&pages=371-376&author=I.+Filaliauthor=J.+Bouajilaauthor=M.+Znatiauthor=F.+Bousejra-El%0AGarahauthor=H.+Ben+Jannet&title=Synthesis+of+new+isoxazoline+derivatives+from+harmine+and+evaluation+of+their+anti-Alzheimer%2C+anti-cancer+and+anti-inflammatory+activities&doi=10.3109%2F14756366.2014.940932"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of new isoxazoline derivatives from harmine and evaluation of their anti-Alzheimer, anti-cancer and anti-inflammatory activities</span></div><div class="casAuthors">Filali, Insaf; Bouajila, Jalloul; Znati, Mansour; Bousejra-El Garah, Fatima; Ben Jannet, Hichem</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">371-376</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A series of new harmine derivs. has been prepd. by cycloaddn. reaction using various arylnitrile oxides and evaluated in vitro against acetylcholinesterase and 5-lipoxygenase enzymes, MCF7 and HCT116 cancer cell lines.  Some of these mols. have been shown to be potent inhibitors of acetylcholinesterase and MCF7 cell line.  The greatest activity against acetylcholinesterase (IC50 = 10.4 μM) was obtained for harmine and cytotoxic activities (IC50 = 0.2 μM) for compd. I.  Two derivs. with the thiophene and furan systems, resp., showed good activity against 5-lipoxygenase enzyme (IC50 = 29.2 and 55.5 μM, resp.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZijpKXEwUVrVg90H21EOLACvtfcHk0lhERcqCG29xuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGlsbrP&md5=f6abdf9bdc760dafab6280d7500bdabb</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3109%2F14756366.2014.940932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2014.940932%26sid%3Dliteratum%253Aachs%26aulast%3DFilali%26aufirst%3DI.%26aulast%3DBouajila%26aufirst%3DJ.%26aulast%3DZnati%26aufirst%3DM.%26aulast%3DBousejra-El%2BGarah%26aufirst%3DF.%26aulast%3DBen%2BJannet%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520new%2520isoxazoline%2520derivatives%2520from%2520harmine%2520and%2520evaluation%2520of%2520their%2520anti-Alzheimer%252C%2520anti-cancer%2520and%2520anti-inflammatory%2520activities%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2015%26volume%3D30%26spage%3D371%26epage%3D376%26doi%3D10.3109%2F14756366.2014.940932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Filali, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belkacem, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Nejma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souchard, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Jannet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouajila, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis, cytotoxic, anti-lipoxygenase and anti-acetylcholinesterase capacities of novel derivatives from harmine</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.3109/14756366.2016.1163342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3109%2F14756366.2016.1163342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=27028352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlSrt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=23-33&author=I.+Filaliauthor=M.+A.+Belkacemauthor=A.+Ben+Nejmaauthor=J.-P.+Souchardauthor=H.+Ben+Jannetauthor=J.+Bouajila&title=Synthesis%2C+cytotoxic%2C+anti-lipoxygenase+and+anti-acetylcholinesterase+capacities+of+novel+derivatives+from+harmine&doi=10.3109%2F14756366.2016.1163342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, cytotoxic, anti-lipoxygenase and anti-acetylcholinesterase capacities of novel derivatives from harmine</span></div><div class="casAuthors">Filali, Insaf; Belkacem, Mohamed Amine; Ben Nejma, Aymen; Souchard, Jean Pierre; Ben Jannet, Hichem; Bouajila, Jalloul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">sup1</span>),
    <span class="NLM_cas:pages">23-33</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">We synthesized two series of new hydrazide harmine derivs.  The reaction of harmine (I; R = H) with Et acetate chloride afforded the corresponding Et ester I (R = CH2CO2Et).  The treatment of with hydrazine hydrate gave the hydrazide I (R = CH2CONHNH2) which further converted into hydrazones I [R = CH2CONHN:CHAr; Ar = C6H4(Bu-t)-4, C6H4(NMe2)-4, C6H3(OMe)2-3,4, C6H4(CF2CHF2)-4, C6H4(SMe)-4, C6H4OMe-4, C6H3Cl-4-NO2-3, C6H4CHO-4, quinolin-6-yl, C6H4(morpholin-4-yl)-4] and dihydrazides II (Z = Z1, Z2, NHCO(CH2)2CO2H).  A series of new triazoles III [R' = H, Me, OMe, Cl, Et, NO2] has also been prepd. from the suitable propargylharmine I (R = CH2C≡CH).  The synthesized derivs. were characterized by 1H-NMR, 13C-NMR, and HRMS and evaluated for their activities against MCF7, HCT116 OVCAR-3, acetylcholinesterase and 5-lipoxygenase.  The hydrazones derivs. I [R = CH2CONHN:CHAr] have a good cytotoxic activity against all cell lines, while I [R = CH2CONHN:CHAr; Ar = C6H4(CMe3)-4, C6H4CF2CHF2, C6H4OMe-4, C6H3Cl-4-NO2-3] are more active than harmine (against OVCAR-3 IC50 16.7-2.5 μM).  The compd. I (R = CH2C≡CH) was the most active (IC50 = 1.9 μM) against acetylcholinesterase.  Some compds. exhibited significant activity against 5-lipoxygenase (IC50 = 30.9-63.1 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDoHik8qxToLVg90H21EOLACvtfcHk0lhERcqCG29xuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlSrt7w%253D&md5=290f03b99a12853a936f77ab220aad0b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3109%2F14756366.2016.1163342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2016.1163342%26sid%3Dliteratum%253Aachs%26aulast%3DFilali%26aufirst%3DI.%26aulast%3DBelkacem%26aufirst%3DM.%2BA.%26aulast%3DBen%2BNejma%26aufirst%3DA.%26aulast%3DSouchard%26aufirst%3DJ.-P.%26aulast%3DBen%2BJannet%26aufirst%3DH.%26aulast%3DBouajila%26aufirst%3DJ.%26atitle%3DSynthesis%252C%2520cytotoxic%252C%2520anti-lipoxygenase%2520and%2520anti-acetylcholinesterase%2520capacities%2520of%2520novel%2520derivatives%2520from%2520harmine%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D23%26epage%3D33%26doi%3D10.3109%2F14756366.2016.1163342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khorana, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changwichit, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingkaninan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utsintong, M.</span></span> <span> </span><span class="NLM_article-title">Prospective acetylcholinesterase inhibitory activity of indole and its analogs</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2885</span>– <span class="NLM_lpage">2888</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmcl.2012.02.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=22425563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2885-2888&author=N.+Khoranaauthor=K.+Changwichitauthor=K.+Ingkaninanauthor=M.+Utsintong&title=Prospective+acetylcholinesterase+inhibitory+activity+of+indole+and+its+analogs&doi=10.1016%2Fj.bmcl.2012.02.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Prospective acetylcholinesterase inhibitory activity of indole and its analogs</span></div><div class="casAuthors">Khorana, Nantaka; Changwichit, Kanokwan; Ingkaninan, Kornkanok; Utsintong, Maleeruk</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2885-2888</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Acetylcholinesterase (AChE) inhibitory activity is one of the proposed targets for indole analogs.  Simple indoles with substitution of methoxy, carboxy or hydroxy at the benzene ring showed a low percent of inhibitory activity in eel-AChE.  Adding a side chain at the pyrrole ring, such as serotonin, β-carbolines and quinolines (the bioisostere of indole), improved the inhibitory activity significantly.  However, proper substitution and conformation of the ring were required for good binding.  The result of inhibition in human-AChE of serotonin, β-carbolines and quinolines showed similar profile as eel-AChE with lower magnitude.  The data from mol. docking showed that they shared the same binding site as galantamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq04HPlsXRs7LVg90H21EOLACvtfcHk0lhERcqCG29xuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSiur0%253D&md5=6a176945ba442c4495e141af23cd1563</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.057%26sid%3Dliteratum%253Aachs%26aulast%3DKhorana%26aufirst%3DN.%26aulast%3DChangwichit%26aufirst%3DK.%26aulast%3DIngkaninan%26aufirst%3DK.%26aulast%3DUtsintong%26aufirst%3DM.%26atitle%3DProspective%2520acetylcholinesterase%2520inhibitory%2520activity%2520of%2520indole%2520and%2520its%2520analogs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2885%26epage%3D2888%26doi%3D10.1016%2Fj.bmcl.2012.02.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">Acetylcholinesterase and butyrylcholinesterase inhibitory activities of β-carboline and quinoline alkaloids derivatives from the plants of genus Peganum</span>. <i>J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_fpage">717232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFCqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=717232&author=T.+Zhaoauthor=K.+Dingauthor=L.+Zhangauthor=X.+Chengauthor=C.+Wangauthor=Z.+Wang&title=Acetylcholinesterase+and+butyrylcholinesterase+inhibitory+activities+of+%CE%B2-carboline+and+quinoline+alkaloids+derivatives+from+the+plants+of+genus+Peganum"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase and butyrylcholinesterase inhibitory activities of β-carboline and quinoline alkaloids derivatives from the plants of genus Peganum</span></div><div class="casAuthors">Zhao, Ting; Ding, Ke-Min; Zhang, Lei; Cheng, Xue-Mei; Wang, Chang-Hong; Wang, Zheng-Tao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">717232, 6 pp.</span>CODEN:
                <span class="NLM_cas:coden">JCOHD5</span>;
        ISSN:<span class="NLM_cas:issn">2090-9071</span>.
    
            (<span class="NLM_cas:orgname">Hindawi Publishing Corp.</span>)
        </div><div class="casAbstract">It was reported that the main chem. constituents in plants of genus Peganum were a serial of β-carboline and quinoline alkaloids.  These alkaloids were quant. assessed for selective inhibitory activities on acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) by in vitro Ellman method.  The results indicated that harmane was the most potent selective AChE inhibitor with an IC50 of 7.11 ± 2.00 μM and AChE selectivity index (SI, IC50 of BChE/IC50 of AChE) of 10.82.  Vasicine was the most potent BChE inhibitor with feature of dual AChE/BChE inhibitory activity, with an IC50 vs. AChE/BChE of 13.68 ± 1.25/2.60 ± 1.47 μM and AChE SI of 0.19.  By analyzing and comparing the IC50 and SI of those chems., it was indicated that the β-carboline alkaloids displayed more potent AChE inhibition but less BChE inhibition than quinoline alkaloids.  The substituent at the C7 position of the β-carboline alkaloids and C3 and C9 positions of quinoline alkaloids played a crit. role in AChE or BChE inhibition.  The potent inhibition suggested that those alkaloids may be used as candidates for treatment of Alzheimer's disease.  The anal. of the quant. structure-activity relationship of those compds. investigated might provide guidance for the design and synthesis of AChE and BChE inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8U_do3_oHiLVg90H21EOLACvtfcHk0liNt5wI6nQ1Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFCqsr4%253D&md5=fb2c67d9d109560c2d74a2b3cd766de8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DAcetylcholinesterase%2520and%2520butyrylcholinesterase%2520inhibitory%2520activities%2520of%2520%25CE%25B2-carboline%2520and%2520quinoline%2520alkaloids%2520derivatives%2520from%2520the%2520plants%2520of%2520genus%2520Peganum%26jtitle%3DJ.%2520Chem.%26date%3D2013%26spage%3D717232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span> <span> </span><span class="NLM_article-title">Rapid and sensitive detection of the inhibitive activities of acetyl- and butyryl-cholinesterases inhibitors by UPLC-ESI-MS/MS</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2014.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.jpba.2014.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=24631841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslGmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2014&pages=215-220&author=W.+Liuauthor=Y.+Yangauthor=X.+Chengauthor=C.+Gongauthor=S.+Liauthor=D.+Heauthor=L.+Yangauthor=Z.+Wangauthor=C.+Wang&title=Rapid+and+sensitive+detection+of+the+inhibitive+activities+of+acetyl-+and+butyryl-cholinesterases+inhibitors+by+UPLC-ESI-MS%2FMS&doi=10.1016%2Fj.jpba.2014.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid and sensitive detection of the inhibitive activities of acetyl- and butyryl-cholinesterases inhibitors by UPLC-ESI-MS/MS</span></div><div class="casAuthors">Liu, Wei; Yang, Yadi; Cheng, Xuemei; Gong, Can; Li, Shuping; He, Dandan; Yang, Li; Wang, Zhengtao; Wang, Changhong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are legitimate therapeutic targets for Alzheimer's disease.  The classical approach for screening potential AChE/BChE inhibitors was developed by Ellman.  However, the background color of compds. or plant exts. remained uncertain and frequently interfered with the detection of the secondary reaction, thereby easily yielding false pos. or false neg. results.  Rapid, selective, and sensitive ultra-performance liq. chromatog. combined with electrospray ionization tandem mass spectrometry method was developed and used for the detection of AChE and BChE inhibition by directly detg. the common product, choline (Ch).  Proper sepn. was achieved for choline and chlormequat (internal std.) within 1.2 min via isocratic elution (0.1% formic acid:methanol = 98:2) on an HSS T3 column following a simple pptn. of proteins for sample treatment.  The relative std. deviations of the intra- and inter-day precisions were below 7.34 and 9.09%, resp., whereas the mean accuracy for the quality control samples was 100.31 ± 10.93%.  The method exhibited the advantages of small total reaction vol. (100 μL), short anal. time (1.2 min), high sensitivity (LOQ of 0.036 μM for Ch), and low cost (little consumption enzymes of 0.0035 and 0.008 unit mL-1 for AChE and BChE, and substrates of 5.505 and 7.152 μM for ACh and BCh in individual inhibition, resp.), and without matrix effect (90.00-105.03%).  The developed method was successfully applied for detecting the AChE and BChE inhibitive activities for model drugs, including galanthamine, tacrine, neostigmine methylsulfate, eserine, as well as β-carboline and quinazoline alkaloids from Peganum harmala.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhTnNVFSimN7Vg90H21EOLACvtfcHk0liNt5wI6nQ1Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslGmtbY%253D&md5=6923ec1a9b3044946f3460bd89c01480</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2014.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2014.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DGong%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DRapid%2520and%2520sensitive%2520detection%2520of%2520the%2520inhibitive%2520activities%2520of%2520acetyl-%2520and%2520butyryl-cholinesterases%2520inhibitors%2520by%2520UPLC-ESI-MS%252FMS%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2014%26volume%3D94%26spage%3D215%26epage%3D220%26doi%3D10.1016%2Fj.jpba.2014.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liew, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaw, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugaiyah, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Looi, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustafa, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litaudon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awang, K.</span></span> <span> </span><span class="NLM_article-title">Natural indole butyrylcholinesterase inhibitors from Nauclea officinalis</span>. <i>Phytomedicine</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.phymed.2014.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.phymed.2014.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=25636869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2gsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=45-48&author=S.+Y.+Liewauthor=K.+Y.+Khawauthor=V.+Murugaiyahauthor=C.+Y.+Looiauthor=Y.+L.+Wongauthor=M.+R.+Mustafaauthor=M.+Litaudonauthor=K.+Awang&title=Natural+indole+butyrylcholinesterase+inhibitors+from+Nauclea+officinalis&doi=10.1016%2Fj.phymed.2014.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Natural indole butyrylcholinesterase inhibitors from Nauclea officinalis</span></div><div class="casAuthors">Liew, Sook Yee; Khaw, Kooi Yeong; Murugaiyah, Vikneswaran; Looi, Chung Yeng; Wong, Yi Li; Mustafa, Mohd Rais; Litaudon, Marc; Awang, Khalijah</div><div class="citationInfo"><span class="NLM_cas:title">Phytomedicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-48</span>CODEN:
                <span class="NLM_cas:coden">PYTOEY</span>;
        ISSN:<span class="NLM_cas:issn">0944-7113</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Nine monoterpenoid indole alkaloids; naucletine (1), angustidine (2), nauclefine (3), angustine (4), naucline (5), angustoline (6), harmane (7), 3,14-dihydroangustoline (8), strictosamide (9) and one quinoline alkaloid glycoside; pumiloside (10) from Nauclea officinalis were tested for cholinesterase inhibitory activity.  All the alkaloids except for pumiloside (10) showed strong to weak BChE inhibitory effect with IC50 values ranging between 1.02-168.55 μM.  Angustidine (2), nauclefine (3), angustine (4), angustoline (6) and harmane (7) showed higher BChE inhibiting potency compared to galanthamine.  Angustidine (2) was the most potent inhibitor towards both AChE and BChE.  Mol. docking (MD) studies showed that angustidine (2) docked deep into the bottom gorge of hBChE and formed hydrogen bonding with Ser 198 and His 438.  Kinetic study of angustidine (2) on BChE suggested a mixed inhibition mode with an inhibition const. (Ki) of 6.12 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmrrkkJW8PfbVg90H21EOLACvtfcHk0liNt5wI6nQ1Ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2gsrjF&md5=345ed9b5d525a83b30fc9e72a7cc91c7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.phymed.2014.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phymed.2014.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DLiew%26aufirst%3DS.%2BY.%26aulast%3DKhaw%26aufirst%3DK.%2BY.%26aulast%3DMurugaiyah%26aufirst%3DV.%26aulast%3DLooi%26aufirst%3DC.%2BY.%26aulast%3DWong%26aufirst%3DY.%2BL.%26aulast%3DMustafa%26aufirst%3DM.%2BR.%26aulast%3DLitaudon%26aufirst%3DM.%26aulast%3DAwang%26aufirst%3DK.%26atitle%3DNatural%2520indole%2520butyrylcholinesterase%2520inhibitors%2520from%2520Nauclea%2520officinalis%26jtitle%3DPhytomedicine%26date%3D2015%26volume%3D22%26spage%3D45%26epage%3D48%26doi%3D10.1016%2Fj.phymed.2014.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torres, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzzo, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sant’Anna, C. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kümmerle, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumjanek, V. M.</span></span> <span> </span><span class="NLM_article-title">Structural insights into cholinesterases inhibition by harmane β-carbolinium derivatives: a kinetics - molecular modeling approach</span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2012.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.phytochem.2012.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=22717507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFGltbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=24-30&author=J.+M.+Torresauthor=A.+F.+Liraauthor=D.+R.+Silvaauthor=L.+M.+Guzzoauthor=C.+M.+R.+Sant%E2%80%99Annaauthor=A.+E.+K%C3%BCmmerleauthor=V.+M.+Rumjanek&title=Structural+insights+into+cholinesterases+inhibition+by+harmane+%CE%B2-carbolinium+derivatives%3A+a+kinetics+-+molecular+modeling+approach&doi=10.1016%2Fj.phytochem.2012.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into cholinesterases inhibition by harmane β-carbolinium derivatives: A kinetics - molecular modeling approach</span></div><div class="casAuthors">Torres, Juliana M.; Lira, Aline F.; Silva, Daniel R.; Guzzo, Lucas M.; Sant'Anna, Carlos M. R.; Kuemmerle, Arthur E.; Rumjanek, Victor M.</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24-30</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The natural indole alkaloids, the β-carbolines, are often assocd. with cholinesterase inhibition, esp. their quaternary salts, which frequently have higher activity than the free bases.  Due to lack of information explaining this fact in the literature, the cholinesterase inhibition by the natural product harmane and its two β-carbolinium synthetic deriv. salts (N-Me and N-ethyl) was explored, together with a combination of kinetics and a mol. modeling approach.  The results, mainly for the β-carbolinium salts, demonstrated a noncompetitive inhibition profile, ruling out previous findings which assocd. cholinesterase inhibition by β-carbolinium salts to a possible mimicking of the choline moiety of the natural substrate, acetylcholine.  Mol. modeling studies corroborate this kind of inhibition through analyses of inhibitor/enzyme and inhibitor/substrate/enzyme complexes of both enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvhOAhn6xAobVg90H21EOLACvtfcHk0liOKJfIcK9hLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFGltbbE&md5=e8ac9bf5e50ebd4e3fdd96f72ac16746</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2012.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2012.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DTorres%26aufirst%3DJ.%2BM.%26aulast%3DLira%26aufirst%3DA.%2BF.%26aulast%3DSilva%26aufirst%3DD.%2BR.%26aulast%3DGuzzo%26aufirst%3DL.%2BM.%26aulast%3DSant%25E2%2580%2599Anna%26aufirst%3DC.%2BM.%2BR.%26aulast%3DK%25C3%25BCmmerle%26aufirst%3DA.%2BE.%26aulast%3DRumjanek%26aufirst%3DV.%2BM.%26atitle%3DStructural%2520insights%2520into%2520cholinesterases%2520inhibition%2520by%2520harmane%2520%25CE%25B2-carbolinium%2520derivatives%253A%2520a%2520kinetics%2520-%2520molecular%2520modeling%2520approach%26jtitle%3DPhytochemistry%26date%3D2012%26volume%3D81%26spage%3D24%26epage%3D30%26doi%3D10.1016%2Fj.phytochem.2012.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fadaeinasab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basiri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karimian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugaiyah, V.</span></span> <span> </span><span class="NLM_article-title">New indole alkaloids from the bark of Rauvolfia reflexa and their cholinesterase inhibitory activity</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1997</span>– <span class="NLM_lpage">2011</span>, <span class="refDoi"> DOI: 10.1159/000438560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1159%2F000438560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=26584298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOrt7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2015&pages=1997-2011&author=M.+Fadaeinasabauthor=A.+Basiriauthor=Y.+Kiaauthor=H.+Karimianauthor=H.+M.+Aliauthor=V.+Murugaiyah&title=New+indole+alkaloids+from+the+bark+of+Rauvolfia+reflexa+and+their+cholinesterase+inhibitory+activity&doi=10.1159%2F000438560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">New Indole Alkaloids from the Bark of Rauvolfia Reflexa and their Cholinesterase Inhibitory Activity</span></div><div class="casAuthors">Fadaeinasab, Mehran; Basiri, Alireza; Kia, Yalda; Karimian, Hamed; Ali, Hapipah Mohd.; Murugaiyah, Vikneswaran</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1997-2011</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background/Aims: Rauvolfia reflexa is a member of the Apocynaceae family.  Plants from the Apocynaceae family have been traditionally used in the treatment of age-related brain disorders Methods and Results: Two new indole alkaloids, rauvolfine C (1) and 3-methyl-10,11-dimethoxy-6-methoxycarbonyl-β-carboline (2), along with five known, macusine B (3), vinorine (4), undulifoline (5), isoresrpiline (6) and rescinnamine (7) were isolated from the bark of Rauvolfia reflexa.  Cholinesterase inhibitory assay and mol. docking were performed to get insight of the inhibitory activity and mol. interactions of the compds.  The compds. showed good to moderate cholinesterase inhibitory activity with IC50 values in the range of 8.06 to 73.23 μM.  Compd. 7 was found to be the most potent inhibitor of both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE).  Compds. 1, 2, 5 and 6 were found to be selective towards BChE, while compds. 3, 4 and 7 were dual inhibitors, having almost equal inhibitory activity on both AChE and BChE.  Mol. docking revealed that compds. 6 and 7 interacted differently on AChE and BChE, by means of hydrophobic interactions and hydrogen bonding.  In AChE, the indole moiety of both compds. interacted with the residues lining the peripheral anionic site, whereas in BChE, their methoxy groups are primarily responsible for the strong inhibitory activity via interactions with residues at the active site of the enzyme.  Conclusion: Two new and five known indole alkaloids were isolated from R. reflexa.  Among the compds., 7 and 6 showed the most potent and promising cholinesterase inhibitory activity, worthy for further investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRZ_njbvExjrVg90H21EOLACvtfcHk0liOKJfIcK9hLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOrt7bL&md5=68b26792529b1b9a20d9a62e6dec3fe0</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1159%2F000438560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000438560%26sid%3Dliteratum%253Aachs%26aulast%3DFadaeinasab%26aufirst%3DM.%26aulast%3DBasiri%26aufirst%3DA.%26aulast%3DKia%26aufirst%3DY.%26aulast%3DKarimian%26aufirst%3DH.%26aulast%3DAli%26aufirst%3DH.%2BM.%26aulast%3DMurugaiyah%26aufirst%3DV.%26atitle%3DNew%2520indole%2520alkaloids%2520from%2520the%2520bark%2520of%2520Rauvolfia%2520reflexa%2520and%2520their%2520cholinesterase%2520inhibitory%2520activity%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2015%26volume%3D37%26spage%3D1997%26epage%3D2011%26doi%3D10.1159%2F000438560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schott, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommelspacher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J.</span></span> <span> </span><span class="NLM_article-title">6-Hydroxy- and 6-methoxy-β-carbolines as acetyl- and butyrylcholinesterase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5840</span>– <span class="NLM_lpage">5843</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.08.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmcl.2006.08.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=16945529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCrt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5840-5843&author=Y.+Schottauthor=M.+Deckerauthor=H.+Rommelspacherauthor=J.+Lehmann&title=6-Hydroxy-+and+6-methoxy-%CE%B2-carbolines+as+acetyl-+and+butyrylcholinesterase+inhibitors&doi=10.1016%2Fj.bmcl.2006.08.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">6-Hydroxy- and 6-methoxy-β-carbolines as acetyl- and butyrylcholinesterase inhibitors</span></div><div class="casAuthors">Schott, Yvonne; Decker, Michael; Rommelspacher, Hans; Lehmann, Jochen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5840-5843</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Studies directed toward the discovery of novel acetyl- and butyrylcholinesterase (AChE and BChE) inhibitors for the treatment of Alzheimer's disease were focused on β-carbolines (BCs).  6-Oxygenated β-carboline, e.g., I (R = H or Me), and β-carbolinium derivs. based on the serotonin template were synthesized and tested in vitro for their ability to inhibit AChE and BChE, resp.  The carbolinium salts, in particular, which could be formed by intracerebral methylation of tertiary-BC prodrugs, showed inhibitory activity levels reaching those of galantamine, physostigmine, and rivastigmine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHSREbW1WrQbVg90H21EOLACvtfcHk0liOKJfIcK9hLQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCrt73M&md5=a61352380685c67f9846a614a9e62806</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.08.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.08.067%26sid%3Dliteratum%253Aachs%26aulast%3DSchott%26aufirst%3DY.%26aulast%3DDecker%26aufirst%3DM.%26aulast%3DRommelspacher%26aufirst%3DH.%26aulast%3DLehmann%26aufirst%3DJ.%26atitle%3D6-Hydroxy-%2520and%25206-methoxy-%25CE%25B2-carbolines%2520as%2520acetyl-%2520and%2520butyrylcholinesterase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5840%26epage%3D5843%26doi%3D10.1016%2Fj.bmcl.2006.08.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span> <span> </span><span class="NLM_article-title">Potent AChE and BChE inhibitors isolated from seeds of Peganum harmala Linn by a bioassay-guided fractionation</span>. <i>J. Ethnopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1016/j.jep.2015.03.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.jep.2015.03.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=25862961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsVajuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2015&pages=279-286&author=Y.+Yangauthor=X.+Chengauthor=W.+Liuauthor=G.+Chouauthor=Z.+Wangauthor=C.+Wang&title=Potent+AChE+and+BChE+inhibitors+isolated+from+seeds+of+Peganum+harmala+Linn+by+a+bioassay-guided+fractionation&doi=10.1016%2Fj.jep.2015.03.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Potent AChE and BChE inhibitors isolated from seeds of Peganum harmala Linn by a bioassay-guided fractionation</span></div><div class="casAuthors">Yang, Yadi; Cheng, Xuemei; Liu, Wei; Chou, Guixin; Wang, Zhengtao; Wang, Changhong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Ethnopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">279-286</span>CODEN:
                <span class="NLM_cas:coden">JOETD7</span>;
        ISSN:<span class="NLM_cas:issn">0378-8741</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Seeds of Peganum harmala Linn are traditionally used as folk medical herb in Uighur medicine in China to treat disorders of hemiplegia and amnesia.  Previously studies have proved that dominating alkaloids in P. harmala show significant inhibitory activities on the cholinesterase.  The aim of the present study is to isolate trace ingredients from seeds of P. harmala and evaluate its inhibitory activities on acetylcholinesterase (AChE) and butyrylcholinesterase (BChE).  For sake of screening effective cholinesterase inhibitors, trace compds. were isolated from seeds of P. harmala through a bioassay-guided fractionation and their structures were detd. via detailed spectral anal.  The inhibitory activities on AChE and BChE were assessed using an improved Ellman method by UPLC-ESI-MS/MS to det. the common final product choline.  The activity-guided fractionation led to the isolation of two new alkaloids 2-aldehyde-tetrahydroharmine (10), 2-carboxyl-3,4-dihydroquinazoline (19), one syringin structure analog 1-O-β-D-xylopyranose sinapyl alc. (22), and along with 19 known compds.  Compds. acetylnorharmine (6), harmic acid methy ester (7), harmine N-oxide (13), 6-methoxyindoline (14), syringin (21) were first found from genus Peganum and compds. 3-hydroxylated harmine (4), 1-hydroxy-7-methoxy-β-carboline (5) were new natural products.  The results showed that the 2-aldehyde-tetrahydroharmine (10) has a potential inbibitive effect on both AChE and BChE with IC50 values of 12.35±0.24 and 5.51±0.33 μM, resp.  Deoxyvasicine (15) and vasicine (16) showed the strongest BChE inhibitory activity with IC50 values of 0.04±0.01 and 0.1±0.01 μM.  The anal. of the structure-activity relationship indicated that the satn. of pyridine ring and the presence of substitution at indole ring, C-1, C-3, C-7 and N-2, for β-carbolines, were essential for effective inhibition of both AChE and BChE and the five-membered ring between C-2 and N-3 as well as the substituent groups sited at C-4 and C-9, for quinazolines, were important to both the AChE/BChE-inhibitory activity.  Bioassay-guided fractionation has led to the isolation of AChE and BChE inhibitors from the seeds of P. harmala.  These results are in agreement with the traditional uses of the seeds of P. harmala.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqppqAK7pOAtrVg90H21EOLACvtfcHk0liMohsUawMs7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsVajuro%253D&md5=36c095e788b3e9a3853f00252a32844f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.jep.2015.03.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jep.2015.03.070%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChou%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DPotent%2520AChE%2520and%2520BChE%2520inhibitors%2520isolated%2520from%2520seeds%2520of%2520Peganum%2520harmala%2520Linn%2520by%2520a%2520bioassay-guided%2520fractionation%26jtitle%3DJ.%2520Ethnopharmacol.%26date%3D2015%26volume%3D168%26spage%3D279%26epage%3D286%26doi%3D10.1016%2Fj.jep.2015.03.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arshad, A. S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chear, N. J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezzat, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanapi, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meesala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arshad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansor, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mordi, M. N.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization and crystal structure of new tetrahydro-β-carboline as acetylcholinesterase inhibitor</span>. <i>J. Mol. Struct.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>1200</i></span>,  <span class="NLM_fpage">127070</span>, <span class="refDoi"> DOI: 10.1016/j.molstruc.2019.127070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.molstruc.2019.127070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVKktbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1200&publication_year=2020&pages=127070&author=A.+S.+M.+Arshadauthor=N.+J.+Y.+Chearauthor=M.+O.+Ezzatauthor=N.+A.+Hanapiauthor=R.+Meesalaauthor=S.+Arshadauthor=S.+M.+Mansorauthor=M.+N.+Mordi&title=Synthesis%2C+characterization+and+crystal+structure+of+new+tetrahydro-%CE%B2-carboline+as+acetylcholinesterase+inhibitor&doi=10.1016%2Fj.molstruc.2019.127070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization and crystal structure of new tetrahydro-β-carboline as acetylcholinesterase inhibitor</span></div><div class="casAuthors">Mohamad Arshad, Ahmad Saifuddin; Chear, Nelson Jeng Yeou; Ezzat, Mohammed Oday; Hanapi, Nur Aziah; Meesala, Ramu; Arshad, Suhana; Mansor, Sharif Mahsufi; Mordi, Mohd Nizam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Structure</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">1200</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127070pp.</span>CODEN:
                <span class="NLM_cas:coden">JMOSB4</span>;
        ISSN:<span class="NLM_cas:issn">0022-2860</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A new tetrahydro-β-carboline deriv., 2-benzoyl-6-methoxy-9-methyl-1-phenyl-1,2,3,4-tetrahydro-β-carboline was synthesized through a three-steps reaction in good yield (76%).  The structure of this compd. was characterized by different spectroscopic methods including NMR (1D and 2D), UV, IR and MS.  Mol. structure of the synthesized compd. was also confirmed by single crystal X-ray diffraction technique.  Further, evaluation of in-vitro acetylcholinesterase (AChE) inhibitory activity showcased the potential of this compd. as AChE inhibitor with an IC50 value of 26.52 ± 0.79 μM.  In addn., this compd. showed minimal toxicol. profile at cellular level.  Docking simulation illustrated a highly selective binding at peripheral side of AChE via hydrophobic interactions.  In silico prediction of blood-brain barrier (BBB) permeation and ADMET properties of the compd. was also reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYXnvNGMw1KLVg90H21EOLACvtfcHk0liMohsUawMs7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVKktbfM&md5=8f19cd55cd53b855c6c61bbc88ba6a2b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.molstruc.2019.127070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molstruc.2019.127070%26sid%3Dliteratum%253Aachs%26aulast%3DArshad%26aufirst%3DA.%2BS.%2BM.%26aulast%3DChear%26aufirst%3DN.%2BJ.%2BY.%26aulast%3DEzzat%26aufirst%3DM.%2BO.%26aulast%3DHanapi%26aufirst%3DN.%2BA.%26aulast%3DMeesala%26aufirst%3DR.%26aulast%3DArshad%26aufirst%3DS.%26aulast%3DMansor%26aufirst%3DS.%2BM.%26aulast%3DMordi%26aufirst%3DM.%2BN.%26atitle%3DSynthesis%252C%2520characterization%2520and%2520crystal%2520structure%2520of%2520new%2520tetrahydro-%25CE%25B2-carboline%2520as%2520acetylcholinesterase%2520inhibitor%26jtitle%3DJ.%2520Mol.%2520Struct.%26date%3D2020%26volume%3D1200%26spage%3D127070%26doi%3D10.1016%2Fj.molstruc.2019.127070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span> <span> </span><span class="NLM_article-title">N-methoxy-β-carboline alkaloids with inhibitory activities against Aβ42 aggregation and acetylcholinesterase from the stems of Picrasma quassioides</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">104043</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.104043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bioorg.2020.104043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=32629286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlCltL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2020&pages=104043&author=J.+Zhangauthor=S.-S.+Zhaoauthor=J.+Xieauthor=J.+Yangauthor=G.-D.+Chenauthor=D.+Huauthor=W.-G.+Zhangauthor=C.-X.+Wangauthor=X.-S.+Yaoauthor=H.+Gao&title=N-methoxy-%CE%B2-carboline+alkaloids+with+inhibitory+activities+against+A%CE%B242+aggregation+and+acetylcholinesterase+from+the+stems+of+Picrasma+quassioides&doi=10.1016%2Fj.bioorg.2020.104043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">N-methoxy-β-carboline alkaloids with inhibitory activities against Aβ42 aggregation and acetylcholinesterase from the stems of Picrasma quassioides</span></div><div class="casAuthors">Zhang, Jie; Zhao, Sen-Sen; Xie, Jun; Yang, Jian; Chen, Guo-Dong; Hu, Dan; Zhang, Wei-Guang; Wang, Chuan-Xi; Yao, Xin-Sheng; Gao, Hao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104043</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nine new N-methoxy-beta-carboline alkaloids (NMCAs) (1a/1b-3a/3b and 4-6) and two known NMCAs (7 and 8) were isolated from the stems of Picrasma quassioides.  Their structures were elucidated by spectroscopic data analyses, quantum chem. calcns., and single-crystal X-ray crystallog. data.  An anal. of the 13C NMR chem. shifts of the N-methoxy groups in these NMCAs and 41 gathered known compds. reveals the phenomenon that the chem. shifts of all these N-methoxy groups are greater than U+03B4 C 62, which can be used to recognize the N-methoxy group rapidly.  In addn., the acetylcholinesterase (AChE) and Abeta42 aggregation inhibitory activities of 1-8 were evaluated.  Compds. 1, 2, 7, and 8 displayed AChE inhibitory activity with IC50 values of 14.9, 13.2, 17.6, and 43.9 microM, resp.  Compd. 2 showed inhibition activity against Abeta42 aggregation with an IC50 value of 10.1 microM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ3z5kJX3NR7Vg90H21EOLACvtfcHk0ljyuc65m4moJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlCltL%252FP&md5=3280247e4989d696013765dc915f3204</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.104043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.104043%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DS.-S.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.-D.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DWang%26aufirst%3DC.-X.%26aulast%3DYao%26aufirst%3DX.-S.%26aulast%3DGao%26aufirst%3DH.%26atitle%3DN-methoxy-%25CE%25B2-carboline%2520alkaloids%2520with%2520inhibitory%2520activities%2520against%2520A%25CE%25B242%2520aggregation%2520and%2520acetylcholinesterase%2520from%2520the%2520stems%2520of%2520Picrasma%2520quassioides%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D101%26spage%3D104043%26doi%3D10.1016%2Fj.bioorg.2020.104043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fadaeinasab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadi, A. H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basiri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugaiyah, V.</span></span> <span> </span><span class="NLM_article-title">Cholinesterase enzymes inhibitors from the leaves of Rauvolfia reflexa and their molecular docking study</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3779</span>– <span class="NLM_lpage">3788</span>, <span class="refDoi"> DOI: 10.3390/molecules18043779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3390%2Fmolecules18043779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=23529036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlslCmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=3779-3788&author=M.+Fadaeinasabauthor=A.+H.+A.+Hadiauthor=Y.+Kiaauthor=A.+Basiriauthor=V.+Murugaiyah&title=Cholinesterase+enzymes+inhibitors+from+the+leaves+of+Rauvolfia+reflexa+and+their+molecular+docking+study&doi=10.3390%2Fmolecules18043779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Cholinesterase enzymes inhibitors from the leaves of Rauvolfia reflexa and their molecular docking study</span></div><div class="casAuthors">Fadaeinasab, Mehran; Hadi, A. Hamid A.; Kia, Yalda; Basiri, Alireza; Murugaiyah, Vikneswaran</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3779-3788</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Plants of the Apocynaceae family have been traditionally used in the treatment of age-related brain disorders.  Rauvolfia reflexa, a member of the family, has been used as an antidote for poisons and to treat malaria.  The dichloromethane, ethanol and methanol exts. from the leaves of Rauvolfia reflexa showed potential acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activities, with IC50 values in the 8.49 to 52.23 g/mL range.  Further cholinesterase inhibitory-guided isolation of these exts. afforded four bioactive compds., namely: (E)-3-(3,4,5-trimethoxyphenyl)acrylic acid (1), (E)-Me 3-(4-hydroxy-3,5-dimethoxyphenyl) acrylate (2), 17-methoxycarbonyl-14-heptadecaenyl-4-hydroxy-3-methoxycinnamate (3) and 1,2,3,4-tetrahydro-1-oxo-β-carboline (4).  The isolated compds. showed moderate cholinesterase inhibitory activity compared to the ref. std., physostigmine.  Compds. 1 and 2 showed the highest inhibitory activity against AChE (IC50 = 60.17 μM) and BChE (IC50 = 61.72 μM), resp.  Despite having similar mol. wt., compds. 1 and 2 were structurally different according to their chem. substitution patterns, leading to their different enzyme inhibition selectivity.  Compd. 2 was more selective against BChE, whereas compd. 1 was a selective inhibitor of AChE.  Mol. docking revealed that both compds. 1 and 2 were inserted, but not deeply into the active site of the cholinesterase enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_M3AXAPvha7Vg90H21EOLACvtfcHk0ljyuc65m4moJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlslCmsr0%253D&md5=0f3efe1f64254166cc04e20bbd42236c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3390%2Fmolecules18043779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules18043779%26sid%3Dliteratum%253Aachs%26aulast%3DFadaeinasab%26aufirst%3DM.%26aulast%3DHadi%26aufirst%3DA.%2BH.%2BA.%26aulast%3DKia%26aufirst%3DY.%26aulast%3DBasiri%26aufirst%3DA.%26aulast%3DMurugaiyah%26aufirst%3DV.%26atitle%3DCholinesterase%2520enzymes%2520inhibitors%2520from%2520the%2520leaves%2520of%2520Rauvolfia%2520reflexa%2520and%2520their%2520molecular%2520docking%2520study%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26spage%3D3779%26epage%3D3788%26doi%3D10.3390%2Fmolecules18043779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abuhamdah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habash, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taha, M. O.</span></span> <span> </span><span class="NLM_article-title">Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitors</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1075</span>– <span class="NLM_lpage">1092</span>, <span class="refDoi"> DOI: 10.1007/s10822-013-9699-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1007%2Fs10822-013-9699-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=24338032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWqu7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=1075-1092&author=S.+Abuhamdahauthor=M.+Habashauthor=M.+O.+Taha&title=Elaborate+ligand-based+modeling+coupled+with+QSAR+analysis+and+in+silico+screening+reveal+new+potent+acetylcholinesterase+inhibitors&doi=10.1007%2Fs10822-013-9699-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitors</span></div><div class="casAuthors">Abuhamdah, Sawsan; Habash, Maha; Taha, Mutasem O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1075-1092</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Inhibition of the enzyme acetylcholinesterase (AChE) has been shown to alleviate neurodegenerative diseases prompting several attempts to discover and optimize new AChE inhibitors.  In this direction, we explored the pharmacophoric space of 85 AChE inhibitors to identify high quality pharmacophores.  Subsequently, we implemented genetic algorithm-based quant. structure-activity relationship (QSAR) modeling to select optimal combination of pharmacophoric models and 2D physicochem. descriptors capable of explaining bioactivity variation among training compds. (r268 = 0.94, F-statistic = 125.8, r2LOO = 0.92, r2PRESS against 17 external test inhibitors = 0.84).  Two orthogonal pharmacophores emerged in the QSAR equation suggesting the existence of at least two binding modes accessible to ligands within AChE binding pocket.  The successful pharmacophores were comparable with crystallog. resolved AChE binding pocket.  We employed the pharmacophoric models and assocd. QSAR equation to screen the national cancer institute list of compds.  Twenty-four low micromolar AChE inhibitors were identified.  The most potent gave IC50 value of 1.0 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBhZYevHRRWrVg90H21EOLACvtfcHk0ljyuc65m4moJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWqu7zM&md5=5645f93992fc010575a355392c260d25</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9699-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9699-6%26sid%3Dliteratum%253Aachs%26aulast%3DAbuhamdah%26aufirst%3DS.%26aulast%3DHabash%26aufirst%3DM.%26aulast%3DTaha%26aufirst%3DM.%2BO.%26atitle%3DElaborate%2520ligand-based%2520modeling%2520coupled%2520with%2520QSAR%2520analysis%2520and%2520in%2520silico%2520screening%2520reveal%2520new%2520potent%2520acetylcholinesterase%2520inhibitors%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D1075%26epage%3D1092%26doi%3D10.1007%2Fs10822-013-9699-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horton, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peerannawar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugyela, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulsan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soule, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeVine, H.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Török, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Török, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and application of β-carbolines as novel multi-functional anti-Alzheimer’s disease agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">232</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.11.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmcl.2016.11.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=27923619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVWmtLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=232-236&author=W.+Hortonauthor=A.+Soodauthor=S.+Peerannawarauthor=N.+Kugyelaauthor=A.+Kulkarniauthor=R.+Tulsanauthor=C.+D.+Tranauthor=J.+Souleauthor=H.+LeVineauthor=B.+T%C3%B6r%C3%B6kauthor=M.+T%C3%B6r%C3%B6k&title=Synthesis+and+application+of+%CE%B2-carbolines+as+novel+multi-functional+anti-Alzheimer%E2%80%99s+disease+agents&doi=10.1016%2Fj.bmcl.2016.11.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and application of β-carbolines as novel multi-functional anti-Alzheimer's disease agents</span></div><div class="casAuthors">Horton, William; Sood, Abha; Peerannawar, Swarada; Kugyela, Nandor; Kulkarni, Aditya; Tulsan, Rekha; Tran, Chris D.; Soule, Jessica; LeVine, Harry III; Torok, Bela; Torok, Marianna</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">232-236</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The design, synthesis and assessment of β-carboline core-based compds. as potential multifunctional agents against several processes that are believed to play a significant role in Alzheimer's disease (AD) pathol., are described.  The activity of the compds. was detd. in Aβ self-assembly (fibril and oligomer formation) and cholinesterase (AChE, BuChE) activity inhibition, and their antioxidant properties were also assessed.  To obtain insight into the mode of action of the compds., HR-MS studies were carried out on the inhibitor-Aβ complex formation and mol. docking was performed on inhibitor-BuChE interactions.  While several compds. exhibited strong activities in individual assays, compd. I emerged as a promising multi-target lead for the further structure-activity relationship studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDCaZu-pq16LVg90H21EOLACvtfcHk0lgs78aP1Le_Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVWmtLrI&md5=a89bb70680241cb381dcf42bc938cb18</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.11.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.11.067%26sid%3Dliteratum%253Aachs%26aulast%3DHorton%26aufirst%3DW.%26aulast%3DSood%26aufirst%3DA.%26aulast%3DPeerannawar%26aufirst%3DS.%26aulast%3DKugyela%26aufirst%3DN.%26aulast%3DKulkarni%26aufirst%3DA.%26aulast%3DTulsan%26aufirst%3DR.%26aulast%3DTran%26aufirst%3DC.%2BD.%26aulast%3DSoule%26aufirst%3DJ.%26aulast%3DLeVine%26aufirst%3DH.%26aulast%3DT%25C3%25B6r%25C3%25B6k%26aufirst%3DB.%26aulast%3DT%25C3%25B6r%25C3%25B6k%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520application%2520of%2520%25CE%25B2-carbolines%2520as%2520novel%2520multi-functional%2520anti-Alzheimer%25E2%2580%2599s%2520disease%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D232%26epage%3D236%26doi%3D10.1016%2Fj.bmcl.2016.11.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tadokoro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsunaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, R.</span></span> <span> </span><span class="NLM_article-title">N-Methyl-β-carbolinium salts and an N-methylated 8-oxoisoguanine as acetylcholinesterase inhibitors from a solitary ascidian, Cnemidocarpa irene</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1074</span>– <span class="NLM_lpage">1080</span>, <span class="refDoi"> DOI: 10.1021/acsomega.7b00127</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.7b00127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXks1SqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=1074-1080&author=Y.+Tadokoroauthor=T.+Nishikawaauthor=T.+Ichimoriauthor=S.+Matsunagaauthor=M.+J.+Fujitaauthor=R.+Sakai&title=N-Methyl-%CE%B2-carbolinium+salts+and+an+N-methylated+8-oxoisoguanine+as+acetylcholinesterase+inhibitors+from+a+solitary+ascidian%2C+Cnemidocarpa+irene&doi=10.1021%2Facsomega.7b00127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">N-Methyl-β-carbolinium Salts and an N-Methylated 8-Oxoisoguanine as Acetylcholinesterase Inhibitors from a Solitary Ascidian, Cnemidocarpa irene</span></div><div class="casAuthors">Tadokoro, Yohei; Nishikawa, Teruaki; Ichimori, Taichi; Matsunaga, Satoko; Fujita, Masaki J.; Sakai, Ryuichi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1074-1080</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New brominated β-carbolines, irenecarbolines A (I) and B (II), along with 2 known β-carbolines (N-methyl-β-carbolinium and N-methyl-β-carboline-3-carboxylate) and a new 8-oxoisoguanine deriv. (III), were isolated from a solitary ascidian Cnemidocarpa irene.  The structures of these compds. were detd. on the basis of their spectral data.  All 3 new compds. inhibited the action of acetylcholinesterase (AchE).  The activities of irenecarboline A and the new 8-oxoisoguanine deriv. were comparable to that of galantamine, a clin. used AchE inhibitor.  I and N-methyl-β-carbolinium were present in high concns. in the blood, and fluorescence was obsd. in certain types of cells found in the blood of the tunicate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTSVI3LC2EirVg90H21EOLACvtfcHk0lgs78aP1Le_Hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXks1SqsLY%253D&md5=3c817edf0c466d046cd05d8799623012</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facsomega.7b00127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.7b00127%26sid%3Dliteratum%253Aachs%26aulast%3DTadokoro%26aufirst%3DY.%26aulast%3DNishikawa%26aufirst%3DT.%26aulast%3DIchimori%26aufirst%3DT.%26aulast%3DMatsunaga%26aufirst%3DS.%26aulast%3DFujita%26aufirst%3DM.%2BJ.%26aulast%3DSakai%26aufirst%3DR.%26atitle%3DN-Methyl-%25CE%25B2-carbolinium%2520salts%2520and%2520an%2520N-methylated%25208-oxoisoguanine%2520as%2520acetylcholinesterase%2520inhibitors%2520from%2520a%2520solitary%2520ascidian%252C%2520Cnemidocarpa%2520irene%26jtitle%3DACS%2520Omega%26date%3D2017%26volume%3D2%26spage%3D1074%26epage%3D1080%26doi%3D10.1021%2Facsomega.7b00127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rook, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidtke, K.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaube, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wünsch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heilmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winckler, T.</span></span> <span> </span><span class="NLM_article-title">Bivalent β-carbolines as potential multitarget anti-Alzheimer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3611</span>– <span class="NLM_lpage">3617</span>, <span class="refDoi"> DOI: 10.1021/jm1000024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1000024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1Wksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3611-3617&author=Y.+Rookauthor=K.-U.+Schmidtkeauthor=F.+Gaubeauthor=D.+Schepmannauthor=B.+W%C3%BCnschauthor=J.+Heilmannauthor=J.+Lehmannauthor=T.+Winckler&title=Bivalent+%CE%B2-carbolines+as+potential+multitarget+anti-Alzheimer+agents&doi=10.1021%2Fjm1000024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Bivalent β-Carbolines as Potential Multitarget Anti-Alzheimer Agents</span></div><div class="casAuthors">Rook, Yvonne; Schmidtke, Kai-Uwe; Gaube, Friedemann; Schepmann, Dirk; Wuensch, Bernhard; Heilmann, Joerg; Lehmann, Jochen; Winckler, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3611-3617</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a prevalent neurodegenerative disorder with multifactorial causes that requires multitargeted treatment.  Inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) improve cholinergic signaling in the central nervous system and thus AChE inhibitors are well established in the therapy of AD to improve memory disturbances and other cognitive symptoms.  On the other hand, AD patients benefit from redn. of pathol. glutamate-induced, Ca2+-mediated excitotoxicity by the N-methyl-D-aspartate receptor (NR) antagonist memantine.  New drugs that simultaneously affect both cholinergic transmission and glutamate-induced excitotoxicity may further improve AD treatment.  While connecting β-carboline units by alkylene spacers in two different series of compds. and subsequent evaluation of their AChE/BChE-inhibitory potential, we found that several of these bivalent β-carbolines were potent NR blockers.  The most promising compd. was a N9-homobivalent β-carboline with a nonylene spacer, which displayed IC50 values of 0.5 nM for AChE, 5.7 nM for BChE, and 1.4 μM for NR, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3hQIsqoLuHbVg90H21EOLACvtfcHk0liyGFsIjR3PgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1Wksbo%253D&md5=0e0bb88f9dc3e023d9538cb186643cd4</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm1000024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1000024%26sid%3Dliteratum%253Aachs%26aulast%3DRook%26aufirst%3DY.%26aulast%3DSchmidtke%26aufirst%3DK.-U.%26aulast%3DGaube%26aufirst%3DF.%26aulast%3DSchepmann%26aufirst%3DD.%26aulast%3DW%25C3%25BCnsch%26aufirst%3DB.%26aulast%3DHeilmann%26aufirst%3DJ.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DWinckler%26aufirst%3DT.%26atitle%3DBivalent%2520%25CE%25B2-carbolines%2520as%2520potential%2520multitarget%2520anti-Alzheimer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3611%26epage%3D3617%26doi%3D10.1021%2Fjm1000024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span> <span> </span><span class="NLM_article-title">Peganumine B-I and two enantiomers: new alkaloids from the seeds of Peganum harmala Linn. and their potential cytotoxicity and cholinesterase inhibitory activities</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">15976</span>– <span class="NLM_lpage">15987</span>, <span class="refDoi"> DOI: 10.1039/C6RA00086J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1039%2FC6RA00086J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVSju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=15976-15987&author=Y.+Yangauthor=X.+Chengauthor=W.+Liuauthor=Z.+Hanauthor=G.+Chouauthor=Y.+Wangauthor=D.+Sunauthor=Z.+Wangauthor=C.+Wang&title=Peganumine+B-I+and+two+enantiomers%3A+new+alkaloids+from+the+seeds+of+Peganum+harmala+Linn.+and+their+potential+cytotoxicity+and+cholinesterase+inhibitory+activities&doi=10.1039%2FC6RA00086J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Peganumine B-I and two enantiomers: new alkaloids from the seeds of Peganum harmala Linn. and their potential cytotoxicity and cholinesterase inhibitory activities</span></div><div class="casAuthors">Yang, Ya-di; Cheng, Xue-mei; Liu, Wei; Han, Zhu-zhen; Chou, Gui-xin; Wang, Ying; Sun, Du-xin; Wang, Zheng-tao; Wang, Chang-hong</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">15976-15987</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Ten new alkaloids (peganumine B-I and two enantiomers), contg. five β-carbolines, three quinazolones, two compds. with both of the above skeletons, and one amphoteric alkaloid with a four-membered ring, were isolated from the ethanol ext. of Peganum harmala.  Their structures were elucidated on the basis of spectral data using 1D and 2D NMR, X-ray crystallog. anal., CD, and ECD.  Peganumine B showed potential inhibitory activity against both AChE and BChE with IC50 values of 0.25 ± 0.04, and 1.45 ± 0.34 μM, resp.  Peganumine C, peganumine D, and peganumine I were found to have selective inhibitory activity against AChE with IC50 values of 14.38 ± 2.49, 5.71 ± 1.22, and 7.17 ± 1.45 μM, resp.  Peganumine G and peganumine H showed significant cytotoxicity against a ZR-75-1 cell line with IC50 values of 6.20 ± 2.71, and 2.43 ± 0.79 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJDp4Lnxl53LVg90H21EOLACvtfcHk0liyGFsIjR3PgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVSju7k%253D&md5=b21784bdb3183446be1318a1ec49a66f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2FC6RA00086J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6RA00086J%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DChou%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DPeganumine%2520B-I%2520and%2520two%2520enantiomers%253A%2520new%2520alkaloids%2520from%2520the%2520seeds%2520of%2520Peganum%2520harmala%2520Linn.%2520and%2520their%2520potential%2520cytotoxicity%2520and%2520cholinesterase%2520inhibitory%2520activities%26jtitle%3DRSC%2520Adv.%26date%3D2016%26volume%3D6%26spage%3D15976%26epage%3D15987%26doi%3D10.1039%2FC6RA00086J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span> <span> </span><span class="NLM_article-title">New 2-aryl-9-methyl-β-carbolinium salts as potential acetylcholinesterase inhibitor agents: synthesis, bioactivity and structure-activity relationship</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1559</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-19999-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1038%2Fs41598-018-19999-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=29367595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADC%252BC1MvktVOgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=1559&author=B.+Zhouauthor=B.+Zhangauthor=X.+Liauthor=X.+Liuauthor=H.+Liauthor=D.+Liauthor=Z.+Cuiauthor=H.+Gengauthor=L.+Zhou&title=New+2-aryl-9-methyl-%CE%B2-carbolinium+salts+as+potential+acetylcholinesterase+inhibitor+agents%3A+synthesis%2C+bioactivity+and+structure-activity+relationship&doi=10.1038%2Fs41598-018-19999-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">New 2-Aryl-9-methyl-β-carbolinium salts as Potential Acetylcholinesterase Inhibitor agents: Synthesis, Bioactivity and Structure-Activity Relationship</span></div><div class="casAuthors">Zhou Bohang; Zhang Bingyu; Li Xingqiang; Liu Xiuxiu; Li Hui; Li Ding; Cui Zhiming; Geng Huiling; Zhou Le</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1559</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A series of 2-aryl-9-methyl-β-carbolinium bromides (B) were synthesized and explored for anti-acetylcholinesterase (AChE) activities in vitro, action mechanism and structure-activity relationship.  All the compounds B along with their respective 3,4-dihydro intermediates (A) presented anti-AChE activity at 10 μM.  Thirteen compounds B showed the excellent activity with IC50 values of 0.11-0.76 μM and high selectivity toward AChE relative to butyrylcholinesterase (BChE), superior to galantamine (IC50 = 0.79 μM), a selective AChE inhibitor drug.  Kinetic analysis showed that the action mechanisms of both compounds B and A are a competitive inhibition model.  Structure-activity relationship analyses showed that the C = N(+) moiety is a determinant for the activity.  Substituents at 6, 7 or 4' site, the indole-N-alkyl and the aromatization of the C-ring can significantly improve the activity.  Molecular docking studies showed that the compounds could combine with the active site of AChE by the π-π or cation-π action between the carboline ring and the phenyl rings of the residues, and the β-carboline moiety is embedded in a cavity surrounded by four aromatic residues of Trp86, Tyr337, Trp439 and Tyr449.  The present results strongly suggest that the para-position of the D-ring should be a preferred modification site for further structural optimization design.  Thus, 2-aryl-9-methyl-β-carboliniums emerged as novel and promising tool compounds for the development of new AChE inhibitor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwTpH_Z9G-FP69nzq6467DfW6udTcc2eaxf2KiwFbNcbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvktVOgsg%253D%253D&md5=a839c7da11fd0f399e884322059a92d4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-19999-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-19999-3%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DCui%26aufirst%3DZ.%26aulast%3DGeng%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DL.%26atitle%3DNew%25202-aryl-9-methyl-%25CE%25B2-carbolinium%2520salts%2520as%2520potential%2520acetylcholinesterase%2520inhibitor%2520agents%253A%2520synthesis%252C%2520bioactivity%2520and%2520structure-activity%2520relationship%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D1559%26doi%3D10.1038%2Fs41598-018-19999-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.-Y.</span></span> <span> </span><span class="NLM_article-title">Monoterpene indole alkaloids from the stem bark of Mitragyna diversifolia and their acetylcholine esterase inhibitory effects</span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2013.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.phytochem.2013.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=24169379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs12lurnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2013&pages=389-396&author=X.-F.+Caoauthor=J.-S.+Wangauthor=X.-B.+Wangauthor=J.+Luoauthor=H.-Y.+Wangauthor=L.-Y.+Kong&title=Monoterpene+indole+alkaloids+from+the+stem+bark+of+Mitragyna+diversifolia+and+their+acetylcholine+esterase+inhibitory+effects&doi=10.1016%2Fj.phytochem.2013.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Monoterpene indole alkaloids from the stem bark of Mitragyna diversifolia and their acetylcholine esterase inhibitory effects</span></div><div class="casAuthors">Cao, Xing-Fen; Wang, Jun-Song; Wang, Xiao-Bing; Luo, Jun; Wang, Hong-Ying; Kong, Ling-Yi</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">389-396</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Five monoterpene indole alkaloids, mitradiversifoline, with a unique rearranged skeleton, specionoxeine-N(4)-oxide, 7-hydroxyisopaynantheine, 3-dehydropaynantheine, and 3-isopaynantheine-N(4)-oxide, and 10 known ones, were isolated from Mitragyna diversifolia.  All the isolates were evaluated for their inhibition of acetylcholinesterase activities, and four showed moderate activities, with IC50 values of 4.1, 5.2, 10.2, and 10.3 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ZZCNm80vvbVg90H21EOLACvtfcHk0ljsLOG_EKUakw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs12lurnF&md5=1eb77ffabd69d63823cfa445da76acc6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2013.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2013.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DX.-F.%26aulast%3DWang%26aufirst%3DJ.-S.%26aulast%3DWang%26aufirst%3DX.-B.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.-Y.%26aulast%3DKong%26aufirst%3DL.-Y.%26atitle%3DMonoterpene%2520indole%2520alkaloids%2520from%2520the%2520stem%2520bark%2520of%2520Mitragyna%2520diversifolia%2520and%2520their%2520acetylcholine%2520esterase%2520inhibitory%2520effects%26jtitle%3DPhytochemistry%26date%3D2013%26volume%3D96%26spage%3D389%26epage%3D396%26doi%3D10.1016%2Fj.phytochem.2013.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro-Gamboa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siqueira Silva, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furlan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de A. Epifanio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Cunha Pinto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraes de Rezende, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alencar Lima, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva Bolzani, V.</span></span> <span> </span><span class="NLM_article-title">Indole glucoalkaloids from Chimarrhis turbinata and their evaluation as antioxidant agents and acetylcholinesterase inhibitors</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">1882</span>– <span class="NLM_lpage">1885</span>, <span class="refDoi"> DOI: 10.1021/np049863m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np049863m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVags7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=1882-1885&author=C.+L.+Cardosoauthor=I.+Castro-Gamboaauthor=D.+H.+Siqueira+Silvaauthor=M.+Furlanauthor=R.+de+A.+Epifanioauthor=A.+da+Cunha+Pintoauthor=C.+Moraes+de+Rezendeauthor=J.+Alencar+Limaauthor=V.+da+Silva+Bolzani&title=Indole+glucoalkaloids+from+Chimarrhis+turbinata+and+their+evaluation+as+antioxidant+agents+and+acetylcholinesterase+inhibitors&doi=10.1021%2Fnp049863m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Indole Glucoalkaloids from Chimarrhis turbinata and Their Evaluation as Antioxidant Agents and Acetylcholinesterase Inhibitors</span></div><div class="casAuthors">Cardoso, Carmem Lucia; Castro-Gamboa, Ian; Silva, Dulce Helena Siqueira; Furlan, Maysa; de Epifanio, Rosangela; Pinto, Angelo da Cunha; Moraes de Rezende, Claudia; Lima, Joselia Alencar; Bolzani, Vanderlan da Silva</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1882-1885</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our study on bioactive agents from Brazilian rainforest plants, two new glucoalkaloids, 3,4-dehydro-strictosidine (I) and 3,4-dehydro-strictosidinic acid (II), were isolated from Chimarrhis turbinata, along with seven known glucoalkaloids, cordifoline (3), strictosidinic acid (4), strictosidine (5), 5α-carboxystrictosidine (6), turbinatine (7), desoxycordifoline (8), and harman-3-carboxylic acid (9).  The structures of the new alkaloids were established on the basis of comprehensive spectral anal., mainly 1D and 2D NMR expts., as well as high-resoln. HRESIMS.  Alkaloid 3 showed strong free-radical scavenging activity against 1,1-diphenyl-2-picrylhydrazyl (DPPH) as well as pronounced antioxidant activity evidenced by redox properties measured by ElCD-HPLC.  Addnl., alkaloids 1-9 were submitted to TLC screening for acetylcholinesterase inhibitors.  Both 7 and 8 were shown to be moderate acetylcholinesterase inhibitors at a concn. of 0.1 and 1.0 μM, resp.  In an in vitro rat brain assay, 7 showed moderate activity (IC50 1.86 μM), compared to the std. compd., galanthamine (IC50 0.92 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoia6mfIDwbK7Vg90H21EOLACvtfcHk0ljsLOG_EKUakw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVags7w%253D&md5=b35a7f07565480aadab2b399490539b2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fnp049863m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp049863m%26sid%3Dliteratum%253Aachs%26aulast%3DCardoso%26aufirst%3DC.%2BL.%26aulast%3DCastro-Gamboa%26aufirst%3DI.%26aulast%3DSiqueira%2BSilva%26aufirst%3DD.%2BH.%26aulast%3DFurlan%26aufirst%3DM.%26aulast%3Dde%2BA.%2BEpifanio%26aufirst%3DR.%26aulast%3Dda%2BCunha%2BPinto%26aufirst%3DA.%26aulast%3DMoraes%2Bde%2BRezende%26aufirst%3DC.%26aulast%3DAlencar%2BLima%26aufirst%3DJ.%26aulast%3Dda%2BSilva%2BBolzani%26aufirst%3DV.%26atitle%3DIndole%2520glucoalkaloids%2520from%2520Chimarrhis%2520turbinata%2520and%2520their%2520evaluation%2520as%2520antioxidant%2520agents%2520and%2520acetylcholinesterase%2520inhibitors%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2004%26volume%3D67%26spage%3D1882%26epage%3D1885%26doi%3D10.1021%2Fnp049863m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Passos, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simões-Pires, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nurisso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soldi, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, C. M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Faria, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcourt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottfried, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrupt, P.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henriques, A. T.</span></span> <span> </span><span class="NLM_article-title">Indole alkaloids of Psychotria as multifunctional cholinesterases and monoamine oxidases inhibitors</span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2012.11.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.phytochem.2012.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=23261030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKqtbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2013&pages=8-20&author=C.+S.+Passosauthor=C.+A.+Sim%C3%B5es-Piresauthor=A.+Nurissoauthor=T.+C.+Soldiauthor=L.+Katoauthor=C.+M.+A.+de+Oliveiraauthor=E.+O.+de+Fariaauthor=L.+Marcourtauthor=C.+Gottfriedauthor=P.-A.+Carruptauthor=A.+T.+Henriques&title=Indole+alkaloids+of+Psychotria+as+multifunctional+cholinesterases+and+monoamine+oxidases+inhibitors&doi=10.1016%2Fj.phytochem.2012.11.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Indole alkaloids of Psychotria as multifunctional cholinesterases and monoamine oxidases inhibitors</span></div><div class="casAuthors">Passos, Carolina S.; Simoes-Pires, Claudia A.; Nurisso, Alessandra; Soldi, Tatiane C.; Kato, Lucilia; de Oliveira, Cecilia M. A.; de Faria, Emiret O.; Marcourt, Laurence; Gottfried, Carmem; Carrupt, Pierre-Alain; Henriques, Amelia T.</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8-20</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Thirteen Psychotria alkaloids were evaluated regarding their interactions with acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and monoamine oxidases A and B (MAO-A and MAO-B), which are enzymic targets related with neurodegenerative diseases.  Two quaternary β-carboline alkaloids, prunifoleine and 14-oxoprunifoleine, inhibited AChE, BChE and MAO-A with IC50 values corresponding to 10 and 3.39 μM for AChE, 100 and 11 μM for BChE, and 7.41 and 6.92 μM for MAO-A, resp.  Both compds. seem to behave as noncompetitive AChE inhibitors and time-dependent MAO-A inhibitors.  In addn., the monoterpene indole alkaloids (MIAs) angustine, vallesiachotamine lactone, E-vallesiachotamine and Z-vallesiachotamine inhibited BChE and MAO-A with IC50 values ranging from 3.47 to 14 μM for BChE inhibition and from 0.85 to 2.14 μM for MAO-A inhibition.  Among the tested MIAs, angustine is able to inhibit MAO-A in a reversible and competitive way while the three vallesiachotamine-like alkaloids display a time-dependent inhibition on this target.  Docking calcns. were performed to understand the binding mode between the most active ligands and the selected targets.  Taken together, our findings established mol. details of AChE, BChE and MAO-A inhibition by quaternary β-carboline alkaloids and MIAs from Psychotria, suggesting these secondary metabolites are scaffolds for the development of multifunctional compds. against neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK6W5xOfzEGLVg90H21EOLACvtfcHk0ljsLOG_EKUakw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKqtbrF&md5=18d1120e43655d165b889525d1a60b91</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2012.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2012.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DPassos%26aufirst%3DC.%2BS.%26aulast%3DSim%25C3%25B5es-Pires%26aufirst%3DC.%2BA.%26aulast%3DNurisso%26aufirst%3DA.%26aulast%3DSoldi%26aufirst%3DT.%2BC.%26aulast%3DKato%26aufirst%3DL.%26aulast%3Dde%2BOliveira%26aufirst%3DC.%2BM.%2BA.%26aulast%3Dde%2BFaria%26aufirst%3DE.%2BO.%26aulast%3DMarcourt%26aufirst%3DL.%26aulast%3DGottfried%26aufirst%3DC.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26aulast%3DHenriques%26aufirst%3DA.%2BT.%26atitle%3DIndole%2520alkaloids%2520of%2520Psychotria%2520as%2520multifunctional%2520cholinesterases%2520and%2520monoamine%2520oxidases%2520inhibitors%26jtitle%3DPhytochemistry%26date%3D2013%26volume%3D86%26spage%3D8%26epage%3D20%26doi%3D10.1016%2Fj.phytochem.2012.11.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mroue, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Euler, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghuman, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M.</span></span> <span> </span><span class="NLM_article-title">Indole alkaloids of Haplophyton crooksii</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">890</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1021/np960070c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np960070c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK28XltlWntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1996&pages=890-893&author=M.+A.+Mroueauthor=K.+L.+Eulerauthor=M.+A.+Ghumanauthor=M.+Alam&title=Indole+alkaloids+of+Haplophyton+crooksii&doi=10.1021%2Fnp960070c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Indole alkaloids of Haplophyton crooksii</span></div><div class="casAuthors">Mroue, Mohamad A.; Euler, K. L.; Ghuman, M. A.; Alam, Maktoob</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">890-893</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An investigation of the indole alkaloids of Haplophyton crooksii has resulted in the identification of two new alkaloids-10-methoxy-N1-methylpericyclivine (I) and 16-decarbomethoxyvinervinine (II)-and 13 known alkaloids-crooksiine, yohimbine, β-yohimbine, crooksidine, decarbomethoxytetrahydrosecodine, akuammicine, tubotaiwine, lanceomigine, lanceomigine N-oxide, haplophytine, cimicine, cimicidine, and akuammidin-as major alkaloids of this shrub.  All of the isolated alkaloids showed an inhibition of acetylcholinesterase activity in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriA9pJBfEO5rVg90H21EOLACvtfcHk0lhte-WLBFo35g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltlWntLk%253D&md5=71e5c15aebaa9fba506e925f2ed1ec2e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fnp960070c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp960070c%26sid%3Dliteratum%253Aachs%26aulast%3DMroue%26aufirst%3DM.%2BA.%26aulast%3DEuler%26aufirst%3DK.%2BL.%26aulast%3DGhuman%26aufirst%3DM.%2BA.%26aulast%3DAlam%26aufirst%3DM.%26atitle%3DIndole%2520alkaloids%2520of%2520Haplophyton%2520crooksii%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1996%26volume%3D59%26spage%3D890%26epage%3D893%26doi%3D10.1021%2Fnp960070c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, L.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.-S.</span></span> <span> </span><span class="NLM_article-title">Geissoschizine methyl ether N-oxide, a new alkaloid with antiacetylcholinesterase activity from Uncaria rhynchophylla</span>. <i>Nat. Prod. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">842</span>– <span class="NLM_lpage">847</span>, <span class="refDoi"> DOI: 10.1080/14786419.2014.989847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1080%2F14786419.2014.989847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=25496282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFegt77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=842-847&author=W.-W.+Jiangauthor=J.+Suauthor=X.-D.+Wuauthor=J.+Heauthor=L.-Y.+Pengauthor=X.+Chengauthor=Q.-S.+Zhao&title=Geissoschizine+methyl+ether+N-oxide%2C+a+new+alkaloid+with+antiacetylcholinesterase+activity+from+Uncaria+rhynchophylla&doi=10.1080%2F14786419.2014.989847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Geissoschizine methyl ether N-oxide, a new alkaloid with antiacetylcholinesterase activity from Uncaria rhynchophylla</span></div><div class="casAuthors">Jiang, Wei-Wei; Su, Jia; Wu, Xing-De; He, Juan; Peng, Li-Yan; Cheng, Xiao; Zhao, Qin-Shi</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">842-847</span>CODEN:
                <span class="NLM_cas:coden">NPRAAT</span>;
        ISSN:<span class="NLM_cas:issn">1478-6419</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Geissoschizine Me ether N-oxide, a new oxindole alkaloid, along with 14 known alkaloids, was isolated from the aerial part of Uncaria rhynchophylla.  Their structures were identified by comprehensive spectral methods, including 2D NMR expts., and confirmed by comparing with the literature data.  In vitro acetylcholinesterase (AChE) inhibitory activity assay showed that the new compd. exhibited anti-AChE activity with IC50 value of 23.4 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo97W6iqB6WfbVg90H21EOLACvtfcHk0lhte-WLBFo35g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFegt77O&md5=c25301a639db0776c7d51adf43d6ba99</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1080%2F14786419.2014.989847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14786419.2014.989847%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DW.-W.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.-D.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DL.-Y.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DQ.-S.%26atitle%3DGeissoschizine%2520methyl%2520ether%2520N-oxide%252C%2520a%2520new%2520alkaloid%2520with%2520antiacetylcholinesterase%2520activity%2520from%2520Uncaria%2520rhynchophylla%26jtitle%3DNat.%2520Prod.%2520Res.%26date%3D2015%26volume%3D29%26spage%3D842%26epage%3D847%26doi%3D10.1080%2F14786419.2014.989847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geissler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porzel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlenzig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wessjohann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, N.</span></span> <span> </span><span class="NLM_article-title">Acetylcholinesterase inhibitors from the toadstool Cortinarius infractus</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2173</span>– <span class="NLM_lpage">2177</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.01.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmc.2010.01.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=20176490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtVCrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=2173-2177&author=T.+Geisslerauthor=W.+Brandtauthor=A.+Porzelauthor=D.+Schlenzigauthor=A.+Kehlenauthor=L.+Wessjohannauthor=N.+Arnold&title=Acetylcholinesterase+inhibitors+from+the+toadstool+Cortinarius+infractus&doi=10.1016%2Fj.bmc.2010.01.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase inhibitors from the toadstool Cortinarius infractus</span></div><div class="casAuthors">Geissler, Torsten; Brandt, Wolfgang; Porzel, Andrea; Schlenzig, Dagmar; Kehlen, Astrid; Wessjohann, Ludger; Arnold, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2173-2177</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibition of acetylcholinesterase (AChE) and therefore prevention of acetylcholine degrdn. is one of the most accepted therapy opportunities for Alzheimer's disease (AD), today.  Due to lack of selectivity of AChE inhibitor drugs on the market, AD-patients suffer from side effects like nausea or vomiting.  In the present study the isolation of two alkaloids, infractopicrin (1) and 10-hydroxy-infractopicrin (2), from Cortinarius infractus Berk. (Cortinariaceae) is presented.  Both compds. show AChE-inhibiting activity and possess a higher selectivity than galanthamine.  Docking studies show that lacking π-π-interactions in butyrylcholinesterase (BChE) are responsible for selectivity.  Studies on other AD pathol. related targets show an inhibitory effect of both compds. on self-aggregation of Aβ-peptides but not on AChE induced Aβ-peptide aggregation.  Low cytotoxicity as well as calcd. pharmacokinetic data suggest that the natural products could be useful candidates for further drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwTVddRsYuirVg90H21EOLACvtfcHk0ljycV1Y8fhW9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtVCrsbo%253D&md5=e6074e77293490cea4b30a6a66f4e725</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.01.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.01.074%26sid%3Dliteratum%253Aachs%26aulast%3DGeissler%26aufirst%3DT.%26aulast%3DBrandt%26aufirst%3DW.%26aulast%3DPorzel%26aufirst%3DA.%26aulast%3DSchlenzig%26aufirst%3DD.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DWessjohann%26aufirst%3DL.%26aulast%3DArnold%26aufirst%3DN.%26atitle%3DAcetylcholinesterase%2520inhibitors%2520from%2520the%2520toadstool%2520Cortinarius%2520infractus%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D2173%26epage%3D2177%26doi%3D10.1016%2Fj.bmc.2010.01.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kashyap, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaiselvan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span> <span> </span><span class="NLM_article-title">Ajmalicine and reserpine: indole alkaloids as multi-target directed ligands towards factors implicated in Alzheimer’s disease</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1609</span>, <span class="refDoi"> DOI: 10.3390/molecules25071609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3390%2Fmolecules25071609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpvVChtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2020&pages=1609&author=P.+Kashyapauthor=V.+Kalaiselvanauthor=R.+Kumarauthor=S.+Kumar&title=Ajmalicine+and+reserpine%3A+indole+alkaloids+as+multi-target+directed+ligands+towards+factors+implicated+in+Alzheimer%E2%80%99s+disease&doi=10.3390%2Fmolecules25071609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Ajmalicine and reserpine: indole alkaloids as multi-target directed ligands towards factors implicated in Alzheimer's disease</span></div><div class="casAuthors">Kashyap, Priya; Kalaiselvan, Vivekanandan; Kumar, Robin; Kumar, Suresh</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1609</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a multifactorial disorder characterized by exponential loss of memory and cognitive deficit involving several disease modifying targets (amyloid beta, beta-secretase, monoaminoxidase-B, and cholinesterase).  The present study explores multi-target directed ligand approach using secondary metabolite reserpine (RES) and ajmalicine (AJM) obtained from Rauwolfia serpentina roots.  Novel LCMS and HPLC methods were developed for identification and quantification of reserpine and ajmalicine.  In vitro enzyme inhibition assays were performed to evaluate anti-cholinesterase, β-site amyloid cleaving enzyme (BACE-1) inhibition and monoamine oxidase-B (MAO-B) inhibition, further analyzed with in silico anal.  Anti-amyloidogenic potential was studied using anti-aggregation studies along with TEM and CD (CD) anal.  In vitro neuroprotective potential against Aβ toxicity and anti-oxidative stress was demonstrated using PC12 cell cultures.  Reserpine is a more potent dual cholinesterase inhibitor than ajmalicine (IC50 values of 1.7μM (AChE) and 2.8μM (BuChE)).  The anti-aggregation activity of reserpine (68%) was more than ajmalicine (56%).  Both compds. demonstrated neuroprotective activity against Aβ42 (92%) and H2O2 (93%) induced toxicity in PC12 cells against controls.  Phytocompounds also inhibited MAO-B and BACE-1 enzymes in concn. dependent manner.  Mol. docking studies indicated the strong binding of compds. to the catalytic site of targets.  This novel study demonstrated that reserpine and ajmalicine as a multi-target directed ligand that have disease modifying potential for amelioration of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1_80GRlvh8LVg90H21EOLACvtfcHk0ljycV1Y8fhW9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpvVChtr8%253D&md5=5a001e3547ff49a1c2aba1bef25943d4</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.3390%2Fmolecules25071609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules25071609%26sid%3Dliteratum%253Aachs%26aulast%3DKashyap%26aufirst%3DP.%26aulast%3DKalaiselvan%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DKumar%26aufirst%3DS.%26atitle%3DAjmalicine%2520and%2520reserpine%253A%2520indole%2520alkaloids%2520as%2520multi-target%2520directed%2520ligands%2520towards%2520factors%2520implicated%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMolecules%26date%3D2020%26volume%3D25%26spage%3D1609%26doi%3D10.3390%2Fmolecules25071609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreres, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, J. M.A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faria, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valentao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sottomayor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrade, P. B.</span></span> <span> </span><span class="NLM_article-title">Pharmacological effects of Catharanthus roseus root alkaloids in acetylcholinesterase inhibition and cholinergic neurotransmission</span>. <i>Phytomedicine</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">652</span>, <span class="refDoi"> DOI: 10.1016/j.phymed.2009.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.phymed.2009.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=19962870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVygsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=646-652&author=D.+M.+Pereiraauthor=F.+Ferreresauthor=J.+M.A.+Oliveiraauthor=L.+Gasparauthor=J.+Fariaauthor=P.+Valentaoauthor=M.+Sottomayorauthor=P.+B.+Andrade&title=Pharmacological+effects+of+Catharanthus+roseus+root+alkaloids+in+acetylcholinesterase+inhibition+and+cholinergic+neurotransmission&doi=10.1016%2Fj.phymed.2009.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological effects of Catharanthus roseus root alkaloids in acetylcholinesterase inhibition and cholinergic neurotransmission</span></div><div class="casAuthors">Pereira, David M.; Ferreres, Federico; Oliveira, Jorge M. A.; Gaspar, Luis; Faria, Joana; Valentao, Patricia; Sottomayor, Mariana; Andrade, Paula B.</div><div class="citationInfo"><span class="NLM_cas:title">Phytomedicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8-9</span>),
    <span class="NLM_cas:pages">646-652</span>CODEN:
                <span class="NLM_cas:coden">PYTOEY</span>;
        ISSN:<span class="NLM_cas:issn">0944-7113</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">The leaves of Catharanthus roseus constitute the only source of the well known indolomonoterpenic alkaloids vincristine and vinblastine.  In this work we studied the biol. potential of the roots, which are used in several countries as decocts or hot water exts. for the treatment of a no. of conditions.  The aq. ext. strongly inhibited acetylcholinesterase (AchE) in an in vitro microassay, an effect ascribable mainly to serpentine (IC50 = 0.775 μM vs physostigmine IC50 = 6.45 μM) as assessed with the pure compd.  Pure alkaloids were tested for muscarinic and nicotinic antagonism using rat ex-vivo prepns., namely, ileum and diaphragm/phrenic-nerve, resp.  Serpentine competitively blocked muscarinic receptors with a pA2 of 5.2, whereas the precursor ajmalicine up to 80 μM was undistinguishable from control, and catharanthine exhibited an unsurmountable muscarinic antagonism at greater than 10 μM concns.  Nicotinic receptor mediated diaphragm contractions were fully inhibited by catharanthine (IC50 = 59.6 μM) and ajmalicine (IC50 = 72.3 μM), in a reversible but non-competitive manner, unlike the more potent nicotinic antagonist tubocurarine (IC50 = 0.35 μM) whose competitive blockade was overcome by a physostigmine-induced increase in acetylcholine.  Serpentine up to 100 μM did not change diaphragm contractions suggesting reduced affinity for neuromuscular nicotinic receptors.  Despite strong in vitro AchE inhibition, serpentine failed to restore diaphragm contractions upon submaximal tubocurarine blockade, suggesting that poor tissue penetration may prevent serpentine from inhibiting AchE in deep neuromuscular synapses in the ex-vivo prepn.  To our knowledge, the present study is the first to assess the effect of C. roseus root exts., as well as of serpentine, ajmalicine and catharanthine on AchE.  The results described herein suggest that the currently overlooked C. roseus roots may constitute a promising source of compds. with pharmaceutical interest.  Moreover, given serpentine's potent in vitro AchE inhibitory activity and low cholinergic receptor affinity, it is conceivable that minor structural modifications may yield a potent and selective AchE inhibitor, potentially useful for the pharmacol. management of conditions such as Alzheimer's disease and/or myasthenia gravis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2Zh0WeIu_wbVg90H21EOLACvtfcHk0ljycV1Y8fhW9A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVygsr0%253D&md5=2d0d300f8e5a83038bd5ac869f4cf73f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.phymed.2009.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phymed.2009.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DD.%2BM.%26aulast%3DFerreres%26aufirst%3DF.%26aulast%3DOliveira%26aufirst%3DJ.%2BM.A.%26aulast%3DGaspar%26aufirst%3DL.%26aulast%3DFaria%26aufirst%3DJ.%26aulast%3DValentao%26aufirst%3DP.%26aulast%3DSottomayor%26aufirst%3DM.%26aulast%3DAndrade%26aufirst%3DP.%2BB.%26atitle%3DPharmacological%2520effects%2520of%2520Catharanthus%2520roseus%2520root%2520alkaloids%2520in%2520acetylcholinesterase%2520inhibition%2520and%2520cholinergic%2520neurotransmission%26jtitle%3DPhytomedicine%26date%3D2010%26volume%3D17%26spage%3D646%26epage%3D652%26doi%3D10.1016%2Fj.phymed.2009.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bharate, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwakarma, R. A.</span></span> <span> </span><span class="NLM_article-title">Total synthesis and anti-cholinesterase activity of marine-derived bis-indole alkaloid fascaplysin</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1098</span>– <span class="NLM_lpage">1103</span>, <span class="refDoi"> DOI: 10.1039/c2md20076g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1039%2Fc2md20076g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Gitb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1098-1103&author=S.+B.+Bharateauthor=S.+Mandaauthor=P.+Joshiauthor=B.+Singhauthor=R.+A.+Vishwakarma&title=Total+synthesis+and+anti-cholinesterase+activity+of+marine-derived+bis-indole+alkaloid+fascaplysin&doi=10.1039%2Fc2md20076g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Total synthesis and anti-cholinesterase activity of marine-derived bis-indole alkaloid fascaplysin</span></div><div class="casAuthors">Bharate, Sandip B.; Manda, Sudhakar; Joshi, Prashant; Singh, Baljinder; Vishwakarma, Ram A.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1098-1103</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A short and efficient two-step total synthesis of marine sponge-derived bis-indole alkaloid fascaplysin (I) starting from com. available tryptamine (1H-indole-3-ethanamine) was designed and the synthesis of the target compd. was achieved in 68% overall yield.  A key step involved in the present strategy is tandem dehydrative condensation between ortho-halo substituted glyoxal with tryptamine followed by dehydrogenation.  Fascaplysin inhibited acetylcholinesterase (AChE) in non-competitive manner with IC50 and ki values of 1.49 and 2.28 μM resp. and with 60-fold selectivity for AChE vs. butyrylcholinesterase.  Mol. docking studies revealed that fascaplysin accommodates within a peripheral anionic site and inner linings of the AChE active site gorge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooiFeR9xsnsrVg90H21EOLACvtfcHk0lgB78UxlcXT4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Gitb%252FI&md5=fd5bbbf5b63d61b1a7ae0710f59c5f61</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1039%2Fc2md20076g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20076g%26sid%3Dliteratum%253Aachs%26aulast%3DBharate%26aufirst%3DS.%2BB.%26aulast%3DManda%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DB.%26aulast%3DVishwakarma%26aufirst%3DR.%2BA.%26atitle%3DTotal%2520synthesis%2520and%2520anti-cholinesterase%2520activity%2520of%2520marine-derived%2520bis-indole%2520alkaloid%2520fascaplysin%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D1098%26epage%3D1103%26doi%3D10.1039%2Fc2md20076g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">Novel inhibitors of acetyl- and butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpine</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2004.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2004.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=15725500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs12itLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2005&pages=305-313&author=M.+Decker&title=Novel+inhibitors+of+acetyl-+and+butyrylcholinesterase+derived+from+the+alkaloids+dehydroevodiamine+and+rutaecarpine&doi=10.1016%2Fj.ejmech.2004.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Novel inhibitors of acetyl- and butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpine</span></div><div class="casAuthors">Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-313</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Derived from the structures of the alkaloids rutaecarpine and dehydroevodiamine (DHED), and the long-known acetylcholinesterase (AChE) inhibitor tacrine, resp., novel compds. were synthesized, including: 13-methyl-5,8-dihydro-6H-isoquino[1,2-b]quinazolin-13-ium chloride (I), (8Z)-5,6-dihydro-8H-isoquino[1,2-b]quinazolin-8-imine (II), 5,8-dihydro-6H-isoquino[1,2-b]quinazoline (III), 13-methyl-5,8-dihydro-6H-isoquino[1,2-b]quinazolin-13-ium chloride (IV), 5,7,8,13-tetrahydroindolo [2',3':3,4]pyrido[2,1-b]quinazoline (V), and N-(2-phenylethyl)-N-[(12Z)-7,8,9,10-tetrahydroazepino [2,1-b]quinazolin-12(6H)-ylidene]amine (VI), resp.  In a first step to evaluate their possible applicability for antiamnesic therapy, the inhibition of AChE and butyrylcholinesterase (BChE) were detd.: compds., II, III, V, and VI are moderate or strong inhibitors of ChE, the latter two compds. show a 10-fold higher affinity to BChE.  I is a moderate inhibitor of AChE showing selectivity towards this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptttlEM9PfTbVg90H21EOLACvtfcHk0lgB78UxlcXT4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs12itLc%253D&md5=f3ec42f29a7cd9957661876a6dee0273</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2004.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2004.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DNovel%2520inhibitors%2520of%2520acetyl-%2520and%2520butyrylcholinesterase%2520derived%2520from%2520the%2520alkaloids%2520dehydroevodiamine%2520and%2520rutaecarpine%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2005%26volume%3D40%26spage%3D305%26epage%3D313%26doi%3D10.1016%2Fj.ejmech.2004.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darras, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heilmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2014.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=24819955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsl2ltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2014&pages=15-21&author=G.+Huangauthor=B.+Klingauthor=F.+H.+Darrasauthor=J.+Heilmannauthor=M.+Decker&title=Identification+of+a+neuroprotective+and+selective+butyrylcholinesterase+inhibitor+derived+from+the+natural+alkaloid+evodiamine&doi=10.1016%2Fj.ejmech.2014.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine</span></div><div class="casAuthors">Huang, Guozheng; Kling, Beata; Darras, Fouad H.; Heilmann, Joerg; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15-21</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Two sets of carbamates based on the natural alkaloid evodiamine were designed, synthesized and evaluated as potential butyrylcholinesterase inhibitors.  Although a set of carbamates of 3-hydroxyevodiamine is inactive both at AChE and BChE, carbamates of 5-deoxo-3-hydroxyevodiamine (I) exhibit much better potency with selectivity toward BChE.  The heptyl carbamate of 5-deoxo-3-hydroxyevodiamine (I; R = heptyl; 11c) shows the best potency with an IC50 value of 77 nM and very good selectivity over AChE.  ORAC and cell-based assays indicate 11c possesses pronounced antioxidant properties with 1.75 Trolox equiv. and strong neuroprotection even from 1 μM onwards.  These combined activities might enable compd. 11c to be a potential candidate for treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCVMUoTorfwbVg90H21EOLACvtfcHk0lgB78UxlcXT4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsl2ltbc%253D&md5=af9aae882ce80c4d89b05403620ad649</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DKling%26aufirst%3DB.%26aulast%3DDarras%26aufirst%3DF.%2BH.%26aulast%3DHeilmann%26aufirst%3DJ.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520a%2520neuroprotective%2520and%2520selective%2520butyrylcholinesterase%2520inhibitor%2520derived%2520from%2520the%2520natural%2520alkaloid%2520evodiamine%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D81%26spage%3D15%26epage%3D21%26doi%3D10.1016%2Fj.ejmech.2014.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, T.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, L.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, L.-Q.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of novel rutaecarpine derivatives and related alkaloids derivatives as selective acetylcholinesterase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1415</span>– <span class="NLM_lpage">1423</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2009.12.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2009.12.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=20079560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFKjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=1415-1423&author=B.+Wangauthor=Y.-C.+Maiauthor=Y.+Liauthor=J.-Q.+Houauthor=S.-L.+Huangauthor=T.-M.+Ouauthor=J.-H.+Tanauthor=L.-K.+Anauthor=D.+Liauthor=L.-Q.+Gu&title=Synthesis+and+evaluation+of+novel+rutaecarpine+derivatives+and+related+alkaloids+derivatives+as+selective+acetylcholinesterase+inhibitors&doi=10.1016%2Fj.ejmech.2009.12.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of novel rutaecarpine derivatives and related alkaloids derivatives as selective acetylcholinesterase inhibitors</span></div><div class="casAuthors">Wang, Bin; Mai, Yi-Chi; Li, Yue; Hou, Jin-Qiang; Huang, Shi-Liang; Ou, Tian-Miao; Tan, Jia-Heng; An, Lin-Kun; Li, Ding; Gu, Lian-Quan; Huang, Zhi-Shu</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1415-1423</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel rutaecarpine derivs. and related alkaloid derivs., 3-aminoalkanamido-substituted rutaecarpine (e.g. I) and 7,8-dehydrorutaecarpine, and 6-aminoalkanamido-substituted 3-[2-(3-indolyl)ethyl]-4(3a)-quinazolinones, were synthesized and subjected to pharmacol. evaluation as acetylcholinesterase (AChE) inhibitors.  The synthetic compds. exhibited strong inhibitory activity for AChE and high selectivity for AChE over BuChE.  The structure-activity relationships were discussed and their binding conformation and simultaneous interactions mode were further clarified by kinetic characterization and the mol. docking studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx29vB3HngwbVg90H21EOLACvtfcHk0lgkL8tbrkxKPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFKjtrw%253D&md5=4e9a207c31c78a17f77bd07751fb671b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.12.044%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMai%26aufirst%3DY.-C.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DJ.-Q.%26aulast%3DHuang%26aufirst%3DS.-L.%26aulast%3DOu%26aufirst%3DT.-M.%26aulast%3DTan%26aufirst%3DJ.-H.%26aulast%3DAn%26aufirst%3DL.-K.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DL.-Q.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%2520rutaecarpine%2520derivatives%2520and%2520related%2520alkaloids%2520derivatives%2520as%2520selective%2520acetylcholinesterase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D1415%26epage%3D1423%26doi%3D10.1016%2Fj.ejmech.2009.12.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiaranaikulwanitch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boonyarat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fokin, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajragupta, O.</span></span> <span> </span><span class="NLM_article-title">Triazolyl tryptoline derivatives as β-secretase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">6572</span>– <span class="NLM_lpage">6576</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.09.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmcl.2010.09.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=20943389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSms7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6572-6576&author=J.+Jiaranaikulwanitchauthor=C.+Boonyaratauthor=V.+V.+Fokinauthor=O.+Vajragupta&title=Triazolyl+tryptoline+derivatives+as+%CE%B2-secretase+inhibitors&doi=10.1016%2Fj.bmcl.2010.09.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Triazolyl tryptoline derivatives as β-secretase inhibitors</span></div><div class="casAuthors">Jiaranaikulwanitch, Jutamas; Boonyarat, Chantana; Fokin, Valery V.; Vajragupta, Opa</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6572-6576</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tryptoline, a core structure of ochrolifuanine E, which is a hit compd. from virtual screening of the Thai herbal database against BACE1 was used as a scaffold for the design of BACE1 inhibitors.  The tryptoline was linked with different side chains by 1,2,3-triazole ring readily synthesized by catalytic azide-alkyne cycloaddn. reactions.  Twenty two triazolyl tryptoline derivs. were synthesized and screened for the inhibitory action against BACE1.  JJCA 140 (I) was the most potent inhibitor (IC50 = 1.49 μM) and was 100 times more selective for BACE1 than for Cat-D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6QRnN07AiCrVg90H21EOLACvtfcHk0lgkL8tbrkxKPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSms7fF&md5=596d7b841d54230f5dd2eb931c73a97e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.043%26sid%3Dliteratum%253Aachs%26aulast%3DJiaranaikulwanitch%26aufirst%3DJ.%26aulast%3DBoonyarat%26aufirst%3DC.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DVajragupta%26aufirst%3DO.%26atitle%3DTriazolyl%2520tryptoline%2520derivatives%2520as%2520%25CE%25B2-secretase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6572%26epage%3D6576%26doi%3D10.1016%2Fj.bmcl.2010.09.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostinho, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C. R.</span></span> <span> </span><span class="NLM_article-title">Vinpocetine attenuates the metabolic dysfunction induced by amyloid β-peptides in PC12 cells</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1080/10715760000301041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1080%2F10715760000301041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=11200083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslOmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2000&pages=497-506&author=C.+Pereiraauthor=P.+Agostinhoauthor=C.+R.+Oliveira&title=Vinpocetine+attenuates+the+metabolic+dysfunction+induced+by+amyloid+%CE%B2-peptides+in+PC12+cells&doi=10.1080%2F10715760000301041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Vinpocetine attenuates the metabolic dysfunction induced by amyloid β-peptides in PC12 cells</span></div><div class="casAuthors">Pereira, Claudia; Agostinho, Paula; Oliveira, Catarina R.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">497-506</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">The cytoprotective effect of vinpocetine [14-ethoxycarbonyl-(3α,16α-ethyl)-14,15-eburnamine] was investigated on PC12 cells treated with the amyloid β-peptides (Aβ) for 24 h.  Vinpocetine was shown to protect cells from the inhibition in redox status induced by exposure to Aβ25-35 and Aβ1-40, the maximal protection being achieved at a vinpocetine concn. of 40 μM.  At this concn., vinpocetine blocked the inhibition of the mitochondrial respiratory chain complexes II-III and IV and completely abolished the depletion of pyruvate levels induced by toxic concns. of Aβ peptides.  Furthermore, the accumulation of ROS in cells exposed to Aβ25-35 and Aβ1-40evaluated using the fluorescent probe 2',7'-dichlorofluorescin (DCF), was reduced in the presence of 40 μM vinpocetine.  Taken together, the data presented herein demonstrate that vinpocetine protects cells from Aβ toxicity, preventing the generation of oxidative stress due to the excessive accumulation of ROS.  This study suggests that vinpocetine can exert neuroprotective properties which might be of importance and contribute to its clin. efficacy in the treatment of Alzheimer's disease or other neurodegenerative disorders in which oxidative stress is involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosw6rZ2ja6hrVg90H21EOLACvtfcHk0lgkL8tbrkxKPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslOmug%253D%253D&md5=ca8eaea193a92788e6ddb6ff7e3ff991</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1080%2F10715760000301041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10715760000301041%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DC.%26aulast%3DAgostinho%26aufirst%3DP.%26aulast%3DOliveira%26aufirst%3DC.%2BR.%26atitle%3DVinpocetine%2520attenuates%2520the%2520metabolic%2520dysfunction%2520induced%2520by%2520amyloid%2520%25CE%25B2-peptides%2520in%2520PC12%2520cells%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2000%26volume%3D33%26spage%3D497%26epage%3D506%26doi%3D10.1080%2F10715760000301041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span> <span> </span><span class="NLM_article-title">Pharmacological basis for the use of evodiamine in Alzheimer’s disease: antioxidation and antiapoptosis</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1527</span>– <span class="NLM_lpage">1540</span>, <span class="refDoi"> DOI: 10.3390/ijms19051527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3390%2Fijms19051527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVOrurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=1527-1540&author=Y.+Zhangauthor=J.+Wangauthor=C.+Wangauthor=Z.+Liauthor=X.+Liuauthor=J.+Zhangauthor=J.+Luauthor=D.+Wang&title=Pharmacological+basis+for+the+use+of+evodiamine+in+Alzheimer%E2%80%99s+disease%3A+antioxidation+and+antiapoptosis&doi=10.3390%2Fijms19051527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological basis for the use of evodiamine in alzheimer's disease: antioxidation and antiapoptosis</span></div><div class="casAuthors">Zhang, Yongfeng; Wang, Jiaqi; Wang, Chunyue; Li, Zhiping; Liu, Xin; Zhang, Jun; Lu, Jiahui; Wang, Di</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1527/1-1527/14</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Evodiamine (Evo), a major alkaloid compd. isolated from the dry unripened fruit of Evodia fructus, has a wide range of pharmacol. activities.  The present study sought to explore the neuroprotective effects of Evo in L-glutamate (L-Glu)-induced apoptosis of HT22 cells, and in a D-galactose and aluminum trichloride-developed Alzheimer's disease (AD) mouse model.  Evo significantly enhanced cell viability, inhibited the accumulation of reactive oxygen species, ameliorated mitochondrial function, increased the B-cell lymphoma-2 protein content, and inhibited the high expression levels of Bax, Bad, and cleaved-caspase-3 and -8 in L-Glu-induced HT22 cells.  Evo also enhanced the phosphorylation activities of protein kinase B and the mammalian target of rapamycin in the L-Glu-induced HT22 cells.  In the AD mouse model, Evo reduced the aimless and chaotic movements, reduced the time spent in the central area in the open field test, and decreased the escape latency time in the Morris water maze test.  Evo reduced the deposition of amyloid beta 42 (Aβ42) in the brain, and increased the serum level of Aβ42, but showed no significant effects on Aβ40.  In addn., six weeks of Evo administration significantly suppressed oxidative stress by modulating the related enzyme levels.  In the central cholinergic system of AD mice, Evo significantly increased the serum levels of acetylcholine and choline acetyltransferase and decreased the level of acetylcholinesterase in the serum, hypothalamus, and brain.  Our results provide exptl. evidence that Evo can serve as a neuroprotective candidate for the prevention and/or treatment of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPH1hdQNxsVLVg90H21EOLACvtfcHk0lguJcSpHFyUEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVOrurfK&md5=4628ac3813d0bbd47f23b076108614dd</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.3390%2Fijms19051527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19051527%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DD.%26atitle%3DPharmacological%2520basis%2520for%2520the%2520use%2520of%2520evodiamine%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520antioxidation%2520and%2520antiapoptosis%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D1527%26epage%3D1540%26doi%3D10.3390%2Fijms19051527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naman, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span> <span> </span><span class="NLM_article-title">9-methylfascaplysin is a more potent Aβ aggregation inhibitor than the marine-derived alkaloid, fascaplysin, and produces nanomolar neuroprotective effects in SH-SY5Y cells</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.3390/md17020121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3390%2Fmd17020121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlaku7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=121-135&author=Q.+Sunauthor=F.+Liuauthor=J.+Sangauthor=M.+Linauthor=J.+Maauthor=X.+Xiaoauthor=S.+Yanauthor=C.+B.+Namanauthor=N.+Wangauthor=S.+Heauthor=X.+Yanauthor=W.+Cuiauthor=H.+Liang&title=9-methylfascaplysin+is+a+more+potent+A%CE%B2+aggregation+inhibitor+than+the+marine-derived+alkaloid%2C+fascaplysin%2C+and+produces+nanomolar+neuroprotective+effects+in+SH-SY5Y+cells&doi=10.3390%2Fmd17020121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">9-Methylfascaplysin is a more potent Aβ aggregation inhibitor than the marine-derived alkaloid, fascaplysin, and produces nanomolar neuroprotective effects in SH-SY5Y cells</span></div><div class="casAuthors">Sun, Qingmei; Liu, Fufeng; Sang, Jingcheng; Lin, Miaoman; Ma, Jiale; Xiao, Xiao; Yan, Sicheng; Naman, C. Benjamin; Wang, Ning; He, Shan; Yan, Xiaojun; Cui, Wei; Liang, Hongze</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">β-Amyloid (Aβ) is regarded as an important pathogenic target for Alzheimer's disease (AD), the most prevalent neurodegenerative disease.  Aβ can assemble into oligomers and fibrils, and produce neurotoxicity.  Therefore, Aβ aggregation inhibitors may have anti-AD therapeutic efficacies.  It was found, here, that the marine-derived alkaloid, fascaplysin, inhibits Aβ fibrillization in vitro.  Moreover, the new analog, 9-methylfascaplysin, was designed and synthesized from 5-methyltryptamine.  Interestingly, 9-methylfascaplysin is a more potent inhibitor of Aβ fibril formation than fascaplysin.  Incubation of 9-methylfascaplysin with Aβ directly reduced Aβ oligomer formation.  Mol. dynamics simulations revealed that 9-methylfascaplysin might interact with neg. charged residues of Aβ42 with polar binding energy.  Hydrogen bonds and π-π interactions between the key amino acid residues of Aβ42 and 9-methylfascaplysin were also suggested.  Most importantly, compared with the typical Aβ oligomer, Aβ modified by nanomolar 9-methylfascaplysin produced less neuronal toxicity in SH-SY5Y cells. 9-Methylfascaplysin appears to be one of the most potent marine-derived compds. that produces anti-Aβ neuroprotective effects.  Given previous reports that fascaplysin inhibits acetylcholinesterase and induces P-glycoprotein, the current study results suggest that fascaplysin derivs. can be developed as novel anti-AD drugs that possibly act via inhibition of Aβ aggregation along with other target mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGE-fvCHpburVg90H21EOLACvtfcHk0lguJcSpHFyUEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlaku7nI&md5=1256cafb0cb9c6bc9b373ddb640390a1</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3390%2Fmd17020121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd17020121%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DSang%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DNaman%26aufirst%3DC.%2BB.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DCui%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DH.%26atitle%3D9-methylfascaplysin%2520is%2520a%2520more%2520potent%2520A%25CE%25B2%2520aggregation%2520inhibitor%2520than%2520the%2520marine-derived%2520alkaloid%252C%2520fascaplysin%252C%2520and%2520produces%2520nanomolar%2520neuroprotective%2520effects%2520in%2520SH-SY5Y%2520cells%26jtitle%3DMar.%2520Drugs%26date%3D2019%26volume%3D17%26spage%3D121%26epage%3D135%26doi%3D10.3390%2Fmd17020121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">Effects of Picrasma quassioides and its active constituents on Alzheimer’s disease in vitro and in vivo</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">103258</span>– <span class="NLM_lpage">103266</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2019.103258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bioorg.2019.103258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=31520892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslOgsLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2019&pages=103258-103266&author=E.+Guoauthor=Y.+Huauthor=T.+Duauthor=H.+Zhuauthor=L.+Chenauthor=W.+Quauthor=J.+Zhangauthor=N.+Xieauthor=W.+Liuauthor=F.+Fengauthor=J.+Xu&title=Effects+of+Picrasma+quassioides+and+its+active+constituents+on+Alzheimer%E2%80%99s+disease+in+vitro+and+in+vivo&doi=10.1016%2Fj.bioorg.2019.103258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Picrasma quassioides and its active constituents on Alzheimer's disease in vitro and in vivo</span></div><div class="casAuthors">Guo, Eryan; Hu, Yunwei; Du, Tao; Zhu, Huilin; Chen, Lei; Qu, Wei; Zhang, Jie; Xie, Ning; Liu, Wenyuan; Feng, Feng; Xu, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103258</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer disease (AD), a prevalent neurodegenerative disorder, is one of the leading causes of dementia.  However, there is no effective drug for this disease to date.  Picrasma quassioides (D.Don) Benn, a Chinese traditional medicine, was used mainly for the treatment of inflammation, fever, microbial infection and dysentery.  In this paper, we reported that the EtOAc ext. of Picrasma quassioides stems showed potential neuroprotective activities in L-glutamate-stimulated PC12 and Aβ25-35-stimulated SH-SY5Y cell models, as well as improved memory and cognitive abilities in AD mice induced by amyloid-β peptide.  Moreover, it was revealed that the anti-AD mechanism was related to suppressing neuroinflammatory and reducing Aβ1-42 deposition using ELISA assay kits.  To clarify the active components of the EtOAc ext. of Picrasma quassioides stems, a systematic phytochem. study led to isolate and identify six β-carboline alkaloids (1-6), seven canthin-6-one alkaloids (7-13), and five quassinoids (14-18).  Among them, four β-carbolines (1-3, and 6) and six canthin-6-ones (7-11, and 13) exhibited potential neuroprotective activities in vitro.  Based on these date, the structure-activity relationships of alkaloids were discussed.  Furthermore, mol. docking expts. showed that compds. 2 and 3 have high affinity for both of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYPKIA) and butyrylcholinesterase (BuChE).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm1avNMniZr7Vg90H21EOLACvtfcHk0lguJcSpHFyUEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslOgsLfP&md5=e050ba4e7b9ed7779b479037914007dd</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2019.103258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2019.103258%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DE.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DEffects%2520of%2520Picrasma%2520quassioides%2520and%2520its%2520active%2520constituents%2520on%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBioorg.%2520Chem.%26date%3D2019%26volume%3D92%26spage%3D103258%26epage%3D103266%26doi%3D10.1016%2Fj.bioorg.2019.103258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latypova, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnaudeix, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yardin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terro, F.</span></span> <span> </span><span class="NLM_article-title">Tau protein kinases: involvement in Alzheimer’s disease</span>. <i>Ageing Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1016/j.arr.2012.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.arr.2012.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=22742992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFKmt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=289-309&author=L.+Martinauthor=X.+Latypovaauthor=C.+M.+Wilsonauthor=A.+Magnaudeixauthor=M.-L.+Perrinauthor=C.+Yardinauthor=F.+Terro&title=Tau+protein+kinases%3A+involvement+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.arr.2012.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Tau protein kinases: Involvement in Alzheimer's disease</span></div><div class="casAuthors">Martin, Ludovic; Latypova, Xenia; Wilson, Cornelia M.; Magnaudeix, Amandine; Perrin, Marie-Laure; Yardin, Catherine; Terro, Faraj</div><div class="citationInfo"><span class="NLM_cas:title">Ageing Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">289-309</span>CODEN:
                <span class="NLM_cas:coden">ARRGAK</span>;
        ISSN:<span class="NLM_cas:issn">1568-1637</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Tau phosphorylation is regulated by a balance between tau kinase and phosphatase activities.  Disruption of this equil. was suggested to be at the origin of abnormal tau phosphorylation and thereby might contribute to tau aggregation.  Thus, understanding the regulation modes of tau phosphorylation is of high interest in detg. the possible causes at the origin of the formation of tau aggregates in order to elaborate protection strategies to cope with these lesions in Alzheimer's disease.  Among the possible and specific interventions that reverse tau phosphorylation is the inhibition of certain tau kinases.  Here, we extensively reviewed tau protein kinases, their physiol. roles and regulation, their involvement in tau phosphorylation and their relevance to AD.  We also reviewed the most common inhibitory compds. acting on each tau kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU914c2pCuALVg90H21EOLACvtfcHk0lg0IRHV09HZ3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFKmt7w%253D&md5=ce41a1cf982105ec7b3cc0ee6fcdf20b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.arr.2012.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arr.2012.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DLatypova%26aufirst%3DX.%26aulast%3DWilson%26aufirst%3DC.%2BM.%26aulast%3DMagnaudeix%26aufirst%3DA.%26aulast%3DPerrin%26aufirst%3DM.-L.%26aulast%3DYardin%26aufirst%3DC.%26aulast%3DTerro%26aufirst%3DF.%26atitle%3DTau%2520protein%2520kinases%253A%2520involvement%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAgeing%2520Res.%2520Rev.%26date%3D2013%26volume%3D12%26spage%3D289%26epage%3D309%26doi%3D10.1016%2Fj.arr.2012.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frost, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meechoovet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gately, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shcherbakova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunckley, T.</span></span> <span> </span><span class="NLM_article-title">β-Carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer’s disease-related sites</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e19264</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0019264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1371%2Fjournal.pone.0019264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=21573099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFKjurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=D.+Frostauthor=B.+Meechoovetauthor=T.+Wangauthor=S.+Gatelyauthor=M.+Giorgettiauthor=I.+Shcherbakovaauthor=T.+Dunckley&title=%CE%B2-Carboline+compounds%2C+including+harmine%2C+inhibit+DYRK1A+and+tau+phosphorylation+at+multiple+Alzheimer%E2%80%99s+disease-related+sites&doi=10.1371%2Fjournal.pone.0019264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">β-Carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer's disease-related sites</span></div><div class="casAuthors">Frost, Danielle; Meechoovet, Bessie; Wang, Tong; Gately, Stephen; Giorgetti, Marco; Shcherbakova, Irina; Dunckley, Travis</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e19264</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Harmine, a β-carboline alkaloid, is a high affinity inhibitor of the dual specificity tyrosine phosphorylation regulated kinase 1A (DYRK1A) protein.  The DYRK1A gene is located within the Down Syndrome Crit. Region (DSCR) on chromosome 21.  We and others have implicated DYRK1A in the phosphorylation of tau protein on multiple sites assocd. with tau pathol. in Down Syndrome and in Alzheimer's disease (AD).  Pharmacol. inhibition of this kinase may provide an opportunity to intervene therapeutically to alter the onset or progression of tau pathol. in AD.  Here we test the ability of harmine, and numerous addnl. β-carboline compds., to inhibit the DYRK1A dependent phosphorylation of tau protein on serine 396, serine 262/serine 356 (12E8 epitope), and threonine 231 in cell culture assays and in vitro phosphorylation assays.  Results demonstrate that the β-carboline compds. (1) potently reduce the expression of all three phosphorylated forms of tau protein, and (2) inhibit the DYRK1A catalyzed direct phosphorylation of tau protein on serine 396.  By assaying several β-carboline compds., we define certain chem. groups that modulate the affinity of this class of compds. for inhibition of tau phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIyW3w-np5NrVg90H21EOLACvtfcHk0lg0IRHV09HZ3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFKjurY%253D&md5=586705088397bfee8f58955b94bcc1db</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0019264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0019264%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DD.%26aulast%3DMeechoovet%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DGately%26aufirst%3DS.%26aulast%3DGiorgetti%26aufirst%3DM.%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DDunckley%26aufirst%3DT.%26atitle%3D%25CE%25B2-Carboline%2520compounds%252C%2520including%2520harmine%252C%2520inhibit%2520DYRK1A%2520and%2520tau%2520phosphorylation%2520at%2520multiple%2520Alzheimer%25E2%2580%2599s%2520disease-related%2520sites%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0019264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adayev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y.-W.</span></span> <span> </span><span class="NLM_article-title">Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>507</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2010.12.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.abb.2010.12.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=21185805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit12jsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=507&publication_year=2011&pages=212-218&author=T.+Adayevauthor=J.+Wegielauthor=Y.-W.+Hwang&title=Harmine+is+an+ATP-competitive+inhibitor+for+dual-specificity+tyrosine+phosphorylation-regulated+kinase+1A+%28Dyrk1A%29&doi=10.1016%2Fj.abb.2010.12.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)</span></div><div class="casAuthors">Adayev, Tatyana; Wegiel, Jerzy; Hwang, Yu-Wen</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">507</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">212-218</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Harmine is a β-carboline alkaloid.  The compd. is a potent inhibitor of dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A), a kinase implicated in Down syndrome.  In this study, we show that harmine functions as an ATP-competitive inhibitor against Dyrk1A.  Our conclusion is supported by kinetic anal. of harmine inhibition as well as by the characterization of a Dyrk1A mutation conferring significant resistance to harmine.  The mutation, V306A, is located next to the highly conserved D307 residue in kinases known to coordinate the phosphate groups of ATP through a Mg2+ ion.  The V306A mutation offers harmine resistance by differentially altering Dyrk1A affinity for harmine and ATP.  The V306A mutation causes no apparent alteration to Dyrk1A activity except for the redn. in ATP affinity.  This deficiency could be fully compensated by supplying ATP with a concn. in the physiol. range.  Our results reveal that harmine inhibits Dyrk1A activity by interacting with residues in the ATP-binding pocket and displacing ATP.  Our results also suggest that harmine will be a good lead compd. for further designing of selective ATP-competitive Dyrk1A inhibitors through exploration of the ATP-binding pocket of Dyrk1A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr-plj_OO0trVg90H21EOLACvtfcHk0lg0IRHV09HZ3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit12jsbo%253D&md5=bd3cd9608d332bc43b5b04f56059b62e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2010.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2010.12.024%26sid%3Dliteratum%253Aachs%26aulast%3DAdayev%26aufirst%3DT.%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DY.-W.%26atitle%3DHarmine%2520is%2520an%2520ATP-competitive%2520inhibitor%2520for%2520dual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A%2520%2528Dyrk1A%2529%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2011%26volume%3D507%26spage%3D212%26epage%3D218%26doi%3D10.1016%2Fj.abb.2010.12.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plater, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shpiro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastie, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLauchlan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klevernic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, J. S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1042/BJ20070797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&author=J.+Bainauthor=L.+Platerauthor=M.+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+McLauchlanauthor=I.+Klevernicauthor=J.+S.+C.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update&doi=10.1042%2FBJ20070797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0liydsZSTp0PkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D297%26epage%3D315%26doi%3D10.1042%2FBJ20070797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orzeszko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazimierczuk, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagotto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaiuto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paolo, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1834</i></span>,  <span class="NLM_fpage">1402</span>– <span class="NLM_lpage">1409</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2013.01.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bbapap.2013.01.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=23360763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivFyntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1834&publication_year=2013&pages=1402-1409&author=G.+Cozzaauthor=S.+Sarnoauthor=M.+Ruzzeneauthor=C.+Girardiauthor=A.+Orzeszkoauthor=Z.+Kazimierczukauthor=G.+Zagottoauthor=E.+Bonaiutoauthor=M.+L.+Di+Paoloauthor=L.+A.+Pinna&title=Exploiting+the+repertoire+of+CK2+inhibitors+to+target+DYRK+and+PIM+kinases&doi=10.1016%2Fj.bbapap.2013.01.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases</span></div><div class="casAuthors">Cozza, Giorgio; Sarno, Stefania; Ruzzene, Maria; Girardi, Cristina; Orzeszko, Andrzej; Kazimierczuk, Zygmunt; Zagotto, Giuseppe; Bonaiuto, Emanuela; Di Paolo, Maria Luisa; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1834</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1402-1409</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Advantage has been taken of the relative promiscuity of commonly used inhibitors of protein kinase CK2 to develop compds. that can be exploited for the selective inhibition of druggable kinases other than CK2 itself.  Here we summarize data obtained by altering the scaffold of CK2 inhibitors to give rise to novel selective inhibitors of DYRK1A and to a powerful cell permeable dual inhibitor of PIM1 and CK2.  In the former case one of the new compds., C624 (naphtho [1,2-b]benzofuran-5,9-diol) displays a potency comparable to that of the first-in-class DYRK1A inhibitor, harmine, lacking however the drawback of drastically inhibiting monoamine oxidase-A (MAO-A) as harmine does.  On the other hand the promiscuous CK2 inhibitor 4,5,6,7-tetrabromo-1H-benzimidazole (TBI,TBBz) has been derivatized with a sugar moiety to generate a 1-(β-D-2'-deoxyribofuranosyl)-4,5,6,7-tetrabromo-1H-benzimidazole (TDB) compd. which inhibits PIM1 and CK2 with comparably high efficacy (IC50 values < 100 nM) and remarkable selectivity.  TDB, unlike other dual PIM1/CK2 inhibitors described in the literature is readily cell permeable and displays a cytotoxic effect on cancer cells consistent with concomitant inhibition of both its onco-kinase targets.  This article is part of a Special Issue entitled: Inhibitors of Protein Kinases (2012).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoAFsk8sxvWrVg90H21EOLACvtfcHk0liydsZSTp0PkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivFyntr4%253D&md5=dd92c6268de52bfe412d546bf42665b4</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2013.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2013.01.018%26sid%3Dliteratum%253Aachs%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DGirardi%26aufirst%3DC.%26aulast%3DOrzeszko%26aufirst%3DA.%26aulast%3DKazimierczuk%26aufirst%3DZ.%26aulast%3DZagotto%26aufirst%3DG.%26aulast%3DBonaiuto%26aufirst%3DE.%26aulast%3DDi%2BPaolo%26aufirst%3DM.%2BL.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DExploiting%2520the%2520repertoire%2520of%2520CK2%2520inhibitors%2520to%2520target%2520DYRK%2520and%2520PIM%2520kinases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2013%26volume%3D1834%26spage%3D1402%26epage%3D1409%26doi%3D10.1016%2Fj.bbapap.2013.01.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Göckler, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jofre, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soppa, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejedor, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">6324</span>– <span class="NLM_lpage">6337</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2009.07346.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1111%2Fj.1742-4658.2009.07346.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=19796173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADC%252BD1MnovVSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6324-6337&author=N.+G%C3%B6cklerauthor=G.+Jofreauthor=C.+Papadopoulosauthor=U.+Soppaauthor=F.+J.+Tejedorauthor=W.+Becker&title=Harmine+specifically+inhibits+protein+kinase+DYRK1A+and+interferes+with+neurite+formation&doi=10.1111%2Fj.1742-4658.2009.07346.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</span></div><div class="casAuthors">Gockler Nora; Jofre Guillermo; Papadopoulos Chrisovalantis; Soppa Ulf; Tejedor Francisco J; Becker Walter</div><div class="citationInfo"><span class="NLM_cas:title">The FEBS journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6324-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">DYRK1A is a dual-specificity protein kinase that autophosphorylates a conserved tyrosine residue in the activation loop but phosphorylates exogenous substrates only at serine or threonine residues.  Tyrosine autophosphorylation of DYRKs is a one-off event that takes place during translation and induces the activation of the kinase.  Here we characterize the beta-carboline alkaloid harmine as a potent and specific inhibitor of DYRK1A both in vitro and in cultured cells.  Comparative in vitro assays of four kinases of the DYRK family showed that harmine inhibited substrate phosphorylation by DYRK1A more potently than it inhibited substrate phosphorylation by the closely related kinase DYRK1B [half maximal inhibitory concentrations (IC(50)) of 33 nm versus 166 nm, respectively] and by the more distant members of the family, DYRK2 and DYRK4 (1.9 microm and 80 microm, respectively).  Much higher concentrations of harmine were required to suppress tyrosine autophosphorylation of the translational intermediate of DYRK1A in a bacterial in vitro translation system (IC(50) = 1.9 microm).  Importantly, harmine inhibited the phosphorylation of a specific substrate by DYRK1A in cultured cells with a potency similar to that observed in vitro (IC(50) = 48 nm), without negative effects on the viability of the cells.  Overexpression of the DYRK1A gene on chromosome 21 has been implicated in the altered neuronal development observed in Down syndrome.  Here, we show that harmine interferes with neuritogenesis in cultured hippocampal neurons.  In summary, our data show that harmine inhibits DYRK1A substrate phosphorylation more potently than it inhibits tyrosine autophosphorylation, and provide evidence for a role of DYRK1A in the regulation of neurite formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYQnyD9o3hqhe4jJGKT5N0fW6udTcc2eZdiJCl6EcKeLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MnovVSmtw%253D%253D&md5=f59bc35eb74546f6351a4705f2d5fda7</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2009.07346.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2009.07346.x%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6ckler%26aufirst%3DN.%26aulast%3DJofre%26aufirst%3DG.%26aulast%3DPapadopoulos%26aufirst%3DC.%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DHarmine%2520specifically%2520inhibits%2520protein%2520kinase%2520DYRK1A%2520and%2520interferes%2520with%2520neurite%2520formation%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6324%26epage%3D6337%26doi%3D10.1111%2Fj.1742-4658.2009.07346.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grabher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouloura, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halabalaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaltsounis, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamburger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potterat, O.</span></span> <span> </span><span class="NLM_article-title">Library-based discovery of DYRK1A/CLKA inhibitors from natural product extracts</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">951</span>– <span class="NLM_lpage">956</span>, <span class="refDoi"> DOI: 10.1055/s-0031-1298625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1055%2Fs-0031-1298625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=22673832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtlalu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2012&pages=951-956&author=P.+Grabherauthor=E.+Durieuauthor=E.+Koulouraauthor=M.+Halabalakiauthor=L.+A.+Skaltsounisauthor=L.+Meijerauthor=M.+Hamburgerauthor=O.+Potterat&title=Library-based+discovery+of+DYRK1A%2FCLKA+inhibitors+from+natural+product+extracts&doi=10.1055%2Fs-0031-1298625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Library-based discovery of DYRK1A/CLK1 inhibitors from natural product extracts</span></div><div class="casAuthors">Grabher, Patrick; Durieu, Emilie; Kouloura, Eirini; Halabalaki, Maria; Skaltsounis, Leandros A.; Meijer, Laurent; Hamburger, Matthias; Potterat, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">951-956</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">The dual specificity tyrosine-phosphorylation-regulated kinase DYRK1A possesses diverse roles in neuronal development and adult brain physiol., and increased activity has been linked to neurodegenerative diseases.  Very few inhibitors of this kinase have been reported up to now.  Screening of a library of > 900 plant and fungal exts. afforded 25 exts. with IC50s < 10 μg/mL against DYRK1A.  To identify the active constituents, the exts. were submitted to a process integrating physicochem. data with biol. information, referred to as HPLC-based activity profiling.  Follow-up investigation of four exts. led to the targeted isolation of harmine (1, IC50 0.022 μM) from Peganum harmala, emodin (3, IC50 4.2 μM) from Cassia nigricans, kaempferol (4, IC50 0.91 μM) from Cuscuta chinensis, and 3,8-di-O-methylherbacetin (11, IC50 8.6 μM), 3,3'-4'-tri-O-methylmyricetin (12, IC50 7.1 μM) and ombuin (15, IC50 1.7 μM) from Larrea tridentata as the active constituents.  Active exts. and compds. were also tested on the closely related cdc2-like kinase CLK1.  Finally, the selectivity profile of compds. was evaluated by including other members of the DYRKs and CLKs families.  While the flavonoids and emodin did not show significant differences in the potency of their activities, harmine (1) was most active against DYRK1A, CLK1, and CLK4, and less potent against the other kinases, with selectivity ranging from 2- to 20-fold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQYs26xh3H3LVg90H21EOLACvtfcHk0lh814-u2VtGuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtlalu7fJ&md5=4b208fb3076d132158355eed8472acc3</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1055%2Fs-0031-1298625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0031-1298625%26sid%3Dliteratum%253Aachs%26aulast%3DGrabher%26aufirst%3DP.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DKouloura%26aufirst%3DE.%26aulast%3DHalabalaki%26aufirst%3DM.%26aulast%3DSkaltsounis%26aufirst%3DL.%2BA.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DHamburger%26aufirst%3DM.%26aulast%3DPotterat%26aufirst%3DO.%26atitle%3DLibrary-based%2520discovery%2520of%2520DYRK1A%252FCLKA%2520inhibitors%2520from%2520natural%2520product%2520extracts%26jtitle%3DPlanta%2520Med.%26date%3D2012%26volume%3D78%26spage%3D951%26epage%3D956%26doi%3D10.1055%2Fs-0031-1298625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mariano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span> <span> </span><span class="NLM_article-title">Systematic diversification of benzylidene heterocycles yields novel inhibitor scaffolds selective for Dyrk1A, Clk1 and CK2</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2016.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=26896709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVChsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2016&pages=209-216&author=M.+Marianoauthor=R.+W.+Hartmannauthor=M.+Engel&title=Systematic+diversification+of+benzylidene+heterocycles+yields+novel+inhibitor+scaffolds+selective+for+Dyrk1A%2C+Clk1+and+CK2&doi=10.1016%2Fj.ejmech.2016.02.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic diversification of benzylidene heterocycles yields novel inhibitor scaffolds selective for Dyrk1A, Clk1 and CK2</span></div><div class="casAuthors">Mariano, Marica; Hartmann, Rolf W.; Engel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">209-216</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The dual-specificity tyrosine-regulated kinase 1A (Dyrk1A) has gathered much interest as a pharmacol. target in Alzheimer's disease (AD), but it plays a role in malignant brain tumors as well.  As both diseases are multi-factorial, further protein kinases, such as Clk1 and CK2, were proposed to contribute to the pathogenesis.  The authors designed a new class of α-benzylidene-γ-butyrolactone inhibitors that showed low micromolar potencies against Dyrk1A and/or Clk1 and a good selectivity profile among the most frequently reported off-target kinases.  A systematic replacement of the heterocyclic moiety gave access to further inhibitor classes with interesting selectivity profiles, demonstrating that the benzylidene heterocycles provide a versatile tool box for developing inhibitors of the CMGC kinase family members Dyr1A/1B, Clk1/4 and CK2.  Efficacy for the inhibition of Dyrk1A-mediated tau phosphorylation was demonstrated in a cell-based assay.  Multi-targeted but not non-specific kinase inhibitors were also obtained, that co-inhibited the lipid kinases PI3Kα/γ.  These compds. were shown to inhibit the proliferation of U87MG cells in the low micromolar range.  Based on the mol. properties, the inhibitors described here hold promise for CNS activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6qXCl7IedNLVg90H21EOLACvtfcHk0lh814-u2VtGuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVChsb4%253D&md5=85bec789a30e7da3dddfc731ed87b227</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DMariano%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3DSystematic%2520diversification%2520of%2520benzylidene%2520heterocycles%2520yields%2520novel%2520inhibitor%2520scaffolds%2520selective%2520for%2520Dyrk1A%252C%2520Clk1%2520and%2520CK2%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D112%26spage%3D209%26epage%3D216%26doi%3D10.1016%2Fj.ejmech.2016.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tahtouh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soundararajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhommel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberholzer, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9312</span>– <span class="NLM_lpage">9330</span>, <span class="refDoi"> DOI: 10.1021/jm301034u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301034u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9312-9330&author=T.+Tahtouhauthor=J.+M.+Elkinsauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=G.+Burgyauthor=E.+Durieuauthor=C.+Cochetauthor=R.+S.+Schmidauthor=D.+C.+Loauthor=F.+Delhommelauthor=A.+E.+Oberholzerauthor=L.+H.+Pearlauthor=F.+Carreauxauthor=J.-P.+Bazureauauthor=S.+Knappauthor=L.+Meijer&title=Selectivity%2C+cocrystal+structures%2C+and+neuroprotective+properties+of+leucettines%2C+a+family+of+protein+kinase+inhibitors+derived+from+the+marine+sponge+alkaloid+leucettamine+B&doi=10.1021%2Fjm301034u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B</span></div><div class="casAuthors">Tahtouh, Tania; Elkins, Jonathan M.; Filippakopoulos, Panagis; Soundararajan, Meera; Burgy, Guillaume; Durieu, Emilie; Cochet, Claude; Schmid, Ralf S.; Lo, Donald C.; Delhommel, Florent; Oberholzer, Anselm E.; Pearl, Laurence H.; Carreaux, Francois; Bazureau, Jean-Pierre; Knapp, Stefan; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9312-9330</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DYRKs (dual specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases) are implicated in the onset and development of Alzheimer's disease and Down syndrome.  The marine sponge alkaloid leucettamine B was recently identified as an inhibitor of DYRKs/CLKs.  Synthesis of analogs (leucettines) led to an optimized product, leucettine L41.  Leucettines were cocrystd. with DYRK1A, DYRK2, CLK3, PIM1, and GSK-3β.  The selectivity of L41 was studied by activity and interaction assays of recombinant kinases and affinity chromatog. and competition affinity assays.  These approaches revealed unexpected potential secondary targets such as CK2, SLK, and the lipid kinase PIKfyve/Vac14.  L41 displayed neuroprotective effects on glutamate-induced HT22 cell death.  L41 also reduced amyloid precursor protein-induced cell death in cultured rat brain slices.  The unusual multitarget selectivity of leucettines may account for their neuroprotective effects.  This family of kinase inhibitors deserves further optimization as potential therapeutics against neurodegenerative diseases such as Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhwr44JiuCrVg90H21EOLACvtfcHk0lgOtvHuUtFByQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF&md5=a1749c347c2e8e0409d8fdd475dc70f9</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm301034u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301034u%26sid%3Dliteratum%253Aachs%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DBurgy%26aufirst%3DG.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DR.%2BS.%26aulast%3DLo%26aufirst%3DD.%2BC.%26aulast%3DDelhommel%26aufirst%3DF.%26aulast%3DOberholzer%26aufirst%3DA.%2BE.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.-P.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DSelectivity%252C%2520cocrystal%2520structures%252C%2520and%2520neuroprotective%2520properties%2520of%2520leucettines%252C%2520a%2520family%2520of%2520protein%2520kinase%2520inhibitors%2520derived%2520from%2520the%2520marine%2520sponge%2520alkaloid%2520leucettamine%2520B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9312%26epage%3D9330%26doi%3D10.1021%2Fjm301034u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loidreau, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubouilh-Benard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nourrisson, M.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaëc, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, P.</span></span> <span> </span><span class="NLM_article-title">Exploring kinase inhibition properties of 9H-pyrimido[5,4-b]- and [4,5-b]indol-4-amine derivatives</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">89</span>, <span class="refDoi"> DOI: 10.3390/ph13050089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3390%2Fph13050089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFKqs7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2020&pages=89&author=Y.+Loidreauauthor=C.+Dubouilh-Benardauthor=M.-R.+Nourrissonauthor=N.+Loa%C3%ABcauthor=L.+Meijerauthor=T.+Bessonauthor=P.+Marchand&title=Exploring+kinase+inhibition+properties+of+9H-pyrimido%5B5%2C4-b%5D-+and+%5B4%2C5-b%5Dindol-4-amine+derivatives&doi=10.3390%2Fph13050089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring kinase inhibition properties of 9H-pyrimido[5,4-b]- and[4,5-b]indol-4-amine derivatives</span></div><div class="casAuthors">Loidreau, Yvonnick; Dubouilh-Benard, Carole; Nourrisson, Marie-Renee; Loaec, Nadege; Meijer, Laurent; Besson, Thierry; Marchand, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">89</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">For the generation of chem. libraries, the formamide-mediated cyclization of the cyanoamidine precursors was carried out under microwave irradn. in an eco-friendly approach.  In order to explore more in-depth the pharmacol. interest in such tricyclic skeletons, the central five member ring, i.e., thiophene or furan, was replaced by a pyrrole to afford 9H-pyrimido[5,4-b]indol-4-amines I (R = H, Me, Et, Bn; R1 = H, nitro) and [4,5-b]indol-4-amine derivs. II inspired from harmine.  The inhibitory potency of the final products was detd. against four protein kinases (CDK5/p25, CK1δ/ε, GSK3α/β, and DYRK1A).  As a result, promising compds. targeting CK1δ/ε and DYRK1A and displaying micromolar and submicromolar IC50 values were identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG8QylpDgjnLVg90H21EOLACvtfcHk0lgOtvHuUtFByQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFKqs7nN&md5=e1623101654be54fb77ccc098e6faab8</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.3390%2Fph13050089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph13050089%26sid%3Dliteratum%253Aachs%26aulast%3DLoidreau%26aufirst%3DY.%26aulast%3DDubouilh-Benard%26aufirst%3DC.%26aulast%3DNourrisson%26aufirst%3DM.-R.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBesson%26aufirst%3DT.%26aulast%3DMarchand%26aufirst%3DP.%26atitle%3DExploring%2520kinase%2520inhibition%2520properties%2520of%25209H-pyrimido%255B5%252C4-b%255D-%2520and%2520%255B4%252C5-b%255Dindol-4-amine%2520derivatives%26jtitle%3DPharmaceuticals%26date%3D2020%26volume%3D13%26spage%3D89%26doi%3D10.3390%2Fph13050089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drung, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nazari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarragiotto, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B.</span></span> <span> </span><span class="NLM_article-title">Computational & experimental evaluation of the structure/activity relationship of β-carbolines as DYRK1A inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4854</span>– <span class="NLM_lpage">4860</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.08.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmcl.2014.08.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=25240617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFWjtbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4854-4860&author=B.+Drungauthor=C.+Scholzauthor=V.+A.+Barbosaauthor=A.+Nazariauthor=M.+H.+Sarragiottoauthor=B.+Schmidt&title=Computational+%26+experimental+evaluation+of+the+structure%2Factivity+relationship+of+%CE%B2-carbolines+as+DYRK1A+inhibitors&doi=10.1016%2Fj.bmcl.2014.08.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Computational & experimental evaluation of the structure/activity relationship of β-carbolines as DYRK1A inhibitors</span></div><div class="casAuthors">Drung, Binia; Scholz, Christoph; Barbosa, Valeria A.; Nazari, Azadeh; Sarragiotto, Maria H.; Schmidt, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4854-4860</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">DYRK1A has been assocd. with Down's syndrome and neurodegenerative diseases, therefore it is an important target for novel pharmacol. interventions.  We combined a ligand-based pharmacophore design with a structure-based protein/ligand docking using the software MOE in order to evaluate the underlying structure/activity relationship.  Based on this knowledge we synthesized several novel β-carboline derivs. to validate the theor. model.  Furthermore we identified a modified lead structure as a potent DYRK1A inhibitor (IC50 = 130 nM) with significant selectivity against MAO-A, DYRK2, DYRK3, DYRK4 & CLK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7toJP2kYJW7Vg90H21EOLACvtfcHk0lgOtvHuUtFByQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFWjtbjJ&md5=d6fe10d53dba2047c291dbb56de5afcb</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.08.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.08.054%26sid%3Dliteratum%253Aachs%26aulast%3DDrung%26aufirst%3DB.%26aulast%3DScholz%26aufirst%3DC.%26aulast%3DBarbosa%26aufirst%3DV.%2BA.%26aulast%3DNazari%26aufirst%3DA.%26aulast%3DSarragiotto%26aufirst%3DM.%2BH.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DComputational%2520%2526%2520experimental%2520evaluation%2520of%2520the%2520structure%252Factivity%2520relationship%2520of%2520%25CE%25B2-carbolines%2520as%2520DYRK1A%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4854%26epage%3D4860%26doi%3D10.1016%2Fj.bmcl.2014.08.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruben, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurzlbauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Selectivity profiling and biological activity of novel β-carbolines as potent and selective DYRK1 kinase inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0132453</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0132453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1371%2Fjournal.pone.0132453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=26192590" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=K.+Rubenauthor=A.+Wurzlbauerauthor=A.+Walteauthor=W.+Sipplauthor=F.+Bracherauthor=W.+Becker&title=Selectivity+profiling+and+biological+activity+of+novel+%CE%B2-carbolines+as+potent+and+selective+DYRK1+kinase+inhibitors&doi=10.1371%2Fjournal.pone.0132453"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0132453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0132453%26sid%3Dliteratum%253Aachs%26aulast%3DRuben%26aufirst%3DK.%26aulast%3DWurzlbauer%26aufirst%3DA.%26aulast%3DWalte%26aufirst%3DA.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DSelectivity%2520profiling%2520and%2520biological%2520activity%2520of%2520novel%2520%25CE%25B2-carbolines%2520as%2520potent%2520and%2520selective%2520DYRK1%2520kinase%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0132453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balint, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruzalegui, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burbridge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotschy, A.</span></span> <span> </span><span class="NLM_article-title">Structure-based design and synthesis of harmine derivatives with different selectivity profiles in kinase versus monoamine oxidase inhibition</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">932</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1002%2Fcmdc.201600539" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=28264138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1Wisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=932-939&author=B.+Balintauthor=C.+Weberauthor=F.+Cruzaleguiauthor=M.+Burbridgeauthor=A.+Kotschy&title=Structure-based+design+and+synthesis+of+harmine+derivatives+with+different+selectivity+profiles+in+kinase+versus+monoamine+oxidase+inhibition&doi=10.1002%2Fcmdc.201600539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design and Synthesis of Harmine Derivatives with Different Selectivity Profiles in Kinase versus Monoamine Oxidase Inhibition</span></div><div class="casAuthors">Balint, Balazs; Weber, Csaba; Cruzalegui, Francisco; Burbridge, Mike; Kotschy, Andras</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">932-939</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) is an emerging biol. target with implications in diverse therapeutic areas such as neurol. disorders (Down syndrome, in particular), metab., and oncol.  Harmine, a natural product that selectively inhibits DYRK1A amongst kinases, could serve as a tool compd. to better understand the biol. processes that arise from DYRK1A inhibition.  On the other hand, harmine is also a potent inhibitor of monoamine oxidase A (MAO-A).  Using structure-based design, we synthesized a collection of harmine analogs with tunable selectivity toward these two enzymes.  Modifications at the 7-position typically decreased affinity for DYRK1A, whereas substitution at the 9-position had a similar effect on MAO-A inhibition but DYRK1A inhibition was maintained.  The resulting collection of compds. can help to understand the biol. role of DYRK1A and also to assess the interference in the biol. effect originating in MAO-A inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsY4lpVOJVlbVg90H21EOLACvtfcHk0lgdxj_w2QNDGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1Wisro%253D&md5=f713602f24c608cbe5c97d965ea3727d</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600539%26sid%3Dliteratum%253Aachs%26aulast%3DBalint%26aufirst%3DB.%26aulast%3DWeber%26aufirst%3DC.%26aulast%3DCruzalegui%26aufirst%3DF.%26aulast%3DBurbridge%26aufirst%3DM.%26aulast%3DKotschy%26aufirst%3DA.%26atitle%3DStructure-based%2520design%2520and%2520synthesis%2520of%2520harmine%2520derivatives%2520with%2520different%2520selectivity%2520profiles%2520in%2520kinase%2520versus%2520monoamine%2520oxidase%2520inhibition%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26spage%3D932%26epage%3D939%26doi%3D10.1002%2Fcmdc.201600539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlatanic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berrouet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khamrui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secor, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swartz, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ocana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVita, R. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological validation of a harmine-based, central nervous system (CNS)-avoidant, selective, human β-cell regenerative dual-specificity tyrosine phosphorylation-regulated kinase A (DYRK1A) inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2986</span>– <span class="NLM_lpage">3003</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01379</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01379" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVOgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=2986-3003&author=K.+Kumarauthor=P.+Wangauthor=J.+Wilsonauthor=V.+Zlatanicauthor=C.+Berrouetauthor=S.+Khamruiauthor=C.+Secorauthor=E.+A.+Swartzauthor=M.+Lazarusauthor=R.+Sanchezauthor=A.+F.+Stewartauthor=A.+Garcia-Ocanaauthor=R.+J.+DeVita&title=Synthesis+and+biological+validation+of+a+harmine-based%2C+central+nervous+system+%28CNS%29-avoidant%2C+selective%2C+human+%CE%B2-cell+regenerative+dual-specificity+tyrosine+phosphorylation-regulated+kinase+A+%28DYRK1A%29+inhibitor&doi=10.1021%2Facs.jmedchem.9b01379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Validation of a Harmine-Based, Central Nervous System (CNS)-Avoidant, Selective, Human β-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor</span></div><div class="casAuthors">Kumar, Kunal; Wang, Peng; Wilson, Jessica; Zlatanic, Viktor; Berrouet, Cecilia; Khamrui, Susmita; Secor, Cody; Swartz, Ethan A.; Lazarus, Michael; Sanchez, Roberto; Stewart, Andrew F.; Garcia-Ocana, Adolfo; DeVita, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2986-3003</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, our group identified that harmine is able to induce β-cell proliferation both in vitro and in vivo, mediated via the DYRK1A-NFAT pathway.  Since, harmine suffers from a lack of selectivity, both against other kinases and CNS off-targets, we therefore sought to expand structure-activity relationships for harmine's DYRK1A activity, to enhance selectivity for off-targets while retaining human β-cell proliferation activity.  We carried out optimization of the 9-N-position of harmine to synthesize 29 harmine-based analogs.  Several novel inhibitors showed excellent DYRK1A inhibition and human β-cell proliferation capability.  An optimized DYRK1A inhibitor, compd. I, was identified as a novel, efficacious in vivo lead candidate.  Compd. I also demonstrates improved selectivity for kinases and CNS off-targets, as well as in vivo efficacy for β-cell proliferation and regeneration at lower doses than harmine.  Collectively, these findings demonstrate that compd. I is a much improved in vivo lead candidate as compared to harmine for the treatment of diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZXVR-g2rCbbVg90H21EOLACvtfcHk0lgdxj_w2QNDGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVOgsr8%253D&md5=c739edc1358acafc412a122c272edceb</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01379%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWilson%26aufirst%3DJ.%26aulast%3DZlatanic%26aufirst%3DV.%26aulast%3DBerrouet%26aufirst%3DC.%26aulast%3DKhamrui%26aufirst%3DS.%26aulast%3DSecor%26aufirst%3DC.%26aulast%3DSwartz%26aufirst%3DE.%2BA.%26aulast%3DLazarus%26aufirst%3DM.%26aulast%3DSanchez%26aufirst%3DR.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26aulast%3DGarcia-Ocana%26aufirst%3DA.%26aulast%3DDeVita%26aufirst%3DR.%2BJ.%26atitle%3DSynthesis%2520and%2520biological%2520validation%2520of%2520a%2520harmine-based%252C%2520central%2520nervous%2520system%2520%2528CNS%2529-avoidant%252C%2520selective%252C%2520human%2520%25CE%25B2-cell%2520regenerative%2520dual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%2520A%2520%2528DYRK1A%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D2986%26epage%3D3003%26doi%3D10.1021%2Facs.jmedchem.9b01379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onogi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">86</span>, <span class="refDoi"> DOI: 10.1038/ncomms1090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1038%2Fncomms1090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=20981014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=86&author=Y.+Ogawaauthor=Y.+Nonakaauthor=T.+Gotoauthor=E.+Ohnishiauthor=T.+Hiramatsuauthor=I.+Kiiauthor=M.+Yoshidaauthor=T.+Ikuraauthor=H.+Onogiauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=N.+Itoauthor=M.+Hagiwara&title=Development+of+a+novel+selective+inhibitor+of+the+Down+syndrome-related+kinase+Dyrk1A&doi=10.1038%2Fncomms1090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span></div><div class="casAuthors">Ogawa Yasushi; Nonaka Yosuke; Goto Toshiyasu; Ohnishi Eriko; Hiramatsu Toshiyuki; Kii Isao; Yoshida Miyo; Ikura Teikichi; Onogi Hiroshi; Shibuya Hiroshi; Hosoya Takamitsu; Ito Nobutoshi; Hagiwara Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dyrk1A (dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A) is a serine/threonine kinase essential for brain development and function, and its excessive activity is considered a pathogenic factor in Down syndrome.  The development of potent, selective inhibitors of Dyrk1A would help to elucidate the molecular mechanisms of normal and diseased brains, and may provide a new lead compound for molecular-targeted drug discovery.  Here, we report a novel Dyrk1A inhibitor, INDY, a benzothiazole derivative showing a potent ATP-competitive inhibitory effect with IC(50) and K(i) values of 0.24 and 0.18 μM, respectively.  X-ray crystallography of the Dyrk1A/INDY complex revealed the binding of INDY in the ATP pocket of the enzyme.  INDY effectively reversed the aberrant tau-phosphorylation and rescued the repressed NFAT (nuclear factor of activated T cell) signalling induced by Dyrk1A overexpression.  Importantly, proINDY, a prodrug of INDY, effectively recovered Xenopus embryos from head malformation induced by Dyrk1A overexpression, resulting in normally developed embryos and demonstrating the utility of proINDY in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtenUz0lpNqnfW6udTcc2eZ7Yl78algpSrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D&md5=ac1d5972bec4085de101bb86194babd1</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fncomms1090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1090%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DE.%26aulast%3DHiramatsu%26aufirst%3DT.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DOnogi%26aufirst%3DH.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520selective%2520inhibitor%2520of%2520the%2520Down%2520syndrome-related%2520kinase%2520Dyrk1A%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D86%26doi%3D10.1038%2Fncomms1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span>; <span class="NLM_string-name">Wurzlbauer, A.</span>; <span class="NLM_string-name">Nowak, R.</span>; <span class="NLM_string-name">von
Delft, F.</span>; <span class="NLM_string-name">Arrowsmith, C. H.</span>; <span class="NLM_string-name">Edwards, A. M.</span>; <span class="NLM_string-name">Bountra, C.</span>; <span class="NLM_string-name">Bracher, F.</span>; <span class="NLM_string-name">Knapp, S.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of DYRK1A with harmine-derivatized AnnH-75 inhibitor</span>.  <i>PDB entry 4YU2</i> (<span class="refDoi"> DOI: 10.2210/pdb4YU2/pdb</span> ).</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.2210%2Fpdb4YU2%2Fpdb" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chaikuad%2C+A.%3B+Wurzlbauer%2C+A.%3B+Nowak%2C+R.%3B+von%0ADelft%2C+F.%3B+Arrowsmith%2C+C.+H.%3B+Edwards%2C+A.+M.%3B+Bountra%2C+C.%3B+Bracher%2C+F.%3B+Knapp%2C+S.+Crystal+structure+of+DYRK1A+with+harmine-derivatized+AnnH-75+inhibitor.+PDB+entry+4YU2+%28+10.2210%2Fpdb4YU2%2Fpdb%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.2210%2Fpdb4YU2%2Fpdb&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.2210%252Fpdb4YU2%252Fpdb%26sid%3Dliteratum%253Aachs%26aulast%3DChaikuad%26aufirst%3DA.%26atitle%3DCrystal%2520structure%2520of%2520DYRK1A%2520with%2520harmine-derivatized%2520AnnH-75%2520inhibitor%26btitle%3DPDB%2520entry%25204YU2%26doi%3D10.2210%2Fpdb4YU2%2Fpdb" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesuma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, R. Z.</span></span> <span> </span><span class="NLM_article-title">Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2004.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bbrc.2004.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=15047157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVKmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2004&pages=128-132&author=Y.+Songauthor=D.+Kesumaauthor=J.+Wangauthor=Y.+Dengauthor=J.+Duanauthor=J.+H.+Wangauthor=R.+Z.+Qi&title=Specific+inhibition+of+cyclin-dependent+kinases+and+cell+proliferation+by+harmine&doi=10.1016%2Fj.bbrc.2004.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine</span></div><div class="casAuthors">Song, Yongcheng; Kesuma, Djohan; Wang, Jian; Deng, Yu; Duan, Jinao; Wang, Jerry H.; Qi, Robert Z.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-132</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">As key regulators of the cell proliferation cycle, cyclin-dependent kinases (CDKs) are attractive targets for the development of anti-tumor drugs.  In the present study, harmine was identified from a collection of herbal compds. to be a specific inhibitor of Cdk1/cyclin B, Cdk2/cyclin A, and Cdk5/p25 with IC50 values at low micromoles.  It displayed little effect on other serine/threonine and tyrosine kinases tested.  The CDK inhibition by harmine is competitive with ATP-Mg2+, suggesting that it binds to the ATP-Mg2+-binding pocket of CDKs.  In cytotoxicity assays, harmine exhibited a strong inhibitory effect on the growth and proliferation of carcinoma cells whereas it had no significant effect on quiescent fibroblasts.  Further, harmine was found to block DNA replication in the carcinoma cells.  Taken together, harmine is a selective inhibitor of CDKs and cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9drfO7NpUHrVg90H21EOLACvtfcHk0lgk6uvXdHN3ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVKmt74%253D&md5=1a88a183ab790612a3e4c3d7c147eca6</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2004.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2004.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DKesuma%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DQi%26aufirst%3DR.%2BZ.%26atitle%3DSpecific%2520inhibition%2520of%2520cyclin-dependent%2520kinases%2520and%2520cell%2520proliferation%2520by%2520harmine%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2004%26volume%3D317%26spage%3D128%26epage%3D132%26doi%3D10.1016%2Fj.bbrc.2004.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dasappa, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagendra, H. G.</span></span> <span> </span><span class="NLM_article-title">Preferential selectivity of inhibitors with human tau protein kinase Gsk3 elucidates their potential roles for off-target Alzheimer’s therapy</span>. <i>Int. J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">809386</span>, <span class="refDoi"> DOI: 10.1155/2013/809386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1155%2F2013%2F809386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=24222885" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=809386&author=J.+K.+Dasappaauthor=H.+G.+Nagendra&title=Preferential+selectivity+of+inhibitors+with+human+tau+protein+kinase+Gsk3+elucidates+their+potential+roles+for+off-target+Alzheimer%E2%80%99s+therapy&doi=10.1155%2F2013%2F809386"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1155%2F2013%2F809386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F809386%26sid%3Dliteratum%253Aachs%26aulast%3DDasappa%26aufirst%3DJ.%2BK.%26aulast%3DNagendra%26aufirst%3DH.%2BG.%26atitle%3DPreferential%2520selectivity%2520of%2520inhibitors%2520with%2520human%2520tau%2520protein%2520kinase%2520Gsk3%2520elucidates%2520their%2520potential%2520roles%2520for%2520off-target%2520Alzheimer%25E2%2580%2599s%2520therapy%26jtitle%3DInt.%2520J.%2520Alzheimer%2527s%2520Dis.%26date%3D2013%26volume%3D2013%26spage%3D809386%26doi%3D10.1155%2F2013%2F809386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deslandes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamoral-Theys, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frongia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chassaing, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruyère, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducommun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delfourne, E.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of analogs of the marine alkaloids granulatimide and isogranulatimide</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">626</span>– <span class="NLM_lpage">636</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2012.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=22809559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWntb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2012&pages=626-636&author=S.+Deslandesauthor=D.+Lamoral-Theysauthor=C.+Frongiaauthor=S.+Chassaingauthor=C.+Bruy%C3%A8reauthor=O.+Lozachauthor=L.+Meijerauthor=B.+Ducommunauthor=R.+Kissauthor=E.+Delfourne&title=Synthesis+and+biological+evaluation+of+analogs+of+the+marine+alkaloids+granulatimide+and+isogranulatimide&doi=10.1016%2Fj.ejmech.2012.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of analogs of the marine alkaloids granulatimide and isogranulatimide</span></div><div class="casAuthors">Deslandes, Sebastien; Lamoral-Theys, Delphine; Frongia, Celine; Chassaing, Stefan; Bruyere, Celine; Lozach, Olivier; Meijer, Laurent; Ducommun, Bernard; Kiss, Robert; Delfourne, Evelyne</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">626-636</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of pyrrolic analogs and two series of regioisomeric pyrazolic analogs of the marine alkaloids granulatimide and isogranulatimide were prepd.  The synthesis of the two first ones was based on the condensation reaction of diversely 5-substituted 3-bromoindoles with pyrrole or pyrazole followed by addn. of the intermediates on maleimide or dibromomaleimide, resp., the so-obtained acyclic adducts being finally photocyclized to the desired analogs.  Compds. of the last series were obtained by reacting different 5-substituted-indole-3-glyoxylates with N-Boc-pyrazole-3-acetamide and subsequent photochem. cyclization of the adducts.  All the compds. were evaluated for their in vitro growth inhibitory properties toward eight cancer cell lines.  Several compds. were also assayed for their ability to abrogate the G2-cell cycle checkpoint or to inhibit a panel of Ser/Thr kinases.  Lastly, computer-assisted phase-contrast microscopy (quant. videomicroscopy) revealed that the three most potent compds. I and II [R = H, OMe], with IC50 growth inhibitory concns. ranging between 10 and 20 μM, displayed cytostatic, not cytotoxic, anticancer effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMnS7Ru38NvLVg90H21EOLACvtfcHk0ljXA3FICTujsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWntb7J&md5=843cca6703c6798b42764e9bae2401bc</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DDeslandes%26aufirst%3DS.%26aulast%3DLamoral-Theys%26aufirst%3DD.%26aulast%3DFrongia%26aufirst%3DC.%26aulast%3DChassaing%26aufirst%3DS.%26aulast%3DBruy%25C3%25A8re%26aufirst%3DC.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DDucommun%26aufirst%3DB.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DDelfourne%26aufirst%3DE.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520analogs%2520of%2520the%2520marine%2520alkaloids%2520granulatimide%2520and%2520isogranulatimide%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D54%26spage%3D626%26epage%3D636%26doi%3D10.1016%2Fj.ejmech.2012.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Aparicio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuertes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Puerto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Monte-Millan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balaiah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahyuono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span> <span> </span><span class="NLM_article-title">Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer’s disease</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1397</span>– <span class="NLM_lpage">1405</span>, <span class="refDoi"> DOI: 10.1021/np060092r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np060092r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptl2lsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=1397-1405&author=M.+Hamannauthor=D.+Alonsoauthor=E.+Martin-Aparicioauthor=A.+Fuertesauthor=M.+J.+P%C3%A9rez-Puertoauthor=A.+Castroauthor=S.+Moralesauthor=M.+L.+Navarroauthor=M.+del+Monte-Millanauthor=M.+Medinaauthor=H.+Pennakaauthor=A.+Balaiahauthor=J.+Pengauthor=J.+Cookauthor=S.+Wahyuonoauthor=A.+Martinez&title=Glycogen+synthase+kinase-3+%28GSK-3%29+inhibitory+activity+and+structure-activity+relationship+%28SAR%29+studies+of+the+manzamine+alkaloids.+Potential+for+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fnp060092r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen Synthase Kinase-3 (GSK-3) Inhibitory Activity and Structure-Activity Relationship (SAR) Studies of the Manzamine Alkaloids. Potential for Alzheimer's Disease</span></div><div class="casAuthors">Hamann, Mark; Alonso, Diana; Martin-Aparicio, Ester; Fuertes, Ana; Perez-Puerto, M. Jose; Castro, Ana; Morales, Susana; Navarro, Maria Luisa; del Monte-Millan, Maria; Medina, Miguel; Pennaka, Hari; Balaiah, Akula; Peng, Jiangnan; Cook, Jennifer; Wahyuono, Subagus; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1397-1405</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Manzamine A and related derivs. isolated from a common Indonesian sponge, Acanthostrongylophora, have been identified as a new class of GSK-3β inhibitors.  The semisynthesis of new analogs and the first structure-activity relationship studies with GSK-3β are also reported.  Moreover, manzamine A proved to be effective in decreasing tau hyperphosphorylation in human neuroblastoma cell lines, a demonstration of its ability to enter cells and interfere with tau pathol.  Inhibition studies of manzamine A against a selected panel of five different kinases related to GSK-3β, specifically CDK-1, PKA, CDK-5, MAPK, and GSK-3α, show the specific inhibition of manzamine A on GSK-3β and CDK-5, the two kinases involved in tau pathol. hyperphosphorylation.  These results suggest that manzamine A constitutes a promising scaffold from which more potent and selective GSK-3 inhibitors could be designed as potential therapeutic agents for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9mYEdxZJqErVg90H21EOLACvtfcHk0ljXA3FICTujsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptl2lsbs%253D&md5=8d303b26c960b54bed732f3d2ac3fdc2</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fnp060092r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp060092r%26sid%3Dliteratum%253Aachs%26aulast%3DHamann%26aufirst%3DM.%26aulast%3DAlonso%26aufirst%3DD.%26aulast%3DMartin-Aparicio%26aufirst%3DE.%26aulast%3DFuertes%26aufirst%3DA.%26aulast%3DP%25C3%25A9rez-Puerto%26aufirst%3DM.%2BJ.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DMorales%26aufirst%3DS.%26aulast%3DNavarro%26aufirst%3DM.%2BL.%26aulast%3Ddel%2BMonte-Millan%26aufirst%3DM.%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DPennaka%26aufirst%3DH.%26aulast%3DBalaiah%26aufirst%3DA.%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DWahyuono%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DGlycogen%2520synthase%2520kinase-3%2520%2528GSK-3%2529%2520inhibitory%2520activity%2520and%2520structure-activity%2520relationship%2520%2528SAR%2529%2520studies%2520of%2520the%2520manzamine%2520alkaloids.%2520Potential%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2007%26volume%3D70%26spage%3D1397%26epage%3D1405%26doi%3D10.1021%2Fnp060092r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesuma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, M. M.</span></span> <span> </span><span class="NLM_article-title">β-Carbolines as specific inhibitors of cyclin-dependent kinases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1129</span>– <span class="NLM_lpage">1132</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)00094-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2FS0960-894X%2802%2900094-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=11909733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFWhtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1129-1132&author=Y.+Songauthor=J.+Wangauthor=S.+F.+Tengauthor=D.+Kesumaauthor=Y.+Dengauthor=J.+Duanauthor=J.+H.+Wangauthor=R.+Z.+Qiauthor=M.+M.+Sim&title=%CE%B2-Carbolines+as+specific+inhibitors+of+cyclin-dependent+kinases&doi=10.1016%2FS0960-894X%2802%2900094-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">β-Carbolines as specific inhibitors of cyclin-dependent kinases</span></div><div class="casAuthors">Song, Yongcheng; Wang, Jian; Teng, Su Fern; Kesuma, Djohan; Deng, Yu; Duan, Jinao; Wang, Jerry H.; Qi, Robert Zhong; Sim, Mui Mui</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1129-1132</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Harmine , 7-fluoro-1-Me β-carboline (35) and 1-(5-methyl-imidazol-4-yl) β-carboline (41) were potent and specific inhibitors of cyclin-dependent kinases.  The degree of aromaticity of the tricyclic ring and the positioning of substituents are important for inhibitory activity.  While most β-carbolines inhibited CDK2 and CDK5 to the same extent, selective inhibition against CDK2 was obsd. in 1-(2-chlorophenyl)- (12), 1-(2-fluorophenyl)- (15), and 1-(2-chloro-5-nitrophenyl)- (28) β-carbolines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx1RVeAY4-ibVg90H21EOLACvtfcHk0ljXA3FICTujsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFWhtrk%253D&md5=2c921f4b9cb2df833fc0684e006310a6</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900094-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900094-X%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DTeng%26aufirst%3DS.%2BF.%26aulast%3DKesuma%26aufirst%3DD.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DQi%26aufirst%3DR.%2BZ.%26aulast%3DSim%26aufirst%3DM.%2BM.%26atitle%3D%25CE%25B2-Carbolines%2520as%2520specific%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1129%26epage%3D1132%26doi%3D10.1016%2FS0960-894X%2802%2900094-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herraiz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaparro, C.</span></span> <span> </span><span class="NLM_article-title">Human monoamine oxidase is inhibited by tobacco smoke: β-carboline alkaloids act as potent and reversible inhibitors</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>326</i></span>,  <span class="NLM_fpage">378</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2004.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bbrc.2004.11.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=15582589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCgtbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2005&pages=378-386&author=T.+Herraizauthor=C.+Chaparro&title=Human+monoamine+oxidase+is+inhibited+by+tobacco+smoke%3A+%CE%B2-carboline+alkaloids+act+as+potent+and+reversible+inhibitors&doi=10.1016%2Fj.bbrc.2004.11.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Human monoamine oxidase is inhibited by tobacco smoke: β-carboline alkaloids act as potent and reversible inhibitors</span></div><div class="casAuthors">Herraiz, Tomas; Chaparro, Carolina</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">378-386</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Monoamine oxidase (MAO) is a mitochondrial outer-membrane flavoenzyme involved in brain and peripheral oxidative catabolism of neurotransmitters and xenobiotic amines, including neurotoxic amines, and a well-known target for antidepressant and neuroprotective drugs.  Recently, positron emission tomog. imaging has shown that smokers have a much lower activity of peripheral and brain MAO-A (30%) and -B (40%) isoenzymes compared to non-smokers.  This MAO inhibition results from a pharmacol. effect of smoke, but little is known about its mechanism.  Working with mainstream smoke collected from com. cigarettes the authors confirmed that cigarette smoke is a potent inhibitor of human MAO-A and -B isoenzymes.  MAO inhibition was partly reversible, competitive for MAO-A, and a mixed-type inhibition for MAO-B.  Two β-carboline alkaloids, norharman (β-carboline) and harman (1-methyl-β-carboline), were identified by GC-MS, quantified, and isolated from the mainstream smoke by solid phase extn. and HPLC.  Kinetics anal. revealed that β-carbolines from cigarette smoke were competitive, reversible, and potent inhibitors of MAO enzymes.  Norharman was an inhibitor of MAO-A (Ki = 1.2 μM) and MAO-B (Ki = 1.12 μM), and harman of MAO-A (Ki = 55.54 nM).  β-Carboline alkaloids are psychopharmacol. active compds. that may occur endogenously in human tissues, including the brain.  These results suggest that β-carboline alkaloids from cigarette smoke acting as potent reversible inhibitors of MAO enzymes may contribute to the MAO-reduced activity produced by tobacco smoke in smokers.  The presence of MAO inhibitors in smoke like β-carbolines and others may help the authors to understand some of the purported neuropharmacol. effects assocd. with smoking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosGeu1O_rPCrVg90H21EOLACvtfcHk0lje0eW1Ivw1fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCgtbjP&md5=cb3a977fa57bbaa60d912907b0ac8313</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2004.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2004.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DHerraiz%26aufirst%3DT.%26aulast%3DChaparro%26aufirst%3DC.%26atitle%3DHuman%2520monoamine%2520oxidase%2520is%2520inhibited%2520by%2520tobacco%2520smoke%253A%2520%25CE%25B2-carboline%2520alkaloids%2520act%2520as%2520potent%2520and%2520reversible%2520inhibitors%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D326%26spage%3D378%26epage%3D386%26doi%3D10.1016%2Fj.bbrc.2004.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herraiz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaparro, C.</span></span> <span> </span><span class="NLM_article-title">Human monoamine oxidase enzyme inhibition by coffee and β-carbolines norharman and harman isolated from coffee</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">795</span>– <span class="NLM_lpage">802</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2005.05.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.lfs.2005.05.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=16139309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvVynug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2006&pages=795-802&author=T.+Herraizauthor=C.+Chaparro&title=Human+monoamine+oxidase+enzyme+inhibition+by+coffee+and+%CE%B2-carbolines+norharman+and+harman+isolated+from+coffee&doi=10.1016%2Fj.lfs.2005.05.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Human monoamine oxidase enzyme inhibition by coffee and β-carbolines norharman and harman isolated from coffee</span></div><div class="casAuthors">Herraiz, Tomas; Chaparro, Carolina</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">795-802</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Monoamine oxidase (MAO) is a mitochondrial outer-membrane flavoenzyme involved in brain and peripheral oxidative catabolism of neurotransmitters and xenobiotic amines, including neurotoxic amines, and a well-known target for antidepressant and neuroprotective drugs.  Recent epidemiol. studies have consistently shown that coffee drinkers have an apparently lower incidence of Parkinson's disease (PD), suggesting that coffee might somehow act as a purported neuroprotectant.  In this paper, "ready to drink" coffee brews exhibited inhibitory properties on recombinant human MAO A and B isoenzymes catalyzing the oxidative deamination of kynuramine, suggesting that coffee contains compds. acting as MAO inhibitors.  MAO inhibition was reversible and competitive for MAO A and MAO B.  Subsequently, the pyrido-indole (β-carboline) alkaloids, norharman and harman, were identified and isolated from MAO-inhibiting coffee, and were good inhibitors on MAO A (harman and norharman) and MAO B (norharman) isoenzymes.  β-Carbolines isolated from ready-to-drink coffee were competitive and reversible inhibitors and appeared up to 210 μg/L, confirming that coffee is the most important exogenous source of these alkaloids in addn. to cigarette smoking.  Inhibition of MAO enzymes by coffee and the presence of MAO inhibitors that are also neuroactive, such as β-carbolines and eventually others, might play a role in the neuroactive actions including a purported neuroprotection assocd. with coffee consumption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYOq0cs2_DgbVg90H21EOLACvtfcHk0lje0eW1Ivw1fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvVynug%253D%253D&md5=32fbb993e500209073342e66ada53ce9</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2005.05.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2005.05.074%26sid%3Dliteratum%253Aachs%26aulast%3DHerraiz%26aufirst%3DT.%26aulast%3DChaparro%26aufirst%3DC.%26atitle%3DHuman%2520monoamine%2520oxidase%2520enzyme%2520inhibition%2520by%2520coffee%2520and%2520%25CE%25B2-carbolines%2520norharman%2520and%2520harman%2520isolated%2520from%2520coffee%26jtitle%3DLife%2520Sci.%26date%3D2006%26volume%3D78%26spage%3D795%26epage%3D802%26doi%3D10.1016%2Fj.lfs.2005.05.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rommelspacher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salewski, B.</span></span> <span> </span><span class="NLM_article-title">Harman (1-methyl-β-carboline) is a natural inhibitor of monoamine oxidase type A in rats</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>252</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(94)90574-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2F0014-2999%2894%2990574-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=8149995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK2cXhvVartbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=1994&pages=51-59&author=H.+Rommelspacherauthor=T.+Mayauthor=B.+Salewski&title=Harman+%281-methyl-%CE%B2-carboline%29+is+a+natural+inhibitor+of+monoamine+oxidase+type+A+in+rats&doi=10.1016%2F0014-2999%2894%2990574-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Harman (1-methyl-β-carboline) is a natural inhibitor of monoamine oxidase type A in rats</span></div><div class="casAuthors">Rommelspacher, Hans; May, Torsten; Salewski, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">252</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-9</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Harman (1-methyl-β-carboline) displaces [3H]pargyline in vitro from high affinity binding sites on membranes from cerebral cortex, provided the exptl. conditions are chosen under which [3H]pargyline labels selectively monoamine oxidase type A.  Norharman (β-carboline) is a much weaker displacing compd.  It is well known that the type A enzyme can be blocked irreversibly in vivo by treatment of rats with clorgyline.  Under these conditions no specific binding of [3H]harman and [3H]pargyline to monoamine oxidase type A was detected in brain, whereas the specific binding was reduced to 5% in liver tissue.  The in vitro and ex vivo expts. suggest that there is a specific binding site for harman on monoamine oxidase type A, thereby extending earlier in vitro findings.  It has been postulated that harman operates as a natural inhibitor of mnoamine oxidase type A in mammals.  The present study demonstrates that harman and norharman occur in rat brain, blood plasma, heart, kidney and liver.  It further shows that pretreatment with clorgyline induces a time-dependent increase in the blood plasma levels of harman, suggesting the displacement of harman from the enzyme in tissue with its subsequent deliver into the blood.  These findings strongly support the hypothesis based on in vitro expts., that harman binds reversibly to the active site of monoamine oxidase type A in vivo.  Dietary sources for mammalian harman play probably only a minor role, because the concns. in beer and wine as well as other foodstuffs are too low to contribute substantially to endogenous levels of harman.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSlTDYF3MuR7Vg90H21EOLACvtfcHk0lhaMhFS-E9OdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhvVartbg%253D&md5=c2fc5375424b41bc674ad3b41ef54862</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2894%2990574-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252894%252990574-6%26sid%3Dliteratum%253Aachs%26aulast%3DRommelspacher%26aufirst%3DH.%26aulast%3DMay%26aufirst%3DT.%26aulast%3DSalewski%26aufirst%3DB.%26atitle%3DHarman%2520%25281-methyl-%25CE%25B2-carboline%2529%2520is%2520a%2520natural%2520inhibitor%2520of%2520monoamine%2520oxidase%2520type%2520A%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D252%26spage%3D51%26epage%3D59%26doi%3D10.1016%2F0014-2999%2894%2990574-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santillo, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vohra, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesenfeld, P. L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase (MAO) by β-carbolines and their interactions in live neuronal (PC12) and liver (HuH-7 and MH1C1) cells</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1016/j.tiv.2013.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.tiv.2013.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=24373881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Kjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=403-410&author=M.+F.+Santilloauthor=Y.+Liuauthor=M.+Fergusonauthor=S.+N.+Vohraauthor=P.+L.+Wiesenfeld&title=Inhibition+of+monoamine+oxidase+%28MAO%29+by+%CE%B2-carbolines+and+their+interactions+in+live+neuronal+%28PC12%29+and+liver+%28HuH-7+and+MH1C1%29+cells&doi=10.1016%2Fj.tiv.2013.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of monoamine oxidase (MAO) by β-carbolines and their interactions in live neuronal (PC12) and liver (HuH-7 and MH1C1) cells</span></div><div class="casAuthors">Santillo, Michael F.; Liu, Yitong; Ferguson, Martine; Vohra, Sanah N.; Wiesenfeld, Paddy L.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology In Vitro</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">403-410</span>CODEN:
                <span class="NLM_cas:coden">TIVIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0887-2333</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Interactions among monoamine oxidase (MAO) inhibitors in drugs, botanicals, and dietary supplements may lead to unpredictable neurochem. dysfunction due to excessive inhibition or therapeutic invalidation.  Often recombinant MAO or brain tissue homogenates have been used to evaluate MAO inhibitors such as the β-carboline alkaloids (harmane, harmine, harmaline, and harmalol).  However, there is a lack of cellular systems for evaluation of MAO activity, which represents a more advanced in vitro model compared to recombinant enzymes or tissue lysates.  Using kynuramine assays, intracellular MAO inhibition by β-carbolines was measured in PC12 (rat pheochromocytoma), MH1C1 (rat liver), and HuH-7 (human liver) cell lines, which were compared with human recombinant MAO and cell lysates.  β-Carbolines (1 μM, 90 min incubations) inhibited MAO by 40-99% in live PC12 cells where MAO A was the active isoform, and <12% in HuH-7 and MH1C1 cells where MAO B was primarily active.  The combination index (CI), which serves as a quant. indicator of pharmacol. interactions, was detd. for harmaline/harmine (CI, 1.01-1.25) and methylene blue/harmine (CI, 0.74-1.07) in PC12 cells.  Overall, this study illustrates applications of cell-based in vitro assay platforms to gain a comprehensive understanding of intracellular MAO inhibitors and their interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnGTjbUWvqHbVg90H21EOLACvtfcHk0lhaMhFS-E9OdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Kjsb4%253D&md5=aa1b4d775de34771b11f1bc653a1d7d1</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.tiv.2013.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tiv.2013.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DSantillo%26aufirst%3DM.%2BF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DFerguson%26aufirst%3DM.%26aulast%3DVohra%26aufirst%3DS.%2BN.%26aulast%3DWiesenfeld%26aufirst%3DP.%2BL.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520%2528MAO%2529%2520by%2520%25CE%25B2-carbolines%2520and%2520their%2520interactions%2520in%2520live%2520neuronal%2520%2528PC12%2529%2520and%2520liver%2520%2528HuH-7%2520and%2520MH1C1%2529%2520cells%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2014%26volume%3D28%26spage%3D403%26epage%3D410%26doi%3D10.1016%2Fj.tiv.2013.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez
de Arriba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lizcano, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balsa, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unzeta, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase from bovine retina by β-carbolines</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">813</span>, <span class="refDoi"> DOI: 10.1111/j.2042-7158.1994.tb03735.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1111%2Fj.2042-7158.1994.tb03735.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=7699568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADyaK2M3htl2hug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1994&pages=809-813&author=A.+Fernandez%0Ade+Arribaauthor=J.+M.+Lizcanoauthor=M.+D.+Balsaauthor=M.+Unzeta&title=Inhibition+of+monoamine+oxidase+from+bovine+retina+by+%CE%B2-carbolines&doi=10.1111%2Fj.2042-7158.1994.tb03735.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of monoamine oxidase from bovine retina by beta-carbolines</span></div><div class="casAuthors">Fernandez de Arriba A; Lizcano J M; Balsa M D; Unzeta M</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacy and pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">809-13</span>
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    </div><div class="casAbstract">The behaviour of some beta-carboline derivatives as inhibitors of monoamine oxidase has been studied in bovine retina.  Inhibition was found not to show any significant time dependence.  Di- and tetrahydro-beta-carbolines were shown to behave as reversible and competitive inhibitors.  In contrast, the fully unsaturated beta-carbolines harmane, harmine and harmaline, which showed deviation from linearity at high substrate concentrations, behaved as tight-binding inhibitors.  In these cases, the concentration of the enzyme and the inhibitor were of the same order.  This was confirmed by the Ki values for these compounds in the nanomolar concentration range.  Consistent with this was that inhibition was only partly reversed by dialysis for 18 h at 4 degrees C, although complete reversal was observed after dialysis for the same period at 37 degrees C.  Structure-activity relationships indicated that substitution of a methoxy group at the C7 position of the aromatic ring is determinant for this tight-binding behaviour; a substitution of this group at the C6 position greatly reduced inhibition.  Since beta-carbolines have been reported to be formed endogenously, this suggests that they might have important physiological actions on monoamine oxidase activity in-vivo.  In contrast, all the beta-carbolines investigated in this study had low potencies as inhibitors of monoamine oxidase B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRZp4ezGwxyrp0d-O_J5C0AfW6udTcc2eaci2g5E3HPMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M3htl2hug%253D%253D&md5=2be963582f130484254ca2c785c1bf3f</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.1994.tb03735.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.1994.tb03735.x%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%2Bde%2BArriba%26aufirst%3DA.%26aulast%3DLizcano%26aufirst%3DJ.%2BM.%26aulast%3DBalsa%26aufirst%3DM.%2BD.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520from%2520bovine%2520retina%2520by%2520%25CE%25B2-carbolines%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D1994%26volume%3D46%26spage%3D809%26epage%3D813%26doi%3D10.1111%2Fj.2042-7158.1994.tb03735.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Samoylenko, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tekwani, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhammad, I.</span></span> <span> </span><span class="NLM_article-title">Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson’s disease</span>. <i>J. Ethnopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1016/j.jep.2009.10.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.jep.2009.10.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=19879939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3cXot12msg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2010&pages=357-367&author=V.+Samoylenkoauthor=M.+M.+Rahmanauthor=B.+L.+Tekwaniauthor=L.+M.+Tripathiauthor=Y.-H.+Wangauthor=S.+I.+Khanauthor=I.+A.+Khanauthor=L.+S.+Millerauthor=V.+C.+Joshiauthor=I.+Muhammad&title=Banisteriopsis+caapi%2C+a+unique+combination+of+MAO+inhibitory+and+antioxidative+constituents+for+the+activities+relevant+to+neurodegenerative+disorders+and+Parkinson%E2%80%99s+disease&doi=10.1016%2Fj.jep.2009.10.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease</span></div><div class="casAuthors">Samoylenko, Volodymyr; Rahman, Md. Mostafizur; Tekwani, Babu L.; Tripathi, Lalit M.; Wang, Yan-Hong; Khan, Shabana I.; Khan, Ikhlas A.; Miller, Loren S.; Joshi, Vaishali C.; Muhammad, Ilias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Ethnopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">357-367</span>CODEN:
                <span class="NLM_cas:coden">JOETD7</span>;
        ISSN:<span class="NLM_cas:issn">0378-8741</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Aim of the study: Parkinson's disease is a neurol. disorder mostly effecting the elder population of the world.  Currently there is no definitive treatment or cure for this disease.  Therefore, in this study the compn. and constituents of the aq. ext. of Banisteriopsis caapi for monoamine oxidases (MAO) inhibitory and antioxidant activities were assessed, which are relevant to the prevention of neurol. disorders, including Parkinsonism.  Materials and methods: The aq. ext. of Banisteriopsis caapi stems was standardized and then fractionated using reversed-phase (RP) chromatog.  Pure compds. were isolated either by reversed-phase (RP) chromatog. or centrifugal preparative TLC, using a Chromatotron.  Structure elucidation was carried out by 1D and 2D NMR, Mass, IR and CD spectroscopy and chem. derivatization.  Chem. profiling of the ext. was carried out with RP-HPLC.  The inhibitory activity of MAO-A, MAO-B, acetylcholinesterase, butyrylcholinesterase and catechol-O-Me transferase enzymes, as well as antioxidant and cytotoxic activities of both Banisteriopsis caapi ext. and isolated compds. was evaluated.  Results: An examn. of the aq. exts. of Banisteriopsis caapi cultivar Da Vine yielded two new alkaloidal glycosides, named banistenoside A (1) and banistenoside B (2), contg. "azepino[1,2-a]tetrahydro-β-carboline" unique carbon framework.  One addnl. new natural tetrahydronorharmine (4), four known β-carbolines harmol (3), tetrahydroharmine (5), harmaline (6) and harmine (7), two known proanthocyanidines (-)-epicatechin (8) and (-)-procyanidin B2 (9), and a new disaccharide β--fructofuranosyl-(2 → 5)-fructopyranose (14) together with known saccharose (15) and β--glucose (16) were also isolated.  In addn., the acetates of 1, 2, 8, 9, 14 and 15 (compds. 10-13, 17, 18) were also prepd.  Harmaline (6) and harmine (7) showed potent in vitro inhibitory activity against recombinant human brain monoamine oxidase (MAO)-A and -B enzymes (IC50 2.5 and 2.0 nM, and 25 and 20 μM, resp.), and (-)-epicatechin (8) and (-)-procyanidin B2 (9) showed potent antioxidant and moderate MAO-B inhibitory activities (IC50 < 0.13 and 0.57 μg/mL, and 65 and 35 μM).  HPLC anal. revealed that most of the dominant chem. and bioactive markers (1, 2, 5, 7-9) were present in high concns. in dried bark of large branch.  Anal. of regular/com. Banisteriopsis caapi dried stems showed a similar qual. HPLC pattern, but relatively low content of dominant markers 1, 2, 7, and 9, which led to decreased MAO inhibitory and antioxidant potency.  Conclusion: Collectively, these results give addnl. basis to the existing claim of Banisteriopsis caapi stem ext. for the treatment of Parkinsonism, including other neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaBgCrkOfxxrVg90H21EOLACvtfcHk0ljqf128tE_NmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXot12msg%253D%253D&md5=85cf0e8497c021bb6fb3107d6e72670a</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.jep.2009.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jep.2009.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DSamoylenko%26aufirst%3DV.%26aulast%3DRahman%26aufirst%3DM.%2BM.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DTripathi%26aufirst%3DL.%2BM.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DKhan%26aufirst%3DS.%2BI.%26aulast%3DKhan%26aufirst%3DI.%2BA.%26aulast%3DMiller%26aufirst%3DL.%2BS.%26aulast%3DJoshi%26aufirst%3DV.%2BC.%26aulast%3DMuhammad%26aufirst%3DI.%26atitle%3DBanisteriopsis%2520caapi%252C%2520a%2520unique%2520combination%2520of%2520MAO%2520inhibitory%2520and%2520antioxidative%2520constituents%2520for%2520the%2520activities%2520relevant%2520to%2520neurodegenerative%2520disorders%2520and%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Ethnopharmacol.%26date%3D2010%26volume%3D127%26spage%3D357%26epage%3D367%26doi%3D10.1016%2Fj.jep.2009.10.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhusban, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaurasiya, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tekwani, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chittiboyina, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I. A.</span></span> <span> </span><span class="NLM_article-title">Isoform selectivity of harmine-conjugated 1,2,3-triazoles against human monoamine oxidase</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1435</span>– <span class="NLM_lpage">1448</span>, <span class="refDoi"> DOI: 10.4155/fmc-2018-0006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.4155%2Ffmc-2018-0006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=29788780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFamtbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=1435-1448&author=S.+Haiderauthor=M.+Alhusbanauthor=N.+D.+Chaurasiyaauthor=B.+L.+Tekwaniauthor=A.+G.+Chittiboyinaauthor=I.+A.+Khan&title=Isoform+selectivity+of+harmine-conjugated+1%2C2%2C3-triazoles+against+human+monoamine+oxidase&doi=10.4155%2Ffmc-2018-0006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform selectivity of harmine-conjugated 1,2,3-triazoles against human monoamine oxidase</span></div><div class="casAuthors">Haider, Saqlain; Alhusban, Manal; Chaurasiya, Narayan D.; Tekwani, Babu L.; Chittiboyina, Amar G.; Khan, Ikhlas A.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1435-1448</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Aim: There is little information available on the monoamine oxidase isoform selectivity of N-alkyl harmine analogs, which exhibit a myriad of activities including MAO-A, DYRK1A and cytotoxicity to several select cancer cell lines.  Results: Compds. 3e and 4c exhibited an IC50 of 0.83 ± 0.03 and 0.43 ± 0.002 μM against MAO-A and an IC50 of 0.26 ± 0.04 and 0.36 ± 0.001 μM against MAO-B, resp.  Mol. docking studies revealed p-p interactions between the synthesized mols. and arom. amino acid residues.  Conclusion & future perspective: The current study delineates the structural requirements for MAO-A selectivity and such information may be helpful in designing selective analogs for kinase, DYRK1A and harmine-based cytotoxics without apparent MAO enzyme inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlcmo-Guls_7Vg90H21EOLACvtfcHk0ljqf128tE_NmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFamtbnI&md5=d6dc18d856623af3d3c0451f55138d51</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2018-0006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2018-0006%26sid%3Dliteratum%253Aachs%26aulast%3DHaider%26aufirst%3DS.%26aulast%3DAlhusban%26aufirst%3DM.%26aulast%3DChaurasiya%26aufirst%3DN.%2BD.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DChittiboyina%26aufirst%3DA.%2BG.%26aulast%3DKhan%26aufirst%3DI.%2BA.%26atitle%3DIsoform%2520selectivity%2520of%2520harmine-conjugated%25201%252C2%252C3-triazoles%2520against%2520human%2520monoamine%2520oxidase%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D1435%26epage%3D1448%26doi%3D10.4155%2Ffmc-2018-0006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Son, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukihara, T.</span></span> <span> </span><span class="NLM_article-title">Structure of human monoamine oxidase A at 2.2-Å resolution: the control of opening the entry for substrates/inhibitors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">5739</span>– <span class="NLM_lpage">5744</span>, <span class="refDoi"> DOI: 10.1073/pnas.0710626105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1073%2Fpnas.0710626105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=18391214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFShsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=5739-5744&author=S.-Y.+Sonauthor=J.+Maauthor=Y.+Kondouauthor=M.+Yoshimuraauthor=E.+Yamashitaauthor=T.+Tsukihara&title=Structure+of+human+monoamine+oxidase+A+at+2.2-%C3%85+resolution%3A+the+control+of+opening+the+entry+for+substrates%2Finhibitors&doi=10.1073%2Fpnas.0710626105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human monoamine oxidase A at 2.2-Å resolution: The control of opening the entry for substrates/inhibitors</span></div><div class="casAuthors">Son, Se-Young; Mat, Jichun; Kondou, Youhei; Yoshimura, Masato; Yamashita, Eiki; Tsukihara, Tomitake</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5739-5744</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mitochondrial outer membrane-anchored monoamine oxidase (MAO) is a biochem. important flavoenzyme that catalyzes the deamination of biogenic and xenobiotic amines.  Its 2 subtypes, MAOA and MAOB, are linked to several psychiatric disorders and therefore are interesting targets for drug design.  To understand the relation between structure and function of this enzyme, the authors extended their previously reported low-resoln. rat MAOA structure to the high-resoln. wild-type and G110A mutant structures of human MAOA complexed with the reversible inhibitor, harmine, at 2.2 and 2.17 Å, resp.  The high-resoln. MAOA structures were similar to those of rat MAOA and human MAOB, but different from the known structure of human MAOA, specifically regarding residues 108-118 and 210-216, which surround the substrate/inhibitor cavity.  The results confirmed that the inhibitor selectivity of MAOA and MAOB is caused by the structural differences arising from Ile-335 in MAOA vs. Tyr-326 in MAOB.  The structures exhibited a C-terminal transmembrane helix with clear electron d., as is also seen in rat MAOA.  Mutations on one residue of loop 108-118, Gly-110, which is far from the active center but close to the membrane surface, caused the solubilized enzyme to undergo a dramatic drop in activity, but have less effect when the enzyme was anchored in the membrane.  These results suggest that the flexibility of loop 108-118, facilitated by anchoring the enzyme into the membrane, is essential for controlling substrate access to the active site.  The authors report on the observation of the structure-function relation between a transmembrane helical anchor and an extra-membrane domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdm8Cs1NxHxLVg90H21EOLACvtfcHk0ljqf128tE_NmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFShsLo%253D&md5=7443fe77547220547312f7259df590df</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710626105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710626105%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DS.-Y.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DKondou%26aufirst%3DY.%26aulast%3DYoshimura%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DE.%26aulast%3DTsukihara%26aufirst%3DT.%26atitle%3DStructure%2520of%2520human%2520monoamine%2520oxidase%2520A%2520at%25202.2-%25C3%2585%2520resolution%253A%2520the%2520control%2520of%2520opening%2520the%2520entry%2520for%2520substrates%252Finhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D5739%26epage%3D5744%26doi%3D10.1073%2Fpnas.0710626105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubalek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Restelli, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">9750</span>– <span class="NLM_lpage">9755</span>, <span class="refDoi"> DOI: 10.1073/pnas.1633804100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1073%2Fpnas.1633804100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=12913124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVejt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=9750-9755&author=C.+Bindaauthor=M.+Liauthor=F.+Hubalekauthor=N.+Restelliauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Insights+into+the+mode+of+inhibition+of+human+mitochondrial+monoamine+oxidase+B+from+high-resolution+crystal+structures&doi=10.1073%2Fpnas.1633804100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures</span></div><div class="casAuthors">Binda, Claudia; Li, Min; Hubalek, Frantisek; Restelli, Nadia; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9750-9755</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO-B) is an outer mitochondrial membrane-bound enzyme that catalyzes the oxidative deamination of arylalkylamine neurotransmitters and has been a target for a no. of clin. used drug inhibitors.  The 1.7-Å structure of the reversible isatin-MAO-B complex has been detd.; it forms a basis for the interpretation of the enzyme's structure when bound to either reversible or irreversible inhibitors.  1,4-Diphenyl-2-butene is found to be a reversible MAO-B inhibitor, which occupies both the entrance and substrate cavity space in the enzyme.  Comparison of these two structures identifies Ile-199 as a "gate" between the two cavities.  Rotation of the side chain allows for either sepn. or fusion of the two cavities.  Inhibition of the enzyme with N-(2-aminoethyl)-p-chlorobenzamide results in the formation of a covalent N(5) flavin adduct with the Ph ring of the inhibitor occupying a position in the catalytic site overlapping that of isatin.  Inhibition of MAO-B with the clin. used trans-2-phenylcyclopropylamine results in the formation of a covalent C(4a) flavin adduct with an opened cyclopropyl ring and the Ph ring in a parallel orientation to the flavin.  The peptide bond between the flavin-substituted Cys-397 and Tyr-398 is in a cis conformation, which allows the proper orientation of the phenolic ring of Tyr-398 in the active site.  The flavin ring exists in a twisted nonplanar conformation, which is obsd. in the oxidized form as well as in both the N(5) and the C(4a) adducts.  An immobile water mol. is H-bonded to Lys-296 and to the N(5) of the flavin as obsd. in other flavin-dependent amine oxidases.  The active site cavities are highly apolar; however, hydrophilic areas exist near the flavin and direct the amine moiety of the substrate for binding and catalysis.  Small conformational changes are obsd. on comparison of the different inhibitor-enzyme complexes.  Future MAO-B drug design will need to consider "induced fit" contributions as an element in ligand-enzyme interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0K1SiYQtmN7Vg90H21EOLACvtfcHk0ljGB371iQECYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVejt7c%253D&md5=41ecf51fec3d1c4c811dc716c43beda5</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1633804100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1633804100%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DHubalek%26aufirst%3DF.%26aulast%3DRestelli%26aufirst%3DN.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DInsights%2520into%2520the%2520mode%2520of%2520inhibition%2520of%2520human%2520mitochondrial%2520monoamine%2520oxidase%2520B%2520from%2520high-resolution%2520crystal%2520structures%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D9750%26epage%3D9755%26doi%3D10.1073%2Fpnas.1633804100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reniers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masereel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wouters, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.11.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmc.2010.11.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=21183355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1WksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=134-144&author=J.+Reniersauthor=S.+Robertauthor=R.+Frederickauthor=B.+Masereelauthor=S.+Vincentauthor=J.+Wouters&title=Synthesis+and+evaluation+of+%CE%B2-carboline+derivatives+as+potential+monoamine+oxidase+inhibitors&doi=10.1016%2Fj.bmc.2010.11.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors</span></div><div class="casAuthors">Reniers, J.; Robert, S.; Frederick, R.; Masereel, B.; Vincent, S.; Wouters, J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-144</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous studies have shown that harmine is a reversible inhibitor of human monoamine oxidase A (MAO-A).  Moreover, the crystal structure of human MAO-A in complex with harmine has been recently solved.  This crystal structure shows that close to the methoxy group of the harmine moiety, a lipophilic pocket is left vacant within the binding site of human MAO-A.  Our objective was to optimize the β-carboline series against human MAO-A in order to explore this pocket.  Therefore, a series of β-carboline derivs. has been synthesized.  The compds. were evaluated for their human monoamine oxidase A and B inhibitory potency and their Ki values were estd.  The results show that O-alkylated compds. with lipophilic groups like cyclohexyl, Ph and aliph. chains increase the inhibition of MAO-A compared to harmine.  Compd. 3e (I), with the trifluorobutyloxy group, was the most active of this series, with a Ki against MAO-A of 3.6 nM.  Mol. docking studies show that the trifluorobutyloxy chain occupies the hydrophobic pocket vacant with harmine.  The O-alkylated compds. are less active on MAO-B than on MAO-A.  However, several compds. show a better inhibition on MAO-B compared to harmine.  Compd. 3f, with the cyclohexylmethoxy chain, displayed the best inhibitory activity against MAO-B with a Ki value of 221.6 nM.  This cyclohexyl bearing analog is also a potent MAO-A inhibitor with a Ki value of 4.3 nM.  Mol. docking studies show that the cyclohexyl chain also occupies a hydrophobic pocket but in different ways in MAO-A or MAO-B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz8NiKL6ru47Vg90H21EOLACvtfcHk0ljGB371iQECYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1WksQ%253D%253D&md5=8e6a16abe22ac5353add1a3eab31d4fb</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.11.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.11.041%26sid%3Dliteratum%253Aachs%26aulast%3DReniers%26aufirst%3DJ.%26aulast%3DRobert%26aufirst%3DS.%26aulast%3DFrederick%26aufirst%3DR.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DVincent%26aufirst%3DS.%26aulast%3DWouters%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520%25CE%25B2-carboline%2520derivatives%2520as%2520potential%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D134%26epage%3D144%26doi%3D10.1016%2Fj.bmc.2010.11.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glover, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebowitz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armando, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandler, M.</span></span> <span> </span><span class="NLM_article-title">β-Carbolines as selective monoamine oxidase inhibitors: in vivo implications</span>. <i>J. Neural Transmission</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1007/BF01254930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1007%2FBF01254930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=7130973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL3sXitFWk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1982&pages=209-218&author=V.+Gloverauthor=J.+Liebowitzauthor=I.+Armandoauthor=M.+Sandler&title=%CE%B2-Carbolines+as+selective+monoamine+oxidase+inhibitors%3A+in+vivo+implications&doi=10.1007%2FBF01254930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">β-Carbolines as selective monoamine oxidase inhibitors:  in vivo implications</span></div><div class="casAuthors">Glover, Vivette; Liebowitz, J.; Armando, Ines; Sandler, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neural Transmission (1972-1989)</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">209-18</span>CODEN:
                <span class="NLM_cas:coden">JNTMAH</span>;
        ISSN:<span class="NLM_cas:issn">0300-9564</span>.
    </div><div class="casAbstract">The inhibitory action of a range of β-carbolines on human and rat monoamine oxidase (MAO) A and B was studied.  Concns. of 5-hydroxytryptamine and phenylethylamine, at their approx. Km values, were used as substrates for MAO A and B, resp.  A wide variation in inhibitor selectivity was found, with harmaline being 10,000-fold more potent an inhibitor of MAO A than MAO B, whereas, using tetrahydro-β-carboline and harmane, the difference was closer to 10-fold.  Of the carbolines which have been found endogenously, tetrahydro-β-carboline, 6-methoxytetrahydro-β-carboline, and harmane were all sufficiently potent inhibitors of human MAO A, (I50 values = 5 × 10-6, 1 × 10-6, and 5 × 10-7 M, resp.) for this property to be of possible physiol. significance.  Harmane, with an I50 of 5 × 10-6 M, may also play a role as an inhibitor of MAO B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIhuMHKj5Qh7Vg90H21EOLACvtfcHk0lgP3fc0TA7VQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXitFWk&md5=62e5e26a339b0b9fac9285ed855371c9</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1007%2FBF01254930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01254930%26sid%3Dliteratum%253Aachs%26aulast%3DGlover%26aufirst%3DV.%26aulast%3DLiebowitz%26aufirst%3DJ.%26aulast%3DArmando%26aufirst%3DI.%26aulast%3DSandler%26aufirst%3DM.%26atitle%3D%25CE%25B2-Carbolines%2520as%2520selective%2520monoamine%2520oxidase%2520inhibitors%253A%2520in%2520vivo%2520implications%26jtitle%3DJ.%2520Neural%2520Transmission%26date%3D1982%26volume%3D54%26spage%3D209%26epage%3D218%26doi%3D10.1007%2FBF01254930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miralles, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esteban, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sastre-Coll, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moranta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asensio, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Sevilla, J. A.</span></span> <span> </span><span class="NLM_article-title">High-affinity binding of β-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>518</i></span>,  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2005.06.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejphar.2005.06.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=16061219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2MXosVCksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=518&publication_year=2005&pages=234-242&author=A.+Mirallesauthor=S.+Estebanauthor=A.+Sastre-Collauthor=D.+Morantaauthor=V.+J.+Asensioauthor=J.+A.+Garcia-Sevilla&title=High-affinity+binding+of+%CE%B2-carbolines+to+imidazoline+I2B+receptors+and+MAO-A+in+rat+tissues%3A+norharman+blocks+the+effect+of+morphine+withdrawal+on+DOPA%2Fnoradrenaline+synthesis+in+the+brain&doi=10.1016%2Fj.ejphar.2005.06.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">High-affinity binding of β-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: Norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain</span></div><div class="casAuthors">Miralles, Antonio; Esteban, Susana; Sastre-Coll, Antonio; Moranta, David; Asensio, Victor Jose; Garcia-Sevilla, Jesus Andres</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">518</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">234-242</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This study was designed to det. the affinity and binding profile of β-carbolines for imidazoline I2 receptors and catalytic sites of monoamine oxidase (MAO)-A/B in rat brain and liver.  Another objective was to assess the in vivo effects of norharman (β-carboline) and LSL 60101 (I2 ligand) on brain 3,4-dihydroxyphenylalanine (DOPA) synthesis in morphine-dependent rats.  Competition expts. against [3H]2-BFI revealed that β-carbolines recognize the high- and low-affinity components of the brain imidazoline I2 receptor with the rank order of potency (KiH in nM): noreleagnine (12) > norharman (20) > harmalol (82) > harmaline (177) » harmine (630) > harman (700) » FG-7142 (>100,000).  In liver, this rank was different: harmine (51) > harmaline (103) = noreleagnine (103) » harmalol (1290) > harman (2000) » norharman (12,382) » FG-7142 (> 100,000).  In brain and liver, competition curves for β-carbolines against [3H]Ro41-1049 (MAO-A) and [3H]Ro19-6327 (MAO-B) were monophasic and resulted in different drug potencies for the two MAO isoenzymes (higher affinities for MAO-A) and in similar pharmacol. profiles in both tissues.  In morphine-dependent rats, naloxone (2 mg/kg, 2 h)-pptd. withdrawal increased the synthesis of DOPA in the cerebral cortex and hippocampus (50%).  Pretreatment with norharman (20 mg/kg) or LSL 60101 (20 mg/kg) (30 min before naloxone) fully prevented the stimulatory effect of opiate withdrawal on DOPA synthesis.  Norharman and LSL 60101 also attenuated the severity of the withdrawal syndrome.  The results indicate that β-carbolines bind with high affinity to imidazoline I2B receptors, and similarly to I2 ligands (LSL 60101) can block the behavioral and biochem. effects of opiate withdrawal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCvzFB8nFMG7Vg90H21EOLACvtfcHk0lgP3fc0TA7VQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXosVCksbg%253D&md5=6ea00978e64eb6e63412ac04a425a584</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2005.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2005.06.023%26sid%3Dliteratum%253Aachs%26aulast%3DMiralles%26aufirst%3DA.%26aulast%3DEsteban%26aufirst%3DS.%26aulast%3DSastre-Coll%26aufirst%3DA.%26aulast%3DMoranta%26aufirst%3DD.%26aulast%3DAsensio%26aufirst%3DV.%2BJ.%26aulast%3DGarcia-Sevilla%26aufirst%3DJ.%2BA.%26atitle%3DHigh-affinity%2520binding%2520of%2520%25CE%25B2-carbolines%2520to%2520imidazoline%2520I2B%2520receptors%2520and%2520MAO-A%2520in%2520rat%2520tissues%253A%2520norharman%2520blocks%2520the%2520effect%2520of%2520morphine%2520withdrawal%2520on%2520DOPA%252Fnoradrenaline%2520synthesis%2520in%2520the%2520brain%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D518%26spage%3D234%26epage%3D242%26doi%3D10.1016%2Fj.ejphar.2005.06.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herraiz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaparro, C.</span></span> <span> </span><span class="NLM_article-title">Analysis of monoamine oxidase enzymatic activity by reversed-phase high performance liquid chromatography and inhibition by β-carboline alkaloids occurring in foods and plants</span>. <i>J. Chromatogr. A</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1120</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1016/j.chroma.2005.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.chroma.2005.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=16386263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtV2qtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1120&publication_year=2006&pages=237-243&author=T.+Herraizauthor=C.+Chaparro&title=Analysis+of+monoamine+oxidase+enzymatic+activity+by+reversed-phase+high+performance+liquid+chromatography+and+inhibition+by+%CE%B2-carboline+alkaloids+occurring+in+foods+and+plants&doi=10.1016%2Fj.chroma.2005.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of monoamine oxidase enzymatic activity by reversed-phase high performance liquid chromatography and inhibition by β-carboline alkaloids occurring in foods and plants</span></div><div class="casAuthors">Herraiz, Tomas; Chaparro, Carolina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography A</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1120</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">237-243</span>CODEN:
                <span class="NLM_cas:coden">JCRAEY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9673</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Monoamine oxidase (MAO) is a FAD-contg. enzyme located at the outer membranes of mitochondria that catalyzes the oxidative deamination of biogenic and xenobiotic amines.  We have used a chromatog. method to measure MAO-enzymic activity by kynuramine as a non-selective substrate with its MAO-oxidn. product subsequently analyzed by RP-HPLC-DAD and HPLC-mass spectrometry (MS).  This method was applied to study the kinetic parameters, inhibition and reaction products of MAO recombinant enzymes in presence of tetrahydro-β-carboline and β-carboline alkaloids occurring in foods, plants and mammals.  Anal. by HPLC showed that tetrahydro-β-carbolines or β-carbolines were not modified by MAO.  Several β-carbolines such as tryptoline (1,2,3,4-tetrahydro-β-carboline) and 1-methyltryptoline (1-methyl-1,2,3,4-tetrahydro-β-carboline) were inhibitors of MAO-A; instead their corresponding 6-hydroxy-derivs. (6-hydroxytryptoline and 6-hydroxy-1-methyltryptoline) lacked this activity.  Tetrahydro-β-carboline-3-carboxylic acids were unable to inhibit MAO enzymes.  In contrast, their oxidn. products, i.e. the fully arom. β-carbolines (norharman and harman), acted as good inhibitors of MAO.  Two tetrahydro-β-carbolines (i.e. tryptoline and 1-methyltryptoline) occurring in foods were isolated by solid-phase extn. (SPE) and RP-HPLC from selected samples of sausages and the corresponding exts. exhibited good inhibition properties over MAO-A.  These results suggest that β-carbolines from foods, plants, and mammals may exert inhibitory actions on MAO enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD7GZ_IXI3mbVg90H21EOLACvtfcHk0lgP3fc0TA7VQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtV2qtL0%253D&md5=6ffeb49b70bdf047232b8f2ed66b0bff</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.chroma.2005.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chroma.2005.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DHerraiz%26aufirst%3DT.%26aulast%3DChaparro%26aufirst%3DC.%26atitle%3DAnalysis%2520of%2520monoamine%2520oxidase%2520enzymatic%2520activity%2520by%2520reversed-phase%2520high%2520performance%2520liquid%2520chromatography%2520and%2520inhibition%2520by%2520%25CE%25B2-carboline%2520alkaloids%2520occurring%2520in%2520foods%2520and%2520plants%26jtitle%3DJ.%2520Chromatogr.%2520A%26date%3D2006%26volume%3D1120%26spage%3D237%26epage%3D243%26doi%3D10.1016%2Fj.chroma.2005.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meller, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweitzer, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedhoff, A. J.</span></span> <span> </span><span class="NLM_article-title">Tetrahydro-β-carbolines: specific inhibitors of type A monoamine oxidase in rat brain</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">1000</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.1977.tb10661.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1111%2Fj.1471-4159.1977.tb10661.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=864473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaE1cXmvV2msA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1977&pages=995-1000&author=E.+Mellerauthor=E.+Friedmanauthor=J.+W.+Schweitzerauthor=A.+J.+Friedhoff&title=Tetrahydro-%CE%B2-carbolines%3A+specific+inhibitors+of+type+A+monoamine+oxidase+in+rat+brain&doi=10.1111%2Fj.1471-4159.1977.tb10661.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrahydro-β-carbolines: specific inhibitors of type A monoamine oxidase in rat brain</span></div><div class="casAuthors">Meller, E.; Friedman, E.; Schweitzer, J. W.; Friedhoff, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">995-1000</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Several tetrahydrocarbazoles, tetrahydroisoquinolines, and aminotetralins inhibited monoamine oxidase (EC 1.4.3.4) (I)  [9001-66-5] selectively, but the most specific and potent were the tetrahydro-β-carbolines, which competitively inhibited the oxidative deamination of serotonin  [50-67-9] at μM concns., but mM concns. were required to inhibit phenethylamine  [64-04-0] deamination.  Redns. of type A, but not type B, I activity were obsd. after administration of tetrahydro-β-carboline (II) or 6-methoxytetrahydro-β-carboline (both 25-100 mg/kg, i.p.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowFO7zBoAWNrVg90H21EOLACvtfcHk0lhhCPE4sXeS2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXmvV2msA%253D%253D&md5=bc403776aaa976957916431d5f50a646</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1977.tb10661.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1977.tb10661.x%26sid%3Dliteratum%253Aachs%26aulast%3DMeller%26aufirst%3DE.%26aulast%3DFriedman%26aufirst%3DE.%26aulast%3DSchweitzer%26aufirst%3DJ.%2BW.%26aulast%3DFriedhoff%26aufirst%3DA.%2BJ.%26atitle%3DTetrahydro-%25CE%25B2-carbolines%253A%2520specific%2520inhibitors%2520of%2520type%2520A%2520monoamine%2520oxidase%2520in%2520rat%2520brain%26jtitle%3DJ.%2520Neurochem.%26date%3D1977%26volume%3D28%26spage%3D995%26epage%3D1000%26doi%3D10.1111%2Fj.1471-4159.1977.tb10661.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sablin, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsay, R. R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase A by β-carboline derivatives</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>337</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1006/abbi.1996.9771</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1006%2Fabbi.1996.9771" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=8990278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK2sXktlGitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=1997&pages=137-142&author=H.+Kimauthor=S.+O.+Sablinauthor=R.+R.+Ramsay&title=Inhibition+of+monoamine+oxidase+A+by+%CE%B2-carboline+derivatives&doi=10.1006%2Fabbi.1996.9771"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of monoamine oxidase A by β-carboline derivatives</span></div><div class="casAuthors">Kim, Hoon; Sablin, Sergey O.; Ramsay, Rona R.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">137-142</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">β-Carbolines are endogenous inhibitors of monoamine oxidase (MAO).  The interaction of nine β-carboline derivs. and four 3,4-dihydro forms with purified MAO A was investigated.  All the compds. tested were reversible competitive inhibitors selective for MAO A, in agreement with previous studies on membrane prepns.  The oxidn. of kynuramine by MAO A in the presence of the more effective inhibitors showed a lag period before reaching the steady state.  In general, the 1-Me and 7-methoxy substituents increased the potency.  Harmine, 2-methylharminium, 2,9-dimethylharminium, and harmaline were the most effective inhibitors of the purified MAO A, with low Ki values of 5,69, 15, and 48 nM, resp.  The inhibitors interacted with the covalently bound flavin to induce distinct spectral changes, the magnitude of which correlated with the efficacy of the inhibition.  The more effective inhibitors could be in situ inhibitors of MAO A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkrxSogWwJzrVg90H21EOLACvtfcHk0lhhCPE4sXeS2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlGitg%253D%253D&md5=04c6fecf6acc0097ab0ee54d0b6fb1e6</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1996.9771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1996.9771%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DSablin%26aufirst%3DS.%2BO.%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520A%2520by%2520%25CE%25B2-carboline%2520derivatives%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1997%26volume%3D337%26spage%3D137%26epage%3D142%26doi%3D10.1006%2Fabbi.1996.9771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heckman, P. R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wouters, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer’s disease: a translational overview</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">331</span>, <span class="refDoi"> DOI: 10.2174/1381612820666140826114601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.2174%2F1381612820666140826114601" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=317-331&author=P.+R.+A.+Heckmanauthor=C.+Woutersauthor=J.+Prickaerts&title=Phosphodiesterase+inhibitors+as+a+target+for+cognition+enhancement+in+aging+and+Alzheimer%E2%80%99s+disease%3A+a+translational+overview&doi=10.2174%2F1381612820666140826114601"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.2174%2F1381612820666140826114601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612820666140826114601%26sid%3Dliteratum%253Aachs%26aulast%3DHeckman%26aufirst%3DP.%2BR.%2BA.%26aulast%3DWouters%26aufirst%3DC.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DPhosphodiesterase%2520inhibitors%2520as%2520a%2520target%2520for%2520cognition%2520enhancement%2520in%2520aging%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520translational%2520overview%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2014%26volume%3D21%26spage%3D317%26epage%3D331%26doi%3D10.2174%2F1381612820666140826114601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">García-Osta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzábal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase as therapeutic targets for Alzheimer’s disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">832</span>– <span class="NLM_lpage">844</span>, <span class="refDoi"> DOI: 10.1021/cn3000907</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn3000907" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVejs7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=832-844&author=A.+Garc%C3%ADa-Ostaauthor=M.+Cuadrado-Tejedorauthor=C.+Garc%C3%ADa-Barrosoauthor=J.+Oyarz%C3%A1balauthor=R.+Franco&title=Phosphodiesterase+as+therapeutic+targets+for+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fcn3000907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease</span></div><div class="casAuthors">Garcia-Osta, Ana; Cuadrado-Tejedor, Mar; Garcia-Barroso, Carolina; Oyarzabal, Julen; Franco, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">832-844</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common form of dementia among the elderly.  In AD patients, memory loss is accompanied by the formation of beta-amyloid plaques and the appearance of tau in a pathol. form.  Given the lack of effective treatments for AD, the development of new management strategies for these patients is crit.  The continued failure to find effective therapies using mols. aimed at addressing the anti-beta amyloid pathol. has led researchers to focus on other non-amyloid-based approaches to restore memory function.  Promising non-amyloid related candidate targets include phosphosdiesterases (PDEs), and indeed, Rolipram, a specific PDE4 inhibitor, was the first compd. found to effectively restore cognitive deficits in animal models of AD.  More recently, PDE5 inhibitors have also been shown to effectively restore memory function.  Accordingly, inhibitors of other members of the PDE family may also improve memory performance in AD and non-AD animal models.  Hence, in this review, we will summarize the data supporting the use of PDE inhibitors as cognitive enhancers and we will discuss the possible mechanisms of action underlying these effects.  We shall also adopt a medicinal chem. perspective that leads us to propose the most promising PDE candidates on the basis of inhibitor selectivity, brain distribution, and mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppeOP4NskdvrVg90H21EOLACvtfcHk0lhhCPE4sXeS2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVejs7nK&md5=53c6dfed22bb240b17132672b13fdcf1</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fcn3000907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn3000907%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa-Osta%26aufirst%3DA.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Barroso%26aufirst%3DC.%26aulast%3DOyarz%25C3%25A1bal%26aufirst%3DJ.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DPhosphodiesterase%2520as%2520therapeutic%2520targets%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D832%26epage%3D844%26doi%3D10.1021%2Fcn3000907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, P.-F.</span></span> <span> </span><span class="NLM_article-title">Vinpocetine improves scopolamine induced learning and memory dysfunction in C57 BL/6J mice</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1412</span>– <span class="NLM_lpage">1418</span>, <span class="refDoi"> DOI: 10.1248/bpb.b15-00881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1248%2Fbpb.b15-00881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=27334578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKmur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2016&pages=1412-1418&author=Y.+Shangauthor=L.+Wangauthor=Y.+Liauthor=P.-F.+Gu&title=Vinpocetine+improves+scopolamine+induced+learning+and+memory+dysfunction+in+C57+BL%2F6J+mice&doi=10.1248%2Fbpb.b15-00881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Vinpocetine improves scopolamine induced learning and memory dysfunction in C57 BL/6J mice</span></div><div class="casAuthors">Shang, Yu; Wang, Lei; Li, Yue; Gu, Pei-fei</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1412-1418</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Vinpocetine is an inhibitor of phosphodiesterase type 1 (PDE1), which has been used for treating stroke for over 40 years.  However, according to current clin. dosage and treatment period, its direct effect on memory is unclear.  In this study, we investigated whether vinpocetine could reverse the scopolamine (SCO)-induced cognitive deficits in animals.  Behavioral expts., including open field, Y-maze, and fear conditioning tests were used to det. the possible role of vinpocetine on scopolamine-induced memory dysfunction.  In the open field and Y-maze tests, there were significant differences between the control (CON) group and SCO group.  Vinpocetine (4 mg/kg) administration for consecutive 28 d significantly improved the scopolamine-induced memory dysfunction.  In the fear conditioning test, vinpocetine (2, 4 mg/kg) administration had certain beneficial effect on emotional memory.  Our results suggest that vinpocetine could improve cognitive function in memory deficient mice and high clinic dosage might be better.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvYbzH65_mSLVg90H21EOLACvtfcHk0lgZwZ7DpgL5AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKmur4%253D&md5=7deb3aedb4d66c801d0ea74bbaf686dc</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1248%2Fbpb.b15-00881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.b15-00881%26sid%3Dliteratum%253Aachs%26aulast%3DShang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DP.-F.%26atitle%3DVinpocetine%2520improves%2520scopolamine%2520induced%2520learning%2520and%2520memory%2520dysfunction%2520in%2520C57%2520BL%252F6J%2520mice%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2016%26volume%3D39%26spage%3D1412%26epage%3D1418%26doi%3D10.1248%2Fbpb.b15-00881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdelwaly, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salama, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomaa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, M. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of tetrahydro-β-carboline derivatives as a new class of phosphodiesterase 4 inhibitors</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3173</span>– <span class="NLM_lpage">3187</span>, <span class="refDoi"> DOI: 10.1007/s00044-017-2011-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1007%2Fs00044-017-2011-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKnurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=3173-3187&author=A.+Abdelwalyauthor=I.+Salamaauthor=M.+Gomaaauthor=M.+A.+Helal&title=Discovery+of+tetrahydro-%CE%B2-carboline+derivatives+as+a+new+class+of+phosphodiesterase+4+inhibitors&doi=10.1007%2Fs00044-017-2011-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of tetrahydro-ss-carboline derivatives as a new class of phosphodiesterase 4 inhibitors</span></div><div class="casAuthors">Abdelwaly, Ahmad; Salama, Ismail; Gomaa, Mohamed S.; Helal, Mohamed A.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3173-3187</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Abstr.: Phosphodiesterase 4 is the primary enzyme responsible for degrdn. of the second messenger cAMP in many of the cells releasing proinflammatory mediators.  Inhibition of this enzyme could help in the management of various inflammatory conditions such as asthma, chronic obstructive pulmonary disorder, arthritis, and psoriasis.  In this study, two novel series of tetrahydro-β-carbolines were designed by combining the pharmacophoric features of both tadalafil and piclamilast.  Twenty-two compds. were synthesized and assessed for Phosphodiesterase 4 inhibition, four of them showed superior activity to the ref. compd. IBMX.  Docking studies showed that the prepd. compds. interact with the crucial Gln443 with variable interactions with the hydrophobic pocket Q2.  This is the first report of tetrahydro-β-carbolines as a scaffold for Phosphodiesterase 4 inhibition.  Currently, further optimization of the substituents is carried out to fine-tune the hydrophobic interactions and enhance the potency of this novel series of inhibitors.  Graphical abstr.: [InlineMediaObject not available: see fulltext.].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQZcFaloGQJrVg90H21EOLACvtfcHk0lgZwZ7DpgL5AQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKnurzP&md5=9b48c510489e974e23927353aa4d7444</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1007%2Fs00044-017-2011-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-017-2011-x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdelwaly%26aufirst%3DA.%26aulast%3DSalama%26aufirst%3DI.%26aulast%3DGomaa%26aufirst%3DM.%26aulast%3DHelal%26aufirst%3DM.%2BA.%26atitle%3DDiscovery%2520of%2520tetrahydro-%25CE%25B2-carboline%2520derivatives%2520as%2520a%2520new%2520class%2520of%2520phosphodiesterase%25204%2520inhibitors%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2017%26volume%3D26%26spage%3D3173%26epage%3D3187%26doi%3D10.1007%2Fs00044-017-2011-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricobaraza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual-Lucas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unceta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rico, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goicolea, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanciego, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span> <span> </span><span class="NLM_article-title">Tadalafil crosses the blood brain barrier and reverses cognitive dysfunction in a mouse model of AD</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2012.06.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.neuropharm.2012.06.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=22776546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2nu77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=114-123&author=C.+Garcia-Barrosoauthor=A.+Ricobarazaauthor=M.+Pascual-Lucasauthor=N.+Uncetaauthor=A.+J.+Ricoauthor=M.+A.+Goicoleaauthor=J.+Sallesauthor=J.+L.+Lanciegoauthor=J.+Oyarzabalauthor=R.+Francoauthor=M.+Cuadrado-Tejedorauthor=A.+Garcia-Osta&title=Tadalafil+crosses+the+blood+brain+barrier+and+reverses+cognitive+dysfunction+in+a+mouse+model+of+AD&doi=10.1016%2Fj.neuropharm.2012.06.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD</span></div><div class="casAuthors">Garcia-Barroso, Carolina; Ricobaraza, Ana; Pascual-Lucas, Maria; Unceta, Nora; Rico, Alberto J.; Goicolea, Maria Aranzazu; Salles, Joan; Lanciego, Jose Luis; Oyarzabal, Julen; Franco, Rafael; Cuadrado-Tejedor, Mar; Garcia-Osta, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114-123</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous studies have demonstrated that cognitive function can be restored in mouse models of Alzheimer's disease (AD) following administration of sildenafil, a specific PDE5 inhibitor (Puzzo et al., 2009; Cuadrado-Tejedor et al.).  Another very potent PDE5 inhibitor with a longer half-life and safe in chronic treatments, tadalafil, may represent a better alternative candidate for AD therapy.  However, tadalafil was proven unable to achieve similar benefits than those of sildenafil in AD animal models (Puzzo et al., 2009).  The lack of efficacy was attributed to inability to cross the blood-brain barrier (BBB).  In this paper we first measured the blood and brain levels of tadalafil to prove that the compd. crosses BBB and that chronic treatment leads to accumulation in the brain of the J20 transgenic mouse model of AD.  We demonstrated the presence of PDE5 mRNA in the brain of the mice and also in the human brain.  After a 10 wk treatment with either of these PDE5 inhibitors, the performance of the J20 mice in the Morris water maze test improved when compared with the transgenic mice that received vehicle.  Biochem. anal. revealed that neither sildenafil nor tadalafil altered the amyloid burden, although both compds. reduced Tau phosphorylation in the mouse hippocampus.  This study provides evidence of the potential benefits of a chronic tadalafil treatment in AD therapy.This article is part of a Special Issue entitled 'Cognitive Enhancers'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfkrxYqIGt7LVg90H21EOLACvtfcHk0li9oFlXWD1nnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2nu77O&md5=aafb7dacec3ffd9d8ef4abc38c08e0f6</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.06.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.06.052%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DRicobaraza%26aufirst%3DA.%26aulast%3DPascual-Lucas%26aufirst%3DM.%26aulast%3DUnceta%26aufirst%3DN.%26aulast%3DRico%26aufirst%3DA.%2BJ.%26aulast%3DGoicolea%26aufirst%3DM.%2BA.%26aulast%3DSalles%26aufirst%3DJ.%26aulast%3DLanciego%26aufirst%3DJ.%2BL.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26atitle%3DTadalafil%2520crosses%2520the%2520blood%2520brain%2520barrier%2520and%2520reverses%2520cognitive%2520dysfunction%2520in%2520a%2520mouse%2520model%2520of%2520AD%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D114%26epage%3D123%26doi%3D10.1016%2Fj.neuropharm.2012.06.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abouel-Ella, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gary, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thaiparambil, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeton, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, G. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of novel tadalafil analogues and their evaluation as phosphodiesterase inhibitors and anticancer agents</span>. <i>Arzneimittelforschung</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=19813465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADC%252BD1MnnvVequw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2009&pages=415-421&author=A.+H.+Abadiauthor=D.+A.+Abouel-Ellaauthor=N.+S.+Ahmedauthor=B.+D.+Garyauthor=J.+T.+Thaiparambilauthor=H.+N.+Tinsleyauthor=A.+B.+Keetonauthor=G.+A.+Piazza&title=Synthesis+of+novel+tadalafil+analogues+and+their+evaluation+as+phosphodiesterase+inhibitors+and+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of novel tadalafil analogues and their evaluation as phosphodiesterase inhibitors and anticancer agents</span></div><div class="casAuthors">Abadi Ashraf H; Abouel-Ella Dalal A; Ahmed Nermin S; Gary Bernard D; Thaiparambil Jose T; Tinsley Heather N; Keeton Adam B; Piazza Gary A</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">415-21</span>
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    </div><div class="casAbstract">Two closely related series of novel beta-carboline derivatives, electronically similar to tadalafil (CAS 171596-29-5), were synthesized and evaluated for their inhibitory effects upon phosphodiesterase 5 (PDE5) and phosphodiesterase 11 (PDE11) and their in vitro tumor cell growth inhibitory activity versus HT29 colorectal carcinoma cell line.  Interestingly, some of the synthesized compounds showed growth inhibitory properties that appear to be associated with their ability to inhibit PDE5.  Moreover, the PDE5 inhibition seems relevant to the stereochemical aspects of the compounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVpRaddYjBj3T4ugvCDgnZfW6udTcc2ea3_zqgpyODNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MnnvVequw%253D%253D&md5=f00e9d233beec1e29a9501c7e9938f17</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26aulast%3DAbouel-Ella%26aufirst%3DD.%2BA.%26aulast%3DAhmed%26aufirst%3DN.%2BS.%26aulast%3DGary%26aufirst%3DB.%2BD.%26aulast%3DThaiparambil%26aufirst%3DJ.%2BT.%26aulast%3DTinsley%26aufirst%3DH.%2BN.%26aulast%3DKeeton%26aufirst%3DA.%2BB.%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26atitle%3DSynthesis%2520of%2520novel%2520tadalafil%2520analogues%2520and%2520their%2520evaluation%2520as%2520phosphodiesterase%2520inhibitors%2520and%2520anticancer%2520agents%26jtitle%3DArzneimittelforschung%26date%3D2009%26volume%3D59%26spage%3D415%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gary, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Halim, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, molecular modeling and biological evaluation of novel tadalafil analogues as phosphodiesterase 5 and colon tumor cell growth inhibitors, new stereochemical perspective</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1278</span>– <span class="NLM_lpage">1286</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2009.10.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2009.10.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=20206015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFKjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=1278-1286&author=A.+H.+Abadiauthor=B.+D.+Garyauthor=H.+N.+Tinsleyauthor=G.+A.+Piazzaauthor=M.+Abdel-Halim&title=Synthesis%2C+molecular+modeling+and+biological+evaluation+of+novel+tadalafil+analogues+as+phosphodiesterase+5+and+colon+tumor+cell+growth+inhibitors%2C+new+stereochemical+perspective&doi=10.1016%2Fj.ejmech.2009.10.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, molecular modeling and biological evaluation of novel tadalafil analogues as phosphodiesterase 5 and colon tumor cell growth inhibitors, new stereochemical perspective</span></div><div class="casAuthors">Abadi, Ashraf H.; Gary, Bernard D.; Tinsley, Heather N.; Piazza, Gary A.; Abdel-Halim, Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1278-1286</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The synthesis of novel tadalafil analogs in which the benzodioxole moiety is replaced by 2-bromophenyl; the chiral carbons swing from R,R to R,S, S,R and S,S; the piperazinedione ring is maintained or reduced to the 5-membered imidazolidinedione or thioxoimidazolinone is described.  The prepd. analogs were evaluated for their capacity to inhibit the cyclic guanosine monophosphate (cGMP) selective phosphodiesterase 5 (PDE5) isoenzyme and the growth of human HT-29 colon adenocarcinoma cells.  The R abs. configuration of C-5 in the β-carboline-hydantoin and C-6 in the β-carboline-piperazinedione derivs. was found to be essential for the PDE5 inhibition.  In addn., tadalafil analogs that were synthesized from L-tryptophan were more active than those derived from D-tryptophan, which is of economic value and expands the horizon for the discovery of new carbolines as PDE5 inhibitors.  While some analogs displayed potent tumor cell growth inhibitory activity, there was no apparent correlation with their PDE5 inhibitory activity, which leads us to conclude that other PDE isoenzymes or PDE5 splice variants may be involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqISHkFRRlEbVg90H21EOLACvtfcHk0li9oFlXWD1nnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFKjsLs%253D&md5=e9f34d2e643623291d21f1b23d90611b</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.10.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.10.046%26sid%3Dliteratum%253Aachs%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26aulast%3DGary%26aufirst%3DB.%2BD.%26aulast%3DTinsley%26aufirst%3DH.%2BN.%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DAbdel-Halim%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520molecular%2520modeling%2520and%2520biological%2520evaluation%2520of%2520novel%2520tadalafil%2520analogues%2520as%2520phosphodiesterase%25205%2520and%2520colon%2520tumor%2520cell%2520growth%2520inhibitors%252C%2520new%2520stereochemical%2520perspective%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D1278%26epage%3D1286%26doi%3D10.1016%2Fj.ejmech.2009.10.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Halim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, M. S. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, molecular modeling, and biological evaluation of novel tetrahydro-β-carboline hydantoin and tetrahydro-β-carboline thiohydantoin derivatives as phosphodiesterase 5 inhibitors</span>. <i>Int. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_fpage">562421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=27471602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslyis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=562421&author=A.+H.+Abadiauthor=J.+Lehmannauthor=G.+A.+Piazzaauthor=M.+Abdel-Halimauthor=M.+S.+M.+Ali&title=Synthesis%2C+molecular+modeling%2C+and+biological+evaluation+of+novel+tetrahydro-%CE%B2-carboline+hydantoin+and+tetrahydro-%CE%B2-carboline+thiohydantoin+derivatives+as+phosphodiesterase+5+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, molecular modeling, and biological evaluation of novel tetrahydro-β-carboline hydantoin and tetrahydro-β-carboline thiohydantoin derivatives as phosphodiesterase 5 inhibitors</span></div><div class="casAuthors">Abadi, Ashraf H.; Lehmann, Jochen; Piazza, Gary A.; Abdel-Halim, Mohammad; Ali, Mohamed S. M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">562421, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCCH</span>;
        ISSN:<span class="NLM_cas:issn">2090-2077</span>.
    
            (<span class="NLM_cas:orgname">Hindawi Publishing Corp.</span>)
        </div><div class="casAbstract">Copyright © 2011 Ashraf H. Abadi et al.  This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reprodn. in any medium, provided the original work is properly cited.  Two series of fused tetrahydro-β-carboline hydantoin and tetrahydro-βcarboline thiohydantoin derivs. with a pendant 2,4-dimethoxyphenyl at position 5 were synthesized, and chiral carbons at positions 5 and 11a swing from R,R to R,S, S,R, and S,S.  The prepd. analogs were evaluated for their capacity to inhibit the phosphodiesterase 5 (PDE5) isoenzyme.  The R abs. configuration of C-5 in the β-carboline hydantoin derivs. was found to be essential for the PDE5 inhibition.  The chiral carbon derived from the amino acid, even if of the S configuration (L-tryptophan), may lead to equiactive or more active isomers than those derived from the amino acid with the R configuration (D-tryptophan).  This expands the pool from which efficient PDE5 inhibitors can be derived and may offer an economic advantage.  The thiohydantoin derivs. were less active than their hydantoin congeners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFbjCIk3fAwrVg90H21EOLACvtfcHk0lhqMp1exWj9cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslyis7Y%253D&md5=79b12daf4f40ac2a18777c41bf2045dc</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DAbdel-Halim%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DM.%2BS.%2BM.%26atitle%3DSynthesis%252C%2520molecular%2520modeling%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520tetrahydro-%25CE%25B2-carboline%2520hydantoin%2520and%2520tetrahydro-%25CE%25B2-carboline%2520thiohydantoin%2520derivatives%2520as%2520phosphodiesterase%25205%2520inhibitors%26jtitle%3DInt.%2520J.%2520Med.%2520Chem.%26date%3D2011%26spage%3D562421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gary, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and structure-activity relationship of functionalized tetrahydro-β-carboline derivatives as novel PDE5 inhibitors</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>344</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1002/ardp.201000236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1002%2Fardp.201000236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=21384413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3MXislOks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2011&pages=149-157&author=N.+S.+Ahmedauthor=B.+D.+Garyauthor=H.+N.+Tinsleyauthor=G.+A.+Piazzaauthor=S.+Lauferauthor=A.+H.+Abadi&title=Design%2C+synthesis+and+structure-activity+relationship+of+functionalized+tetrahydro-%CE%B2-carboline+derivatives+as+novel+PDE5+inhibitors&doi=10.1002%2Fardp.201000236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis and Structure-Activity Relationship of Functionalized Tetrahydro-β-carboline Derivatives as Novel PDE5 Inhibitors</span></div><div class="casAuthors">Ahmed, Nermin S.; Gary, Bernard D.; Tinsley, Hethar N.; Piazza, Gary A.; Laufer, Stefan; Abadi, Ashraf H.</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">149-157</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Starting from tadalafil as a template, a series of functionalized tetrahydro-β-carboline derivs. have been prepd. and identified as novel potent and selective PDE5 inhibitors.  Replacing the 3,4-methylenedioxyphenyl at position 6 of tadalafil, together with elongation of the N2-Me substituent and manipulation of the stereochem. aspects of the two chiral carbons led to the identification of compd. XXI, a highly potent PDE5 inhibitor (IC50 = 3 nM).  Compd. XXI (I) was also highly selective for PDE5 vs. PDE3B, PDE4B, and PDE11A, with a selectivity index of 52 and 235 towards PDE5 rather than PDE11 with both cAMP and cGMP as substrate, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ipgehDVMHLVg90H21EOLACvtfcHk0lhqMp1exWj9cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXislOks7s%253D&md5=c4611618b98474f0a8e534adc372af95</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1002%2Fardp.201000236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201000236%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DN.%2BS.%26aulast%3DGary%26aufirst%3DB.%2BD.%26aulast%3DTinsley%26aufirst%3DH.%2BN.%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DLaufer%26aufirst%3DS.%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26atitle%3DDesign%252C%2520synthesis%2520and%2520structure-activity%2520relationship%2520of%2520functionalized%2520tetrahydro-%25CE%25B2-carboline%2520derivatives%2520as%2520novel%2520PDE5%2520inhibitors%26jtitle%3DArch.%2520Pharm.%26date%3D2011%26volume%3D344%26spage%3D149%26epage%3D157%26doi%3D10.1002%2Fardp.201000236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Gamil, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gary, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span> <span> </span><span class="NLM_article-title">Design of novel β-carboline derivatives with pendant 5-bromothienyl and their evaluation as phosphodiesterase-5 inhibitors</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>346</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1002/ardp.201200334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1002%2Fardp.201200334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=23307609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsl2rsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2013&pages=23-33&author=D.+S.+El-Gamilauthor=N.+S.+Ahmedauthor=B.+D.+Garyauthor=G.+A.+Piazzaauthor=M.+Engelauthor=R.+W.+Hartmannauthor=A.+H.+Abadi&title=Design+of+novel+%CE%B2-carboline+derivatives+with+pendant+5-bromothienyl+and+their+evaluation+as+phosphodiesterase-5+inhibitors&doi=10.1002%2Fardp.201200334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Novel β-Carboline Derivatives with Pendant 5-Bromothienyl and Their Evaluation as Phosphodiesterase-5 Inhibitors</span></div><div class="casAuthors">El-Gamil, Dalia S.; Ahmed, Nermin S.; Gary, Bernard D.; Piazza, Gary A.; Engel, Matthias; Hartmann, Rolf W.; Abadi, Ashraf H.</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-33</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">New derivs. with the tetrahydro-β-carboline-imidazolidinedione and tetrahydro-β-carboline-piperazinedione scaffolds and a pendant bromothienyl moiety at C-5/C-6 were synthesized and tested for their ability to inhibit PDE5 in vitro.  The following SAR can be concluded: The tetracyclic scaffold is essential for PDE5 inhibition; the Et group is the most suitable among the adopted N-substituents on the terminal ring (hydantoin/piperazinedione); the appropriate stereochem. of C-5/C-6 derived from the aldehyde rather than C-11a/C-12a derived from tryptophan appears crucial for inhibition of PDE5; surprisingly, derivs. with the hydantoin terminal ring are more active than their analogs with the piperazinedione ring; the selectivity vs. PDE5 relative to PDE11 with cGMP as a substrate is mainly a function of the substitution and stereochem. pattern of the external ring, in other words of the interaction with the H-loop residues of the isoenzymes.  Thirteen derivs. showed PDE5 inhibitory activity with IC50 values in the range of 0.16-5.4 μm.  Compd. 8 was the most potent PDE5 inhibitor and showed selectivity towards PDE5 vs. other PDEs, with a selectivity index of 49 towards PDE5 rather than PDE11 with cGMP as the substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2FTFCI7wG-7Vg90H21EOLACvtfcHk0lhqMp1exWj9cw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsl2rsQ%253D%253D&md5=2d789b55b501b02417abc49fc3bfc230</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1002%2Fardp.201200334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201200334%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Gamil%26aufirst%3DD.%2BS.%26aulast%3DAhmed%26aufirst%3DN.%2BS.%26aulast%3DGary%26aufirst%3DB.%2BD.%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DEngel%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26atitle%3DDesign%2520of%2520novel%2520%25CE%25B2-carboline%2520derivatives%2520with%2520pendant%25205-bromothienyl%2520and%2520their%2520evaluation%2520as%2520phosphodiesterase-5%2520inhibitors%26jtitle%3DArch.%2520Pharm.%26date%3D2013%26volume%3D346%26spage%3D23%26epage%3D33%26doi%3D10.1002%2Fardp.201200334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macielag, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraft, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haynes-Johnson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clancy, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activities of novel β-carbolines as PDE5 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">765</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)01036-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2FS0960-894X%2802%2901036-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=12639576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvV2gt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=761-765&author=Z.+Suiauthor=J.+Guanauthor=M.+J.+Macielagauthor=W.+Jiangauthor=Y.+Qiuauthor=P.+Kraftauthor=S.+Bhattacharjeeauthor=T.+M.+Johnauthor=E.+Craigauthor=D.+Haynes-Johnsonauthor=J.+Clancy&title=Synthesis+and+biological+activities+of+novel+%CE%B2-carbolines+as+PDE5+inhibitors&doi=10.1016%2FS0960-894X%2802%2901036-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activities of novel β-Carbolines as PDE5 inhibitors</span></div><div class="casAuthors">Sui, Zhihua; Guan, Jihua; Macielag, Mark J.; Jiang, Weiqin; Qiu, Yuhong; Kraft, Patricia; Bhattacharjee, Sheela; John, T. Matthew; Craig, Elizabeth; Haynes-Johnson, Donna; Clancy, Joanna</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">761-765</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A series of N2-furoyl and N2-pyrimidinyl β-carbolines, e.g. I and II, was discovered to possess potent inhibitory activity against PDE5.  During the synthesis we developed a tandem resin quenching protocol, which allowed us to synthesize large no. of target compds. in a rapid fashion.  Representative compds. exhibit superior selectivity to sildenafil vs. other isoenzymes of PDEs, and demonstrated in vivo efficacy in increasing introcavernosal pressure in dogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeCeaV7QFPb7Vg90H21EOLACvtfcHk0liDop4Hmj6nCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvV2gt7g%253D&md5=fda05e2076c5d21ed1e47308eef9be33</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2901036-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252901036-3%26sid%3Dliteratum%253Aachs%26aulast%3DSui%26aufirst%3DZ.%26aulast%3DGuan%26aufirst%3DJ.%26aulast%3DMacielag%26aufirst%3DM.%2BJ.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DKraft%26aufirst%3DP.%26aulast%3DBhattacharjee%26aufirst%3DS.%26aulast%3DJohn%26aufirst%3DT.%2BM.%26aulast%3DCraig%26aufirst%3DE.%26aulast%3DHaynes-Johnson%26aufirst%3DD.%26aulast%3DClancy%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520biological%2520activities%2520of%2520novel%2520%25CE%25B2-carbolines%2520as%2520PDE5%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D761%26epage%3D765%26doi%3D10.1016%2FS0960-894X%2802%2901036-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, G.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.-F.</span></span> <span> </span><span class="NLM_article-title">Novel PDE5 inhibitors derived from rutaecarpine for the treatment of Alzheimer’s disease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">127097</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2020.127097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmcl.2020.127097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=32171616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkvFyltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=127097&author=X.-F.+Huangauthor=Y.-H.+Dongauthor=J.-H.+Wangauthor=H.-M.+Keauthor=G.-Q.+Songauthor=D.-F.+Xu&title=Novel+PDE5+inhibitors+derived+from+rutaecarpine+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2020.127097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Novel PDE5 inhibitors derived from rutaecarpine for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Huang, Xian-Feng; Dong, Yan-Hua; Wang, Jin-Hui; Ke, Heng-Ming; Song, Guo-Qiang; Xu, De-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">127097</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel rutaecarpine derivs. I [R1, R2 = H, OMe, OH, R3 = H, Et, n-Pr, (CH2)2CHMe2] were synthesized and subjected to pharmacol. evaluation as PDE5 inhibitors.  The structure-activity relationships were discussed and their binding conformation and simultaneous interaction mode were further clarified by the mol. docking studies.  Among the 25 analogs, compd. I [R1 = R2 = OH, R3 = (CH2)2CHMe2] exhibited the most potent PDE5 inhibition with IC50 values around 0.086μM.  Moreover, it also produced good effects against scopolamine-induced cognitive impairment in vivo.  These results might bring significant instruction for further development of potential PDE5 inhibitors derived from rutaecarpine as a good candidate drug for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_VbrWwSrdVrVg90H21EOLACvtfcHk0liDop4Hmj6nCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkvFyltL8%253D&md5=7fd028cbbce5a8956164b2075d388c3c</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2020.127097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2020.127097%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.-F.%26aulast%3DDong%26aufirst%3DY.-H.%26aulast%3DWang%26aufirst%3DJ.-H.%26aulast%3DKe%26aufirst%3DH.-M.%26aulast%3DSong%26aufirst%3DG.-Q.%26aulast%3DXu%26aufirst%3DD.-F.%26atitle%3DNovel%2520PDE5%2520inhibitors%2520derived%2520from%2520rutaecarpine%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D30%26spage%3D127097%26doi%3D10.1016%2Fj.bmcl.2020.127097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daugan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grondin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Monnier de Gouville, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coste, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirilovsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyafil, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaudinière, R.</span></span> <span> </span><span class="NLM_article-title">The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 1:5,6,11,11a-tetrahydro-1H-imidazo[1’,5′:1,6]pyrido[3,4-b]indole-1,3(2H)-dione analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4525</span>– <span class="NLM_lpage">4532</span>, <span class="refDoi"> DOI: 10.1021/jm030056e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030056e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVCju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4525-4532&author=A.+Dauganauthor=P.+Grondinauthor=C.+Ruaultauthor=A.-C.+Le+Monnier+de+Gouvilleauthor=H.+Costeauthor=J.+Kirilovskyauthor=F.+Hyafilauthor=R.+Labaudini%C3%A8re&title=The+discovery+of+tadalafil%3A+a+novel+and+highly+selective+PDE5+inhibitor.+1%3A5%2C6%2C11%2C11a-tetrahydro-1H-imidazo%5B1%E2%80%99%2C5%E2%80%B2%3A1%2C6%5Dpyrido%5B3%2C4-b%5Dindole-1%2C3%282H%29-dione+analogues&doi=10.1021%2Fjm030056e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 1: 5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido[3,4-b]indole-1,3(2H)-dione analogues</span></div><div class="casAuthors">Daugan, Alain; Grondin, Pascal; Ruault, Cecile; Le Monnier de Gouville, Anne-Charlotte; Coste, Herve; Kirilovsky, Jorge; Hyafil, Francois; Labaudiniere, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4525-4532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Starting from Et β-carboline-3-carboxylate (β-CCE), 1, a modest inhibitor of type 5 phosphodiesterase (PDE5), a series of functionalized tetrahydro-β-carboline derivs. has been identified as a novel chem. class of potent and selective PDE5 inhibitors.  Optimization of the side chain on the hydantoin ring of initial lead compd. 2 and of the arom. ring on position 5 led to the identification of compd. 6e, a highly potent and selective PDE5 inhibitor, with greater selectivity for PDE5 vs. PDE1-4 than sildenafil.  Compd. 6e demonstrated a long lasting and significant blood pressure lowering effect after iv administration in the spontaneously hypertensive rat model but showed only moderate oral in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF0Ynxcj9_8rVg90H21EOLACvtfcHk0lggtxVbmrqp7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVCju78%253D&md5=7c3b9aaf206cb18faaafc398c304357c</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fjm030056e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030056e%26sid%3Dliteratum%253Aachs%26aulast%3DDaugan%26aufirst%3DA.%26aulast%3DGrondin%26aufirst%3DP.%26aulast%3DRuault%26aufirst%3DC.%26aulast%3DLe%2BMonnier%2Bde%2BGouville%26aufirst%3DA.-C.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DHyafil%26aufirst%3DF.%26aulast%3DLabaudini%25C3%25A8re%26aufirst%3DR.%26atitle%3DThe%2520discovery%2520of%2520tadalafil%253A%2520a%2520novel%2520and%2520highly%2520selective%2520PDE5%2520inhibitor.%25201%253A5%252C6%252C11%252C11a-tetrahydro-1H-imidazo%255B1%25E2%2580%2599%252C5%25E2%2580%25B2%253A1%252C6%255Dpyrido%255B3%252C4-b%255Dindole-1%252C3%25282H%2529-dione%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4525%26epage%3D4532%26doi%3D10.1021%2Fjm030056e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Nashar, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gary, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fajardo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span> <span> </span><span class="NLM_article-title">Exploring the PDE5 H-pocket by ensemble docking and structure-based design and synthesis of novel β-carboline derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.09.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2012.09.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=23117589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsleisLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2012&pages=329-343&author=N.+S.+Ahmedauthor=A.+H.+Aliauthor=S.+M.+El-Nasharauthor=B.+D.+Garyauthor=A.+M.+Fajardoauthor=H.+N.+Tinsleyauthor=G.+A.+Piazzaauthor=M.+Negriauthor=A.+H.+Abadi&title=Exploring+the+PDE5+H-pocket+by+ensemble+docking+and+structure-based+design+and+synthesis+of+novel+%CE%B2-carboline+derivatives&doi=10.1016%2Fj.ejmech.2012.09.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the PDE5 H-pocket by ensemble docking and structure-based design and synthesis of novel β-carboline derivatives</span></div><div class="casAuthors">Ahmed, Nermin S.; Ali, Amal H.; El-Nashar, Shreen M.; Gary, Bernard D.; Fajardo, Alexandra M.; Tinsley, Heather N.; Piazza, Gary A.; Negri, Matthias; Abadi, Ashraf H.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">329-343</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">By studying the co-crystal information of interactions between PDE5 and its inhibitors, forty new tetrahydro-β-carbolines based-analogs e. g., I, II were synthesized, and tested for their PDE5 inhibition.  Some compds. were as active as tadalafil in inhibiting PDE5 and of better selectivity profile particularly vs. PDE11A, the nature of the terminal ring and its nitrogen substituent are the main determinants of selectivity.  Ensemble docking confirmed the role of H-loop closed conformer in activity vs. its occluded and open forms.  Conformational studies showed the effect of bulkiness of the terminal ring N-alkyl substituent on the formation of stable enzyme ligands conformers.  The difference in potencies of hydantoin and piperazinedione analogs, together with the necessity of C-5/C-6 R-abs. configuration has been revealed through mol. docking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6PsCyIZH-uLVg90H21EOLACvtfcHk0lggtxVbmrqp7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsleisLjJ&md5=502b1e56712d787442627c8acb27d82d</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.09.029%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DN.%2BS.%26aulast%3DAli%26aufirst%3DA.%2BH.%26aulast%3DEl-Nashar%26aufirst%3DS.%2BM.%26aulast%3DGary%26aufirst%3DB.%2BD.%26aulast%3DFajardo%26aufirst%3DA.%2BM.%26aulast%3DTinsley%26aufirst%3DH.%2BN.%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DNegri%26aufirst%3DM.%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26atitle%3DExploring%2520the%2520PDE5%2520H-pocket%2520by%2520ensemble%2520docking%2520and%2520structure-based%2520design%2520and%2520synthesis%2520of%2520novel%2520%25CE%25B2-carboline%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D57%26spage%3D329%26epage%3D343%26doi%3D10.1016%2Fj.ejmech.2012.09.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daugan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grondin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Monnier
de Gouville, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coste, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linget, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirilovsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyafil, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaudinière, R.</span></span> <span> </span><span class="NLM_article-title">The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 2:2,3,6,7,12,12a-hexahydropyrazino[1’,2’:1,6]pyrido[3,4-b]indole-1,4-dione analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4533</span>– <span class="NLM_lpage">4542</span>, <span class="refDoi"> DOI: 10.1021/jm0300577</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0300577" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVCisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4533-4542&author=A.+Dauganauthor=P.+Grondinauthor=C.+Ruaultauthor=A.-C.+Le+Monnier%0Ade+Gouvilleauthor=H.+Costeauthor=J.-M.+Lingetauthor=J.+Kirilovskyauthor=F.+Hyafilauthor=R.+Labaudini%C3%A8re&title=The+discovery+of+tadalafil%3A+a+novel+and+highly+selective+PDE5+inhibitor.+2%3A2%2C3%2C6%2C7%2C12%2C12a-hexahydropyrazino%5B1%E2%80%99%2C2%E2%80%99%3A1%2C6%5Dpyrido%5B3%2C4-b%5Dindole-1%2C4-dione+analogues&doi=10.1021%2Fjm0300577"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione analogue</span></div><div class="casAuthors">Daugan, Alain; Grondin, Pascal; Ruault, Cecile; Le Monnier de Gouville, Anne-Charlotte; Coste, Herve; Linget, Jean Michel; Kirilovsky, Jorge; Hyafil, Francois; Labaudiniere, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4533-4542</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modification of the hydantoin ring in the previously described lead compd. 2a has led to the discovery of compd. 12a, tadalafil, a highly potent and highly selective PDE5 inhibitor.  The replacement of the hydantoin in compd. 2a by a piperazinedione ring led to compd. cis-11a which showed similar PDE5 inhibitory potency.  Introduction of a 3,4-methylenedioxy substitution on the Ph ring in position 6 led to a potent PDE5 inhibitor cis-11c with increased cellular potency.  Optimization of the chain on the piperazinedione ring led to the identification of the racemic cis-N-Me deriv. 11i.  High diastereospecificity for PDE5 inhibition was obsd. in the piperazinedione series with the cis-(6R,12aR) enantiomer displaying the highest PDE5 inhibitory activity.  The piperazinedione 12a, tadalafil (GF196960), has been identified as a highly potent PDE5 inhibitor (IC50 = 5 nM) with high selectivity for PDE5 vs. PDE1-4 and PDE6.  Compd. 12a displays 85-fold greater selectivity vs. PDE6 than sildenafil 1.  12A showed profound and long-lasting blood pressure lowering activity (30 mmHg/>7 h) in the spontaneously hypertensive rat model after oral administration (5 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGcrjCLR1ZLrVg90H21EOLACvtfcHk0lggtxVbmrqp7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVCisrs%253D&md5=daaf79b5155dcea5b8c258fe7b05f436</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fjm0300577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0300577%26sid%3Dliteratum%253Aachs%26aulast%3DDaugan%26aufirst%3DA.%26aulast%3DGrondin%26aufirst%3DP.%26aulast%3DRuault%26aufirst%3DC.%26aulast%3DLe%2BMonnier%2Bde%2BGouville%26aufirst%3DA.-C.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DLinget%26aufirst%3DJ.-M.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DHyafil%26aufirst%3DF.%26aulast%3DLabaudini%25C3%25A8re%26aufirst%3DR.%26atitle%3DThe%2520discovery%2520of%2520tadalafil%253A%2520a%2520novel%2520and%2520highly%2520selective%2520PDE5%2520inhibitor.%25202%253A2%252C3%252C6%252C7%252C12%252C12a-hexahydropyrazino%255B1%25E2%2580%2599%252C2%25E2%2580%2599%253A1%252C6%255Dpyrido%255B3%252C4-b%255Dindole-1%252C4-dione%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4533%26epage%3D4542%26doi%3D10.1021%2Fjm0300577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sung, B.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heo, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyun, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eum, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. M.</span></span> <span> </span><span class="NLM_article-title">Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>425</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1038/nature01914</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1038%2Fnature01914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=12955149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFansrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=98-102&author=B.-J.+Sungauthor=K.+Y.+Hwangauthor=Y.+H.+Jeonauthor=J.+I.+Leeauthor=Y.-S.+Heoauthor=J.+H.+Kimauthor=J.+Moonauthor=J.+M.+Yoonauthor=Y.-L.+Hyunauthor=E.+Kimauthor=S.+J.+Eumauthor=S.-Y.+Parkauthor=J.-O.+Leeauthor=T.+G.+Leeauthor=S.+Roauthor=J.+M.+Cho&title=Structure+of+the+catalytic+domain+of+human+phosphodiesterase+5+with+bound+drug+molecules&doi=10.1038%2Fnature01914"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules</span></div><div class="casAuthors">Sung, Byung-Je; Hwang, Kwang Yeon; Jeon, Young Ho; Lee, Jae Il; Heo, Yong-Seok; Kim, Jin Hwan; Moon, Jinho; Yoon, Jung Min; Hyun, Young-Lan; Kim, Eunmi; Eum, Sung Jin; Park, Sam-Yong; Lee, Jie-Oh; Lee, Tae Gyu; Ro, Seonggu; Cho, Joong Myung</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">6953</span>),
    <span class="NLM_cas:pages">98-102</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) are a superfamily of enzymes that degrade the intracellular second messengers cAMP and cGMP.  As essential regulators of cyclic nucleotide signaling with diverse physiol. functions, PDEs are drug targets for the treatment of various diseases, including heart failure, depression, asthma, inflammation and erectile dysfunction.  Of the 12 PDE gene families, cGMP-specific PDE5 carries out the principal cGMP-hydrolyzing activity in human corpus cavernosum tissue.  It is well known as the target of sildenafil citrate (Viagra) and other similar drugs for the treatment of erectile dysfunction.  Despite the pressing need to develop selective PDE inhibitors as therapeutic drugs, only the cAMP-specific PDE4 structures are currently available.  Here we present the three-dimensional structures of the catalytic domain (residues 537-860) of human PDE5 complexed with the three drug mols. sildenafil, tadalafil (Cialis) and vardenafil (Levitra).  These structures will provide opportunities to design potent and selective PDE inhibitors with improved pharmacol. profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr5pTrMfa72rVg90H21EOLACvtfcHk0lgzpti56o8T0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFansrg%253D&md5=8459333ee12ed3469f7b48d6e7f9fd5d</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1038%2Fnature01914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01914%26sid%3Dliteratum%253Aachs%26aulast%3DSung%26aufirst%3DB.-J.%26aulast%3DHwang%26aufirst%3DK.%2BY.%26aulast%3DJeon%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BI.%26aulast%3DHeo%26aufirst%3DY.-S.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DMoon%26aufirst%3DJ.%26aulast%3DYoon%26aufirst%3DJ.%2BM.%26aulast%3DHyun%26aufirst%3DY.-L.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DEum%26aufirst%3DS.%2BJ.%26aulast%3DPark%26aufirst%3DS.-Y.%26aulast%3DLee%26aufirst%3DJ.-O.%26aulast%3DLee%26aufirst%3DT.%2BG.%26aulast%3DRo%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DJ.%2BM.%26atitle%3DStructure%2520of%2520the%2520catalytic%2520domain%2520of%2520human%2520phosphodiesterase%25205%2520with%2520bound%2520drug%2520molecules%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D98%26epage%3D102%26doi%3D10.1038%2Fnature01914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Card, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">England, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizizad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillette, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artis, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milburn, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlessinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K. Y. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the activity of drugs that inhibits phosphodiesterases</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2233</span>– <span class="NLM_lpage">2247</span>, <span class="refDoi"> DOI: 10.1016/j.str.2004.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.str.2004.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=15576036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVClur3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2233-2247&author=G.+L.+Cardauthor=B.+P.+Englandauthor=Y.+Suzukiauthor=D.+Fongauthor=B.+Powellauthor=B.+Leeauthor=C.+Luuauthor=M.+Tabrizizadauthor=S.+Gilletteauthor=P.+N.+Ibrahimauthor=D.+R.+Artisauthor=G.+Bollagauthor=M.+V.+Milburnauthor=S.-H.+Kimauthor=J.+Schlessingerauthor=K.+Y.+J.+Zhang&title=Structural+basis+for+the+activity+of+drugs+that+inhibits+phosphodiesterases&doi=10.1016%2Fj.str.2004.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases</span></div><div class="casAuthors">Card, Graeme L.; England, Bruce P.; Suzuki, Yoshihisa; Fong, Daniel; Powell, Ben; Lee, Byunghun; Luu, Catherine; Tabrizizad, Maryam; Gillette, Sam; Ibrahim, Prabha N.; Artis, Dean R.; Bollag, Gideon; Milburn, Michael V.; Kim, Sung-Hou; Schlessinger, Joseph; Zhang, Kam Y. J.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2233-2247</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) comprise a large family of enzymes that catalyze the hydrolysis of cAMP or cGMP and are implicated in various diseases.  The authors describe the high-resoln. crystal structures of the catalytic domains of PDE4B, PDE4D, and PDE5A with ten different inhibitors, including the drug candidates cilomilast and roflumilast, for respiratory diseases.  These cocrystal structures reveal a common scheme of inhibitor binding to the PDEs: (i) a hydrophobic clamp formed by highly conserved hydrophobic residues that sandwich the inhibitor in the active site; (ii) hydrogen bonding to an invariant glutamine that controls the orientation of inhibitor binding.  A scaffold can be readily identified for any given inhibitor based on the formation of these two types of conserved interactions.  These structural insights will enable the design of isoform-selective inhibitors with improved binding affinity and should facilitate the discovery of more potent and selective PDE inhibitors for the treatment of a variety of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8l4KWCohSy7Vg90H21EOLACvtfcHk0lgzpti56o8T0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVClur3K&md5=0fa91e4b9047e3df3946c526592be396</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2004.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2004.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DCard%26aufirst%3DG.%2BL.%26aulast%3DEngland%26aufirst%3DB.%2BP.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DFong%26aufirst%3DD.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DLuu%26aufirst%3DC.%26aulast%3DTabrizizad%26aufirst%3DM.%26aulast%3DGillette%26aufirst%3DS.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DMilburn%26aufirst%3DM.%2BV.%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DK.%2BY.%2BJ.%26atitle%3DStructural%2520basis%2520for%2520the%2520activity%2520of%2520drugs%2520that%2520inhibits%2520phosphodiesterases%26jtitle%3DStructure%26date%3D2004%26volume%3D12%26spage%3D2233%26epage%3D2247%26doi%3D10.1016%2Fj.str.2004.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Felding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorensen, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Refer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladefoged, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thormann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinggaard, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegardt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohoel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, S. F.</span></span> <span> </span><span class="NLM_article-title">Discovery and early clinical development of 2-{6-[2-(3,5-Dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a soft-drug inhibitor of phosphodiesterase 4 for topical treatment of atopic dermatitis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5893</span>– <span class="NLM_lpage">5903</span>, <span class="refDoi"> DOI: 10.1021/jm500378a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500378a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtV2jsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5893-5903&author=J.+Feldingauthor=M.+D.+Sorensenauthor=T.+D.+Poulsenauthor=J.+Larsenauthor=C.+Anderssonauthor=P.+Referauthor=K.+Engellauthor=L.+G.+Ladefogedauthor=T.+Thormannauthor=A.+M.+Vinggaardauthor=P.+Hegardtauthor=A.+Sohoelauthor=S.+F.+Nielsen&title=Discovery+and+early+clinical+development+of+2-%7B6-%5B2-%283%2C5-Dichloro-4-pyridyl%29acetyl%5D-2%2C3-dimethoxyphenoxy%7D-N-propylacetamide+%28LEO+29102%29%2C+a+soft-drug+inhibitor+of+phosphodiesterase+4+for+topical+treatment+of+atopic+dermatitis&doi=10.1021%2Fjm500378a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Early Clinical Development of 2-{6-[2-(3,5-Dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a Soft-Drug Inhibitor of Phosphodiesterase 4 for Topical Treatment of Atopic Dermatitis</span></div><div class="casAuthors">Felding, Jakob; Soerensen, Morten D.; Poulsen, Tina D.; Larsen, Jens; Andersson, Christina; Refer, Pia; Engell, Karen; Ladefoged, Lotte G.; Thormann, Thorsten; Vinggaard, Anne Marie; Hegardt, Pontus; Soehoel, Anders; Nielsen, Simon Feldbaek</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5893-5903</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Development of orally available phosphodiesterase 4 (PDE4) inhibitors as anti-inflammatory drugs has been going on for decades.  However, only roflumilast has received FDA approval.  One key challenge has been the low therapeutic window obsd. in the clinic for PDE4 inhibitors, primarily due to PDE4 mediated side effects.  Here we describe our approach to circumvent this issue by applying a soft-drug concept in the design of a topically acting PDE4 inhibitor for treatment of dermatol. diseases.  We used a fast follower approach, starting from piclamilast.  In particular, simultaneous introduction of 2'-alkoxy substituents and changing an amide to a keto linker proved to be beneficial when designing potential soft-drug candidates.  This effort culminated in identification of LEO 29102 (20), a potent, selective, and soft-drug PDE4 inhibitor with properties suitable for patient-friendly formulations giving efficient drug delivery to the skin.  Compd. 20 has reached phase 2 and demonstrated clin. relevant efficacy in the treatment of atopic dermatitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6hRC8lktjRrVg90H21EOLACvtfcHk0lhz2a7-deO2Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtV2jsrfF&md5=9d236da8f314edec69f5b442e1a41141</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm500378a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500378a%26sid%3Dliteratum%253Aachs%26aulast%3DFelding%26aufirst%3DJ.%26aulast%3DSorensen%26aufirst%3DM.%2BD.%26aulast%3DPoulsen%26aufirst%3DT.%2BD.%26aulast%3DLarsen%26aufirst%3DJ.%26aulast%3DAndersson%26aufirst%3DC.%26aulast%3DRefer%26aufirst%3DP.%26aulast%3DEngell%26aufirst%3DK.%26aulast%3DLadefoged%26aufirst%3DL.%2BG.%26aulast%3DThormann%26aufirst%3DT.%26aulast%3DVinggaard%26aufirst%3DA.%2BM.%26aulast%3DHegardt%26aufirst%3DP.%26aulast%3DSohoel%26aufirst%3DA.%26aulast%3DNielsen%26aufirst%3DS.%2BF.%26atitle%3DDiscovery%2520and%2520early%2520clinical%2520development%2520of%25202-%257B6-%255B2-%25283%252C5-Dichloro-4-pyridyl%2529acetyl%255D-2%252C3-dimethoxyphenoxy%257D-N-propylacetamide%2520%2528LEO%252029102%2529%252C%2520a%2520soft-drug%2520inhibitor%2520of%2520phosphodiesterase%25204%2520for%2520topical%2520treatment%2520of%2520atopic%2520dermatitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5893%26epage%3D5903%26doi%3D10.1021%2Fjm500378a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beghyn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hounsou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez, B. P.</span></span> <span> </span><span class="NLM_article-title">PDE5 inhibitors: an original access to novel potent arylated analogues of tadalafil</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.10.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmcl.2006.10.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=17107795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFalsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=789-792&author=T.+Beghynauthor=C.+Hounsouauthor=B.+P.+Deprez&title=PDE5+inhibitors%3A+an+original+access+to+novel+potent+arylated+analogues+of+tadalafil&doi=10.1016%2Fj.bmcl.2006.10.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">PDE5 inhibitors: An original access to novel potent arylated analogues of tadalafil</span></div><div class="casAuthors">Beghyn, Terence; Hounsou, Candide; Deprez, Benoit P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">789-792</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A method to access totally new analogs of tadalafil, e.g., I, was explored.  The Buchwald reaction was adapted and used to replace the Me group of tadalafil by various aryl groups.  Inhibition potencies on PDE5 of these analogs were detd. and proved to be comparable to the one of tadalafil.  Using the same route, compds. with the same level of activity but improved water soly. were produced by introducing a pyridine or a pyrimidine ring.  This original route also opens access to new unpatented compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHEuLfICWSTrVg90H21EOLACvtfcHk0lhz2a7-deO2Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFalsA%253D%253D&md5=f9159ca13ab26c3d4c75cb7924bd293a</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.10.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.10.069%26sid%3Dliteratum%253Aachs%26aulast%3DBeghyn%26aufirst%3DT.%26aulast%3DHounsou%26aufirst%3DC.%26aulast%3DDeprez%26aufirst%3DB.%2BP.%26atitle%3DPDE5%2520inhibitors%253A%2520an%2520original%2520access%2520to%2520novel%2520potent%2520arylated%2520analogues%2520of%2520tadalafil%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D789%26epage%3D792%26doi%3D10.1016%2Fj.bmcl.2006.10.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maw, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allerton, C. M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gbekor, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Million, W. A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological activity of β-carboline-based type-5 phosphodiesterase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1425</span>– <span class="NLM_lpage">1428</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(03)00159-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2FS0960-894X%2803%2900159-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=12668004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1aqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1425-1428&author=G.+N.+Mawauthor=C.+M.+N.+Allertonauthor=E.+Gbekorauthor=W.+A.+Million&title=Design%2C+synthesis+and+biological+activity+of+%CE%B2-carboline-based+type-5+phosphodiesterase+inhibitors&doi=10.1016%2FS0960-894X%2803%2900159-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological activity of β-carboline-based type-5 phosphodiesterase inhibitors</span></div><div class="casAuthors">Maw, Graham N.; Allerton, Charlotte M. N.; Gbekor, Eugene; Million, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1425-1428</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The SAR of a series of β-carboline derived type 5 phosphodiesterase inhibitors has been explored and we have discovered compds. with excellent levels of PDE5 potency and selectivity over PDE6.  However, the series exhibits low levels of selectivity over PDE11, a phosphodiesterase with unknown function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_rN-WnGiu37Vg90H21EOLACvtfcHk0lhz2a7-deO2Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1aqtrY%253D&md5=07f48da05629e870a75dd17f7c4922d1</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900159-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900159-8%26sid%3Dliteratum%253Aachs%26aulast%3DMaw%26aufirst%3DG.%2BN.%26aulast%3DAllerton%26aufirst%3DC.%2BM.%2BN.%26aulast%3DGbekor%26aufirst%3DE.%26aulast%3DMillion%26aufirst%3DW.%2BA.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520activity%2520of%2520%25CE%25B2-carboline-based%2520type-5%2520phosphodiesterase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1425%26epage%3D1428%26doi%3D10.1016%2FS0960-894X%2803%2900159-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elhady, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigler, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noureldin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canzoneri, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of novel tetrahydro-beta-carboline derivatives with a hydrophilic side chain as potential phosphodiesterase inhibitors</span>. <i>Sci. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">446</span>, <span class="refDoi"> DOI: 10.3390/scipharm84030428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3390%2Fscipharm84030428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktl2msb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2016&pages=428-446&author=A.+K.+Elhadyauthor=S.+C.+Siglerauthor=N.+Noureldinauthor=J.+C.+Canzoneriauthor=N.+S.+Ahmedauthor=G.+A.+Piazzaauthor=A.+H.+Abadi&title=Structure-based+design+of+novel+tetrahydro-beta-carboline+derivatives+with+a+hydrophilic+side+chain+as+potential+phosphodiesterase+inhibitors&doi=10.3390%2Fscipharm84030428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of novel tetrahydro-beta-carboline derivatives with a hydrophilic side chain as potential phosphodiesterase inhibitors</span></div><div class="casAuthors">Elhady, Ahmed K.; Sigler, Sara C.; Noureldin, Nazih; Canzoneri, Joshua C.; Ahmed, Nermin S.; Piazza, Gary A.; Abadi, Ashraf H.</div><div class="citationInfo"><span class="NLM_cas:title">Scientia Pharmaceutica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">428-446</span>CODEN:
                <span class="NLM_cas:coden">SCPHA4</span>;
        ISSN:<span class="NLM_cas:issn">2218-0532</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Tadalafil is a clin. approved phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction and pulmonary arterial hypertension.  It contains two chiral carbons, and the marketed isomer is the 6R, 12aR isomer with a Me substituent on the terminal nitrogen of the piperazinedione ring.  In this report, tadalafil analogs with an extended hydrophilic side chain on the piperazine nitrogen were designed to interact with particular hydrophilic residues in the binding pocket.  This leads to analogs with moderate inhibitory activity on phosphodiesterase-5, even for isomers in which chiral carbons are of the S configuration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAE_r8VPylXLVg90H21EOLACvtfcHk0lh6igqKtHVP6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktl2msb4%253D&md5=b400fb905bae340f81149440dc0e9799</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.3390%2Fscipharm84030428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fscipharm84030428%26sid%3Dliteratum%253Aachs%26aulast%3DElhady%26aufirst%3DA.%2BK.%26aulast%3DSigler%26aufirst%3DS.%2BC.%26aulast%3DNoureldin%26aufirst%3DN.%26aulast%3DCanzoneri%26aufirst%3DJ.%2BC.%26aulast%3DAhmed%26aufirst%3DN.%2BS.%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520tetrahydro-beta-carboline%2520derivatives%2520with%2520a%2520hydrophilic%2520side%2520chain%2520as%2520potential%2520phosphodiesterase%2520inhibitors%26jtitle%3DSci.%2520Pharm.%26date%3D2016%26volume%3D84%26spage%3D428%26epage%3D446%26doi%3D10.3390%2Fscipharm84030428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beghyn, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henninot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboule, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez, B.</span></span> <span> </span><span class="NLM_article-title">Drug-to-genome-to-drug, step 2: reversing selectivity in a series of antiplasmodial compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1274</span>– <span class="NLM_lpage">1286</span>, <span class="refDoi"> DOI: 10.1021/jm201422e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201422e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12hsL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1274-1286&author=T.+B.+Beghynauthor=J.+Chartonauthor=F.+Lerouxauthor=A.+Henninotauthor=I.+Rebouleauthor=P.+Cosauthor=L.+Maesauthor=B.+Deprez&title=Drug-to-genome-to-drug%2C+step+2%3A+reversing+selectivity+in+a+series+of+antiplasmodial+compounds&doi=10.1021%2Fjm201422e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-to-Genome-to-Drug, Step 2: Reversing Selectivity in a Series of Antiplasmodial Compounds</span></div><div class="casAuthors">Beghyn, Terence B.; Charton, Julie; Leroux, Florence; Henninot, Antoine; Reboule, Irena; Cos, Paul; Maes, Louis; Deprez, Benoit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1274-1286</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In a recent paper, we have described the discovery of antimalarial compds. derived from tadalafil, using a drug-to-genome-to-drug approach (J. Med. CHem. 2011, 54 (9), pp 3222-3240).  We have shown that these derivs. inhibit the phosphodiesterase activity of Plasmodium falciparum and the parasite growth in culture.  In this paper, we describe the optimization of these compds.  A direct consequence of our approach based on gene orthol. is the lack of selectivity of the compds. over the original activity on the human target.  We demonstrate here that it is possible to take advantage of subtle differences in SAR between HsPDE5 inhibition and antiplasmodial activity to improve significantly the selectivity.  In particular, the replacement of the piperonyl group in compd. I by a dimethoxyphenyl group was the best way to optimize selectivity.  This observation is consistent with the differences between human and plasmodial sequences in the Q2 pocket receiving this group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGudK7UKU_qbVg90H21EOLACvtfcHk0lh6igqKtHVP6A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12hsL3P&md5=4cafbcc78b39d613f9ef6192d93d04f8</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fjm201422e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201422e%26sid%3Dliteratum%253Aachs%26aulast%3DBeghyn%26aufirst%3DT.%2BB.%26aulast%3DCharton%26aufirst%3DJ.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DHenninot%26aufirst%3DA.%26aulast%3DReboule%26aufirst%3DI.%26aulast%3DCos%26aufirst%3DP.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DDeprez%26aufirst%3DB.%26atitle%3DDrug-to-genome-to-drug%252C%2520step%25202%253A%2520reversing%2520selectivity%2520in%2520a%2520series%2520of%2520antiplasmodial%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1274%26epage%3D1286%26doi%3D10.1021%2Fjm201422e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamiz, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittemore, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upasani, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keana, J. F. W.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship for a series of 2-substituted 1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indoles: potent subtype-selective inhibitors of N-methyl-D-aspartate (NMDA) receptors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1619</span>– <span class="NLM_lpage">1624</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(99)00248-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2FS0960-894X%2899%2900248-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10386947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK1MXjvVKisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=1619-1624&author=A.+P.+Tamizauthor=E.+R.+Whittemoreauthor=R.+M.+Woodwardauthor=R.+B.+Upasaniauthor=J.+F.+W.+Keana&title=Structure-activity+relationship+for+a+series+of+2-substituted+1%2C2%2C3%2C4-tetrahydro-9H-pyrido%5B3%2C4-b%5Dindoles%3A+potent+subtype-selective+inhibitors+of+N-methyl-D-aspartate+%28NMDA%29+receptors&doi=10.1016%2FS0960-894X%2899%2900248-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship for a series of 2-substituted 1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indoles: potent subtype-selective inhibitors of N-methyl-D-aspartate (NMDA) receptors</span></div><div class="casAuthors">Tamiz, Amir P.; Whittemore, Edward R.; Woodward, Richard M.; Upasani, Ravindra B.; Keana, John F. W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1619-1624</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A series of 2-substituted 1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indoles was synthesized as potential antagonists for the NR1A/2B subtype of N-methyl-D-aspartate (NMDA) receptors.  Assayed by elec. recording under steady-state conditions, 7-hydroxy-2-(4-phenylbutyl)-1,2,3,4-tetrahydropyrido-[3,4-b]indole (30) was the most potent compd. in the series having an IC50 value of 50 nM at the NR1A/2B receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpia5hKHj6WWLVg90H21EOLACvtfcHk0lhEkejoHP9Imw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvVKisbo%253D&md5=51573f56e18805a8c19372ec1c331889</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2899%2900248-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252899%252900248-6%26sid%3Dliteratum%253Aachs%26aulast%3DTamiz%26aufirst%3DA.%2BP.%26aulast%3DWhittemore%26aufirst%3DE.%2BR.%26aulast%3DWoodward%26aufirst%3DR.%2BM.%26aulast%3DUpasani%26aufirst%3DR.%2BB.%26aulast%3DKeana%26aufirst%3DJ.%2BF.%2BW.%26atitle%3DStructure-activity%2520relationship%2520for%2520a%2520series%2520of%25202-substituted%25201%252C2%252C3%252C4-tetrahydro-9H-pyrido%255B3%252C4-b%255Dindoles%253A%2520potent%2520subtype-selective%2520inhibitors%2520of%2520N-methyl-D-aspartate%2520%2528NMDA%2529%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D1619%26epage%3D1624%26doi%3D10.1016%2FS0960-894X%2899%2900248-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Espinoza-Moraga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caballero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaube, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winckler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, L. S.</span></span> <span> </span><span class="NLM_article-title">1-Benzyl-1,2,3,4-tetrahydro-β-carboline as channel blocker of N-methyl-D-aspartate receptors</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">594</span>– <span class="NLM_lpage">599</span>, <span class="refDoi"> DOI: 10.1111/j.1747-0285.2012.01317.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1111%2Fj.1747-0285.2012.01317.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=22226015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVajs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2012&pages=594-599&author=M.+Espinoza-Moragaauthor=J.+Caballeroauthor=F.+Gaubeauthor=T.+Wincklerauthor=L.+S.+Santos&title=1-Benzyl-1%2C2%2C3%2C4-tetrahydro-%CE%B2-carboline+as+channel+blocker+of+N-methyl-D-aspartate+receptors&doi=10.1111%2Fj.1747-0285.2012.01317.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">1-benzyl-1,2,3,4-tetrahydro-β-carboline as channel blocker of N-methyl-D-aspartate receptors</span></div><div class="casAuthors">Espinoza-Moraga, Marlene; Caballero, Julio; Gaube, Friedemann; Winckler, Thomas; Santos, Leonardo S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">594-599</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate (NMDA) receptors belong to the family of ligand-gated ion channels and are important for synaptic plasticity and memory function.  The NMDA receptor consists of a voltage-dependent channel permeable to Ca2+ and Na+.  In Alzheimer's disease, neuronal degeneration is thought to cause an excessive release of glutamate to the extracellular space, which may in turn mediate prolonged stimulation of the NMDA receptor complex and, as a consequence, excessive calcium influx into neuronal cells, leading to subsequent cell death.  This process is called glutamate-induced excitotoxicity, and its inhibition may present an effective antidementive therapy.  We found that 1-benzyl-1,2,3,4-tetrahydro-β-carboline (1a) blocked NMDA receptor-mediated, glutamate-induced excitotoxicity with an IC50 value of 27.4 μM, whereas the closely related 1-phenyl-1,2,3,4-tetrahydro-β-carboline (1b) had no effect.  The binding modes of the reported compds. were studied by in silico docking simulations.  We demonstrate that compds. (S)-1a and (R)-1a, but not (S)-1b and (R)-1b, have the same characteristics of potent NMDA receptor blockers, because they establish the main interactions inside the vestibule region of the receptor described previously for the high-affinity NMDA receptor blocker, MK-801.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpof6sldb57WrVg90H21EOLACvtfcHk0lhEkejoHP9Imw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVajs7g%253D&md5=693b4df86257261a85920cd1efb3eaa6</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2012.01317.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2012.01317.x%26sid%3Dliteratum%253Aachs%26aulast%3DEspinoza-Moraga%26aufirst%3DM.%26aulast%3DCaballero%26aufirst%3DJ.%26aulast%3DGaube%26aufirst%3DF.%26aulast%3DWinckler%26aufirst%3DT.%26aulast%3DSantos%26aufirst%3DL.%2BS.%26atitle%3D1-Benzyl-1%252C2%252C3%252C4-tetrahydro-%25CE%25B2-carboline%2520as%2520channel%2520blocker%2520of%2520N-methyl-D-aspartate%2520receptors%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2012%26volume%3D79%26spage%3D594%26epage%3D599%26doi%3D10.1111%2Fj.1747-0285.2012.01317.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, N. A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureda, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. M. M.</span></span> <span> </span><span class="NLM_article-title">Enantiopure indolo[2,3-a]quinolizidines: synthesis and evaluation as NMDA receptor antagonists</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1027</span>– <span class="NLM_lpage">1038</span>, <span class="refDoi"> DOI: 10.3390/molecules21081027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3390%2Fmolecules21081027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVWktrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1027-1038&author=N.+A.+L.+Pereiraauthor=F.+X.+Suredaauthor=M.+P%C3%A9rezauthor=M.+Amatauthor=M.+M.+M.+Santos&title=Enantiopure+indolo%5B2%2C3-a%5Dquinolizidines%3A+synthesis+and+evaluation+as+NMDA+receptor+antagonists&doi=10.3390%2Fmolecules21081027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Enantiopure indolo[2,3-a]quinolizidines: synthesis and evaluation as NMDA receptor antagonists</span></div><div class="casAuthors">Pereira, Nuno A. L.; Sureda, Francesc X.; Perez, Maria; Amat, Mercedes; Santos, Maria M. M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1027/1-1027/12</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The development of a small library of indolo[2,3-a]quinolizidines and evaluation of their activity as N-Me D-Aspartate (NMDA) receptor antagonists was reported.  The indolo[2,3-a]quinolizidine scaffold was obtained using the following key steps: (i) a stereoselective cyclocondensation of (S)- or (R)-tryptophanol with appropriate racemic δ-oxoesters; (ii) a stereocontrolled cyclization on the indole nucleus.  The synthesized enantiopure indolo[2,3-a]quinolizidines were evaluated as NMDA receptor antagonists and one compd. was identified to be 2.9-fold more potent as NMDA receptor blocker than amantadine (used in the clinic for Parkinson's disease).  This compd. represented a hit compd. for the development of novel NMDA receptor antagonists with potential applications in neurodegenerative disorders assocd. with overactivation of NMDA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwN99YB2U0rVg90H21EOLACvtfcHk0lhEkejoHP9Imw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVWktrnL&md5=86055090f84fd018b2d84a6be6cf99f4</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21081027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21081027%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DN.%2BA.%2BL.%26aulast%3DSureda%26aufirst%3DF.%2BX.%26aulast%3DP%25C3%25A9rez%26aufirst%3DM.%26aulast%3DAmat%26aufirst%3DM.%26aulast%3DSantos%26aufirst%3DM.%2BM.%2BM.%26atitle%3DEnantiopure%2520indolo%255B2%252C3-a%255Dquinolizidines%253A%2520synthesis%2520and%2520evaluation%2520as%2520NMDA%2520receptor%2520antagonists%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D1027%26epage%3D1038%26doi%3D10.3390%2Fmolecules21081027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webber, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casadesus, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marlatt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raina, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. A.</span></span> <span> </span><span class="NLM_article-title">The role of metabotropic glutamate receptors in Alzheimer’s disease</span>. <i>Acta Neurobiol. Exp.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">98</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=15190683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ptVGjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=89-98&author=H.-G.+Leeauthor=X.+Zhuauthor=M.+J.+O%E2%80%99Neillauthor=K.+Webberauthor=G.+Casadesusauthor=M.+Marlattauthor=K.+R.+Rainaauthor=G.+Perryauthor=M.+A.+Smith&title=The+role+of+metabotropic+glutamate+receptors+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">The role of metabotropic glutamate receptors in Alzheimer's disease</span></div><div class="casAuthors">Lee Hyoung-gon; Zhu Xiongwei; O'Neill Michael J; Webber Kate; Casadesus Gemma; Marlatt Michael; Raina Arun K; Perry George; Smith Mark A</div><div class="citationInfo"><span class="NLM_cas:title">Acta neurobiologiae experimentalis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-98</span>
        ISSN:<span class="NLM_cas:issn">0065-1400</span>.
    </div><div class="casAbstract">While glutamatergic transmission is severely altered by early degeneration of cortico-cortical connections and hippocampal projections in Alzheimer's disease (AD), the role of glutamate receptors in the pathogenesis of AD is not yet defined clearly.  Nonetheless, as reviewed here, the topographical distribution of different types of receptors likely contributes to the regional selective nature of neuronal degeneration.  In particular, metabotropic glutamate receptors (mGluR) may contribute the pathogenesis of many neurological conditions and also regulate neuronal vulnerability against cytotoxic stress.  Thus, we here discuss the possible role of mGluR in the pathogenesis of AD based on the results from other neurodegenerative diseases that may give us clues to solve the mysterious selective neurodegeneration evident in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR6CrmAaD06JCjiVMCqkKxVfW6udTcc2eYL3qola0Gdb7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ptVGjsA%253D%253D&md5=e3c14363b0ef8c6225a28d2acd6f0a69</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.-G.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DM.%2BJ.%26aulast%3DWebber%26aufirst%3DK.%26aulast%3DCasadesus%26aufirst%3DG.%26aulast%3DMarlatt%26aufirst%3DM.%26aulast%3DRaina%26aufirst%3DK.%2BR.%26aulast%3DPerry%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26atitle%3DThe%2520role%2520of%2520metabotropic%2520glutamate%2520receptors%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neurobiol.%2520Exp.%26date%3D2004%26volume%3D64%26spage%3D89%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di Fabio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micheli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvaro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavanni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagliardi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovannini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maffeis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mingardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tranquillini, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitulli, G.</span></span> <span> </span><span class="NLM_article-title">From pyrroles to 1-oxo-2,3,4,9-tetrahydro-1H-β-carbolines: a new class of orally bioavailable mGluR1 antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2254</span>– <span class="NLM_lpage">2259</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.01.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmcl.2007.01.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=17276684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvVaitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2254-2259&author=R.+Di+Fabioauthor=F.+Micheliauthor=G.+Alvaroauthor=P.+Cavanniauthor=D.+Donatiauthor=T.+Gagliardiauthor=G.+Fontanaauthor=R.+Giovanniniauthor=M.+Maffeisauthor=A.+Mingardiauthor=M.+E.+Tranquilliniauthor=G.+Vitulli&title=From+pyrroles+to+1-oxo-2%2C3%2C4%2C9-tetrahydro-1H-%CE%B2-carbolines%3A+a+new+class+of+orally+bioavailable+mGluR1+antagonists&doi=10.1016%2Fj.bmcl.2007.01.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">From pyrroles to 1-oxo-2,3,4,9-tetrahydro-1H-β-carbolines: A new class of orally bioavailable mGluR1 antagonists</span></div><div class="casAuthors">Di Fabio, Romano; Micheli, Fabrizio; Alvaro, Giuseppe; Cavanni, Paolo; Donati, Daniele; Gagliardi, Tatiana; Fontana, Gabriele; Giovannini, Riccardo; Maffeis, Micaela; Mingardi, Anna; Tranquillini, Maria Elvira; Vitulli, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2254-2259</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Exploiting the SAR of the known pyrrole derivs., a new class of mGluR1 antagonists was designed by replacement of the pyrrole core with an indole scaffold and consequent cyclization of the C-2 position into a tricyclic β-carboline template.  The appropriate exploration of the position C-6 with a combination of H-bond acceptor groups coupled with bulky/lipophilic moieties led to the discovery of a new series of mGluR1 antagonists.  These compds. exhibited a noncompetitive behavior, excellent pharmacokinetic properties, and good in vivo activity in animal models of acute and chronic pain, after oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoduwR7y9-xMLVg90H21EOLACvtfcHk0lg55NU7uzb2jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvVaitrw%253D&md5=e8cc6bdbb00b35d51318efd87d1bd0fd</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.01.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.01.055%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFabio%26aufirst%3DR.%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DAlvaro%26aufirst%3DG.%26aulast%3DCavanni%26aufirst%3DP.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DGagliardi%26aufirst%3DT.%26aulast%3DFontana%26aufirst%3DG.%26aulast%3DGiovannini%26aufirst%3DR.%26aulast%3DMaffeis%26aufirst%3DM.%26aulast%3DMingardi%26aufirst%3DA.%26aulast%3DTranquillini%26aufirst%3DM.%2BE.%26aulast%3DVitulli%26aufirst%3DG.%26atitle%3DFrom%2520pyrroles%2520to%25201-oxo-2%252C3%252C4%252C9-tetrahydro-1H-%25CE%25B2-carbolines%253A%2520a%2520new%2520class%2520of%2520orally%2520bioavailable%2520mGluR1%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2254%26epage%3D2259%26doi%3D10.1016%2Fj.bmcl.2007.01.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Govindpani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvo-Flores Guzmán, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinnakota, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldvogel, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faull, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwakowsky, A.</span></span> <span> </span><span class="NLM_article-title">Towards a better understanding of GABAergic remodeling in Alzheimer’s disease</span>. <i>Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1813</span>– <span class="NLM_lpage">1853</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3390%2Fijms18081813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVOmtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=1813-1853&author=K.+Govindpaniauthor=B.+Calvo-Flores+Guzm%C3%A1nauthor=C.+Vinnakotaauthor=H.+J.+Waldvogelauthor=R.+L.+Faullauthor=A.+Kwakowsky&title=Towards+a+better+understanding+of+GABAergic+remodeling+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a better understanding of GABAergic remodeling in Alzheimer's disease</span></div><div class="casAuthors">Govindpani, Karan; Guzman, Beatriz Calvo-Flores; Vinnakota, Chitra; Waldvogel, Henry J.; Faull, Richard L.; Kwakowsky, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1813/1-1813/41</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">γ-Aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the vertebrate brain.  In the past, there has been a major research drive focused on the dysfunction of the glutamatergic and cholinergic neurotransmitter systems in Alzheimer's disease (AD).  However, there is now growing evidence in support of a GABAergic contribution to the pathogenesis of this neurodegenerative disease.  Previous studies paint a complex, convoluted and often inconsistent picture of AD-assocd. GABAergic remodeling.  Given the importance of the GABAergic system in neuronal function and homeostasis, in the maintenance of the excitatory/inhibitory balance, and in the processes of learning and memory, such changes in GABAergic function could be an important factor in both early and later stages of AD pathogenesis.  Given the limited scope of currently available therapies in modifying the course of the disease, a better understanding of GABAergic remodeling in AD could open up innovative and novel therapeutic opportunities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDk53DIMXlE7Vg90H21EOLACvtfcHk0lg55NU7uzb2jw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVOmtrnO&md5=de355673bd7876e1d6f62f5f14de954d</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.3390%2Fijms18081813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18081813%26sid%3Dliteratum%253Aachs%26aulast%3DGovindpani%26aufirst%3DK.%26aulast%3DCalvo-Flores%2BGuzm%25C3%25A1n%26aufirst%3DB.%26aulast%3DVinnakota%26aufirst%3DC.%26aulast%3DWaldvogel%26aufirst%3DH.%2BJ.%26aulast%3DFaull%26aufirst%3DR.%2BL.%26aulast%3DKwakowsky%26aufirst%3DA.%26atitle%3DTowards%2520a%2520better%2520understanding%2520of%2520GABAergic%2520remodeling%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Sci.%26date%3D2017%26volume%3D18%26spage%3D1813%26epage%3D1853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calvo-Flores Guzmán, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinnakota, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govindpani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldvogel, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faull, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwakowsky, A.</span></span> <span> </span><span class="NLM_article-title">The GABAergic system as a therapeutic target for Alzheimer’s disease</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">669</span>, <span class="refDoi"> DOI: 10.1111/jnc.14345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1111%2Fjnc.14345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=29645219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVeiu7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2018&pages=649-669&author=B.+Calvo-Flores+Guzm%C3%A1nauthor=C.+Vinnakotaauthor=K.+Govindpaniauthor=H.+J.+Waldvogelauthor=R.+L.+M.+Faullauthor=A.+Kwakowsky&title=The+GABAergic+system+as+a+therapeutic+target+for+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fjnc.14345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">The GABAergic system as a therapeutic target for Alzheimer's disease</span></div><div class="casAuthors">Calvo-Flores Guzman, Beatriz; Vinnakota, Chitra; Govindpani, Karan; Waldvogel, Henry J.; Faull, Richard L. M.; Kwakowsky, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">649-669</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Glutamatergic and cholinergic dysfunction are well-attested features of Alzheimer's disease (AD), progressing with other pathol. indexes of the disorder and exacerbating neuronal and network dysfunction.  However, relatively little attention has been paid to the inhibitory component of the excitatory/inhibitory (E/I) network, particularly dysfunction in the gamma-aminobutyric acid (GABA) signaling system.  There is growing evidence in support of GABAergic remodeling in the AD brain, potentially beginning in early stages of disease pathogenesis, and this could thus be a valid mol. target for drug development and pharmacol. therapies.  Several GABAergic drugs have been tested for efficacy in attenuating or reversing various features and symptoms of AD, and this could represent a novel path by which we might address the growing need for more effective and benign therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDgcgTZzN3mbVg90H21EOLACvtfcHk0lhCFS-QnsccvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVeiu7%252FN&md5=0e3efd4ca632d4e04efdd98354eccde0</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1111%2Fjnc.14345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.14345%26sid%3Dliteratum%253Aachs%26aulast%3DCalvo-Flores%2BGuzm%25C3%25A1n%26aufirst%3DB.%26aulast%3DVinnakota%26aufirst%3DC.%26aulast%3DGovindpani%26aufirst%3DK.%26aulast%3DWaldvogel%26aufirst%3DH.%2BJ.%26aulast%3DFaull%26aufirst%3DR.%2BL.%2BM.%26aulast%3DKwakowsky%26aufirst%3DA.%26atitle%3DThe%2520GABAergic%2520system%2520as%2520a%2520therapeutic%2520target%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2018%26volume%3D146%26spage%3D649%26epage%3D669%26doi%3D10.1111%2Fjnc.14345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stute, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höfling, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartlage-Rübsamen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matysik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roβner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alia, A.</span></span> <span> </span><span class="NLM_article-title">Sex- and age-specific modulation of brain GABA levels in a mouse model of Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2017.10.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.neurobiolaging.2017.10.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=29154037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslylsrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=168-179&author=U.+Royauthor=L.+Stuteauthor=C.+H%C3%B6flingauthor=M.+Hartlage-R%C3%BCbsamenauthor=J.+Matysikauthor=S.+Ro%CE%B2nerauthor=A.+Alia&title=Sex-+and+age-specific+modulation+of+brain+GABA+levels+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neurobiolaging.2017.10.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Sex- and age-specific modulation of brain GABA levels in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Roy, Upasana; Stute, Lara; Hoefling, Corinna; Hartlage-Ruebsamen, Maike; Matysik, Joerg; Roβner, Steffen; Alia, A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">168-179</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Age and sex are risk factors of Alzheimer's disease (AD).  Among the neurotransmitter systems, gamma-aminobutyric acid (GABA) has been implicated in AD pathogenesis but the relevance of sex-specific GABAergic dysfunction during AD progression remains unknown.  In the present study, we utilized state-of-the-art high-resoln. magic angle spinning NMR to systematically monitor the brain region-, age-, and sex-specific modulation of GABA levels in wild-type and Tg2576 mice with amyloid pathol.  In addn., we followed the possible role of reactive astrocytes in sex-specific GABA modulation.  In female Tg2576 mice, hippocampal GABA levels were significantly elevated, along with higher no. of reactive astrocytes and amyloid deposition.  The elevated GABA was found to be produced via the monoamine oxidase-B route from putrescine in reactive astrocytes, more substantially in female than male mice, thus suggesting a role of astrocytes in memory impairment and sex-related differences in AD.  Our results paint a coherent model of memory impairment in AD and signify that dynamic changes in regional GABA may be at the root of marked sex disparities obsd. in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozCzQt3Kt4HrVg90H21EOLACvtfcHk0lhCFS-QnsccvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslylsrrK&md5=1132e6c2251bb833736aa186995edb7d</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2017.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2017.10.015%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DU.%26aulast%3DStute%26aufirst%3DL.%26aulast%3DH%25C3%25B6fling%26aufirst%3DC.%26aulast%3DHartlage-R%25C3%25BCbsamen%26aufirst%3DM.%26aulast%3DMatysik%26aufirst%3DJ.%26aulast%3DRo%25CE%25B2ner%26aufirst%3DS.%26aulast%3DAlia%26aufirst%3DA.%26atitle%3DSex-%2520and%2520age-specific%2520modulation%2520of%2520brain%2520GABA%2520levels%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2018%26volume%3D62%26spage%3D168%26epage%3D179%26doi%3D10.1016%2Fj.neurobiolaging.2017.10.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DasGupta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span> <span> </span><span class="NLM_article-title">Altered neurochemistry in Alzheimer’s disease: targeting neurotransmitter receptor mechanisms and therapeutic strategy</span>. <i>Neurophysiology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1007/s11062-019-09823-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1007%2Fs11062-019-09823-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVyktLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2019&pages=293-309&author=S.+Kaurauthor=G.+DasGuptaauthor=S.+Singh&title=Altered+neurochemistry+in+Alzheimer%E2%80%99s+disease%3A+targeting+neurotransmitter+receptor+mechanisms+and+therapeutic+strategy&doi=10.1007%2Fs11062-019-09823-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Altered Neurochemistry in Alzheimer's Disease: Targeting Neurotransmitter Receptor Mechanisms and Therapeutic Strategy</span></div><div class="casAuthors">Kaur, S.; DasGupta, G.; Singh, S.</div><div class="citationInfo"><span class="NLM_cas:title">Neurophysiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-309</span>CODEN:
                <span class="NLM_cas:coden">NPHYBI</span>;
        ISSN:<span class="NLM_cas:issn">0090-2977</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common form of dementia characterized by impaired cognitive functions assocd. with altered neurotransmitter levels in the brain.  In AD with advancement of age, symptoms that affect memory, learning ability, language perception, and behavior start to progress.  These shifts correlate with accumulations of amyloid beta plaques and neurofibrillary tangles.  Such pathol. changes are thought to distort synaptic neurotransmitter levels and interrupt neuron-toneuron functioning.  The current drugs in AD, like donepezil, rivastigmine, etc., rely to a significant extent on ameliorated cholinergic neurotransmission and utilization of anticholinesterase inhibitors.  The recent outbreaks in this disease also target neurotransmitters such as dopamine, serotonin, and their receptor signaling, rather than focusing on cholinergic neurotransmission.  This concept emerges due to findings of altered neurotransmitter levels in the post mortem brains of AD patients.  The current review summarizes some data underlying mechanisms targeting the role of neurotransmitters and their assocn. with AD, as well as those related to the resp. therapeutic aspects.  In addn., the review describes advances in recent drugs targeting neurotransmission preclinically and clin. for their neuroprotective role in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPlRA9o7xGJbVg90H21EOLACvtfcHk0lhCFS-QnsccvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVyktLrO&md5=0ff4b4e3191f08ce24c1716540068473</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1007%2Fs11062-019-09823-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11062-019-09823-7%26sid%3Dliteratum%253Aachs%26aulast%3DKaur%26aufirst%3DS.%26aulast%3DDasGupta%26aufirst%3DG.%26aulast%3DSingh%26aufirst%3DS.%26atitle%3DAltered%2520neurochemistry%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520targeting%2520neurotransmitter%2520receptor%2520mechanisms%2520and%2520therapeutic%2520strategy%26jtitle%3DNeurophysiology%26date%3D2019%26volume%3D51%26spage%3D293%26epage%3D309%26doi%3D10.1007%2Fs11062-019-09823-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutts, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benderly, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locock, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, I. L.</span></span> <span> </span><span class="NLM_article-title">Interactions of β-carbolines with the benzodiazepine receptor: structure-activity relationships</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(81)90515-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2F0014-2999%2881%2990515-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=6277646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL38XhtlGgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1981&pages=281-284&author=H.+A.+Robertsonauthor=G.+B.+Bakerauthor=R.+T.+Couttsauthor=A.+Benderlyauthor=R.+A.+Locockauthor=I.+L.+Martin&title=Interactions+of+%CE%B2-carbolines+with+the+benzodiazepine+receptor%3A+structure-activity+relationships&doi=10.1016%2F0014-2999%2881%2990515-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions of β-carbolines with the benzodiazepine receptor:  structure-activity relationships</span></div><div class="casAuthors">Robertson, Harold A.; Baker, Glen B.; Coutts, Ronald T.; Benderly, Avi; Locock, R. Anthony; Martin, Ian L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">281-4</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The effects of a no. of β-carboline derivs. I (R1 = H or Me; R2 = H, or CO2Me, or CO2Et and R3 = H or OMe) and II (R1 = H or Me; R2 = H or CO2Et; R3 = H or OH or OMe; R4 = H or CH2OEt; 3,4-satd. or unsatd.) on 3H labeled flunitrazepam  [1622-62-4] binding to the benzodiazepine binding site were investigated.  In rat cortex the potency of β-carbolines at the benzodiazepine binding site appeared to be detd. largely by the aromaticity of the mol.  norharmane-3-carboxylic acid Et ester  [74214-62-3] Was considerably more potent (IC50 10 nM) than its tetrahydro-β-carboline analog (IC50 6 μM).  There is essentially no difference in potency between the (+)-  [80994-41-8] and (-)-forms  [80994-42-9] of the tetrahydro-β-carboline-3-carboxylate analogs.  Structure-activity relation are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS0lf7Mn1dELVg90H21EOLACvtfcHk0lj7lSvtMt3J0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XhtlGgs7s%253D&md5=00cd3c7c67729cac6d1bc0a394140ba0</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2881%2990515-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252881%252990515-X%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DH.%2BA.%26aulast%3DBaker%26aufirst%3DG.%2BB.%26aulast%3DCoutts%26aufirst%3DR.%2BT.%26aulast%3DBenderly%26aufirst%3DA.%26aulast%3DLocock%26aufirst%3DR.%2BA.%26aulast%3DMartin%26aufirst%3DI.%2BL.%26atitle%3DInteractions%2520of%2520%25CE%25B2-carbolines%2520with%2520the%2520benzodiazepine%2520receptor%253A%2520structure-activity%2520relationships%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1981%26volume%3D76%26spage%3D281%26epage%3D284%26doi%3D10.1016%2F0014-2999%2881%2990515-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rommelspacher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borbe, H. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehske, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wollert, U.</span></span> <span> </span><span class="NLM_article-title">1-Methyl-β-carboline (harmane), a potent endogenous inhibitor of benzodiazepine receptor binding</span>. <i>Naunyn-Schmiedeberg's Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>314</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1007/BF00498436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1007%2FBF00498436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=6255348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL3MXpsFOhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=1980&pages=97-100&author=H.+Rommelspacherauthor=C.+Nanzauthor=H.+O.+Borbeauthor=K.+J.+Fehskeauthor=W.+E.+M%C3%BCllerauthor=U.+Wollert&title=1-Methyl-%CE%B2-carboline+%28harmane%29%2C+a+potent+endogenous+inhibitor+of+benzodiazepine+receptor+binding&doi=10.1007%2FBF00498436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">1-Methyl-β-carboline (harmane), a potent endogenous inhibitor of benzodiazepine receptor binding</span></div><div class="casAuthors">Rommelspacher, Hans; Nanz, Christel; Borbe, Harald O.; Fehske, Klaus J.; Mueller, Walter E.; Wollert, Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-100</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    </div><div class="casAbstract">The interaction of several β-carbolines with specific [3H]flunitrazepam binding to benzodiazepine receptors in rat brain membranes was investigated.  Of the investigated compds., harmane (I)  [486-84-0] and norharmane  [244-63-3] were the most potent inhibitors of specific [3]flunitrazepam binding, with 50% inhibitory concn. values in the micromolar range.  All other derivs., including harmine  [442-51-3], harmaline  [304-21-2], and several other tetrahydro derivs., were at least 10 times less potent.  Harmane has been previously found in rat brain and human urine, so it is the most potent endogenous inhibitor of specific [3H]flunitrazepam binding known so far, with a several-hundred-fold higher affinity for the benzodiazepine receptor than inosine  [58-63-9] and hypoxanthine  [68-94-0].  Harmane or other related β-carbolines may be potential candidates as endogenous ligands of the benzodiazepine receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnJD2iKNtZPLVg90H21EOLACvtfcHk0lj7lSvtMt3J0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXpsFOhuw%253D%253D&md5=eed009c540297d4e4c6fa539019dae47</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1007%2FBF00498436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00498436%26sid%3Dliteratum%253Aachs%26aulast%3DRommelspacher%26aufirst%3DH.%26aulast%3DNanz%26aufirst%3DC.%26aulast%3DBorbe%26aufirst%3DH.%2BO.%26aulast%3DFehske%26aufirst%3DK.%2BJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DW.%2BE.%26aulast%3DWollert%26aufirst%3DU.%26atitle%3D1-Methyl-%25CE%25B2-carboline%2520%2528harmane%2529%252C%2520a%2520potent%2520endogenous%2520inhibitor%2520of%2520benzodiazepine%2520receptor%2520binding%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D1980%26volume%3D314%26spage%3D97%26epage%3D100%26doi%3D10.1007%2FBF00498436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uyeno, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nienow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loew, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toll, L.</span></span> <span> </span><span class="NLM_article-title">Structure-activity studies of β-carboline analogs</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">2007</span>– <span class="NLM_lpage">2013</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(84)90365-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2F0024-3205%2884%2990365-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=6328151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL2cXktFKrs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1984&pages=2007-2013&author=J.+A.+Lawsonauthor=E.+T.+Uyenoauthor=J.+Nienowauthor=G.+H.+Loewauthor=L.+Toll&title=Structure-activity+studies+of+%CE%B2-carboline+analogs&doi=10.1016%2F0024-3205%2884%2990365-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity studies of β-carboline analogs</span></div><div class="casAuthors">Lawson, John A.; Uyeno, Edward T.; Nienow, John; Loew, Gilda H.; Toll, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2007-13</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    </div><div class="casAbstract">A no. of β-carboline analogs I (R1 = H or Me; R2 = H, CN, CONH2, CO2Me, or CO2Et, R3 = H or NO2, and X = N or CH) were obtained or synthesized, and their in vitro receptor affinities and in vivo antagonist activities detd.  The choice of analogs was made in order to explore the importance of the N9-H, the arom. N and the C3-ester moiety for high-receptor affinity and antagonist activity of this class of benzodiazepine antagonist.  Among the analogs investigated, the properties of 3-cyano-β-carboline (I, R1-R3 = H, R2 = CN, X = N)  [83911-48-2], the first potent β-carboline antagonist without a carbonyl at the C3-position are described.  The results obtained indicate: (1) Specific interactions of the C3-substituent with key cationic receptor sites rather than electron-withdrawing properties are important for high-receptor affinity and antagonist activity.  (2) Specific in-plane interactions of the arom. N with a cationic receptor site, rather than stacking with neutral arom. residues of the receptor are also important for high affinity and antagonist activity.  (3) While the presence of an N9-H enhances receptor affinity, interaction with an anionic receptor site does not appear essential for antagonist activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjkP2HHeLV7bVg90H21EOLACvtfcHk0lj7lSvtMt3J0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXktFKrs7g%253D&md5=40c1b4b8cb45cdd1766e9dcce42e2bf1</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2884%2990365-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252884%252990365-5%26sid%3Dliteratum%253Aachs%26aulast%3DLawson%26aufirst%3DJ.%2BA.%26aulast%3DUyeno%26aufirst%3DE.%2BT.%26aulast%3DNienow%26aufirst%3DJ.%26aulast%3DLoew%26aufirst%3DG.%2BH.%26aulast%3DToll%26aufirst%3DL.%26atitle%3DStructure-activity%2520studies%2520of%2520%25CE%25B2-carboline%2520analogs%26jtitle%3DLife%2520Sci.%26date%3D1984%26volume%3D34%26spage%3D2007%26epage%3D2013%26doi%3D10.1016%2F0024-3205%2884%2990365-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trudell, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codding, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of novel 3-substituted β-carbolines as benzodiazepine receptor ligands: probing the benzodiazepine receptor pharmacophore</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1854</span>– <span class="NLM_lpage">1861</span>, <span class="refDoi"> DOI: 10.1021/jm00117a029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00117a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL1cXkvFartrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=1854-1861&author=M.+S.+Allenauthor=T.+J.+Hagenauthor=M.+L.+Trudellauthor=P.+W.+Coddingauthor=P.+Skolnickauthor=J.+M.+Cook&title=Synthesis+of+novel+3-substituted+%CE%B2-carbolines+as+benzodiazepine+receptor+ligands%3A+probing+the+benzodiazepine+receptor+pharmacophore&doi=10.1021%2Fjm00117a029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of novel 3-substituted β-carbolines as benzodiazepine receptor ligands:  probing the benzodiazepine receptor pharmacophore</span></div><div class="casAuthors">Allen, Michael S.; Hagen, Timothy J.; Trudell, Mark L.; Codding, Penelope W.; Skolnick, Phil; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1854-61</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">In order to det. their binding affinity for benzodiazepine receptors (BzR), the 3-substituted β-carbolines I (R = Cl, NO2, MeO, EtO, PrO, isothiocyano) were prepd. from 3-amino-β-carboline I (R = NH2) in one step via diazotization, followed by reaction with the appropriate nucleophile.  All three of the 3-alkoxy-β-carbolines I (R = MeO) (IC50 = 124 nM), I (R = EtO) (IC50 = 24 nM), and I (R = PrO) (IC50 11 nM) have high affinities for BzR.  The β-carbolines substituted with electron-withdrawing groups including I (R = Cl) (IC50 = 45 nM), I (R = NO2) (IC50 = 125 nM), I (R = isothiocyano) (IC50 = 8 nM) also had high affinities for BzR.  The affinities of I (R = Cl, NO2, MeO, isothiocyano) clearly indicate that a carbonyl moiety at position 3 of a β-carboline is not required for high-affinity binding to BzR.  These findings have led to the development of a model for the binding of ligands to an inverse agonist domain at BzR.  This model is supported by the recent synthesis of 3-ethoxy-β-carboline I (R = EtO), a potent, long-lived partial inverse agonist, and I (R = isothiocyano) an irreversible BzR ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYcYWjJ8CyJrVg90H21EOLACvtfcHk0lieYC6g56EugA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXkvFartrk%253D&md5=3819b32cfc302daa6077003e998cb902</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Fjm00117a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00117a029%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DM.%2BS.%26aulast%3DHagen%26aufirst%3DT.%2BJ.%26aulast%3DTrudell%26aufirst%3DM.%2BL.%26aulast%3DCodding%26aufirst%3DP.%2BW.%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DSynthesis%2520of%2520novel%25203-substituted%2520%25CE%25B2-carbolines%2520as%2520benzodiazepine%2520receptor%2520ligands%253A%2520probing%2520the%2520benzodiazepine%2520receptor%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D1854%26epage%3D1861%26doi%3D10.1021%2Fjm00117a029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trudell, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindler, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, K. F.</span></span> <span> </span><span class="NLM_article-title">Synthetic and computer-assisted analyses of the pharmacophore for the benzodiazepine receptor inverse agonist site</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2343</span>– <span class="NLM_lpage">2357</span>, <span class="refDoi"> DOI: 10.1021/jm00171a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00171a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK3MXitVKqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=2343-2357&author=M.+S.+Allenauthor=Y.+C.+Tanauthor=M.+L.+Trudellauthor=K.+Narayananauthor=L.+R.+Schindlerauthor=M.+J.+Martinauthor=C.+Schultzauthor=T.+J.+Hagenauthor=K.+F.+Koehler&title=Synthetic+and+computer-assisted+analyses+of+the+pharmacophore+for+the+benzodiazepine+receptor+inverse+agonist+site&doi=10.1021%2Fjm00171a007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic and computer-assisted analyses of the pharmacophore for the benzodiazepine receptor inverse agonist site</span></div><div class="casAuthors">Allen, Michael S.; Tan, Yun C.; Trudell, Mark L.; Narayanan, Kris; Schindler, Liesl R.; Martin, Michael J.; Schultz, Christopher; Hagen, Timothy J.; Koehler, Konrad F.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2343-57</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The structural requirements for ligand binding of the benzodiazepine receptor inverse agonist site was probed through 3-substituted β-carbolines I (R = OCHMe2, OBu, COPr, Bu, CO2Me) and diindoles, e.g. II (R1-R5 = H, Me).  Based on the binding affinities of I and II the receptor is proposed to interact with the H in the 9-N position on I and with the H in the 7-N position of II; likewise a H bonding site exists for the 2-N position in I and the 5-N position in II.  I (R = OPr) was an antagonist at the benzodiazepine receptor site.  A 3D-quant. structure-activity relationship (3D-QSAR) was established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopxj-FH5PV07Vg90H21EOLACvtfcHk0lieYC6g56EugA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXitVKqt7o%253D&md5=4be24f2b84cf70eeeabfe4e9cfed967b</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Fjm00171a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00171a007%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DM.%2BS.%26aulast%3DTan%26aufirst%3DY.%2BC.%26aulast%3DTrudell%26aufirst%3DM.%2BL.%26aulast%3DNarayanan%26aufirst%3DK.%26aulast%3DSchindler%26aufirst%3DL.%2BR.%26aulast%3DMartin%26aufirst%3DM.%2BJ.%26aulast%3DSchultz%26aufirst%3DC.%26aulast%3DHagen%26aufirst%3DT.%2BJ.%26aulast%3DKoehler%26aufirst%3DK.%2BF.%26atitle%3DSynthetic%2520and%2520computer-assisted%2520analyses%2520of%2520the%2520pharmacophore%2520for%2520the%2520benzodiazepine%2520receptor%2520inverse%2520agonist%2520site%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D2343%26epage%3D2357%26doi%3D10.1021%2Fjm00171a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaLoggia, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costantino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Predictive binding of β-carboline inverse agonists and antagonists via the CoMFA/GOLPE approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">4001</span>– <span class="NLM_lpage">4010</span>, <span class="refDoi"> DOI: 10.1021/jm00100a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00100a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK3sXmvVyq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=4001-4010&author=M.+S.+Allenauthor=A.+J.+LaLoggiaauthor=L.+J.+Dornauthor=M.+J.+Martinauthor=G.+Costantinoauthor=T.+J.+Hagenauthor=K.+F.+Koehlerauthor=P.+Skolnickauthor=J.+M.+Cook&title=Predictive+binding+of+%CE%B2-carboline+inverse+agonists+and+antagonists+via+the+CoMFA%2FGOLPE+approach&doi=10.1021%2Fjm00100a004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Predictive binding of β-carboline inverse agonists and antagonists via the CoMFA/GOLPE approach</span></div><div class="casAuthors">Allen, Michael S.; LaLoggia, Anthony J.; Dorn, Linda J.; Martin, Michael J.; Costantino, Gabriele; Hagen, Timothy J.; Koehler, Konrad F.; Skolnick, Phil; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4001-10</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The synthesis and affinities of six new 3-substituted β-carbolines I (R = EtCHMeO, Me2CHCH2O, Me2CHCH2CH2O, Me3CCH2O, PhCH2O, Me3CCO) for the benzodiazepine receptor is described.  These analogs were used both to probe the dimensions of the hydrophobic pocket in the benzodiazepine receptor and to test the predictive ability of a previously reported 3D-QSAR regression model.  Of the new analogs synthesized, the γ-branched derivs. I (R = Me2CHCH2O, Me3CCH2O) display significantly higher receptor affinity than either the β-branched I (R = MeCH2CHMeO, Me3CCO or δ-branched I (R = Me2CHCH2CH2O) analogs.  An exception to this rule is the γ-branched I (R = PhCH2O) which appears to have a chain length that is too long to be accommodated by the benzodiazepine receptor.  The std. error of prediction for these six new β-carbolines using the original regression model is significantly lower than the std. error est. of the cross validation runs on the training set, hence the predictions made using this model are much better than expected.  In order to obtain more credible predictions, a new procedure called GOLPE (generating optimal linear PLS ests.) was used to eliminate irrelevant electrostatic and steric descriptors from the regression equation.  A substantial redn. in the std. error est. resulted.  The predictions from this new regression equation were somewhat less accurate than the ones obtained with the original regression equation; however the std. error of prediction and the std. error est. are in much closer agreement.  Finally, to probe the effect that the steric and electrostatic potentials have on 3D-QSAR analyses, the semiempirical MNDO//PRDDO geometries and Mulliken charges used in the original anal. were replaced with ab initio 3-21G//6-31G* geometries and electrostatic potential fit charges.  A modest decrease in the std. error est. and increase in cross validated R2 resulted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjn3YzT4pprLVg90H21EOLACvtfcHk0lizzD9acPVW0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmvVyq&md5=d4ee9fa7217a9eb6b458ee3f6e79ac01</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fjm00100a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00100a004%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DM.%2BS.%26aulast%3DLaLoggia%26aufirst%3DA.%2BJ.%26aulast%3DDorn%26aufirst%3DL.%2BJ.%26aulast%3DMartin%26aufirst%3DM.%2BJ.%26aulast%3DCostantino%26aufirst%3DG.%26aulast%3DHagen%26aufirst%3DT.%2BJ.%26aulast%3DKoehler%26aufirst%3DK.%2BF.%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DPredictive%2520binding%2520of%2520%25CE%25B2-carboline%2520inverse%2520agonists%2520and%2520antagonists%2520via%2520the%2520CoMFA%252FGOLPE%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D4001%26epage%3D4010%26doi%3D10.1021%2Fjm00100a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larscheid, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S. M.</span></span> <span> </span><span class="NLM_article-title">Biomimetic approach to potential benzodiazepine receptor agonists and antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">564</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1021/jm00371a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00371a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL2cXhsFSlsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1984&pages=564-570&author=F.+Guzmanauthor=M.+Cainauthor=P.+Larscheidauthor=T.+Hagenauthor=J.+M.+Cookauthor=M.+Schweriauthor=P.+Skolnickauthor=S.+M.+Paul&title=Biomimetic+approach+to+potential+benzodiazepine+receptor+agonists+and+antagonists&doi=10.1021%2Fjm00371a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Biomimetic approach to potential benzodiazepine receptor agonists and antagonists</span></div><div class="casAuthors">Guzman, Filadelfo; Cain, Michael; Larscheid, Paul; Hagen, Tim; Cook, James M.; Schweri, Margaret; Skolnick, Phil; Paul, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">564-70</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Isoquinolines I (R1 and R2 = H or MeO; R3 = H or Me), imidazopyridines II (R1 = H or Ph; R2 = H or Me), canthinones III (R = H or CO2Me), and β-carboline-3-carboxamide (IV)  [88932-13-2] were prepd. and they and some previously prepd. analogs were evaluated for their ability to bind to benzodiazepine receptors.  Me isoquinoline-3-carboxylate (I; R1 = R2 = H, R3 = Me)  [27104-73-0] binds with moderate affinity, whereas 2-carbomethoxycanthin-6-one (III; R = CO2Me)  [84133-31-3] binds with an affinity comparable to several active benzodiazepines.  Structure-activity relations are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryQQMBerbyXbVg90H21EOLACvtfcHk0lizzD9acPVW0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhsFSlsb4%253D&md5=62cde58661bf6473a2642d745397d84b</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1021%2Fjm00371a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00371a002%26sid%3Dliteratum%253Aachs%26aulast%3DGuzman%26aufirst%3DF.%26aulast%3DCain%26aufirst%3DM.%26aulast%3DLarscheid%26aufirst%3DP.%26aulast%3DHagen%26aufirst%3DT.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26aulast%3DSchweri%26aufirst%3DM.%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DPaul%26aufirst%3DS.%2BM.%26atitle%3DBiomimetic%2520approach%2520to%2520potential%2520benzodiazepine%2520receptor%2520agonists%2520and%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1984%26volume%3D27%26spage%3D564%26epage%3D570%26doi%3D10.1021%2Fjm00371a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Braestrup, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, C. E.</span></span> <span> </span><span class="NLM_article-title">Urinary and brain β-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">2288</span>– <span class="NLM_lpage">2292</span>, <span class="refDoi"> DOI: 10.1073/pnas.77.4.2288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1073%2Fpnas.77.4.2288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=6246535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL3cXks1Wjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1980&pages=2288-2292&author=C.+Braestrupauthor=M.+Nielsenauthor=C.+E.+Olsen&title=Urinary+and+brain+%CE%B2-carboline-3-carboxylates+as+potent+inhibitors+of+brain+benzodiazepine+receptors&doi=10.1073%2Fpnas.77.4.2288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Urinary and brain β-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors</span></div><div class="casAuthors">Braestrup, Claus; Nielsen, Mogens; Olsen, Carl Erik</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2288-92</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">In searching for possible endogenous ligands for benzodiazepine receptors, a compd. was purified 107-fold from human urine by extns., treatment with hot ethanol, and column chromatog.  The compd. was identified as β-carboline-3-carboxylic acid Et ester (I)  [74214-62-3] by mass spectrometry, NMR spectrometry, and synthesis; I was also isolated from brain tissues (20 ng/g) by similar procedures.  Very small concns. of I displaced labeled diazepam completely from specific cerebral receptors, but not from liver and kidney binding sites; the concn. causing 50% inhibition of specific diazepam binding (IC50) was 4-7 nM compared to ∼5 nM for lorazepam.  Specific binding sites for quinuclidinyl benzilate, naloxone, spiroperidol, serotonin, muscimol, and WB 4101 were not affected by I.  In contrast to benzodiazepines, I exhibits mixed-type competitive inhibition of forebrain benzodiazepine receptors.  A structure activity study showed that tetrahydro-β-carbolines were almost inactive on benzodiazepine receptors.  Esters of β-carboline-3-carboxylic acid were active.  Substitution of a Me group in the 1st position of the ring structure decreased the activity remarkably.  Endogenous ligand for I receptors may be a deriv. of β-carboline-3-carboxylic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrab1wHiZqfb7Vg90H21EOLACvtfcHk0lizzD9acPVW0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXks1Wjsb4%253D&md5=093c92b2da5dcd0e196810231306863c</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1073%2Fpnas.77.4.2288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.77.4.2288%26sid%3Dliteratum%253Aachs%26aulast%3DBraestrup%26aufirst%3DC.%26aulast%3DNielsen%26aufirst%3DM.%26aulast%3DOlsen%26aufirst%3DC.%2BE.%26atitle%3DUrinary%2520and%2520brain%2520%25CE%25B2-carboline-3-carboxylates%2520as%2520potent%2520inhibitors%2520of%2520brain%2520benzodiazepine%2520receptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1980%26volume%3D77%26spage%3D2288%26epage%3D2292%26doi%3D10.1073%2Fpnas.77.4.2288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poissonnet, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Carvalho, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venault, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapouthier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, R. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and benzodiazepine receptor affinities of rigid analogues of 3-carboxy-β-carbolines: demonstration that the benzodiazepine receptor recognizes preferentially the s-cis conformation of the 3-carboxy group</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1799</span>– <span class="NLM_lpage">1804</span>, <span class="refDoi"> DOI: 10.1021/jm00128a023</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00128a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL1MXkvFOisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=1799-1804&author=G.+Doreyauthor=G.+Poissonnetauthor=M.-C.+Potierauthor=L.+P.+de+Carvalhoauthor=P.+Venaultauthor=G.+Chapouthierauthor=J.+Rossierauthor=P.+Potierauthor=R.+H.+Dodd&title=Synthesis+and+benzodiazepine+receptor+affinities+of+rigid+analogues+of+3-carboxy-%CE%B2-carbolines%3A+demonstration+that+the+benzodiazepine+receptor+recognizes+preferentially+the+s-cis+conformation+of+the+3-carboxy+group&doi=10.1021%2Fjm00128a023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and benzodiazepine receptor affinities of rigid analogs of 3-carboxy-β-carbolines:  demonstration that the benzodiazepine receptor recognizes preferentially the s-cis conformation of the 3-carboxy group</span></div><div class="casAuthors">Dorey, Gilbert; Poissonnet, Guillaume; Potier, Marie Claude; De Carvalho, Lia Prado; Venault, Patrice; Chapouthier, Georges; Rossier, Jean; Potier, Pierre; Dodd, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1799-804</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Indolopyrido-2-penten-5-olide I (X = O; II) and indolopyridopyridinone I (X = NH), rigid analogs of Me 4-ethyl-β-carboline-3-carboxylate III (R = OMe; IV) and N-methyl-4-ethyl-β-carboline-3-carboxamide III (R = NHMe; V), resp., were synthesized and their in vitro binding affinities to the central type benzodiazepine receptors were compared.  The IC50 values of II and IV were approx. equiv. (42 and 27 nM, resp.).  The amide deriv. V, for which theor. energy calcns. indicate that the s-trans carbonyl conformation is the preferred one, displayed very low affinity (IC50 > 104 nM).  However, when the carbonyl group of V was forced to adopt the s-cis conformation as in lactam I (X = NH), binding to the benzodiazepine receptor was largely restored (IC50 = 150 nM), indicating that the s-cis carboxy conformation at C-3 of β-carbolines is preferentially recognized by this receptor.  In vivo, II showed neither convulsant, proconvulsant, nor anticonvulsant activity in mice.  Moreover, II did not antagonize Me β-carboline-3-carboxylate induced convulsions in mice.  This lack of activity of II was attributed to its inability to cross the blood-brain barrier since no significant displacement of [3H]Ro 15-1788 from mouse brain benzodiazepine receptors by II could be obsd. in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWkoHFbwHY-rVg90H21EOLACvtfcHk0lhk16LTJD9fsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXkvFOisL8%253D&md5=41b326cecefe4f5cccbd7de45525f4d9</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjm00128a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00128a023%26sid%3Dliteratum%253Aachs%26aulast%3DDorey%26aufirst%3DG.%26aulast%3DPoissonnet%26aufirst%3DG.%26aulast%3DPotier%26aufirst%3DM.-C.%26aulast%3Dde%2BCarvalho%26aufirst%3DL.%2BP.%26aulast%3DVenault%26aufirst%3DP.%26aulast%3DChapouthier%26aufirst%3DG.%26aulast%3DRossier%26aufirst%3DJ.%26aulast%3DPotier%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%2520and%2520benzodiazepine%2520receptor%2520affinities%2520of%2520rigid%2520analogues%2520of%25203-carboxy-%25CE%25B2-carbolines%253A%2520demonstration%2520that%2520the%2520benzodiazepine%2520receptor%2520recognizes%2520preferentially%2520the%2520s-cis%2520conformation%2520of%2520the%25203-carboxy%2520group%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D1799%26epage%3D1804%26doi%3D10.1021%2Fjm00128a023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawley, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span> <span> </span><span class="NLM_article-title">β-Carbolines: synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1091</span>, <span class="refDoi"> DOI: 10.1021/jm00351a015</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00351a015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL38Xkslahtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1982&pages=1081-1091&author=M.+Cainauthor=R.+W.+Weberauthor=F.+Guzmanauthor=J.+M.+Cookauthor=S.+A.+Barkerauthor=K.+C.+Riceauthor=J.+N.+Crawleyauthor=S.+M.+Paulauthor=P.+Skolnick&title=%CE%B2-Carbolines%3A+synthesis+and+neurochemical+and+pharmacological+actions+on+brain+benzodiazepine+receptors&doi=10.1021%2Fjm00351a015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">β-Carbolines:  synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptors</span></div><div class="casAuthors">Cain, Michael; Weber, Robert W.; Guzman, Fil; Cook, James M.; Barker, Steven A.; Rice, Kenner C.; Crawley, Jacqueline N.; Paul, Steven M.; Skolnick, Phil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1081-91</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of tetrahydro-β-carbolines, e.g. I, β-carbolines, e.g. II, and other nitrogen heterocycles were prepd. and evaluated in vitro with respect to their ability to bind to benzodiazepine receptors.  Thus, 5-hydroxytryptophan was cyclized with EtCHO and then esterified by methanolic hydrochloric acid to give 58% cis-I, which was dehydrogenated to give 48% II.  The fully arom. β-carbolines were more potent than their corresponding tetrahydro-β-carboline derivs.  When substituents possessing a carbonyl (CO2Me, COCH3, CHO) were introduced at the β-C-3 position the in vitro potency was augmented.  Alc. substituents (CH2OH, CHOHCH3) demonstrated decreased in vitro potency.  The importance of the carbonyl moiety was further demonstrated when β-carboline-3-carboxylic acid was shown to bind tighter to benzodiazepine receptors at lower pH.  A lower pH increases the concn. of the acid and decreases the concn. of the anion.  3-(Hydroxymethyl)-β-carboline, 3-formyl-β-carboline, and 3-acetyl-β-carboline were benzodiazepine antagonists in vivo.  Me isoquinoline-3-carboxylate also had in vitro activity.  The same structure-activity relationships seen in β-carbolines were also obsd. for isoquinolines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOrGGXq0IFxLVg90H21EOLACvtfcHk0lhk16LTJD9fsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xkslahtbw%253D&md5=a7a48935c6eec5eae59957270a0ddbb6</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fjm00351a015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00351a015%26sid%3Dliteratum%253Aachs%26aulast%3DCain%26aufirst%3DM.%26aulast%3DWeber%26aufirst%3DR.%2BW.%26aulast%3DGuzman%26aufirst%3DF.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26aulast%3DBarker%26aufirst%3DS.%2BA.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DCrawley%26aufirst%3DJ.%2BN.%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DSkolnick%26aufirst%3DP.%26atitle%3D%25CE%25B2-Carbolines%253A%2520synthesis%2520and%2520neurochemical%2520and%2520pharmacological%2520actions%2520on%2520brain%2520benzodiazepine%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1982%26volume%3D25%26spage%3D1081%26epage%3D1091%26doi%3D10.1021%2Fjm00351a015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouannès, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prado de Carvalho, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venault, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapouthier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, P.</span></span> <span> </span><span class="NLM_article-title">3-Amino-β-carboline derivatives and the benzodiazepine receptor. Synthesis of a selective antagonist of the sedative action of diazepam</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">824</span>– <span class="NLM_lpage">828</span>, <span class="refDoi"> DOI: 10.1021/jm00383a024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00383a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL2MXitVerurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=824-828&author=R.+H.+Doddauthor=C.+Ouann%C3%A8sauthor=L.+Prado+de+Carvalhoauthor=A.+Valinauthor=P.+Venaultauthor=G.+Chapouthierauthor=J.+Rossierauthor=P.+Potier&title=3-Amino-%CE%B2-carboline+derivatives+and+the+benzodiazepine+receptor.+Synthesis+of+a+selective+antagonist+of+the+sedative+action+of+diazepam&doi=10.1021%2Fjm00383a024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">3-Amino-β-carboline derivatives and the benzodiazepine receptor.  Synthesis of a selective antagonist of the sedative action of diazepam</span></div><div class="casAuthors">Dodd, Robert H.; Ouannes, Catherine; Prado de Carvalho, Lia; Valin, Anne; Venault, Patrice; Chapouthier, Georges; Rossier, Jean; Potier, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">824-8</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Seven 3-N-substituted derivs. I (R = CO2Me, CO2Et, CHO, SO2Me, COMe, COCF3, Et) of 3-amino-β-carboline were synthesized from Et β-carboline-3-carboxylate and their affinities for the benzodiazepine receptor were assessed in vitro.  Two compds., 3-(ethylamino)-β-carboline and 3-(methoxycarbonylamino)-β-carboline (II), showing IC50 values of 460 and 71 nM, resp., were selected for in vivo studies.  The former compd. showed long-lasting proconvulsant activity in Papio papio baboons while II in mice selectively antagonized the sedative effects of diazepam without exhibiting convulsant, proconvulsant, or anxiogenic activity by itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_nmqwK-27RbVg90H21EOLACvtfcHk0lhk16LTJD9fsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXitVerurc%253D&md5=225f8d20ecf42d144c3cf3eef6845fca</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm00383a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00383a024%26sid%3Dliteratum%253Aachs%26aulast%3DDodd%26aufirst%3DR.%2BH.%26aulast%3DOuann%25C3%25A8s%26aufirst%3DC.%26aulast%3DPrado%2Bde%2BCarvalho%26aufirst%3DL.%26aulast%3DValin%26aufirst%3DA.%26aulast%3DVenault%26aufirst%3DP.%26aulast%3DChapouthier%26aufirst%3DG.%26aulast%3DRossier%26aufirst%3DJ.%26aulast%3DPotier%26aufirst%3DP.%26atitle%3D3-Amino-%25CE%25B2-carboline%2520derivatives%2520and%2520the%2520benzodiazepine%2520receptor.%2520Synthesis%2520of%2520a%2520selective%2520antagonist%2520of%2520the%2520sedative%2520action%2520of%2520diazepam%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26spage%3D824%26epage%3D828%26doi%3D10.1021%2Fjm00383a024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 6-substituted β-carbolines that behave as benzodiazepine receptor antagonists or inverse agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">750</span>– <span class="NLM_lpage">753</span>, <span class="refDoi"> DOI: 10.1021/jm00387a033</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00387a033" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL2sXhvFKhu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=750-753&author=T.+J.+Hagenauthor=P.+Skolnickauthor=J.+M.+Cook&title=Synthesis+of+6-substituted+%CE%B2-carbolines+that+behave+as+benzodiazepine+receptor+antagonists+or+inverse+agonists&doi=10.1021%2Fjm00387a033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 6-substituted β-carbolines that behave as benzodiazepine receptor antagonists or inverse agonists</span></div><div class="casAuthors">Hagen, Timothy J.; Skolnick, Phil; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">750-3</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The synthesis of the first β-carboline (I; R = H, R1 = PhCH2) devoid of a substituent at the 3-position but capable of binding to benzodiazepine receptors with potent affinity is described.  Thus, I (R = R1 = H) was treated with KOH and BzH in MeOH and then NaBH3CN to give I (R = H, R1 = PhCH2).  I (R = H, R1 = PhCH2) proved to be a partial inverse agonist when tested in mice.  Addn. of the benzylamino group at the 6-position of the β-carboline nucleus is primarily responsible for the activity of I (R = H, R1 = PhCH2; R = HOCH2, R1 = PhCH2).  The importance of the Nb-nitrogen atom for binding affinity was also demonstrated since 3-(benzylamino)carbazole (II) exhibited little or no affinity for benzodiazepine receptors in vitro, in contrast to the activity of I (R = H, R1 = PhCH2).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3e6_cm4M8F7Vg90H21EOLACvtfcHk0lgdFYnnfpDDGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhvFKhu7s%253D&md5=ca05594d001f4bd261b523675d94381c</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fjm00387a033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00387a033%26sid%3Dliteratum%253Aachs%26aulast%3DHagen%26aufirst%3DT.%2BJ.%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DSynthesis%2520of%25206-substituted%2520%25CE%25B2-carbolines%2520that%2520behave%2520as%2520benzodiazepine%2520receptor%2520antagonists%2520or%2520inverse%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D750%26epage%3D753%26doi%3D10.1021%2Fjm00387a033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hollinshead, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trudell, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Structural requirements for agonist actions at the benzodiazepine receptor: studies with analogues of 6-(benzyloxy)-4-(methoxymethyl)-β-carboline-3-carboxylic acid ethyl ester</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1062</span>– <span class="NLM_lpage">1069</span>, <span class="refDoi"> DOI: 10.1021/jm00165a028</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00165a028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK3cXhtFylu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=1062-1069&author=S.+P.+Hollinsheadauthor=M.+L.+Trudellauthor=P.+Skolnickauthor=J.+M.+Cook&title=Structural+requirements+for+agonist+actions+at+the+benzodiazepine+receptor%3A+studies+with+analogues+of+6-%28benzyloxy%29-4-%28methoxymethyl%29-%CE%B2-carboline-3-carboxylic+acid+ethyl+ester&doi=10.1021%2Fjm00165a028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Structural requirements for agonist actions at the benzodiazepine receptor:  studies with analogs of 6-(benzyloxy)-4-(methoxymethyl)-β-carboline-3-carboxylic acid ethyl ester</span></div><div class="casAuthors">Hollinshead, Sean P.; Trudell, Mark L.; Skolnick, Phil; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1062-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The β-carboline analogs I (R = H, Me; R1= H, Et, CH2OMe, R2 = H, OMe, OH, OCH2Ph) were synthesized in order to det. which functional groups are required for agonist activity exhibited by the parent compd. I ( R = H, R1 = CH2OMe, R2 = OCH2Ph)(II) at the benzodiazepine receptor (BzR).  The potencies of these compds. were evaluated in vitro and in vivo; the β-carbolines I (R = H, R1 = CH2OMe, R2 = OH, OMe, H; R1 = Et, R2 = OCH2Ph; R1 = H, R2 = CH2OPh) exhibited high affinity (0.5-22 nM) for BzR, but in vivo studies demonstrated they were not anticonvulsant while I (R = H, R1 = CH2OMe, R2 = OMe, H) antagonized the effects of diazepam.  These results are in agreement with the model proposed for the pharmacophore of the agonist site (domain) of the BzR, which requires the interaction of three sites of electron d. [N(2), C(4), and C(6)] and two of lipophilicity [C(3) and C(6)] of the ligand with the BzR protein.  The pharmacophore for the agonist site is derived from the structure-activity relationship of the benzodiazepines, pyrazoloquinolines, and II and compared to interactions required for ligand inverse agonist activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruxC6588LpNrVg90H21EOLACvtfcHk0lgdFYnnfpDDGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhtFylu74%253D&md5=32734d22fa4784a12a5fdc068686eb26</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fjm00165a028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00165a028%26sid%3Dliteratum%253Aachs%26aulast%3DHollinshead%26aufirst%3DS.%2BP.%26aulast%3DTrudell%26aufirst%3DM.%2BL.%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DStructural%2520requirements%2520for%2520agonist%2520actions%2520at%2520the%2520benzodiazepine%2520receptor%253A%2520studies%2520with%2520analogues%2520of%25206-%2528benzyloxy%2529-4-%2528methoxymethyl%2529-%25CE%25B2-carboline-3-carboxylic%2520acid%2520ethyl%2520ester%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D1062%26epage%3D1069%26doi%3D10.1021%2Fjm00165a028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Arauzo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKernan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-β-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-β-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2537</span>– <span class="NLM_lpage">2552</span>, <span class="refDoi"> DOI: 10.1021/jm970460b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970460b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK1cXkt12jt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2537-2552&author=E.+D.+Coxauthor=H.+Diaz-Arauzoauthor=Q.+Huangauthor=M.+S.+Reddyauthor=C.+Maauthor=B.+Harrisauthor=R.+McKernanauthor=P.+Skolnickauthor=J.+M.+Cook&title=Synthesis+and+evaluation+of+analogues+of+the+partial+agonist+6-%28propyloxy%29-4-%28methoxymethyl%29-%CE%B2-carboline-3-carboxylic+acid+ethyl+ester+%286-PBC%29+and+the+full+agonist+6-%28benzyloxy%29-4-%28methoxymethyl%29-%CE%B2-carboline-3-carboxylic+acid+ethyl+ester+%28Zk+93423%29+at+wild+type+and+recombinant+GABAA+receptors&doi=10.1021%2Fjm970460b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of analogs of the partial agonist 6-(Propyloxy)-4-(methoxymethyl)-β-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(Benzyloxy)-4-(methoxymethyl)-β- carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors</span></div><div class="casAuthors">Cox, Eric D.; Diaz-Arauzo, Hernando; Huang, Qi; Reddy, Mundla S.; Ma, Chunrong; Harris, Brad; McKernan, Ruth; Skolnick, Phil; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2537-2552</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A pharmacophore and an alignment rule have previously been reported for BzR agonist ligands.  The design and synthesis of 6-(propyloxy)-4-(methoxymethyl)-β-carboline-3-carboxylic acid Et ester (6-PBC, 24, IC50 = 8.1 nM) was based on this pharmacophore.  When evaluated in vivo this ligand exhibited anticonvulsant/anxiolytic activity but was devoid of the muscle relaxant/ataxic effects of "classical" 1,4-benzodiazepines (i.e., diazepam).  Significantly, 6-PBC 24 also reversed diazepam-induced muscle relaxation in mice.  The 3-substituted analogs of 6-PBC 24 and Zk 93423 27 (IC50 = 1 nM) were synthesized and evaluated in vitro to det. what affect these modifications would have on the binding affinity at recombinant BzR subtypes.  With the exception of the 3-amino ligands, all the β-carbolines were found to exhibit high binding affinity at BzR sites.  The 3-Pr ether deriv. was also evaluated in vivo and found to be devoid of any proconvulsant or anticonvulsant activity at doses up to 40 mg/kg.  The 6-(1-naphthylmethyloxy) and 6-octyloxy analogs of 6-PBC 24 were synthesized to further evaluate the proposed alignment of agonists vs inverse agonists in the pharmacophore of the BzR.  These and other related β-carbolines were also examd. in five recombinant GABAA receptor subtypes.  Moderate to high affinity at GABAA receptors contg. α1 subunits was obsd.  These ligands will be useful in further defining the pharmacophore at α1β3γ2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjRuoXhM4xcLVg90H21EOLACvtfcHk0lgqjsZPblmK5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt12jt7k%253D&md5=be85a0d7e1d3c5236f72d58df85cf81d</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjm970460b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970460b%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DE.%2BD.%26aulast%3DDiaz-Arauzo%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DReddy%26aufirst%3DM.%2BS.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DB.%26aulast%3DMcKernan%26aufirst%3DR.%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520analogues%2520of%2520the%2520partial%2520agonist%25206-%2528propyloxy%2529-4-%2528methoxymethyl%2529-%25CE%25B2-carboline-3-carboxylic%2520acid%2520ethyl%2520ester%2520%25286-PBC%2529%2520and%2520the%2520full%2520agonist%25206-%2528benzyloxy%2529-4-%2528methoxymethyl%2529-%25CE%25B2-carboline-3-carboxylic%2520acid%2520ethyl%2520ester%2520%2528Zk%252093423%2529%2520at%2520wild%2520type%2520and%2520recombinant%2520GABAA%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2537%26epage%3D2552%26doi%3D10.1021%2Fjm970460b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olesen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidelmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, J. B.</span></span> <span> </span><span class="NLM_article-title">Oxazolo[4,5-g]-β-carbolines and pyrazino[2,3-g]-β-carbolines. Synthesis of modulators of the GABAA/chloride channel complex</span>. <i>Heterocycles</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.3987/COM-97-7959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3987%2FCOM-97-7959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK1cXitFWrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1998&pages=31-40&author=P.+H.+Olesenauthor=D.+Seidelmannauthor=J.+B.+Hansen&title=Oxazolo%5B4%2C5-g%5D-%CE%B2-carbolines+and+pyrazino%5B2%2C3-g%5D-%CE%B2-carbolines.+Synthesis+of+modulators+of+the+GABAA%2Fchloride+channel+complex&doi=10.3987%2FCOM-97-7959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Oxazolo[4,5-g]-β-carbolines and pyrazino[2,3-g]-β-carbolines. Synthesis of modulators of the GABAA/chloride channel complex</span></div><div class="casAuthors">Olesen, Preben H.; Seidelmann, Dieter; Hansen, John Bondo</div><div class="citationInfo"><span class="NLM_cas:title">Heterocycles</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-40</span>CODEN:
                <span class="NLM_cas:coden">HTCYAM</span>;
        ISSN:<span class="NLM_cas:issn">0385-5414</span>.
    
            (<span class="NLM_cas:orgname">Japan Institute of Heterocyclic Chemistry</span>)
        </div><div class="casAbstract">The synthesis of oxazolo[4,5-g]-β-carbolines, e.g., I, and pyrazino[2,3-g]-β-carbolines II [R1 = R2 = H; R1R2 = (CH2)4] starting from 6-hydroxy-β-carboline III was investigated in order to prep. new ligands for the benzodiazepine site of the GABAA/chloride channel complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZdotE6pEBFrVg90H21EOLACvtfcHk0lgqjsZPblmK5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitFWrsbg%253D&md5=4b91a10b47a03486a650f2bd50ac81e3</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.3987%2FCOM-97-7959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-97-7959%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DP.%2BH.%26aulast%3DSeidelmann%26aufirst%3DD.%26aulast%3DHansen%26aufirst%3DJ.%2BB.%26atitle%3DOxazolo%255B4%252C5-g%255D-%25CE%25B2-carbolines%2520and%2520pyrazino%255B2%252C3-g%255D-%25CE%25B2-carbolines.%2520Synthesis%2520of%2520modulators%2520of%2520the%2520GABAA%252Fchloride%2520channel%2520complex%26jtitle%3DHeterocycles%26date%3D1998%26volume%3D48%26spage%3D31%26epage%3D40%26doi%3D10.3987%2FCOM-97-7959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honoré, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braestrup, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehr, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wachtel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidelman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmiechen, R.</span></span> <span> </span><span class="NLM_article-title">ZK 91296, a partial agonist at benzodiazepine receptors</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1007/BF00464788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1007%2FBF00464788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=6089246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL2cXltVeqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1984&pages=240-248&author=E.+N.+Petersenauthor=L.+H.+Jensenauthor=T.+Honor%C3%A9author=C.+Braestrupauthor=W.+Kehrauthor=D.+N.+Stephensauthor=H.+Wachtelauthor=D.+Seidelmanauthor=R.+Schmiechen&title=ZK+91296%2C+a+partial+agonist+at+benzodiazepine+receptors&doi=10.1007%2FBF00464788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">ZK 91296, a partial agonist at benzodiazepine receptors</span></div><div class="casAuthors">Petersen, Erling N.; Jensen, Leif H.; Honore, Tage; Braestrup, Claus; Kehr, Wolfgang; Stephens, David N.; Wachtel, Helmuth; Seidelman, Dieter; Schmiechen, Ralph</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-8</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">ZK 91296 (I)  [83910-34-3] is a potent and selective ligand for benzodiazepine (BZ) receptors.  I may be a partial agonist at BZ receptors; this may explain to some extent why I needs higher BZ receptor occupancy than diazepam for the same effect against chem. convulsants and for behavioral effects.  The lack of sedative effects and the very potent inhibition of reflex epilepsy, spontaneous epilepsy, and DMCM-induced seizures suggest, furthermore, that I may possess pharmacol. selectivity for a particular type of BZ receptor interaction, perhaps including topog. as well as receptor subtype differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2e4s8TvyLJbVg90H21EOLACvtfcHk0lgqjsZPblmK5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXltVeqtrY%253D&md5=295ca439a33e166324497cdc5d8b8a80</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1007%2FBF00464788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00464788%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DE.%2BN.%26aulast%3DJensen%26aufirst%3DL.%2BH.%26aulast%3DHonor%25C3%25A9%26aufirst%3DT.%26aulast%3DBraestrup%26aufirst%3DC.%26aulast%3DKehr%26aufirst%3DW.%26aulast%3DStephens%26aufirst%3DD.%2BN.%26aulast%3DWachtel%26aufirst%3DH.%26aulast%3DSeidelman%26aufirst%3DD.%26aulast%3DSchmiechen%26aufirst%3DR.%26atitle%3DZK%252091296%252C%2520a%2520partial%2520agonist%2520at%2520benzodiazepine%2520receptors%26jtitle%3DPsychopharmacology%26date%3D1984%26volume%3D83%26spage%3D240%26epage%3D248%26doi%3D10.1007%2FBF00464788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braestrup, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honoré, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehr, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidelmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmiechen, R.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the β-carboline ZK 93 426 as a benzodiazepine receptor antagonist</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1007/BF00464789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1007%2FBF00464789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=6089247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL2cXltVeqtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1984&pages=249-256&author=L.+H.+Jensenauthor=E.+N.+Petersenauthor=C.+Braestrupauthor=T.+Honor%C3%A9author=W.+Kehrauthor=D.+N.+Stephensauthor=H.+Schneiderauthor=D.+Seidelmannauthor=R.+Schmiechen&title=Evaluation+of+the+%CE%B2-carboline+ZK+93+426+as+a+benzodiazepine+receptor+antagonist&doi=10.1007%2FBF00464789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the β-carboline ZK 93426 as a benzodiazepine receptor antagonist</span></div><div class="casAuthors">Jensen, Leif H.; Petersen, Erling N.; Braestrup, Claus; Honore, Tage; Kehr, Wolfgang; Stephens, David N.; Schneider, Herbert; Seidelmann, Dieter; Schmiechen, Ralph</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-56</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">Certain biochem. effects of ZK 93426 (I)  [89592-45-0] were quite similar to those of the benzodiazepine antagonists Ro 15-1788 and CGS 8216 (e.g., [3H]flunitrazepam displacement, GABA ratio, photoshift).  In most pharmacol. tests I and Ro 15-1788 lacked overt effects; Ro 15-1788 was a weak agonist in some paradigms, whereas I exhibited a potent proconflict effect but also a weak anticonvulsant effect.  This finding with I suggests that benzodiazepine (BZ) receptor ligands may possess differential efficacy at BZ receptor subtypes.  In contrast, CGS 8216 exhibited potent proconvulsant effects in several paradigms in addn. to proconflict and pentylenetetrazole generalizing effects.  I, Ro 15-1788, and CGS 8216 were almost equally potent as antagonists of the effects of BZ receptor agonists, such as diazepam and lorazepam.  However, I was the most potent inhibitor of the convulsions produced by the BZ receptor inverse agonist DMCM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRYwTDdrU2UbVg90H21EOLACvtfcHk0lj7ij_pYcSpjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXltVeqtrc%253D&md5=b1510536223f22d79ad78986e033e918</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1007%2FBF00464789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00464789%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DL.%2BH.%26aulast%3DPetersen%26aufirst%3DE.%2BN.%26aulast%3DBraestrup%26aufirst%3DC.%26aulast%3DHonor%25C3%25A9%26aufirst%3DT.%26aulast%3DKehr%26aufirst%3DW.%26aulast%3DStephens%26aufirst%3DD.%2BN.%26aulast%3DSchneider%26aufirst%3DH.%26aulast%3DSeidelmann%26aufirst%3DD.%26aulast%3DSchmiechen%26aufirst%3DR.%26atitle%3DEvaluation%2520of%2520the%2520%25CE%25B2-carboline%2520ZK%252093%2520426%2520as%2520a%2520benzodiazepine%2520receptor%2520antagonist%26jtitle%3DPsychopharmacology%26date%3D1984%26volume%3D83%26spage%3D249%26epage%3D256%26doi%3D10.1007%2FBF00464789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, H.</span></span> <span> </span><span class="NLM_article-title">Ligands of the GABAA receptor benzodiazepine binding site</span>. <i>CNS Drug Rev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1111/j.1527-3458.1999.tb00094.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1111%2Fj.1527-3458.1999.tb00094.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK1MXmsFKku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=125-144&author=Q.+Wangauthor=Y.+Hanauthor=H.+Xue&title=Ligands+of+the+GABAA+receptor+benzodiazepine+binding+site&doi=10.1111%2Fj.1527-3458.1999.tb00094.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Ligands of the GABAA receptor benzodiazepine binding site</span></div><div class="casAuthors">Wang, Qinmi; Han, Yifan; Xue, Hong</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drug Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-144</span>CODEN:
                <span class="NLM_cas:coden">CDREFB</span>;
        ISSN:<span class="NLM_cas:issn">1080-563X</span>.
    
            (<span class="NLM_cas:orgname">Neva Press</span>)
        </div><div class="casAbstract">A review, with 74 refs. describing the developments related to the structure-activity and structure-efficacy relationships that surround various benzodiazepine (BZ)-binding site ligands, along with their relevant pharmacophore models.  These relationships and models can provide useful signposts for the study of the structural properties of the BZ-binding site and their assocd. interactions with ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr41-pM9vDebVg90H21EOLACvtfcHk0lj7ij_pYcSpjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsFKku7o%253D&md5=6144a6b1c9ee9099c76e7eb50c6392fc</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3458.1999.tb00094.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3458.1999.tb00094.x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DH.%26atitle%3DLigands%2520of%2520the%2520GABAA%2520receptor%2520benzodiazepine%2520binding%2520site%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D1999%26volume%3D5%26spage%3D125%26epage%3D144%26doi%3D10.1111%2Fj.1527-3458.1999.tb00094.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, C. R.</span></span> <span> </span><span class="NLM_article-title">Functional in vivo correlates of the benzodiazepine agonist-inverse agonist continuum</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">425</span>– <span class="NLM_lpage">476</span>, <span class="refDoi"> DOI: 10.1016/0301-0082(88)90011-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2F0301-0082%2888%2990011-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=2849142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL1MXhsl2nsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=425-476&author=C.+R.+Gardner&title=Functional+in+vivo+correlates+of+the+benzodiazepine+agonist-inverse+agonist+continuum&doi=10.1016%2F0301-0082%2888%2990011-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Functional in vivo correlates of the benzodiazepine agonist-inverse agonist continuum</span></div><div class="casAuthors">Gardner, Colin R.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">425-76</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    </div><div class="casAbstract">A review with ∼500 refs. of benzodiazepine agonists, antagonists, and inverse agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvLHp-kxAeW7Vg90H21EOLACvtfcHk0lj7ij_pYcSpjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhsl2nsg%253D%253D&md5=495191a9fc542a6af741eeda9d3b61e1</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2F0301-0082%2888%2990011-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0301-0082%252888%252990011-1%26sid%3Dliteratum%253Aachs%26aulast%3DGardner%26aufirst%3DC.%2BR.%26atitle%3DFunctional%2520in%2520vivo%2520correlates%2520of%2520the%2520benzodiazepine%2520agonist-inverse%2520agonist%2520continuum%26jtitle%3DProg.%2520Neurobiol.%26date%3D1988%26volume%3D31%26spage%3D425%26epage%3D476%26doi%3D10.1016%2F0301-0082%2888%2990011-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedgecock, C. J. R.</span></span> <span> </span><span class="NLM_article-title">The rapidly expanding range of neuronal benzodiazepine receptor ligands</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/0301-0082(93)90047-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2F0301-0082%2893%2990047-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=8380934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK3sXhsFOgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1993&pages=1-61&author=C.+R.+Gardnerauthor=W.+R.+Tullyauthor=C.+J.+R.+Hedgecock&title=The+rapidly+expanding+range+of+neuronal+benzodiazepine+receptor+ligands&doi=10.1016%2F0301-0082%2893%2990047-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">The rapidly expanding range of neuronal benzodiazepine receptor ligands</span></div><div class="casAuthors">Gardner, Colin R.; Tully, W. Roger; Hedgecock, Charles J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-61</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    </div><div class="casAbstract">A review with ≈400 ref.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP17ux6SV5nrVg90H21EOLACvtfcHk0lifJbszwuB-aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhsFOgtw%253D%253D&md5=4d546bf15110feb5e6f4db3800d673be</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2F0301-0082%2893%2990047-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0301-0082%252893%252990047-V%26sid%3Dliteratum%253Aachs%26aulast%3DGardner%26aufirst%3DC.%2BR.%26aulast%3DTully%26aufirst%3DW.%2BR.%26aulast%3DHedgecock%26aufirst%3DC.%2BJ.%2BR.%26atitle%3DThe%2520rapidly%2520expanding%2520range%2520of%2520neuronal%2520benzodiazepine%2520receptor%2520ligands%26jtitle%3DProg.%2520Neurobiol.%26date%3D1993%26volume%3D40%26spage%3D1%26epage%3D61%26doi%3D10.1016%2F0301-0082%2893%2990047-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenger, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKernan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacophore/receptor models for GABAA/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a comprehensive ligand-mapping approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1021/jm990341r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990341r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK1MXnslKgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=71-95&author=Q.+Huangauthor=X.+Heauthor=C.+Maauthor=R.+Liuauthor=S.+Yuauthor=C.+A.+Dayerauthor=G.+R.+Wengerauthor=R.+McKernanauthor=J.+M.+Cook&title=Pharmacophore%2Freceptor+models+for+GABAA%2FBzR+subtypes+%28%CE%B11%CE%B23%CE%B32%2C+%CE%B15%CE%B23%CE%B32%2C+and+%CE%B16%CE%B23%CE%B32%29+via+a+comprehensive+ligand-mapping+approach&doi=10.1021%2Fjm990341r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore/receptor models for GABAA/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a comprehensive ligand-mapping approach</span></div><div class="casAuthors">Huang, Qi; He, Xiaohui; Ma, Chunrong; Liu, Ruiyan; Yu, Shu; Dayer, Charlotte A.; Wenger, Galen R.; McKernan, Ruth; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-95</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pharmacophore/receptor models for three recombinant GABAA/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) have been established via an SAR ligand-mapping approach.  This study was based on the affinities of 151 BzR ligands at five distinct (α1-3,5,6β3γ2) recombinant GABAA/BzR receptor subtypes from at least nine different structural families.  Examn. of the included vols. of the α1-, α5-, and α6-contg. subtypes indicated that region L2 for the α5-contg. subtype appeared to be larger in size than the analogous region of the other receptor subtypes.  Region LDi, in contrast, appeared to be larger in the α1 subtype than in the other two subtypes. Moreover, region L3 in the α6 subtype is either very small or nonexistent in this diazepam-insensitive subtype (see Figure 16 for details) as compared to the other subtypes.  Use of the pharmacophore/receptor models for these subtypes has resulted in the design of novel BzR ligands (see 27) selective for the α5β3γ2 receptor subtype. α5-Selective ligand 27 when injected directly into the hippocampus did enhance memory in one paradigm (Bailey et al., unpublished observations); however, systemic administration of either 9 or 27 into animals did not provide an observable enhancement.  This result is in complete agreement with the observation of Liu (1996).  It has been shown (Liu, 1996; Wisden et al., 1992) that in the central nervous system of the rat (as well as monkeys and pigeons) there are several native subtypes of the GABAA receptor which exhibit different functions, regional distributions, and neuronal locations.  Although 27 binds more potently at α5β3γ2 receptor subtypes and is clearly an inverse agonist (Liu et al., 1996; Liu, 1996), it is possible that this ligand acts as an agonist at one or more subtypes.  Liu (1996) clearly showed that a no. of imidazobenzodiazepines were neg. modulators at one subtype and agonists at another. Therefore, selectivity for a particular subtype at this point is not sufficient to rule out some physiol. effect at other GABAA/BzR subtypes.  The inability of 27 to potentiate memory when given systemically is again in support of this hypothesis, esp. since α1β2γ2 subtypes are distributed throughout the brain (Wisden et al., 1992).  A drug delivered systemically is far more likely to interact with all subtypes than one delivered to a specific brain region.  This observation (systemic vs intrahippocampal) provides further support for the design of more subtype-specific ligands at the BzR to accurately define their pharmacol., one key to the design of new drugs with fewer side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX43jXnLKV1rVg90H21EOLACvtfcHk0lifJbszwuB-aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslKgt7Y%253D&md5=2ff8989f0201c03ff7fd7ae64574a066</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Fjm990341r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990341r%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DDayer%26aufirst%3DC.%2BA.%26aulast%3DWenger%26aufirst%3DG.%2BR.%26aulast%3DMcKernan%26aufirst%3DR.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DPharmacophore%252Freceptor%2520models%2520for%2520GABAA%252FBzR%2520subtypes%2520%2528%25CE%25B11%25CE%25B23%25CE%25B32%252C%2520%25CE%25B15%25CE%25B23%25CE%25B32%252C%2520and%2520%25CE%25B16%25CE%25B23%25CE%25B32%2529%2520via%2520a%2520comprehensive%2520ligand-mapping%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D71%26epage%3D95%26doi%3D10.1021%2Fjm990341r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adkins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scales, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerby, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wafford, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKernan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atack, J. R.</span></span> <span> </span><span class="NLM_article-title">Effect of a subunit on allosteric modulation of ion channel function in stably expressed human recombinant γ-aminobutyric acidA receptors determined using 36Cl ion flux</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1108</span>– <span class="NLM_lpage">1118</span>, <span class="refDoi"> DOI: 10.1124/mol.59.5.1108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1124%2Fmol.59.5.1108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=11306694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt1aqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2001&pages=1108-1118&author=A.+J.+Smithauthor=L.+Alderauthor=J.+Silkauthor=J.+Adkinsauthor=A.+E.+Fletcherauthor=T.+Scalesauthor=J.+Kerbyauthor=G.+Marshallauthor=K.+A.+Waffordauthor=R.+M.+McKernanauthor=J.+R.+Atack&title=Effect+of+a+subunit+on+allosteric+modulation+of+ion+channel+function+in+stably+expressed+human+recombinant+%CE%B3-aminobutyric+acidA+receptors+determined+using+36Cl+ion+flux&doi=10.1124%2Fmol.59.5.1108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of α subunit on allosteric modulation of ion channel function in stably expressed human recombinant γ-aminobutyric acidA receptors determined using 36Cl ion flux</span></div><div class="casAuthors">Smith, Alison J.; Alder, Luanda; Silk, Jonathan; Adkins, Charles; Fletcher, Alan E.; Scales, Tim; Kerby, Julie; Marshall, George; Wafford, Keith A.; Mckernan, Ruth M.; Atack, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1108-1118</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Inhibitory γ-aminobutyric acid (GABA)A receptors are subject to modulation at a variety of allosteric sites, with pharmacol. dependent on receptor subunit combination.  The influence of different α subunits in combination with β3γ2s was examd. in stably expressed human recombinant GABAA receptors by measuring 36Cl influx through the ion channel pore.  Muscimol and GABA exhibited similar maximal efficacy at each receptor subtype, although muscimol was more potent, with responses blocked by picrotoxin and bicuculline.  Receptors contg. the α3 subunit exhibited slightly lower potency.  The comparative pharmacol. of a range of benzodiazepine site ligands was examd., revealing a range of intrinsic efficacies at different receptor subtypes.  Of the diazepam-sensitive GABAA receptors (α1, α2, α3, α5), α5 showed the most divergence, being discriminated by zolpidem in terms of very low affinity, and CL 218872 and CGS 9895 with different efficacies.  Benzodiazepine potentiation at α3β3γ2s with nonselective agonist chlordiazepoxide was greater than at α1, α2, or α5 (P < 0.001).  The presence of an α4 subunit conferred a unique pharmacol. profile.  The partial agonist bretazenil was the most efficacious benzodiazepine, despite lower α4 affinity, and FG 8205 displayed similar efficacy.  Most striking were the lack of affinity/efficacy for classical benzodiazepines and the relatively high efficacy of Ro 15-1788 (53%), CGS 8216 (56%), CGS 9895 (65%), and the weak partial inverse agonist Ro 15-4513 (87%).  Each receptor subtype was modulated by pentobarbital, loreclezole, and 5α-pregnan-3α-ol-20-one, but the type of α subunit influenced the level of potentiation.  The maximal pentobarbital response was significantly greater at α4β3γ2s (226% increase in the EC20 response to GABA) than any other modulator.  The rank order of potentiation for pregnanolone was α5 > α2 > α3 = α4 > α1, for loreclezole α1 = α2 = α3 > α5 > α4, and for pentobarbital α4 = α5 = α2 > α1 = α3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqRE39F8EK9LVg90H21EOLACvtfcHk0lifJbszwuB-aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt1aqsbk%253D&md5=0294f7356c3d726a26f823e08fd8fd09</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1124%2Fmol.59.5.1108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.59.5.1108%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DA.%2BJ.%26aulast%3DAlder%26aufirst%3DL.%26aulast%3DSilk%26aufirst%3DJ.%26aulast%3DAdkins%26aufirst%3DJ.%26aulast%3DFletcher%26aufirst%3DA.%2BE.%26aulast%3DScales%26aufirst%3DT.%26aulast%3DKerby%26aufirst%3DJ.%26aulast%3DMarshall%26aufirst%3DG.%26aulast%3DWafford%26aufirst%3DK.%2BA.%26aulast%3DMcKernan%26aufirst%3DR.%2BM.%26aulast%3DAtack%26aufirst%3DJ.%2BR.%26atitle%3DEffect%2520of%2520a%2520subunit%2520on%2520allosteric%2520modulation%2520of%2520ion%2520channel%2520function%2520in%2520stably%2520expressed%2520human%2520recombinant%2520%25CE%25B3-aminobutyric%2520acidA%2520receptors%2520determined%2520using%252036Cl%2520ion%2520flux%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D59%26spage%3D1108%26epage%3D1118%26doi%3D10.1124%2Fmol.59.5.1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wingrove, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiting, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atack, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seabrook, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maubach, K. A.</span></span> <span> </span><span class="NLM_article-title">Role of the histidine residue at position 105 in the human α5 containing GABAA receptor on the affinity and efficacy of benzodiazepine site ligands</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0704459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1038%2Fsj.bjp.0704459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=11786501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVemsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2002&pages=248-256&author=M.+D.+Kellyauthor=A.+Smithauthor=G.+Banksauthor=P.+Wingroveauthor=P.+W.+Whitingauthor=J.+Atackauthor=G.+R.+Seabrookauthor=K.+A.+Maubach&title=Role+of+the+histidine+residue+at+position+105+in+the+human+%CE%B15+containing+GABAA+receptor+on+the+affinity+and+efficacy+of+benzodiazepine+site+ligands&doi=10.1038%2Fsj.bjp.0704459"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the histidine residue at position 105 in the human α5 containing GABAA receptor on the affinity and efficacy of benzodiazepine site ligands</span></div><div class="casAuthors">Kelly, M. D.; Smith, A.; Banks, G.; Wingrove, P.; Whiting, P. W.; Atack, J.; Seabrook, G. R.; Maubach, K. A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">248-256</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A histidine residue in the N-terminal extracellular region of α1,2,3,5 subunits of the human GABAA receptor, which is replaced by an arginine in α4 and α6 subunits, is a major determinant for high affinity binding of classical benzodiazepine (BZ)-site ligands.  The effect of mutating this histidine at position 105 in the α5 subunit to an arginine (α5H105R) on BZ-site pharmacol. has been investigated using radioligand binding on HEK293 and L(tk-) cells and two electrode voltage clamp recording on Xenopus oocytes in which GABAA receptors of subtypes α5, α5H105R, α4 and α6 were co-expressed with β3γ2s.  The classical BZs, diazepam and flunitrazepam (full agonists on the α5 receptor) showed negligible affinity and therefore negligible efficacy on α5H105R receptors.  The β-carbolines DMCM and βCCE (inverse agonists on the α5 receptor) retained some affinity but did not exhibit inverse agonist efficacy at α5H105R receptors.  Therefore, the α5H105R mutation confers an α4/α6-like pharmacol. to the classical BZs and β-carbolines.  Ro 15-4513, flumazenil, bretazenil and FG 8094, which share a common imidazobenzodiazepine core structure, retained high affinity and were higher efficacy agonists on α5H105R receptors than would be predicted from an α4/α6 pharmacol. profile.  This effect was antagonized by DMCM, which competes for the BZ-site and therefore is likely to be mediated via the BZ-site.  These data indicate that the conserved histidine residue in the α subunit is not only a key determinant in the affinity of BZ-site ligands on α5 contg. GABAA receptors, but also influences ligand efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx-1n2Lxv11rVg90H21EOLACvtfcHk0li1wTtETWtl5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVemsQ%253D%253D&md5=b82b9ec52a06ed6717fa7eab22fc25b7</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704459%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DM.%2BD.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DBanks%26aufirst%3DG.%26aulast%3DWingrove%26aufirst%3DP.%26aulast%3DWhiting%26aufirst%3DP.%2BW.%26aulast%3DAtack%26aufirst%3DJ.%26aulast%3DSeabrook%26aufirst%3DG.%2BR.%26aulast%3DMaubach%26aufirst%3DK.%2BA.%26atitle%3DRole%2520of%2520the%2520histidine%2520residue%2520at%2520position%2520105%2520in%2520the%2520human%2520%25CE%25B15%2520containing%2520GABAA%2520receptor%2520on%2520the%2520affinity%2520and%2520efficacy%2520of%2520benzodiazepine%2520site%2520ligands%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D135%26spage%3D248%26epage%3D256%26doi%3D10.1038%2Fsj.bjp.0704459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clayton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanLinn, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namjoshi, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cromer, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platt, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">7548</span>– <span class="NLM_lpage">7564</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.08.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmc.2010.08.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=20888240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSms73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=7548-7564&author=W.+Yinauthor=S.+Majumderauthor=T.+Claytonauthor=S.+Petrouauthor=M.+L.+VanLinnauthor=O.+A.+Namjoshiauthor=C.+Maauthor=B.+A.+Cromerauthor=B.+L.+Rothauthor=D.+M.+Plattauthor=J.+M.+Cook&title=Design%2C+synthesis%2C+and+subtype+selectivity+of+3%2C6-disubstituted+%CE%B2-carbolines+at+Bz%2FGABA%28A%29ergic+receptors.+SAR+and+studies+directed+toward+agents+for+treatment+of+alcohol+abuse&doi=10.1016%2Fj.bmc.2010.08.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse</span></div><div class="casAuthors">Yin, Wenyuan; Majumder, Samarpan; Clayton, Terry; Petrou, Steven; VanLinn, Michael L.; Namjoshi, Ojas A.; Ma, Chunrong; Cromer, Brett A.; Roth, Bryan L.; Platt, Donna M.; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7548-7564</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 3,6-disubstituted β-carbolines was synthesized and evaluated for their in vitro affinities at αxβ3γ2 GABAA/benzodiazepine receptor subtypes by radioligand binding assays in search of α1 subtype selective ligands to treat alc. abuse.  Analogs of β-carboline-3-carboxylate-t-Bu ester (βCCt, 1) were synthesized via a CDI-mediated process and the related 6-substituted β-carboline-3-carboxylates 6 including WYS8 (7) were synthesized via a Sonogashira or Stille coupling processes from 6-iodo-βCCt (5).  The bivalent ligands of βCCt (32 and 33) were also designed and prepd. via a palladium-catalyzed homocoupling process to expand the structure-activity relationships (SAR) to larger ligands.  Based on the pharmacophore/receptor model, a preliminary SAR study on 34 analogs illustrated that large substituents at position-6 of the β-carbolines were well tolerated.  As expected, these groups are proposed to project into the extracellular domain (LDi region) of GABAA/Bz receptors (see 32 and 33).  Moreover, substituents located at position-3 of the β-carboline nucleus exhibited a conserved stereo interaction in lipophilic pocket L1, while N(2) presumably underwent a hydrogen bonding interaction with H1.  Three novel β-carboline ligands (βCCt, 3PBC and WYS8), which preferentially bound to α1 BzR subtypes permitted a comparison of the pharmacol. efficacies with a range of classical BzR antagonists (flumazenil, ZK93426) from several different structural groups and indicated these β-carbolines were near GABA neutral antagonists'.  Based on the SAR, the most potent (in vitro) α1 selective ligand was the 6-substituted acetylenyl βCCt (WYS8, 7).  Earlier both βCCt and 3PBC had been shown to reduce alc. self-administration in alc. preferring (P) and high alc. drinking (HAD) rats but had little or no effect on sucrose self-administration.  Moreover, these two β-carbolines were orally active, and in addn., were anxiolytic in P rats but were only weakly anxiolytic in rodents.  These data prompted the synthesis of the β-carbolines presented here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDob07fAiYDLVg90H21EOLACvtfcHk0li1wTtETWtl5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSms73K&md5=3339b0d8ed30c7cb64f503f61d7396bb</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.08.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.08.049%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DW.%26aulast%3DMajumder%26aufirst%3DS.%26aulast%3DClayton%26aufirst%3DT.%26aulast%3DPetrou%26aufirst%3DS.%26aulast%3DVanLinn%26aufirst%3DM.%2BL.%26aulast%3DNamjoshi%26aufirst%3DO.%2BA.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DCromer%26aufirst%3DB.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DPlatt%26aufirst%3DD.%2BM.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520subtype%2520selectivity%2520of%25203%252C6-disubstituted%2520%25CE%25B2-carbolines%2520at%2520Bz%252FGABA%2528A%2529ergic%2520receptors.%2520SAR%2520and%2520studies%2520directed%2520toward%2520agents%2520for%2520treatment%2520of%2520alcohol%2520abuse%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D7548%26epage%3D7564%26doi%3D10.1016%2Fj.bmc.2010.08.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarma, P. V. V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of bivalent ligands of β-carboline-3-carboxylates via a palladium-catalyzed homocoupling process</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">6363</span>– <span class="NLM_lpage">6368</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2005.07.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.tetlet.2005.07.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2MXns1SgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=6363-6368&author=W.+Yinauthor=P.+V.+V.+S.+Sarmaauthor=J.+Maauthor=D.+Hanauthor=J.+L.+Chenauthor=J.+M.+Cook&title=Synthesis+of+bivalent+ligands+of+%CE%B2-carboline-3-carboxylates+via+a+palladium-catalyzed+homocoupling+process&doi=10.1016%2Fj.tetlet.2005.07.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of bivalent ligands of β-carboline-3-carboxylates via a palladium-catalyzed homocoupling process</span></div><div class="casAuthors">Yin, Wenyuan; Sarma, P. V. V. Srirama; Ma, Jun; Han, Dongmei; Chen, Jessica L.; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">6363-6368</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The first synthesis of bivalent ligands of β-carboline-3-carboxylates was achieved from β-carboline-3-carboxylate tert-Bu ester (βCCt) via Sonogashira and palladium-catalyzed homocoupling processes.  The Boc-protected intermediate, an iodo-β-carboline-3-carboxylate, was employed to provide a general entry into a series of bivalent ligands structurally similar to βCCt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXcwGcYMHBnLVg90H21EOLACvtfcHk0ljnUtMcRnLfIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXns1SgsLk%253D&md5=4158e1c49fef715f2e0e5c3025d541a9</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2005.07.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2005.07.022%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DW.%26aulast%3DSarma%26aufirst%3DP.%2BV.%2BV.%2BS.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DJ.%2BL.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DSynthesis%2520of%2520bivalent%2520ligands%2520of%2520%25CE%25B2-carboline-3-carboxylates%2520via%2520a%2520palladium-catalyzed%2520homocoupling%2520process%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D6363%26epage%3D6368%26doi%3D10.1016%2Fj.tetlet.2005.07.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griebel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrault, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simiand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depoortere, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Françon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avenet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoemaker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evanno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevrin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scatton, B.</span></span> <span> </span><span class="NLM_article-title">SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms</span>. <i>CNS Drug Rev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1111/j.1527-3458.2003.tb00241.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1111%2Fj.1527-3458.2003.tb00241.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=12595909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsFyht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=3-20&author=G.+Griebelauthor=G.+Perraultauthor=J.+Simiandauthor=C.+Cohenauthor=P.+Grangerauthor=H.+Depoortereauthor=D.+Fran%C3%A7onauthor=P.+Avenetauthor=H.+Schoemakerauthor=Y.+Evannoauthor=M.+Sevrinauthor=P.+Georgeauthor=B.+Scatton&title=SL651498%2C+a+GABAA+receptor+agonist+with+subtype-selective+efficacy%2C+as+a+potential+treatment+for+generalized+anxiety+disorder+and+muscle+spasms&doi=10.1111%2Fj.1527-3458.2003.tb00241.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms</span></div><div class="casAuthors">Griebel, Guy; Perrault, Ghislaine; Simiand, Jacques; Cohen, Caroline; Granger, Patrick; Depoortere, Henri; Francon, Dominique; Avenet, Patrick; Schoemaker, Hans; Evanno, Yannick; Sevrin, Mireille; George, Pascal; Scatton, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drug Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-20</span>CODEN:
                <span class="NLM_cas:coden">CDREFB</span>;
        ISSN:<span class="NLM_cas:issn">1080-563X</span>.
    
            (<span class="NLM_cas:orgname">Neva Press</span>)
        </div><div class="casAbstract">A review.  SL651498 (6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2, 9-dihydro-1H-pyrido[3,4-b]indol-1-one) was identified as a drug development candidate from a research program designed to discover subtype-selective GABAA receptor agonists for the treatment of generalized anxiety disorder and muscle spasms.  The drug displays high affinity for rat native GABAA receptors contg. α1 (Ki = 6.8 nM) and α2 (Ki = 12.3 nM) subunits, and weaker affinity for as-contg. GABAA receptors (Ki = 117 nM).  Studies on recombinant rat GABAA receptors confirm these findings and indicate intermediate affinity for the α3β2γ2 subtype.  SL651498 behaves as a full agonist at recombinant rat GABAA receptors contg. α2 and α3 subunits, and as a partial agonist at recombinant GABAA receptors expressing α1 and α5 subunits.  SL651498 produced anxiolytic-like and skeletal muscle relaxant effects qual. similar to those of benzodiazepines (BZs) [minimal ED (MED): 1 to 10 mg/kg, i.p. and 3 to 10 mg/kg, p.o.].  However, unlike these latter drugs, SL651498 induced muscle weakness, ataxia or sedation at doses much higher than those having anxiolytic-like activity (MED: 30 to 100 mg/kg, i.p. or p.o.).  Moreover, in contrast to BZs, SL651498 did not produce tolerance to its anticonvulsant activity or phys. dependence.  It was much less active than BZs in potentiating the depressant effects of ethanol or impairing cognitive processes in rodents.  The differential profile of SL651498 as compared to BZs may be related to its selective efficacy at the α2- and α3-contg. GABAA receptors.  This suggests that selectively targeting GABAA receptor subtypes can lead to drugs with increased clin. specificity.  SL651498 represents a promising alternative to agents currently used for the treatment of anxiety disorders and muscle spasms without the major side effects seen with classical BZs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxyItz_ZQayLVg90H21EOLACvtfcHk0ljnUtMcRnLfIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsFyht70%253D&md5=79ace63273f5be34a70bd0a6f42a95e6</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3458.2003.tb00241.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3458.2003.tb00241.x%26sid%3Dliteratum%253Aachs%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DPerrault%26aufirst%3DG.%26aulast%3DSimiand%26aufirst%3DJ.%26aulast%3DCohen%26aufirst%3DC.%26aulast%3DGranger%26aufirst%3DP.%26aulast%3DDepoortere%26aufirst%3DH.%26aulast%3DFran%25C3%25A7on%26aufirst%3DD.%26aulast%3DAvenet%26aufirst%3DP.%26aulast%3DSchoemaker%26aufirst%3DH.%26aulast%3DEvanno%26aufirst%3DY.%26aulast%3DSevrin%26aufirst%3DM.%26aulast%3DGeorge%26aufirst%3DP.%26aulast%3DScatton%26aufirst%3DB.%26atitle%3DSL651498%252C%2520a%2520GABAA%2520receptor%2520agonist%2520with%2520subtype-selective%2520efficacy%252C%2520as%2520a%2520potential%2520treatment%2520for%2520generalized%2520anxiety%2520disorder%2520and%2520muscle%2520spasms%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2003%26volume%3D9%26spage%3D3%26epage%3D20%26doi%3D10.1111%2Fj.1527-3458.2003.tb00241.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trudell, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basile, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 7,12-dihydropyrido[3,4-b:5,4-b’]diindoles. A novel class of rigid, planar benzodiazepine receptor ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">456</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1021/jm00386a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00386a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL2sXhtF2ksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=456-458&author=M.+L.+Trudellauthor=A.+S.+Basileauthor=H.+E.+Shannonauthor=P.+Skolnickauthor=J.+M.+Cook&title=Synthesis+of+7%2C12-dihydropyrido%5B3%2C4-b%3A5%2C4-b%E2%80%99%5Ddiindoles.+A+novel+class+of+rigid%2C+planar+benzodiazepine+receptor+ligands&doi=10.1021%2Fjm00386a003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 7,12-dihydropyrido[3,2-b:5,4-b']diindoles.  A novel class of rigid, planar benzodiazepine receptor ligands</span></div><div class="casAuthors">Trudell, Mark L.; Basile, Anthony S.; Shannon, Harlan E.; Skolnick, Phil; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">456-8</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A new series of rigid, planar compds. I (R = H, Cl, OMe), which possess a high affinity for the benzodiazepine receptor(s) based on the novel heterocyclic system, dihydropyridodiindole I (R = H) were prepd. and evaluated for biol. activity.  Substitution on the E ring had a marked effect on the intrinsic biol.  activity of these benzodiazepine receptor ligands.  The 2-substituted analogs demonstrated the greatest affinity for the benzodiazepine receptor.  I (R = H, Cl, OMe) antagonized the anticonvulsant effects of diazepam (ED53 = 5 nM) in mice; however, I (R = H, OMe) also behaved as partial inverse agonists for they possessed convulsant activity.  I (R = Cl) did not elicit convulsant activity at the highest dose tested (30 mg/Kg) even though it was the most potent antagonist of diazepam with a ED50 of 2.5 mg/Kg.  The biol. profile of these rigid, planar analogs does suggest selectivity of action when the activity of I (R = H, OMe) are compared to that of I (R = Cl).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaSm8vIdwVHbVg90H21EOLACvtfcHk0ljnUtMcRnLfIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhtF2ksL0%253D&md5=932daa5911862564e1c7012d113b7a8f</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Fjm00386a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00386a003%26sid%3Dliteratum%253Aachs%26aulast%3DTrudell%26aufirst%3DM.%2BL.%26aulast%3DBasile%26aufirst%3DA.%2BS.%26aulast%3DShannon%26aufirst%3DH.%2BE.%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DSynthesis%2520of%25207%252C12-dihydropyrido%255B3%252C4-b%253A5%252C4-b%25E2%2580%2599%255Ddiindoles.%2520A%2520novel%2520class%2520of%2520rigid%252C%2520planar%2520benzodiazepine%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D456%26epage%3D458%26doi%3D10.1021%2Fjm00386a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geldenhuys, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Schyf, C. J.</span></span> <span> </span><span class="NLM_article-title">Role of serotonin in Alzheimer’s disease: a new therapeutic target?</span>. <i>CNS Drugs</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">765</span>– <span class="NLM_lpage">781</span>, <span class="refDoi"> DOI: 10.2165/11590190-000000000-00000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.2165%2F11590190-000000000-00000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=21870888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVWjsbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=765-781&author=W.+J.+Geldenhuysauthor=C.+J.+Van+der+Schyf&title=Role+of+serotonin+in+Alzheimer%E2%80%99s+disease%3A+a+new+therapeutic+target%3F&doi=10.2165%2F11590190-000000000-00000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Role of serotonin in Alzheimer's disease: a new therapeutic target?</span></div><div class="casAuthors">Geldenhuys, Werner J.; Van der Schyf, Cornelis J.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">765-781</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Adis Data Information BV</span>)
        </div><div class="casAbstract">A review.  Mounting evidence accumulated over the past few years indicates that the neurotransmitter serotonin plays a significant role in cognition.  As a drug target, serotonin receptors have received notable attention due in particular to the role of several serotonin-receptor subclasses in cognition and memory.  The intimate anatomical and neurochem. assocn. of the serotonergic system with brain areas that regulate memory and learning has directed current drug discovery programs to focus on this system as a major therapeutic drug target.  Thus far, none of these programs has yielded unambiguous data that suggest that any of the new drug entities possesses disease-modifying properties, and significantly more research in this promising area of investigation is required.  Compds. are currently being investigated for activity against serotonin 5-HT1, 5-HT4 and 5-HT6 receptors.  This review concludes that most work done in the development of selective serotonin receptor ligands is in the pre-clin. or early clin. phase.  Also, while many of these compds. will likely find application as adjuvant therapy in the symptomatic treatment of Alzheimer's disease, there are currently only a few drug entities with activity against serotonin receptors that may offer the potential to alter the progression of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTAnnw7_1LMLVg90H21EOLACvtfcHk0ljLOSBWULWxFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVWjsbrK&md5=87559be5dea4eda592186e0038e1ece9</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.2165%2F11590190-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11590190-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26atitle%3DRole%2520of%2520serotonin%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520new%2520therapeutic%2520target%253F%26jtitle%3DCNS%2520Drugs%26date%3D2011%26volume%3D25%26spage%3D765%26epage%3D781%26doi%3D10.2165%2F11590190-000000000-00000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Švob Štrac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pivac, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mück-Šeler, D.</span></span> <span> </span><span class="NLM_article-title">The serotonergic system and cognitive function</span>. <i>Transl. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1515/tnsci-2016-0007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1515%2Ftnsci-2016-0007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=28123820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADC%252BC1c7ptlOnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=35-49&author=D.+%C5%A0vob+%C5%A0tracauthor=N.+Pivacauthor=D.+M%C3%BCck-%C5%A0eler&title=The+serotonergic+system+and+cognitive+function&doi=10.1515%2Ftnsci-2016-0007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">The serotonergic system and cognitive function</span></div><div class="casAuthors">Svob Strac Dubravka; Pivac Nela; Muck-Seler Dorotea</div><div class="citationInfo"><span class="NLM_cas:title">Translational neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-49</span>
        ISSN:<span class="NLM_cas:issn">2081-3856</span>.
    </div><div class="casAbstract">Symptoms of cognitive dysfunction like memory loss, poor concentration, impaired learning and executive functions are characteristic features of both schizophrenia and Alzheimer's disease (AD).  The neurobiological mechanisms underlying cognition in healthy subjects and neuropsychiatric patients are not completely understood.  Studies have focused on serotonin (5-hydroxytryptamine, 5-HT) as one of the possible cognitionrelated biomarkers.  The aim of this review is to provide a summary of the current literature on the role of the serotonergic (5-HTergic) system in cognitive function, particularly in AD and schizophrenia.  The role of the 5-HTergic system in cognition is modulated by the activity and function of 5-HT receptors (5-HTR) classified into seven groups, which differ in structure, action, and localization.  Many 5-HTR are located in the regions linked to various cognitive processes.  Preclinical studies using animal models of learning and memory, as well as clinical in vivo (neuroimaging) and in vitro (post-mortem) studies in humans have shown that alterations in 5-HTR activity influence cognitive performance.  The current evidence implies that reduced 5-HT neurotransmission negatively influences cognitive functions and that normalization of 5-HT activity may have beneficial effects, suggesting that 5-HT and 5-HTR represent important pharmacological targets for cognition enhancement and restoration of impaired cognitive performance in neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-nK0Ed8w9D3p3bfzSLaX5fW6udTcc2eaGKQ9AVikBA7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7ptlOnsQ%253D%253D&md5=338ed0985629c57ac200901e38001bf0</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1515%2Ftnsci-2016-0007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Ftnsci-2016-0007%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0vob%2B%25C5%25A0trac%26aufirst%3DD.%26aulast%3DPivac%26aufirst%3DN.%26aulast%3DM%25C3%25BCck-%25C5%25A0eler%26aufirst%3DD.%26atitle%3DThe%2520serotonergic%2520system%2520and%2520cognitive%2520function%26jtitle%3DTransl.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D35%26epage%3D49%26doi%3D10.1515%2Ftnsci-2016-0007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grella, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teitler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrick-Davis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glennon, R. A.</span></span> <span> </span><span class="NLM_article-title">Investigation of hallucinogenic and related β-carbolines</span>. <i>Drug Alcohol Depend.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1016/S0376-8716(97)00163-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2FS0376-8716%2897%2900163-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=9649961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK1cXjvFemur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1998&pages=99-107&author=B.+Grellaauthor=M.+Dukatauthor=R.+Youngauthor=M.+Teitlerauthor=K.+Herrick-Davisauthor=C.+B.+Gauthierauthor=R.+A.+Glennon&title=Investigation+of+hallucinogenic+and+related+%CE%B2-carbolines&doi=10.1016%2FS0376-8716%2897%2900163-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of hallucinogenic and related β-carbolines</span></div><div class="casAuthors">Grella, Brian; Dukat, Malgorzata; Young, Richard; Teitler, Milt; Herrick-Davis, Katharine; Gauthier, Colleen B.; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-107</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Certain β-carbolines are known to be hallucinogenic in humans, and several produce stimulus effects in animals similar to those of the classical hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM).  Classical hallucinogens bind at 5-HT2 serotonin receptors and these receptors are thought to play a role in their mechanism of action.  In the present study, we examd. the binding of 15 β-carbolines at rat 5-HT2A and 5-HT2C receptors.  Affinities (Ki values) of the β-carbolines ranged from about 100 nM to greater than 10 000 nM depending upon the degree of satn. of the pyridyl ring, and upon the presence and location of methoxy substituents in the benzenoid ring.  In a further study, six rats were trained to discriminate the hallucinogenic β-carboline harmaline (3.0 mg/kg, i.p.) from vehicle using a VI-15s schedule of reinforcement.  This represents the first time a hallucinogenic β-carboline has been used as a training drug in a drug discrimination study.  Administration of DOM to the harmaline-trained animals resulted in 76% harmaline-appropriate responding at 1.25 mg/kg DOM and disruption of behavior at a higher dose.  Taken together, the results of the present investigation demonstrate that: (a) certain β-carbolines bind at 5-HT2 receptors; (b) that harmaline serves as a training drug at 3.0 mg/kg in drug discrimination studies with rats as subjects; and that (c) there is some similarity between the stimulus effects produced by harmaline and DOM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoym92j5UaRtbVg90H21EOLACvtfcHk0ljLOSBWULWxFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvFemur4%253D&md5=cd616378c0004ab942d4fe243a48ada7</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2FS0376-8716%2897%2900163-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0376-8716%252897%252900163-4%26sid%3Dliteratum%253Aachs%26aulast%3DGrella%26aufirst%3DB.%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DTeitler%26aufirst%3DM.%26aulast%3DHerrick-Davis%26aufirst%3DK.%26aulast%3DGauthier%26aufirst%3DC.%2BB.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DInvestigation%2520of%2520hallucinogenic%2520and%2520related%2520%25CE%25B2-carbolines%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D1998%26volume%3D50%26spage%3D99%26epage%3D107%26doi%3D10.1016%2FS0376-8716%2897%2900163-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glennon, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grella, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costantino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teitler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. V.</span></span> <span> </span><span class="NLM_article-title">Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors</span>. <i>Drug Alcohol Depend.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1016/S0376-8716(99)00148-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2FS0376-8716%2899%2900148-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10940539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFCis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=121-132&author=R.+A.+Glennonauthor=M.+Dukatauthor=B.+Grellaauthor=S.-S.+Hongauthor=L.+Costantinoauthor=M.+Teitlerauthor=C.+Smithauthor=C.+Eganauthor=K.+Davisauthor=M.+V.+Mattson&title=Binding+of+%CE%B2-carbolines+and+related+agents+at+serotonin+%285-HT2+and+5-HT1A%29%2C+dopamine+%28D2%29+and+benzodiazepine+receptors&doi=10.1016%2FS0376-8716%2899%2900148-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors</span></div><div class="casAuthors">Glennon, R. A.; Dukat, M.; Grella, B.; Hong, S.-S.; Costantino, L.; Teitler, M.; Smith, C.; Egan, C.; Davis, K.; Mattson, M. V.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-132</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A large series of β-carbolines was examd. for their ability to bind at [3H]agonist-labeled 5-HT2A serotonin receptors.  Selected β-carbolines were also examd. at 5-HT2C serotonin receptors, 5-HT1A serotonin receptors, dopamine D2 receptors, and benzodiazepine receptors.  Indolealkylamines and phenylisopropylamines were also evaluated in some of these binding assays.  The β-carbolines were found to bind with modest affinity at 5-HT2A receptors, and affinity was highly dependent upon the presence of ring substituents and ring satn.  The β-carbolines displayed little to no affinity for 5-HT1A serotonin receptors, dopamine D2 receptors and, with the exception of β-CCM, for benzodiazepine receptors.  Examples of β-carbolines, indolealkylamines (i.e. N,N-dimethyltryptamine analogs), and phenylisopropylamines have been previously shown to produce common stimulus effects in animals trained to discriminate the phenyliisopropylamine hallucinogen DOM 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane from vehicle.  Although the only common receptor population that might account for this action is 5-HT2A, on the basis of a lack of enhanced affinity for agonist-labeled 5-HT2A receptors, as well as on their lack of agonist action in the PI hydrolysis assay, it is difficult to conclude that the β-carbolines behave in a manner consistent with that of other classical hallucinogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaypy9C8pdJrVg90H21EOLACvtfcHk0ljTWF8HPw9MSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFCis70%253D&md5=81e7b5842567ef2a43229f158112cec6</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2FS0376-8716%2899%2900148-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0376-8716%252899%252900148-9%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DGrella%26aufirst%3DB.%26aulast%3DHong%26aufirst%3DS.-S.%26aulast%3DCostantino%26aufirst%3DL.%26aulast%3DTeitler%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DEgan%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DK.%26aulast%3DMattson%26aufirst%3DM.%2BV.%26atitle%3DBinding%2520of%2520%25CE%25B2-carbolines%2520and%2520related%2520agents%2520at%2520serotonin%2520%25285-HT2%2520and%25205-HT1A%2529%252C%2520dopamine%2520%2528D2%2529%2520and%2520benzodiazepine%2520receptors%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D2000%26volume%3D60%26spage%3D121%26epage%3D132%26doi%3D10.1016%2FS0376-8716%2899%2900148-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grella, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teitler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrick-Davis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glennon, R. A.</span></span> <span> </span><span class="NLM_article-title">Binding of β-carbolines at 5-HT2 serotonin receptors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">4421</span>– <span class="NLM_lpage">4425</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2003.09.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmcl.2003.09.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=14643338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1yrur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=4421-4425&author=B.+Grellaauthor=M.+Teitlerauthor=C.+Smithauthor=K.+Herrick-Davisauthor=R.+A.+Glennon&title=Binding+of+%CE%B2-carbolines+at+5-HT2+serotonin+receptors&doi=10.1016%2Fj.bmcl.2003.09.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of β-carbolines at 5-HT2 serotonin receptors</span></div><div class="casAuthors">Grella, Brian; Teitler, Milt; Smith, Carol; Herrick-Davis, Katharine; Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4421-4425</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A series of ring-substituted (i.e., methoxy and bromo) 3,4-dihydro- and 1,2,3,4-tetrahydro-β-carbolines was examd. at 5-HT2A and 5-HT2C serotonin receptors.  Whereas most of the methoxy-substituted derivs. typically displayed affinities similar to their unsubstituted parents, certain (particularly 8-substituted) bromo derivs. displayed enhanced affinity.  A binding profile was obtained for selected β-carbolines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOohuBjbKuCLVg90H21EOLACvtfcHk0ljTWF8HPw9MSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1yrur0%253D&md5=a369be6edf8222e3d1eb2bd65eebc2d0</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.09.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.09.027%26sid%3Dliteratum%253Aachs%26aulast%3DGrella%26aufirst%3DB.%26aulast%3DTeitler%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DHerrick-Davis%26aufirst%3DK.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DBinding%2520of%2520%25CE%25B2-carbolines%2520at%25205-HT2%2520serotonin%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D4421%26epage%3D4425%26doi%3D10.1016%2Fj.bmcl.2003.09.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de la Fuente Revenga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Garcia, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso-Gil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Castillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caignard, D.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yañez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Franco, M. I.</span></span> <span> </span><span class="NLM_article-title">Neurogenic potential assessment and pharmacological characterization of 6-methoxy-1,2,3,4-tetrahydro-β-carboline (pinoline) and melatonin-pinoline hybrids</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">800</span>– <span class="NLM_lpage">810</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.5b00041</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVShsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=800-810&author=M.+de+la+Fuente+Revengaauthor=C.+P%C3%A9rezauthor=J.+A.+Morales-Garciaauthor=S.+Alonso-Gilauthor=A.+P%C3%A9rez-Castilloauthor=D.-H.+Caignardauthor=M.+Ya%C3%B1ezauthor=A.+M.+Gamoauthor=M.+I.+Rodriguez-Franco&title=Neurogenic+potential+assessment+and+pharmacological+characterization+of+6-methoxy-1%2C2%2C3%2C4-tetrahydro-%CE%B2-carboline+%28pinoline%29+and+melatonin-pinoline+hybrids&doi=10.1021%2Facschemneuro.5b00041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Neurogenic Potential Assessment and Pharmacological Characterization of 6-Methoxy-1,2,3,4-tetrahydro-β-carboline (Pinoline) and Melatonin-Pinoline Hybrids</span></div><div class="casAuthors">de la Fuente Revenga, Mario; Perez, Concepcion; Morales-Garcia, Jose A.; Alonso-Gil, Sandra; Perez-Castillo, Ana; Caignard, Daniel-Henri; Yanez, Matilde; Gamo, Ana M.; Rodriguez-Franco, Maria Isabel</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">800-810</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">6-Methoxy-1,2,3,4-tetrahydro-β-carboline (pinoline) and N-acetyl-5-methoxytryptamine (melatonin) are both structurally related to 5-hydroxytryptamine (serotonin).  Here we describe the design, synthesis, and characterization of a series of melatonin rigid analogs resulting from the hybridization of both pinoline and melatonin structures.  The pharmacol. evaluation of melatonin-pinoline hybrids comprises serotonergic and melatonergic receptors, metabolic enzymes (monoamine oxidases), antioxidant potential, the in vitro blood-brain barrier permeability, and neurogenic studies.  Pinoline at trace concns. and 2-acetyl-6-methoxy-1,2,3,4-tetrahydro-β-carboline were able to stimulate early neurogenesis and neuronal maturation in an in vitro model of neural stem cells isolated from the adult rat subventricular zone.  Such effects are presumably mediated via serotonergic and melatonergic stimulation, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKQ6b1mXG0V7Vg90H21EOLACvtfcHk0ljtZzzmH5nSQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVShsb0%253D&md5=b2cb37ef83402c47895a769035e73250</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00041%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2Bla%2BFuente%2BRevenga%26aufirst%3DM.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DMorales-Garcia%26aufirst%3DJ.%2BA.%26aulast%3DAlonso-Gil%26aufirst%3DS.%26aulast%3DP%25C3%25A9rez-Castillo%26aufirst%3DA.%26aulast%3DCaignard%26aufirst%3DD.-H.%26aulast%3DYa%25C3%25B1ez%26aufirst%3DM.%26aulast%3DGamo%26aufirst%3DA.%2BM.%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNeurogenic%2520potential%2520assessment%2520and%2520pharmacological%2520characterization%2520of%25206-methoxy-1%252C2%252C3%252C4-tetrahydro-%25CE%25B2-carboline%2520%2528pinoline%2529%2520and%2520melatonin-pinoline%2520hybrids%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2015%26volume%3D6%26spage%3D800%26epage%3D810%26doi%3D10.1021%2Facschemneuro.5b00041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evrard, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdoch, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Droste, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenck, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fludzinski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucaites, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M. L.</span></span> <span> </span><span class="NLM_article-title">Potent, selective tetrahydro-β-carboline antagonists of the serotonin 2B (5HT2B) contractile receptor in the rat stomach fundus</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2773</span>– <span class="NLM_lpage">2780</span>, <span class="refDoi"> DOI: 10.1021/jm960062t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960062t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK28XjsFeqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=2773-2780&author=J.+E.+Audiaauthor=D.+A.+Evrardauthor=G.+R.+Murdochauthor=J.+J.+Drosteauthor=J.+S.+Nissenauthor=K.+W.+Schenckauthor=P.+Fludzinskiauthor=V.+L.+Lucaitesauthor=D.+L.+Nelsonauthor=M.+L.+Cohen&title=Potent%2C+selective+tetrahydro-%CE%B2-carboline+antagonists+of+the+serotonin+2B+%285HT2B%29+contractile+receptor+in+the+rat+stomach+fundus&doi=10.1021%2Fjm960062t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Potent, Selective Tetrahydro-β-carboline Antagonists of the Serotonin 2B (5HT2B) Contractile Receptor in the Rat Stomach Fundus</span></div><div class="casAuthors">Audia, James E.; Evrard, Deborah A.; Murdoch, Gwyn R.; Droste, James J.; Nissen, Jeffrey S.; Schenck, Kathy W.; Fludzinski, Pawel; Lucaites, Virginia L.; Nelson, David L.; Cohen, Marlene L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2773-2780</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of potent, selective 5HT2B receptor antagonists has been identified based upon yohimbine, with SAR studies resulting in a 1000-fold increase in 5HT2B receptor affinity relative to the starting structure (-log KBs >10.0 have been obtained).  These high-affinity tetrahydro-β-carboline antagonists are able to discriminate among the 5HT2 family of serotonin receptors, with members of the series showing selectivities of more than 100-fold vs. both the 5HT2A and 5HT2C receptors based upon radioligand binding and functional assays.  As the first compds. reported with such selectivity and enhanced receptor affinity, these tetrahydro-β-carboline antagonists are useful tools for elucidating the role of serotonin acting at the 5HT2B receptor in normal and disease physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOL3gJ44WLvrVg90H21EOLACvtfcHk0ljtZzzmH5nSQQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjsFeqs7Y%253D&md5=8b11769eabacad2a63142e887bb7173c</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fjm960062t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960062t%26sid%3Dliteratum%253Aachs%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DEvrard%26aufirst%3DD.%2BA.%26aulast%3DMurdoch%26aufirst%3DG.%2BR.%26aulast%3DDroste%26aufirst%3DJ.%2BJ.%26aulast%3DNissen%26aufirst%3DJ.%2BS.%26aulast%3DSchenck%26aufirst%3DK.%2BW.%26aulast%3DFludzinski%26aufirst%3DP.%26aulast%3DLucaites%26aufirst%3DV.%2BL.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DCohen%26aufirst%3DM.%2BL.%26atitle%3DPotent%252C%2520selective%2520tetrahydro-%25CE%25B2-carboline%2520antagonists%2520of%2520the%2520serotonin%25202B%2520%25285HT2B%2529%2520contractile%2520receptor%2520in%2520the%2520rat%2520stomach%2520fundus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D2773%26epage%3D2780%26doi%3D10.1021%2Fjm960062t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Millan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman-Tancredi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audinot, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cussac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lejeune, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coge, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galizzi, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivet, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekeyne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobert, A.</span></span> <span> </span><span class="NLM_article-title">Agonist and antagonist actions of yohimbine as compared to fluparoxan at α2-adrenergic receptors (AR)s, serotonin (5-HT)1A, 5-HT1B, 5-HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1098-2396(200002)35:2<79::AID-SYN1>3.0.CO;2-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1002%2F%28SICI%291098-2396%28200002%2935%3A2%3C79%3A%3AAID-SYN1%3E3.0.CO%3B2-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10611634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1SksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2000&pages=79-95&author=M.+J.+Millanauthor=A.+Newman-Tancrediauthor=V.+Audinotauthor=D.+Cussacauthor=F.+Lejeuneauthor=J.-P.+Nicolasauthor=F.+Cogeauthor=J.-P.+Galizziauthor=J.+A.+Boutinauthor=J.-M.+Rivetauthor=A.+Dekeyneauthor=A.+Gobert&title=Agonist+and+antagonist+actions+of+yohimbine+as+compared+to+fluparoxan+at+%CE%B12-adrenergic+receptors+%28AR%29s%2C+serotonin+%285-HT%291A%2C+5-HT1B%2C+5-HT1D+and+dopamine+D2+and+D3+receptors.+Significance+for+the+modulation+of+frontocortical+monoaminergic+transmission+and+depressive+states&doi=10.1002%2F%28SICI%291098-2396%28200002%2935%3A2%3C79%3A%3AAID-SYN1%3E3.0.CO%3B2-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Agonist and antagonist actions of yohimbine as compared to fluparoxan at α2-adrenergic receptors (AR)s, serotonin (5-HT)1A, 5-HT1B, 5-HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states</span></div><div class="casAuthors">Millan, Mark J.; Newman-Tancredi, Adrian; Audinot, Valerie; Cussac, Didier; Lejeune, Francoise; Nicolas, Jean-Paul; Coge, Francis; Galizzi, Jean-Pierre; Boutin, Jean A.; Rivet, Jean-Michel; Dekeyne, Anne; Gobert, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">79-95</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Herein, we evaluate the interaction of the α2-AR antagonist, yohimbine, as compared to fluparoxan, at multiple monoaminergic receptors and examine their roles in the modulation of adrenergic, dopaminergic and serotonergic transmission in freely-moving rats.  Yohimbine displays marked affinity at human (h)α2A-, hα2B- and hα2C-ARs, significant affinity for h5-HT1A, h5-HT1B, h5-HT1D, and hD2 receptors and weak affinity for hD3 receptors.  In [35S]GTPγS binding protocols, yohimbine exerts antagonist actions at hα2A-AR, h5-HT1B, h5-HT1D, and hD2 sites, yet partial agonist actions at h5-HT1A sites.  In vivo, agonist actions of yohimbine at 5-HT1A sites are revealed by WAY100,635-reversible induction of hypothermia in the rat.  In guinea pigs, antagonist actions of yohimbine at 5-HT1B receptors are revealed by blockade of hypothermia evoked by the 5-HT1B agonist, GR46,611.  In distinction to yohimbine, fluparoxan shows only modest partial agonist actions at h5-HT1A sites vs. marked antagonist actions at hα2-ARs.  While fluparoxan selectively enhances hippocampal noradrenaline (NAD) turnover, yohimbine also enhances striatal dopamine (DA) turnover and suppresses striatal turnover of 5-HT.  Further, yohimbine decreases firing of serotonergic neurons in raphe nuclei, an action reversed by WAY100,635.  Fluparoxan increases extracellular levels of DA and NAD, but not 5-HT, in frontal cortex.  In analogy, yohimbine enhances FCX levels of DA and NAD, yet suppresses those of 5-HT, the latter effect being antagonized by WAY100,635.  The induction by fluoxetine of FCX levels of 5-HT, DA, and NAD is potentiated by fluparoxan.  Yohimbine likewise facilitates the influence of fluoxetine upon DA and NAD levels, but not those of 5-HT.  In conclusion, the α2-AR antagonist properties of yohimbine increase DA and NAD levels both alone and in assocn. with fluoxetine.  However, in contrast to the selective α2-AR antagonist, fluparoxan, the 5-HT1A agonist actions of yohimbine suppress 5-HT levels alone and underlie its inability to augment the influence of fluoxetine upon 5-HT levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPZkgvlHjfqbVg90H21EOLACvtfcHk0lhsU8nHyCqDEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1SksA%253D%253D&md5=a8b3addd5a98957ac63230b67004b37e</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-2396%28200002%2935%3A2%3C79%3A%3AAID-SYN1%3E3.0.CO%3B2-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-2396%2528200002%252935%253A2%253C79%253A%253AAID-SYN1%253E3.0.CO%253B2-X%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26aulast%3DAudinot%26aufirst%3DV.%26aulast%3DCussac%26aufirst%3DD.%26aulast%3DLejeune%26aufirst%3DF.%26aulast%3DNicolas%26aufirst%3DJ.-P.%26aulast%3DCoge%26aufirst%3DF.%26aulast%3DGalizzi%26aufirst%3DJ.-P.%26aulast%3DBoutin%26aufirst%3DJ.%2BA.%26aulast%3DRivet%26aufirst%3DJ.-M.%26aulast%3DDekeyne%26aufirst%3DA.%26aulast%3DGobert%26aufirst%3DA.%26atitle%3DAgonist%2520and%2520antagonist%2520actions%2520of%2520yohimbine%2520as%2520compared%2520to%2520fluparoxan%2520at%2520%25CE%25B12-adrenergic%2520receptors%2520%2528AR%2529s%252C%2520serotonin%2520%25285-HT%25291A%252C%25205-HT1B%252C%25205-HT1D%2520and%2520dopamine%2520D2%2520and%2520D3%2520receptors.%2520Significance%2520for%2520the%2520modulation%2520of%2520frontocortical%2520monoaminergic%2520transmission%2520and%2520depressive%2520states%26jtitle%3DSynapse%26date%3D2000%26volume%3D35%26spage%3D79%26epage%3D95%26doi%3D10.1002%2F%28SICI%291098-2396%28200002%2935%3A2%3C79%3A%3AAID-SYN1%3E3.0.CO%3B2-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boksa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokrosz, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charakchieva-Minol, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatarczynska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klodzinska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesolowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misztal, S.</span></span> <span> </span><span class="NLM_article-title">2-H- and 2-acyl-9-{ω-[4-(2-methoxyphenyl)piperazinyl]-alkyl}-1,2,3,4-tetrahydro-β-carbolines as ligands of 5-HT1A and 5-HT2A receptors</span>. <i>Polym. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">508</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=11990069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvFOhurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2001&pages=501-508&author=J.+Boksaauthor=M.+J.+Mokroszauthor=S.+Charakchieva-Minolauthor=E.+Tatarczynskaauthor=A.+Klodzinskaauthor=A.+Wesolowskaauthor=S.+Misztal&title=2-H-+and+2-acyl-9-%7B%CF%89-%5B4-%282-methoxyphenyl%29piperazinyl%5D-alkyl%7D-1%2C2%2C3%2C4-tetrahydro-%CE%B2-carbolines+as+ligands+of+5-HT1A+and+5-HT2A+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">2-H- and 2-acyl-9-{ω-[4-(2-methoxyphenyl)piperazinyl]-alkyl} -1,2,3,4-tetrahydro-β-carbolines as ligands of 5-HT1A and 5-HT2A receptors</span></div><div class="casAuthors">Boksa, Jan; Mokrosz, Maria J.; Charakchieva-Minol, Sijka; Tatarczynska, Ewa; Klodzinska, Aleksandra; Wesolowska, Anna; Misztal, Stanislaw</div><div class="citationInfo"><span class="NLM_cas:title">Polish Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">501-508</span>CODEN:
                <span class="NLM_cas:coden">PJPAE3</span>;
        ISSN:<span class="NLM_cas:issn">1230-6002</span>.
    
            (<span class="NLM_cas:orgname">Polish Academy of Sciences, Institute of Pharmacology</span>)
        </div><div class="casAbstract">Three series of new unsubstituted or 2-acyl 1,2,3,4-tetrahydro-β-carbolines (THBC), connected to 1-(o-methoxyphenyl)piperazine by 2-, 3- or 4- -membered alkylene spacer in position 9, were synthesized and their 5-HT1A/5-HT2A receptor affinities and functional in vivo activities were investigated.  Radioligand binding studies showed that unsubstituted and acyl derivs. with prop-1,3-ylene and particularly with but-1,4-ylene (5) spacer had a high 5-HT1A receptor affinity (Ki = 30-110 nM), whereas the 5-HT1A affinity of derivs. with ethylene spacer was low.  All those compds. (except one, Ki = 44 nM) did not distinctly bind to 5-HT2A receptors.  The obtained results indicated that the length of an alkylene chain was a crucial parameter for detg. 5-HT1A receptor affinities of the tested compds., while acyl substituents in position 2 of THBC were not important for their 5-HT1A/5-HT2A activities.  It was also demonstrated that the few selected compds. with the highest affinity (Ki up to 50 nM) for 5-HT1A receptors, administered at doses of 10-20 mg/kg, behaved like antagonists of postsynaptic 5-HT1A receptors, as they reduced the 8-OH-DPAT (5-HT1A agonist)-induced lower lip retraction and behavioral syndrome in rats.  Moreover, one of compd. seemed to be an agonist of presynaptic 5-HT1A receptors, since the hypothermia induced by its administration was attenuated by WAY 100635 (5-HT1A antagonist).  One of the Compds., a 5-HT2A receptor ligand, demonstrated an antagonistic activity, as it inhibited the (±) DOI (5-HT2A agonist)-induced head twitches in mice.  The obtained results of in vivo studies suggest that introduction of different acyl substituents in position 2 of THBC with propylene or butylene spacer between tricyclous and arylpiperazine moiety is insignificant for the post-synaptic 5-HT1A receptor activity of the compds. tested in vivo.  On the other hand, only compd. with an acryloyl group and a butylene chain behaved like a 5-HT1A/5-HT2A antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruUh1zNe4VbbVg90H21EOLACvtfcHk0lhsU8nHyCqDEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvFOhurw%253D&md5=518b7b7922cd0be293af48c7e118c256</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoksa%26aufirst%3DJ.%26aulast%3DMokrosz%26aufirst%3DM.%2BJ.%26aulast%3DCharakchieva-Minol%26aufirst%3DS.%26aulast%3DTatarczynska%26aufirst%3DE.%26aulast%3DKlodzinska%26aufirst%3DA.%26aulast%3DWesolowska%26aufirst%3DA.%26aulast%3DMisztal%26aufirst%3DS.%26atitle%3D2-H-%2520and%25202-acyl-9-%257B%25CF%2589-%255B4-%25282-methoxyphenyl%2529piperazinyl%255D-alkyl%257D-1%252C2%252C3%252C4-tetrahydro-%25CE%25B2-carbolines%2520as%2520ligands%2520of%25205-HT1A%2520and%25205-HT2A%2520receptors%26jtitle%3DPolym.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D53%26spage%3D501%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foley, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Issa, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiller, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulcahy, S. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of 1-aryl-β-carbolines as affinity probes for the 5-hydroxytryptamine receptor</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">9807</span>– <span class="NLM_lpage">9812</span>, <span class="refDoi"> DOI: 10.1021/acsomega.9b01111</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.9b01111" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtV2jsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2019&pages=9807-9812&author=C.+A.+Foleyauthor=Y.+A.+Al-Issaauthor=K.+P.+Hillerauthor=S.+P.+Mulcahy&title=Synthesis+and+structure-activity+relationships+of+1-aryl-%CE%B2-carbolines+as+affinity+probes+for+the+5-hydroxytryptamine+receptor&doi=10.1021%2Facsomega.9b01111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of 1-Aryl-β-carbolines as Affinity Probes for the 5-Hydroxytryptamine Receptor</span></div><div class="casAuthors">Foley, Caroline A.; Al-Issa, Yazan A.; Hiller, Kathryn P.; Mulcahy, Seann P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">9807-9812</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Simple β-carbolines have been shown to bind several protein receptors that are important for signaling in the central nervous system.  Herein, we expand our previous efforts into the synthesis and biol. activity of these heterocycles by studying their neuropharmacol. activity.  A diverse set of 1-aryl-β-carbolines has been synthesized via Suzuki cross-coupling from a common triflate precursor and several substituted aryl boronic acids.  The resulting 26-member library was subjected to primary screening at 10 μM for activity against 40 protein receptors implicated in brain signaling.  The Ki was subsequently detd. for several lead structures.  The most potent activity, as low as 100 nM, was found against the 5-hydroxytryptamine subtype-2 family of receptors.  In-depth structure-activity relationships for these synthetic β-carbolines have been developed, which point to the importance of a 3-indolyl substituent attached to the 1-position of the β-carboline and a 6-methoxy substituent on the β-carboline core.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP9aOfqyWTsLVg90H21EOLACvtfcHk0lhsU8nHyCqDEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtV2jsb7I&md5=a8d6a31ab22a8920019da2749bda1854</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1021%2Facsomega.9b01111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.9b01111%26sid%3Dliteratum%253Aachs%26aulast%3DFoley%26aufirst%3DC.%2BA.%26aulast%3DAl-Issa%26aufirst%3DY.%2BA.%26aulast%3DHiller%26aufirst%3DK.%2BP.%26aulast%3DMulcahy%26aufirst%3DS.%2BP.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%25201-aryl-%25CE%25B2-carbolines%2520as%2520affinity%2520probes%2520for%2520the%25205-hydroxytryptamine%2520receptor%26jtitle%3DACS%2520Omega%26date%3D2019%26volume%3D4%26spage%3D9807%26epage%3D9812%26doi%3D10.1021%2Facsomega.9b01111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-F.</span></span> <span> </span><span class="NLM_article-title">The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer’s disease</span>. <i>Transl. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">19</span>, <span class="refDoi"> DOI: 10.1186/s40035-017-0089-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1186%2Fs40035-017-0089-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=28702178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltlClsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=19&author=S.-S.+Yangauthor=R.+Zhangauthor=G.+Wangauthor=Y.-F.+Zhang&title=The+development+prospection+of+HDAC+inhibitors+as+a+potential+therapeutic+direction+in+Alzheimer%E2%80%99s+disease&doi=10.1186%2Fs40035-017-0089-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer's disease</span></div><div class="casAuthors">Yang, Shuang-shuang; Zhang, Rui; Wang, Gang; Zhang, Yong-fang</div><div class="citationInfo"><span class="NLM_cas:title">Translational Neurodegeneration</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19/1-19/6</span>CODEN:
                <span class="NLM_cas:coden">TNREAP</span>;
        ISSN:<span class="NLM_cas:issn">2047-9158</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a chronic neurodegenerative disease, which is assocd. with learning and memory impairment in the elderly.  Recent studies have found that treating AD in the way of chromatin remodeling via histone acetylation is a promising therapeutic regimen.  In a no. of recent studies, inhibitors of histone deacetylase (HDACs) have been found to be a novel promising therapeutic agents for neurol. disorders, particularly for AD and other neurodegenerative diseases.  Although HDAC inhibitors have the ability to ameliorate cognitive impairment, successful treatments in the classic AD animal model are rarely translated into clin. trials.  As for the redn. of unwanted side effects, the development of HDAC inhibitors with increased isoform selectivity or seeking other directions is a key issue that needs to be addressed.  The review focused on literatures on epigenetic mechanisms in recent years, esp. on histone acetylation in terms of the enhancement of specificity, efficacy and avoiding side effects for treating AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsk05xY8AF9rVg90H21EOLACvtfcHk0lif08kEbW6adw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltlClsrw%253D&md5=8fa7452c294fb986aa1033691a39f871</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1186%2Fs40035-017-0089-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40035-017-0089-1%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.-S.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DY.-F.%26atitle%3DThe%2520development%2520prospection%2520of%2520HDAC%2520inhibitors%2520as%2520a%2520potential%2520therapeutic%2520direction%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTransl.%2520Neurodegener.%26date%3D2017%26volume%3D6%26spage%3D19%26doi%3D10.1186%2Fs40035-017-0089-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, X.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-F.</span></span> <span> </span><span class="NLM_article-title">Targeting HDACs: a promising therapy for Alzheimer’s Disease</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2011</i></span>,  <span class="NLM_fpage">143269</span>, <span class="refDoi"> DOI: 10.1155/2011/143269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1155%2F2011%2F143269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=21941604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADC%252BC3MflvVWitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=143269&author=K.+Xuauthor=X.-L.+Daiauthor=H.-C.+Huangauthor=Z.-F.+Jiang&title=Targeting+HDACs%3A+a+promising+therapy+for+Alzheimer%E2%80%99s+Disease&doi=10.1155%2F2011%2F143269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting HDACs: a promising therapy for Alzheimer's disease</span></div><div class="casAuthors">Xu Ke; Dai Xue-Ling; Huang Han-Chang; Jiang Zhao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Oxidative medicine and cellular longevity</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">143269</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Epigenetic modifications like DNA methylation and histone acetylation play an important role in a wide range of brain disorders.  Histone deacetylases (HDACs) regulate the homeostasis of histone acetylation.  Histone deacetylase inhibitors, which initially were used as anticancer drugs, are recently suggested to act as neuroprotectors by enhancing synaptic plasticity and learning and memory in a wide range of neurodegenerative and psychiatric disorders, such as Alzheimer's disease (AD) and Parkinson's disease (PD).  To reveal the physiological roles of HDACs may provide us with a new perspective to understand the mechanism of AD and to develop selective HDAC inhibitors.  This paper focuses on the recent research progresses of HDAC proteins and their inhibitors on the roles of the treatment for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRVYQlbx4kqny-c-E1v-fmfW6udTcc2eY1aFRgRiAaOLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MflvVWitA%253D%253D&md5=0f0bed71a4778db8838e676d9e2e81f7</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1155%2F2011%2F143269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2011%252F143269%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DK.%26aulast%3DDai%26aufirst%3DX.-L.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DJiang%26aufirst%3DZ.-F.%26atitle%3DTargeting%2520HDACs%253A%2520a%2520promising%2520therapy%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2011%26volume%3D2011%26spage%3D143269%26doi%3D10.1155%2F2011%2F143269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, X.</span></span> <span> </span><span class="NLM_article-title">Novel β-carboline/hydroxamic acid hybrids targeting both histone deacetylase and DNA display high anticancer activity via regulation of the p53 signaling pathway</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">9214</span>– <span class="NLM_lpage">9227</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01052</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01052" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVWnsb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9214-9227&author=Y.+Lingauthor=C.+Xuauthor=L.+Luoauthor=J.+Caoauthor=J.+Fengauthor=Y.+Xueauthor=Q.+Zhuauthor=C.+Juauthor=F.+Liauthor=Y.+Zhangauthor=Y.+Zhangauthor=X.+Ling&title=Novel+%CE%B2-carboline%2Fhydroxamic+acid+hybrids+targeting+both+histone+deacetylase+and+DNA+display+high+anticancer+activity+via+regulation+of+the+p53+signaling+pathway&doi=10.1021%2Facs.jmedchem.5b01052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Novel β-Carboline/Hydroxamic Acid Hybrids Targeting Both Histone Deacetylase and DNA Display High Anticancer Activity via Regulation of the p53 Signaling Pathway</span></div><div class="casAuthors">Ling, Yong; Xu, Chenjun; Luo, Lin; Cao, Jingyi; Feng, Jiao; Xue, Yu; Zhu, Qing; Ju, Caoyun; Li, Fengzhi; Zhang, Yihua; Zhang, Yanan; Ling, Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9214-9227</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of hybrids from β-carboline and hydroxamic acid were designed and synthesized.  Several compds. not only exerted significant antiproliferation activity against four human colorectal cancer (CRC) cell lines but also showed histone deacetylase inhibitory effects in vitro.  The most potent compd., I, exhibited anticancer potency sevenfold higher than that of SAHA. I triggered more significant cancer cell apoptosis than did SAHA by cleavage of both PARP and caspase 3 in a dose-dependent manner.  Furthermore, I simultaneously increased the acetylation of histone H3 and α-tubulin, enhanced expression of DNA damage markers histone H2AX phosphorylation and p-p53 (Ser15), and activated p53 signaling pathway in HCT116 cells.  Finally, I showed low acute toxicity in mice and inhibited the growth of implanted human CRC in mice more potently than did SAHA.  Together, I possessed potent antitumor activity and may be a promising candidate for the potential treatment of human CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgOotCbux7PrVg90H21EOLACvtfcHk0lif08kEbW6adw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVWnsb3O&md5=a7a5ce18806d731f8a5bf7d0eba63d72</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01052%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DJu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLing%26aufirst%3DX.%26atitle%3DNovel%2520%25CE%25B2-carboline%252Fhydroxamic%2520acid%2520hybrids%2520targeting%2520both%2520histone%2520deacetylase%2520and%2520DNA%2520display%2520high%2520anticancer%2520activity%2520via%2520regulation%2520of%2520the%2520p53%2520signaling%2520pathway%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D9214%26epage%3D9227%26doi%3D10.1021%2Facs.jmedchem.5b01052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">398</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.12.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2017.12.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=29288941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Kksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2018&pages=398-409&author=Y.+Lingauthor=J.+Guoauthor=Q.+Yangauthor=P.+Zhuauthor=J.+Miaoauthor=W.+Gaoauthor=Y.+Pengauthor=J.+Yangauthor=K.+Xuauthor=B.+Xiongauthor=G.+Liuauthor=J.+Taoauthor=L.+Luoauthor=Q.+Zhuauthor=Y.+Zhang&title=Development+of+novel+%CE%B2-carboline-based+hydroxamate+derivatives+as+HDAC+inhibitors+with+antiproliferative+and+antimetastatic+activities+in+human+cancer+cells&doi=10.1016%2Fj.ejmech.2017.12.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells</span></div><div class="casAuthors">Ling, Yong; Guo, Jing; Yang, Qiuxing; Zhu, Peng; Miao, Jiefei; Gao, Weijie; Peng, Yanfu; Yang, Jiaying; Xu, Kun; Xiong, Biao; Liu, Gongqing; Tao, Jinhua; Luo, Lin; Zhu, Qing; Zhang, Yanan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">398-409</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel β-carboline-based hydroxamate derivs. were designed and synthesized, and their biol. activities in a series of in vitro assays were evaluated.  Several of these β-carboline derivs. not only showed excellent HDAC1/3/6 inhibitory effects, but also displayed significant antitumor activities against five human cancer cells.  The most potent compd. I demonstrated the highest anticancer potency against cancer cell lines with IC50 values of 0.53-1.56 μM, which was considerably more potent than harmine (IC50 = 46.7-55.3 μM) and also three-to ten-fold lower than that of SAHA (IC50 = 4.48-6.26 μM).  Immunoblot anal. revealed that I dose-dependently inhibited histone H3 and α-tubulin acetylation, confirming its HDAC inhibitory effects.  Moreover, I significantly arrested HepG2 cells at G2/M phase through inhibiting cell cycle related protein CDK1 and cyclin B in a concn. dependent manner.  Interestingly, I also exerted strong anti-metastasis activity by simultaneously reducing the protein level of MMP2 and MMP9 and inhibiting MAPK signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP40En19G3YrVg90H21EOLACvtfcHk0ljFEcwN7sC62w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Kksg%253D%253D&md5=3f2af1df25fba676748a69d95b89feb4</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.12.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.12.061%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DMiao%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DXiong%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DTao%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DDevelopment%2520of%2520novel%2520%25CE%25B2-carboline-based%2520hydroxamate%2520derivatives%2520as%2520HDAC%2520inhibitors%2520with%2520antiproliferative%2520and%2520antimetastatic%2520activities%2520in%2520human%2520cancer%2520cells%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D144%26spage%3D398%26epage%3D409%26doi%3D10.1016%2Fj.ejmech.2017.12.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y.</span></span> <span> </span><span class="NLM_article-title">Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with DNA damage and apoptosis inducing abilities</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1213</span>– <span class="NLM_lpage">1219</span>, <span class="refDoi"> DOI: 10.1039/C6MD00681G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1039%2FC6MD00681G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=30108831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlt12lsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1213-1219&author=J.+Liuauthor=T.+Wangauthor=X.+Wangauthor=L.+Luoauthor=J.+Guoauthor=Y.+Pengauthor=Q.+Xuauthor=J.+Miaoauthor=Y.+Zhangauthor=Y.+Ling&title=Development+of+novel+%CE%B2-carboline-based+hydroxamate+derivatives+as+HDAC+inhibitors+with+DNA+damage+and+apoptosis+inducing+abilities&doi=10.1039%2FC6MD00681G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with DNA damage and apoptosis inducing abilities</span></div><div class="casAuthors">Liu, Ji; Wang, Tingting; Wang, Xinyang; Luo, Lin; Guo, Jing; Peng, Yanfu; Xu, Qibing; Miao, Jiefei; Zhang, Yanan; Ling, Yong</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1213-1219</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of novel β-carboline-based hydroxamate derivs. (8a-n) as HDAC inhibitors have been designed and synthesized.  Most of these compds. displayed potent histone deacetylase inhibitory effects and good antiproliferative activity with IC50s in the low micromolar range.  One of the most potent compds. (8k) showed the strongest inhibition of the proliferation of human hepatocellular carcinoma (HCC) cells in vitro, with IC50 values lower than that of the currently approved HDAC inhibitor SAHA.  Compd. 8k also increased acetylation of histone H3 and α-tubulin, consistent with its potent HDAC inhibition.  Importantly, 8k induced hypochromism by electrostatic interactions with CT-DNA, suggesting potential induction of DNA damage.  Finally, 8k significantly induced HepG2 cell apoptosis by regulating apoptotic relative proteins expression.  Together, our findings suggest that these novel β-carboline-based hydroxamate derivs. may provide a new framework for the discovery of novel antitumor agents for the intervention of human carcinoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokFVfBv2K3abVg90H21EOLACvtfcHk0lh-o04zxIkE6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlt12lsLw%253D&md5=98a212981539adea727be3d59dd38bba</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1039%2FC6MD00681G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MD00681G%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DMiao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLing%26aufirst%3DY.%26atitle%3DDevelopment%2520of%2520novel%2520%25CE%25B2-carboline-based%2520hydroxamate%2520derivatives%2520as%2520HDAC%2520inhibitors%2520with%2520DNA%2520damage%2520and%2520apoptosis%2520inducing%2520abilities%26jtitle%3DMedChemComm%26date%3D2017%26volume%3D8%26spage%3D1213%26epage%3D1219%26doi%3D10.1039%2FC6MD00681G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of C3-substituted β-carboline-based histone deacetylase inhibitors with potent antitumor activities</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">651</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1002%2Fcmdc.201700133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=28425177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtlSgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=646-651&author=Y.+Lingauthor=J.+Fengauthor=L.+Luoauthor=J.+Guoauthor=Y.+Pengauthor=T.+Wangauthor=X.+Geauthor=Q.+Xuauthor=X.+Wangauthor=H.+Daiauthor=Y.+Zhang&title=Design+and+synthesis+of+C3-substituted+%CE%B2-carboline-based+histone+deacetylase+inhibitors+with+potent+antitumor+activities&doi=10.1002%2Fcmdc.201700133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of C3-Substituted β-Carboline-Based Histone Deacetylase Inhibitors with Potent Antitumor Activities</span></div><div class="casAuthors">Ling, Yong; Feng, Jiao; Luo, Lin; Guo, Jing; Peng, Yanfu; Wang, Tingting; Ge, Xiang; Xu, Qibing; Wang, Xinyang; Dai, Hong; Zhang, Yanan</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">646-651</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of hydroxamic acid histone deacetylase (HDAC) inhibitors in which the β-carboline motif has been incorporated were designed and synthesized.  The effect of substitution at the C3 amide on HDAC inhibition and antiproliferative activities was investigated.  Most of these compds. were found to display significant HDAC inhibitory effects and good antiproliferative activity, with IC50 values in the low-micromolar range.  In particular, the HDAC inhibition IC50 value of N-(2-(dimethylamino)ethyl)-N-(4-(hydroxylcarbamoyl)benzyl)-1-(4-methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxamide (9 h) is five-fold lower than that of suberoylanilide hydroxamic acid (SAHA, vorinostat).  Furthermore, 9 h was found to increase the acetylation of histone H3 and α-tubulin, and to induce DNA damage as evidenced by hypochromism and enhanced phosphorylation of histone H2AX.  Compd. 9 h inhibits Stat3, Akt, and ERK signaling, important cell-growth-promoting pathways that are aberrantly activated in most cancers.  Finally, 9 h showed reasonable soly. and permeability in Caco-2 cells.  Our findings suggest that these novel β-carboline-based HDAC inhibitors may hold great promise as therapeutic agents for the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBREclS6eZbLVg90H21EOLACvtfcHk0liHE9ssLyHXzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtlSgsL0%253D&md5=4be538b8314386b032d38e9df5ab6325</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700133%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DY.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDai%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520C3-substituted%2520%25CE%25B2-carboline-based%2520histone%2520deacetylase%2520inhibitors%2520with%2520potent%2520antitumor%2520activities%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26spage%3D646%26epage%3D651%26doi%3D10.1002%2Fcmdc.201700133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brochier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Rational design and Simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">10842</span>– <span class="NLM_lpage">10846</span>, <span class="refDoi"> DOI: 10.1021/ja102758v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja102758v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ers7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=10842-10846&author=K.+V.+Butlerauthor=J.+Kalinauthor=C.+Brochierauthor=G.+Vistoliauthor=B.+Langleyauthor=A.+P.+Kozikowski&title=Rational+design+and+Simple+chemistry+yield+a+superior%2C+neuroprotective+HDAC6+inhibitor%2C+tubastatin+A&doi=10.1021%2Fja102758v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A</span></div><div class="casAuthors">Butler, Kyle V.; Kalin, Jay; Brochier, Camille; Vistoli, Guilio; Langley, Brett; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">10842-10846</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based drug design combined with homol. modeling techniques were used to develop potent inhibitors of HDAC6 that display superior selectivity for the HDAC6 isoenzyme compared to other inhibitors.  These inhibitors can be assembled in a few synthetic steps, and thus are readily scaled up for in vivo studies.  An optimized compd. from this series, designated Tubastatin A, was tested in primary cortical neuron cultures in which it was found to induce elevated levels of acetylated α-tubulin, but not histone, consistent with its HDAC6 selectivity.  Tubastatin A also conferred dose-dependent protection in primary cortical neuron cultures against glutathione depletion-induced oxidative stress.  Importantly, when given alone at all concns. tested, this hydroxamate-contg. HDAC6-selective compd. displayed no neuronal toxicity, thus, forecasting the potential application of this agent and its analogs to neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruEaJPWQfjH7Vg90H21EOLACvtfcHk0liHE9ssLyHXzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ers7k%253D&md5=f0cc68bb68f94ad1ef48f88cc6b57129</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Fja102758v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja102758v%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DKalin%26aufirst%3DJ.%26aulast%3DBrochier%26aufirst%3DC.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DLangley%26aufirst%3DB.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DRational%2520design%2520and%2520Simple%2520chemistry%2520yield%2520a%2520superior%252C%2520neuroprotective%2520HDAC6%2520inhibitor%252C%2520tubastatin%2520A%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D10842%26epage%3D10846%26doi%3D10.1021%2Fja102758v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akimova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">639</span>– <span class="NLM_lpage">651</span>, <span class="refDoi"> DOI: 10.1021/jm200773h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200773h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1SrtbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=639-651&author=J.+H.+Kalinauthor=K.+V.+Butlerauthor=T.+Akimovaauthor=W.+W.+Hancockauthor=A.+P.+Kozikowski&title=Second-generation+histone+deacetylase+6+inhibitors+enhance+the+immunosuppressive+effects+of+Foxp3%2B+T-regulatory+cells&doi=10.1021%2Fjm200773h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Second-Generation Histone Deacetylase 6 Inhibitors Enhance the Immunosuppressive Effects of Foxp3+ T-Regulatory Cells</span></div><div class="casAuthors">Kalin, Jay H.; Butler, Kyle V.; Akimova, Tatiana; Hancock, Wayne W.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">639-651</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Second-generation Tubastatin A analogs were synthesized and evaluated for their ability to inhibit selectively histone deacetylase 6 (HDAC6).  Substitutions to the carboline cap group were well-tolerated with substitution at the 2-position of both β- and γ-carbolines being optimal for HDAC6 activity and selectivity.  Some compds. in this series were detd. to have subnanomolar activity at HDAC6 with more than 7000 fold selectivity for HDAC6 vs. HDAC1.  Selected compds. were then evaluated for their ability to augment the immunosuppressive effect of Foxp3+ regulatory T cells.  All compds. tested were found to enhance the ability of regulatory T cells to inhibit the mitotic division of effector T cells both in vitro and in vivo, suggesting that further investigation into the use of these compds. for the treatment of autoimmune disorders is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzt2Rz2tD6ibVg90H21EOLACvtfcHk0liHE9ssLyHXzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1SrtbzM&md5=88a4f02045fdc5387970abe53ec00c7a</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fjm200773h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200773h%26sid%3Dliteratum%253Aachs%26aulast%3DKalin%26aufirst%3DJ.%2BH.%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DAkimova%26aufirst%3DT.%26aulast%3DHancock%26aufirst%3DW.%2BW.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DSecond-generation%2520histone%2520deacetylase%25206%2520inhibitors%2520enhance%2520the%2520immunosuppressive%2520effects%2520of%2520Foxp3%252B%2520T-regulatory%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D639%26epage%3D651%26doi%3D10.1021%2Fjm200773h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leonhardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellmer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krämer, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dove, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahboobi, S.</span></span> <span> </span><span class="NLM_article-title">Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.04.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2018.04.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=29738953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpt1agtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2018&pages=329-357&author=M.+Leonhardtauthor=A.+Sellmerauthor=O.+H.+Kr%C3%A4merauthor=S.+Doveauthor=S.+Elzauthor=B.+Krausauthor=M.+Beyerauthor=S.+Mahboobi&title=Design+and+biological+evaluation+of+tetrahydro-%CE%B2-carboline+derivatives+as+highly+potent+histone+deacetylase+6+%28HDAC6%29+inhibitors&doi=10.1016%2Fj.ejmech.2018.04.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors</span></div><div class="casAuthors">Leonhardt, Michel; Sellmer, Andreas; Kraemer, Oliver H.; Dove, Stefan; Elz, Sigurd; Kraus, Birgit; Beyer, Mandy; Mahboobi, Siavosh</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">329-357</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Various diseases are related to epigenetic modifications.  Histone deacetylases (HDACs) and histone acetyltransferases (HATs) det. the pattern of histone acetylation, and thus are involved in the regulation of gene expression.  First generation histone deacetylase inhibitors (HDACi) are unselective, hinder all different kinds of zinc dependent HDACs and addnl. cause several side effects.  Subsequently, selective HDACi are gaining more and more interest.  Esp., selective histone deacetylase 6 inhibitors (HDAC6i) are supposed to be less toxic.  Here the authors present a successful optimization study of tubastatin A, the synthesis and biol. evaluation of new inhibitors based on hydroxamic acids linked to various tetrahydro-β-carboline derivs.  The potency of the authors' selective HDAC6 inhibitors, exhibiting IC50 values in a range of 1-10 nM towards HDAC6, was evaluated with the help of a recombinant human HDAC6 enzyme assay.  Selectivity was proofed in cellular assays by the hyperacetylation of surrogate parameter α-tubulin in the absence of acetylated histone H3 analyzed by Western Blot.  The authors show that all synthesized compds., with varies modifications of the rigid cap group, were selective and potent HDAC6 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO3jAwqO8N0LVg90H21EOLACvtfcHk0lgsQH2eJ8QQ1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpt1agtbY%253D&md5=668b7ae179e680a0ae7116589e315cb5</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.04.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.04.046%26sid%3Dliteratum%253Aachs%26aulast%3DLeonhardt%26aufirst%3DM.%26aulast%3DSellmer%26aufirst%3DA.%26aulast%3DKr%25C3%25A4mer%26aufirst%3DO.%2BH.%26aulast%3DDove%26aufirst%3DS.%26aulast%3DElz%26aufirst%3DS.%26aulast%3DKraus%26aufirst%3DB.%26aulast%3DBeyer%26aufirst%3DM.%26aulast%3DMahboobi%26aufirst%3DS.%26atitle%3DDesign%2520and%2520biological%2520evaluation%2520of%2520tetrahydro-%25CE%25B2-carboline%2520derivatives%2520as%2520highly%2520potent%2520histone%2520deacetylase%25206%2520%2528HDAC6%2529%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D152%26spage%3D329%26epage%3D357%26doi%3D10.1016%2Fj.ejmech.2018.04.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grünstein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellmer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahboobi, S.</span></span> <span> </span><span class="NLM_article-title">Enantioselective synthesis and biological investigation of tetrahydro-β-carboline-based HDAC6 inhibitors with improved solubility</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>352</i></span>, <span class="NLM_elocation-id">e1900026</span> <span class="refDoi"> DOI: 10.1002/ardp.201900026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1002%2Fardp.201900026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=31056792" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2019&author=E.+Gr%C3%BCnsteinauthor=A.+Sellmerauthor=S.+Mahboobi&title=Enantioselective+synthesis+and+biological+investigation+of+tetrahydro-%CE%B2-carboline-based+HDAC6+inhibitors+with+improved+solubility&doi=10.1002%2Fardp.201900026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1002%2Fardp.201900026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201900026%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25BCnstein%26aufirst%3DE.%26aulast%3DSellmer%26aufirst%3DA.%26aulast%3DMahboobi%26aufirst%3DS.%26atitle%3DEnantioselective%2520synthesis%2520and%2520biological%2520investigation%2520of%2520tetrahydro-%25CE%25B2-carboline-based%2520HDAC6%2520inhibitors%2520with%2520improved%2520solubility%26jtitle%3DArch.%2520Pharm.%26date%3D2019%26volume%3D352%26doi%3D10.1002%2Fardp.201900026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel multiacting topoisomerase I/II and histone deacetylase inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1021/ml500327q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500327q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=239-243&author=S.+Heauthor=G.+Dongauthor=Z.+Wangauthor=W.+Chenauthor=Y.+Huangauthor=Z.+Liauthor=Y.+Jiangauthor=N.+Liuauthor=J.+Yaoauthor=Z.+Miaoauthor=W.+Zhangauthor=C.+Sheng&title=Discovery+of+novel+multiacting+topoisomerase+I%2FII+and+histone+deacetylase+inhibitors&doi=10.1021%2Fml500327q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase Inhibitors</span></div><div class="casAuthors">He, Shipeng; Dong, Guoqiang; Wang, Zhibin; Chen, Wei; Huang, Yahui; Li, Zhengang; Jiang, Yan; Liu, Na; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">239-243</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Designing multitarget drugs remains a significant challenge in current antitumor drug discovery.  Because of the synergistic effect between topoisomerase and HDAC inhibitors, the present study reported the first-in-class triple inhibitors of topoisomerase I/II and HDAC.  On the basis of 3-amino-10-hydroxylevodiamine and SAHA, a series of hybrid mols. was successfully designed and synthesized.  In particular, compd. 8c was proven to be a potent inhibitor of topoisomerase I/II and HDAC with good antiproliferative and apoptotic activities.  This proof-of-concept study also validated the effectiveness of discovering triple topoisomerase I/II and HDAC inhibitors as novel antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNFr6sR4u6kbVg90H21EOLACvtfcHk0lgsQH2eJ8QQ1Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVGitw%253D%253D&md5=9630a82acaa4df7023a07aa7ed395e86</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1021%2Fml500327q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500327q%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520novel%2520multiacting%2520topoisomerase%2520I%252FII%2520and%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D239%26epage%3D243%26doi%3D10.1021%2Fml500327q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mehndiratta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, L.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, J.-P.</span></span> <span> </span><span class="NLM_article-title">Indole-3-ethylsulfamoylphenylacrylamides: potent histone deacetylase inhibitors with anti-inflammatory activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.08.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2014.08.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=25113875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtleisr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=468-479&author=S.+Mehndirattaauthor=Y.-L.+Hsiehauthor=Y.-M.+Liuauthor=A.+W.+Wangauthor=H.-Y.+Leeauthor=L.-Y.+Liangauthor=S.+Kumarauthor=C.-M.+Tengauthor=C.-R.+Yangauthor=J.-P.+Liou&title=Indole-3-ethylsulfamoylphenylacrylamides%3A+potent+histone+deacetylase+inhibitors+with+anti-inflammatory+activity&doi=10.1016%2Fj.ejmech.2014.08.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Indole-3-ethylsulfamoylphenylacrylamides: Potent histone deacetylase inhibitors with anti-inflammatory activity</span></div><div class="casAuthors">Mehndiratta, Samir; Hsieh, Yi-Ling; Liu, Yi-Min; Wang, Amber Weiching; Lee, Hsueh-Yun; Liang, Lung-Yu; Kumar, Sunil; Teng, Che-Ming; Yang, Chia-Ron; Liou, Jing-Ping</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">468-479</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of 2-methyl-1H-indol-3-ethylsulfamoylphenylacrylamides based on the LBH589-PXD101 core have been synthesized and evaluated for their histone deacetylase (HDAC) inhibitory and anti-inflammatory activity.  In vitro, four of these compds. show 2.6-fold better HDAC inhibition and 3-fold better IL-6 suppression compared to LBH589·HCl.  Furthermore, these compds. did not show apparent cell viability suppression on macrophages while in contrast, treatment with LBH589·HCl. resulted in significant redn. in cell viability as demonstrated by an MTT assay.  Repressed expression of iNOS, COX-2 and reduced phosphorylation of p65 revealed the inhibitory effect of these analogs on inflammatory mediator release which is related to inhibited NF-kB signals.  N-Hydroxy-3-{3-[2-(2-methyl-1H-indol-3-yl)ethylsulfamoyl]phenyl}acrylamide (I) exhibited ability superior to that of LBH589·HCl. and was able to reduce carrageenan-induced acute inflammation in an animal model.  Several of these compds. have potential anti-inflammatory activity and compd. I can serve as the lead compd. for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJq3jOkXNVHrVg90H21EOLACvtfcHk0ljN43vcanDcGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtleisr%252FE&md5=3f5f8c998c188eb8541b7a33ce9494d7</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.08.020%26sid%3Dliteratum%253Aachs%26aulast%3DMehndiratta%26aufirst%3DS.%26aulast%3DHsieh%26aufirst%3DY.-L.%26aulast%3DLiu%26aufirst%3DY.-M.%26aulast%3DWang%26aufirst%3DA.%2BW.%26aulast%3DLee%26aufirst%3DH.-Y.%26aulast%3DLiang%26aufirst%3DL.-Y.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DTeng%26aufirst%3DC.-M.%26aulast%3DYang%26aufirst%3DC.-R.%26aulast%3DLiou%26aufirst%3DJ.-P.%26atitle%3DIndole-3-ethylsulfamoylphenylacrylamides%253A%2520potent%2520histone%2520deacetylase%2520inhibitors%2520with%2520anti-inflammatory%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D85%26spage%3D468%26epage%3D479%26doi%3D10.1016%2Fj.ejmech.2014.08.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span> <span> </span><span class="NLM_article-title">Multifactorial hypothesis and multi-targets for Alzheimer’s disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">S107</span>– <span class="NLM_lpage">S117</span>, <span class="refDoi"> DOI: 10.3233/JAD-179921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3233%2FJAD-179921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=29562523" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2018&pages=S107-S117&author=C.-X.+Gongauthor=F.+Liuauthor=K.+Iqbal&title=Multifactorial+hypothesis+and+multi-targets+for+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-179921"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.3233%2FJAD-179921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-179921%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DC.-X.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DIqbal%26aufirst%3DK.%26atitle%3DMultifactorial%2520hypothesis%2520and%2520multi-targets%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2018%26volume%3D64%26spage%3DS107%26epage%3DS117%26doi%3D10.3233%2FJAD-179921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichur, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godyn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasieka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malawska, B.</span></span> <span> </span><span class="NLM_article-title">Advances toward multifunctional cholinesterase and β-amyloid aggregation inhibitors</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1835</span>– <span class="NLM_lpage">1854</span>, <span class="refDoi"> DOI: 10.4155/fmc-2017-0094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.4155%2Ffmc-2017-0094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=28925729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFylsrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1835-1854&author=D.+Panekauthor=T.+Wichurauthor=J.+Godynauthor=A.+Pasiekaauthor=B.+Malawska&title=Advances+toward+multifunctional+cholinesterase+and+%CE%B2-amyloid+aggregation+inhibitors&doi=10.4155%2Ffmc-2017-0094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Advances toward multifunctional cholinesterase and β-amyloid aggregation inhibitors</span></div><div class="casAuthors">Panek, Dawid; Wichur, Tomasz; Godyn, Justyna; Pasieka, Anna; Malawska, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1835-1854</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">The emergence of a multitarget design approach in the development of new potential anti-Alzheimer's disease agents has resulted in the discovery of many multifunctional compds. focusing on various targets.  Among them the largest group comprises inhibitors of both cholinesterases, with addnl. anti-β-amyloid aggregation activity.  This review describes recent advances in this research area and presents the most interesting compds. reported over a 2-yr span (2015-2016).  The majority of hybrids possess heterodimeric structures obtained by linking structurally active fragments interacting with different targets.  Multipotent cholinesterase inhibitors with β-amyloid antiaggregating activity may addnl. possess antioxidative, neuroprotective or metal-chelating properties or less common features such as anti-β-secretase or τ-antiaggregation activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxd2zZfQmQp7Vg90H21EOLACvtfcHk0ljN43vcanDcGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFylsrfN&md5=5ea0721d2c8568c41567dd950c1e1aeb</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2017-0094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2017-0094%26sid%3Dliteratum%253Aachs%26aulast%3DPanek%26aufirst%3DD.%26aulast%3DWichur%26aufirst%3DT.%26aulast%3DGodyn%26aufirst%3DJ.%26aulast%3DPasieka%26aufirst%3DA.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DAdvances%2520toward%2520multifunctional%2520cholinesterase%2520and%2520%25CE%25B2-amyloid%2520aggregation%2520inhibitors%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D1835%26epage%3D1854%26doi%3D10.4155%2Ffmc-2017-0094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, P.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, L.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.-S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">299</span>– <span class="NLM_lpage">312</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2013.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=23501115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFejs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2013&pages=299-312&author=Y.+Heauthor=P.-F.+Yaoauthor=S.+Chenauthor=Z.+Huangauthor=S.-L.+Huangauthor=J.-T.+Tanauthor=D.+Liauthor=L.-Q.+Guauthor=Z.-S.+Huang&title=Synthesis+and+evaluation+of+7%2C8-dehydrorutaecarpine+derivatives+as+potential+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2013.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease</span></div><div class="casAuthors">He, Yan; Yao, Pei-Fen; Chen, Shuo-bin; Huang, Zhi-hong; Huang, Shi-Liang; Tan, Jia-Heng; Li, Ding; Gu, Lian-Quan; Huang, Zhi-Shu</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">299-312</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of 7,8-dehydrorutaecarpine derivs. were synthesized and characterized as potential multifunctional agents for treatment of Alzheimer's disease (AD).  All of these synthetic compds. showed high acetylcholinesterase (AChE) inhibitory activity with IC50 values ranged from 0.60 to 196.7 nM, and good selectivity for AChE over butyrylcholinesterase (BuChE) (125- to 3225-fold).  A Lineweaver-Burk plot and mol. modeling study indicated these compds. could bind to both catalytic active site and the peripheral anionic site of AChE.  Besides, compds. showed higher activity of inhibiting AChE-induced amyloid-beta (Aβ) aggregation than curcumin, higher anti-oxidative activity than Trolox, and could also be good metal chelators.  Considering their low cytotoxicity, our results indicated that these derivs. provide good templates for developing new multifunctional agents for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV3tzQW7M0x7Vg90H21EOLACvtfcHk0ljx-ZZ-uZ3zbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFejs7Y%253D&md5=c977a85f61bed7ae0b705d6cb1ebcad9</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DP.-F.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DS.-L.%26aulast%3DTan%26aufirst%3DJ.-T.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DL.-Q.%26aulast%3DHuang%26aufirst%3DZ.-S.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25207%252C8-dehydrorutaecarpine%2520derivatives%2520as%2520potential%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D63%26spage%3D299%26epage%3D312%26doi%3D10.1016%2Fj.ejmech.2013.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.05.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2019.05.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=31136894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVOjsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2019&pages=198-211&author=M.+Wuauthor=J.+Maauthor=L.+Jiauthor=M.+Wangauthor=J.+Hanauthor=Z.+Li&title=Design%2C+synthesis%2C+and+biological+evaluation+of+rutacecarpine+derivatives+as+multitarget-directed+ligands+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2019.05.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Wu, Mingfei; Ma, Jie; Ji, Lijun; Wang, Min; Han, Jianfei; Li, Zeng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">198-211</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of 3-amino-substituted rutacecarpine derivs. were synthesized to identify novel multitarget-directed ligands (MTDLs) for the treatment of Alzheimer's disease (AD).  Biol. evaluation showed that most of the synthesized compds. inhibited butyrylcholinesterase (BuChE) and exerted antioxidant effects.  Among the synthesized compds., I was subjected to further biol. evaluation.  Lineweaver-Burk plotting and mol. modeling illustrated that I bound simultaneously to the peripheral anionic site (PAS) and catalytic sites (CAS) of BuChE.  Furthermore, I modulated Aβ aggregation; chelated biometals; presented good absorption, distribution, metab., excretion, and toxicity properties; and showed remarkable neuroprotective activity.  Previous research has shown that the optimized compd. I has considerable potential for development as an MTDL for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB6vo8fb0dxLVg90H21EOLACvtfcHk0ljx-ZZ-uZ3zbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVOjsrbM&md5=f1b51d7c2a192cddc8520ac045e7fa09</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.05.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.05.055%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520rutacecarpine%2520derivatives%2520as%2520multitarget-directed%2520ligands%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D177%26spage%3D198%26epage%3D211%26doi%3D10.1016%2Fj.ejmech.2019.05.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.-Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer’s disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">6089</span>– <span class="NLM_lpage">6104</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.08.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmc.2014.08.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=25282654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFCnsbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=6089-6104&author=J.-S.+Lanauthor=S.-S.+Xieauthor=S.-Y.+Liauthor=L.-F.+Panauthor=X.-B.+Wangauthor=L.-Y.+Kong&title=Design%2C+synthesis+and+evaluation+of+novel+tacrine-%28%CE%B2-carboline%29+hybrids+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2014.08.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Lan, Jin-Shuai; Xie, Sai-Sai; Li, Su-Yi; Pan, Long-Fei; Wang, Xiao-Bing; Kong, Ling-Yi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6089-6104</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of tacrine-(β-carboline) hybrids were designed, synthesized and evaluated as multifunctional cholinesterase inhibitors against Alzheimer's disease.  In vitro studies showed that most of them exhibited significant potency to inhibit acetylcholinesterase (AChE and hAChE), butyrylcholinesterase (BuChE) and self-induced β-amyloid (Aβ) aggregation, Cu2+-induced Aβ (1-42) aggregation, and to chelate metal ions.  Compd. I had the greatest ability to inhibit cholinesterase (IC50, 21.6 nM for AChE, 63.2 nM for hAChE and 39.8 nM for BuChE), good inhibition of Aβ aggregation (65.8% at 20 μM) and good antioxidant activity (1.57 trolox equiv.).  Kinetic and mol. modeling studies indicated that I was a mixed-type inhibitor, binding simultaneously to the catalytic anionic site and the peripheral anionic site of AChE.  In addn., I could chelate metal ions, reduce PC12 cells death induced by oxidative stress and penetrate the blood-brain barrier.  These results suggested that I might be an excellent multifunctional agent for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonc2vpVkzQn7Vg90H21EOLACvtfcHk0lhLNzM65IThNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFCnsbnJ&md5=e13e874f9adb8855952c19fdcafce8ab</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.08.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.08.035%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DJ.-S.%26aulast%3DXie%26aufirst%3DS.-S.%26aulast%3DLi%26aufirst%3DS.-Y.%26aulast%3DPan%26aufirst%3DL.-F.%26aulast%3DWang%26aufirst%3DX.-B.%26aulast%3DKong%26aufirst%3DL.-Y.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520novel%2520tacrine-%2528%25CE%25B2-carboline%2529%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D6089%26epage%3D6104%26doi%3D10.1016%2Fj.bmc.2014.08.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and evaluation of novel bivalent β-carboline derivatives as multifunctional agents for the treatment of Alzheimer’s disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3812</span>– <span class="NLM_lpage">3824</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmc.2018.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=29960728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1agsbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=3812-3824&author=Y.+Zhaoauthor=F.+Yeauthor=J.+Xuauthor=Q.+Liaoauthor=L.+Chenauthor=W.+Zhangauthor=H.+Sunauthor=W.+Liuauthor=F.+Fengauthor=W.+Qu&title=Design%2C+synthesis+and+evaluation+of+novel+bivalent+%CE%B2-carboline+derivatives+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2018.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of novel bivalent β-carboline derivatives as multifunctional agents for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Zhao, Yifan; Ye, Feng; Xu, Jian; Liao, Qinghong; Chen, Lei; Zhang, Weijia; Sun, Haopeng; Liu, Wenyuan; Feng, Feng; Qu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3812-3824</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">To develop potent multi-target ligands against Alzheimer's disease (AD), a series of novel bivalent β-carboline derivs. were designed, synthesized, and evaluated.  In vitro studies revealed these compds. exhibited good multifunctional activities.  In particular, compds. 8f (N,N'-dimethyl-bis(1-(1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid Me ester) propan-1-one)ethylenediamine) and 8g (bis(1-(1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid Me ester) butan-1-one)piperazine) showed the good selectivity potency on BuChE inhibition (IC50 = 1.7 and 2.7 μM, resp.), Aβ1-42 disaggregation and neuroprotection.  Compared with the pos. control resveratrol, 8f and 8g showed better activity in inhibiting Aβ1-42 aggregation, with inhibitory rate 82.7% and 85.7% at 25 μM, resp.  Moreover, compds. 8e (bis(1-(1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid Me ester) propan-1-one)piperazine), 8f and 8g displayed excellent neuroprotective activity by ameliorating the impairment induced by H2O2, okadaic acid (OA) and Aβ1-42 without cytotoxicity in SH-SY5Y cells.  Thus, the present study evidently showed that compds. 8f and 8g are potent multifunctional agents against AD and might serve as promising lead candidates for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJbHSYxu1u3rVg90H21EOLACvtfcHk0lhLNzM65IThNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1agsbzO&md5=ef847d15386e4344139c1ee653a2f13b</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DQu%26aufirst%3DW.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520novel%2520bivalent%2520%25CE%25B2-carboline%2520derivatives%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D3812%26epage%3D3824%26doi%3D10.1016%2Fj.bmc.2018.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of novel carboline-cinnamic acid hybrids as multifunctional agents for treatment of Alzheimer’s disease</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">103844</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103844</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bioorg.2020.103844" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=32325336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BB3cXos1Sitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2020&pages=103844&author=Q.+Liaoauthor=Q.+Liauthor=Y.+Zhaoauthor=P.+Jiangauthor=Y.+Yanauthor=H.+Sunauthor=W.+Liuauthor=F.+Fengauthor=W.+Qu&title=Design%2C+synthesis+and+biological+evaluation+of+novel+carboline-cinnamic+acid+hybrids+as+multifunctional+agents+for+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bioorg.2020.103844"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of novel carboline-cinnamic acid hybrids as multifunctional agents for treatment of Alzheimer's disease</span></div><div class="casAuthors">Liao, Qinghong; Li, Qi; Zhao, Yifan; Jiang, Pan; Yan, Yuhui; Sun, Haopeng; Liu, Wenyuan; Feng, Feng; Qu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103844</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Herein, a series of carboline-cinnamic acid hybrids, compds. I [R1 = H, MeO; R2 = 4-OH, 3,4-(OMe)2, etc.] was designed and synthesized to obtain new multifunctional mols. with low toxicity and good physicochem. properties.  In particular, compds. I [R1 = H, MeO; R2 = 3,4-(OH)2] exhibited significant inhibition of Aβ aggregation (inhibitory rate at 25μM: 65% and 72% resp.), moderate BuChE inhibition, excellent neuroprotective effects and low neurotoxicity.  Furthermore, in the AD mice model, compds. I [R1 = H, MeO; R2 = 3,4-(OH)2] could restore learning and memory function to a comparable level to that of the control and did not exhibit any acute toxicity in vivo at a relatively high dose of 600 mg/kg.  Thus, these new compds. can be further studied as multifunctional mols. for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprFmQxWhmearVg90H21EOLACvtfcHk0lg7qee4PYrM5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXos1Sitrc%253D&md5=f0625bc4e4ae931dbf7cbed012574c9e</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103844%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DQu%26aufirst%3DW.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520carboline-cinnamic%2520acid%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D99%26spage%3D103844%26doi%3D10.1016%2Fj.bioorg.2020.103844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiaranaikulwanitch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govitrapong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fokin, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajragupta, O.</span></span> <span> </span><span class="NLM_article-title">From BACE1 inhibitor to multifunctionality tryptoline and tryptamine triazole derivatives for Alzheimer’s disease</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">8312</span>– <span class="NLM_lpage">8333</span>, <span class="refDoi"> DOI: 10.3390/molecules17078312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3390%2Fmolecules17078312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=22781443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2mtr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=8312-8333&author=J.+Jiaranaikulwanitchauthor=P.+Govitrapongauthor=V.+V.+Fokinauthor=O.+Vajragupta&title=From+BACE1+inhibitor+to+multifunctionality+tryptoline+and+tryptamine+triazole+derivatives+for+Alzheimer%E2%80%99s+disease&doi=10.3390%2Fmolecules17078312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">From BACE1 inhibitor to multifunctionality of tryptoline and tryptamine triazole derivatives for Alzheimer's disease</span></div><div class="casAuthors">Jiaranaikulwanitch, Jutamas; Govitrapong, Piyarat; Fokin, Valery V.; Vajragupta, Opa</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8312-8333</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Efforts to discover new drugs for Alzheimer's disease emphasizing multiple targets was conducted seeking to inhibit amyloid oligomer formation and to prevent radical formation.  The tryptoline and tryptamine cores of BACE1 inhibitors previously identified by virtual screening were modified in silico for addnl. modes of action.  These core structures were readily linked to different side chains using 1,2,3-triazole rings as bridges by copper catalyzed azide-alkyne cycloaddn. reactions.  Three compds. among the sixteen designed compds. exerted multifunctional activities including β-secretase inhibitory action, anti-amyloid aggregation, metal chelating and antioxidant effects at micromolar levels.  The neuroprotective effects of several multifunctional compds. induced neuronal cell death at 1 μM were significantly greater than those of the potent single target compd., a known BACE1 inhibitor and were comparable to curcumin.  The obsd. synergistic effect resulting from the redn. of the Aβ1-42 neurotoxicity cascade substantiates the validity of our multifunctional strategy in drug discovery for Alzheimer's disease.  The title compds. thus formed included (3S)-2,3,4,9-tetrahydro-3-[[4-(6-methoxy-2-naphthalenyl)-1H-1,2,3-triazol-1-yl]methyl]-1H-pyrido[3,4-b]indole (I) and related substances.  The synthesis of the target compds. was achieved by a cycloaddn. of (αS)-α-(azidomethyl)-1H-indole-3-ethanamine or (3S)-3-(azidomethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole with alkyne derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryOpIFtfQsLLVg90H21EOLACvtfcHk0lg7qee4PYrM5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2mtr3M&md5=7b4eedc2212e7ce15a001fdb760c198b</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.3390%2Fmolecules17078312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules17078312%26sid%3Dliteratum%253Aachs%26aulast%3DJiaranaikulwanitch%26aufirst%3DJ.%26aulast%3DGovitrapong%26aufirst%3DP.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DVajragupta%26aufirst%3DO.%26atitle%3DFrom%2520BACE1%2520inhibitor%2520to%2520multifunctionality%2520tryptoline%2520and%2520tryptamine%2520triazole%2520derivatives%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMolecules%26date%3D2012%26volume%3D17%26spage%3D8312%26epage%3D8333%26doi%3D10.3390%2Fmolecules17078312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiaranaikulwanitch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadtong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govitrapong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fokin, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajragupta, O.</span></span> <span> </span><span class="NLM_article-title">Neuritogenic activity of bi-functional bis-tryptoline triazole</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1201</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmc.2016.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=28043778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit12mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1195-1201&author=J.+Jiaranaikulwanitchauthor=S.+Tadtongauthor=P.+Govitrapongauthor=V.+V.+Fokinauthor=O.+Vajragupta&title=Neuritogenic+activity+of+bi-functional+bis-tryptoline+triazole&doi=10.1016%2Fj.bmc.2016.12.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Neuritogenic activity of bi-functional bis-tryptoline triazole</span></div><div class="casAuthors">Jiaranaikulwanitch, Jutamas; Tadtong, Sarin; Govitrapong, Piyarat; Fokin, Valery V.; Vajragupta, Opa</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1195-1201</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a common neurodegenerative disorder, one of the hallmarks of which is the deposition of aggregated β-amyloid peptides (Aβ40,42) as plaques in the brain.  Oligomers of these peptides have been reported to be toxic and to inhibit neurite outgrowth, as evidenced by neurite dystrophy and significant loss of synaptic connectivity of neurons in the AD brain resulting in cognitive decline.  These peptides also react with biol. metal in the brain to generate free radicals, thereby aggravating neuronal cell injury and death.  Herein, multifunctional triazole-based compds. acting on multiple targets, namely β-secretase (BACE1), β-amyloid peptides (Aβ) as well as those possessing metal chelation and antioxidant properties, were developed and evaluated for neuritogenic activity in P19-derived neurons.  At the non-cytotoxic concn. (1 nM), all multifunctional compds. significantly enhanced neurite outgrowth.  New bis-tryptoline triazole (BTT) increased the neurite length and neurite no., by 93.25% and 136.09% over the control, resp.  This finding demonstrates the ability of multifunctional compds. targeting Aβ to enhance neurite outgrowth in addn. to their neuroprotective action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0ZMBuiD49HbVg90H21EOLACvtfcHk0li1FO2Klgyl-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit12mtQ%253D%253D&md5=f98199404e438be0db02d1009af5e1b6</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DJiaranaikulwanitch%26aufirst%3DJ.%26aulast%3DTadtong%26aufirst%3DS.%26aulast%3DGovitrapong%26aufirst%3DP.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DVajragupta%26aufirst%3DO.%26atitle%3DNeuritogenic%2520activity%2520of%2520bi-functional%2520bis-tryptoline%2520triazole%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D1195%26epage%3D1201%26doi%3D10.1016%2Fj.bmc.2016.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Staay, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vente, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span> <span> </span><span class="NLM_article-title">Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1007/s00213-004-1967-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1007%2Fs00213-004-1967-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=15630588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslCi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2005&pages=381-390&author=J.+Prickaertsauthor=A.+Sikauthor=F.+J.+van+der%0AStaayauthor=J.+de+Venteauthor=A.+Blokland&title=Dissociable+effects+of+acetylcholinesterase+inhibitors+and+phosphodiesterase+type+5+inhibitors+on+object+recognition+memory%3A+acquisition+versus+consolidation&doi=10.1007%2Fs00213-004-1967-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation</span></div><div class="casAuthors">Prickaerts, Jos; Sik, Ayhan; Staay, Franz Josef; Vente, Jan; Blokland, Arjan</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">381-390</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Phosphodiesterase enzyme type 5 (PDE5) inhibitors and acetylcholinesterase (AChE) inhibitors have cognition-enhancing properties.  However, it is not known whether these drug classes affect the same memory processes.  The authors investigated the memory-enhancing effects of the PDE5 inhibitor sildenafil and AChE inhibitors metrifonate and donepezil in the object recognition task to find out whether acquisition or consolidation processes were affected by these drugs.  The object recognition task measures whether rats remembered an object they have explored in a previous learning trial.  All drugs were given orally 30 min before or immediately after learning to study acquisition and consolidation, resp.  Sildenafil given immediately after the 1st trial improved the memory performance after 24 h and resulted in an inverted U-shaped dose-effect curve with the peak dose at 3 mg/kg.  When given before the 1st trial, sildenafil also improved the memory performance.  However, the dose needed for the best performance under this condition was 10 mg/kg, suggesting that the dose-effect curve shifted to the right.  This can be explained by the metabolic clearance of the high dose of sildenafil.  Donepezil had no memory improving effect when given after the 1st trial.  However, when given before the 1st trial, a gradually increasing dose-effect curve was found which had its max. effect at the highest dose tested (1 mg/kg).  Likewise, only when metrifonate (30 mg/kg) was given before the 1st trial did rats show an improved memory performance.  The authors' data strongly suggest that PDE5 inhibitors improve processes of consolidation of object information, whereas AChE inhibitors improve processes of acquisition of object information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcXq9JR0IqT7Vg90H21EOLACvtfcHk0lj9HgdYyDYuvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslCi&md5=d60e39add7d18b9338b2a7e5a17ffb37</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1007%2Fs00213-004-1967-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-004-1967-7%26sid%3Dliteratum%253Aachs%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DSik%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BStaay%26aufirst%3DF.%2BJ.%26aulast%3Dde%2BVente%26aufirst%3DJ.%26aulast%3DBlokland%26aufirst%3DA.%26atitle%3DDissociable%2520effects%2520of%2520acetylcholinesterase%2520inhibitors%2520and%2520phosphodiesterase%2520type%25205%2520inhibitors%2520on%2520object%2520recognition%2520memory%253A%2520acquisition%2520versus%2520consolidation%26jtitle%3DPsychopharmacology%26date%3D2005%26volume%3D177%26spage%3D381%26epage%3D390%26doi%3D10.1007%2Fs00213-004-1967-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of orally available first-generation dual-target selective inhibitors of acetylcholinesterase (AChE) and phosphodiesterase 5 (PDE5) for the treatment of Alzheimer’s disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">345</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00345</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00345" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWrs7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=328-345&author=F.+Maoauthor=H.+Wangauthor=W.+Niauthor=X.+Zhengauthor=M.+Wangauthor=K.+Baoauthor=D.+Lingauthor=X.+Liauthor=Y.+Xuauthor=H.+Zhangauthor=J.+Li&title=Design%2C+synthesis%2C+and+biological+evaluation+of+orally+available+first-generation+dual-target+selective+inhibitors+of+acetylcholinesterase+%28AChE%29+and+phosphodiesterase+5+%28PDE5%29+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facschemneuro.7b00345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Mao, Fei; Wang, Huan; Ni, Wei; Zheng, Xinyu; Wang, Manjiong; Bao, Keting; Ling, Dazheng; Li, Xiaokang; Xu, Yixiang; Zhang, Haiyan; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">328-345</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Through drug discovery strategies of repurposing and redeveloping existing drugs, a series of novel tadalafil derivs. were rationally designed, synthesized, and evaluated to seek dual-target AChE/PDE5 inhibitors as good candidate drugs for Alzheimer's disease (AD).  Among these derivs., (6R,12aR)-6-(benzo[d][1,3]dioxol-5-yl)-2-(2-(1-benzylpiperidin-4yl)ethyl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione (1p, I) and (6R,12aS)-6-(benzo[d][1,3]dioxol-5-yl)-2-(2-(1-benzylpiperidin-4yl)ethyl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione (1w, II) exhibited excellent selective dual-target AChE/PDE5 inhibitory activities and improved blood-brain barrier (BBB) penetrability.  Importantly, II·Cit (citrate of II) could reverse the cognitive dysfunction of scopolamine-induced AD mice and exhibited an excellent effect on enhancing cAMP response element-binding protein (CREB) phosphorylation in vivo, a crucial factor in memory formation and synaptic plasticity.  Moreover, the mol. docking simulations of II with hAChE and hPDE5A confirmed that the design strategy was rational.  In summary, the research provides a potential selective dual-target AChE/PDE5 inhibitor as a good candidate drug for the treatment of AD, and it could also be regarded as a small mol. probe to validate the novel AD therapeutic approach in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoThEyISqB-vrVg90H21EOLACvtfcHk0ligqvorP4SXiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWrs7rF&md5=f681ad7b8ce0bf011d30d36a869eedd0</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00345%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DNi%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DBao%26aufirst%3DK.%26aulast%3DLing%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520orally%2520available%2520first-generation%2520dual-target%2520selective%2520inhibitors%2520of%2520acetylcholinesterase%2520%2528AChE%2529%2520and%2520phosphodiesterase%25205%2520%2528PDE5%2529%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26spage%3D328%26epage%3D345%26doi%3D10.1021%2Facschemneuro.7b00345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ni, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Novel tadalafil derivatives ameliorates scopolamine-induced cognitive impairment in mice via inhibition of acetylcholinesterase (AChE) and phosphodiesterase 5 (PDE5)</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1625</span>– <span class="NLM_lpage">1636</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmvFansbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1625-1636&author=W.+Niauthor=H.+Wangauthor=X.+Liauthor=X.+Zhengauthor=M.+Wangauthor=J.+Zhangauthor=Q.+Gongauthor=D.+Lingauthor=F.+Maoauthor=H.+Zhangauthor=J.+Li&title=Novel+tadalafil+derivatives+ameliorates+scopolamine-induced+cognitive+impairment+in+mice+via+inhibition+of+acetylcholinesterase+%28AChE%29+and+phosphodiesterase+5+%28PDE5%29&doi=10.1021%2Facschemneuro.8b00014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Tadalafil Derivatives Ameliorates Scopolamine-Induced Cognitive Impairment in Mice via Inhibition of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5)</span></div><div class="casAuthors">Ni, Wei; Wang, Huan; Li, Xiaokang; Zheng, Xinyu; Wang, Manjiong; Zhang, Jian; Gong, Qi; Ling, Dazheng; Mao, Fei; Zhang, Haiyan; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1625-1636</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of the drug-repositioning and redeveloping strategy, first-generation dual-target inhibitors of acetylcholinesterase (AChE) and phosphodiesterase 5 (PDE5) have been recently reported as a potentially novel therapeutic method for the treatment of Alzheimer's disease (AD), and the lead compd. 2 has proven this method was feasible in AD mouse models.  In this study, our work focused on exploring alternative novel tadalafil derivs. (3a-s).  Among the 19 analogs, compd. I exhibited good selective dual-target AChE/PDE5 inhibition and good blood-brain barrier (BBB) permeability.  Moreover, its citrate (3c·Cit) possessed improved water soly. and good effects against scopolamine-induced cognitive impairment with inhibition of cortical AChE activities and enhancement of cAMP response element-binding protein (CREB) phosphorylation ex vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGYmE-ZOSvnLVg90H21EOLACvtfcHk0ligqvorP4SXiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmvFansbY%253D&md5=4bcd7bac48de27c00afbea39949d331c</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00014%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DLing%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DNovel%2520tadalafil%2520derivatives%2520ameliorates%2520scopolamine-induced%2520cognitive%2520impairment%2520in%2520mice%2520via%2520inhibition%2520of%2520acetylcholinesterase%2520%2528AChE%2529%2520and%2520phosphodiesterase%25205%2520%2528PDE5%2529%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26spage%3D1625%26epage%3D1636%26doi%3D10.1021%2Facschemneuro.8b00014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Otto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penzis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaube, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adolph, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Föhr, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warncke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robaa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appenroth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleck, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enzensperger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winckler, T.</span></span> <span> </span><span class="NLM_article-title">Evaluation of homobivalent carbolines as designed multiple ligands for the treatment of neurodegenerative disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6710</span>– <span class="NLM_lpage">6715</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00958</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00958" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlequ7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6710-6715&author=R.+Ottoauthor=R.+Penzisauthor=F.+Gaubeauthor=O.+Adolphauthor=K.+J.+F%C3%B6hrauthor=P.+Warnckeauthor=D.+Robaaauthor=D.+Appenrothauthor=C.+Fleckauthor=C.+Enzenspergerauthor=J.+Lehmannauthor=T.+Winckler&title=Evaluation+of+homobivalent+carbolines+as+designed+multiple+ligands+for+the+treatment+of+neurodegenerative+disorders&doi=10.1021%2Facs.jmedchem.5b00958"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Homobivalent Carbolines as Designed Multiple Ligands for the Treatment of Neurodegenerative Disorders</span></div><div class="casAuthors">Otto, Robert; Penzis, Robert; Gaube, Friedemann; Adolph, Oliver; Foehr, Karl J.; Warncke, Paul; Robaa, Dina; Appenroth, Dorothea; Fleck, Christian; Enzensperger, Christoph; Lehmann, Jochen; Winckler, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6710-6715</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurodegenerative diseases represent a challenge for biomedical research due to their high prevalence and lack of mechanism-based treatments.  Because of the complex pathol. of neurodegenerative disorders, multifunctional drugs have been increasingly recognized as potential treatments.  We identified homobivalent γ-carbolinium salts as potent inhibitors of both cholinesterases, N-methyl-D-aspartate receptors, and monoamine oxidases.  Homobivalent γ-carbolines displayed similar structure-activity relationships on all tested targets and may present promising designed multiple ligands for the treatment of neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoggGUTF85gz7Vg90H21EOLACvtfcHk0lhVpOasO3vUXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlequ7fP&md5=ccd884b3ed035287c7bbfd5bf17582c8</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00958%26sid%3Dliteratum%253Aachs%26aulast%3DOtto%26aufirst%3DR.%26aulast%3DPenzis%26aufirst%3DR.%26aulast%3DGaube%26aufirst%3DF.%26aulast%3DAdolph%26aufirst%3DO.%26aulast%3DF%25C3%25B6hr%26aufirst%3DK.%2BJ.%26aulast%3DWarncke%26aufirst%3DP.%26aulast%3DRobaa%26aufirst%3DD.%26aulast%3DAppenroth%26aufirst%3DD.%26aulast%3DFleck%26aufirst%3DC.%26aulast%3DEnzensperger%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DWinckler%26aufirst%3DT.%26atitle%3DEvaluation%2520of%2520homobivalent%2520carbolines%2520as%2520designed%2520multiple%2520ligands%2520for%2520the%2520treatment%2520of%2520neurodegenerative%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6710%26epage%3D6715%26doi%3D10.1021%2Facs.jmedchem.5b00958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Arias, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Miguel, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Gonzalez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espelosin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haizhong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span> <span> </span><span class="NLM_article-title">Impact of scaffold exploration on novel dual-acting histone deacetylases and phosphodiesterase 5 inhibitors for the treatment of Alzheimer’s disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">638</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00370</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00370" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVKqtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=638-661&author=J.+A.+Sanchez-Ariasauthor=O.+Rabalauthor=M.+Cuadrado-Tejedorauthor=I.+de+Miguelauthor=M.+Perez-Gonzalezauthor=A.+Ugarteauthor=E.+Saezauthor=M.+Espelosinauthor=S.+Ursuaauthor=T.+Haizhongauthor=W.+Weiauthor=X.+Mushengauthor=A.+Garcia-Ostaauthor=J.+Oyarzabal&title=Impact+of+scaffold+exploration+on+novel+dual-acting+histone+deacetylases+and+phosphodiesterase+5+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facschemneuro.6b00370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of Scaffold Exploration on Novel Dual-Acting Histone Deacetylases and Phosphodiesterase 5 Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Sanchez-Arias, Juan A.; Rabal, Obdulia; Cuadrado-Tejedor, Mar; de Miguel, Irene; Perez-Gonzalez, Marta; Ugarte, Ana; Saez, Elena; Espelosin, Maria; Ursua, Susana; Haizhong, Tan; Wei, Wu; Musheng, Xu; Garcia-Osta, Ana; Oyarzabal, Julen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">638-661</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel systems therapeutics approach, involving simultaneous inhibition of phosphodiesterase 5 (PDE5) and histone deacetylase (HDAC), has been validated as a potentially novel therapeutic strategy for the treatment of Alzheimer's disease (AD).  First-in-class dual inhibitors bearing a sildenafil core have been very recently reported, and the lead mol. CM-414 has proven this strategy in AD animal models.  Because scaffolds may play a crit. role in primary activities and ADME-Tox profiling as well as on intellectual property, the authors have explored alternative scaffolds (vardenafil- and tadalafil-based cores) and evaluated their impact on crit. parameters such as primary activities, permeability, toxicity, and in vivo (pharmacokinetics and functional response in hippocampus) to identify a potential alternative lead mol. bearing a different chemotype for in vivo testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKdULOaIw0N7Vg90H21EOLACvtfcHk0lhVpOasO3vUXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVKqtL3F&md5=ac897538f818e202a961eb7c74acd8f5</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00370%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez-Arias%26aufirst%3DJ.%2BA.%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3Dde%2BMiguel%26aufirst%3DI.%26aulast%3DPerez-Gonzalez%26aufirst%3DM.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3DSaez%26aufirst%3DE.%26aulast%3DEspelosin%26aufirst%3DM.%26aulast%3DUrsua%26aufirst%3DS.%26aulast%3DHaizhong%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DMusheng%26aufirst%3DX.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26aulast%3DOyarzabal%26aufirst%3DJ.%26atitle%3DImpact%2520of%2520scaffold%2520exploration%2520on%2520novel%2520dual-acting%2520histone%2520deacetylases%2520and%2520phosphodiesterase%25205%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D638%26epage%3D661%26doi%3D10.1021%2Facschemneuro.6b00370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Arias, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Miguel, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Gonzalez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estella-Hermoso de Mendoza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espelosin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haizhong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of in vivo chemical probes for treating Alzheimer’s disease: dual phosphodiesterase 5 (PDE5) and class I histone deacetylase selective inhibitors</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1765</span>– <span class="NLM_lpage">1782</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00648</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00648" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVKjtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1765-1782&author=O.+Rabalauthor=J.+A.+Sanchez-Ariasauthor=M.+Cuadrado-Tejedorauthor=I.+de+Miguelauthor=M.+Perez-Gonzalezauthor=C.+Garcia-Barrosoauthor=A.+Ugarteauthor=A.+Estella-Hermoso+de+Mendozaauthor=E.+Saezauthor=M.+Espelosinauthor=S.+Ursuaauthor=T.+Haizhongauthor=W.+Weiauthor=X.+Mushengauthor=A.+Garcia-Ostaauthor=J.+Oyarzabal&title=Discovery+of+in+vivo+chemical+probes+for+treating+Alzheimer%E2%80%99s+disease%3A+dual+phosphodiesterase+5+%28PDE5%29+and+class+I+histone+deacetylase+selective+inhibitors&doi=10.1021%2Facschemneuro.8b00648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of in Vivo Chemical Probes for Treating Alzheimer's Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors</span></div><div class="casAuthors">Rabal, Obdulia; Sanchez-Arias, Juan A.; Cuadrado-Tejedor, Mar; de Miguel, Irene; Perez-Gonzalez, Marta; Garcia-Barroso, Carolina; Ugarte, Ana; Estella-Hermoso de Mendoza, Ander; Saez, Elena; Espelosin, Maria; Ursua, Susana; Haizhong, Tan; Wei, Wu; Musheng, Xu; Garcia-Osta, Ana; Oyarzabal, Julen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1765-1782</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In order to det. the contributions of histone deacetylase (HDAC) isoforms to the beneficial effects of dual phosphodiesterase 5 (PDE5) and pan-HDAC inhibitors on in vivo models of Alzheimer's disease (AD), we have designed, synthesized, and tested novel chem. probes with the desired target compd. profile of PDE5 and class I HDAC selective inhibitors.  Compared to previous hydroxamate-based series, these mols. exhibit longer residence times on HDACs.  In this scenario, shorter or longer preincubation times may have a significant impact on the IC50 values of these compds. and therefore on their corresponding selectivity profiles on the different HDAC isoforms.  On the other hand, different chem. series have been explored and, as expected, some pairwise comparisons show a clear impact of the scaffold on biol. responses.  The lead identification process led to compd. I, which shows an adequate ADME-Tox profile and in vivo target engagement (histone acetylation and cAMP/cGMP response element-binding (CREB) phosphorylation) in the central nervous system (CNS), suggesting that this compd. represents an optimized chem. probe; thus, I has been assayed in a mouse model of AD (Tg2576).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpMx-DcLUAMrVg90H21EOLACvtfcHk0liRpfS-bWESLg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVKjtLvF&md5=d3d13a9121111b166ea69c09106eb3c5</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00648%26sid%3Dliteratum%253Aachs%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DSanchez-Arias%26aufirst%3DJ.%2BA.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3Dde%2BMiguel%26aufirst%3DI.%26aulast%3DPerez-Gonzalez%26aufirst%3DM.%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3DEstella-Hermoso%2Bde%2BMendoza%26aufirst%3DA.%26aulast%3DSaez%26aufirst%3DE.%26aulast%3DEspelosin%26aufirst%3DM.%26aulast%3DUrsua%26aufirst%3DS.%26aulast%3DHaizhong%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DMusheng%26aufirst%3DX.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26aulast%3DOyarzabal%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520in%2520vivo%2520chemical%2520probes%2520for%2520treating%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520dual%2520phosphodiesterase%25205%2520%2528PDE5%2529%2520and%2520class%2520I%2520histone%2520deacetylase%2520selective%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D1765%26epage%3D1782%26doi%3D10.1021%2Facschemneuro.8b00648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">ElHady, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeton, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Halim, M.</span></span> <span> </span><span class="NLM_article-title">Extending the use of tadalafil scaffold: Development of novel selective phosphodiesterase 5 inhibitors and histone deacetylase inhibitors</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">103742</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103742</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bioorg.2020.103742" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=32199305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADC%252BB383mtFGhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2020&pages=103742&author=A.+K.+ElHadyauthor=S.-P.+Shihauthor=Y.-C.+Chenauthor=Y.-C.+Liuauthor=N.+S.+Ahmedauthor=A.+B.+Keetonauthor=G.+A.+Piazzaauthor=M.+Engelauthor=A.+H.+Abadiauthor=M.+Abdel-Halim&title=Extending+the+use+of+tadalafil+scaffold%3A+Development+of+novel+selective+phosphodiesterase+5+inhibitors+and+histone+deacetylase+inhibitors&doi=10.1016%2Fj.bioorg.2020.103742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Extending the use of tadalafil scaffold: Development of novel selective phosphodiesterase 5 inhibitors and histone deacetylase inhibitors</span></div><div class="casAuthors">ElHady Ahmed K; Ahmed Nermin S; Abadi Ashraf H; Shih Shou-Ping; Chen Yu-Cheng; Liu Yi-Chang; Keeton Adam B; Piazza Gary A; Engel Matthias; Abdel-Halim Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103742</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Herein we present the synthesis and characterization of a novel chemical series of tadalafil analogues that display different pharmacological profiles.  Compounds that have the 6R, 12aR configuration and terminal carboxylic acid group at the side chain arising from the piperazinedione nitrogen were potent PDE5 inhibitors, with compound 11 having almost equal potency to tadalafil and superior selectivity over PDE11, the most common off-target for tadalafil.  Modifying the stereochemistry into 6S, 12aS configuration and adopting the hydroxamic acid moiety as a terminal group gave rise to compounds that only inhibited HDAC.  Dual PDE5/HDAC inhibition could be achieved with compounds having 6R, 12aR configuration and hydroxamic acid moiety as a terminal group.  The anticancer activity of the synthesized compounds was evaluated against a diverse number of cell lines of different origin.  The compounds elicited anticancer activity against cell lines belonging to lymphoproliferative cancer as well as solid tumors.  Despite the previous reports suggesting anticancer activity of PDE5 inhibitors, the growth inhibitory activity of the compounds seemed to be solely dependent on HDAC inhibition.  Compound 26 (pan HDAC IC50 = 14 nM, PDE5 IC50 = 46 nM) displayed the most potent anticancer activity in the present series and was shown to induce apoptosis in Molt-4 cells.  HDAC isoform selectivity testing for compound 26 showed that it is more selective for HDAC6 and 8 over HDAC1 by more than 20-fold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKSTByA9pE9wHqQV89nF-2fW6udTcc2eb0A5PNNVM6CLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB383mtFGhsg%253D%253D&md5=ebfd14af9b97a2e0b7782878622a7062</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103742%26sid%3Dliteratum%253Aachs%26aulast%3DElHady%26aufirst%3DA.%2BK.%26aulast%3DShih%26aufirst%3DS.-P.%26aulast%3DChen%26aufirst%3DY.-C.%26aulast%3DLiu%26aufirst%3DY.-C.%26aulast%3DAhmed%26aufirst%3DN.%2BS.%26aulast%3DKeeton%26aufirst%3DA.%2BB.%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DEngel%26aufirst%3DM.%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26aulast%3DAbdel-Halim%26aufirst%3DM.%26atitle%3DExtending%2520the%2520use%2520of%2520tadalafil%2520scaffold%253A%2520Development%2520of%2520novel%2520selective%2520phosphodiesterase%25205%2520inhibitors%2520and%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D98%26spage%3D103742%26doi%3D10.1016%2Fj.bioorg.2020.103742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 2 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenwu  Liu</span>, <span class="hlFld-ContribAuthor ">Xin  Liu</span>, <span class="hlFld-ContribAuthor ">Liting  Tian</span>, <span class="hlFld-ContribAuthor ">Yaping  Gao</span>, <span class="hlFld-ContribAuthor ">Wenjie  Liu</span>, <span class="hlFld-ContribAuthor ">Huanhua  Chen</span>, <span class="hlFld-ContribAuthor ">Xiaowen  Jiang</span>, <span class="hlFld-ContribAuthor ">Zihua  Xu</span>, <span class="hlFld-ContribAuthor ">Huaiwei  Ding</span>, <span class="hlFld-ContribAuthor ">Qingchun  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of harmine derivatives as potent GSK-3β/DYRK1A dual inhibitors for the treatment of Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>222 </em>, 113554. <a href="https://doi.org/10.1016/j.ejmech.2021.113554" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113554</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113554%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bharmine%252Bderivatives%252Bas%252Bpotent%252BGSK-3%2525CE%2525B2%25252FDYRK1A%252Bdual%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%252527s%252Bdisease%26aulast%3DLiu%26aufirst%3DWenwu%26date%3D2021%26volume%3D222%26spage%3D113554" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Giovanni  Ribaudo</span>, <span class="hlFld-ContribAuthor ">Maurizio  Memo</span>, <span class="hlFld-ContribAuthor ">Alessandra  Gianoncelli</span>. </span><span class="cited-content_cbyCitation_article-title">Multi-target Natural and Nature-Inspired Compounds against Neurodegeneration: A Focus on Dual Cholinesterase and Phosphodiesterase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Applied Sciences</span><span> <strong>2021,</strong> <em>11 </em>
                                    (11)
                                     , 5044. <a href="https://doi.org/10.3390/app11115044" title="DOI URL">https://doi.org/10.3390/app11115044</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/app11115044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fapp11115044%26sid%3Dliteratum%253Aachs%26jtitle%3DApplied%2520Sciences%26atitle%3DMulti-target%252BNatural%252Band%252BNature-Inspired%252BCompounds%252Bagainst%252BNeurodegeneration%25253A%252BA%252BFocus%252Bon%252BDual%252BCholinesterase%252Band%252BPhosphodiesterase%252BInhibitors%26aulast%3DRibaudo%26aufirst%3DGiovanni%26date%3D2021%26date%3D2021%26volume%3D11%26issue%3D11%26spage%3D5044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0029.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0029.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Numbering of the β-carboline scaffold. Structure of representative β-carbolines in various oxidation states (<b>1</b>–<b>3</b>) and derivatives from natural sources (<b>4</b>–<b>7</b>) and drug discovery (<b>8</b>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Selected structures and IC<sub>50</sub> of simple substituted β-carbolines as AChE and/or BuChE inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Selected structures and IC<sub>50</sub> of β-carboliniums as AChE and/or BuChE inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Selected structures and IC<sub>50</sub> of natural or bioinspired extended β-carbolines as AChE and/or BuChE inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Selected structures and IC<sub>50</sub> of β-carbolines as BACE1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Selected structures, IC<sub>50</sub> and aggregation inhibition percentages of β-carbolines as Aβ aggregation inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Selected structures and IC<sub>50</sub> (or <i>K</i><sub>i</sub> where indicated) of β-carbolines as inhibitors of tau phosphorylation kinases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. (A) Crystal structure of <b>1</b> (in green) bound to DYRK1A (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ANR">3ANR</a>). (B) Crystal structure of <b>41d</b> (in mauve) bound to DYRK1A (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UWY">6UWY</a>). (C) Crystal structure of <b>44</b> (in blue) bound to DYRK1A (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YU2">4YU2</a>). (D) Crystal structure of <b>46</b> (in pink) bound to CLK1 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YTG">6YTG</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Selected structures and IC<sub>50</sub> (or <i>K</i><sub>i</sub> where indicated) of β-carbolines as MAO-A/B inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. (A) Crystal structure of <b>1</b> (in green) bound to MAO-A (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z5X">2Z5X</a>). (B) Overlay of crystal structures of <b>1</b> (in green) bound to MAO-A (in gold, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z5X">2Z5X</a>) and of MAO-B (in silver, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OJ9">1OJ9</a>). In orange, the FAD cofactor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Selected structures and IC<sub>50</sub> (or <i>K</i><sub>i</sub> where indicated) of 1-aryl dihydro-β-carbolines as PDE5 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Selected structures and IC<sub>50</sub> of β-carbolines with a fused hydantoin ring or analogue as PDE5 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Selected structures and IC<sub>50</sub> of β-carbolines with a fused piperazinedione ring as PDE5 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. (A) Crystal structure of <b>8</b> (in orange) bound to PDE5 (PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UDU">1UDU</a>). (B) Overlay of crystal structures of <b>8</b> (in orange) bound to PDE5 (in gold, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UDU">1UDU</a>) and of PDE4 (in silver, PDB code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WCU">4WCU</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Selected structures and IC<sub>50</sub> of β-carbolines as glutamate receptors binders.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Selected structures and IC<sub>50</sub> of 3- and 4-substituted β-carbolines as GABA<sub>A</sub> ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. GABA<sub>A</sub> efficacy continuum of β-carbolines 3-esters as a function of the ester chain length.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig18" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 18</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 18. Selected structures of second-generation β-carbolines as GABA<sub>A</sub> ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig18"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig19" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 19</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0019.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 19. Selected structures and IC<sub>50</sub> (or <i>K</i><sub>i</sub> where indicated) of fused β-carboline-based aromatic derivatives as GABA<sub>A</sub> ligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig19"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig20" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Figure 20</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0020.jpeg" id="rightTab-gr20" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 20. Selected structures and <i>K</i><sub>i</sub> of tetrahydro-β-carbolines as ligands of various subtypes of 5-HT receptors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig20"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig21" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Figure 21</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0021.jpeg" id="rightTab-gr21" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 21. Selected structures and <i>K</i><sub>i</sub> of dihydro- and fully aromatic β-carbolines as ligands of 5-HT receptors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig21"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig22" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Figure 22</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0022.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0022.jpeg" id="rightTab-gr22" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 22. Selected structures and IC<sub>50</sub> (or <i>K</i><sub>i</sub> where indicated) of β-carbolines as inhibitors of HDAC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig22"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig23" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Figure 23</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0023.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0023.jpeg" id="rightTab-gr23" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 23. Selected structures, IC<sub>50</sub>, and aggregation inhibition percentages of β-carbolines as multitarget agents, inhibitors of AChE/BuChE and Aβ aggregation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0023.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig23"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig24" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Figure 24</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0024.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0024.jpeg" id="rightTab-gr24" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 24. Selected structures, IC<sub>50</sub> and aggregation inhibition percentages of β-carbolines as multitarget agents, inhibitors of BACE1 and Aβ aggregation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0024.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig24"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig25" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Figure 25</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0025.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0025.jpeg" id="rightTab-gr25" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 25. Selected structures and IC<sub>50</sub> of β-carbolines as multitarget agents, inhibitors of AChE and PDE5.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0025.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig25"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig26" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Figure 26</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0026.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0026.jpeg" id="rightTab-gr26" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 26. Selected structures and IC<sub>50</sub> of β-carbolines as multitarget agents, inhibitors of AChE/BuChE and NMDA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0026.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig26"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig27" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Figure 27</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0027.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0027.jpeg" id="rightTab-gr27" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 27. Selected structures and IC<sub>50</sub> of β-carbolines as multitarget agents, inhibitors of PDE5 and HDAC.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0027.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig27"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig28" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Figure 28</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/medium/jm0c01887_0028.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0028.jpeg" id="rightTab-gr28" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 28. Overview of crucial (++), favorable (+) and unfavorable (−) elements of SAR regarding the effect of β-carbolines on the previously mentioned AD-related targets.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-3/acs.jmedchem.0c01887/20210204/images/large/jm0c01887_0028.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c01887&amp;id=fig28"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i45">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_86054" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_86054" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 179 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, A.</span></span> <span> </span><span class="NLM_article-title">β-Carboline alkaloids: biochemical and pharmacological functions</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">479</span>– <span class="NLM_lpage">500</span>, <span class="refDoi"> DOI: 10.2174/092986707779940998</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.2174%2F092986707779940998" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=17305548" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhs1yhu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2007&pages=479-500&author=R.+Caoauthor=W.+Pengauthor=Z.+Wangauthor=A.+Xu&title=%CE%B2-Carboline+alkaloids%3A+biochemical+and+pharmacological+functions&doi=10.2174%2F092986707779940998"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">β-Carboline alkaloids: biochemical and pharmacological functions</span></div><div class="casAuthors">Cao, Rihui; Peng, Wenlie; Wang, Zihou; Xu, Anlong</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">479-500</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  β-Carboline alkaloids are a large group of natural and synthetic indole alkaloids with different degrees of aromaticity, some of which are widely distributed in nature, including various plants, foodstuffs, marine creatures, insects, mammalians as well as human tissues and body fluids.  These compds. are of great interest due to their diverse biol. activities.  Particularly, these compds. have been shown to intercalate into DNA, to inhibit CDK, Topoisomerase, and monoamine oxidase, and to interact with benzodiazepine receptors and 5-hydroxy serotonin receptors.  Furthermore, these chems. also demonstrated a broad spectrum of pharmacol. properties including sedative, anxiolytic, hypnotic, anticonvulsant, antitumor, antiviral, antiparasitic as well as antimicrobial activities.  In this review, we summarized the biochem. and pharmacol. functions of β-carboline alkaloids.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrweya4vQLb5bVg90H21EOLACvtfcHk0limZZ4mPZTI5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhs1yhu78%253D&md5=5a5bb8fc6c45e4880249d1d6c3df3d27</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.2174%2F092986707779940998&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986707779940998%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DR.%26aulast%3DPeng%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DA.%26atitle%3D%25CE%25B2-Carboline%2520alkaloids%253A%2520biochemical%2520and%2520pharmacological%2520functions%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2007%26volume%3D14%26spage%3D479%26epage%3D500%26doi%3D10.2174%2F092986707779940998" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dai, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dan, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span> <span> </span><span class="NLM_article-title">β-Carboline alkaloids monomers and dimers: occurrence, structural diversity, and biological activities</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>157</i></span>,  <span class="NLM_fpage">622</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.08.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2018.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=30125723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFOqsb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=157&publication_year=2018&pages=622-656&author=J.+Daiauthor=W.+Danauthor=U.+Schneiderauthor=J.+Wang&title=%CE%B2-Carboline+alkaloids+monomers+and+dimers%3A+occurrence%2C+structural+diversity%2C+and+biological+activities&doi=10.1016%2Fj.ejmech.2018.08.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">β-Carboline alkaloid monomers and dimers: Occurrence, structural diversity, and biological activities</span></div><div class="casAuthors">Dai, Jiangkun; Dan, Wenjia; Schneider, Uwe; Wang, Junru</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">157</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">622-656</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A review.  β-Carboline alkaloids are a family of natural and synthetic products with great structural diversity and outstanding biol. activities.  This review covers critically important developments in the field of β-carbolines, predominantly over the past decade (2006-2017).  It is focused on both natural and synthetic monomers as well as dimers, and includes key information on occurrence, structural diversity, and biol. activities.  In cases where sufficient information is available, the structure-activity relation (SAR) and mechanism of their biol. activities are presented.  In addn., innovative syntheses of the β-carboline core and potential future directions are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGocA6exouyLkLVg90H21EOLACvtfcHk0lgGKx2ao-W1Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFOqsb7J&md5=920aa3e66da1ba5599847e3b35a698d3</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.08.027%26sid%3Dliteratum%253Aachs%26aulast%3DDai%26aufirst%3DJ.%26aulast%3DDan%26aufirst%3DW.%26aulast%3DSchneider%26aufirst%3DU.%26aulast%3DWang%26aufirst%3DJ.%26atitle%3D%25CE%25B2-Carboline%2520alkaloids%2520monomers%2520and%2520dimers%253A%2520occurrence%252C%2520structural%2520diversity%252C%2520and%2520biological%2520activities%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D157%26spage%3D622%26epage%3D656%26doi%3D10.1016%2Fj.ejmech.2018.08.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nikam, T. D.</span>; <span class="NLM_string-name">Nitnaware, K. M.</span>; <span class="NLM_string-name">Ahire, M. L.</span></span> <span> </span><span class="NLM_article-title">Alkaloids Derived from Tryptophan: Harmine and Related Alkaloids</span>. In  <i>Natural Products</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramawat, K. G.</span>, <span class="NLM_string-name">Mérillon, J.-M.</span></span>, Eds.; <span class="NLM_publisher-name">Springer</span>: <span class="NLM_publisher-loc">Berlin, Heidelberg</span>, <span class="NLM_year">2013</span>; pp  <span class="NLM_fpage">553</span>– <span class="NLM_lpage">574</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1007%2F978-3-642-22144-6_20" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=553-574&author=T.+D.+Nikam&author=K.+M.+Nitnaware&author=M.+L.+Ahireauthor=K.+G.+Ramawat&author=J.-M.+M%C3%A9rillon&title=Natural+Products"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1007%2F978-3-642-22144-6_20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1007%252F978-3-642-22144-6_20%26sid%3Dliteratum%253Aachs%26aulast%3DNikam%26aufirst%3DT.%2BD.%26atitle%3DAlkaloids%2520Derived%2520from%2520Tryptophan%253A%2520Harmine%2520and%2520Related%2520Alkaloids%26btitle%3DNatural%2520Products%26aulast%3DRamawat%26aufirst%3DK.%2BG.%26pub%3DSpringer%26date%3D2013%26spage%3D553%26epage%3D574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abeysinghe, A. A. D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deshapriya, R. D. U. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udawatte, C.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease; a review of the pathophysiological basis and therapeutic intervention</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>256</i></span>,  <span class="NLM_fpage">117996</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2020.117996</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.lfs.2020.117996" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=32585249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlWnsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=256&publication_year=2020&pages=117996&author=A.+A.+D.+T.+Abeysingheauthor=R.+D.+U.+S.+Deshapriyaauthor=C.+Udawatte&title=Alzheimer%E2%80%99s+disease%3B+a+review+of+the+pathophysiological+basis+and+therapeutic+intervention&doi=10.1016%2Fj.lfs.2020.117996"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease; a review of the pathophysiological basis and therapeutic interventions</span></div><div class="casAuthors">Abeysinghe, A. A. D. T.; Deshapriya, R. D. U. S.; Udawatte, C.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">256</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">117996</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a neurodegenerative disorder and is identified as the most common cause for dementia.  Despite huge global economic burden and the impact on the close family of the patients, there is no definitive cure and thus, improved treatment methods are of need.  While memory and cognition are severely affected in AD, exact etiol. is yet unknown.  The β-Amyloid plaque formation and aggregation hypothesis is among the well-known hypotheses used to explain disease pathogenesis.  Currently there are five Food and Drug Administration (FDA) approved drugs as treatment options.  All these drugs are used for symptomatic treatment of AD.  Thus, disease modifying therapies which can directly address the pathol. changes in AD, are needed.  Such therapies could be designed based on inhibiting key steps of pathogenesis.  Currently there are novel AD drug candidates with various therapeutic mechanisms, undergoing different stages of drug development.  Extensive research is being done globally to broaden understanding of the exact mechanisms involved in AD and to develop therapeutic agents that can successfully hinder the occurrence and progression of the disease.  In this review, a comprehensive approach to understanding AD and suggestions to be considered in the development of therapeutics for it are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXyoafzRz7Z7Vg90H21EOLACvtfcHk0lgGKx2ao-W1Aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlWnsrbM&md5=85aa42fe67fa61a4a40284a77f595077</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2020.117996&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2020.117996%26sid%3Dliteratum%253Aachs%26aulast%3DAbeysinghe%26aufirst%3DA.%2BA.%2BD.%2BT.%26aulast%3DDeshapriya%26aufirst%3DR.%2BD.%2BU.%2BS.%26aulast%3DUdawatte%26aufirst%3DC.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253B%2520a%2520review%2520of%2520the%2520pathophysiological%2520basis%2520and%2520therapeutic%2520intervention%26jtitle%3DLife%2520Sci.%26date%3D2020%26volume%3D256%26spage%3D117996%26doi%3D10.1016%2Fj.lfs.2020.117996" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mohamed, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, P. P. N.</span></span> <span> </span><span class="NLM_article-title">Alzheimer’s disease: emerging trends in small molecule therapies</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">4299</span>– <span class="NLM_lpage">4320</span>, <span class="refDoi"> DOI: 10.2174/092986711797200435</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.2174%2F092986711797200435" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=21861820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtlSqsrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2011&pages=4299-4320&author=T.+Mohamedauthor=P.+P.+N.+Rao&title=Alzheimer%E2%80%99s+disease%3A+emerging+trends+in+small+molecule+therapies&doi=10.2174%2F092986711797200435"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Alzheimer's disease: emerging trends in small molecule therapies</span></div><div class="casAuthors">Mohamed, T.; Rao, P. P. N.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">4299-4320</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is a highly complex and rapidly progressive neurodegenerative disorder characterized by the systemic collapse of cognitive function and formation of dense amyloid plaques and neurofibrillary tangles.  AD pathol. is derived from the cholinergic, amyloid and tau hypotheses, resp.  Current pharmacotherapy with known anti-cholinesterases, such as Aricept and Exelon, only offer symptomatic relief without any disease-modifying effects.  It is now clear that in order to prevent the rapid progression of AD, new therapeutic treatments should target multiple AD pathways as opposed to the traditional "one drug, one target" approach.  This review will focus on the recent advances in medicinal chem. aimed at the development of small mol. therapies that target various AD pathol. routes such as the cholinesterases (AChE and BuChE), amyloidogenic secretases (β/γ - secretase), amyloid-β aggregation, tau phosphorylation and fibrillation and metal-ion redox/reactive oxygen species (ROS).  Some notable ring templates will be discussed along with their structure-activity relationship (SAR) data and their multiple modes of action.  These emerging trends signal a paradigm shift in anti-AD therapies aimed at the development of multifunctional small mols. as disease modifying agents (DMAs).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq7KOYLD281AbVg90H21EOLACvtfcHk0lgiK9cCQX2Img"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtlSqsrbO&md5=a8528d67ebe66b8e8f29079a37edb6e4</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.2174%2F092986711797200435&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986711797200435%26sid%3Dliteratum%253Aachs%26aulast%3DMohamed%26aufirst%3DT.%26aulast%3DRao%26aufirst%3DP.%2BP.%2BN.%26atitle%3DAlzheimer%25E2%2580%2599s%2520disease%253A%2520emerging%2520trends%2520in%2520small%2520molecule%2520therapies%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2011%26volume%3D18%26spage%3D4299%26epage%3D4320%26doi%3D10.2174%2F092986711797200435" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, B.</span></span> <span> </span><span class="NLM_article-title">Progress in target drug molecules for Alzheimer’s disease</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">4</span>– <span class="NLM_lpage">36</span>, <span class="refDoi"> DOI: 10.2174/1568026619666191203113745</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.2174%2F1568026619666191203113745" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=31797761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjs1Wrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2020&pages=4-36&author=J.+Xieauthor=R.+Liangauthor=Y.+Wangauthor=J.+Huangauthor=X.+Caoauthor=B.+Niu&title=Progress+in+target+drug+molecules+for+Alzheimer%E2%80%99s+disease&doi=10.2174%2F1568026619666191203113745"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Progress in Target Drug Molecules for Alzheimer's Disease</span></div><div class="casAuthors">Xie, Jiayang; Liang, Ruirui; Wang, Yajiang; Huang, Junyi; Cao, Xin; Niu, Bing</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">4-36</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a chronic neurodegenerative disease that 4 widespread in the elderly.  The etiol. of AD is complicated, and its pathogenesis is still unclear.  Although there are many researches on anti-AD drugs, they are limited to reverse relief symptoms and cannot treat diseases.  Therefore, the development of high-efficiency anti-AD drugs with no side effects has become an urgent need.  Based on the published literature, this paper summarizes the main targets of AD and their drugs, and focuses on the research and development progress of these drugs in recent years.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-wKjH6SnEo7Vg90H21EOLACvtfcHk0lgiK9cCQX2Img"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjs1Wrsbo%253D&md5=c287b0068f23a4c9a169fadf92759e11</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.2174%2F1568026619666191203113745&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1568026619666191203113745%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DCao%26aufirst%3DX.%26aulast%3DNiu%26aufirst%3DB.%26atitle%3DProgress%2520in%2520target%2520drug%2520molecules%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2020%26volume%3D20%26spage%3D4%26epage%3D36%26doi%3D10.2174%2F1568026619666191203113745" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">León, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marco-Contelles, J.</span></span> <span> </span><span class="NLM_article-title">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer’s disease</span>. <i>Med. Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1002/med.20248</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1002%2Fmed.20248" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=21793014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2013&pages=139-189&author=R.+Le%C3%B3nauthor=A.+G.+Garciaauthor=J.+Marco-Contelles&title=Recent+advances+in+the+multitarget-directed+ligands+approach+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1002%2Fmed.20248"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Recent advances in the multitarget-directed ligands approach for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Leon, Rafael; Garcia, Antonio G.; Marco-Contelles, Jose</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">139-189</span>CODEN:
                <span class="NLM_cas:coden">MRREDD</span>;
        ISSN:<span class="NLM_cas:issn">0198-6325</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons, Inc.</span>)
        </div><div class="casAbstract">A review.  With 27 million cases worldwide documented in 2006, Alzheimer's disease (AD) constitutes an overwhelming health, social, economic, and political problem to nations.  Unless a new medicine capable to delay disease progression is found, the no. of cases will reach 107 million in 2050.  So far, the therapeutic paradigm one-compd.-one-target has failed.  This could be due to the multiple pathogenic mechanisms involved in AD including amyloid β (Aβ) aggregation to form plaques, τ hyperphosphorylation to disrupt microtubule to form neurofibrillary tangles, calcium imbalance, enhanced oxidative stress, impaired mitochondrial function, apoptotic neuronal death, and deterioration of synaptic transmission, particularly at cholinergic neurons.  Approx. 100 compds. are presently been investigated directed to single targets, namely inhibitors of β and γ secretase, vaccines or antibodies that clear Aβ, metal chelators to inhibit Aβ aggregation, blockers of glycogen synthase kinase 3β, enhancers of mitochondrial function, antioxidants, modulators of calcium-permeable channels such as voltage-dependent calcium channels, N-methyl-D-aspartate receptors for glutamate, or enhancers of cholinergic neurotransmission such as inhibitors of acetylcholinesterase or butyrylcholinesterase.  In view of this complex pathogenic mechanisms, and the successful treatment of chronic diseases such as HIV or cancer, with multiple drugs having complementary mechanisms of action, the concern is growing that AD could better be treated with a single compd. targeting two or more of the pathogenic mechanisms leading to neuronal death.  This review summarizes the current therapeutic strategies based on the paradigm one-compd.-various targets to treat AD.  A treatment that delays disease onset and/or progression by 5 years could halve the no. of people requiring institutionalization and/or dying from AD.  © 2011 Wiley Periodicals, Inc.  Med Res Rev.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YQ_Czzj5brVg90H21EOLACvtfcHk0lgiK9cCQX2Img"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVCktrvL&md5=b08806a8a4ca71c35a3594338c881e74</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1002%2Fmed.20248&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmed.20248%26sid%3Dliteratum%253Aachs%26aulast%3DLe%25C3%25B3n%26aufirst%3DR.%26aulast%3DGarcia%26aufirst%3DA.%2BG.%26aulast%3DMarco-Contelles%26aufirst%3DJ.%26atitle%3DRecent%2520advances%2520in%2520the%2520multitarget-directed%2520ligands%2520approach%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMed.%2520Res.%2520Rev.%26date%3D2013%26volume%3D33%26spage%3D139%26epage%3D189%26doi%3D10.1002%2Fmed.20248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guzior, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wieckowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malawska, B.</span></span> <span> </span><span class="NLM_article-title">Recent development of multifunctional agents as potential drug candidates for the treatment of Alzheimer’s disease</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">404</span>, <span class="refDoi"> DOI: 10.2174/0929867321666141106122628</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.2174%2F0929867321666141106122628" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=373-404&author=N.+Guziorauthor=A.+Wieckowskaauthor=D.+Panekauthor=B.+Malawska&title=Recent+development+of+multifunctional+agents+as+potential+drug+candidates+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.2174%2F0929867321666141106122628"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2174%2F0929867321666141106122628&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867321666141106122628%26sid%3Dliteratum%253Aachs%26aulast%3DGuzior%26aufirst%3DN.%26aulast%3DWieckowska%26aufirst%3DA.%26aulast%3DPanek%26aufirst%3DD.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DRecent%2520development%2520of%2520multifunctional%2520agents%2520as%2520potential%2520drug%2520candidates%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D373%26epage%3D404%26doi%3D10.2174%2F0929867321666141106122628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maramai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benchekroun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabr, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yahiaoui, S.</span></span> <span> </span><span class="NLM_article-title">Multitarget therapeutic strategies for Alzheimer’s disease: review on emerging target combinations</span>. <i>BioMed Res. Int.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>2020</i></span>,  <span class="NLM_fpage">5120230</span>, <span class="refDoi"> DOI: 10.1155/2020/5120230</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1155%2F2020%2F5120230" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=32714977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADC%252BB38jnsVOgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2020&publication_year=2020&pages=5120230&author=S.+Maramaiauthor=M.+Benchekrounauthor=M.+T.+Gabrauthor=S.+Yahiaoui&title=Multitarget+therapeutic+strategies+for+Alzheimer%E2%80%99s+disease%3A+review+on+emerging+target+combinations&doi=10.1155%2F2020%2F5120230"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget Therapeutic Strategies for Alzheimer's Disease: Review on Emerging Target Combinations</span></div><div class="casAuthors">Maramai Samuele; Benchekroun Mohamed; Gabr Moustafa T; Yahiaoui Samir</div><div class="citationInfo"><span class="NLM_cas:title">BioMed research international</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">2020</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">5120230</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Neurodegenerative diseases represent nowadays one of the major health problems.  Despite the efforts made to unveil the mechanism leading to neurodegeneration, it is still not entirely clear what triggers this phenomenon and what allows its progression.  Nevertheless, it is accepted that neurodegeneration is a consequence of several detrimental processes, such as protein aggregation, oxidative stress, and neuroinflammation, finally resulting in the loss of neuronal functions.  Starting from these evidences, there has been a wide search for novel agents able to address more than a single event at the same time, the so-called multitarget-directed ligands (MTDLs).  These compounds originated from the combination of different pharmacophoric elements which endowed them with the ability to interfere with different enzymatic and/or receptor systems, or to exert neuroprotective effects by modulating proteins and metal homeostasis.  MTDLs have been the focus of the latest strategies to discover a new treatment for Alzheimer's disease (AD), which is considered the most common form of dementia characterized by neurodegeneration and cognitive dysfunctions.  This review is aimed at collecting the latest and most interesting target combinations for the treatment of AD, with a detailed discussion on new agents with favorable in vitro properties and on optimized structures that have already been assessed in vivo in animal models of dementia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTf-nmJ6xXlVC86Js-BCLiifW6udTcc2eYlLC09lm_fgrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38jnsVOgtA%253D%253D&md5=ab46a4d0bdd352cadf2f0257ef40ac84</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1155%2F2020%2F5120230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2020%252F5120230%26sid%3Dliteratum%253Aachs%26aulast%3DMaramai%26aufirst%3DS.%26aulast%3DBenchekroun%26aufirst%3DM.%26aulast%3DGabr%26aufirst%3DM.%2BT.%26aulast%3DYahiaoui%26aufirst%3DS.%26atitle%3DMultitarget%2520therapeutic%2520strategies%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520review%2520on%2520emerging%2520target%2520combinations%26jtitle%3DBioMed%2520Res.%2520Int.%26date%3D2020%26volume%3D2020%26spage%3D5120230%26doi%3D10.1155%2F2020%2F5120230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ghosal, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharya, S.K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehta, R.</span></span> <span> </span><span class="NLM_article-title">Naturally occurring and synthetic β-carbolines as cholinesterase inhibitors</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">1972</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">808</span>– <span class="NLM_lpage">810</span>, <span class="refDoi"> DOI: 10.1002/jps.2600610535</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1002%2Fjps.2600610535" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=5035798" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaE38Xks12qurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=1972&pages=808-810&author=S.+Ghosalauthor=S.K.+Bhattacharyaauthor=R.+Mehta&title=Naturally+occurring+and+synthetic+%CE%B2-carbolines+as+cholinesterase+inhibitors&doi=10.1002%2Fjps.2600610535"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Naturally occurring and synthetic β-carbolines as cholinesterase inhibitors</span></div><div class="casAuthors">Ghosal, S.; Bhattacharya, S. K.; Mehta, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">1972</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">808-10</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    </div><div class="casAbstract">The inhibitory activities of a no. of naturally occurring and synthetic aromatic and tetrahydro-β-carbolines toward true cholinesterases [9001-08-5] and pseudocholinesterases [9001-08-5] were detd.  Some quaternary aromatic β-carbolines such as 3-methylindolo[2,3-c]pyridinium (I) [17994-14-8] had .sim.1/6th the in vitro anticholinesterase activity of physostigmine [57-47-6].  The tertiary aromatic β-carbolines tested such as pyrido[3,4-b]indole [244-63-3] had only weak activity and the tetrahydro-β-carbolines tested were inactive.  Structure-activity relations involved in the anticholinesterase activity of β-carbolines were discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMZLz-6JyEnbVg90H21EOLACvtfcHk0lj7uLHvxdcjLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE38Xks12qurw%253D&md5=ad81c6748cc10db1d89be884ef6f10cc</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fjps.2600610535&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.2600610535%26sid%3Dliteratum%253Aachs%26aulast%3DGhosal%26aufirst%3DS.%26aulast%3DBhattacharya%26aufirst%3DS.K.%26aulast%3DMehta%26aufirst%3DR.%26atitle%3DNaturally%2520occurring%2520and%2520synthetic%2520%25CE%25B2-carbolines%2520as%2520cholinesterase%2520inhibitors%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D1972%26volume%3D61%26spage%3D808%26epage%3D810%26doi%3D10.1002%2Fjps.2600610535" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Otto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penzis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaube, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winckler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appenroth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleck, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tränkle, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enzensperger, C.</span></span> <span> </span><span class="NLM_article-title">Beta and gamma carboline derivatives as potential anti-Alzheimer agents: a comparison</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">70</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.09.048</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2014.09.048" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=25240096" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFOlsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2014&pages=63-70&author=R.+Ottoauthor=R.+Penzisauthor=F.+Gaubeauthor=T.+Wincklerauthor=D.+Appenrothauthor=C.+Fleckauthor=C.+Tr%C3%A4nkleauthor=J.+Lehmannauthor=C.+Enzensperger&title=Beta+and+gamma+carboline+derivatives+as+potential+anti-Alzheimer+agents%3A+a+comparison&doi=10.1016%2Fj.ejmech.2014.09.048"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Beta and gamma carboline derivatives as potential anti-Alzheimer agents: A comparison</span></div><div class="casAuthors">Otto, Robert; Penzis, Robert; Gaube, Friedemann; Winckler, Thomas; Appenroth, Dorothea; Fleck, Christian; Traenkle, Christian; Lehmann, Jochen; Enzensperger, Christoph</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-70</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Nine novel β- and γ-carboline derivs. bearing either methyl-, propargyl- or phenethyl-residues at the indole nitrogen were synthesized and tested as potential anti-Alzheimer drugs.  Antagonism of recombinantly expressed NMDA receptors, inhibition of cholinesterases, and radical scavenging properties were detd. for all compds.  Some were addnl. tested in vivo for their ability to reverse scopolamine-induced cognitive impairment in an 8-arm radial maze expt. with rats.  For the most promising candidates, the interaction with muscarinic M1 receptors was also investigated.  With this set of compds. assays the influence of the scaffold itself and the substituents can be investigated sep.  5-Methyl-γ-carboline (I) was the most potent (0.25 μmol/100 g b.w.) compd. in the in vivo test and might be a good starting point for the development of novel anti-Alzheimer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRwXrBRAcmgbVg90H21EOLACvtfcHk0lj7uLHvxdcjLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFOlsLzM&md5=d12fd4e4f527b4fe894e9aa80dd361cc</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.09.048&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.09.048%26sid%3Dliteratum%253Aachs%26aulast%3DOtto%26aufirst%3DR.%26aulast%3DPenzis%26aufirst%3DR.%26aulast%3DGaube%26aufirst%3DF.%26aulast%3DWinckler%26aufirst%3DT.%26aulast%3DAppenroth%26aufirst%3DD.%26aulast%3DFleck%26aufirst%3DC.%26aulast%3DTr%25C3%25A4nkle%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DEnzensperger%26aufirst%3DC.%26atitle%3DBeta%2520and%2520gamma%2520carboline%2520derivatives%2520as%2520potential%2520anti-Alzheimer%2520agents%253A%2520a%2520comparison%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D87%26spage%3D63%26epage%3D70%26doi%3D10.1016%2Fj.ejmech.2014.09.048" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Filali, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouajila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Znati, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bousejra-El
Garah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Jannet, H.</span></span> <span> </span><span class="NLM_article-title">Synthesis of new isoxazoline derivatives from harmine and evaluation of their anti-Alzheimer, anti-cancer and anti-inflammatory activities</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">371</span>– <span class="NLM_lpage">376</span>, <span class="refDoi"> DOI: 10.3109/14756366.2014.940932</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3109%2F14756366.2014.940932" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=25068731" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFGlsbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2015&pages=371-376&author=I.+Filaliauthor=J.+Bouajilaauthor=M.+Znatiauthor=F.+Bousejra-El%0AGarahauthor=H.+Ben+Jannet&title=Synthesis+of+new+isoxazoline+derivatives+from+harmine+and+evaluation+of+their+anti-Alzheimer%2C+anti-cancer+and+anti-inflammatory+activities&doi=10.3109%2F14756366.2014.940932"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of new isoxazoline derivatives from harmine and evaluation of their anti-Alzheimer, anti-cancer and anti-inflammatory activities</span></div><div class="casAuthors">Filali, Insaf; Bouajila, Jalloul; Znati, Mansour; Bousejra-El Garah, Fatima; Ben Jannet, Hichem</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">371-376</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A series of new harmine derivs. has been prepd. by cycloaddn. reaction using various arylnitrile oxides and evaluated in vitro against acetylcholinesterase and 5-lipoxygenase enzymes, MCF7 and HCT116 cancer cell lines.  Some of these mols. have been shown to be potent inhibitors of acetylcholinesterase and MCF7 cell line.  The greatest activity against acetylcholinesterase (IC50 = 10.4 μM) was obtained for harmine and cytotoxic activities (IC50 = 0.2 μM) for compd. I.  Two derivs. with the thiophene and furan systems, resp., showed good activity against 5-lipoxygenase enzyme (IC50 = 29.2 and 55.5 μM, resp.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZijpKXEwUVrVg90H21EOLACvtfcHk0lgpBloopzoA-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFGlsbrP&md5=f6abdf9bdc760dafab6280d7500bdabb</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.3109%2F14756366.2014.940932&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2014.940932%26sid%3Dliteratum%253Aachs%26aulast%3DFilali%26aufirst%3DI.%26aulast%3DBouajila%26aufirst%3DJ.%26aulast%3DZnati%26aufirst%3DM.%26aulast%3DBousejra-El%2BGarah%26aufirst%3DF.%26aulast%3DBen%2BJannet%26aufirst%3DH.%26atitle%3DSynthesis%2520of%2520new%2520isoxazoline%2520derivatives%2520from%2520harmine%2520and%2520evaluation%2520of%2520their%2520anti-Alzheimer%252C%2520anti-cancer%2520and%2520anti-inflammatory%2520activities%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2015%26volume%3D30%26spage%3D371%26epage%3D376%26doi%3D10.3109%2F14756366.2014.940932" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Filali, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belkacem, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Nejma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Souchard, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Jannet, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bouajila, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis, cytotoxic, anti-lipoxygenase and anti-acetylcholinesterase capacities of novel derivatives from harmine</span>. <i>J. Enzyme Inhib. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.3109/14756366.2016.1163342</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3109%2F14756366.2016.1163342" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=27028352" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC28XltlSrt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2016&pages=23-33&author=I.+Filaliauthor=M.+A.+Belkacemauthor=A.+Ben+Nejmaauthor=J.-P.+Souchardauthor=H.+Ben+Jannetauthor=J.+Bouajila&title=Synthesis%2C+cytotoxic%2C+anti-lipoxygenase+and+anti-acetylcholinesterase+capacities+of+novel+derivatives+from+harmine&doi=10.3109%2F14756366.2016.1163342"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, cytotoxic, anti-lipoxygenase and anti-acetylcholinesterase capacities of novel derivatives from harmine</span></div><div class="casAuthors">Filali, Insaf; Belkacem, Mohamed Amine; Ben Nejma, Aymen; Souchard, Jean Pierre; Ben Jannet, Hichem; Bouajila, Jalloul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Enzyme Inhibition and Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">sup1</span>),
    <span class="NLM_cas:pages">23-33</span>CODEN:
                <span class="NLM_cas:coden">JEIMAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-6366</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">We synthesized two series of new hydrazide harmine derivs.  The reaction of harmine (I; R = H) with Et acetate chloride afforded the corresponding Et ester I (R = CH2CO2Et).  The treatment of with hydrazine hydrate gave the hydrazide I (R = CH2CONHNH2) which further converted into hydrazones I [R = CH2CONHN:CHAr; Ar = C6H4(Bu-t)-4, C6H4(NMe2)-4, C6H3(OMe)2-3,4, C6H4(CF2CHF2)-4, C6H4(SMe)-4, C6H4OMe-4, C6H3Cl-4-NO2-3, C6H4CHO-4, quinolin-6-yl, C6H4(morpholin-4-yl)-4] and dihydrazides II (Z = Z1, Z2, NHCO(CH2)2CO2H).  A series of new triazoles III [R' = H, Me, OMe, Cl, Et, NO2] has also been prepd. from the suitable propargylharmine I (R = CH2C≡CH).  The synthesized derivs. were characterized by 1H-NMR, 13C-NMR, and HRMS and evaluated for their activities against MCF7, HCT116 OVCAR-3, acetylcholinesterase and 5-lipoxygenase.  The hydrazones derivs. I [R = CH2CONHN:CHAr] have a good cytotoxic activity against all cell lines, while I [R = CH2CONHN:CHAr; Ar = C6H4(CMe3)-4, C6H4CF2CHF2, C6H4OMe-4, C6H3Cl-4-NO2-3] are more active than harmine (against OVCAR-3 IC50 16.7-2.5 μM).  The compd. I (R = CH2C≡CH) was the most active (IC50 = 1.9 μM) against acetylcholinesterase.  Some compds. exhibited significant activity against 5-lipoxygenase (IC50 = 30.9-63.1 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDoHik8qxToLVg90H21EOLACvtfcHk0lgpBloopzoA-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltlSrt7w%253D&md5=290f03b99a12853a936f77ab220aad0b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3109%2F14756366.2016.1163342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F14756366.2016.1163342%26sid%3Dliteratum%253Aachs%26aulast%3DFilali%26aufirst%3DI.%26aulast%3DBelkacem%26aufirst%3DM.%2BA.%26aulast%3DBen%2BNejma%26aufirst%3DA.%26aulast%3DSouchard%26aufirst%3DJ.-P.%26aulast%3DBen%2BJannet%26aufirst%3DH.%26aulast%3DBouajila%26aufirst%3DJ.%26atitle%3DSynthesis%252C%2520cytotoxic%252C%2520anti-lipoxygenase%2520and%2520anti-acetylcholinesterase%2520capacities%2520of%2520novel%2520derivatives%2520from%2520harmine%26jtitle%3DJ.%2520Enzyme%2520Inhib.%2520Med.%2520Chem.%26date%3D2016%26volume%3D31%26spage%3D23%26epage%3D33%26doi%3D10.3109%2F14756366.2016.1163342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khorana, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Changwichit, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingkaninan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Utsintong, M.</span></span> <span> </span><span class="NLM_article-title">Prospective acetylcholinesterase inhibitory activity of indole and its analogs</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2885</span>– <span class="NLM_lpage">2888</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.02.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmcl.2012.02.057" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=22425563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XktFSiur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=2885-2888&author=N.+Khoranaauthor=K.+Changwichitauthor=K.+Ingkaninanauthor=M.+Utsintong&title=Prospective+acetylcholinesterase+inhibitory+activity+of+indole+and+its+analogs&doi=10.1016%2Fj.bmcl.2012.02.057"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Prospective acetylcholinesterase inhibitory activity of indole and its analogs</span></div><div class="casAuthors">Khorana, Nantaka; Changwichit, Kanokwan; Ingkaninan, Kornkanok; Utsintong, Maleeruk</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2885-2888</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Acetylcholinesterase (AChE) inhibitory activity is one of the proposed targets for indole analogs.  Simple indoles with substitution of methoxy, carboxy or hydroxy at the benzene ring showed a low percent of inhibitory activity in eel-AChE.  Adding a side chain at the pyrrole ring, such as serotonin, β-carbolines and quinolines (the bioisostere of indole), improved the inhibitory activity significantly.  However, proper substitution and conformation of the ring were required for good binding.  The result of inhibition in human-AChE of serotonin, β-carbolines and quinolines showed similar profile as eel-AChE with lower magnitude.  The data from mol. docking showed that they shared the same binding site as galantamine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq04HPlsXRs7LVg90H21EOLACvtfcHk0lgpBloopzoA-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktFSiur0%253D&md5=6a176945ba442c4495e141af23cd1563</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.02.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.02.057%26sid%3Dliteratum%253Aachs%26aulast%3DKhorana%26aufirst%3DN.%26aulast%3DChangwichit%26aufirst%3DK.%26aulast%3DIngkaninan%26aufirst%3DK.%26aulast%3DUtsintong%26aufirst%3DM.%26atitle%3DProspective%2520acetylcholinesterase%2520inhibitory%2520activity%2520of%2520indole%2520and%2520its%2520analogs%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D2885%26epage%3D2888%26doi%3D10.1016%2Fj.bmcl.2012.02.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span> <span> </span><span class="NLM_article-title">Acetylcholinesterase and butyrylcholinesterase inhibitory activities of β-carboline and quinoline alkaloids derivatives from the plants of genus Peganum</span>. <i>J. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_fpage">717232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3sXksFCqsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&pages=717232&author=T.+Zhaoauthor=K.+Dingauthor=L.+Zhangauthor=X.+Chengauthor=C.+Wangauthor=Z.+Wang&title=Acetylcholinesterase+and+butyrylcholinesterase+inhibitory+activities+of+%CE%B2-carboline+and+quinoline+alkaloids+derivatives+from+the+plants+of+genus+Peganum"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase and butyrylcholinesterase inhibitory activities of β-carboline and quinoline alkaloids derivatives from the plants of genus Peganum</span></div><div class="casAuthors">Zhao, Ting; Ding, Ke-Min; Zhang, Lei; Cheng, Xue-Mei; Wang, Chang-Hong; Wang, Zheng-Tao</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">717232, 6 pp.</span>CODEN:
                <span class="NLM_cas:coden">JCOHD5</span>;
        ISSN:<span class="NLM_cas:issn">2090-9071</span>.
    
            (<span class="NLM_cas:orgname">Hindawi Publishing Corp.</span>)
        </div><div class="casAbstract">It was reported that the main chem. constituents in plants of genus Peganum were a serial of β-carboline and quinoline alkaloids.  These alkaloids were quant. assessed for selective inhibitory activities on acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) by in vitro Ellman method.  The results indicated that harmane was the most potent selective AChE inhibitor with an IC50 of 7.11 ± 2.00 μM and AChE selectivity index (SI, IC50 of BChE/IC50 of AChE) of 10.82.  Vasicine was the most potent BChE inhibitor with feature of dual AChE/BChE inhibitory activity, with an IC50 vs. AChE/BChE of 13.68 ± 1.25/2.60 ± 1.47 μM and AChE SI of 0.19.  By analyzing and comparing the IC50 and SI of those chems., it was indicated that the β-carboline alkaloids displayed more potent AChE inhibition but less BChE inhibition than quinoline alkaloids.  The substituent at the C7 position of the β-carboline alkaloids and C3 and C9 positions of quinoline alkaloids played a crit. role in AChE or BChE inhibition.  The potent inhibition suggested that those alkaloids may be used as candidates for treatment of Alzheimer's disease.  The anal. of the quant. structure-activity relationship of those compds. investigated might provide guidance for the design and synthesis of AChE and BChE inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8U_do3_oHiLVg90H21EOLACvtfcHk0lhe5796zbk9lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXksFCqsr4%253D&md5=fb2c67d9d109560c2d74a2b3cd766de8</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DT.%26aulast%3DDing%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DZ.%26atitle%3DAcetylcholinesterase%2520and%2520butyrylcholinesterase%2520inhibitory%2520activities%2520of%2520%25CE%25B2-carboline%2520and%2520quinoline%2520alkaloids%2520derivatives%2520from%2520the%2520plants%2520of%2520genus%2520Peganum%26jtitle%3DJ.%2520Chem.%26date%3D2013%26spage%3D717232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span> <span> </span><span class="NLM_article-title">Rapid and sensitive detection of the inhibitive activities of acetyl- and butyryl-cholinesterases inhibitors by UPLC-ESI-MS/MS</span>. <i>J. Pharm. Biomed. Anal.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>94</i></span>,  <span class="NLM_fpage">215</span>– <span class="NLM_lpage">220</span>, <span class="refDoi"> DOI: 10.1016/j.jpba.2014.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.jpba.2014.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=24631841" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXkslGmtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=94&publication_year=2014&pages=215-220&author=W.+Liuauthor=Y.+Yangauthor=X.+Chengauthor=C.+Gongauthor=S.+Liauthor=D.+Heauthor=L.+Yangauthor=Z.+Wangauthor=C.+Wang&title=Rapid+and+sensitive+detection+of+the+inhibitive+activities+of+acetyl-+and+butyryl-cholinesterases+inhibitors+by+UPLC-ESI-MS%2FMS&doi=10.1016%2Fj.jpba.2014.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid and sensitive detection of the inhibitive activities of acetyl- and butyryl-cholinesterases inhibitors by UPLC-ESI-MS/MS</span></div><div class="casAuthors">Liu, Wei; Yang, Yadi; Cheng, Xuemei; Gong, Can; Li, Shuping; He, Dandan; Yang, Li; Wang, Zhengtao; Wang, Changhong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical and Biomedical Analysis</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">94</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">215-220</span>CODEN:
                <span class="NLM_cas:coden">JPBADA</span>;
        ISSN:<span class="NLM_cas:issn">0731-7085</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) are legitimate therapeutic targets for Alzheimer's disease.  The classical approach for screening potential AChE/BChE inhibitors was developed by Ellman.  However, the background color of compds. or plant exts. remained uncertain and frequently interfered with the detection of the secondary reaction, thereby easily yielding false pos. or false neg. results.  Rapid, selective, and sensitive ultra-performance liq. chromatog. combined with electrospray ionization tandem mass spectrometry method was developed and used for the detection of AChE and BChE inhibition by directly detg. the common product, choline (Ch).  Proper sepn. was achieved for choline and chlormequat (internal std.) within 1.2 min via isocratic elution (0.1% formic acid:methanol = 98:2) on an HSS T3 column following a simple pptn. of proteins for sample treatment.  The relative std. deviations of the intra- and inter-day precisions were below 7.34 and 9.09%, resp., whereas the mean accuracy for the quality control samples was 100.31 ± 10.93%.  The method exhibited the advantages of small total reaction vol. (100 μL), short anal. time (1.2 min), high sensitivity (LOQ of 0.036 μM for Ch), and low cost (little consumption enzymes of 0.0035 and 0.008 unit mL-1 for AChE and BChE, and substrates of 5.505 and 7.152 μM for ACh and BCh in individual inhibition, resp.), and without matrix effect (90.00-105.03%).  The developed method was successfully applied for detecting the AChE and BChE inhibitive activities for model drugs, including galanthamine, tacrine, neostigmine methylsulfate, eserine, as well as β-carboline and quinazoline alkaloids from Peganum harmala.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhTnNVFSimN7Vg90H21EOLACvtfcHk0lhe5796zbk9lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXkslGmtbY%253D&md5=6923ec1a9b3044946f3460bd89c01480</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1016%2Fj.jpba.2014.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jpba.2014.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DGong%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DHe%26aufirst%3DD.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DRapid%2520and%2520sensitive%2520detection%2520of%2520the%2520inhibitive%2520activities%2520of%2520acetyl-%2520and%2520butyryl-cholinesterases%2520inhibitors%2520by%2520UPLC-ESI-MS%252FMS%26jtitle%3DJ.%2520Pharm.%2520Biomed.%2520Anal.%26date%3D2014%26volume%3D94%26spage%3D215%26epage%3D220%26doi%3D10.1016%2Fj.jpba.2014.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liew, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khaw, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugaiyah, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Looi, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, Y. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustafa, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Litaudon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awang, K.</span></span> <span> </span><span class="NLM_article-title">Natural indole butyrylcholinesterase inhibitors from Nauclea officinalis</span>. <i>Phytomedicine</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">45</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1016/j.phymed.2014.11.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.phymed.2014.11.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=25636869" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvF2gsrjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2015&pages=45-48&author=S.+Y.+Liewauthor=K.+Y.+Khawauthor=V.+Murugaiyahauthor=C.+Y.+Looiauthor=Y.+L.+Wongauthor=M.+R.+Mustafaauthor=M.+Litaudonauthor=K.+Awang&title=Natural+indole+butyrylcholinesterase+inhibitors+from+Nauclea+officinalis&doi=10.1016%2Fj.phymed.2014.11.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Natural indole butyrylcholinesterase inhibitors from Nauclea officinalis</span></div><div class="casAuthors">Liew, Sook Yee; Khaw, Kooi Yeong; Murugaiyah, Vikneswaran; Looi, Chung Yeng; Wong, Yi Li; Mustafa, Mohd Rais; Litaudon, Marc; Awang, Khalijah</div><div class="citationInfo"><span class="NLM_cas:title">Phytomedicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">45-48</span>CODEN:
                <span class="NLM_cas:coden">PYTOEY</span>;
        ISSN:<span class="NLM_cas:issn">0944-7113</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">Nine monoterpenoid indole alkaloids; naucletine (1), angustidine (2), nauclefine (3), angustine (4), naucline (5), angustoline (6), harmane (7), 3,14-dihydroangustoline (8), strictosamide (9) and one quinoline alkaloid glycoside; pumiloside (10) from Nauclea officinalis were tested for cholinesterase inhibitory activity.  All the alkaloids except for pumiloside (10) showed strong to weak BChE inhibitory effect with IC50 values ranging between 1.02-168.55 μM.  Angustidine (2), nauclefine (3), angustine (4), angustoline (6) and harmane (7) showed higher BChE inhibiting potency compared to galanthamine.  Angustidine (2) was the most potent inhibitor towards both AChE and BChE.  Mol. docking (MD) studies showed that angustidine (2) docked deep into the bottom gorge of hBChE and formed hydrogen bonding with Ser 198 and His 438.  Kinetic study of angustidine (2) on BChE suggested a mixed inhibition mode with an inhibition const. (Ki) of 6.12 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmrrkkJW8PfbVg90H21EOLACvtfcHk0lhe5796zbk9lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvF2gsrjF&md5=345ed9b5d525a83b30fc9e72a7cc91c7</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.phymed.2014.11.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phymed.2014.11.003%26sid%3Dliteratum%253Aachs%26aulast%3DLiew%26aufirst%3DS.%2BY.%26aulast%3DKhaw%26aufirst%3DK.%2BY.%26aulast%3DMurugaiyah%26aufirst%3DV.%26aulast%3DLooi%26aufirst%3DC.%2BY.%26aulast%3DWong%26aufirst%3DY.%2BL.%26aulast%3DMustafa%26aufirst%3DM.%2BR.%26aulast%3DLitaudon%26aufirst%3DM.%26aulast%3DAwang%26aufirst%3DK.%26atitle%3DNatural%2520indole%2520butyrylcholinesterase%2520inhibitors%2520from%2520Nauclea%2520officinalis%26jtitle%3DPhytomedicine%26date%3D2015%26volume%3D22%26spage%3D45%26epage%3D48%26doi%3D10.1016%2Fj.phymed.2014.11.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Torres, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lira, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silva, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzzo, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sant’Anna, C. M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kümmerle, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumjanek, V. M.</span></span> <span> </span><span class="NLM_article-title">Structural insights into cholinesterases inhibition by harmane β-carbolinium derivatives: a kinetics - molecular modeling approach</span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2012.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.phytochem.2012.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=22717507" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFGltbbE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=24-30&author=J.+M.+Torresauthor=A.+F.+Liraauthor=D.+R.+Silvaauthor=L.+M.+Guzzoauthor=C.+M.+R.+Sant%E2%80%99Annaauthor=A.+E.+K%C3%BCmmerleauthor=V.+M.+Rumjanek&title=Structural+insights+into+cholinesterases+inhibition+by+harmane+%CE%B2-carbolinium+derivatives%3A+a+kinetics+-+molecular+modeling+approach&doi=10.1016%2Fj.phytochem.2012.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural insights into cholinesterases inhibition by harmane β-carbolinium derivatives: A kinetics - molecular modeling approach</span></div><div class="casAuthors">Torres, Juliana M.; Lira, Aline F.; Silva, Daniel R.; Guzzo, Lucas M.; Sant'Anna, Carlos M. R.; Kuemmerle, Arthur E.; Rumjanek, Victor M.</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">24-30</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The natural indole alkaloids, the β-carbolines, are often assocd. with cholinesterase inhibition, esp. their quaternary salts, which frequently have higher activity than the free bases.  Due to lack of information explaining this fact in the literature, the cholinesterase inhibition by the natural product harmane and its two β-carbolinium synthetic deriv. salts (N-Me and N-ethyl) was explored, together with a combination of kinetics and a mol. modeling approach.  The results, mainly for the β-carbolinium salts, demonstrated a noncompetitive inhibition profile, ruling out previous findings which assocd. cholinesterase inhibition by β-carbolinium salts to a possible mimicking of the choline moiety of the natural substrate, acetylcholine.  Mol. modeling studies corroborate this kind of inhibition through analyses of inhibitor/enzyme and inhibitor/substrate/enzyme complexes of both enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvhOAhn6xAobVg90H21EOLACvtfcHk0ljtDg_EvY8LyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFGltbbE&md5=e8ac9bf5e50ebd4e3fdd96f72ac16746</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2012.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2012.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DTorres%26aufirst%3DJ.%2BM.%26aulast%3DLira%26aufirst%3DA.%2BF.%26aulast%3DSilva%26aufirst%3DD.%2BR.%26aulast%3DGuzzo%26aufirst%3DL.%2BM.%26aulast%3DSant%25E2%2580%2599Anna%26aufirst%3DC.%2BM.%2BR.%26aulast%3DK%25C3%25BCmmerle%26aufirst%3DA.%2BE.%26aulast%3DRumjanek%26aufirst%3DV.%2BM.%26atitle%3DStructural%2520insights%2520into%2520cholinesterases%2520inhibition%2520by%2520harmane%2520%25CE%25B2-carbolinium%2520derivatives%253A%2520a%2520kinetics%2520-%2520molecular%2520modeling%2520approach%26jtitle%3DPhytochemistry%26date%3D2012%26volume%3D81%26spage%3D24%26epage%3D30%26doi%3D10.1016%2Fj.phytochem.2012.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fadaeinasab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basiri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karimian, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugaiyah, V.</span></span> <span> </span><span class="NLM_article-title">New indole alkaloids from the bark of Rauvolfia reflexa and their cholinesterase inhibitory activity</span>. <i>Cell. Physiol. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">1997</span>– <span class="NLM_lpage">2011</span>, <span class="refDoi"> DOI: 10.1159/000438560</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1159%2F000438560" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=26584298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVOrt7bL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2015&pages=1997-2011&author=M.+Fadaeinasabauthor=A.+Basiriauthor=Y.+Kiaauthor=H.+Karimianauthor=H.+M.+Aliauthor=V.+Murugaiyah&title=New+indole+alkaloids+from+the+bark+of+Rauvolfia+reflexa+and+their+cholinesterase+inhibitory+activity&doi=10.1159%2F000438560"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">New Indole Alkaloids from the Bark of Rauvolfia Reflexa and their Cholinesterase Inhibitory Activity</span></div><div class="casAuthors">Fadaeinasab, Mehran; Basiri, Alireza; Kia, Yalda; Karimian, Hamed; Ali, Hapipah Mohd.; Murugaiyah, Vikneswaran</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Physiology and Biochemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1997-2011</span>CODEN:
                <span class="NLM_cas:coden">CEPBEW</span>;
        ISSN:<span class="NLM_cas:issn">1015-8987</span>.
    
            (<span class="NLM_cas:orgname">S. Karger AG</span>)
        </div><div class="casAbstract">Background/Aims: Rauvolfia reflexa is a member of the Apocynaceae family.  Plants from the Apocynaceae family have been traditionally used in the treatment of age-related brain disorders Methods and Results: Two new indole alkaloids, rauvolfine C (1) and 3-methyl-10,11-dimethoxy-6-methoxycarbonyl-β-carboline (2), along with five known, macusine B (3), vinorine (4), undulifoline (5), isoresrpiline (6) and rescinnamine (7) were isolated from the bark of Rauvolfia reflexa.  Cholinesterase inhibitory assay and mol. docking were performed to get insight of the inhibitory activity and mol. interactions of the compds.  The compds. showed good to moderate cholinesterase inhibitory activity with IC50 values in the range of 8.06 to 73.23 μM.  Compd. 7 was found to be the most potent inhibitor of both acetylcholinesterase (AChE) and butyrylcholinesterase (BChE).  Compds. 1, 2, 5 and 6 were found to be selective towards BChE, while compds. 3, 4 and 7 were dual inhibitors, having almost equal inhibitory activity on both AChE and BChE.  Mol. docking revealed that compds. 6 and 7 interacted differently on AChE and BChE, by means of hydrophobic interactions and hydrogen bonding.  In AChE, the indole moiety of both compds. interacted with the residues lining the peripheral anionic site, whereas in BChE, their methoxy groups are primarily responsible for the strong inhibitory activity via interactions with residues at the active site of the enzyme.  Conclusion: Two new and five known indole alkaloids were isolated from R. reflexa.  Among the compds., 7 and 6 showed the most potent and promising cholinesterase inhibitory activity, worthy for further investigations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRZ_njbvExjrVg90H21EOLACvtfcHk0ljtDg_EvY8LyQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVOrt7bL&md5=68b26792529b1b9a20d9a62e6dec3fe0</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1159%2F000438560&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000438560%26sid%3Dliteratum%253Aachs%26aulast%3DFadaeinasab%26aufirst%3DM.%26aulast%3DBasiri%26aufirst%3DA.%26aulast%3DKia%26aufirst%3DY.%26aulast%3DKarimian%26aufirst%3DH.%26aulast%3DAli%26aufirst%3DH.%2BM.%26aulast%3DMurugaiyah%26aufirst%3DV.%26atitle%3DNew%2520indole%2520alkaloids%2520from%2520the%2520bark%2520of%2520Rauvolfia%2520reflexa%2520and%2520their%2520cholinesterase%2520inhibitory%2520activity%26jtitle%3DCell.%2520Physiol.%2520Biochem.%26date%3D2015%26volume%3D37%26spage%3D1997%26epage%3D2011%26doi%3D10.1159%2F000438560" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schott, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommelspacher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J.</span></span> <span> </span><span class="NLM_article-title">6-Hydroxy- and 6-methoxy-β-carbolines as acetyl- and butyrylcholinesterase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">5840</span>– <span class="NLM_lpage">5843</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.08.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmcl.2006.08.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=16945529" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCrt73M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2006&pages=5840-5843&author=Y.+Schottauthor=M.+Deckerauthor=H.+Rommelspacherauthor=J.+Lehmann&title=6-Hydroxy-+and+6-methoxy-%CE%B2-carbolines+as+acetyl-+and+butyrylcholinesterase+inhibitors&doi=10.1016%2Fj.bmcl.2006.08.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">6-Hydroxy- and 6-methoxy-β-carbolines as acetyl- and butyrylcholinesterase inhibitors</span></div><div class="casAuthors">Schott, Yvonne; Decker, Michael; Rommelspacher, Hans; Lehmann, Jochen</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">5840-5843</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Studies directed toward the discovery of novel acetyl- and butyrylcholinesterase (AChE and BChE) inhibitors for the treatment of Alzheimer's disease were focused on β-carbolines (BCs).  6-Oxygenated β-carboline, e.g., I (R = H or Me), and β-carbolinium derivs. based on the serotonin template were synthesized and tested in vitro for their ability to inhibit AChE and BChE, resp.  The carbolinium salts, in particular, which could be formed by intracerebral methylation of tertiary-BC prodrugs, showed inhibitory activity levels reaching those of galantamine, physostigmine, and rivastigmine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHSREbW1WrQbVg90H21EOLACvtfcHk0ljEGU3_fCzIHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCrt73M&md5=a61352380685c67f9846a614a9e62806</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.08.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.08.067%26sid%3Dliteratum%253Aachs%26aulast%3DSchott%26aufirst%3DY.%26aulast%3DDecker%26aufirst%3DM.%26aulast%3DRommelspacher%26aufirst%3DH.%26aulast%3DLehmann%26aufirst%3DJ.%26atitle%3D6-Hydroxy-%2520and%25206-methoxy-%25CE%25B2-carbolines%2520as%2520acetyl-%2520and%2520butyrylcholinesterase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2006%26volume%3D16%26spage%3D5840%26epage%3D5843%26doi%3D10.1016%2Fj.bmcl.2006.08.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span> <span> </span><span class="NLM_article-title">Potent AChE and BChE inhibitors isolated from seeds of Peganum harmala Linn by a bioassay-guided fractionation</span>. <i>J. Ethnopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">286</span>, <span class="refDoi"> DOI: 10.1016/j.jep.2015.03.070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.jep.2015.03.070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=25862961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmsVajuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2015&pages=279-286&author=Y.+Yangauthor=X.+Chengauthor=W.+Liuauthor=G.+Chouauthor=Z.+Wangauthor=C.+Wang&title=Potent+AChE+and+BChE+inhibitors+isolated+from+seeds+of+Peganum+harmala+Linn+by+a+bioassay-guided+fractionation&doi=10.1016%2Fj.jep.2015.03.070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Potent AChE and BChE inhibitors isolated from seeds of Peganum harmala Linn by a bioassay-guided fractionation</span></div><div class="casAuthors">Yang, Yadi; Cheng, Xuemei; Liu, Wei; Chou, Guixin; Wang, Zhengtao; Wang, Changhong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Ethnopharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">279-286</span>CODEN:
                <span class="NLM_cas:coden">JOETD7</span>;
        ISSN:<span class="NLM_cas:issn">0378-8741</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Seeds of Peganum harmala Linn are traditionally used as folk medical herb in Uighur medicine in China to treat disorders of hemiplegia and amnesia.  Previously studies have proved that dominating alkaloids in P. harmala show significant inhibitory activities on the cholinesterase.  The aim of the present study is to isolate trace ingredients from seeds of P. harmala and evaluate its inhibitory activities on acetylcholinesterase (AChE) and butyrylcholinesterase (BChE).  For sake of screening effective cholinesterase inhibitors, trace compds. were isolated from seeds of P. harmala through a bioassay-guided fractionation and their structures were detd. via detailed spectral anal.  The inhibitory activities on AChE and BChE were assessed using an improved Ellman method by UPLC-ESI-MS/MS to det. the common final product choline.  The activity-guided fractionation led to the isolation of two new alkaloids 2-aldehyde-tetrahydroharmine (10), 2-carboxyl-3,4-dihydroquinazoline (19), one syringin structure analog 1-O-β-D-xylopyranose sinapyl alc. (22), and along with 19 known compds.  Compds. acetylnorharmine (6), harmic acid methy ester (7), harmine N-oxide (13), 6-methoxyindoline (14), syringin (21) were first found from genus Peganum and compds. 3-hydroxylated harmine (4), 1-hydroxy-7-methoxy-β-carboline (5) were new natural products.  The results showed that the 2-aldehyde-tetrahydroharmine (10) has a potential inbibitive effect on both AChE and BChE with IC50 values of 12.35±0.24 and 5.51±0.33 μM, resp.  Deoxyvasicine (15) and vasicine (16) showed the strongest BChE inhibitory activity with IC50 values of 0.04±0.01 and 0.1±0.01 μM.  The anal. of the structure-activity relationship indicated that the satn. of pyridine ring and the presence of substitution at indole ring, C-1, C-3, C-7 and N-2, for β-carbolines, were essential for effective inhibition of both AChE and BChE and the five-membered ring between C-2 and N-3 as well as the substituent groups sited at C-4 and C-9, for quinazolines, were important to both the AChE/BChE-inhibitory activity.  Bioassay-guided fractionation has led to the isolation of AChE and BChE inhibitors from the seeds of P. harmala.  These results are in agreement with the traditional uses of the seeds of P. harmala.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqppqAK7pOAtrVg90H21EOLACvtfcHk0ljEGU3_fCzIHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmsVajuro%253D&md5=36c095e788b3e9a3853f00252a32844f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1016%2Fj.jep.2015.03.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jep.2015.03.070%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DChou%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DPotent%2520AChE%2520and%2520BChE%2520inhibitors%2520isolated%2520from%2520seeds%2520of%2520Peganum%2520harmala%2520Linn%2520by%2520a%2520bioassay-guided%2520fractionation%26jtitle%3DJ.%2520Ethnopharmacol.%26date%3D2015%26volume%3D168%26spage%3D279%26epage%3D286%26doi%3D10.1016%2Fj.jep.2015.03.070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arshad, A. S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chear, N. J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ezzat, M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanapi, N. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meesala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arshad, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mansor, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mordi, M. N.</span></span> <span> </span><span class="NLM_article-title">Synthesis, characterization and crystal structure of new tetrahydro-β-carboline as acetylcholinesterase inhibitor</span>. <i>J. Mol. Struct.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>1200</i></span>,  <span class="NLM_fpage">127070</span>, <span class="refDoi"> DOI: 10.1016/j.molstruc.2019.127070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.molstruc.2019.127070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVKktbfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1200&publication_year=2020&pages=127070&author=A.+S.+M.+Arshadauthor=N.+J.+Y.+Chearauthor=M.+O.+Ezzatauthor=N.+A.+Hanapiauthor=R.+Meesalaauthor=S.+Arshadauthor=S.+M.+Mansorauthor=M.+N.+Mordi&title=Synthesis%2C+characterization+and+crystal+structure+of+new+tetrahydro-%CE%B2-carboline+as+acetylcholinesterase+inhibitor&doi=10.1016%2Fj.molstruc.2019.127070"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, characterization and crystal structure of new tetrahydro-β-carboline as acetylcholinesterase inhibitor</span></div><div class="casAuthors">Mohamad Arshad, Ahmad Saifuddin; Chear, Nelson Jeng Yeou; Ezzat, Mohammed Oday; Hanapi, Nur Aziah; Meesala, Ramu; Arshad, Suhana; Mansor, Sharif Mahsufi; Mordi, Mohd Nizam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Structure</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">1200</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">127070pp.</span>CODEN:
                <span class="NLM_cas:coden">JMOSB4</span>;
        ISSN:<span class="NLM_cas:issn">0022-2860</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A new tetrahydro-β-carboline deriv., 2-benzoyl-6-methoxy-9-methyl-1-phenyl-1,2,3,4-tetrahydro-β-carboline was synthesized through a three-steps reaction in good yield (76%).  The structure of this compd. was characterized by different spectroscopic methods including NMR (1D and 2D), UV, IR and MS.  Mol. structure of the synthesized compd. was also confirmed by single crystal X-ray diffraction technique.  Further, evaluation of in-vitro acetylcholinesterase (AChE) inhibitory activity showcased the potential of this compd. as AChE inhibitor with an IC50 value of 26.52 ± 0.79 μM.  In addn., this compd. showed minimal toxicol. profile at cellular level.  Docking simulation illustrated a highly selective binding at peripheral side of AChE via hydrophobic interactions.  In silico prediction of blood-brain barrier (BBB) permeation and ADMET properties of the compd. was also reported.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYXnvNGMw1KLVg90H21EOLACvtfcHk0ljEGU3_fCzIHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVKktbfM&md5=8f19cd55cd53b855c6c61bbc88ba6a2b</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.molstruc.2019.127070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molstruc.2019.127070%26sid%3Dliteratum%253Aachs%26aulast%3DArshad%26aufirst%3DA.%2BS.%2BM.%26aulast%3DChear%26aufirst%3DN.%2BJ.%2BY.%26aulast%3DEzzat%26aufirst%3DM.%2BO.%26aulast%3DHanapi%26aufirst%3DN.%2BA.%26aulast%3DMeesala%26aufirst%3DR.%26aulast%3DArshad%26aufirst%3DS.%26aulast%3DMansor%26aufirst%3DS.%2BM.%26aulast%3DMordi%26aufirst%3DM.%2BN.%26atitle%3DSynthesis%252C%2520characterization%2520and%2520crystal%2520structure%2520of%2520new%2520tetrahydro-%25CE%25B2-carboline%2520as%2520acetylcholinesterase%2520inhibitor%26jtitle%3DJ.%2520Mol.%2520Struct.%26date%3D2020%26volume%3D1200%26spage%3D127070%26doi%3D10.1016%2Fj.molstruc.2019.127070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, X.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, H.</span></span> <span> </span><span class="NLM_article-title">N-methoxy-β-carboline alkaloids with inhibitory activities against Aβ42 aggregation and acetylcholinesterase from the stems of Picrasma quassioides</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">104043</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.104043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bioorg.2020.104043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=32629286" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtlCltL%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2020&pages=104043&author=J.+Zhangauthor=S.-S.+Zhaoauthor=J.+Xieauthor=J.+Yangauthor=G.-D.+Chenauthor=D.+Huauthor=W.-G.+Zhangauthor=C.-X.+Wangauthor=X.-S.+Yaoauthor=H.+Gao&title=N-methoxy-%CE%B2-carboline+alkaloids+with+inhibitory+activities+against+A%CE%B242+aggregation+and+acetylcholinesterase+from+the+stems+of+Picrasma+quassioides&doi=10.1016%2Fj.bioorg.2020.104043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">N-methoxy-β-carboline alkaloids with inhibitory activities against Aβ42 aggregation and acetylcholinesterase from the stems of Picrasma quassioides</span></div><div class="casAuthors">Zhang, Jie; Zhao, Sen-Sen; Xie, Jun; Yang, Jian; Chen, Guo-Dong; Hu, Dan; Zhang, Wei-Guang; Wang, Chuan-Xi; Yao, Xin-Sheng; Gao, Hao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">104043</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Nine new N-methoxy-beta-carboline alkaloids (NMCAs) (1a/1b-3a/3b and 4-6) and two known NMCAs (7 and 8) were isolated from the stems of Picrasma quassioides.  Their structures were elucidated by spectroscopic data analyses, quantum chem. calcns., and single-crystal X-ray crystallog. data.  An anal. of the 13C NMR chem. shifts of the N-methoxy groups in these NMCAs and 41 gathered known compds. reveals the phenomenon that the chem. shifts of all these N-methoxy groups are greater than U+03B4 C 62, which can be used to recognize the N-methoxy group rapidly.  In addn., the acetylcholinesterase (AChE) and Abeta42 aggregation inhibitory activities of 1-8 were evaluated.  Compds. 1, 2, 7, and 8 displayed AChE inhibitory activity with IC50 values of 14.9, 13.2, 17.6, and 43.9 microM, resp.  Compd. 2 showed inhibition activity against Abeta42 aggregation with an IC50 value of 10.1 microM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJ3z5kJX3NR7Vg90H21EOLACvtfcHk0lgNxJ46je7EzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtlCltL%252FP&md5=3280247e4989d696013765dc915f3204</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.104043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.104043%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DZhao%26aufirst%3DS.-S.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DG.-D.%26aulast%3DHu%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DW.-G.%26aulast%3DWang%26aufirst%3DC.-X.%26aulast%3DYao%26aufirst%3DX.-S.%26aulast%3DGao%26aufirst%3DH.%26atitle%3DN-methoxy-%25CE%25B2-carboline%2520alkaloids%2520with%2520inhibitory%2520activities%2520against%2520A%25CE%25B242%2520aggregation%2520and%2520acetylcholinesterase%2520from%2520the%2520stems%2520of%2520Picrasma%2520quassioides%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D101%26spage%3D104043%26doi%3D10.1016%2Fj.bioorg.2020.104043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fadaeinasab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hadi, A. H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kia, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basiri, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murugaiyah, V.</span></span> <span> </span><span class="NLM_article-title">Cholinesterase enzymes inhibitors from the leaves of Rauvolfia reflexa and their molecular docking study</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">3779</span>– <span class="NLM_lpage">3788</span>, <span class="refDoi"> DOI: 10.3390/molecules18043779</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3390%2Fmolecules18043779" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=23529036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3sXlslCmsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2013&pages=3779-3788&author=M.+Fadaeinasabauthor=A.+H.+A.+Hadiauthor=Y.+Kiaauthor=A.+Basiriauthor=V.+Murugaiyah&title=Cholinesterase+enzymes+inhibitors+from+the+leaves+of+Rauvolfia+reflexa+and+their+molecular+docking+study&doi=10.3390%2Fmolecules18043779"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Cholinesterase enzymes inhibitors from the leaves of Rauvolfia reflexa and their molecular docking study</span></div><div class="casAuthors">Fadaeinasab, Mehran; Hadi, A. Hamid A.; Kia, Yalda; Basiri, Alireza; Murugaiyah, Vikneswaran</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">3779-3788</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Plants of the Apocynaceae family have been traditionally used in the treatment of age-related brain disorders.  Rauvolfia reflexa, a member of the family, has been used as an antidote for poisons and to treat malaria.  The dichloromethane, ethanol and methanol exts. from the leaves of Rauvolfia reflexa showed potential acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activities, with IC50 values in the 8.49 to 52.23 g/mL range.  Further cholinesterase inhibitory-guided isolation of these exts. afforded four bioactive compds., namely: (E)-3-(3,4,5-trimethoxyphenyl)acrylic acid (1), (E)-Me 3-(4-hydroxy-3,5-dimethoxyphenyl) acrylate (2), 17-methoxycarbonyl-14-heptadecaenyl-4-hydroxy-3-methoxycinnamate (3) and 1,2,3,4-tetrahydro-1-oxo-β-carboline (4).  The isolated compds. showed moderate cholinesterase inhibitory activity compared to the ref. std., physostigmine.  Compds. 1 and 2 showed the highest inhibitory activity against AChE (IC50 = 60.17 μM) and BChE (IC50 = 61.72 μM), resp.  Despite having similar mol. wt., compds. 1 and 2 were structurally different according to their chem. substitution patterns, leading to their different enzyme inhibition selectivity.  Compd. 2 was more selective against BChE, whereas compd. 1 was a selective inhibitor of AChE.  Mol. docking revealed that both compds. 1 and 2 were inserted, but not deeply into the active site of the cholinesterase enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_M3AXAPvha7Vg90H21EOLACvtfcHk0lgNxJ46je7EzA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXlslCmsr0%253D&md5=0f3efe1f64254166cc04e20bbd42236c</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3390%2Fmolecules18043779&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules18043779%26sid%3Dliteratum%253Aachs%26aulast%3DFadaeinasab%26aufirst%3DM.%26aulast%3DHadi%26aufirst%3DA.%2BH.%2BA.%26aulast%3DKia%26aufirst%3DY.%26aulast%3DBasiri%26aufirst%3DA.%26aulast%3DMurugaiyah%26aufirst%3DV.%26atitle%3DCholinesterase%2520enzymes%2520inhibitors%2520from%2520the%2520leaves%2520of%2520Rauvolfia%2520reflexa%2520and%2520their%2520molecular%2520docking%2520study%26jtitle%3DMolecules%26date%3D2013%26volume%3D18%26spage%3D3779%26epage%3D3788%26doi%3D10.3390%2Fmolecules18043779" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abuhamdah, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Habash, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taha, M. O.</span></span> <span> </span><span class="NLM_article-title">Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitors</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1075</span>– <span class="NLM_lpage">1092</span>, <span class="refDoi"> DOI: 10.1007/s10822-013-9699-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1007%2Fs10822-013-9699-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=24338032" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFWqu7zM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2013&pages=1075-1092&author=S.+Abuhamdahauthor=M.+Habashauthor=M.+O.+Taha&title=Elaborate+ligand-based+modeling+coupled+with+QSAR+analysis+and+in+silico+screening+reveal+new+potent+acetylcholinesterase+inhibitors&doi=10.1007%2Fs10822-013-9699-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Elaborate ligand-based modeling coupled with QSAR analysis and in silico screening reveal new potent acetylcholinesterase inhibitors</span></div><div class="casAuthors">Abuhamdah, Sawsan; Habash, Maha; Taha, Mutasem O.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1075-1092</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Inhibition of the enzyme acetylcholinesterase (AChE) has been shown to alleviate neurodegenerative diseases prompting several attempts to discover and optimize new AChE inhibitors.  In this direction, we explored the pharmacophoric space of 85 AChE inhibitors to identify high quality pharmacophores.  Subsequently, we implemented genetic algorithm-based quant. structure-activity relationship (QSAR) modeling to select optimal combination of pharmacophoric models and 2D physicochem. descriptors capable of explaining bioactivity variation among training compds. (r268 = 0.94, F-statistic = 125.8, r2LOO = 0.92, r2PRESS against 17 external test inhibitors = 0.84).  Two orthogonal pharmacophores emerged in the QSAR equation suggesting the existence of at least two binding modes accessible to ligands within AChE binding pocket.  The successful pharmacophores were comparable with crystallog. resolved AChE binding pocket.  We employed the pharmacophoric models and assocd. QSAR equation to screen the national cancer institute list of compds.  Twenty-four low micromolar AChE inhibitors were identified.  The most potent gave IC50 value of 1.0 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBhZYevHRRWrVg90H21EOLACvtfcHk0lhGJM_aetOQ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFWqu7zM&md5=5645f93992fc010575a355392c260d25</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1007%2Fs10822-013-9699-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-013-9699-6%26sid%3Dliteratum%253Aachs%26aulast%3DAbuhamdah%26aufirst%3DS.%26aulast%3DHabash%26aufirst%3DM.%26aulast%3DTaha%26aufirst%3DM.%2BO.%26atitle%3DElaborate%2520ligand-based%2520modeling%2520coupled%2520with%2520QSAR%2520analysis%2520and%2520in%2520silico%2520screening%2520reveal%2520new%2520potent%2520acetylcholinesterase%2520inhibitors%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2013%26volume%3D27%26spage%3D1075%26epage%3D1092%26doi%3D10.1007%2Fs10822-013-9699-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Horton, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peerannawar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kugyela, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kulkarni, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tulsan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tran, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soule, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LeVine, H.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Török, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Török, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and application of β-carbolines as novel multi-functional anti-Alzheimer’s disease agents</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">232</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2016.11.067</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmcl.2016.11.067" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=27923619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVWmtLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=232-236&author=W.+Hortonauthor=A.+Soodauthor=S.+Peerannawarauthor=N.+Kugyelaauthor=A.+Kulkarniauthor=R.+Tulsanauthor=C.+D.+Tranauthor=J.+Souleauthor=H.+LeVineauthor=B.+T%C3%B6r%C3%B6kauthor=M.+T%C3%B6r%C3%B6k&title=Synthesis+and+application+of+%CE%B2-carbolines+as+novel+multi-functional+anti-Alzheimer%E2%80%99s+disease+agents&doi=10.1016%2Fj.bmcl.2016.11.067"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and application of β-carbolines as novel multi-functional anti-Alzheimer's disease agents</span></div><div class="casAuthors">Horton, William; Sood, Abha; Peerannawar, Swarada; Kugyela, Nandor; Kulkarni, Aditya; Tulsan, Rekha; Tran, Chris D.; Soule, Jessica; LeVine, Harry III; Torok, Bela; Torok, Marianna</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">232-236</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The design, synthesis and assessment of β-carboline core-based compds. as potential multifunctional agents against several processes that are believed to play a significant role in Alzheimer's disease (AD) pathol., are described.  The activity of the compds. was detd. in Aβ self-assembly (fibril and oligomer formation) and cholinesterase (AChE, BuChE) activity inhibition, and their antioxidant properties were also assessed.  To obtain insight into the mode of action of the compds., HR-MS studies were carried out on the inhibitor-Aβ complex formation and mol. docking was performed on inhibitor-BuChE interactions.  While several compds. exhibited strong activities in individual assays, compd. I emerged as a promising multi-target lead for the further structure-activity relationship studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDCaZu-pq16LVg90H21EOLACvtfcHk0lhGJM_aetOQ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVWmtLrI&md5=a89bb70680241cb381dcf42bc938cb18</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2016.11.067&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2016.11.067%26sid%3Dliteratum%253Aachs%26aulast%3DHorton%26aufirst%3DW.%26aulast%3DSood%26aufirst%3DA.%26aulast%3DPeerannawar%26aufirst%3DS.%26aulast%3DKugyela%26aufirst%3DN.%26aulast%3DKulkarni%26aufirst%3DA.%26aulast%3DTulsan%26aufirst%3DR.%26aulast%3DTran%26aufirst%3DC.%2BD.%26aulast%3DSoule%26aufirst%3DJ.%26aulast%3DLeVine%26aufirst%3DH.%26aulast%3DT%25C3%25B6r%25C3%25B6k%26aufirst%3DB.%26aulast%3DT%25C3%25B6r%25C3%25B6k%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520application%2520of%2520%25CE%25B2-carbolines%2520as%2520novel%2520multi-functional%2520anti-Alzheimer%25E2%2580%2599s%2520disease%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D232%26epage%3D236%26doi%3D10.1016%2Fj.bmcl.2016.11.067" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tadokoro, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichimori, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsunaga, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakai, R.</span></span> <span> </span><span class="NLM_article-title">N-Methyl-β-carbolinium salts and an N-methylated 8-oxoisoguanine as acetylcholinesterase inhibitors from a solitary ascidian, Cnemidocarpa irene</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1074</span>– <span class="NLM_lpage">1080</span>, <span class="refDoi"> DOI: 10.1021/acsomega.7b00127</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.7b00127" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXks1SqsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=1074-1080&author=Y.+Tadokoroauthor=T.+Nishikawaauthor=T.+Ichimoriauthor=S.+Matsunagaauthor=M.+J.+Fujitaauthor=R.+Sakai&title=N-Methyl-%CE%B2-carbolinium+salts+and+an+N-methylated+8-oxoisoguanine+as+acetylcholinesterase+inhibitors+from+a+solitary+ascidian%2C+Cnemidocarpa+irene&doi=10.1021%2Facsomega.7b00127"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">N-Methyl-β-carbolinium Salts and an N-Methylated 8-Oxoisoguanine as Acetylcholinesterase Inhibitors from a Solitary Ascidian, Cnemidocarpa irene</span></div><div class="casAuthors">Tadokoro, Yohei; Nishikawa, Teruaki; Ichimori, Taichi; Matsunaga, Satoko; Fujita, Masaki J.; Sakai, Ryuichi</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1074-1080</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">New brominated β-carbolines, irenecarbolines A (I) and B (II), along with 2 known β-carbolines (N-methyl-β-carbolinium and N-methyl-β-carboline-3-carboxylate) and a new 8-oxoisoguanine deriv. (III), were isolated from a solitary ascidian Cnemidocarpa irene.  The structures of these compds. were detd. on the basis of their spectral data.  All 3 new compds. inhibited the action of acetylcholinesterase (AchE).  The activities of irenecarboline A and the new 8-oxoisoguanine deriv. were comparable to that of galantamine, a clin. used AchE inhibitor.  I and N-methyl-β-carbolinium were present in high concns. in the blood, and fluorescence was obsd. in certain types of cells found in the blood of the tunicate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTSVI3LC2EirVg90H21EOLACvtfcHk0lhGJM_aetOQ7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXks1SqsLY%253D&md5=3c817edf0c466d046cd05d8799623012</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Facsomega.7b00127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.7b00127%26sid%3Dliteratum%253Aachs%26aulast%3DTadokoro%26aufirst%3DY.%26aulast%3DNishikawa%26aufirst%3DT.%26aulast%3DIchimori%26aufirst%3DT.%26aulast%3DMatsunaga%26aufirst%3DS.%26aulast%3DFujita%26aufirst%3DM.%2BJ.%26aulast%3DSakai%26aufirst%3DR.%26atitle%3DN-Methyl-%25CE%25B2-carbolinium%2520salts%2520and%2520an%2520N-methylated%25208-oxoisoguanine%2520as%2520acetylcholinesterase%2520inhibitors%2520from%2520a%2520solitary%2520ascidian%252C%2520Cnemidocarpa%2520irene%26jtitle%3DACS%2520Omega%26date%3D2017%26volume%3D2%26spage%3D1074%26epage%3D1080%26doi%3D10.1021%2Facsomega.7b00127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rook, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidtke, K.-U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaube, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schepmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wünsch, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heilmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winckler, T.</span></span> <span> </span><span class="NLM_article-title">Bivalent β-carbolines as potential multitarget anti-Alzheimer agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">3611</span>– <span class="NLM_lpage">3617</span>, <span class="refDoi"> DOI: 10.1021/jm1000024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm1000024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3cXkt1Wksbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=3611-3617&author=Y.+Rookauthor=K.-U.+Schmidtkeauthor=F.+Gaubeauthor=D.+Schepmannauthor=B.+W%C3%BCnschauthor=J.+Heilmannauthor=J.+Lehmannauthor=T.+Winckler&title=Bivalent+%CE%B2-carbolines+as+potential+multitarget+anti-Alzheimer+agents&doi=10.1021%2Fjm1000024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Bivalent β-Carbolines as Potential Multitarget Anti-Alzheimer Agents</span></div><div class="casAuthors">Rook, Yvonne; Schmidtke, Kai-Uwe; Gaube, Friedemann; Schepmann, Dirk; Wuensch, Bernhard; Heilmann, Joerg; Lehmann, Jochen; Winckler, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3611-3617</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a prevalent neurodegenerative disorder with multifactorial causes that requires multitargeted treatment.  Inhibitors of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) improve cholinergic signaling in the central nervous system and thus AChE inhibitors are well established in the therapy of AD to improve memory disturbances and other cognitive symptoms.  On the other hand, AD patients benefit from redn. of pathol. glutamate-induced, Ca2+-mediated excitotoxicity by the N-methyl-D-aspartate receptor (NR) antagonist memantine.  New drugs that simultaneously affect both cholinergic transmission and glutamate-induced excitotoxicity may further improve AD treatment.  While connecting β-carboline units by alkylene spacers in two different series of compds. and subsequent evaluation of their AChE/BChE-inhibitory potential, we found that several of these bivalent β-carbolines were potent NR blockers.  The most promising compd. was a N9-homobivalent β-carboline with a nonylene spacer, which displayed IC50 values of 0.5 nM for AChE, 5.7 nM for BChE, and 1.4 μM for NR, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3hQIsqoLuHbVg90H21EOLACvtfcHk0linGNs1B-QDyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXkt1Wksbo%253D&md5=0e0bb88f9dc3e023d9538cb186643cd4</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fjm1000024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1000024%26sid%3Dliteratum%253Aachs%26aulast%3DRook%26aufirst%3DY.%26aulast%3DSchmidtke%26aufirst%3DK.-U.%26aulast%3DGaube%26aufirst%3DF.%26aulast%3DSchepmann%26aufirst%3DD.%26aulast%3DW%25C3%25BCnsch%26aufirst%3DB.%26aulast%3DHeilmann%26aufirst%3DJ.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DWinckler%26aufirst%3DT.%26atitle%3DBivalent%2520%25CE%25B2-carbolines%2520as%2520potential%2520multitarget%2520anti-Alzheimer%2520agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D3611%26epage%3D3617%26doi%3D10.1021%2Fjm1000024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span> <span> </span><span class="NLM_article-title">Peganumine B-I and two enantiomers: new alkaloids from the seeds of Peganum harmala Linn. and their potential cytotoxicity and cholinesterase inhibitory activities</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">15976</span>– <span class="NLM_lpage">15987</span>, <span class="refDoi"> DOI: 10.1039/C6RA00086J</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1039%2FC6RA00086J" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVSju7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&pages=15976-15987&author=Y.+Yangauthor=X.+Chengauthor=W.+Liuauthor=Z.+Hanauthor=G.+Chouauthor=Y.+Wangauthor=D.+Sunauthor=Z.+Wangauthor=C.+Wang&title=Peganumine+B-I+and+two+enantiomers%3A+new+alkaloids+from+the+seeds+of+Peganum+harmala+Linn.+and+their+potential+cytotoxicity+and+cholinesterase+inhibitory+activities&doi=10.1039%2FC6RA00086J"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Peganumine B-I and two enantiomers: new alkaloids from the seeds of Peganum harmala Linn. and their potential cytotoxicity and cholinesterase inhibitory activities</span></div><div class="casAuthors">Yang, Ya-di; Cheng, Xue-mei; Liu, Wei; Han, Zhu-zhen; Chou, Gui-xin; Wang, Ying; Sun, Du-xin; Wang, Zheng-tao; Wang, Chang-hong</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">15976-15987</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Ten new alkaloids (peganumine B-I and two enantiomers), contg. five β-carbolines, three quinazolones, two compds. with both of the above skeletons, and one amphoteric alkaloid with a four-membered ring, were isolated from the ethanol ext. of Peganum harmala.  Their structures were elucidated on the basis of spectral data using 1D and 2D NMR, X-ray crystallog. anal., CD, and ECD.  Peganumine B showed potential inhibitory activity against both AChE and BChE with IC50 values of 0.25 ± 0.04, and 1.45 ± 0.34 μM, resp.  Peganumine C, peganumine D, and peganumine I were found to have selective inhibitory activity against AChE with IC50 values of 14.38 ± 2.49, 5.71 ± 1.22, and 7.17 ± 1.45 μM, resp.  Peganumine G and peganumine H showed significant cytotoxicity against a ZR-75-1 cell line with IC50 values of 6.20 ± 2.71, and 2.43 ± 0.79 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJDp4Lnxl53LVg90H21EOLACvtfcHk0linGNs1B-QDyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVSju7k%253D&md5=b21784bdb3183446be1318a1ec49a66f</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1039%2FC6RA00086J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6RA00086J%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DHan%26aufirst%3DZ.%26aulast%3DChou%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DC.%26atitle%3DPeganumine%2520B-I%2520and%2520two%2520enantiomers%253A%2520new%2520alkaloids%2520from%2520the%2520seeds%2520of%2520Peganum%2520harmala%2520Linn.%2520and%2520their%2520potential%2520cytotoxicity%2520and%2520cholinesterase%2520inhibitory%2520activities%26jtitle%3DRSC%2520Adv.%26date%3D2016%26volume%3D6%26spage%3D15976%26epage%3D15987%26doi%3D10.1039%2FC6RA00086J" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geng, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span> <span> </span><span class="NLM_article-title">New 2-aryl-9-methyl-β-carbolinium salts as potential acetylcholinesterase inhibitor agents: synthesis, bioactivity and structure-activity relationship</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1559</span>, <span class="refDoi"> DOI: 10.1038/s41598-018-19999-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1038%2Fs41598-018-19999-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=29367595" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADC%252BC1MvktVOgsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2018&pages=1559&author=B.+Zhouauthor=B.+Zhangauthor=X.+Liauthor=X.+Liuauthor=H.+Liauthor=D.+Liauthor=Z.+Cuiauthor=H.+Gengauthor=L.+Zhou&title=New+2-aryl-9-methyl-%CE%B2-carbolinium+salts+as+potential+acetylcholinesterase+inhibitor+agents%3A+synthesis%2C+bioactivity+and+structure-activity+relationship&doi=10.1038%2Fs41598-018-19999-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">New 2-Aryl-9-methyl-β-carbolinium salts as Potential Acetylcholinesterase Inhibitor agents: Synthesis, Bioactivity and Structure-Activity Relationship</span></div><div class="casAuthors">Zhou Bohang; Zhang Bingyu; Li Xingqiang; Liu Xiuxiu; Li Hui; Li Ding; Cui Zhiming; Geng Huiling; Zhou Le</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1559</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">A series of 2-aryl-9-methyl-β-carbolinium bromides (B) were synthesized and explored for anti-acetylcholinesterase (AChE) activities in vitro, action mechanism and structure-activity relationship.  All the compounds B along with their respective 3,4-dihydro intermediates (A) presented anti-AChE activity at 10 μM.  Thirteen compounds B showed the excellent activity with IC50 values of 0.11-0.76 μM and high selectivity toward AChE relative to butyrylcholinesterase (BChE), superior to galantamine (IC50 = 0.79 μM), a selective AChE inhibitor drug.  Kinetic analysis showed that the action mechanisms of both compounds B and A are a competitive inhibition model.  Structure-activity relationship analyses showed that the C = N(+) moiety is a determinant for the activity.  Substituents at 6, 7 or 4' site, the indole-N-alkyl and the aromatization of the C-ring can significantly improve the activity.  Molecular docking studies showed that the compounds could combine with the active site of AChE by the π-π or cation-π action between the carboline ring and the phenyl rings of the residues, and the β-carboline moiety is embedded in a cavity surrounded by four aromatic residues of Trp86, Tyr337, Trp439 and Tyr449.  The present results strongly suggest that the para-position of the D-ring should be a preferred modification site for further structural optimization design.  Thus, 2-aryl-9-methyl-β-carboliniums emerged as novel and promising tool compounds for the development of new AChE inhibitor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSwTpH_Z9G-FP69nzq6467DfW6udTcc2eapli03mb4Lx7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MvktVOgsg%253D%253D&md5=a839c7da11fd0f399e884322059a92d4</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41598-018-19999-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-018-19999-3%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DB.%26aulast%3DZhang%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DCui%26aufirst%3DZ.%26aulast%3DGeng%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DL.%26atitle%3DNew%25202-aryl-9-methyl-%25CE%25B2-carbolinium%2520salts%2520as%2520potential%2520acetylcholinesterase%2520inhibitor%2520agents%253A%2520synthesis%252C%2520bioactivity%2520and%2520structure-activity%2520relationship%26jtitle%3DSci.%2520Rep.%26date%3D2018%26volume%3D8%26spage%3D1559%26doi%3D10.1038%2Fs41598-018-19999-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.-Y.</span></span> <span> </span><span class="NLM_article-title">Monoterpene indole alkaloids from the stem bark of Mitragyna diversifolia and their acetylcholine esterase inhibitory effects</span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">389</span>– <span class="NLM_lpage">396</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2013.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.phytochem.2013.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=24169379" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhs12lurnF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2013&pages=389-396&author=X.-F.+Caoauthor=J.-S.+Wangauthor=X.-B.+Wangauthor=J.+Luoauthor=H.-Y.+Wangauthor=L.-Y.+Kong&title=Monoterpene+indole+alkaloids+from+the+stem+bark+of+Mitragyna+diversifolia+and+their+acetylcholine+esterase+inhibitory+effects&doi=10.1016%2Fj.phytochem.2013.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Monoterpene indole alkaloids from the stem bark of Mitragyna diversifolia and their acetylcholine esterase inhibitory effects</span></div><div class="casAuthors">Cao, Xing-Fen; Wang, Jun-Song; Wang, Xiao-Bing; Luo, Jun; Wang, Hong-Ying; Kong, Ling-Yi</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">389-396</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Five monoterpene indole alkaloids, mitradiversifoline, with a unique rearranged skeleton, specionoxeine-N(4)-oxide, 7-hydroxyisopaynantheine, 3-dehydropaynantheine, and 3-isopaynantheine-N(4)-oxide, and 10 known ones, were isolated from Mitragyna diversifolia.  All the isolates were evaluated for their inhibition of acetylcholinesterase activities, and four showed moderate activities, with IC50 values of 4.1, 5.2, 10.2, and 10.3 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ZZCNm80vvbVg90H21EOLACvtfcHk0lgEya5u5sl8PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhs12lurnF&md5=1eb77ffabd69d63823cfa445da76acc6</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2013.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2013.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DX.-F.%26aulast%3DWang%26aufirst%3DJ.-S.%26aulast%3DWang%26aufirst%3DX.-B.%26aulast%3DLuo%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.-Y.%26aulast%3DKong%26aufirst%3DL.-Y.%26atitle%3DMonoterpene%2520indole%2520alkaloids%2520from%2520the%2520stem%2520bark%2520of%2520Mitragyna%2520diversifolia%2520and%2520their%2520acetylcholine%2520esterase%2520inhibitory%2520effects%26jtitle%3DPhytochemistry%26date%3D2013%26volume%3D96%26spage%3D389%26epage%3D396%26doi%3D10.1016%2Fj.phytochem.2013.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cardoso, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro-Gamboa, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siqueira Silva, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Furlan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de A. Epifanio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Cunha Pinto, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moraes de Rezende, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alencar Lima, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">da Silva Bolzani, V.</span></span> <span> </span><span class="NLM_article-title">Indole glucoalkaloids from Chimarrhis turbinata and their evaluation as antioxidant agents and acetylcholinesterase inhibitors</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">1882</span>– <span class="NLM_lpage">1885</span>, <span class="refDoi"> DOI: 10.1021/np049863m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np049863m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2cXnvVags7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2004&pages=1882-1885&author=C.+L.+Cardosoauthor=I.+Castro-Gamboaauthor=D.+H.+Siqueira+Silvaauthor=M.+Furlanauthor=R.+de+A.+Epifanioauthor=A.+da+Cunha+Pintoauthor=C.+Moraes+de+Rezendeauthor=J.+Alencar+Limaauthor=V.+da+Silva+Bolzani&title=Indole+glucoalkaloids+from+Chimarrhis+turbinata+and+their+evaluation+as+antioxidant+agents+and+acetylcholinesterase+inhibitors&doi=10.1021%2Fnp049863m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Indole Glucoalkaloids from Chimarrhis turbinata and Their Evaluation as Antioxidant Agents and Acetylcholinesterase Inhibitors</span></div><div class="casAuthors">Cardoso, Carmem Lucia; Castro-Gamboa, Ian; Silva, Dulce Helena Siqueira; Furlan, Maysa; de Epifanio, Rosangela; Pinto, Angelo da Cunha; Moraes de Rezende, Claudia; Lima, Joselia Alencar; Bolzani, Vanderlan da Silva</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1882-1885</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our study on bioactive agents from Brazilian rainforest plants, two new glucoalkaloids, 3,4-dehydro-strictosidine (I) and 3,4-dehydro-strictosidinic acid (II), were isolated from Chimarrhis turbinata, along with seven known glucoalkaloids, cordifoline (3), strictosidinic acid (4), strictosidine (5), 5α-carboxystrictosidine (6), turbinatine (7), desoxycordifoline (8), and harman-3-carboxylic acid (9).  The structures of the new alkaloids were established on the basis of comprehensive spectral anal., mainly 1D and 2D NMR expts., as well as high-resoln. HRESIMS.  Alkaloid 3 showed strong free-radical scavenging activity against 1,1-diphenyl-2-picrylhydrazyl (DPPH) as well as pronounced antioxidant activity evidenced by redox properties measured by ElCD-HPLC.  Addnl., alkaloids 1-9 were submitted to TLC screening for acetylcholinesterase inhibitors.  Both 7 and 8 were shown to be moderate acetylcholinesterase inhibitors at a concn. of 0.1 and 1.0 μM, resp.  In an in vitro rat brain assay, 7 showed moderate activity (IC50 1.86 μM), compared to the std. compd., galanthamine (IC50 0.92 μM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoia6mfIDwbK7Vg90H21EOLACvtfcHk0lgEya5u5sl8PA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXnvVags7w%253D&md5=b35a7f07565480aadab2b399490539b2</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1021%2Fnp049863m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp049863m%26sid%3Dliteratum%253Aachs%26aulast%3DCardoso%26aufirst%3DC.%2BL.%26aulast%3DCastro-Gamboa%26aufirst%3DI.%26aulast%3DSiqueira%2BSilva%26aufirst%3DD.%2BH.%26aulast%3DFurlan%26aufirst%3DM.%26aulast%3Dde%2BA.%2BEpifanio%26aufirst%3DR.%26aulast%3Dda%2BCunha%2BPinto%26aufirst%3DA.%26aulast%3DMoraes%2Bde%2BRezende%26aufirst%3DC.%26aulast%3DAlencar%2BLima%26aufirst%3DJ.%26aulast%3Dda%2BSilva%2BBolzani%26aufirst%3DV.%26atitle%3DIndole%2520glucoalkaloids%2520from%2520Chimarrhis%2520turbinata%2520and%2520their%2520evaluation%2520as%2520antioxidant%2520agents%2520and%2520acetylcholinesterase%2520inhibitors%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2004%26volume%3D67%26spage%3D1882%26epage%3D1885%26doi%3D10.1021%2Fnp049863m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Passos, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simões-Pires, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nurisso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soldi, T. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Oliveira, C. M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Faria, E. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marcourt, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gottfried, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carrupt, P.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henriques, A. T.</span></span> <span> </span><span class="NLM_article-title">Indole alkaloids of Psychotria as multifunctional cholinesterases and monoamine oxidases inhibitors</span>. <i>Phytochemistry</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1016/j.phytochem.2012.11.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.phytochem.2012.11.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=23261030" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XhvVKqtbrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2013&pages=8-20&author=C.+S.+Passosauthor=C.+A.+Sim%C3%B5es-Piresauthor=A.+Nurissoauthor=T.+C.+Soldiauthor=L.+Katoauthor=C.+M.+A.+de+Oliveiraauthor=E.+O.+de+Fariaauthor=L.+Marcourtauthor=C.+Gottfriedauthor=P.-A.+Carruptauthor=A.+T.+Henriques&title=Indole+alkaloids+of+Psychotria+as+multifunctional+cholinesterases+and+monoamine+oxidases+inhibitors&doi=10.1016%2Fj.phytochem.2012.11.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Indole alkaloids of Psychotria as multifunctional cholinesterases and monoamine oxidases inhibitors</span></div><div class="casAuthors">Passos, Carolina S.; Simoes-Pires, Claudia A.; Nurisso, Alessandra; Soldi, Tatiane C.; Kato, Lucilia; de Oliveira, Cecilia M. A.; de Faria, Emiret O.; Marcourt, Laurence; Gottfried, Carmem; Carrupt, Pierre-Alain; Henriques, Amelia T.</div><div class="citationInfo"><span class="NLM_cas:title">Phytochemistry (Elsevier)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8-20</span>CODEN:
                <span class="NLM_cas:coden">PYTCAS</span>;
        ISSN:<span class="NLM_cas:issn">0031-9422</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Thirteen Psychotria alkaloids were evaluated regarding their interactions with acetylcholinesterase (AChE), butyrylcholinesterase (BChE), and monoamine oxidases A and B (MAO-A and MAO-B), which are enzymic targets related with neurodegenerative diseases.  Two quaternary β-carboline alkaloids, prunifoleine and 14-oxoprunifoleine, inhibited AChE, BChE and MAO-A with IC50 values corresponding to 10 and 3.39 μM for AChE, 100 and 11 μM for BChE, and 7.41 and 6.92 μM for MAO-A, resp.  Both compds. seem to behave as noncompetitive AChE inhibitors and time-dependent MAO-A inhibitors.  In addn., the monoterpene indole alkaloids (MIAs) angustine, vallesiachotamine lactone, E-vallesiachotamine and Z-vallesiachotamine inhibited BChE and MAO-A with IC50 values ranging from 3.47 to 14 μM for BChE inhibition and from 0.85 to 2.14 μM for MAO-A inhibition.  Among the tested MIAs, angustine is able to inhibit MAO-A in a reversible and competitive way while the three vallesiachotamine-like alkaloids display a time-dependent inhibition on this target.  Docking calcns. were performed to understand the binding mode between the most active ligands and the selected targets.  Taken together, our findings established mol. details of AChE, BChE and MAO-A inhibition by quaternary β-carboline alkaloids and MIAs from Psychotria, suggesting these secondary metabolites are scaffolds for the development of multifunctional compds. against neurodegeneration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrK6W5xOfzEGLVg90H21EOLACvtfcHk0lgOxdvw1DIkmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhvVKqtbrF&md5=18d1120e43655d165b889525d1a60b91</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1016%2Fj.phytochem.2012.11.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phytochem.2012.11.015%26sid%3Dliteratum%253Aachs%26aulast%3DPassos%26aufirst%3DC.%2BS.%26aulast%3DSim%25C3%25B5es-Pires%26aufirst%3DC.%2BA.%26aulast%3DNurisso%26aufirst%3DA.%26aulast%3DSoldi%26aufirst%3DT.%2BC.%26aulast%3DKato%26aufirst%3DL.%26aulast%3Dde%2BOliveira%26aufirst%3DC.%2BM.%2BA.%26aulast%3Dde%2BFaria%26aufirst%3DE.%2BO.%26aulast%3DMarcourt%26aufirst%3DL.%26aulast%3DGottfried%26aufirst%3DC.%26aulast%3DCarrupt%26aufirst%3DP.-A.%26aulast%3DHenriques%26aufirst%3DA.%2BT.%26atitle%3DIndole%2520alkaloids%2520of%2520Psychotria%2520as%2520multifunctional%2520cholinesterases%2520and%2520monoamine%2520oxidases%2520inhibitors%26jtitle%3DPhytochemistry%26date%3D2013%26volume%3D86%26spage%3D8%26epage%3D20%26doi%3D10.1016%2Fj.phytochem.2012.11.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mroue, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Euler, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghuman, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M.</span></span> <span> </span><span class="NLM_article-title">Indole alkaloids of Haplophyton crooksii</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">890</span>– <span class="NLM_lpage">893</span>, <span class="refDoi"> DOI: 10.1021/np960070c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np960070c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK28XltlWntLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=1996&pages=890-893&author=M.+A.+Mroueauthor=K.+L.+Eulerauthor=M.+A.+Ghumanauthor=M.+Alam&title=Indole+alkaloids+of+Haplophyton+crooksii&doi=10.1021%2Fnp960070c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Indole alkaloids of Haplophyton crooksii</span></div><div class="casAuthors">Mroue, Mohamad A.; Euler, K. L.; Ghuman, M. A.; Alam, Maktoob</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">890-893</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An investigation of the indole alkaloids of Haplophyton crooksii has resulted in the identification of two new alkaloids-10-methoxy-N1-methylpericyclivine (I) and 16-decarbomethoxyvinervinine (II)-and 13 known alkaloids-crooksiine, yohimbine, β-yohimbine, crooksidine, decarbomethoxytetrahydrosecodine, akuammicine, tubotaiwine, lanceomigine, lanceomigine N-oxide, haplophytine, cimicine, cimicidine, and akuammidin-as major alkaloids of this shrub.  All of the isolated alkaloids showed an inhibition of acetylcholinesterase activity in vitro.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriA9pJBfEO5rVg90H21EOLACvtfcHk0lgOxdvw1DIkmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XltlWntLk%253D&md5=71e5c15aebaa9fba506e925f2ed1ec2e</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fnp960070c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp960070c%26sid%3Dliteratum%253Aachs%26aulast%3DMroue%26aufirst%3DM.%2BA.%26aulast%3DEuler%26aufirst%3DK.%2BL.%26aulast%3DGhuman%26aufirst%3DM.%2BA.%26aulast%3DAlam%26aufirst%3DM.%26atitle%3DIndole%2520alkaloids%2520of%2520Haplophyton%2520crooksii%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D1996%26volume%3D59%26spage%3D890%26epage%3D893%26doi%3D10.1021%2Fnp960070c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.-D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, L.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Q.-S.</span></span> <span> </span><span class="NLM_article-title">Geissoschizine methyl ether N-oxide, a new alkaloid with antiacetylcholinesterase activity from Uncaria rhynchophylla</span>. <i>Nat. Prod. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">842</span>– <span class="NLM_lpage">847</span>, <span class="refDoi"> DOI: 10.1080/14786419.2014.989847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1080%2F14786419.2014.989847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=25496282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFegt77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2015&pages=842-847&author=W.-W.+Jiangauthor=J.+Suauthor=X.-D.+Wuauthor=J.+Heauthor=L.-Y.+Pengauthor=X.+Chengauthor=Q.-S.+Zhao&title=Geissoschizine+methyl+ether+N-oxide%2C+a+new+alkaloid+with+antiacetylcholinesterase+activity+from+Uncaria+rhynchophylla&doi=10.1080%2F14786419.2014.989847"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Geissoschizine methyl ether N-oxide, a new alkaloid with antiacetylcholinesterase activity from Uncaria rhynchophylla</span></div><div class="casAuthors">Jiang, Wei-Wei; Su, Jia; Wu, Xing-De; He, Juan; Peng, Li-Yan; Cheng, Xiao; Zhao, Qin-Shi</div><div class="citationInfo"><span class="NLM_cas:title">Natural Product Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">842-847</span>CODEN:
                <span class="NLM_cas:coden">NPRAAT</span>;
        ISSN:<span class="NLM_cas:issn">1478-6419</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Geissoschizine Me ether N-oxide, a new oxindole alkaloid, along with 14 known alkaloids, was isolated from the aerial part of Uncaria rhynchophylla.  Their structures were identified by comprehensive spectral methods, including 2D NMR expts., and confirmed by comparing with the literature data.  In vitro acetylcholinesterase (AChE) inhibitory activity assay showed that the new compd. exhibited anti-AChE activity with IC50 value of 23.4 μM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo97W6iqB6WfbVg90H21EOLACvtfcHk0lgOxdvw1DIkmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFegt77O&md5=c25301a639db0776c7d51adf43d6ba99</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1080%2F14786419.2014.989847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F14786419.2014.989847%26sid%3Dliteratum%253Aachs%26aulast%3DJiang%26aufirst%3DW.-W.%26aulast%3DSu%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DX.-D.%26aulast%3DHe%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DL.-Y.%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DZhao%26aufirst%3DQ.-S.%26atitle%3DGeissoschizine%2520methyl%2520ether%2520N-oxide%252C%2520a%2520new%2520alkaloid%2520with%2520antiacetylcholinesterase%2520activity%2520from%2520Uncaria%2520rhynchophylla%26jtitle%3DNat.%2520Prod.%2520Res.%26date%3D2015%26volume%3D29%26spage%3D842%26epage%3D847%26doi%3D10.1080%2F14786419.2014.989847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geissler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandt, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porzel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlenzig, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehlen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wessjohann, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, N.</span></span> <span> </span><span class="NLM_article-title">Acetylcholinesterase inhibitors from the toadstool Cortinarius infractus</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">2173</span>– <span class="NLM_lpage">2177</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.01.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmc.2010.01.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=20176490" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtVCrsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=2173-2177&author=T.+Geisslerauthor=W.+Brandtauthor=A.+Porzelauthor=D.+Schlenzigauthor=A.+Kehlenauthor=L.+Wessjohannauthor=N.+Arnold&title=Acetylcholinesterase+inhibitors+from+the+toadstool+Cortinarius+infractus&doi=10.1016%2Fj.bmc.2010.01.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Acetylcholinesterase inhibitors from the toadstool Cortinarius infractus</span></div><div class="casAuthors">Geissler, Torsten; Brandt, Wolfgang; Porzel, Andrea; Schlenzig, Dagmar; Kehlen, Astrid; Wessjohann, Ludger; Arnold, Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2173-2177</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Inhibition of acetylcholinesterase (AChE) and therefore prevention of acetylcholine degrdn. is one of the most accepted therapy opportunities for Alzheimer's disease (AD), today.  Due to lack of selectivity of AChE inhibitor drugs on the market, AD-patients suffer from side effects like nausea or vomiting.  In the present study the isolation of two alkaloids, infractopicrin (1) and 10-hydroxy-infractopicrin (2), from Cortinarius infractus Berk. (Cortinariaceae) is presented.  Both compds. show AChE-inhibiting activity and possess a higher selectivity than galanthamine.  Docking studies show that lacking π-π-interactions in butyrylcholinesterase (BChE) are responsible for selectivity.  Studies on other AD pathol. related targets show an inhibitory effect of both compds. on self-aggregation of Aβ-peptides but not on AChE induced Aβ-peptide aggregation.  Low cytotoxicity as well as calcd. pharmacokinetic data suggest that the natural products could be useful candidates for further drug development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwTVddRsYuirVg90H21EOLACvtfcHk0lgAy9fssY97hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtVCrsbo%253D&md5=e6074e77293490cea4b30a6a66f4e725</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.01.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.01.074%26sid%3Dliteratum%253Aachs%26aulast%3DGeissler%26aufirst%3DT.%26aulast%3DBrandt%26aufirst%3DW.%26aulast%3DPorzel%26aufirst%3DA.%26aulast%3DSchlenzig%26aufirst%3DD.%26aulast%3DKehlen%26aufirst%3DA.%26aulast%3DWessjohann%26aufirst%3DL.%26aulast%3DArnold%26aufirst%3DN.%26atitle%3DAcetylcholinesterase%2520inhibitors%2520from%2520the%2520toadstool%2520Cortinarius%2520infractus%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D2173%26epage%3D2177%26doi%3D10.1016%2Fj.bmc.2010.01.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kashyap, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalaiselvan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span> <span> </span><span class="NLM_article-title">Ajmalicine and reserpine: indole alkaloids as multi-target directed ligands towards factors implicated in Alzheimer’s disease</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1609</span>, <span class="refDoi"> DOI: 10.3390/molecules25071609</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3390%2Fmolecules25071609" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BB3cXpvVChtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2020&pages=1609&author=P.+Kashyapauthor=V.+Kalaiselvanauthor=R.+Kumarauthor=S.+Kumar&title=Ajmalicine+and+reserpine%3A+indole+alkaloids+as+multi-target+directed+ligands+towards+factors+implicated+in+Alzheimer%E2%80%99s+disease&doi=10.3390%2Fmolecules25071609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Ajmalicine and reserpine: indole alkaloids as multi-target directed ligands towards factors implicated in Alzheimer's disease</span></div><div class="casAuthors">Kashyap, Priya; Kalaiselvan, Vivekanandan; Kumar, Robin; Kumar, Suresh</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1609</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a multifactorial disorder characterized by exponential loss of memory and cognitive deficit involving several disease modifying targets (amyloid beta, beta-secretase, monoaminoxidase-B, and cholinesterase).  The present study explores multi-target directed ligand approach using secondary metabolite reserpine (RES) and ajmalicine (AJM) obtained from Rauwolfia serpentina roots.  Novel LCMS and HPLC methods were developed for identification and quantification of reserpine and ajmalicine.  In vitro enzyme inhibition assays were performed to evaluate anti-cholinesterase, β-site amyloid cleaving enzyme (BACE-1) inhibition and monoamine oxidase-B (MAO-B) inhibition, further analyzed with in silico anal.  Anti-amyloidogenic potential was studied using anti-aggregation studies along with TEM and CD (CD) anal.  In vitro neuroprotective potential against Aβ toxicity and anti-oxidative stress was demonstrated using PC12 cell cultures.  Reserpine is a more potent dual cholinesterase inhibitor than ajmalicine (IC50 values of 1.7μM (AChE) and 2.8μM (BuChE)).  The anti-aggregation activity of reserpine (68%) was more than ajmalicine (56%).  Both compds. demonstrated neuroprotective activity against Aβ42 (92%) and H2O2 (93%) induced toxicity in PC12 cells against controls.  Phytocompounds also inhibited MAO-B and BACE-1 enzymes in concn. dependent manner.  Mol. docking studies indicated the strong binding of compds. to the catalytic site of targets.  This novel study demonstrated that reserpine and ajmalicine as a multi-target directed ligand that have disease modifying potential for amelioration of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp1_80GRlvh8LVg90H21EOLACvtfcHk0lgAy9fssY97hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXpvVChtr8%253D&md5=5a001e3547ff49a1c2aba1bef25943d4</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.3390%2Fmolecules25071609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules25071609%26sid%3Dliteratum%253Aachs%26aulast%3DKashyap%26aufirst%3DP.%26aulast%3DKalaiselvan%26aufirst%3DV.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DKumar%26aufirst%3DS.%26atitle%3DAjmalicine%2520and%2520reserpine%253A%2520indole%2520alkaloids%2520as%2520multi-target%2520directed%2520ligands%2520towards%2520factors%2520implicated%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMolecules%26date%3D2020%26volume%3D25%26spage%3D1609%26doi%3D10.3390%2Fmolecules25071609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreres, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, J. M.A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaspar, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faria, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valentao, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sottomayor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andrade, P. B.</span></span> <span> </span><span class="NLM_article-title">Pharmacological effects of Catharanthus roseus root alkaloids in acetylcholinesterase inhibition and cholinergic neurotransmission</span>. <i>Phytomedicine</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">652</span>, <span class="refDoi"> DOI: 10.1016/j.phymed.2009.10.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.phymed.2009.10.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=19962870" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpsVygsr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=646-652&author=D.+M.+Pereiraauthor=F.+Ferreresauthor=J.+M.A.+Oliveiraauthor=L.+Gasparauthor=J.+Fariaauthor=P.+Valentaoauthor=M.+Sottomayorauthor=P.+B.+Andrade&title=Pharmacological+effects+of+Catharanthus+roseus+root+alkaloids+in+acetylcholinesterase+inhibition+and+cholinergic+neurotransmission&doi=10.1016%2Fj.phymed.2009.10.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological effects of Catharanthus roseus root alkaloids in acetylcholinesterase inhibition and cholinergic neurotransmission</span></div><div class="casAuthors">Pereira, David M.; Ferreres, Federico; Oliveira, Jorge M. A.; Gaspar, Luis; Faria, Joana; Valentao, Patricia; Sottomayor, Mariana; Andrade, Paula B.</div><div class="citationInfo"><span class="NLM_cas:title">Phytomedicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8-9</span>),
    <span class="NLM_cas:pages">646-652</span>CODEN:
                <span class="NLM_cas:coden">PYTOEY</span>;
        ISSN:<span class="NLM_cas:issn">0944-7113</span>.
    
            (<span class="NLM_cas:orgname">Elsevier GmbH</span>)
        </div><div class="casAbstract">The leaves of Catharanthus roseus constitute the only source of the well known indolomonoterpenic alkaloids vincristine and vinblastine.  In this work we studied the biol. potential of the roots, which are used in several countries as decocts or hot water exts. for the treatment of a no. of conditions.  The aq. ext. strongly inhibited acetylcholinesterase (AchE) in an in vitro microassay, an effect ascribable mainly to serpentine (IC50 = 0.775 μM vs physostigmine IC50 = 6.45 μM) as assessed with the pure compd.  Pure alkaloids were tested for muscarinic and nicotinic antagonism using rat ex-vivo prepns., namely, ileum and diaphragm/phrenic-nerve, resp.  Serpentine competitively blocked muscarinic receptors with a pA2 of 5.2, whereas the precursor ajmalicine up to 80 μM was undistinguishable from control, and catharanthine exhibited an unsurmountable muscarinic antagonism at greater than 10 μM concns.  Nicotinic receptor mediated diaphragm contractions were fully inhibited by catharanthine (IC50 = 59.6 μM) and ajmalicine (IC50 = 72.3 μM), in a reversible but non-competitive manner, unlike the more potent nicotinic antagonist tubocurarine (IC50 = 0.35 μM) whose competitive blockade was overcome by a physostigmine-induced increase in acetylcholine.  Serpentine up to 100 μM did not change diaphragm contractions suggesting reduced affinity for neuromuscular nicotinic receptors.  Despite strong in vitro AchE inhibition, serpentine failed to restore diaphragm contractions upon submaximal tubocurarine blockade, suggesting that poor tissue penetration may prevent serpentine from inhibiting AchE in deep neuromuscular synapses in the ex-vivo prepn.  To our knowledge, the present study is the first to assess the effect of C. roseus root exts., as well as of serpentine, ajmalicine and catharanthine on AchE.  The results described herein suggest that the currently overlooked C. roseus roots may constitute a promising source of compds. with pharmaceutical interest.  Moreover, given serpentine's potent in vitro AchE inhibitory activity and low cholinergic receptor affinity, it is conceivable that minor structural modifications may yield a potent and selective AchE inhibitor, potentially useful for the pharmacol. management of conditions such as Alzheimer's disease and/or myasthenia gravis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp2Zh0WeIu_wbVg90H21EOLACvtfcHk0lgAy9fssY97hw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpsVygsr0%253D&md5=2d0d300f8e5a83038bd5ac869f4cf73f</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1016%2Fj.phymed.2009.10.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.phymed.2009.10.008%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DD.%2BM.%26aulast%3DFerreres%26aufirst%3DF.%26aulast%3DOliveira%26aufirst%3DJ.%2BM.A.%26aulast%3DGaspar%26aufirst%3DL.%26aulast%3DFaria%26aufirst%3DJ.%26aulast%3DValentao%26aufirst%3DP.%26aulast%3DSottomayor%26aufirst%3DM.%26aulast%3DAndrade%26aufirst%3DP.%2BB.%26atitle%3DPharmacological%2520effects%2520of%2520Catharanthus%2520roseus%2520root%2520alkaloids%2520in%2520acetylcholinesterase%2520inhibition%2520and%2520cholinergic%2520neurotransmission%26jtitle%3DPhytomedicine%26date%3D2010%26volume%3D17%26spage%3D646%26epage%3D652%26doi%3D10.1016%2Fj.phymed.2009.10.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bharate, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vishwakarma, R. A.</span></span> <span> </span><span class="NLM_article-title">Total synthesis and anti-cholinesterase activity of marine-derived bis-indole alkaloid fascaplysin</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1098</span>– <span class="NLM_lpage">1103</span>, <span class="refDoi"> DOI: 10.1039/c2md20076g</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1039%2Fc2md20076g" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht1Gitb%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=1098-1103&author=S.+B.+Bharateauthor=S.+Mandaauthor=P.+Joshiauthor=B.+Singhauthor=R.+A.+Vishwakarma&title=Total+synthesis+and+anti-cholinesterase+activity+of+marine-derived+bis-indole+alkaloid+fascaplysin&doi=10.1039%2Fc2md20076g"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Total synthesis and anti-cholinesterase activity of marine-derived bis-indole alkaloid fascaplysin</span></div><div class="casAuthors">Bharate, Sandip B.; Manda, Sudhakar; Joshi, Prashant; Singh, Baljinder; Vishwakarma, Ram A.</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1098-1103</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A short and efficient two-step total synthesis of marine sponge-derived bis-indole alkaloid fascaplysin (I) starting from com. available tryptamine (1H-indole-3-ethanamine) was designed and the synthesis of the target compd. was achieved in 68% overall yield.  A key step involved in the present strategy is tandem dehydrative condensation between ortho-halo substituted glyoxal with tryptamine followed by dehydrogenation.  Fascaplysin inhibited acetylcholinesterase (AChE) in non-competitive manner with IC50 and ki values of 1.49 and 2.28 μM resp. and with 60-fold selectivity for AChE vs. butyrylcholinesterase.  Mol. docking studies revealed that fascaplysin accommodates within a peripheral anionic site and inner linings of the AChE active site gorge.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooiFeR9xsnsrVg90H21EOLACvtfcHk0ljfELVVqLnXUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht1Gitb%252FI&md5=fd5bbbf5b63d61b1a7ae0710f59c5f61</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1039%2Fc2md20076g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20076g%26sid%3Dliteratum%253Aachs%26aulast%3DBharate%26aufirst%3DS.%2BB.%26aulast%3DManda%26aufirst%3DS.%26aulast%3DJoshi%26aufirst%3DP.%26aulast%3DSingh%26aufirst%3DB.%26aulast%3DVishwakarma%26aufirst%3DR.%2BA.%26atitle%3DTotal%2520synthesis%2520and%2520anti-cholinesterase%2520activity%2520of%2520marine-derived%2520bis-indole%2520alkaloid%2520fascaplysin%26jtitle%3DMedChemComm%26date%3D2012%26volume%3D3%26spage%3D1098%26epage%3D1103%26doi%3D10.1039%2Fc2md20076g" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">Novel inhibitors of acetyl- and butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpine</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">305</span>– <span class="NLM_lpage">313</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2004.12.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2004.12.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=15725500" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhs12itLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2005&pages=305-313&author=M.+Decker&title=Novel+inhibitors+of+acetyl-+and+butyrylcholinesterase+derived+from+the+alkaloids+dehydroevodiamine+and+rutaecarpine&doi=10.1016%2Fj.ejmech.2004.12.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Novel inhibitors of acetyl- and butyrylcholinesterase derived from the alkaloids dehydroevodiamine and rutaecarpine</span></div><div class="casAuthors">Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-313</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Derived from the structures of the alkaloids rutaecarpine and dehydroevodiamine (DHED), and the long-known acetylcholinesterase (AChE) inhibitor tacrine, resp., novel compds. were synthesized, including: 13-methyl-5,8-dihydro-6H-isoquino[1,2-b]quinazolin-13-ium chloride (I), (8Z)-5,6-dihydro-8H-isoquino[1,2-b]quinazolin-8-imine (II), 5,8-dihydro-6H-isoquino[1,2-b]quinazoline (III), 13-methyl-5,8-dihydro-6H-isoquino[1,2-b]quinazolin-13-ium chloride (IV), 5,7,8,13-tetrahydroindolo [2',3':3,4]pyrido[2,1-b]quinazoline (V), and N-(2-phenylethyl)-N-[(12Z)-7,8,9,10-tetrahydroazepino [2,1-b]quinazolin-12(6H)-ylidene]amine (VI), resp.  In a first step to evaluate their possible applicability for antiamnesic therapy, the inhibition of AChE and butyrylcholinesterase (BChE) were detd.: compds., II, III, V, and VI are moderate or strong inhibitors of ChE, the latter two compds. show a 10-fold higher affinity to BChE.  I is a moderate inhibitor of AChE showing selectivity towards this enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptttlEM9PfTbVg90H21EOLACvtfcHk0ljfELVVqLnXUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhs12itLc%253D&md5=f3ec42f29a7cd9957661876a6dee0273</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2004.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2004.12.003%26sid%3Dliteratum%253Aachs%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DNovel%2520inhibitors%2520of%2520acetyl-%2520and%2520butyrylcholinesterase%2520derived%2520from%2520the%2520alkaloids%2520dehydroevodiamine%2520and%2520rutaecarpine%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2005%26volume%3D40%26spage%3D305%26epage%3D313%26doi%3D10.1016%2Fj.ejmech.2004.12.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kling, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darras, F. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heilmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Decker, M.</span></span> <span> </span><span class="NLM_article-title">Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">15</span>– <span class="NLM_lpage">21</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2014.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=24819955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpsl2ltbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2014&pages=15-21&author=G.+Huangauthor=B.+Klingauthor=F.+H.+Darrasauthor=J.+Heilmannauthor=M.+Decker&title=Identification+of+a+neuroprotective+and+selective+butyrylcholinesterase+inhibitor+derived+from+the+natural+alkaloid+evodiamine&doi=10.1016%2Fj.ejmech.2014.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine</span></div><div class="casAuthors">Huang, Guozheng; Kling, Beata; Darras, Fouad H.; Heilmann, Joerg; Decker, Michael</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">81</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">15-21</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Two sets of carbamates based on the natural alkaloid evodiamine were designed, synthesized and evaluated as potential butyrylcholinesterase inhibitors.  Although a set of carbamates of 3-hydroxyevodiamine is inactive both at AChE and BChE, carbamates of 5-deoxo-3-hydroxyevodiamine (I) exhibit much better potency with selectivity toward BChE.  The heptyl carbamate of 5-deoxo-3-hydroxyevodiamine (I; R = heptyl; 11c) shows the best potency with an IC50 value of 77 nM and very good selectivity over AChE.  ORAC and cell-based assays indicate 11c possesses pronounced antioxidant properties with 1.75 Trolox equiv. and strong neuroprotection even from 1 μM onwards.  These combined activities might enable compd. 11c to be a potential candidate for treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCVMUoTorfwbVg90H21EOLACvtfcHk0lh0DNZOQv1tAA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpsl2ltbc%253D&md5=af9aae882ce80c4d89b05403620ad649</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DKling%26aufirst%3DB.%26aulast%3DDarras%26aufirst%3DF.%2BH.%26aulast%3DHeilmann%26aufirst%3DJ.%26aulast%3DDecker%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520a%2520neuroprotective%2520and%2520selective%2520butyrylcholinesterase%2520inhibitor%2520derived%2520from%2520the%2520natural%2520alkaloid%2520evodiamine%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D81%26spage%3D15%26epage%3D21%26doi%3D10.1016%2Fj.ejmech.2014.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mai, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ou, T.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">An, L.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, L.-Q.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of novel rutaecarpine derivatives and related alkaloids derivatives as selective acetylcholinesterase inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1415</span>– <span class="NLM_lpage">1423</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2009.12.044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2009.12.044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=20079560" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFKjtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=1415-1423&author=B.+Wangauthor=Y.-C.+Maiauthor=Y.+Liauthor=J.-Q.+Houauthor=S.-L.+Huangauthor=T.-M.+Ouauthor=J.-H.+Tanauthor=L.-K.+Anauthor=D.+Liauthor=L.-Q.+Gu&title=Synthesis+and+evaluation+of+novel+rutaecarpine+derivatives+and+related+alkaloids+derivatives+as+selective+acetylcholinesterase+inhibitors&doi=10.1016%2Fj.ejmech.2009.12.044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of novel rutaecarpine derivatives and related alkaloids derivatives as selective acetylcholinesterase inhibitors</span></div><div class="casAuthors">Wang, Bin; Mai, Yi-Chi; Li, Yue; Hou, Jin-Qiang; Huang, Shi-Liang; Ou, Tian-Miao; Tan, Jia-Heng; An, Lin-Kun; Li, Ding; Gu, Lian-Quan; Huang, Zhi-Shu</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1415-1423</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel rutaecarpine derivs. and related alkaloid derivs., 3-aminoalkanamido-substituted rutaecarpine (e.g. I) and 7,8-dehydrorutaecarpine, and 6-aminoalkanamido-substituted 3-[2-(3-indolyl)ethyl]-4(3a)-quinazolinones, were synthesized and subjected to pharmacol. evaluation as acetylcholinesterase (AChE) inhibitors.  The synthetic compds. exhibited strong inhibitory activity for AChE and high selectivity for AChE over BuChE.  The structure-activity relationships were discussed and their binding conformation and simultaneous interactions mode were further clarified by kinetic characterization and the mol. docking studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx29vB3HngwbVg90H21EOLACvtfcHk0lhU8VIqlD8Sdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFKjtrw%253D&md5=4e9a207c31c78a17f77bd07751fb671b</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.12.044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.12.044%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMai%26aufirst%3DY.-C.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DHou%26aufirst%3DJ.-Q.%26aulast%3DHuang%26aufirst%3DS.-L.%26aulast%3DOu%26aufirst%3DT.-M.%26aulast%3DTan%26aufirst%3DJ.-H.%26aulast%3DAn%26aufirst%3DL.-K.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DL.-Q.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520novel%2520rutaecarpine%2520derivatives%2520and%2520related%2520alkaloids%2520derivatives%2520as%2520selective%2520acetylcholinesterase%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D1415%26epage%3D1423%26doi%3D10.1016%2Fj.ejmech.2009.12.044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiaranaikulwanitch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boonyarat, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fokin, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajragupta, O.</span></span> <span> </span><span class="NLM_article-title">Triazolyl tryptoline derivatives as β-secretase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">6572</span>– <span class="NLM_lpage">6576</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2010.09.043</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmcl.2010.09.043" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=20943389" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSms7fF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=6572-6576&author=J.+Jiaranaikulwanitchauthor=C.+Boonyaratauthor=V.+V.+Fokinauthor=O.+Vajragupta&title=Triazolyl+tryptoline+derivatives+as+%CE%B2-secretase+inhibitors&doi=10.1016%2Fj.bmcl.2010.09.043"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Triazolyl tryptoline derivatives as β-secretase inhibitors</span></div><div class="casAuthors">Jiaranaikulwanitch, Jutamas; Boonyarat, Chantana; Fokin, Valery V.; Vajragupta, Opa</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">6572-6576</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Tryptoline, a core structure of ochrolifuanine E, which is a hit compd. from virtual screening of the Thai herbal database against BACE1 was used as a scaffold for the design of BACE1 inhibitors.  The tryptoline was linked with different side chains by 1,2,3-triazole ring readily synthesized by catalytic azide-alkyne cycloaddn. reactions.  Twenty two triazolyl tryptoline derivs. were synthesized and screened for the inhibitory action against BACE1.  JJCA 140 (I) was the most potent inhibitor (IC50 = 1.49 μM) and was 100 times more selective for BACE1 than for Cat-D.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6QRnN07AiCrVg90H21EOLACvtfcHk0lhU8VIqlD8Sdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSms7fF&md5=596d7b841d54230f5dd2eb931c73a97e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2010.09.043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2010.09.043%26sid%3Dliteratum%253Aachs%26aulast%3DJiaranaikulwanitch%26aufirst%3DJ.%26aulast%3DBoonyarat%26aufirst%3DC.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DVajragupta%26aufirst%3DO.%26atitle%3DTriazolyl%2520tryptoline%2520derivatives%2520as%2520%25CE%25B2-secretase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D6572%26epage%3D6576%26doi%3D10.1016%2Fj.bmcl.2010.09.043" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostinho, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C. R.</span></span> <span> </span><span class="NLM_article-title">Vinpocetine attenuates the metabolic dysfunction induced by amyloid β-peptides in PC12 cells</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">497</span>– <span class="NLM_lpage">506</span>, <span class="refDoi"> DOI: 10.1080/10715760000301041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1080%2F10715760000301041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=11200083" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlslOmug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2000&pages=497-506&author=C.+Pereiraauthor=P.+Agostinhoauthor=C.+R.+Oliveira&title=Vinpocetine+attenuates+the+metabolic+dysfunction+induced+by+amyloid+%CE%B2-peptides+in+PC12+cells&doi=10.1080%2F10715760000301041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Vinpocetine attenuates the metabolic dysfunction induced by amyloid β-peptides in PC12 cells</span></div><div class="casAuthors">Pereira, Claudia; Agostinho, Paula; Oliveira, Catarina R.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">497-506</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Harwood Academic Publishers</span>)
        </div><div class="casAbstract">The cytoprotective effect of vinpocetine [14-ethoxycarbonyl-(3α,16α-ethyl)-14,15-eburnamine] was investigated on PC12 cells treated with the amyloid β-peptides (Aβ) for 24 h.  Vinpocetine was shown to protect cells from the inhibition in redox status induced by exposure to Aβ25-35 and Aβ1-40, the maximal protection being achieved at a vinpocetine concn. of 40 μM.  At this concn., vinpocetine blocked the inhibition of the mitochondrial respiratory chain complexes II-III and IV and completely abolished the depletion of pyruvate levels induced by toxic concns. of Aβ peptides.  Furthermore, the accumulation of ROS in cells exposed to Aβ25-35 and Aβ1-40evaluated using the fluorescent probe 2',7'-dichlorofluorescin (DCF), was reduced in the presence of 40 μM vinpocetine.  Taken together, the data presented herein demonstrate that vinpocetine protects cells from Aβ toxicity, preventing the generation of oxidative stress due to the excessive accumulation of ROS.  This study suggests that vinpocetine can exert neuroprotective properties which might be of importance and contribute to its clin. efficacy in the treatment of Alzheimer's disease or other neurodegenerative disorders in which oxidative stress is involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosw6rZ2ja6hrVg90H21EOLACvtfcHk0lhU8VIqlD8Sdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlslOmug%253D%253D&md5=ca8eaea193a92788e6ddb6ff7e3ff991</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1080%2F10715760000301041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10715760000301041%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DC.%26aulast%3DAgostinho%26aufirst%3DP.%26aulast%3DOliveira%26aufirst%3DC.%2BR.%26atitle%3DVinpocetine%2520attenuates%2520the%2520metabolic%2520dysfunction%2520induced%2520by%2520amyloid%2520%25CE%25B2-peptides%2520in%2520PC12%2520cells%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2000%26volume%3D33%26spage%3D497%26epage%3D506%26doi%3D10.1080%2F10715760000301041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D.</span></span> <span> </span><span class="NLM_article-title">Pharmacological basis for the use of evodiamine in Alzheimer’s disease: antioxidation and antiapoptosis</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1527</span>– <span class="NLM_lpage">1540</span>, <span class="refDoi"> DOI: 10.3390/ijms19051527</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3390%2Fijms19051527" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVOrurfK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2018&pages=1527-1540&author=Y.+Zhangauthor=J.+Wangauthor=C.+Wangauthor=Z.+Liauthor=X.+Liuauthor=J.+Zhangauthor=J.+Luauthor=D.+Wang&title=Pharmacological+basis+for+the+use+of+evodiamine+in+Alzheimer%E2%80%99s+disease%3A+antioxidation+and+antiapoptosis&doi=10.3390%2Fijms19051527"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological basis for the use of evodiamine in alzheimer's disease: antioxidation and antiapoptosis</span></div><div class="casAuthors">Zhang, Yongfeng; Wang, Jiaqi; Wang, Chunyue; Li, Zhiping; Liu, Xin; Zhang, Jun; Lu, Jiahui; Wang, Di</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1527/1-1527/14</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Evodiamine (Evo), a major alkaloid compd. isolated from the dry unripened fruit of Evodia fructus, has a wide range of pharmacol. activities.  The present study sought to explore the neuroprotective effects of Evo in L-glutamate (L-Glu)-induced apoptosis of HT22 cells, and in a D-galactose and aluminum trichloride-developed Alzheimer's disease (AD) mouse model.  Evo significantly enhanced cell viability, inhibited the accumulation of reactive oxygen species, ameliorated mitochondrial function, increased the B-cell lymphoma-2 protein content, and inhibited the high expression levels of Bax, Bad, and cleaved-caspase-3 and -8 in L-Glu-induced HT22 cells.  Evo also enhanced the phosphorylation activities of protein kinase B and the mammalian target of rapamycin in the L-Glu-induced HT22 cells.  In the AD mouse model, Evo reduced the aimless and chaotic movements, reduced the time spent in the central area in the open field test, and decreased the escape latency time in the Morris water maze test.  Evo reduced the deposition of amyloid beta 42 (Aβ42) in the brain, and increased the serum level of Aβ42, but showed no significant effects on Aβ40.  In addn., six weeks of Evo administration significantly suppressed oxidative stress by modulating the related enzyme levels.  In the central cholinergic system of AD mice, Evo significantly increased the serum levels of acetylcholine and choline acetyltransferase and decreased the level of acetylcholinesterase in the serum, hypothalamus, and brain.  Our results provide exptl. evidence that Evo can serve as a neuroprotective candidate for the prevention and/or treatment of neurodegenerative diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPH1hdQNxsVLVg90H21EOLACvtfcHk0lgGLYQfjcU-kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVOrurfK&md5=4628ac3813d0bbd47f23b076108614dd</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.3390%2Fijms19051527&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms19051527%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DD.%26atitle%3DPharmacological%2520basis%2520for%2520the%2520use%2520of%2520evodiamine%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520antioxidation%2520and%2520antiapoptosis%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2018%26volume%3D19%26spage%3D1527%26epage%3D1540%26doi%3D10.3390%2Fijms19051527" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sun, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naman, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, H.</span></span> <span> </span><span class="NLM_article-title">9-methylfascaplysin is a more potent Aβ aggregation inhibitor than the marine-derived alkaloid, fascaplysin, and produces nanomolar neuroprotective effects in SH-SY5Y cells</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">135</span>, <span class="refDoi"> DOI: 10.3390/md17020121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3390%2Fmd17020121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlaku7nI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2019&pages=121-135&author=Q.+Sunauthor=F.+Liuauthor=J.+Sangauthor=M.+Linauthor=J.+Maauthor=X.+Xiaoauthor=S.+Yanauthor=C.+B.+Namanauthor=N.+Wangauthor=S.+Heauthor=X.+Yanauthor=W.+Cuiauthor=H.+Liang&title=9-methylfascaplysin+is+a+more+potent+A%CE%B2+aggregation+inhibitor+than+the+marine-derived+alkaloid%2C+fascaplysin%2C+and+produces+nanomolar+neuroprotective+effects+in+SH-SY5Y+cells&doi=10.3390%2Fmd17020121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">9-Methylfascaplysin is a more potent Aβ aggregation inhibitor than the marine-derived alkaloid, fascaplysin, and produces nanomolar neuroprotective effects in SH-SY5Y cells</span></div><div class="casAuthors">Sun, Qingmei; Liu, Fufeng; Sang, Jingcheng; Lin, Miaoman; Ma, Jiale; Xiao, Xiao; Yan, Sicheng; Naman, C. Benjamin; Wang, Ning; He, Shan; Yan, Xiaojun; Cui, Wei; Liang, Hongze</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">β-Amyloid (Aβ) is regarded as an important pathogenic target for Alzheimer's disease (AD), the most prevalent neurodegenerative disease.  Aβ can assemble into oligomers and fibrils, and produce neurotoxicity.  Therefore, Aβ aggregation inhibitors may have anti-AD therapeutic efficacies.  It was found, here, that the marine-derived alkaloid, fascaplysin, inhibits Aβ fibrillization in vitro.  Moreover, the new analog, 9-methylfascaplysin, was designed and synthesized from 5-methyltryptamine.  Interestingly, 9-methylfascaplysin is a more potent inhibitor of Aβ fibril formation than fascaplysin.  Incubation of 9-methylfascaplysin with Aβ directly reduced Aβ oligomer formation.  Mol. dynamics simulations revealed that 9-methylfascaplysin might interact with neg. charged residues of Aβ42 with polar binding energy.  Hydrogen bonds and π-π interactions between the key amino acid residues of Aβ42 and 9-methylfascaplysin were also suggested.  Most importantly, compared with the typical Aβ oligomer, Aβ modified by nanomolar 9-methylfascaplysin produced less neuronal toxicity in SH-SY5Y cells. 9-Methylfascaplysin appears to be one of the most potent marine-derived compds. that produces anti-Aβ neuroprotective effects.  Given previous reports that fascaplysin inhibits acetylcholinesterase and induces P-glycoprotein, the current study results suggest that fascaplysin derivs. can be developed as novel anti-AD drugs that possibly act via inhibition of Aβ aggregation along with other target mechanisms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGE-fvCHpburVg90H21EOLACvtfcHk0lgGLYQfjcU-kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlaku7nI&md5=1256cafb0cb9c6bc9b373ddb640390a1</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.3390%2Fmd17020121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd17020121%26sid%3Dliteratum%253Aachs%26aulast%3DSun%26aufirst%3DQ.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DSang%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DXiao%26aufirst%3DX.%26aulast%3DYan%26aufirst%3DS.%26aulast%3DNaman%26aufirst%3DC.%2BB.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DHe%26aufirst%3DS.%26aulast%3DYan%26aufirst%3DX.%26aulast%3DCui%26aufirst%3DW.%26aulast%3DLiang%26aufirst%3DH.%26atitle%3D9-methylfascaplysin%2520is%2520a%2520more%2520potent%2520A%25CE%25B2%2520aggregation%2520inhibitor%2520than%2520the%2520marine-derived%2520alkaloid%252C%2520fascaplysin%252C%2520and%2520produces%2520nanomolar%2520neuroprotective%2520effects%2520in%2520SH-SY5Y%2520cells%26jtitle%3DMar.%2520Drugs%26date%3D2019%26volume%3D17%26spage%3D121%26epage%3D135%26doi%3D10.3390%2Fmd17020121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">Effects of Picrasma quassioides and its active constituents on Alzheimer’s disease in vitro and in vivo</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">103258</span>– <span class="NLM_lpage">103266</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2019.103258</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bioorg.2019.103258" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=31520892" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhslOgsLfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=2019&pages=103258-103266&author=E.+Guoauthor=Y.+Huauthor=T.+Duauthor=H.+Zhuauthor=L.+Chenauthor=W.+Quauthor=J.+Zhangauthor=N.+Xieauthor=W.+Liuauthor=F.+Fengauthor=J.+Xu&title=Effects+of+Picrasma+quassioides+and+its+active+constituents+on+Alzheimer%E2%80%99s+disease+in+vitro+and+in+vivo&doi=10.1016%2Fj.bioorg.2019.103258"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of Picrasma quassioides and its active constituents on Alzheimer's disease in vitro and in vivo</span></div><div class="casAuthors">Guo, Eryan; Hu, Yunwei; Du, Tao; Zhu, Huilin; Chen, Lei; Qu, Wei; Zhang, Jie; Xie, Ning; Liu, Wenyuan; Feng, Feng; Xu, Jian</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103258</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer disease (AD), a prevalent neurodegenerative disorder, is one of the leading causes of dementia.  However, there is no effective drug for this disease to date.  Picrasma quassioides (D.Don) Benn, a Chinese traditional medicine, was used mainly for the treatment of inflammation, fever, microbial infection and dysentery.  In this paper, we reported that the EtOAc ext. of Picrasma quassioides stems showed potential neuroprotective activities in L-glutamate-stimulated PC12 and Aβ25-35-stimulated SH-SY5Y cell models, as well as improved memory and cognitive abilities in AD mice induced by amyloid-β peptide.  Moreover, it was revealed that the anti-AD mechanism was related to suppressing neuroinflammatory and reducing Aβ1-42 deposition using ELISA assay kits.  To clarify the active components of the EtOAc ext. of Picrasma quassioides stems, a systematic phytochem. study led to isolate and identify six β-carboline alkaloids (1-6), seven canthin-6-one alkaloids (7-13), and five quassinoids (14-18).  Among them, four β-carbolines (1-3, and 6) and six canthin-6-ones (7-11, and 13) exhibited potential neuroprotective activities in vitro.  Based on these date, the structure-activity relationships of alkaloids were discussed.  Furthermore, mol. docking expts. showed that compds. 2 and 3 have high affinity for both of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYPKIA) and butyrylcholinesterase (BuChE).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm1avNMniZr7Vg90H21EOLACvtfcHk0lhdO40PXaFsSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhslOgsLfP&md5=e050ba4e7b9ed7779b479037914007dd</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2019.103258&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2019.103258%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DE.%26aulast%3DHu%26aufirst%3DY.%26aulast%3DDu%26aufirst%3DT.%26aulast%3DZhu%26aufirst%3DH.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DQu%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DN.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DEffects%2520of%2520Picrasma%2520quassioides%2520and%2520its%2520active%2520constituents%2520on%2520Alzheimer%25E2%2580%2599s%2520disease%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DBioorg.%2520Chem.%26date%3D2019%26volume%3D92%26spage%3D103258%26epage%3D103266%26doi%3D10.1016%2Fj.bioorg.2019.103258" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latypova, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnaudeix, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrin, M.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yardin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terro, F.</span></span> <span> </span><span class="NLM_article-title">Tau protein kinases: involvement in Alzheimer’s disease</span>. <i>Ageing Res. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1016/j.arr.2012.06.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.arr.2012.06.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=22742992" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFKmt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=289-309&author=L.+Martinauthor=X.+Latypovaauthor=C.+M.+Wilsonauthor=A.+Magnaudeixauthor=M.-L.+Perrinauthor=C.+Yardinauthor=F.+Terro&title=Tau+protein+kinases%3A+involvement+in+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.arr.2012.06.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Tau protein kinases: Involvement in Alzheimer's disease</span></div><div class="casAuthors">Martin, Ludovic; Latypova, Xenia; Wilson, Cornelia M.; Magnaudeix, Amandine; Perrin, Marie-Laure; Yardin, Catherine; Terro, Faraj</div><div class="citationInfo"><span class="NLM_cas:title">Ageing Research Reviews</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">289-309</span>CODEN:
                <span class="NLM_cas:coden">ARRGAK</span>;
        ISSN:<span class="NLM_cas:issn">1568-1637</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Tau phosphorylation is regulated by a balance between tau kinase and phosphatase activities.  Disruption of this equil. was suggested to be at the origin of abnormal tau phosphorylation and thereby might contribute to tau aggregation.  Thus, understanding the regulation modes of tau phosphorylation is of high interest in detg. the possible causes at the origin of the formation of tau aggregates in order to elaborate protection strategies to cope with these lesions in Alzheimer's disease.  Among the possible and specific interventions that reverse tau phosphorylation is the inhibition of certain tau kinases.  Here, we extensively reviewed tau protein kinases, their physiol. roles and regulation, their involvement in tau phosphorylation and their relevance to AD.  We also reviewed the most common inhibitory compds. acting on each tau kinase.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqU914c2pCuALVg90H21EOLACvtfcHk0lhdO40PXaFsSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFKmt7w%253D&md5=ce41a1cf982105ec7b3cc0ee6fcdf20b</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1016%2Fj.arr.2012.06.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arr.2012.06.003%26sid%3Dliteratum%253Aachs%26aulast%3DMartin%26aufirst%3DL.%26aulast%3DLatypova%26aufirst%3DX.%26aulast%3DWilson%26aufirst%3DC.%2BM.%26aulast%3DMagnaudeix%26aufirst%3DA.%26aulast%3DPerrin%26aufirst%3DM.-L.%26aulast%3DYardin%26aufirst%3DC.%26aulast%3DTerro%26aufirst%3DF.%26atitle%3DTau%2520protein%2520kinases%253A%2520involvement%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAgeing%2520Res.%2520Rev.%26date%3D2013%26volume%3D12%26spage%3D289%26epage%3D309%26doi%3D10.1016%2Fj.arr.2012.06.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Frost, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meechoovet, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gately, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giorgetti, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shcherbakova, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunckley, T.</span></span> <span> </span><span class="NLM_article-title">β-Carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer’s disease-related sites</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">e19264</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0019264</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1371%2Fjournal.pone.0019264" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=21573099" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmtFKjurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&author=D.+Frostauthor=B.+Meechoovetauthor=T.+Wangauthor=S.+Gatelyauthor=M.+Giorgettiauthor=I.+Shcherbakovaauthor=T.+Dunckley&title=%CE%B2-Carboline+compounds%2C+including+harmine%2C+inhibit+DYRK1A+and+tau+phosphorylation+at+multiple+Alzheimer%E2%80%99s+disease-related+sites&doi=10.1371%2Fjournal.pone.0019264"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">β-Carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimer's disease-related sites</span></div><div class="casAuthors">Frost, Danielle; Meechoovet, Bessie; Wang, Tong; Gately, Stephen; Giorgetti, Marco; Shcherbakova, Irina; Dunckley, Travis</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e19264</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Harmine, a β-carboline alkaloid, is a high affinity inhibitor of the dual specificity tyrosine phosphorylation regulated kinase 1A (DYRK1A) protein.  The DYRK1A gene is located within the Down Syndrome Crit. Region (DSCR) on chromosome 21.  We and others have implicated DYRK1A in the phosphorylation of tau protein on multiple sites assocd. with tau pathol. in Down Syndrome and in Alzheimer's disease (AD).  Pharmacol. inhibition of this kinase may provide an opportunity to intervene therapeutically to alter the onset or progression of tau pathol. in AD.  Here we test the ability of harmine, and numerous addnl. β-carboline compds., to inhibit the DYRK1A dependent phosphorylation of tau protein on serine 396, serine 262/serine 356 (12E8 epitope), and threonine 231 in cell culture assays and in vitro phosphorylation assays.  Results demonstrate that the β-carboline compds. (1) potently reduce the expression of all three phosphorylated forms of tau protein, and (2) inhibit the DYRK1A catalyzed direct phosphorylation of tau protein on serine 396.  By assaying several β-carboline compds., we define certain chem. groups that modulate the affinity of this class of compds. for inhibition of tau phosphorylation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIyW3w-np5NrVg90H21EOLACvtfcHk0lhnnPAXCRtfPw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmtFKjurY%253D&md5=586705088397bfee8f58955b94bcc1db</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0019264&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0019264%26sid%3Dliteratum%253Aachs%26aulast%3DFrost%26aufirst%3DD.%26aulast%3DMeechoovet%26aufirst%3DB.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DGately%26aufirst%3DS.%26aulast%3DGiorgetti%26aufirst%3DM.%26aulast%3DShcherbakova%26aufirst%3DI.%26aulast%3DDunckley%26aufirst%3DT.%26atitle%3D%25CE%25B2-Carboline%2520compounds%252C%2520including%2520harmine%252C%2520inhibit%2520DYRK1A%2520and%2520tau%2520phosphorylation%2520at%2520multiple%2520Alzheimer%25E2%2580%2599s%2520disease-related%2520sites%26jtitle%3DPLoS%2520One%26date%3D2011%26volume%3D6%26doi%3D10.1371%2Fjournal.pone.0019264" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Adayev, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wegiel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, Y.-W.</span></span> <span> </span><span class="NLM_article-title">Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>507</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2010.12.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.abb.2010.12.024" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=21185805" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3MXit12jsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=507&publication_year=2011&pages=212-218&author=T.+Adayevauthor=J.+Wegielauthor=Y.-W.+Hwang&title=Harmine+is+an+ATP-competitive+inhibitor+for+dual-specificity+tyrosine+phosphorylation-regulated+kinase+1A+%28Dyrk1A%29&doi=10.1016%2Fj.abb.2010.12.024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)</span></div><div class="casAuthors">Adayev, Tatyana; Wegiel, Jerzy; Hwang, Yu-Wen</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">507</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">212-218</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Harmine is a β-carboline alkaloid.  The compd. is a potent inhibitor of dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A), a kinase implicated in Down syndrome.  In this study, we show that harmine functions as an ATP-competitive inhibitor against Dyrk1A.  Our conclusion is supported by kinetic anal. of harmine inhibition as well as by the characterization of a Dyrk1A mutation conferring significant resistance to harmine.  The mutation, V306A, is located next to the highly conserved D307 residue in kinases known to coordinate the phosphate groups of ATP through a Mg2+ ion.  The V306A mutation offers harmine resistance by differentially altering Dyrk1A affinity for harmine and ATP.  The V306A mutation causes no apparent alteration to Dyrk1A activity except for the redn. in ATP affinity.  This deficiency could be fully compensated by supplying ATP with a concn. in the physiol. range.  Our results reveal that harmine inhibits Dyrk1A activity by interacting with residues in the ATP-binding pocket and displacing ATP.  Our results also suggest that harmine will be a good lead compd. for further designing of selective ATP-competitive Dyrk1A inhibitors through exploration of the ATP-binding pocket of Dyrk1A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr-plj_OO0trVg90H21EOLACvtfcHk0liyq3tv2H7PQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXit12jsbo%253D&md5=bd3cd9608d332bc43b5b04f56059b62e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2010.12.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2010.12.024%26sid%3Dliteratum%253Aachs%26aulast%3DAdayev%26aufirst%3DT.%26aulast%3DWegiel%26aufirst%3DJ.%26aulast%3DHwang%26aufirst%3DY.-W.%26atitle%3DHarmine%2520is%2520an%2520ATP-competitive%2520inhibitor%2520for%2520dual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%25201A%2520%2528Dyrk1A%2529%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2011%26volume%3D507%26spage%3D212%26epage%3D218%26doi%3D10.1016%2Fj.abb.2010.12.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bain, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plater, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shpiro, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hastie, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLauchlan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klevernic, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arthur, J. S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alessi, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span> <span> </span><span class="NLM_article-title">The selectivity of protein kinase inhibitors: a further update</span>. <i>Biochem. J.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">297</span>– <span class="NLM_lpage">315</span>, <span class="refDoi"> DOI: 10.1042/BJ20070797</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1042%2FBJ20070797" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=17850214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2007&pages=297-315&author=J.+Bainauthor=L.+Platerauthor=M.+Elliottauthor=N.+Shpiroauthor=C.+J.+Hastieauthor=H.+McLauchlanauthor=I.+Klevernicauthor=J.+S.+C.+Arthurauthor=D.+R.+Alessiauthor=P.+Cohen&title=The+selectivity+of+protein+kinase+inhibitors%3A+a+further+update&doi=10.1042%2FBJ20070797"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">The selectivity of protein kinase inhibitors: a further update</span></div><div class="casAuthors">Bain, Jenny; Plater, Lorna; Elliott, Matt; Shpiro, Natalia; Hastie, C. James; McLauchlan, Hilary; Klevernic, Iva; Arthur, J. Simon C.; Alessi, Dario R.; Cohen, Philip</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Journal</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">297-315</span>CODEN:
                <span class="NLM_cas:coden">BIJOAK</span>;
        ISSN:<span class="NLM_cas:issn">0264-6021</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The specificities of 65 compds. reported to be relatively specific inhibitors of protein kinases have been profiled against a panel of 70-80 protein kinases.  On the basis of this information, the effects of compds. that we have studied in cells and other data in the literature, we recommend the use of the following small-mol. inhibitors: SB 203580/SB202190 and BIRB 0796 to be used in parallel to assess the physiol. roles of p38 MAPK (mitogen-activated protein kinase) isoforms, PI-103 and wortmannin to be used in parallel to inhibit phosphatidylinositol (phosphoinositide) 3-kinases, PP1 or PP2 to be used in parallel with Src-I1 (Src inhibitor-1) to inhibit Src family members; PD 184352 or PD 0325901 to inhibit MKK1 (MAPK kinase-1) or MKK1 plus MKK5, Akt-I-1/2 to inhibit the activation of PKB (protein kinase B/Akt), rapamycin to inhibit TORC1 [mTOR (mammalian target of rapamycin)-raptor (regulatory assocd. protein of mTOR) complex], CT 99021 to inhibit GSK3 (glycogen synthase kinase 3), BI-D1870 and SL0101 or FMK (fluoromethylketone) to be used in parallel to inhibit RSK (ribosomal S6 kinase), D4476 to inhibit CK1 (casein kinase 1), VX680 to inhibit Aurora kinases, and roscovitine as a pan-CDK (cyclin-dependent kinase) inhibitor.  We have also identified harmine as a potent and specific inhibitor of DYRK1A (dual-specificity tyrosine-phosphorylated and -regulated kinase 1A) in vitro.  The results have further emphasized the need for considerable caution in using small-mol. inhibitors of protein kinases to assess the physiol. roles of these enzymes.  Despite being used widely, many of the compds. that we analyzed were too non-specific for useful conclusions to be made, other than to exclude the involvement of particular protein kinases in cellular processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQPaieWftdVrVg90H21EOLACvtfcHk0lhHK8vvl88J8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtlGmtbjE&md5=e2334e35897dd1b9770bbcca8f82bb9c</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1042%2FBJ20070797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBJ20070797%26sid%3Dliteratum%253Aachs%26aulast%3DBain%26aufirst%3DJ.%26aulast%3DPlater%26aufirst%3DL.%26aulast%3DElliott%26aufirst%3DM.%26aulast%3DShpiro%26aufirst%3DN.%26aulast%3DHastie%26aufirst%3DC.%2BJ.%26aulast%3DMcLauchlan%26aufirst%3DH.%26aulast%3DKlevernic%26aufirst%3DI.%26aulast%3DArthur%26aufirst%3DJ.%2BS.%2BC.%26aulast%3DAlessi%26aufirst%3DD.%2BR.%26aulast%3DCohen%26aufirst%3DP.%26atitle%3DThe%2520selectivity%2520of%2520protein%2520kinase%2520inhibitors%253A%2520a%2520further%2520update%26jtitle%3DBiochem.%2520J.%26date%3D2007%26volume%3D408%26spage%3D297%26epage%3D315%26doi%3D10.1042%2FBJ20070797" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cozza, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarno, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruzzene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girardi, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orzeszko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazimierczuk, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zagotto, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonaiuto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Di Paolo, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinna, L. A.</span></span> <span> </span><span class="NLM_article-title">Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases</span>. <i>Biochim. Biophys. Acta, Proteins Proteomics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>1834</i></span>,  <span class="NLM_fpage">1402</span>– <span class="NLM_lpage">1409</span>, <span class="refDoi"> DOI: 10.1016/j.bbapap.2013.01.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bbapap.2013.01.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=23360763" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3sXivFyntr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1834&publication_year=2013&pages=1402-1409&author=G.+Cozzaauthor=S.+Sarnoauthor=M.+Ruzzeneauthor=C.+Girardiauthor=A.+Orzeszkoauthor=Z.+Kazimierczukauthor=G.+Zagottoauthor=E.+Bonaiutoauthor=M.+L.+Di+Paoloauthor=L.+A.+Pinna&title=Exploiting+the+repertoire+of+CK2+inhibitors+to+target+DYRK+and+PIM+kinases&doi=10.1016%2Fj.bbapap.2013.01.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Exploiting the repertoire of CK2 inhibitors to target DYRK and PIM kinases</span></div><div class="casAuthors">Cozza, Giorgio; Sarno, Stefania; Ruzzene, Maria; Girardi, Cristina; Orzeszko, Andrzej; Kazimierczuk, Zygmunt; Zagotto, Giuseppe; Bonaiuto, Emanuela; Di Paolo, Maria Luisa; Pinna, Lorenzo A.</div><div class="citationInfo"><span class="NLM_cas:title">Biochimica et Biophysica Acta, Proteins and Proteomics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">1834</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1402-1409</span>CODEN:
                <span class="NLM_cas:coden">BBAPBW</span>;
        ISSN:<span class="NLM_cas:issn">1570-9639</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B. V.</span>)
        </div><div class="casAbstract">Advantage has been taken of the relative promiscuity of commonly used inhibitors of protein kinase CK2 to develop compds. that can be exploited for the selective inhibition of druggable kinases other than CK2 itself.  Here we summarize data obtained by altering the scaffold of CK2 inhibitors to give rise to novel selective inhibitors of DYRK1A and to a powerful cell permeable dual inhibitor of PIM1 and CK2.  In the former case one of the new compds., C624 (naphtho [1,2-b]benzofuran-5,9-diol) displays a potency comparable to that of the first-in-class DYRK1A inhibitor, harmine, lacking however the drawback of drastically inhibiting monoamine oxidase-A (MAO-A) as harmine does.  On the other hand the promiscuous CK2 inhibitor 4,5,6,7-tetrabromo-1H-benzimidazole (TBI,TBBz) has been derivatized with a sugar moiety to generate a 1-(β-D-2'-deoxyribofuranosyl)-4,5,6,7-tetrabromo-1H-benzimidazole (TDB) compd. which inhibits PIM1 and CK2 with comparably high efficacy (IC50 values < 100 nM) and remarkable selectivity.  TDB, unlike other dual PIM1/CK2 inhibitors described in the literature is readily cell permeable and displays a cytotoxic effect on cancer cells consistent with concomitant inhibition of both its onco-kinase targets.  This article is part of a Special Issue entitled: Inhibitors of Protein Kinases (2012).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqoAFsk8sxvWrVg90H21EOLACvtfcHk0lhHK8vvl88J8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXivFyntr4%253D&md5=dd92c6268de52bfe412d546bf42665b4</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2Fj.bbapap.2013.01.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbapap.2013.01.018%26sid%3Dliteratum%253Aachs%26aulast%3DCozza%26aufirst%3DG.%26aulast%3DSarno%26aufirst%3DS.%26aulast%3DRuzzene%26aufirst%3DM.%26aulast%3DGirardi%26aufirst%3DC.%26aulast%3DOrzeszko%26aufirst%3DA.%26aulast%3DKazimierczuk%26aufirst%3DZ.%26aulast%3DZagotto%26aufirst%3DG.%26aulast%3DBonaiuto%26aufirst%3DE.%26aulast%3DDi%2BPaolo%26aufirst%3DM.%2BL.%26aulast%3DPinna%26aufirst%3DL.%2BA.%26atitle%3DExploiting%2520the%2520repertoire%2520of%2520CK2%2520inhibitors%2520to%2520target%2520DYRK%2520and%2520PIM%2520kinases%26jtitle%3DBiochim.%2520Biophys.%2520Acta%252C%2520Proteins%2520Proteomics%26date%3D2013%26volume%3D1834%26spage%3D1402%26epage%3D1409%26doi%3D10.1016%2Fj.bbapap.2013.01.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Göckler, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jofre, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papadopoulos, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soppa, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejedor, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</span>. <i>FEBS J.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">6324</span>– <span class="NLM_lpage">6337</span>, <span class="refDoi"> DOI: 10.1111/j.1742-4658.2009.07346.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1111%2Fj.1742-4658.2009.07346.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=19796173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADC%252BD1MnovVSmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2009&pages=6324-6337&author=N.+G%C3%B6cklerauthor=G.+Jofreauthor=C.+Papadopoulosauthor=U.+Soppaauthor=F.+J.+Tejedorauthor=W.+Becker&title=Harmine+specifically+inhibits+protein+kinase+DYRK1A+and+interferes+with+neurite+formation&doi=10.1111%2Fj.1742-4658.2009.07346.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Harmine specifically inhibits protein kinase DYRK1A and interferes with neurite formation</span></div><div class="casAuthors">Gockler Nora; Jofre Guillermo; Papadopoulos Chrisovalantis; Soppa Ulf; Tejedor Francisco J; Becker Walter</div><div class="citationInfo"><span class="NLM_cas:title">The FEBS journal</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">276</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6324-37</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">DYRK1A is a dual-specificity protein kinase that autophosphorylates a conserved tyrosine residue in the activation loop but phosphorylates exogenous substrates only at serine or threonine residues.  Tyrosine autophosphorylation of DYRKs is a one-off event that takes place during translation and induces the activation of the kinase.  Here we characterize the beta-carboline alkaloid harmine as a potent and specific inhibitor of DYRK1A both in vitro and in cultured cells.  Comparative in vitro assays of four kinases of the DYRK family showed that harmine inhibited substrate phosphorylation by DYRK1A more potently than it inhibited substrate phosphorylation by the closely related kinase DYRK1B [half maximal inhibitory concentrations (IC(50)) of 33 nm versus 166 nm, respectively] and by the more distant members of the family, DYRK2 and DYRK4 (1.9 microm and 80 microm, respectively).  Much higher concentrations of harmine were required to suppress tyrosine autophosphorylation of the translational intermediate of DYRK1A in a bacterial in vitro translation system (IC(50) = 1.9 microm).  Importantly, harmine inhibited the phosphorylation of a specific substrate by DYRK1A in cultured cells with a potency similar to that observed in vitro (IC(50) = 48 nm), without negative effects on the viability of the cells.  Overexpression of the DYRK1A gene on chromosome 21 has been implicated in the altered neuronal development observed in Down syndrome.  Here, we show that harmine interferes with neuritogenesis in cultured hippocampal neurons.  In summary, our data show that harmine inhibits DYRK1A substrate phosphorylation more potently than it inhibits tyrosine autophosphorylation, and provide evidence for a role of DYRK1A in the regulation of neurite formation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTYQnyD9o3hqhe4jJGKT5N0fW6udTcc2eaaw0Hb7wtzBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MnovVSmtw%253D%253D&md5=f59bc35eb74546f6351a4705f2d5fda7</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1111%2Fj.1742-4658.2009.07346.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1742-4658.2009.07346.x%26sid%3Dliteratum%253Aachs%26aulast%3DG%25C3%25B6ckler%26aufirst%3DN.%26aulast%3DJofre%26aufirst%3DG.%26aulast%3DPapadopoulos%26aufirst%3DC.%26aulast%3DSoppa%26aufirst%3DU.%26aulast%3DTejedor%26aufirst%3DF.%2BJ.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DHarmine%2520specifically%2520inhibits%2520protein%2520kinase%2520DYRK1A%2520and%2520interferes%2520with%2520neurite%2520formation%26jtitle%3DFEBS%2520J.%26date%3D2009%26volume%3D276%26spage%3D6324%26epage%3D6337%26doi%3D10.1111%2Fj.1742-4658.2009.07346.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grabher, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouloura, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halabalaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaltsounis, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamburger, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potterat, O.</span></span> <span> </span><span class="NLM_article-title">Library-based discovery of DYRK1A/CLKA inhibitors from natural product extracts</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">951</span>– <span class="NLM_lpage">956</span>, <span class="refDoi"> DOI: 10.1055/s-0031-1298625</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1055%2Fs-0031-1298625" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=22673832" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtlalu7fJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2012&pages=951-956&author=P.+Grabherauthor=E.+Durieuauthor=E.+Koulouraauthor=M.+Halabalakiauthor=L.+A.+Skaltsounisauthor=L.+Meijerauthor=M.+Hamburgerauthor=O.+Potterat&title=Library-based+discovery+of+DYRK1A%2FCLKA+inhibitors+from+natural+product+extracts&doi=10.1055%2Fs-0031-1298625"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Library-based discovery of DYRK1A/CLK1 inhibitors from natural product extracts</span></div><div class="casAuthors">Grabher, Patrick; Durieu, Emilie; Kouloura, Eirini; Halabalaki, Maria; Skaltsounis, Leandros A.; Meijer, Laurent; Hamburger, Matthias; Potterat, Olivier</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">951-956</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">The dual specificity tyrosine-phosphorylation-regulated kinase DYRK1A possesses diverse roles in neuronal development and adult brain physiol., and increased activity has been linked to neurodegenerative diseases.  Very few inhibitors of this kinase have been reported up to now.  Screening of a library of > 900 plant and fungal exts. afforded 25 exts. with IC50s < 10 μg/mL against DYRK1A.  To identify the active constituents, the exts. were submitted to a process integrating physicochem. data with biol. information, referred to as HPLC-based activity profiling.  Follow-up investigation of four exts. led to the targeted isolation of harmine (1, IC50 0.022 μM) from Peganum harmala, emodin (3, IC50 4.2 μM) from Cassia nigricans, kaempferol (4, IC50 0.91 μM) from Cuscuta chinensis, and 3,8-di-O-methylherbacetin (11, IC50 8.6 μM), 3,3'-4'-tri-O-methylmyricetin (12, IC50 7.1 μM) and ombuin (15, IC50 1.7 μM) from Larrea tridentata as the active constituents.  Active exts. and compds. were also tested on the closely related cdc2-like kinase CLK1.  Finally, the selectivity profile of compds. was evaluated by including other members of the DYRKs and CLKs families.  While the flavonoids and emodin did not show significant differences in the potency of their activities, harmine (1) was most active against DYRK1A, CLK1, and CLK4, and less potent against the other kinases, with selectivity ranging from 2- to 20-fold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQYs26xh3H3LVg90H21EOLACvtfcHk0lg8AYETfqQzOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtlalu7fJ&md5=4b208fb3076d132158355eed8472acc3</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1055%2Fs-0031-1298625&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0031-1298625%26sid%3Dliteratum%253Aachs%26aulast%3DGrabher%26aufirst%3DP.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DKouloura%26aufirst%3DE.%26aulast%3DHalabalaki%26aufirst%3DM.%26aulast%3DSkaltsounis%26aufirst%3DL.%2BA.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DHamburger%26aufirst%3DM.%26aulast%3DPotterat%26aufirst%3DO.%26atitle%3DLibrary-based%2520discovery%2520of%2520DYRK1A%252FCLKA%2520inhibitors%2520from%2520natural%2520product%2520extracts%26jtitle%3DPlanta%2520Med.%26date%3D2012%26volume%3D78%26spage%3D951%26epage%3D956%26doi%3D10.1055%2Fs-0031-1298625" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mariano, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span> <span> </span><span class="NLM_article-title">Systematic diversification of benzylidene heterocycles yields novel inhibitor scaffolds selective for Dyrk1A, Clk1 and CK2</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>112</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">216</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.02.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2016.02.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=26896709" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC28XivVChsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=112&publication_year=2016&pages=209-216&author=M.+Marianoauthor=R.+W.+Hartmannauthor=M.+Engel&title=Systematic+diversification+of+benzylidene+heterocycles+yields+novel+inhibitor+scaffolds+selective+for+Dyrk1A%2C+Clk1+and+CK2&doi=10.1016%2Fj.ejmech.2016.02.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Systematic diversification of benzylidene heterocycles yields novel inhibitor scaffolds selective for Dyrk1A, Clk1 and CK2</span></div><div class="casAuthors">Mariano, Marica; Hartmann, Rolf W.; Engel, Matthias</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">112</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">209-216</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The dual-specificity tyrosine-regulated kinase 1A (Dyrk1A) has gathered much interest as a pharmacol. target in Alzheimer's disease (AD), but it plays a role in malignant brain tumors as well.  As both diseases are multi-factorial, further protein kinases, such as Clk1 and CK2, were proposed to contribute to the pathogenesis.  The authors designed a new class of α-benzylidene-γ-butyrolactone inhibitors that showed low micromolar potencies against Dyrk1A and/or Clk1 and a good selectivity profile among the most frequently reported off-target kinases.  A systematic replacement of the heterocyclic moiety gave access to further inhibitor classes with interesting selectivity profiles, demonstrating that the benzylidene heterocycles provide a versatile tool box for developing inhibitors of the CMGC kinase family members Dyr1A/1B, Clk1/4 and CK2.  Efficacy for the inhibition of Dyrk1A-mediated tau phosphorylation was demonstrated in a cell-based assay.  Multi-targeted but not non-specific kinase inhibitors were also obtained, that co-inhibited the lipid kinases PI3Kα/γ.  These compds. were shown to inhibit the proliferation of U87MG cells in the low micromolar range.  Based on the mol. properties, the inhibitors described here hold promise for CNS activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr6qXCl7IedNLVg90H21EOLACvtfcHk0lg8AYETfqQzOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XivVChsb4%253D&md5=85bec789a30e7da3dddfc731ed87b227</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.02.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.02.017%26sid%3Dliteratum%253Aachs%26aulast%3DMariano%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DEngel%26aufirst%3DM.%26atitle%3DSystematic%2520diversification%2520of%2520benzylidene%2520heterocycles%2520yields%2520novel%2520inhibitor%2520scaffolds%2520selective%2520for%2520Dyrk1A%252C%2520Clk1%2520and%2520CK2%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D112%26spage%3D209%26epage%3D216%26doi%3D10.1016%2Fj.ejmech.2016.02.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tahtouh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elkins, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soundararajan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Durieu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cochet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmid, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lo, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delhommel, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberholzer, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pearl, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carreaux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bazureau, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span> <span> </span><span class="NLM_article-title">Selectivity, cocrystal structures, and neuroprotective properties of leucettines, a family of protein kinase inhibitors derived from the marine sponge alkaloid leucettamine B</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9312</span>– <span class="NLM_lpage">9330</span>, <span class="refDoi"> DOI: 10.1021/jm301034u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301034u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9312-9330&author=T.+Tahtouhauthor=J.+M.+Elkinsauthor=P.+Filippakopoulosauthor=M.+Soundararajanauthor=G.+Burgyauthor=E.+Durieuauthor=C.+Cochetauthor=R.+S.+Schmidauthor=D.+C.+Loauthor=F.+Delhommelauthor=A.+E.+Oberholzerauthor=L.+H.+Pearlauthor=F.+Carreauxauthor=J.-P.+Bazureauauthor=S.+Knappauthor=L.+Meijer&title=Selectivity%2C+cocrystal+structures%2C+and+neuroprotective+properties+of+leucettines%2C+a+family+of+protein+kinase+inhibitors+derived+from+the+marine+sponge+alkaloid+leucettamine+B&doi=10.1021%2Fjm301034u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Selectivity, Cocrystal Structures, and Neuroprotective Properties of Leucettines, a Family of Protein Kinase Inhibitors Derived from the Marine Sponge Alkaloid Leucettamine B</span></div><div class="casAuthors">Tahtouh, Tania; Elkins, Jonathan M.; Filippakopoulos, Panagis; Soundararajan, Meera; Burgy, Guillaume; Durieu, Emilie; Cochet, Claude; Schmid, Ralf S.; Lo, Donald C.; Delhommel, Florent; Oberholzer, Anselm E.; Pearl, Laurence H.; Carreaux, Francois; Bazureau, Jean-Pierre; Knapp, Stefan; Meijer, Laurent</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9312-9330</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">DYRKs (dual specificity, tyrosine phosphorylation regulated kinases) and CLKs (cdc2-like kinases) are implicated in the onset and development of Alzheimer's disease and Down syndrome.  The marine sponge alkaloid leucettamine B was recently identified as an inhibitor of DYRKs/CLKs.  Synthesis of analogs (leucettines) led to an optimized product, leucettine L41.  Leucettines were cocrystd. with DYRK1A, DYRK2, CLK3, PIM1, and GSK-3β.  The selectivity of L41 was studied by activity and interaction assays of recombinant kinases and affinity chromatog. and competition affinity assays.  These approaches revealed unexpected potential secondary targets such as CK2, SLK, and the lipid kinase PIKfyve/Vac14.  L41 displayed neuroprotective effects on glutamate-induced HT22 cell death.  L41 also reduced amyloid precursor protein-induced cell death in cultured rat brain slices.  The unusual multitarget selectivity of leucettines may account for their neuroprotective effects.  This family of kinase inhibitors deserves further optimization as potential therapeutics against neurodegenerative diseases such as Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOhwr44JiuCrVg90H21EOLACvtfcHk0lhhSRwv8aI6Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhtl2mu7vF&md5=a1749c347c2e8e0409d8fdd475dc70f9</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1021%2Fjm301034u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301034u%26sid%3Dliteratum%253Aachs%26aulast%3DTahtouh%26aufirst%3DT.%26aulast%3DElkins%26aufirst%3DJ.%2BM.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DSoundararajan%26aufirst%3DM.%26aulast%3DBurgy%26aufirst%3DG.%26aulast%3DDurieu%26aufirst%3DE.%26aulast%3DCochet%26aufirst%3DC.%26aulast%3DSchmid%26aufirst%3DR.%2BS.%26aulast%3DLo%26aufirst%3DD.%2BC.%26aulast%3DDelhommel%26aufirst%3DF.%26aulast%3DOberholzer%26aufirst%3DA.%2BE.%26aulast%3DPearl%26aufirst%3DL.%2BH.%26aulast%3DCarreaux%26aufirst%3DF.%26aulast%3DBazureau%26aufirst%3DJ.-P.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DMeijer%26aufirst%3DL.%26atitle%3DSelectivity%252C%2520cocrystal%2520structures%252C%2520and%2520neuroprotective%2520properties%2520of%2520leucettines%252C%2520a%2520family%2520of%2520protein%2520kinase%2520inhibitors%2520derived%2520from%2520the%2520marine%2520sponge%2520alkaloid%2520leucettamine%2520B%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9312%26epage%3D9330%26doi%3D10.1021%2Fjm301034u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Loidreau, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubouilh-Benard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nourrisson, M.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loaëc, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Besson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marchand, P.</span></span> <span> </span><span class="NLM_article-title">Exploring kinase inhibition properties of 9H-pyrimido[5,4-b]- and [4,5-b]indol-4-amine derivatives</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">89</span>, <span class="refDoi"> DOI: 10.3390/ph13050089</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3390%2Fph13050089" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFKqs7nN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2020&pages=89&author=Y.+Loidreauauthor=C.+Dubouilh-Benardauthor=M.-R.+Nourrissonauthor=N.+Loa%C3%ABcauthor=L.+Meijerauthor=T.+Bessonauthor=P.+Marchand&title=Exploring+kinase+inhibition+properties+of+9H-pyrimido%5B5%2C4-b%5D-+and+%5B4%2C5-b%5Dindol-4-amine+derivatives&doi=10.3390%2Fph13050089"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring kinase inhibition properties of 9H-pyrimido[5,4-b]- and[4,5-b]indol-4-amine derivatives</span></div><div class="casAuthors">Loidreau, Yvonnick; Dubouilh-Benard, Carole; Nourrisson, Marie-Renee; Loaec, Nadege; Meijer, Laurent; Besson, Thierry; Marchand, Pascal</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">89</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">For the generation of chem. libraries, the formamide-mediated cyclization of the cyanoamidine precursors was carried out under microwave irradn. in an eco-friendly approach.  In order to explore more in-depth the pharmacol. interest in such tricyclic skeletons, the central five member ring, i.e., thiophene or furan, was replaced by a pyrrole to afford 9H-pyrimido[5,4-b]indol-4-amines I (R = H, Me, Et, Bn; R1 = H, nitro) and [4,5-b]indol-4-amine derivs. II inspired from harmine.  The inhibitory potency of the final products was detd. against four protein kinases (CDK5/p25, CK1δ/ε, GSK3α/β, and DYRK1A).  As a result, promising compds. targeting CK1δ/ε and DYRK1A and displaying micromolar and submicromolar IC50 values were identified.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG8QylpDgjnLVg90H21EOLACvtfcHk0lhhSRwv8aI6Fg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFKqs7nN&md5=e1623101654be54fb77ccc098e6faab8</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.3390%2Fph13050089&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph13050089%26sid%3Dliteratum%253Aachs%26aulast%3DLoidreau%26aufirst%3DY.%26aulast%3DDubouilh-Benard%26aufirst%3DC.%26aulast%3DNourrisson%26aufirst%3DM.-R.%26aulast%3DLoa%25C3%25ABc%26aufirst%3DN.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DBesson%26aufirst%3DT.%26aulast%3DMarchand%26aufirst%3DP.%26atitle%3DExploring%2520kinase%2520inhibition%2520properties%2520of%25209H-pyrimido%255B5%252C4-b%255D-%2520and%2520%255B4%252C5-b%255Dindol-4-amine%2520derivatives%26jtitle%3DPharmaceuticals%26date%3D2020%26volume%3D13%26spage%3D89%26doi%3D10.3390%2Fph13050089" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Drung, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scholz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa, V. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nazari, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarragiotto, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, B.</span></span> <span> </span><span class="NLM_article-title">Computational & experimental evaluation of the structure/activity relationship of β-carbolines as DYRK1A inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4854</span>– <span class="NLM_lpage">4860</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.08.054</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmcl.2014.08.054" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=25240617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFWjtbjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2014&pages=4854-4860&author=B.+Drungauthor=C.+Scholzauthor=V.+A.+Barbosaauthor=A.+Nazariauthor=M.+H.+Sarragiottoauthor=B.+Schmidt&title=Computational+%26+experimental+evaluation+of+the+structure%2Factivity+relationship+of+%CE%B2-carbolines+as+DYRK1A+inhibitors&doi=10.1016%2Fj.bmcl.2014.08.054"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Computational & experimental evaluation of the structure/activity relationship of β-carbolines as DYRK1A inhibitors</span></div><div class="casAuthors">Drung, Binia; Scholz, Christoph; Barbosa, Valeria A.; Nazari, Azadeh; Sarragiotto, Maria H.; Schmidt, Boris</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">4854-4860</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">DYRK1A has been assocd. with Down's syndrome and neurodegenerative diseases, therefore it is an important target for novel pharmacol. interventions.  We combined a ligand-based pharmacophore design with a structure-based protein/ligand docking using the software MOE in order to evaluate the underlying structure/activity relationship.  Based on this knowledge we synthesized several novel β-carboline derivs. to validate the theor. model.  Furthermore we identified a modified lead structure as a potent DYRK1A inhibitor (IC50 = 130 nM) with significant selectivity against MAO-A, DYRK2, DYRK3, DYRK4 & CLK2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7toJP2kYJW7Vg90H21EOLACvtfcHk0lg9mjl86Jn46Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFWjtbjJ&md5=d6fe10d53dba2047c291dbb56de5afcb</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.08.054&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.08.054%26sid%3Dliteratum%253Aachs%26aulast%3DDrung%26aufirst%3DB.%26aulast%3DScholz%26aufirst%3DC.%26aulast%3DBarbosa%26aufirst%3DV.%2BA.%26aulast%3DNazari%26aufirst%3DA.%26aulast%3DSarragiotto%26aufirst%3DM.%2BH.%26aulast%3DSchmidt%26aufirst%3DB.%26atitle%3DComputational%2520%2526%2520experimental%2520evaluation%2520of%2520the%2520structure%252Factivity%2520relationship%2520of%2520%25CE%25B2-carbolines%2520as%2520DYRK1A%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2014%26volume%3D24%26spage%3D4854%26epage%3D4860%26doi%3D10.1016%2Fj.bmcl.2014.08.054" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ruben, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurzlbauer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sippl, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bracher, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, W.</span></span> <span> </span><span class="NLM_article-title">Selectivity profiling and biological activity of novel β-carbolines as potent and selective DYRK1 kinase inhibitors</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">e0132453</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0132453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1371%2Fjournal.pone.0132453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=26192590" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2015&author=K.+Rubenauthor=A.+Wurzlbauerauthor=A.+Walteauthor=W.+Sipplauthor=F.+Bracherauthor=W.+Becker&title=Selectivity+profiling+and+biological+activity+of+novel+%CE%B2-carbolines+as+potent+and+selective+DYRK1+kinase+inhibitors&doi=10.1371%2Fjournal.pone.0132453"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0132453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0132453%26sid%3Dliteratum%253Aachs%26aulast%3DRuben%26aufirst%3DK.%26aulast%3DWurzlbauer%26aufirst%3DA.%26aulast%3DWalte%26aufirst%3DA.%26aulast%3DSippl%26aufirst%3DW.%26aulast%3DBracher%26aufirst%3DF.%26aulast%3DBecker%26aufirst%3DW.%26atitle%3DSelectivity%2520profiling%2520and%2520biological%2520activity%2520of%2520novel%2520%25CE%25B2-carbolines%2520as%2520potent%2520and%2520selective%2520DYRK1%2520kinase%2520inhibitors%26jtitle%3DPLoS%2520One%26date%3D2015%26volume%3D10%26doi%3D10.1371%2Fjournal.pone.0132453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balint, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cruzalegui, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burbridge, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotschy, A.</span></span> <span> </span><span class="NLM_article-title">Structure-based design and synthesis of harmine derivatives with different selectivity profiles in kinase versus monoamine oxidase inhibition</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">932</span>– <span class="NLM_lpage">939</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201600539</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1002%2Fcmdc.201600539" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=28264138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXls1Wisro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=932-939&author=B.+Balintauthor=C.+Weberauthor=F.+Cruzaleguiauthor=M.+Burbridgeauthor=A.+Kotschy&title=Structure-based+design+and+synthesis+of+harmine+derivatives+with+different+selectivity+profiles+in+kinase+versus+monoamine+oxidase+inhibition&doi=10.1002%2Fcmdc.201600539"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design and Synthesis of Harmine Derivatives with Different Selectivity Profiles in Kinase versus Monoamine Oxidase Inhibition</span></div><div class="casAuthors">Balint, Balazs; Weber, Csaba; Cruzalegui, Francisco; Burbridge, Mike; Kotschy, Andras</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">932-939</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) is an emerging biol. target with implications in diverse therapeutic areas such as neurol. disorders (Down syndrome, in particular), metab., and oncol.  Harmine, a natural product that selectively inhibits DYRK1A amongst kinases, could serve as a tool compd. to better understand the biol. processes that arise from DYRK1A inhibition.  On the other hand, harmine is also a potent inhibitor of monoamine oxidase A (MAO-A).  Using structure-based design, we synthesized a collection of harmine analogs with tunable selectivity toward these two enzymes.  Modifications at the 7-position typically decreased affinity for DYRK1A, whereas substitution at the 9-position had a similar effect on MAO-A inhibition but DYRK1A inhibition was maintained.  The resulting collection of compds. can help to understand the biol. role of DYRK1A and also to assess the interference in the biol. effect originating in MAO-A inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsY4lpVOJVlbVg90H21EOLACvtfcHk0lg9mjl86Jn46Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXls1Wisro%253D&md5=f713602f24c608cbe5c97d965ea3727d</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201600539&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201600539%26sid%3Dliteratum%253Aachs%26aulast%3DBalint%26aufirst%3DB.%26aulast%3DWeber%26aufirst%3DC.%26aulast%3DCruzalegui%26aufirst%3DF.%26aulast%3DBurbridge%26aufirst%3DM.%26aulast%3DKotschy%26aufirst%3DA.%26atitle%3DStructure-based%2520design%2520and%2520synthesis%2520of%2520harmine%2520derivatives%2520with%2520different%2520selectivity%2520profiles%2520in%2520kinase%2520versus%2520monoamine%2520oxidase%2520inhibition%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26spage%3D932%26epage%3D939%26doi%3D10.1002%2Fcmdc.201600539" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zlatanic, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berrouet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khamrui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Secor, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swartz, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazarus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stewart, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Ocana, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeVita, R. J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological validation of a harmine-based, central nervous system (CNS)-avoidant, selective, human β-cell regenerative dual-specificity tyrosine phosphorylation-regulated kinase A (DYRK1A) inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">2986</span>– <span class="NLM_lpage">3003</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01379</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01379" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitVOgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=2986-3003&author=K.+Kumarauthor=P.+Wangauthor=J.+Wilsonauthor=V.+Zlatanicauthor=C.+Berrouetauthor=S.+Khamruiauthor=C.+Secorauthor=E.+A.+Swartzauthor=M.+Lazarusauthor=R.+Sanchezauthor=A.+F.+Stewartauthor=A.+Garcia-Ocanaauthor=R.+J.+DeVita&title=Synthesis+and+biological+validation+of+a+harmine-based%2C+central+nervous+system+%28CNS%29-avoidant%2C+selective%2C+human+%CE%B2-cell+regenerative+dual-specificity+tyrosine+phosphorylation-regulated+kinase+A+%28DYRK1A%29+inhibitor&doi=10.1021%2Facs.jmedchem.9b01379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Validation of a Harmine-Based, Central Nervous System (CNS)-Avoidant, Selective, Human β-Cell Regenerative Dual-Specificity Tyrosine Phosphorylation-Regulated Kinase A (DYRK1A) Inhibitor</span></div><div class="casAuthors">Kumar, Kunal; Wang, Peng; Wilson, Jessica; Zlatanic, Viktor; Berrouet, Cecilia; Khamrui, Susmita; Secor, Cody; Swartz, Ethan A.; Lazarus, Michael; Sanchez, Roberto; Stewart, Andrew F.; Garcia-Ocana, Adolfo; DeVita, Robert J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2986-3003</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Recently, our group identified that harmine is able to induce β-cell proliferation both in vitro and in vivo, mediated via the DYRK1A-NFAT pathway.  Since, harmine suffers from a lack of selectivity, both against other kinases and CNS off-targets, we therefore sought to expand structure-activity relationships for harmine's DYRK1A activity, to enhance selectivity for off-targets while retaining human β-cell proliferation activity.  We carried out optimization of the 9-N-position of harmine to synthesize 29 harmine-based analogs.  Several novel inhibitors showed excellent DYRK1A inhibition and human β-cell proliferation capability.  An optimized DYRK1A inhibitor, compd. I, was identified as a novel, efficacious in vivo lead candidate.  Compd. I also demonstrates improved selectivity for kinases and CNS off-targets, as well as in vivo efficacy for β-cell proliferation and regeneration at lower doses than harmine.  Collectively, these findings demonstrate that compd. I is a much improved in vivo lead candidate as compared to harmine for the treatment of diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZXVR-g2rCbbVg90H21EOLACvtfcHk0lg9mjl86Jn46Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitVOgsr8%253D&md5=c739edc1358acafc412a122c272edceb</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01379%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DP.%26aulast%3DWilson%26aufirst%3DJ.%26aulast%3DZlatanic%26aufirst%3DV.%26aulast%3DBerrouet%26aufirst%3DC.%26aulast%3DKhamrui%26aufirst%3DS.%26aulast%3DSecor%26aufirst%3DC.%26aulast%3DSwartz%26aufirst%3DE.%2BA.%26aulast%3DLazarus%26aufirst%3DM.%26aulast%3DSanchez%26aufirst%3DR.%26aulast%3DStewart%26aufirst%3DA.%2BF.%26aulast%3DGarcia-Ocana%26aufirst%3DA.%26aulast%3DDeVita%26aufirst%3DR.%2BJ.%26atitle%3DSynthesis%2520and%2520biological%2520validation%2520of%2520a%2520harmine-based%252C%2520central%2520nervous%2520system%2520%2528CNS%2529-avoidant%252C%2520selective%252C%2520human%2520%25CE%25B2-cell%2520regenerative%2520dual-specificity%2520tyrosine%2520phosphorylation-regulated%2520kinase%2520A%2520%2528DYRK1A%2529%2520inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D2986%26epage%3D3003%26doi%3D10.1021%2Facs.jmedchem.9b01379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nonaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohnishi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kii, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshida, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ikura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Onogi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibuya, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosoya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ito, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagiwara, M.</span></span> <span> </span><span class="NLM_article-title">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">86</span>, <span class="refDoi"> DOI: 10.1038/ncomms1090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1038%2Fncomms1090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=20981014" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=86&author=Y.+Ogawaauthor=Y.+Nonakaauthor=T.+Gotoauthor=E.+Ohnishiauthor=T.+Hiramatsuauthor=I.+Kiiauthor=M.+Yoshidaauthor=T.+Ikuraauthor=H.+Onogiauthor=H.+Shibuyaauthor=T.+Hosoyaauthor=N.+Itoauthor=M.+Hagiwara&title=Development+of+a+novel+selective+inhibitor+of+the+Down+syndrome-related+kinase+Dyrk1A&doi=10.1038%2Fncomms1090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A</span></div><div class="casAuthors">Ogawa Yasushi; Nonaka Yosuke; Goto Toshiyasu; Ohnishi Eriko; Hiramatsu Toshiyuki; Kii Isao; Yoshida Miyo; Ikura Teikichi; Onogi Hiroshi; Shibuya Hiroshi; Hosoya Takamitsu; Ito Nobutoshi; Hagiwara Masatoshi</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">86</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Dyrk1A (dual-specificity tyrosine-(Y)-phosphorylation-regulated kinase 1A) is a serine/threonine kinase essential for brain development and function, and its excessive activity is considered a pathogenic factor in Down syndrome.  The development of potent, selective inhibitors of Dyrk1A would help to elucidate the molecular mechanisms of normal and diseased brains, and may provide a new lead compound for molecular-targeted drug discovery.  Here, we report a novel Dyrk1A inhibitor, INDY, a benzothiazole derivative showing a potent ATP-competitive inhibitory effect with IC(50) and K(i) values of 0.24 and 0.18 μM, respectively.  X-ray crystallography of the Dyrk1A/INDY complex revealed the binding of INDY in the ATP pocket of the enzyme.  INDY effectively reversed the aberrant tau-phosphorylation and rescued the repressed NFAT (nuclear factor of activated T cell) signalling induced by Dyrk1A overexpression.  Importantly, proINDY, a prodrug of INDY, effectively recovered Xenopus embryos from head malformation induced by Dyrk1A overexpression, resulting in normally developed embryos and demonstrating the utility of proINDY in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTOCqf6rsXbPtenUz0lpNqnfW6udTcc2eY7jSFIdzb_i7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3cbislehtw%253D%253D&md5=ac1d5972bec4085de101bb86194babd1</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1038%2Fncomms1090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms1090%26sid%3Dliteratum%253Aachs%26aulast%3DOgawa%26aufirst%3DY.%26aulast%3DNonaka%26aufirst%3DY.%26aulast%3DGoto%26aufirst%3DT.%26aulast%3DOhnishi%26aufirst%3DE.%26aulast%3DHiramatsu%26aufirst%3DT.%26aulast%3DKii%26aufirst%3DI.%26aulast%3DYoshida%26aufirst%3DM.%26aulast%3DIkura%26aufirst%3DT.%26aulast%3DOnogi%26aufirst%3DH.%26aulast%3DShibuya%26aufirst%3DH.%26aulast%3DHosoya%26aufirst%3DT.%26aulast%3DIto%26aufirst%3DN.%26aulast%3DHagiwara%26aufirst%3DM.%26atitle%3DDevelopment%2520of%2520a%2520novel%2520selective%2520inhibitor%2520of%2520the%2520Down%2520syndrome-related%2520kinase%2520Dyrk1A%26jtitle%3DNat.%2520Commun.%26date%3D2010%26volume%3D1%26spage%3D86%26doi%3D10.1038%2Fncomms1090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span>; <span class="NLM_string-name">Wurzlbauer, A.</span>; <span class="NLM_string-name">Nowak, R.</span>; <span class="NLM_string-name">von
Delft, F.</span>; <span class="NLM_string-name">Arrowsmith, C. H.</span>; <span class="NLM_string-name">Edwards, A. M.</span>; <span class="NLM_string-name">Bountra, C.</span>; <span class="NLM_string-name">Bracher, F.</span>; <span class="NLM_string-name">Knapp, S.</span></span> <span> </span><span class="NLM_article-title">Crystal structure of DYRK1A with harmine-derivatized AnnH-75 inhibitor</span>.  <i>PDB entry 4YU2</i> (<span class="refDoi"> DOI: 10.2210/pdb4YU2/pdb</span> ).</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.2210%2Fpdb4YU2%2Fpdb" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Chaikuad%2C+A.%3B+Wurzlbauer%2C+A.%3B+Nowak%2C+R.%3B+von%0ADelft%2C+F.%3B+Arrowsmith%2C+C.+H.%3B+Edwards%2C+A.+M.%3B+Bountra%2C+C.%3B+Bracher%2C+F.%3B+Knapp%2C+S.+Crystal+structure+of+DYRK1A+with+harmine-derivatized+AnnH-75+inhibitor.+PDB+entry+4YU2+%28+10.2210%2Fpdb4YU2%2Fpdb%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.2210%2Fpdb4YU2%2Fpdb&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.2210%252Fpdb4YU2%252Fpdb%26sid%3Dliteratum%253Aachs%26aulast%3DChaikuad%26aufirst%3DA.%26atitle%3DCrystal%2520structure%2520of%2520DYRK1A%2520with%2520harmine-derivatized%2520AnnH-75%2520inhibitor%26btitle%3DPDB%2520entry%25204YU2%26doi%3D10.2210%2Fpdb4YU2%2Fpdb" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesuma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, R. Z.</span></span> <span> </span><span class="NLM_article-title">Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>317</i></span>,  <span class="NLM_fpage">128</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2004.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bbrc.2004.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=15047157" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2cXisVKmt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=317&publication_year=2004&pages=128-132&author=Y.+Songauthor=D.+Kesumaauthor=J.+Wangauthor=Y.+Dengauthor=J.+Duanauthor=J.+H.+Wangauthor=R.+Z.+Qi&title=Specific+inhibition+of+cyclin-dependent+kinases+and+cell+proliferation+by+harmine&doi=10.1016%2Fj.bbrc.2004.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Specific inhibition of cyclin-dependent kinases and cell proliferation by harmine</span></div><div class="casAuthors">Song, Yongcheng; Kesuma, Djohan; Wang, Jian; Deng, Yu; Duan, Jinao; Wang, Jerry H.; Qi, Robert Z.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">317</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">128-132</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science</span>)
        </div><div class="casAbstract">As key regulators of the cell proliferation cycle, cyclin-dependent kinases (CDKs) are attractive targets for the development of anti-tumor drugs.  In the present study, harmine was identified from a collection of herbal compds. to be a specific inhibitor of Cdk1/cyclin B, Cdk2/cyclin A, and Cdk5/p25 with IC50 values at low micromoles.  It displayed little effect on other serine/threonine and tyrosine kinases tested.  The CDK inhibition by harmine is competitive with ATP-Mg2+, suggesting that it binds to the ATP-Mg2+-binding pocket of CDKs.  In cytotoxicity assays, harmine exhibited a strong inhibitory effect on the growth and proliferation of carcinoma cells whereas it had no significant effect on quiescent fibroblasts.  Further, harmine was found to block DNA replication in the carcinoma cells.  Taken together, harmine is a selective inhibitor of CDKs and cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9drfO7NpUHrVg90H21EOLACvtfcHk0lgr6pKRYILbDQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXisVKmt74%253D&md5=1a88a183ab790612a3e4c3d7c147eca6</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2004.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2004.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DKesuma%26aufirst%3DD.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DQi%26aufirst%3DR.%2BZ.%26atitle%3DSpecific%2520inhibition%2520of%2520cyclin-dependent%2520kinases%2520and%2520cell%2520proliferation%2520by%2520harmine%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2004%26volume%3D317%26spage%3D128%26epage%3D132%26doi%3D10.1016%2Fj.bbrc.2004.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dasappa, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagendra, H. G.</span></span> <span> </span><span class="NLM_article-title">Preferential selectivity of inhibitors with human tau protein kinase Gsk3 elucidates their potential roles for off-target Alzheimer’s therapy</span>. <i>Int. J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2013</i></span>,  <span class="NLM_fpage">809386</span>, <span class="refDoi"> DOI: 10.1155/2013/809386</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1155%2F2013%2F809386" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=24222885" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2013&publication_year=2013&pages=809386&author=J.+K.+Dasappaauthor=H.+G.+Nagendra&title=Preferential+selectivity+of+inhibitors+with+human+tau+protein+kinase+Gsk3+elucidates+their+potential+roles+for+off-target+Alzheimer%E2%80%99s+therapy&doi=10.1155%2F2013%2F809386"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1155%2F2013%2F809386&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2013%252F809386%26sid%3Dliteratum%253Aachs%26aulast%3DDasappa%26aufirst%3DJ.%2BK.%26aulast%3DNagendra%26aufirst%3DH.%2BG.%26atitle%3DPreferential%2520selectivity%2520of%2520inhibitors%2520with%2520human%2520tau%2520protein%2520kinase%2520Gsk3%2520elucidates%2520their%2520potential%2520roles%2520for%2520off-target%2520Alzheimer%25E2%2580%2599s%2520therapy%26jtitle%3DInt.%2520J.%2520Alzheimer%2527s%2520Dis.%26date%3D2013%26volume%3D2013%26spage%3D809386%26doi%3D10.1155%2F2013%2F809386" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deslandes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamoral-Theys, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frongia, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chassaing, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruyère, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lozach, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meijer, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ducommun, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delfourne, E.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of analogs of the marine alkaloids granulatimide and isogranulatimide</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">626</span>– <span class="NLM_lpage">636</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.06.012</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2012.06.012" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=22809559" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFWntb7J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2012&pages=626-636&author=S.+Deslandesauthor=D.+Lamoral-Theysauthor=C.+Frongiaauthor=S.+Chassaingauthor=C.+Bruy%C3%A8reauthor=O.+Lozachauthor=L.+Meijerauthor=B.+Ducommunauthor=R.+Kissauthor=E.+Delfourne&title=Synthesis+and+biological+evaluation+of+analogs+of+the+marine+alkaloids+granulatimide+and+isogranulatimide&doi=10.1016%2Fj.ejmech.2012.06.012"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological evaluation of analogs of the marine alkaloids granulatimide and isogranulatimide</span></div><div class="casAuthors">Deslandes, Sebastien; Lamoral-Theys, Delphine; Frongia, Celine; Chassaing, Stefan; Bruyere, Celine; Lozach, Olivier; Meijer, Laurent; Ducommun, Bernard; Kiss, Robert; Delfourne, Evelyne</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">626-636</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of pyrrolic analogs and two series of regioisomeric pyrazolic analogs of the marine alkaloids granulatimide and isogranulatimide were prepd.  The synthesis of the two first ones was based on the condensation reaction of diversely 5-substituted 3-bromoindoles with pyrrole or pyrazole followed by addn. of the intermediates on maleimide or dibromomaleimide, resp., the so-obtained acyclic adducts being finally photocyclized to the desired analogs.  Compds. of the last series were obtained by reacting different 5-substituted-indole-3-glyoxylates with N-Boc-pyrazole-3-acetamide and subsequent photochem. cyclization of the adducts.  All the compds. were evaluated for their in vitro growth inhibitory properties toward eight cancer cell lines.  Several compds. were also assayed for their ability to abrogate the G2-cell cycle checkpoint or to inhibit a panel of Ser/Thr kinases.  Lastly, computer-assisted phase-contrast microscopy (quant. videomicroscopy) revealed that the three most potent compds. I and II [R = H, OMe], with IC50 growth inhibitory concns. ranging between 10 and 20 μM, displayed cytostatic, not cytotoxic, anticancer effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpMnS7Ru38NvLVg90H21EOLACvtfcHk0lj4jSgMk3TUzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFWntb7J&md5=843cca6703c6798b42764e9bae2401bc</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.06.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.06.012%26sid%3Dliteratum%253Aachs%26aulast%3DDeslandes%26aufirst%3DS.%26aulast%3DLamoral-Theys%26aufirst%3DD.%26aulast%3DFrongia%26aufirst%3DC.%26aulast%3DChassaing%26aufirst%3DS.%26aulast%3DBruy%25C3%25A8re%26aufirst%3DC.%26aulast%3DLozach%26aufirst%3DO.%26aulast%3DMeijer%26aufirst%3DL.%26aulast%3DDucommun%26aufirst%3DB.%26aulast%3DKiss%26aufirst%3DR.%26aulast%3DDelfourne%26aufirst%3DE.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520analogs%2520of%2520the%2520marine%2520alkaloids%2520granulatimide%2520and%2520isogranulatimide%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D54%26spage%3D626%26epage%3D636%26doi%3D10.1016%2Fj.ejmech.2012.06.012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hamann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Aparicio, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuertes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Puerto, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navarro, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">del Monte-Millan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Medina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pennaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balaiah, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wahyuono, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span> <span> </span><span class="NLM_article-title">Glycogen synthase kinase-3 (GSK-3) inhibitory activity and structure-activity relationship (SAR) studies of the manzamine alkaloids. Potential for Alzheimer’s disease</span>. <i>J. Nat. Prod.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1397</span>– <span class="NLM_lpage">1405</span>, <span class="refDoi"> DOI: 10.1021/np060092r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/np060092r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2sXptl2lsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2007&pages=1397-1405&author=M.+Hamannauthor=D.+Alonsoauthor=E.+Martin-Aparicioauthor=A.+Fuertesauthor=M.+J.+P%C3%A9rez-Puertoauthor=A.+Castroauthor=S.+Moralesauthor=M.+L.+Navarroauthor=M.+del+Monte-Millanauthor=M.+Medinaauthor=H.+Pennakaauthor=A.+Balaiahauthor=J.+Pengauthor=J.+Cookauthor=S.+Wahyuonoauthor=A.+Martinez&title=Glycogen+synthase+kinase-3+%28GSK-3%29+inhibitory+activity+and+structure-activity+relationship+%28SAR%29+studies+of+the+manzamine+alkaloids.+Potential+for+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fnp060092r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Glycogen Synthase Kinase-3 (GSK-3) Inhibitory Activity and Structure-Activity Relationship (SAR) Studies of the Manzamine Alkaloids. Potential for Alzheimer's Disease</span></div><div class="casAuthors">Hamann, Mark; Alonso, Diana; Martin-Aparicio, Ester; Fuertes, Ana; Perez-Puerto, M. Jose; Castro, Ana; Morales, Susana; Navarro, Maria Luisa; del Monte-Millan, Maria; Medina, Miguel; Pennaka, Hari; Balaiah, Akula; Peng, Jiangnan; Cook, Jennifer; Wahyuono, Subagus; Martinez, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Natural Products</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1397-1405</span>CODEN:
                <span class="NLM_cas:coden">JNPRDF</span>;
        ISSN:<span class="NLM_cas:issn">0163-3864</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society-American Society of Pharmacognosy</span>)
        </div><div class="casAbstract">Manzamine A and related derivs. isolated from a common Indonesian sponge, Acanthostrongylophora, have been identified as a new class of GSK-3β inhibitors.  The semisynthesis of new analogs and the first structure-activity relationship studies with GSK-3β are also reported.  Moreover, manzamine A proved to be effective in decreasing tau hyperphosphorylation in human neuroblastoma cell lines, a demonstration of its ability to enter cells and interfere with tau pathol.  Inhibition studies of manzamine A against a selected panel of five different kinases related to GSK-3β, specifically CDK-1, PKA, CDK-5, MAPK, and GSK-3α, show the specific inhibition of manzamine A on GSK-3β and CDK-5, the two kinases involved in tau pathol. hyperphosphorylation.  These results suggest that manzamine A constitutes a promising scaffold from which more potent and selective GSK-3 inhibitors could be designed as potential therapeutic agents for Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp9mYEdxZJqErVg90H21EOLACvtfcHk0lj4jSgMk3TUzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXptl2lsbs%253D&md5=8d303b26c960b54bed732f3d2ac3fdc2</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fnp060092r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fnp060092r%26sid%3Dliteratum%253Aachs%26aulast%3DHamann%26aufirst%3DM.%26aulast%3DAlonso%26aufirst%3DD.%26aulast%3DMartin-Aparicio%26aufirst%3DE.%26aulast%3DFuertes%26aufirst%3DA.%26aulast%3DP%25C3%25A9rez-Puerto%26aufirst%3DM.%2BJ.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DMorales%26aufirst%3DS.%26aulast%3DNavarro%26aufirst%3DM.%2BL.%26aulast%3Ddel%2BMonte-Millan%26aufirst%3DM.%26aulast%3DMedina%26aufirst%3DM.%26aulast%3DPennaka%26aufirst%3DH.%26aulast%3DBalaiah%26aufirst%3DA.%26aulast%3DPeng%26aufirst%3DJ.%26aulast%3DCook%26aufirst%3DJ.%26aulast%3DWahyuono%26aufirst%3DS.%26aulast%3DMartinez%26aufirst%3DA.%26atitle%3DGlycogen%2520synthase%2520kinase-3%2520%2528GSK-3%2529%2520inhibitory%2520activity%2520and%2520structure-activity%2520relationship%2520%2528SAR%2529%2520studies%2520of%2520the%2520manzamine%2520alkaloids.%2520Potential%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Nat.%2520Prod.%26date%3D2007%26volume%3D70%26spage%3D1397%26epage%3D1405%26doi%3D10.1021%2Fnp060092r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kesuma, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, R. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, M. M.</span></span> <span> </span><span class="NLM_article-title">β-Carbolines as specific inhibitors of cyclin-dependent kinases</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1129</span>– <span class="NLM_lpage">1132</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)00094-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2FS0960-894X%2802%2900094-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=11909733" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD38XitFWhtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=1129-1132&author=Y.+Songauthor=J.+Wangauthor=S.+F.+Tengauthor=D.+Kesumaauthor=Y.+Dengauthor=J.+Duanauthor=J.+H.+Wangauthor=R.+Z.+Qiauthor=M.+M.+Sim&title=%CE%B2-Carbolines+as+specific+inhibitors+of+cyclin-dependent+kinases&doi=10.1016%2FS0960-894X%2802%2900094-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">β-Carbolines as specific inhibitors of cyclin-dependent kinases</span></div><div class="casAuthors">Song, Yongcheng; Wang, Jian; Teng, Su Fern; Kesuma, Djohan; Deng, Yu; Duan, Jinao; Wang, Jerry H.; Qi, Robert Zhong; Sim, Mui Mui</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1129-1132</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">Harmine , 7-fluoro-1-Me β-carboline (35) and 1-(5-methyl-imidazol-4-yl) β-carboline (41) were potent and specific inhibitors of cyclin-dependent kinases.  The degree of aromaticity of the tricyclic ring and the positioning of substituents are important for inhibitory activity.  While most β-carbolines inhibited CDK2 and CDK5 to the same extent, selective inhibition against CDK2 was obsd. in 1-(2-chlorophenyl)- (12), 1-(2-fluorophenyl)- (15), and 1-(2-chloro-5-nitrophenyl)- (28) β-carbolines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpx1RVeAY4-ibVg90H21EOLACvtfcHk0liW_njBRJwcUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XitFWhtrk%253D&md5=2c921f4b9cb2df833fc0684e006310a6</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900094-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900094-X%26sid%3Dliteratum%253Aachs%26aulast%3DSong%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DTeng%26aufirst%3DS.%2BF.%26aulast%3DKesuma%26aufirst%3DD.%26aulast%3DDeng%26aufirst%3DY.%26aulast%3DDuan%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DJ.%2BH.%26aulast%3DQi%26aufirst%3DR.%2BZ.%26aulast%3DSim%26aufirst%3DM.%2BM.%26atitle%3D%25CE%25B2-Carbolines%2520as%2520specific%2520inhibitors%2520of%2520cyclin-dependent%2520kinases%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D1129%26epage%3D1132%26doi%3D10.1016%2FS0960-894X%2802%2900094-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herraiz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaparro, C.</span></span> <span> </span><span class="NLM_article-title">Human monoamine oxidase is inhibited by tobacco smoke: β-carboline alkaloids act as potent and reversible inhibitors</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>326</i></span>,  <span class="NLM_fpage">378</span>– <span class="NLM_lpage">386</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2004.11.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bbrc.2004.11.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=15582589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVCgtbjP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=326&publication_year=2005&pages=378-386&author=T.+Herraizauthor=C.+Chaparro&title=Human+monoamine+oxidase+is+inhibited+by+tobacco+smoke%3A+%CE%B2-carboline+alkaloids+act+as+potent+and+reversible+inhibitors&doi=10.1016%2Fj.bbrc.2004.11.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Human monoamine oxidase is inhibited by tobacco smoke: β-carboline alkaloids act as potent and reversible inhibitors</span></div><div class="casAuthors">Herraiz, Tomas; Chaparro, Carolina</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">326</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">378-386</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Monoamine oxidase (MAO) is a mitochondrial outer-membrane flavoenzyme involved in brain and peripheral oxidative catabolism of neurotransmitters and xenobiotic amines, including neurotoxic amines, and a well-known target for antidepressant and neuroprotective drugs.  Recently, positron emission tomog. imaging has shown that smokers have a much lower activity of peripheral and brain MAO-A (30%) and -B (40%) isoenzymes compared to non-smokers.  This MAO inhibition results from a pharmacol. effect of smoke, but little is known about its mechanism.  Working with mainstream smoke collected from com. cigarettes the authors confirmed that cigarette smoke is a potent inhibitor of human MAO-A and -B isoenzymes.  MAO inhibition was partly reversible, competitive for MAO-A, and a mixed-type inhibition for MAO-B.  Two β-carboline alkaloids, norharman (β-carboline) and harman (1-methyl-β-carboline), were identified by GC-MS, quantified, and isolated from the mainstream smoke by solid phase extn. and HPLC.  Kinetics anal. revealed that β-carbolines from cigarette smoke were competitive, reversible, and potent inhibitors of MAO enzymes.  Norharman was an inhibitor of MAO-A (Ki = 1.2 μM) and MAO-B (Ki = 1.12 μM), and harman of MAO-A (Ki = 55.54 nM).  β-Carboline alkaloids are psychopharmacol. active compds. that may occur endogenously in human tissues, including the brain.  These results suggest that β-carboline alkaloids from cigarette smoke acting as potent reversible inhibitors of MAO enzymes may contribute to the MAO-reduced activity produced by tobacco smoke in smokers.  The presence of MAO inhibitors in smoke like β-carbolines and others may help the authors to understand some of the purported neuropharmacol. effects assocd. with smoking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosGeu1O_rPCrVg90H21EOLACvtfcHk0liW_njBRJwcUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVCgtbjP&md5=cb3a977fa57bbaa60d912907b0ac8313</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2004.11.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2004.11.033%26sid%3Dliteratum%253Aachs%26aulast%3DHerraiz%26aufirst%3DT.%26aulast%3DChaparro%26aufirst%3DC.%26atitle%3DHuman%2520monoamine%2520oxidase%2520is%2520inhibited%2520by%2520tobacco%2520smoke%253A%2520%25CE%25B2-carboline%2520alkaloids%2520act%2520as%2520potent%2520and%2520reversible%2520inhibitors%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2005%26volume%3D326%26spage%3D378%26epage%3D386%26doi%3D10.1016%2Fj.bbrc.2004.11.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herraiz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaparro, C.</span></span> <span> </span><span class="NLM_article-title">Human monoamine oxidase enzyme inhibition by coffee and β-carbolines norharman and harman isolated from coffee</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">795</span>– <span class="NLM_lpage">802</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2005.05.074</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.lfs.2005.05.074" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=16139309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvVynug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2006&pages=795-802&author=T.+Herraizauthor=C.+Chaparro&title=Human+monoamine+oxidase+enzyme+inhibition+by+coffee+and+%CE%B2-carbolines+norharman+and+harman+isolated+from+coffee&doi=10.1016%2Fj.lfs.2005.05.074"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Human monoamine oxidase enzyme inhibition by coffee and β-carbolines norharman and harman isolated from coffee</span></div><div class="casAuthors">Herraiz, Tomas; Chaparro, Carolina</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">795-802</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Monoamine oxidase (MAO) is a mitochondrial outer-membrane flavoenzyme involved in brain and peripheral oxidative catabolism of neurotransmitters and xenobiotic amines, including neurotoxic amines, and a well-known target for antidepressant and neuroprotective drugs.  Recent epidemiol. studies have consistently shown that coffee drinkers have an apparently lower incidence of Parkinson's disease (PD), suggesting that coffee might somehow act as a purported neuroprotectant.  In this paper, "ready to drink" coffee brews exhibited inhibitory properties on recombinant human MAO A and B isoenzymes catalyzing the oxidative deamination of kynuramine, suggesting that coffee contains compds. acting as MAO inhibitors.  MAO inhibition was reversible and competitive for MAO A and MAO B.  Subsequently, the pyrido-indole (β-carboline) alkaloids, norharman and harman, were identified and isolated from MAO-inhibiting coffee, and were good inhibitors on MAO A (harman and norharman) and MAO B (norharman) isoenzymes.  β-Carbolines isolated from ready-to-drink coffee were competitive and reversible inhibitors and appeared up to 210 μg/L, confirming that coffee is the most important exogenous source of these alkaloids in addn. to cigarette smoking.  Inhibition of MAO enzymes by coffee and the presence of MAO inhibitors that are also neuroactive, such as β-carbolines and eventually others, might play a role in the neuroactive actions including a purported neuroprotection assocd. with coffee consumption.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYOq0cs2_DgbVg90H21EOLACvtfcHk0liW_njBRJwcUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvVynug%253D%253D&md5=32fbb993e500209073342e66ada53ce9</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2005.05.074&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2005.05.074%26sid%3Dliteratum%253Aachs%26aulast%3DHerraiz%26aufirst%3DT.%26aulast%3DChaparro%26aufirst%3DC.%26atitle%3DHuman%2520monoamine%2520oxidase%2520enzyme%2520inhibition%2520by%2520coffee%2520and%2520%25CE%25B2-carbolines%2520norharman%2520and%2520harman%2520isolated%2520from%2520coffee%26jtitle%3DLife%2520Sci.%26date%3D2006%26volume%3D78%26spage%3D795%26epage%3D802%26doi%3D10.1016%2Fj.lfs.2005.05.074" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rommelspacher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">May, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salewski, B.</span></span> <span> </span><span class="NLM_article-title">Harman (1-methyl-β-carboline) is a natural inhibitor of monoamine oxidase type A in rats</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>252</i></span>,  <span class="NLM_fpage">51</span>– <span class="NLM_lpage">59</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(94)90574-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2F0014-2999%2894%2990574-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=8149995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK2cXhvVartbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=252&publication_year=1994&pages=51-59&author=H.+Rommelspacherauthor=T.+Mayauthor=B.+Salewski&title=Harman+%281-methyl-%CE%B2-carboline%29+is+a+natural+inhibitor+of+monoamine+oxidase+type+A+in+rats&doi=10.1016%2F0014-2999%2894%2990574-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit71R"><div class="casContent"><span class="casTitleNuber">71</span><div class="casTitle"><span class="NLM_cas:atitle">Harman (1-methyl-β-carboline) is a natural inhibitor of monoamine oxidase type A in rats</span></div><div class="casAuthors">Rommelspacher, Hans; May, Torsten; Salewski, Bernd</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">252</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">51-9</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">Harman (1-methyl-β-carboline) displaces [3H]pargyline in vitro from high affinity binding sites on membranes from cerebral cortex, provided the exptl. conditions are chosen under which [3H]pargyline labels selectively monoamine oxidase type A.  Norharman (β-carboline) is a much weaker displacing compd.  It is well known that the type A enzyme can be blocked irreversibly in vivo by treatment of rats with clorgyline.  Under these conditions no specific binding of [3H]harman and [3H]pargyline to monoamine oxidase type A was detected in brain, whereas the specific binding was reduced to 5% in liver tissue.  The in vitro and ex vivo expts. suggest that there is a specific binding site for harman on monoamine oxidase type A, thereby extending earlier in vitro findings.  It has been postulated that harman operates as a natural inhibitor of mnoamine oxidase type A in mammals.  The present study demonstrates that harman and norharman occur in rat brain, blood plasma, heart, kidney and liver.  It further shows that pretreatment with clorgyline induces a time-dependent increase in the blood plasma levels of harman, suggesting the displacement of harman from the enzyme in tissue with its subsequent deliver into the blood.  These findings strongly support the hypothesis based on in vitro expts., that harman binds reversibly to the active site of monoamine oxidase type A in vivo.  Dietary sources for mammalian harman play probably only a minor role, because the concns. in beer and wine as well as other foodstuffs are too low to contribute substantially to endogenous levels of harman.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSlTDYF3MuR7Vg90H21EOLACvtfcHk0lgd1lnKDMNphg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXhvVartbg%253D&md5=c2fc5375424b41bc674ad3b41ef54862</span></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2894%2990574-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252894%252990574-6%26sid%3Dliteratum%253Aachs%26aulast%3DRommelspacher%26aufirst%3DH.%26aulast%3DMay%26aufirst%3DT.%26aulast%3DSalewski%26aufirst%3DB.%26atitle%3DHarman%2520%25281-methyl-%25CE%25B2-carboline%2529%2520is%2520a%2520natural%2520inhibitor%2520of%2520monoamine%2520oxidase%2520type%2520A%2520in%2520rats%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1994%26volume%3D252%26spage%3D51%26epage%3D59%26doi%3D10.1016%2F0014-2999%2894%2990574-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Santillo, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferguson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vohra, S. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiesenfeld, P. L.</span></span> <span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase (MAO) by β-carbolines and their interactions in live neuronal (PC12) and liver (HuH-7 and MH1C1) cells</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1016/j.tiv.2013.12.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.tiv.2013.12.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=24373881" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1Kjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2014&pages=403-410&author=M.+F.+Santilloauthor=Y.+Liuauthor=M.+Fergusonauthor=S.+N.+Vohraauthor=P.+L.+Wiesenfeld&title=Inhibition+of+monoamine+oxidase+%28MAO%29+by+%CE%B2-carbolines+and+their+interactions+in+live+neuronal+%28PC12%29+and+liver+%28HuH-7+and+MH1C1%29+cells&doi=10.1016%2Fj.tiv.2013.12.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of monoamine oxidase (MAO) by β-carbolines and their interactions in live neuronal (PC12) and liver (HuH-7 and MH1C1) cells</span></div><div class="casAuthors">Santillo, Michael F.; Liu, Yitong; Ferguson, Martine; Vohra, Sanah N.; Wiesenfeld, Paddy L.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology In Vitro</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">403-410</span>CODEN:
                <span class="NLM_cas:coden">TIVIEQ</span>;
        ISSN:<span class="NLM_cas:issn">0887-2333</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Interactions among monoamine oxidase (MAO) inhibitors in drugs, botanicals, and dietary supplements may lead to unpredictable neurochem. dysfunction due to excessive inhibition or therapeutic invalidation.  Often recombinant MAO or brain tissue homogenates have been used to evaluate MAO inhibitors such as the β-carboline alkaloids (harmane, harmine, harmaline, and harmalol).  However, there is a lack of cellular systems for evaluation of MAO activity, which represents a more advanced in vitro model compared to recombinant enzymes or tissue lysates.  Using kynuramine assays, intracellular MAO inhibition by β-carbolines was measured in PC12 (rat pheochromocytoma), MH1C1 (rat liver), and HuH-7 (human liver) cell lines, which were compared with human recombinant MAO and cell lysates.  β-Carbolines (1 μM, 90 min incubations) inhibited MAO by 40-99% in live PC12 cells where MAO A was the active isoform, and <12% in HuH-7 and MH1C1 cells where MAO B was primarily active.  The combination index (CI), which serves as a quant. indicator of pharmacol. interactions, was detd. for harmaline/harmine (CI, 1.01-1.25) and methylene blue/harmine (CI, 0.74-1.07) in PC12 cells.  Overall, this study illustrates applications of cell-based in vitro assay platforms to gain a comprehensive understanding of intracellular MAO inhibitors and their interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnGTjbUWvqHbVg90H21EOLACvtfcHk0lgd1lnKDMNphg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1Kjsb4%253D&md5=aa1b4d775de34771b11f1bc653a1d7d1</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1016%2Fj.tiv.2013.12.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tiv.2013.12.006%26sid%3Dliteratum%253Aachs%26aulast%3DSantillo%26aufirst%3DM.%2BF.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DFerguson%26aufirst%3DM.%26aulast%3DVohra%26aufirst%3DS.%2BN.%26aulast%3DWiesenfeld%26aufirst%3DP.%2BL.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520%2528MAO%2529%2520by%2520%25CE%25B2-carbolines%2520and%2520their%2520interactions%2520in%2520live%2520neuronal%2520%2528PC12%2529%2520and%2520liver%2520%2528HuH-7%2520and%2520MH1C1%2529%2520cells%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2014%26volume%3D28%26spage%3D403%26epage%3D410%26doi%3D10.1016%2Fj.tiv.2013.12.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez
de Arriba, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lizcano, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balsa, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unzeta, M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase from bovine retina by β-carbolines</span>. <i>J. Pharm. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1994</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">809</span>– <span class="NLM_lpage">813</span>, <span class="refDoi"> DOI: 10.1111/j.2042-7158.1994.tb03735.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1111%2Fj.2042-7158.1994.tb03735.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=7699568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADyaK2M3htl2hug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=1994&pages=809-813&author=A.+Fernandez%0Ade+Arribaauthor=J.+M.+Lizcanoauthor=M.+D.+Balsaauthor=M.+Unzeta&title=Inhibition+of+monoamine+oxidase+from+bovine+retina+by+%CE%B2-carbolines&doi=10.1111%2Fj.2042-7158.1994.tb03735.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of monoamine oxidase from bovine retina by beta-carbolines</span></div><div class="casAuthors">Fernandez de Arriba A; Lizcano J M; Balsa M D; Unzeta M</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of pharmacy and pharmacology</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">809-13</span>
        ISSN:<span class="NLM_cas:issn">0022-3573</span>.
    </div><div class="casAbstract">The behaviour of some beta-carboline derivatives as inhibitors of monoamine oxidase has been studied in bovine retina.  Inhibition was found not to show any significant time dependence.  Di- and tetrahydro-beta-carbolines were shown to behave as reversible and competitive inhibitors.  In contrast, the fully unsaturated beta-carbolines harmane, harmine and harmaline, which showed deviation from linearity at high substrate concentrations, behaved as tight-binding inhibitors.  In these cases, the concentration of the enzyme and the inhibitor were of the same order.  This was confirmed by the Ki values for these compounds in the nanomolar concentration range.  Consistent with this was that inhibition was only partly reversed by dialysis for 18 h at 4 degrees C, although complete reversal was observed after dialysis for the same period at 37 degrees C.  Structure-activity relationships indicated that substitution of a methoxy group at the C7 position of the aromatic ring is determinant for this tight-binding behaviour; a substitution of this group at the C6 position greatly reduced inhibition.  Since beta-carbolines have been reported to be formed endogenously, this suggests that they might have important physiological actions on monoamine oxidase activity in-vivo.  In contrast, all the beta-carbolines investigated in this study had low potencies as inhibitors of monoamine oxidase B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRZp4ezGwxyrp0d-O_J5C0AfW6udTcc2eZ186DKT-E42bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK2M3htl2hug%253D%253D&md5=2be963582f130484254ca2c785c1bf3f</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1111%2Fj.2042-7158.1994.tb03735.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.2042-7158.1994.tb03735.x%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez%2Bde%2BArriba%26aufirst%3DA.%26aulast%3DLizcano%26aufirst%3DJ.%2BM.%26aulast%3DBalsa%26aufirst%3DM.%2BD.%26aulast%3DUnzeta%26aufirst%3DM.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520from%2520bovine%2520retina%2520by%2520%25CE%25B2-carbolines%26jtitle%3DJ.%2520Pharm.%2520Pharmacol.%26date%3D1994%26volume%3D46%26spage%3D809%26epage%3D813%26doi%3D10.1111%2Fj.2042-7158.1994.tb03735.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Samoylenko, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rahman, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tekwani, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripathi, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, S. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhammad, I.</span></span> <span> </span><span class="NLM_article-title">Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson’s disease</span>. <i>J. Ethnopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">357</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1016/j.jep.2009.10.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.jep.2009.10.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=19879939" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3cXot12msg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2010&pages=357-367&author=V.+Samoylenkoauthor=M.+M.+Rahmanauthor=B.+L.+Tekwaniauthor=L.+M.+Tripathiauthor=Y.-H.+Wangauthor=S.+I.+Khanauthor=I.+A.+Khanauthor=L.+S.+Millerauthor=V.+C.+Joshiauthor=I.+Muhammad&title=Banisteriopsis+caapi%2C+a+unique+combination+of+MAO+inhibitory+and+antioxidative+constituents+for+the+activities+relevant+to+neurodegenerative+disorders+and+Parkinson%E2%80%99s+disease&doi=10.1016%2Fj.jep.2009.10.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit74R"><div class="casContent"><span class="casTitleNuber">74</span><div class="casTitle"><span class="NLM_cas:atitle">Banisteriopsis caapi, a unique combination of MAO inhibitory and antioxidative constituents for the activities relevant to neurodegenerative disorders and Parkinson's disease</span></div><div class="casAuthors">Samoylenko, Volodymyr; Rahman, Md. Mostafizur; Tekwani, Babu L.; Tripathi, Lalit M.; Wang, Yan-Hong; Khan, Shabana I.; Khan, Ikhlas A.; Miller, Loren S.; Joshi, Vaishali C.; Muhammad, Ilias</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Ethnopharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">357-367</span>CODEN:
                <span class="NLM_cas:coden">JOETD7</span>;
        ISSN:<span class="NLM_cas:issn">0378-8741</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Aim of the study: Parkinson's disease is a neurol. disorder mostly effecting the elder population of the world.  Currently there is no definitive treatment or cure for this disease.  Therefore, in this study the compn. and constituents of the aq. ext. of Banisteriopsis caapi for monoamine oxidases (MAO) inhibitory and antioxidant activities were assessed, which are relevant to the prevention of neurol. disorders, including Parkinsonism.  Materials and methods: The aq. ext. of Banisteriopsis caapi stems was standardized and then fractionated using reversed-phase (RP) chromatog.  Pure compds. were isolated either by reversed-phase (RP) chromatog. or centrifugal preparative TLC, using a Chromatotron.  Structure elucidation was carried out by 1D and 2D NMR, Mass, IR and CD spectroscopy and chem. derivatization.  Chem. profiling of the ext. was carried out with RP-HPLC.  The inhibitory activity of MAO-A, MAO-B, acetylcholinesterase, butyrylcholinesterase and catechol-O-Me transferase enzymes, as well as antioxidant and cytotoxic activities of both Banisteriopsis caapi ext. and isolated compds. was evaluated.  Results: An examn. of the aq. exts. of Banisteriopsis caapi cultivar Da Vine yielded two new alkaloidal glycosides, named banistenoside A (1) and banistenoside B (2), contg. "azepino[1,2-a]tetrahydro-β-carboline" unique carbon framework.  One addnl. new natural tetrahydronorharmine (4), four known β-carbolines harmol (3), tetrahydroharmine (5), harmaline (6) and harmine (7), two known proanthocyanidines (-)-epicatechin (8) and (-)-procyanidin B2 (9), and a new disaccharide β--fructofuranosyl-(2 → 5)-fructopyranose (14) together with known saccharose (15) and β--glucose (16) were also isolated.  In addn., the acetates of 1, 2, 8, 9, 14 and 15 (compds. 10-13, 17, 18) were also prepd.  Harmaline (6) and harmine (7) showed potent in vitro inhibitory activity against recombinant human brain monoamine oxidase (MAO)-A and -B enzymes (IC50 2.5 and 2.0 nM, and 25 and 20 μM, resp.), and (-)-epicatechin (8) and (-)-procyanidin B2 (9) showed potent antioxidant and moderate MAO-B inhibitory activities (IC50 < 0.13 and 0.57 μg/mL, and 65 and 35 μM).  HPLC anal. revealed that most of the dominant chem. and bioactive markers (1, 2, 5, 7-9) were present in high concns. in dried bark of large branch.  Anal. of regular/com. Banisteriopsis caapi dried stems showed a similar qual. HPLC pattern, but relatively low content of dominant markers 1, 2, 7, and 9, which led to decreased MAO inhibitory and antioxidant potency.  Conclusion: Collectively, these results give addnl. basis to the existing claim of Banisteriopsis caapi stem ext. for the treatment of Parkinsonism, including other neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaBgCrkOfxxrVg90H21EOLACvtfcHk0ljQUIRZUXqNZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXot12msg%253D%253D&md5=85cf0e8497c021bb6fb3107d6e72670a</span></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1016%2Fj.jep.2009.10.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jep.2009.10.030%26sid%3Dliteratum%253Aachs%26aulast%3DSamoylenko%26aufirst%3DV.%26aulast%3DRahman%26aufirst%3DM.%2BM.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DTripathi%26aufirst%3DL.%2BM.%26aulast%3DWang%26aufirst%3DY.-H.%26aulast%3DKhan%26aufirst%3DS.%2BI.%26aulast%3DKhan%26aufirst%3DI.%2BA.%26aulast%3DMiller%26aufirst%3DL.%2BS.%26aulast%3DJoshi%26aufirst%3DV.%2BC.%26aulast%3DMuhammad%26aufirst%3DI.%26atitle%3DBanisteriopsis%2520caapi%252C%2520a%2520unique%2520combination%2520of%2520MAO%2520inhibitory%2520and%2520antioxidative%2520constituents%2520for%2520the%2520activities%2520relevant%2520to%2520neurodegenerative%2520disorders%2520and%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Ethnopharmacol.%26date%3D2010%26volume%3D127%26spage%3D357%26epage%3D367%26doi%3D10.1016%2Fj.jep.2009.10.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Haider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alhusban, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaurasiya, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tekwani, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chittiboyina, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, I. A.</span></span> <span> </span><span class="NLM_article-title">Isoform selectivity of harmine-conjugated 1,2,3-triazoles against human monoamine oxidase</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1435</span>– <span class="NLM_lpage">1448</span>, <span class="refDoi"> DOI: 10.4155/fmc-2018-0006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.4155%2Ffmc-2018-0006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=29788780" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtFamtbnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2018&pages=1435-1448&author=S.+Haiderauthor=M.+Alhusbanauthor=N.+D.+Chaurasiyaauthor=B.+L.+Tekwaniauthor=A.+G.+Chittiboyinaauthor=I.+A.+Khan&title=Isoform+selectivity+of+harmine-conjugated+1%2C2%2C3-triazoles+against+human+monoamine+oxidase&doi=10.4155%2Ffmc-2018-0006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Isoform selectivity of harmine-conjugated 1,2,3-triazoles against human monoamine oxidase</span></div><div class="casAuthors">Haider, Saqlain; Alhusban, Manal; Chaurasiya, Narayan D.; Tekwani, Babu L.; Chittiboyina, Amar G.; Khan, Ikhlas A.</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1435-1448</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">Aim: There is little information available on the monoamine oxidase isoform selectivity of N-alkyl harmine analogs, which exhibit a myriad of activities including MAO-A, DYRK1A and cytotoxicity to several select cancer cell lines.  Results: Compds. 3e and 4c exhibited an IC50 of 0.83 ± 0.03 and 0.43 ± 0.002 μM against MAO-A and an IC50 of 0.26 ± 0.04 and 0.36 ± 0.001 μM against MAO-B, resp.  Mol. docking studies revealed p-p interactions between the synthesized mols. and arom. amino acid residues.  Conclusion & future perspective: The current study delineates the structural requirements for MAO-A selectivity and such information may be helpful in designing selective analogs for kinase, DYRK1A and harmine-based cytotoxics without apparent MAO enzyme inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlcmo-Guls_7Vg90H21EOLACvtfcHk0ljQUIRZUXqNZQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtFamtbnI&md5=d6dc18d856623af3d3c0451f55138d51</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2018-0006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2018-0006%26sid%3Dliteratum%253Aachs%26aulast%3DHaider%26aufirst%3DS.%26aulast%3DAlhusban%26aufirst%3DM.%26aulast%3DChaurasiya%26aufirst%3DN.%2BD.%26aulast%3DTekwani%26aufirst%3DB.%2BL.%26aulast%3DChittiboyina%26aufirst%3DA.%2BG.%26aulast%3DKhan%26aufirst%3DI.%2BA.%26atitle%3DIsoform%2520selectivity%2520of%2520harmine-conjugated%25201%252C2%252C3-triazoles%2520against%2520human%2520monoamine%2520oxidase%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2018%26volume%3D10%26spage%3D1435%26epage%3D1448%26doi%3D10.4155%2Ffmc-2018-0006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Son, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kondou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshimura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamashita, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukihara, T.</span></span> <span> </span><span class="NLM_article-title">Structure of human monoamine oxidase A at 2.2-Å resolution: the control of opening the entry for substrates/inhibitors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">5739</span>– <span class="NLM_lpage">5744</span>, <span class="refDoi"> DOI: 10.1073/pnas.0710626105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1073%2Fpnas.0710626105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=18391214" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltFShsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=5739-5744&author=S.-Y.+Sonauthor=J.+Maauthor=Y.+Kondouauthor=M.+Yoshimuraauthor=E.+Yamashitaauthor=T.+Tsukihara&title=Structure+of+human+monoamine+oxidase+A+at+2.2-%C3%85+resolution%3A+the+control+of+opening+the+entry+for+substrates%2Finhibitors&doi=10.1073%2Fpnas.0710626105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of human monoamine oxidase A at 2.2-Å resolution: The control of opening the entry for substrates/inhibitors</span></div><div class="casAuthors">Son, Se-Young; Mat, Jichun; Kondou, Youhei; Yoshimura, Masato; Yamashita, Eiki; Tsukihara, Tomitake</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">5739-5744</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Mitochondrial outer membrane-anchored monoamine oxidase (MAO) is a biochem. important flavoenzyme that catalyzes the deamination of biogenic and xenobiotic amines.  Its 2 subtypes, MAOA and MAOB, are linked to several psychiatric disorders and therefore are interesting targets for drug design.  To understand the relation between structure and function of this enzyme, the authors extended their previously reported low-resoln. rat MAOA structure to the high-resoln. wild-type and G110A mutant structures of human MAOA complexed with the reversible inhibitor, harmine, at 2.2 and 2.17 Å, resp.  The high-resoln. MAOA structures were similar to those of rat MAOA and human MAOB, but different from the known structure of human MAOA, specifically regarding residues 108-118 and 210-216, which surround the substrate/inhibitor cavity.  The results confirmed that the inhibitor selectivity of MAOA and MAOB is caused by the structural differences arising from Ile-335 in MAOA vs. Tyr-326 in MAOB.  The structures exhibited a C-terminal transmembrane helix with clear electron d., as is also seen in rat MAOA.  Mutations on one residue of loop 108-118, Gly-110, which is far from the active center but close to the membrane surface, caused the solubilized enzyme to undergo a dramatic drop in activity, but have less effect when the enzyme was anchored in the membrane.  These results suggest that the flexibility of loop 108-118, facilitated by anchoring the enzyme into the membrane, is essential for controlling substrate access to the active site.  The authors report on the observation of the structure-function relation between a transmembrane helical anchor and an extra-membrane domain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpdm8Cs1NxHxLVg90H21EOLACvtfcHk0lizsUInCZ7NzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltFShsLo%253D&md5=7443fe77547220547312f7259df590df</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0710626105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0710626105%26sid%3Dliteratum%253Aachs%26aulast%3DSon%26aufirst%3DS.-Y.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DKondou%26aufirst%3DY.%26aulast%3DYoshimura%26aufirst%3DM.%26aulast%3DYamashita%26aufirst%3DE.%26aulast%3DTsukihara%26aufirst%3DT.%26atitle%3DStructure%2520of%2520human%2520monoamine%2520oxidase%2520A%2520at%25202.2-%25C3%2585%2520resolution%253A%2520the%2520control%2520of%2520opening%2520the%2520entry%2520for%2520substrates%252Finhibitors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D5739%26epage%3D5744%26doi%3D10.1073%2Fpnas.0710626105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Binda, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hubalek, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Restelli, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edmondson, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattevi, A.</span></span> <span> </span><span class="NLM_article-title">Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>100</i></span>,  <span class="NLM_fpage">9750</span>– <span class="NLM_lpage">9755</span>, <span class="refDoi"> DOI: 10.1073/pnas.1633804100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1073%2Fpnas.1633804100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=12913124" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvVejt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=100&publication_year=2003&pages=9750-9755&author=C.+Bindaauthor=M.+Liauthor=F.+Hubalekauthor=N.+Restelliauthor=D.+E.+Edmondsonauthor=A.+Mattevi&title=Insights+into+the+mode+of+inhibition+of+human+mitochondrial+monoamine+oxidase+B+from+high-resolution+crystal+structures&doi=10.1073%2Fpnas.1633804100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Insights into the mode of inhibition of human mitochondrial monoamine oxidase B from high-resolution crystal structures</span></div><div class="casAuthors">Binda, Claudia; Li, Min; Hubalek, Frantisek; Restelli, Nadia; Edmondson, Dale E.; Mattevi, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">100</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">9750-9755</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Monoamine oxidase B (MAO-B) is an outer mitochondrial membrane-bound enzyme that catalyzes the oxidative deamination of arylalkylamine neurotransmitters and has been a target for a no. of clin. used drug inhibitors.  The 1.7-Å structure of the reversible isatin-MAO-B complex has been detd.; it forms a basis for the interpretation of the enzyme's structure when bound to either reversible or irreversible inhibitors.  1,4-Diphenyl-2-butene is found to be a reversible MAO-B inhibitor, which occupies both the entrance and substrate cavity space in the enzyme.  Comparison of these two structures identifies Ile-199 as a "gate" between the two cavities.  Rotation of the side chain allows for either sepn. or fusion of the two cavities.  Inhibition of the enzyme with N-(2-aminoethyl)-p-chlorobenzamide results in the formation of a covalent N(5) flavin adduct with the Ph ring of the inhibitor occupying a position in the catalytic site overlapping that of isatin.  Inhibition of MAO-B with the clin. used trans-2-phenylcyclopropylamine results in the formation of a covalent C(4a) flavin adduct with an opened cyclopropyl ring and the Ph ring in a parallel orientation to the flavin.  The peptide bond between the flavin-substituted Cys-397 and Tyr-398 is in a cis conformation, which allows the proper orientation of the phenolic ring of Tyr-398 in the active site.  The flavin ring exists in a twisted nonplanar conformation, which is obsd. in the oxidized form as well as in both the N(5) and the C(4a) adducts.  An immobile water mol. is H-bonded to Lys-296 and to the N(5) of the flavin as obsd. in other flavin-dependent amine oxidases.  The active site cavities are highly apolar; however, hydrophilic areas exist near the flavin and direct the amine moiety of the substrate for binding and catalysis.  Small conformational changes are obsd. on comparison of the different inhibitor-enzyme complexes.  Future MAO-B drug design will need to consider "induced fit" contributions as an element in ligand-enzyme interactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0K1SiYQtmN7Vg90H21EOLACvtfcHk0lizsUInCZ7NzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvVejt7c%253D&md5=41ecf51fec3d1c4c811dc716c43beda5</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1633804100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1633804100%26sid%3Dliteratum%253Aachs%26aulast%3DBinda%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DHubalek%26aufirst%3DF.%26aulast%3DRestelli%26aufirst%3DN.%26aulast%3DEdmondson%26aufirst%3DD.%2BE.%26aulast%3DMattevi%26aufirst%3DA.%26atitle%3DInsights%2520into%2520the%2520mode%2520of%2520inhibition%2520of%2520human%2520mitochondrial%2520monoamine%2520oxidase%2520B%2520from%2520high-resolution%2520crystal%2520structures%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2003%26volume%3D100%26spage%3D9750%26epage%3D9755%26doi%3D10.1073%2Fpnas.1633804100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reniers, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robert, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frederick, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masereel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wouters, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.11.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmc.2010.11.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=21183355" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1WksQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=134-144&author=J.+Reniersauthor=S.+Robertauthor=R.+Frederickauthor=B.+Masereelauthor=S.+Vincentauthor=J.+Wouters&title=Synthesis+and+evaluation+of+%CE%B2-carboline+derivatives+as+potential+monoamine+oxidase+inhibitors&doi=10.1016%2Fj.bmc.2010.11.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of β-carboline derivatives as potential monoamine oxidase inhibitors</span></div><div class="casAuthors">Reniers, J.; Robert, S.; Frederick, R.; Masereel, B.; Vincent, S.; Wouters, J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">134-144</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous studies have shown that harmine is a reversible inhibitor of human monoamine oxidase A (MAO-A).  Moreover, the crystal structure of human MAO-A in complex with harmine has been recently solved.  This crystal structure shows that close to the methoxy group of the harmine moiety, a lipophilic pocket is left vacant within the binding site of human MAO-A.  Our objective was to optimize the β-carboline series against human MAO-A in order to explore this pocket.  Therefore, a series of β-carboline derivs. has been synthesized.  The compds. were evaluated for their human monoamine oxidase A and B inhibitory potency and their Ki values were estd.  The results show that O-alkylated compds. with lipophilic groups like cyclohexyl, Ph and aliph. chains increase the inhibition of MAO-A compared to harmine.  Compd. 3e (I), with the trifluorobutyloxy group, was the most active of this series, with a Ki against MAO-A of 3.6 nM.  Mol. docking studies show that the trifluorobutyloxy chain occupies the hydrophobic pocket vacant with harmine.  The O-alkylated compds. are less active on MAO-B than on MAO-A.  However, several compds. show a better inhibition on MAO-B compared to harmine.  Compd. 3f, with the cyclohexylmethoxy chain, displayed the best inhibitory activity against MAO-B with a Ki value of 221.6 nM.  This cyclohexyl bearing analog is also a potent MAO-A inhibitor with a Ki value of 4.3 nM.  Mol. docking studies show that the cyclohexyl chain also occupies a hydrophobic pocket but in different ways in MAO-A or MAO-B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoz8NiKL6ru47Vg90H21EOLACvtfcHk0lizsUInCZ7NzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1WksQ%253D%253D&md5=8e6a16abe22ac5353add1a3eab31d4fb</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.11.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.11.041%26sid%3Dliteratum%253Aachs%26aulast%3DReniers%26aufirst%3DJ.%26aulast%3DRobert%26aufirst%3DS.%26aulast%3DFrederick%26aufirst%3DR.%26aulast%3DMasereel%26aufirst%3DB.%26aulast%3DVincent%26aufirst%3DS.%26aulast%3DWouters%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520%25CE%25B2-carboline%2520derivatives%2520as%2520potential%2520monoamine%2520oxidase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D134%26epage%3D144%26doi%3D10.1016%2Fj.bmc.2010.11.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glover, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebowitz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Armando, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sandler, M.</span></span> <span> </span><span class="NLM_article-title">β-Carbolines as selective monoamine oxidase inhibitors: in vivo implications</span>. <i>J. Neural Transmission</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">209</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1007/BF01254930</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1007%2FBF01254930" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=7130973" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL3sXitFWk" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=1982&pages=209-218&author=V.+Gloverauthor=J.+Liebowitzauthor=I.+Armandoauthor=M.+Sandler&title=%CE%B2-Carbolines+as+selective+monoamine+oxidase+inhibitors%3A+in+vivo+implications&doi=10.1007%2FBF01254930"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">β-Carbolines as selective monoamine oxidase inhibitors:  in vivo implications</span></div><div class="casAuthors">Glover, Vivette; Liebowitz, J.; Armando, Ines; Sandler, M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neural Transmission (1972-1989)</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3-4</span>),
    <span class="NLM_cas:pages">209-18</span>CODEN:
                <span class="NLM_cas:coden">JNTMAH</span>;
        ISSN:<span class="NLM_cas:issn">0300-9564</span>.
    </div><div class="casAbstract">The inhibitory action of a range of β-carbolines on human and rat monoamine oxidase (MAO) A and B was studied.  Concns. of 5-hydroxytryptamine and phenylethylamine, at their approx. Km values, were used as substrates for MAO A and B, resp.  A wide variation in inhibitor selectivity was found, with harmaline being 10,000-fold more potent an inhibitor of MAO A than MAO B, whereas, using tetrahydro-β-carboline and harmane, the difference was closer to 10-fold.  Of the carbolines which have been found endogenously, tetrahydro-β-carboline, 6-methoxytetrahydro-β-carboline, and harmane were all sufficiently potent inhibitors of human MAO A, (I50 values = 5 × 10-6, 1 × 10-6, and 5 × 10-7 M, resp.) for this property to be of possible physiol. significance.  Harmane, with an I50 of 5 × 10-6 M, may also play a role as an inhibitor of MAO B.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIhuMHKj5Qh7Vg90H21EOLACvtfcHk0ljWvgLSU0fWUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3sXitFWk&md5=62e5e26a339b0b9fac9285ed855371c9</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1007%2FBF01254930&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF01254930%26sid%3Dliteratum%253Aachs%26aulast%3DGlover%26aufirst%3DV.%26aulast%3DLiebowitz%26aufirst%3DJ.%26aulast%3DArmando%26aufirst%3DI.%26aulast%3DSandler%26aufirst%3DM.%26atitle%3D%25CE%25B2-Carbolines%2520as%2520selective%2520monoamine%2520oxidase%2520inhibitors%253A%2520in%2520vivo%2520implications%26jtitle%3DJ.%2520Neural%2520Transmission%26date%3D1982%26volume%3D54%26spage%3D209%26epage%3D218%26doi%3D10.1007%2FBF01254930" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miralles, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esteban, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sastre-Coll, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moranta, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asensio, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Sevilla, J. A.</span></span> <span> </span><span class="NLM_article-title">High-affinity binding of β-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>518</i></span>,  <span class="NLM_fpage">234</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2005.06.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejphar.2005.06.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=16061219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2MXosVCksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=518&publication_year=2005&pages=234-242&author=A.+Mirallesauthor=S.+Estebanauthor=A.+Sastre-Collauthor=D.+Morantaauthor=V.+J.+Asensioauthor=J.+A.+Garcia-Sevilla&title=High-affinity+binding+of+%CE%B2-carbolines+to+imidazoline+I2B+receptors+and+MAO-A+in+rat+tissues%3A+norharman+blocks+the+effect+of+morphine+withdrawal+on+DOPA%2Fnoradrenaline+synthesis+in+the+brain&doi=10.1016%2Fj.ejphar.2005.06.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">High-affinity binding of β-carbolines to imidazoline I2B receptors and MAO-A in rat tissues: Norharman blocks the effect of morphine withdrawal on DOPA/noradrenaline synthesis in the brain</span></div><div class="casAuthors">Miralles, Antonio; Esteban, Susana; Sastre-Coll, Antonio; Moranta, David; Asensio, Victor Jose; Garcia-Sevilla, Jesus Andres</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">518</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">234-242</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This study was designed to det. the affinity and binding profile of β-carbolines for imidazoline I2 receptors and catalytic sites of monoamine oxidase (MAO)-A/B in rat brain and liver.  Another objective was to assess the in vivo effects of norharman (β-carboline) and LSL 60101 (I2 ligand) on brain 3,4-dihydroxyphenylalanine (DOPA) synthesis in morphine-dependent rats.  Competition expts. against [3H]2-BFI revealed that β-carbolines recognize the high- and low-affinity components of the brain imidazoline I2 receptor with the rank order of potency (KiH in nM): noreleagnine (12) > norharman (20) > harmalol (82) > harmaline (177) » harmine (630) > harman (700) » FG-7142 (>100,000).  In liver, this rank was different: harmine (51) > harmaline (103) = noreleagnine (103) » harmalol (1290) > harman (2000) » norharman (12,382) » FG-7142 (> 100,000).  In brain and liver, competition curves for β-carbolines against [3H]Ro41-1049 (MAO-A) and [3H]Ro19-6327 (MAO-B) were monophasic and resulted in different drug potencies for the two MAO isoenzymes (higher affinities for MAO-A) and in similar pharmacol. profiles in both tissues.  In morphine-dependent rats, naloxone (2 mg/kg, 2 h)-pptd. withdrawal increased the synthesis of DOPA in the cerebral cortex and hippocampus (50%).  Pretreatment with norharman (20 mg/kg) or LSL 60101 (20 mg/kg) (30 min before naloxone) fully prevented the stimulatory effect of opiate withdrawal on DOPA synthesis.  Norharman and LSL 60101 also attenuated the severity of the withdrawal syndrome.  The results indicate that β-carbolines bind with high affinity to imidazoline I2B receptors, and similarly to I2 ligands (LSL 60101) can block the behavioral and biochem. effects of opiate withdrawal.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCvzFB8nFMG7Vg90H21EOLACvtfcHk0ljWvgLSU0fWUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXosVCksbg%253D&md5=6ea00978e64eb6e63412ac04a425a584</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2005.06.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2005.06.023%26sid%3Dliteratum%253Aachs%26aulast%3DMiralles%26aufirst%3DA.%26aulast%3DEsteban%26aufirst%3DS.%26aulast%3DSastre-Coll%26aufirst%3DA.%26aulast%3DMoranta%26aufirst%3DD.%26aulast%3DAsensio%26aufirst%3DV.%2BJ.%26aulast%3DGarcia-Sevilla%26aufirst%3DJ.%2BA.%26atitle%3DHigh-affinity%2520binding%2520of%2520%25CE%25B2-carbolines%2520to%2520imidazoline%2520I2B%2520receptors%2520and%2520MAO-A%2520in%2520rat%2520tissues%253A%2520norharman%2520blocks%2520the%2520effect%2520of%2520morphine%2520withdrawal%2520on%2520DOPA%252Fnoradrenaline%2520synthesis%2520in%2520the%2520brain%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2005%26volume%3D518%26spage%3D234%26epage%3D242%26doi%3D10.1016%2Fj.ejphar.2005.06.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Herraiz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaparro, C.</span></span> <span> </span><span class="NLM_article-title">Analysis of monoamine oxidase enzymatic activity by reversed-phase high performance liquid chromatography and inhibition by β-carboline alkaloids occurring in foods and plants</span>. <i>J. Chromatogr. A</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>1120</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1016/j.chroma.2005.12.009</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.chroma.2005.12.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=16386263" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD28XmtV2qtL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1120&publication_year=2006&pages=237-243&author=T.+Herraizauthor=C.+Chaparro&title=Analysis+of+monoamine+oxidase+enzymatic+activity+by+reversed-phase+high+performance+liquid+chromatography+and+inhibition+by+%CE%B2-carboline+alkaloids+occurring+in+foods+and+plants&doi=10.1016%2Fj.chroma.2005.12.009"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of monoamine oxidase enzymatic activity by reversed-phase high performance liquid chromatography and inhibition by β-carboline alkaloids occurring in foods and plants</span></div><div class="casAuthors">Herraiz, Tomas; Chaparro, Carolina</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chromatography A</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">1120</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">237-243</span>CODEN:
                <span class="NLM_cas:coden">JCRAEY</span>;
        ISSN:<span class="NLM_cas:issn">0021-9673</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Monoamine oxidase (MAO) is a FAD-contg. enzyme located at the outer membranes of mitochondria that catalyzes the oxidative deamination of biogenic and xenobiotic amines.  We have used a chromatog. method to measure MAO-enzymic activity by kynuramine as a non-selective substrate with its MAO-oxidn. product subsequently analyzed by RP-HPLC-DAD and HPLC-mass spectrometry (MS).  This method was applied to study the kinetic parameters, inhibition and reaction products of MAO recombinant enzymes in presence of tetrahydro-β-carboline and β-carboline alkaloids occurring in foods, plants and mammals.  Anal. by HPLC showed that tetrahydro-β-carbolines or β-carbolines were not modified by MAO.  Several β-carbolines such as tryptoline (1,2,3,4-tetrahydro-β-carboline) and 1-methyltryptoline (1-methyl-1,2,3,4-tetrahydro-β-carboline) were inhibitors of MAO-A; instead their corresponding 6-hydroxy-derivs. (6-hydroxytryptoline and 6-hydroxy-1-methyltryptoline) lacked this activity.  Tetrahydro-β-carboline-3-carboxylic acids were unable to inhibit MAO enzymes.  In contrast, their oxidn. products, i.e. the fully arom. β-carbolines (norharman and harman), acted as good inhibitors of MAO.  Two tetrahydro-β-carbolines (i.e. tryptoline and 1-methyltryptoline) occurring in foods were isolated by solid-phase extn. (SPE) and RP-HPLC from selected samples of sausages and the corresponding exts. exhibited good inhibition properties over MAO-A.  These results suggest that β-carbolines from foods, plants, and mammals may exert inhibitory actions on MAO enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpD7GZ_IXI3mbVg90H21EOLACvtfcHk0ljWvgLSU0fWUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XmtV2qtL0%253D&md5=6ffeb49b70bdf047232b8f2ed66b0bff</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1016%2Fj.chroma.2005.12.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chroma.2005.12.009%26sid%3Dliteratum%253Aachs%26aulast%3DHerraiz%26aufirst%3DT.%26aulast%3DChaparro%26aufirst%3DC.%26atitle%3DAnalysis%2520of%2520monoamine%2520oxidase%2520enzymatic%2520activity%2520by%2520reversed-phase%2520high%2520performance%2520liquid%2520chromatography%2520and%2520inhibition%2520by%2520%25CE%25B2-carboline%2520alkaloids%2520occurring%2520in%2520foods%2520and%2520plants%26jtitle%3DJ.%2520Chromatogr.%2520A%26date%3D2006%26volume%3D1120%26spage%3D237%26epage%3D243%26doi%3D10.1016%2Fj.chroma.2005.12.009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meller, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweitzer, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedhoff, A. J.</span></span> <span> </span><span class="NLM_article-title">Tetrahydro-β-carbolines: specific inhibitors of type A monoamine oxidase in rat brain</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">1977</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">995</span>– <span class="NLM_lpage">1000</span>, <span class="refDoi"> DOI: 10.1111/j.1471-4159.1977.tb10661.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1111%2Fj.1471-4159.1977.tb10661.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=864473" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaE1cXmvV2msA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1977&pages=995-1000&author=E.+Mellerauthor=E.+Friedmanauthor=J.+W.+Schweitzerauthor=A.+J.+Friedhoff&title=Tetrahydro-%CE%B2-carbolines%3A+specific+inhibitors+of+type+A+monoamine+oxidase+in+rat+brain&doi=10.1111%2Fj.1471-4159.1977.tb10661.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Tetrahydro-β-carbolines: specific inhibitors of type A monoamine oxidase in rat brain</span></div><div class="casAuthors">Meller, E.; Friedman, E.; Schweitzer, J. W.; Friedhoff, A. J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">1977</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">995-1000</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    </div><div class="casAbstract">Several tetrahydrocarbazoles, tetrahydroisoquinolines, and aminotetralins inhibited monoamine oxidase (EC 1.4.3.4) (I)  [9001-66-5] selectively, but the most specific and potent were the tetrahydro-β-carbolines, which competitively inhibited the oxidative deamination of serotonin  [50-67-9] at μM concns., but mM concns. were required to inhibit phenethylamine  [64-04-0] deamination.  Redns. of type A, but not type B, I activity were obsd. after administration of tetrahydro-β-carboline (II) or 6-methoxytetrahydro-β-carboline (both 25-100 mg/kg, i.p.).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowFO7zBoAWNrVg90H21EOLACvtfcHk0lgvZOhmpfUasw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaE1cXmvV2msA%253D%253D&md5=bc403776aaa976957916431d5f50a646</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1111%2Fj.1471-4159.1977.tb10661.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1471-4159.1977.tb10661.x%26sid%3Dliteratum%253Aachs%26aulast%3DMeller%26aufirst%3DE.%26aulast%3DFriedman%26aufirst%3DE.%26aulast%3DSchweitzer%26aufirst%3DJ.%2BW.%26aulast%3DFriedhoff%26aufirst%3DA.%2BJ.%26atitle%3DTetrahydro-%25CE%25B2-carbolines%253A%2520specific%2520inhibitors%2520of%2520type%2520A%2520monoamine%2520oxidase%2520in%2520rat%2520brain%26jtitle%3DJ.%2520Neurochem.%26date%3D1977%26volume%3D28%26spage%3D995%26epage%3D1000%26doi%3D10.1111%2Fj.1471-4159.1977.tb10661.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sablin, S. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramsay, R. R.</span></span> <span> </span><span class="NLM_article-title">Inhibition of monoamine oxidase A by β-carboline derivatives</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>337</i></span>,  <span class="NLM_fpage">137</span>– <span class="NLM_lpage">142</span>, <span class="refDoi"> DOI: 10.1006/abbi.1996.9771</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1006%2Fabbi.1996.9771" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=8990278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK2sXktlGitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=337&publication_year=1997&pages=137-142&author=H.+Kimauthor=S.+O.+Sablinauthor=R.+R.+Ramsay&title=Inhibition+of+monoamine+oxidase+A+by+%CE%B2-carboline+derivatives&doi=10.1006%2Fabbi.1996.9771"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of monoamine oxidase A by β-carboline derivatives</span></div><div class="casAuthors">Kim, Hoon; Sablin, Sergey O.; Ramsay, Rona R.</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">337</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">137-142</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Academic</span>)
        </div><div class="casAbstract">β-Carbolines are endogenous inhibitors of monoamine oxidase (MAO).  The interaction of nine β-carboline derivs. and four 3,4-dihydro forms with purified MAO A was investigated.  All the compds. tested were reversible competitive inhibitors selective for MAO A, in agreement with previous studies on membrane prepns.  The oxidn. of kynuramine by MAO A in the presence of the more effective inhibitors showed a lag period before reaching the steady state.  In general, the 1-Me and 7-methoxy substituents increased the potency.  Harmine, 2-methylharminium, 2,9-dimethylharminium, and harmaline were the most effective inhibitors of the purified MAO A, with low Ki values of 5,69, 15, and 48 nM, resp.  The inhibitors interacted with the covalently bound flavin to induce distinct spectral changes, the magnitude of which correlated with the efficacy of the inhibition.  The more effective inhibitors could be in situ inhibitors of MAO A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqkrxSogWwJzrVg90H21EOLACvtfcHk0lgvZOhmpfUasw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXktlGitg%253D%253D&md5=04c6fecf6acc0097ab0ee54d0b6fb1e6</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1996.9771&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1996.9771%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DH.%26aulast%3DSablin%26aufirst%3DS.%2BO.%26aulast%3DRamsay%26aufirst%3DR.%2BR.%26atitle%3DInhibition%2520of%2520monoamine%2520oxidase%2520A%2520by%2520%25CE%25B2-carboline%2520derivatives%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1997%26volume%3D337%26spage%3D137%26epage%3D142%26doi%3D10.1006%2Fabbi.1996.9771" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heckman, P. R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wouters, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase inhibitors as a target for cognition enhancement in aging and Alzheimer’s disease: a translational overview</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">317</span>– <span class="NLM_lpage">331</span>, <span class="refDoi"> DOI: 10.2174/1381612820666140826114601</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.2174%2F1381612820666140826114601" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=317-331&author=P.+R.+A.+Heckmanauthor=C.+Woutersauthor=J.+Prickaerts&title=Phosphodiesterase+inhibitors+as+a+target+for+cognition+enhancement+in+aging+and+Alzheimer%E2%80%99s+disease%3A+a+translational+overview&doi=10.2174%2F1381612820666140826114601"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.2174%2F1381612820666140826114601&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1381612820666140826114601%26sid%3Dliteratum%253Aachs%26aulast%3DHeckman%26aufirst%3DP.%2BR.%2BA.%26aulast%3DWouters%26aufirst%3DC.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DPhosphodiesterase%2520inhibitors%2520as%2520a%2520target%2520for%2520cognition%2520enhancement%2520in%2520aging%2520and%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520translational%2520overview%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2014%26volume%3D21%26spage%3D317%26epage%3D331%26doi%3D10.2174%2F1381612820666140826114601" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">García-Osta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">García-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzábal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase as therapeutic targets for Alzheimer’s disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">832</span>– <span class="NLM_lpage">844</span>, <span class="refDoi"> DOI: 10.1021/cn3000907</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cn3000907" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVejs7nK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=832-844&author=A.+Garc%C3%ADa-Ostaauthor=M.+Cuadrado-Tejedorauthor=C.+Garc%C3%ADa-Barrosoauthor=J.+Oyarz%C3%A1balauthor=R.+Franco&title=Phosphodiesterase+as+therapeutic+targets+for+Alzheimer%E2%80%99s+disease&doi=10.1021%2Fcn3000907"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterases as Therapeutic Targets for Alzheimer's Disease</span></div><div class="casAuthors">Garcia-Osta, Ana; Cuadrado-Tejedor, Mar; Garcia-Barroso, Carolina; Oyarzabal, Julen; Franco, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">832-844</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common form of dementia among the elderly.  In AD patients, memory loss is accompanied by the formation of beta-amyloid plaques and the appearance of tau in a pathol. form.  Given the lack of effective treatments for AD, the development of new management strategies for these patients is crit.  The continued failure to find effective therapies using mols. aimed at addressing the anti-beta amyloid pathol. has led researchers to focus on other non-amyloid-based approaches to restore memory function.  Promising non-amyloid related candidate targets include phosphosdiesterases (PDEs), and indeed, Rolipram, a specific PDE4 inhibitor, was the first compd. found to effectively restore cognitive deficits in animal models of AD.  More recently, PDE5 inhibitors have also been shown to effectively restore memory function.  Accordingly, inhibitors of other members of the PDE family may also improve memory performance in AD and non-AD animal models.  Hence, in this review, we will summarize the data supporting the use of PDE inhibitors as cognitive enhancers and we will discuss the possible mechanisms of action underlying these effects.  We shall also adopt a medicinal chem. perspective that leads us to propose the most promising PDE candidates on the basis of inhibitor selectivity, brain distribution, and mechanism of action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGppeOP4NskdvrVg90H21EOLACvtfcHk0lg9y9ivk6reVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVejs7nK&md5=53c6dfed22bb240b17132672b13fdcf1</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1021%2Fcn3000907&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn3000907%26sid%3Dliteratum%253Aachs%26aulast%3DGarc%25C3%25ADa-Osta%26aufirst%3DA.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DGarc%25C3%25ADa-Barroso%26aufirst%3DC.%26aulast%3DOyarz%25C3%25A1bal%26aufirst%3DJ.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DPhosphodiesterase%2520as%2520therapeutic%2520targets%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2012%26volume%3D3%26spage%3D832%26epage%3D844%26doi%3D10.1021%2Fcn3000907" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, P.-F.</span></span> <span> </span><span class="NLM_article-title">Vinpocetine improves scopolamine induced learning and memory dysfunction in C57 BL/6J mice</span>. <i>Biol. Pharm. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">1412</span>– <span class="NLM_lpage">1418</span>, <span class="refDoi"> DOI: 10.1248/bpb.b15-00881</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1248%2Fbpb.b15-00881" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=27334578" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKmur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2016&pages=1412-1418&author=Y.+Shangauthor=L.+Wangauthor=Y.+Liauthor=P.-F.+Gu&title=Vinpocetine+improves+scopolamine+induced+learning+and+memory+dysfunction+in+C57+BL%2F6J+mice&doi=10.1248%2Fbpb.b15-00881"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Vinpocetine improves scopolamine induced learning and memory dysfunction in C57 BL/6J mice</span></div><div class="casAuthors">Shang, Yu; Wang, Lei; Li, Yue; Gu, Pei-fei</div><div class="citationInfo"><span class="NLM_cas:title">Biological & Pharmaceutical Bulletin</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1412-1418</span>CODEN:
                <span class="NLM_cas:coden">BPBLEO</span>;
        ISSN:<span class="NLM_cas:issn">0918-6158</span>.
    
            (<span class="NLM_cas:orgname">Pharmaceutical Society of Japan</span>)
        </div><div class="casAbstract">Vinpocetine is an inhibitor of phosphodiesterase type 1 (PDE1), which has been used for treating stroke for over 40 years.  However, according to current clin. dosage and treatment period, its direct effect on memory is unclear.  In this study, we investigated whether vinpocetine could reverse the scopolamine (SCO)-induced cognitive deficits in animals.  Behavioral expts., including open field, Y-maze, and fear conditioning tests were used to det. the possible role of vinpocetine on scopolamine-induced memory dysfunction.  In the open field and Y-maze tests, there were significant differences between the control (CON) group and SCO group.  Vinpocetine (4 mg/kg) administration for consecutive 28 d significantly improved the scopolamine-induced memory dysfunction.  In the fear conditioning test, vinpocetine (2, 4 mg/kg) administration had certain beneficial effect on emotional memory.  Our results suggest that vinpocetine could improve cognitive function in memory deficient mice and high clinic dosage might be better.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvYbzH65_mSLVg90H21EOLACvtfcHk0lh12Oh3V-7_EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKmur4%253D&md5=7deb3aedb4d66c801d0ea74bbaf686dc</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1248%2Fbpb.b15-00881&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1248%252Fbpb.b15-00881%26sid%3Dliteratum%253Aachs%26aulast%3DShang%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DP.-F.%26atitle%3DVinpocetine%2520improves%2520scopolamine%2520induced%2520learning%2520and%2520memory%2520dysfunction%2520in%2520C57%2520BL%252F6J%2520mice%26jtitle%3DBiol.%2520Pharm.%2520Bull.%26date%3D2016%26volume%3D39%26spage%3D1412%26epage%3D1418%26doi%3D10.1248%2Fbpb.b15-00881" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abdelwaly, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salama, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomaa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, M. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of tetrahydro-β-carboline derivatives as a new class of phosphodiesterase 4 inhibitors</span>. <i>Med. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3173</span>– <span class="NLM_lpage">3187</span>, <span class="refDoi"> DOI: 10.1007/s00044-017-2011-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1007%2Fs00044-017-2011-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlKnurzP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=3173-3187&author=A.+Abdelwalyauthor=I.+Salamaauthor=M.+Gomaaauthor=M.+A.+Helal&title=Discovery+of+tetrahydro-%CE%B2-carboline+derivatives+as+a+new+class+of+phosphodiesterase+4+inhibitors&doi=10.1007%2Fs00044-017-2011-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of tetrahydro-ss-carboline derivatives as a new class of phosphodiesterase 4 inhibitors</span></div><div class="casAuthors">Abdelwaly, Ahmad; Salama, Ismail; Gomaa, Mohamed S.; Helal, Mohamed A.</div><div class="citationInfo"><span class="NLM_cas:title">Medicinal Chemistry Research</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3173-3187</span>CODEN:
                <span class="NLM_cas:coden">MCREEB</span>;
        ISSN:<span class="NLM_cas:issn">1054-2523</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Abstr.: Phosphodiesterase 4 is the primary enzyme responsible for degrdn. of the second messenger cAMP in many of the cells releasing proinflammatory mediators.  Inhibition of this enzyme could help in the management of various inflammatory conditions such as asthma, chronic obstructive pulmonary disorder, arthritis, and psoriasis.  In this study, two novel series of tetrahydro-β-carbolines were designed by combining the pharmacophoric features of both tadalafil and piclamilast.  Twenty-two compds. were synthesized and assessed for Phosphodiesterase 4 inhibition, four of them showed superior activity to the ref. compd. IBMX.  Docking studies showed that the prepd. compds. interact with the crucial Gln443 with variable interactions with the hydrophobic pocket Q2.  This is the first report of tetrahydro-β-carbolines as a scaffold for Phosphodiesterase 4 inhibition.  Currently, further optimization of the substituents is carried out to fine-tune the hydrophobic interactions and enhance the potency of this novel series of inhibitors.  Graphical abstr.: [InlineMediaObject not available: see fulltext.].</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQZcFaloGQJrVg90H21EOLACvtfcHk0lh12Oh3V-7_EA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlKnurzP&md5=9b48c510489e974e23927353aa4d7444</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1007%2Fs00044-017-2011-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00044-017-2011-x%26sid%3Dliteratum%253Aachs%26aulast%3DAbdelwaly%26aufirst%3DA.%26aulast%3DSalama%26aufirst%3DI.%26aulast%3DGomaa%26aufirst%3DM.%26aulast%3DHelal%26aufirst%3DM.%2BA.%26atitle%3DDiscovery%2520of%2520tetrahydro-%25CE%25B2-carboline%2520derivatives%2520as%2520a%2520new%2520class%2520of%2520phosphodiesterase%25204%2520inhibitors%26jtitle%3DMed.%2520Chem.%2520Res.%26date%3D2017%26volume%3D26%26spage%3D3173%26epage%3D3187%26doi%3D10.1007%2Fs00044-017-2011-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ricobaraza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual-Lucas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Unceta, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rico, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goicolea, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salles, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanciego, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span> <span> </span><span class="NLM_article-title">Tadalafil crosses the blood brain barrier and reverses cognitive dysfunction in a mouse model of AD</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">114</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2012.06.052</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.neuropharm.2012.06.052" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=22776546" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2nu77O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2013&pages=114-123&author=C.+Garcia-Barrosoauthor=A.+Ricobarazaauthor=M.+Pascual-Lucasauthor=N.+Uncetaauthor=A.+J.+Ricoauthor=M.+A.+Goicoleaauthor=J.+Sallesauthor=J.+L.+Lanciegoauthor=J.+Oyarzabalauthor=R.+Francoauthor=M.+Cuadrado-Tejedorauthor=A.+Garcia-Osta&title=Tadalafil+crosses+the+blood+brain+barrier+and+reverses+cognitive+dysfunction+in+a+mouse+model+of+AD&doi=10.1016%2Fj.neuropharm.2012.06.052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Tadalafil crosses the blood-brain barrier and reverses cognitive dysfunction in a mouse model of AD</span></div><div class="casAuthors">Garcia-Barroso, Carolina; Ricobaraza, Ana; Pascual-Lucas, Maria; Unceta, Nora; Rico, Alberto J.; Goicolea, Maria Aranzazu; Salles, Joan; Lanciego, Jose Luis; Oyarzabal, Julen; Franco, Rafael; Cuadrado-Tejedor, Mar; Garcia-Osta, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">114-123</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Previous studies have demonstrated that cognitive function can be restored in mouse models of Alzheimer's disease (AD) following administration of sildenafil, a specific PDE5 inhibitor (Puzzo et al., 2009; Cuadrado-Tejedor et al.).  Another very potent PDE5 inhibitor with a longer half-life and safe in chronic treatments, tadalafil, may represent a better alternative candidate for AD therapy.  However, tadalafil was proven unable to achieve similar benefits than those of sildenafil in AD animal models (Puzzo et al., 2009).  The lack of efficacy was attributed to inability to cross the blood-brain barrier (BBB).  In this paper we first measured the blood and brain levels of tadalafil to prove that the compd. crosses BBB and that chronic treatment leads to accumulation in the brain of the J20 transgenic mouse model of AD.  We demonstrated the presence of PDE5 mRNA in the brain of the mice and also in the human brain.  After a 10 wk treatment with either of these PDE5 inhibitors, the performance of the J20 mice in the Morris water maze test improved when compared with the transgenic mice that received vehicle.  Biochem. anal. revealed that neither sildenafil nor tadalafil altered the amyloid burden, although both compds. reduced Tau phosphorylation in the mouse hippocampus.  This study provides evidence of the potential benefits of a chronic tadalafil treatment in AD therapy.This article is part of a Special Issue entitled 'Cognitive Enhancers'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfkrxYqIGt7LVg90H21EOLACvtfcHk0ljwV48H0KyH_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2nu77O&md5=aafb7dacec3ffd9d8ef4abc38c08e0f6</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2012.06.052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2012.06.052%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DRicobaraza%26aufirst%3DA.%26aulast%3DPascual-Lucas%26aufirst%3DM.%26aulast%3DUnceta%26aufirst%3DN.%26aulast%3DRico%26aufirst%3DA.%2BJ.%26aulast%3DGoicolea%26aufirst%3DM.%2BA.%26aulast%3DSalles%26aufirst%3DJ.%26aulast%3DLanciego%26aufirst%3DJ.%2BL.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DFranco%26aufirst%3DR.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26atitle%3DTadalafil%2520crosses%2520the%2520blood%2520brain%2520barrier%2520and%2520reverses%2520cognitive%2520dysfunction%2520in%2520a%2520mouse%2520model%2520of%2520AD%26jtitle%3DNeuropharmacology%26date%3D2013%26volume%3D64%26spage%3D114%26epage%3D123%26doi%3D10.1016%2Fj.neuropharm.2012.06.052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abouel-Ella, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gary, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thaiparambil, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeton, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, G. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis of novel tadalafil analogues and their evaluation as phosphodiesterase inhibitors and anticancer agents</span>. <i>Arzneimittelforschung</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">415</span>– <span class="NLM_lpage">421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=19813465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADC%252BD1MnnvVequw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2009&pages=415-421&author=A.+H.+Abadiauthor=D.+A.+Abouel-Ellaauthor=N.+S.+Ahmedauthor=B.+D.+Garyauthor=J.+T.+Thaiparambilauthor=H.+N.+Tinsleyauthor=A.+B.+Keetonauthor=G.+A.+Piazza&title=Synthesis+of+novel+tadalafil+analogues+and+their+evaluation+as+phosphodiesterase+inhibitors+and+anticancer+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of novel tadalafil analogues and their evaluation as phosphodiesterase inhibitors and anticancer agents</span></div><div class="casAuthors">Abadi Ashraf H; Abouel-Ella Dalal A; Ahmed Nermin S; Gary Bernard D; Thaiparambil Jose T; Tinsley Heather N; Keeton Adam B; Piazza Gary A</div><div class="citationInfo"><span class="NLM_cas:title">Arzneimittel-Forschung</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">415-21</span>
        ISSN:<span class="NLM_cas:issn">0004-4172</span>.
    </div><div class="casAbstract">Two closely related series of novel beta-carboline derivatives, electronically similar to tadalafil (CAS 171596-29-5), were synthesized and evaluated for their inhibitory effects upon phosphodiesterase 5 (PDE5) and phosphodiesterase 11 (PDE11) and their in vitro tumor cell growth inhibitory activity versus HT29 colorectal carcinoma cell line.  Interestingly, some of the synthesized compounds showed growth inhibitory properties that appear to be associated with their ability to inhibit PDE5.  Moreover, the PDE5 inhibition seems relevant to the stereochemical aspects of the compounds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRVpRaddYjBj3T4ugvCDgnZfW6udTcc2eaKKuCgBcaWLbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1MnnvVequw%253D%253D&md5=f00e9d233beec1e29a9501c7e9938f17</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26aulast%3DAbouel-Ella%26aufirst%3DD.%2BA.%26aulast%3DAhmed%26aufirst%3DN.%2BS.%26aulast%3DGary%26aufirst%3DB.%2BD.%26aulast%3DThaiparambil%26aufirst%3DJ.%2BT.%26aulast%3DTinsley%26aufirst%3DH.%2BN.%26aulast%3DKeeton%26aufirst%3DA.%2BB.%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26atitle%3DSynthesis%2520of%2520novel%2520tadalafil%2520analogues%2520and%2520their%2520evaluation%2520as%2520phosphodiesterase%2520inhibitors%2520and%2520anticancer%2520agents%26jtitle%3DArzneimittelforschung%26date%3D2009%26volume%3D59%26spage%3D415%26epage%3D421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gary, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Halim, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, molecular modeling and biological evaluation of novel tadalafil analogues as phosphodiesterase 5 and colon tumor cell growth inhibitors, new stereochemical perspective</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">1278</span>– <span class="NLM_lpage">1286</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2009.10.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2009.10.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=20206015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3cXivFKjsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=1278-1286&author=A.+H.+Abadiauthor=B.+D.+Garyauthor=H.+N.+Tinsleyauthor=G.+A.+Piazzaauthor=M.+Abdel-Halim&title=Synthesis%2C+molecular+modeling+and+biological+evaluation+of+novel+tadalafil+analogues+as+phosphodiesterase+5+and+colon+tumor+cell+growth+inhibitors%2C+new+stereochemical+perspective&doi=10.1016%2Fj.ejmech.2009.10.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, molecular modeling and biological evaluation of novel tadalafil analogues as phosphodiesterase 5 and colon tumor cell growth inhibitors, new stereochemical perspective</span></div><div class="casAuthors">Abadi, Ashraf H.; Gary, Bernard D.; Tinsley, Heather N.; Piazza, Gary A.; Abdel-Halim, Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1278-1286</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The synthesis of novel tadalafil analogs in which the benzodioxole moiety is replaced by 2-bromophenyl; the chiral carbons swing from R,R to R,S, S,R and S,S; the piperazinedione ring is maintained or reduced to the 5-membered imidazolidinedione or thioxoimidazolinone is described.  The prepd. analogs were evaluated for their capacity to inhibit the cyclic guanosine monophosphate (cGMP) selective phosphodiesterase 5 (PDE5) isoenzyme and the growth of human HT-29 colon adenocarcinoma cells.  The R abs. configuration of C-5 in the β-carboline-hydantoin and C-6 in the β-carboline-piperazinedione derivs. was found to be essential for the PDE5 inhibition.  In addn., tadalafil analogs that were synthesized from L-tryptophan were more active than those derived from D-tryptophan, which is of economic value and expands the horizon for the discovery of new carbolines as PDE5 inhibitors.  While some analogs displayed potent tumor cell growth inhibitory activity, there was no apparent correlation with their PDE5 inhibitory activity, which leads us to conclude that other PDE isoenzymes or PDE5 splice variants may be involved.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpqISHkFRRlEbVg90H21EOLACvtfcHk0lgN1mQtu8y9WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXivFKjsLs%253D&md5=e9f34d2e643623291d21f1b23d90611b</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2009.10.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2009.10.046%26sid%3Dliteratum%253Aachs%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26aulast%3DGary%26aufirst%3DB.%2BD.%26aulast%3DTinsley%26aufirst%3DH.%2BN.%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DAbdel-Halim%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520molecular%2520modeling%2520and%2520biological%2520evaluation%2520of%2520novel%2520tadalafil%2520analogues%2520as%2520phosphodiesterase%25205%2520and%2520colon%2520tumor%2520cell%2520growth%2520inhibitors%252C%2520new%2520stereochemical%2520perspective%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D1278%26epage%3D1286%26doi%3D10.1016%2Fj.ejmech.2009.10.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Halim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, M. S. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, molecular modeling, and biological evaluation of novel tetrahydro-β-carboline hydantoin and tetrahydro-β-carboline thiohydantoin derivatives as phosphodiesterase 5 inhibitors</span>. <i>Int. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_fpage">562421</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=27471602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkslyis7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&pages=562421&author=A.+H.+Abadiauthor=J.+Lehmannauthor=G.+A.+Piazzaauthor=M.+Abdel-Halimauthor=M.+S.+M.+Ali&title=Synthesis%2C+molecular+modeling%2C+and+biological+evaluation+of+novel+tetrahydro-%CE%B2-carboline+hydantoin+and+tetrahydro-%CE%B2-carboline+thiohydantoin+derivatives+as+phosphodiesterase+5+inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, molecular modeling, and biological evaluation of novel tetrahydro-β-carboline hydantoin and tetrahydro-β-carboline thiohydantoin derivatives as phosphodiesterase 5 inhibitors</span></div><div class="casAuthors">Abadi, Ashraf H.; Lehmann, Jochen; Piazza, Gary A.; Abdel-Halim, Mohammad; Ali, Mohamed S. M.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume"></span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">562421, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">IJMCCH</span>;
        ISSN:<span class="NLM_cas:issn">2090-2077</span>.
    
            (<span class="NLM_cas:orgname">Hindawi Publishing Corp.</span>)
        </div><div class="casAbstract">Copyright © 2011 Ashraf H. Abadi et al.  This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reprodn. in any medium, provided the original work is properly cited.  Two series of fused tetrahydro-β-carboline hydantoin and tetrahydro-βcarboline thiohydantoin derivs. with a pendant 2,4-dimethoxyphenyl at position 5 were synthesized, and chiral carbons at positions 5 and 11a swing from R,R to R,S, S,R, and S,S.  The prepd. analogs were evaluated for their capacity to inhibit the phosphodiesterase 5 (PDE5) isoenzyme.  The R abs. configuration of C-5 in the β-carboline hydantoin derivs. was found to be essential for the PDE5 inhibition.  The chiral carbon derived from the amino acid, even if of the S configuration (L-tryptophan), may lead to equiactive or more active isomers than those derived from the amino acid with the R configuration (D-tryptophan).  This expands the pool from which efficient PDE5 inhibitors can be derived and may offer an economic advantage.  The thiohydantoin derivs. were less active than their hydantoin congeners.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpFbjCIk3fAwrVg90H21EOLACvtfcHk0lgN1mQtu8y9WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkslyis7Y%253D&md5=79b12daf4f40ac2a18777c41bf2045dc</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DAbdel-Halim%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DM.%2BS.%2BM.%26atitle%3DSynthesis%252C%2520molecular%2520modeling%252C%2520and%2520biological%2520evaluation%2520of%2520novel%2520tetrahydro-%25CE%25B2-carboline%2520hydantoin%2520and%2520tetrahydro-%25CE%25B2-carboline%2520thiohydantoin%2520derivatives%2520as%2520phosphodiesterase%25205%2520inhibitors%26jtitle%3DInt.%2520J.%2520Med.%2520Chem.%26date%3D2011%26spage%3D562421" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gary, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laufer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and structure-activity relationship of functionalized tetrahydro-β-carboline derivatives as novel PDE5 inhibitors</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>344</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">157</span>, <span class="refDoi"> DOI: 10.1002/ardp.201000236</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1002%2Fardp.201000236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=21384413" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3MXislOks7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=344&publication_year=2011&pages=149-157&author=N.+S.+Ahmedauthor=B.+D.+Garyauthor=H.+N.+Tinsleyauthor=G.+A.+Piazzaauthor=S.+Lauferauthor=A.+H.+Abadi&title=Design%2C+synthesis+and+structure-activity+relationship+of+functionalized+tetrahydro-%CE%B2-carboline+derivatives+as+novel+PDE5+inhibitors&doi=10.1002%2Fardp.201000236"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis and Structure-Activity Relationship of Functionalized Tetrahydro-β-carboline Derivatives as Novel PDE5 Inhibitors</span></div><div class="casAuthors">Ahmed, Nermin S.; Gary, Bernard D.; Tinsley, Hethar N.; Piazza, Gary A.; Laufer, Stefan; Abadi, Ashraf H.</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">344</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">149-157</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Starting from tadalafil as a template, a series of functionalized tetrahydro-β-carboline derivs. have been prepd. and identified as novel potent and selective PDE5 inhibitors.  Replacing the 3,4-methylenedioxyphenyl at position 6 of tadalafil, together with elongation of the N2-Me substituent and manipulation of the stereochem. aspects of the two chiral carbons led to the identification of compd. XXI, a highly potent PDE5 inhibitor (IC50 = 3 nM).  Compd. XXI (I) was also highly selective for PDE5 vs. PDE3B, PDE4B, and PDE11A, with a selectivity index of 52 and 235 towards PDE5 rather than PDE11 with both cAMP and cGMP as substrate, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ipgehDVMHLVg90H21EOLACvtfcHk0lgN1mQtu8y9WA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXislOks7s%253D&md5=c4611618b98474f0a8e534adc372af95</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1002%2Fardp.201000236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201000236%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DN.%2BS.%26aulast%3DGary%26aufirst%3DB.%2BD.%26aulast%3DTinsley%26aufirst%3DH.%2BN.%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DLaufer%26aufirst%3DS.%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26atitle%3DDesign%252C%2520synthesis%2520and%2520structure-activity%2520relationship%2520of%2520functionalized%2520tetrahydro-%25CE%25B2-carboline%2520derivatives%2520as%2520novel%2520PDE5%2520inhibitors%26jtitle%3DArch.%2520Pharm.%26date%3D2011%26volume%3D344%26spage%3D149%26epage%3D157%26doi%3D10.1002%2Fardp.201000236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">El-Gamil, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gary, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span> <span> </span><span class="NLM_article-title">Design of novel β-carboline derivatives with pendant 5-bromothienyl and their evaluation as phosphodiesterase-5 inhibitors</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>346</i></span>,  <span class="NLM_fpage">23</span>– <span class="NLM_lpage">33</span>, <span class="refDoi"> DOI: 10.1002/ardp.201200334</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1002%2Fardp.201200334" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=23307609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3sXmsl2rsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=346&publication_year=2013&pages=23-33&author=D.+S.+El-Gamilauthor=N.+S.+Ahmedauthor=B.+D.+Garyauthor=G.+A.+Piazzaauthor=M.+Engelauthor=R.+W.+Hartmannauthor=A.+H.+Abadi&title=Design+of+novel+%CE%B2-carboline+derivatives+with+pendant+5-bromothienyl+and+their+evaluation+as+phosphodiesterase-5+inhibitors&doi=10.1002%2Fardp.201200334"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit93R"><div class="casContent"><span class="casTitleNuber">93</span><div class="casTitle"><span class="NLM_cas:atitle">Design of Novel β-Carboline Derivatives with Pendant 5-Bromothienyl and Their Evaluation as Phosphodiesterase-5 Inhibitors</span></div><div class="casAuthors">El-Gamil, Dalia S.; Ahmed, Nermin S.; Gary, Bernard D.; Piazza, Gary A.; Engel, Matthias; Hartmann, Rolf W.; Abadi, Ashraf H.</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">346</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">23-33</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">New derivs. with the tetrahydro-β-carboline-imidazolidinedione and tetrahydro-β-carboline-piperazinedione scaffolds and a pendant bromothienyl moiety at C-5/C-6 were synthesized and tested for their ability to inhibit PDE5 in vitro.  The following SAR can be concluded: The tetracyclic scaffold is essential for PDE5 inhibition; the Et group is the most suitable among the adopted N-substituents on the terminal ring (hydantoin/piperazinedione); the appropriate stereochem. of C-5/C-6 derived from the aldehyde rather than C-11a/C-12a derived from tryptophan appears crucial for inhibition of PDE5; surprisingly, derivs. with the hydantoin terminal ring are more active than their analogs with the piperazinedione ring; the selectivity vs. PDE5 relative to PDE11 with cGMP as a substrate is mainly a function of the substitution and stereochem. pattern of the external ring, in other words of the interaction with the H-loop residues of the isoenzymes.  Thirteen derivs. showed PDE5 inhibitory activity with IC50 values in the range of 0.16-5.4 μm.  Compd. 8 was the most potent PDE5 inhibitor and showed selectivity towards PDE5 vs. other PDEs, with a selectivity index of 49 towards PDE5 rather than PDE11 with cGMP as the substrate.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2FTFCI7wG-7Vg90H21EOLACvtfcHk0lip0iulQTKgAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXmsl2rsQ%253D%253D&md5=2d789b55b501b02417abc49fc3bfc230</span></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1002%2Fardp.201200334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201200334%26sid%3Dliteratum%253Aachs%26aulast%3DEl-Gamil%26aufirst%3DD.%2BS.%26aulast%3DAhmed%26aufirst%3DN.%2BS.%26aulast%3DGary%26aufirst%3DB.%2BD.%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DEngel%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DR.%2BW.%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26atitle%3DDesign%2520of%2520novel%2520%25CE%25B2-carboline%2520derivatives%2520with%2520pendant%25205-bromothienyl%2520and%2520their%2520evaluation%2520as%2520phosphodiesterase-5%2520inhibitors%26jtitle%3DArch.%2520Pharm.%26date%3D2013%26volume%3D346%26spage%3D23%26epage%3D33%26doi%3D10.1002%2Fardp.201200334" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macielag, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraft, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhattacharjee, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">John, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haynes-Johnson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clancy, J.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological activities of novel β-carbolines as PDE5 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">761</span>– <span class="NLM_lpage">765</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)01036-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2FS0960-894X%2802%2901036-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=12639576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhvV2gt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=761-765&author=Z.+Suiauthor=J.+Guanauthor=M.+J.+Macielagauthor=W.+Jiangauthor=Y.+Qiuauthor=P.+Kraftauthor=S.+Bhattacharjeeauthor=T.+M.+Johnauthor=E.+Craigauthor=D.+Haynes-Johnsonauthor=J.+Clancy&title=Synthesis+and+biological+activities+of+novel+%CE%B2-carbolines+as+PDE5+inhibitors&doi=10.1016%2FS0960-894X%2802%2901036-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and biological activities of novel β-Carbolines as PDE5 inhibitors</span></div><div class="casAuthors">Sui, Zhihua; Guan, Jihua; Macielag, Mark J.; Jiang, Weiqin; Qiu, Yuhong; Kraft, Patricia; Bhattacharjee, Sheela; John, T. Matthew; Craig, Elizabeth; Haynes-Johnson, Donna; Clancy, Joanna</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">761-765</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A series of N2-furoyl and N2-pyrimidinyl β-carbolines, e.g. I and II, was discovered to possess potent inhibitory activity against PDE5.  During the synthesis we developed a tandem resin quenching protocol, which allowed us to synthesize large no. of target compds. in a rapid fashion.  Representative compds. exhibit superior selectivity to sildenafil vs. other isoenzymes of PDEs, and demonstrated in vivo efficacy in increasing introcavernosal pressure in dogs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpeCeaV7QFPb7Vg90H21EOLACvtfcHk0lip0iulQTKgAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhvV2gt7g%253D&md5=fda05e2076c5d21ed1e47308eef9be33</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2901036-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252901036-3%26sid%3Dliteratum%253Aachs%26aulast%3DSui%26aufirst%3DZ.%26aulast%3DGuan%26aufirst%3DJ.%26aulast%3DMacielag%26aufirst%3DM.%2BJ.%26aulast%3DJiang%26aufirst%3DW.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DKraft%26aufirst%3DP.%26aulast%3DBhattacharjee%26aufirst%3DS.%26aulast%3DJohn%26aufirst%3DT.%2BM.%26aulast%3DCraig%26aufirst%3DE.%26aulast%3DHaynes-Johnson%26aufirst%3DD.%26aulast%3DClancy%26aufirst%3DJ.%26atitle%3DSynthesis%2520and%2520biological%2520activities%2520of%2520novel%2520%25CE%25B2-carbolines%2520as%2520PDE5%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D761%26epage%3D765%26doi%3D10.1016%2FS0960-894X%2802%2901036-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, G.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.-F.</span></span> <span> </span><span class="NLM_article-title">Novel PDE5 inhibitors derived from rutaecarpine for the treatment of Alzheimer’s disease</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">127097</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2020.127097</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmcl.2020.127097" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=32171616" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkvFyltL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2020&pages=127097&author=X.-F.+Huangauthor=Y.-H.+Dongauthor=J.-H.+Wangauthor=H.-M.+Keauthor=G.-Q.+Songauthor=D.-F.+Xu&title=Novel+PDE5+inhibitors+derived+from+rutaecarpine+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmcl.2020.127097"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Novel PDE5 inhibitors derived from rutaecarpine for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Huang, Xian-Feng; Dong, Yan-Hua; Wang, Jin-Hui; Ke, Heng-Ming; Song, Guo-Qiang; Xu, De-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">127097</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of novel rutaecarpine derivs. I [R1, R2 = H, OMe, OH, R3 = H, Et, n-Pr, (CH2)2CHMe2] were synthesized and subjected to pharmacol. evaluation as PDE5 inhibitors.  The structure-activity relationships were discussed and their binding conformation and simultaneous interaction mode were further clarified by the mol. docking studies.  Among the 25 analogs, compd. I [R1 = R2 = OH, R3 = (CH2)2CHMe2] exhibited the most potent PDE5 inhibition with IC50 values around 0.086μM.  Moreover, it also produced good effects against scopolamine-induced cognitive impairment in vivo.  These results might bring significant instruction for further development of potential PDE5 inhibitors derived from rutaecarpine as a good candidate drug for the treatment of Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_VbrWwSrdVrVg90H21EOLACvtfcHk0lhEBSGbZSV91Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkvFyltL8%253D&md5=7fd028cbbce5a8956164b2075d388c3c</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2020.127097&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2020.127097%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.-F.%26aulast%3DDong%26aufirst%3DY.-H.%26aulast%3DWang%26aufirst%3DJ.-H.%26aulast%3DKe%26aufirst%3DH.-M.%26aulast%3DSong%26aufirst%3DG.-Q.%26aulast%3DXu%26aufirst%3DD.-F.%26atitle%3DNovel%2520PDE5%2520inhibitors%2520derived%2520from%2520rutaecarpine%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D30%26spage%3D127097%26doi%3D10.1016%2Fj.bmcl.2020.127097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daugan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grondin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Monnier de Gouville, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coste, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirilovsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyafil, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaudinière, R.</span></span> <span> </span><span class="NLM_article-title">The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 1:5,6,11,11a-tetrahydro-1H-imidazo[1’,5′:1,6]pyrido[3,4-b]indole-1,3(2H)-dione analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4525</span>– <span class="NLM_lpage">4532</span>, <span class="refDoi"> DOI: 10.1021/jm030056e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm030056e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVCju78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4525-4532&author=A.+Dauganauthor=P.+Grondinauthor=C.+Ruaultauthor=A.-C.+Le+Monnier+de+Gouvilleauthor=H.+Costeauthor=J.+Kirilovskyauthor=F.+Hyafilauthor=R.+Labaudini%C3%A8re&title=The+discovery+of+tadalafil%3A+a+novel+and+highly+selective+PDE5+inhibitor.+1%3A5%2C6%2C11%2C11a-tetrahydro-1H-imidazo%5B1%E2%80%99%2C5%E2%80%B2%3A1%2C6%5Dpyrido%5B3%2C4-b%5Dindole-1%2C3%282H%29-dione+analogues&doi=10.1021%2Fjm030056e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 1: 5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido[3,4-b]indole-1,3(2H)-dione analogues</span></div><div class="casAuthors">Daugan, Alain; Grondin, Pascal; Ruault, Cecile; Le Monnier de Gouville, Anne-Charlotte; Coste, Herve; Kirilovsky, Jorge; Hyafil, Francois; Labaudiniere, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4525-4532</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Starting from Et β-carboline-3-carboxylate (β-CCE), 1, a modest inhibitor of type 5 phosphodiesterase (PDE5), a series of functionalized tetrahydro-β-carboline derivs. has been identified as a novel chem. class of potent and selective PDE5 inhibitors.  Optimization of the side chain on the hydantoin ring of initial lead compd. 2 and of the arom. ring on position 5 led to the identification of compd. 6e, a highly potent and selective PDE5 inhibitor, with greater selectivity for PDE5 vs. PDE1-4 than sildenafil.  Compd. 6e demonstrated a long lasting and significant blood pressure lowering effect after iv administration in the spontaneously hypertensive rat model but showed only moderate oral in vivo efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF0Ynxcj9_8rVg90H21EOLACvtfcHk0lhEBSGbZSV91Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVCju78%253D&md5=7c3b9aaf206cb18faaafc398c304357c</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1021%2Fjm030056e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030056e%26sid%3Dliteratum%253Aachs%26aulast%3DDaugan%26aufirst%3DA.%26aulast%3DGrondin%26aufirst%3DP.%26aulast%3DRuault%26aufirst%3DC.%26aulast%3DLe%2BMonnier%2Bde%2BGouville%26aufirst%3DA.-C.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DHyafil%26aufirst%3DF.%26aulast%3DLabaudini%25C3%25A8re%26aufirst%3DR.%26atitle%3DThe%2520discovery%2520of%2520tadalafil%253A%2520a%2520novel%2520and%2520highly%2520selective%2520PDE5%2520inhibitor.%25201%253A5%252C6%252C11%252C11a-tetrahydro-1H-imidazo%255B1%25E2%2580%2599%252C5%25E2%2580%25B2%253A1%252C6%255Dpyrido%255B3%252C4-b%255Dindole-1%252C3%25282H%2529-dione%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4525%26epage%3D4532%26doi%3D10.1021%2Fjm030056e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">El-Nashar, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gary, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fajardo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tinsley, H. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span> <span> </span><span class="NLM_article-title">Exploring the PDE5 H-pocket by ensemble docking and structure-based design and synthesis of novel β-carboline derivatives</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">343</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2012.09.029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2012.09.029" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=23117589" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsleisLjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2012&pages=329-343&author=N.+S.+Ahmedauthor=A.+H.+Aliauthor=S.+M.+El-Nasharauthor=B.+D.+Garyauthor=A.+M.+Fajardoauthor=H.+N.+Tinsleyauthor=G.+A.+Piazzaauthor=M.+Negriauthor=A.+H.+Abadi&title=Exploring+the+PDE5+H-pocket+by+ensemble+docking+and+structure-based+design+and+synthesis+of+novel+%CE%B2-carboline+derivatives&doi=10.1016%2Fj.ejmech.2012.09.029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Exploring the PDE5 H-pocket by ensemble docking and structure-based design and synthesis of novel β-carboline derivatives</span></div><div class="casAuthors">Ahmed, Nermin S.; Ali, Amal H.; El-Nashar, Shreen M.; Gary, Bernard D.; Fajardo, Alexandra M.; Tinsley, Heather N.; Piazza, Gary A.; Negri, Matthias; Abadi, Ashraf H.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">329-343</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">By studying the co-crystal information of interactions between PDE5 and its inhibitors, forty new tetrahydro-β-carbolines based-analogs e. g., I, II were synthesized, and tested for their PDE5 inhibition.  Some compds. were as active as tadalafil in inhibiting PDE5 and of better selectivity profile particularly vs. PDE11A, the nature of the terminal ring and its nitrogen substituent are the main determinants of selectivity.  Ensemble docking confirmed the role of H-loop closed conformer in activity vs. its occluded and open forms.  Conformational studies showed the effect of bulkiness of the terminal ring N-alkyl substituent on the formation of stable enzyme ligands conformers.  The difference in potencies of hydantoin and piperazinedione analogs, together with the necessity of C-5/C-6 R-abs. configuration has been revealed through mol. docking.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo6PsCyIZH-uLVg90H21EOLACvtfcHk0lh8vg55cadvcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsleisLjJ&md5=502b1e56712d787442627c8acb27d82d</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2012.09.029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2012.09.029%26sid%3Dliteratum%253Aachs%26aulast%3DAhmed%26aufirst%3DN.%2BS.%26aulast%3DAli%26aufirst%3DA.%2BH.%26aulast%3DEl-Nashar%26aufirst%3DS.%2BM.%26aulast%3DGary%26aufirst%3DB.%2BD.%26aulast%3DFajardo%26aufirst%3DA.%2BM.%26aulast%3DTinsley%26aufirst%3DH.%2BN.%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DNegri%26aufirst%3DM.%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26atitle%3DExploring%2520the%2520PDE5%2520H-pocket%2520by%2520ensemble%2520docking%2520and%2520structure-based%2520design%2520and%2520synthesis%2520of%2520novel%2520%25CE%25B2-carboline%2520derivatives%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2012%26volume%3D57%26spage%3D329%26epage%3D343%26doi%3D10.1016%2Fj.ejmech.2012.09.029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Daugan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grondin, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruault, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Monnier
de Gouville, A.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coste, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linget, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirilovsky, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyafil, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaudinière, R.</span></span> <span> </span><span class="NLM_article-title">The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 2:2,3,6,7,12,12a-hexahydropyrazino[1’,2’:1,6]pyrido[3,4-b]indole-1,4-dione analogues</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">4533</span>– <span class="NLM_lpage">4542</span>, <span class="refDoi"> DOI: 10.1021/jm0300577</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0300577" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3sXnvVCisrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=4533-4542&author=A.+Dauganauthor=P.+Grondinauthor=C.+Ruaultauthor=A.-C.+Le+Monnier%0Ade+Gouvilleauthor=H.+Costeauthor=J.-M.+Lingetauthor=J.+Kirilovskyauthor=F.+Hyafilauthor=R.+Labaudini%C3%A8re&title=The+discovery+of+tadalafil%3A+a+novel+and+highly+selective+PDE5+inhibitor.+2%3A2%2C3%2C6%2C7%2C12%2C12a-hexahydropyrazino%5B1%E2%80%99%2C2%E2%80%99%3A1%2C6%5Dpyrido%5B3%2C4-b%5Dindole-1%2C4-dione+analogues&doi=10.1021%2Fjm0300577"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione analogue</span></div><div class="casAuthors">Daugan, Alain; Grondin, Pascal; Ruault, Cecile; Le Monnier de Gouville, Anne-Charlotte; Coste, Herve; Linget, Jean Michel; Kirilovsky, Jorge; Hyafil, Francois; Labaudiniere, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4533-4542</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Modification of the hydantoin ring in the previously described lead compd. 2a has led to the discovery of compd. 12a, tadalafil, a highly potent and highly selective PDE5 inhibitor.  The replacement of the hydantoin in compd. 2a by a piperazinedione ring led to compd. cis-11a which showed similar PDE5 inhibitory potency.  Introduction of a 3,4-methylenedioxy substitution on the Ph ring in position 6 led to a potent PDE5 inhibitor cis-11c with increased cellular potency.  Optimization of the chain on the piperazinedione ring led to the identification of the racemic cis-N-Me deriv. 11i.  High diastereospecificity for PDE5 inhibition was obsd. in the piperazinedione series with the cis-(6R,12aR) enantiomer displaying the highest PDE5 inhibitory activity.  The piperazinedione 12a, tadalafil (GF196960), has been identified as a highly potent PDE5 inhibitor (IC50 = 5 nM) with high selectivity for PDE5 vs. PDE1-4 and PDE6.  Compd. 12a displays 85-fold greater selectivity vs. PDE6 than sildenafil 1.  12A showed profound and long-lasting blood pressure lowering activity (30 mmHg/>7 h) in the spontaneously hypertensive rat model after oral administration (5 mg/kg).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGcrjCLR1ZLrVg90H21EOLACvtfcHk0lgrMzIm_bkKsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXnvVCisrs%253D&md5=daaf79b5155dcea5b8c258fe7b05f436</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1021%2Fjm0300577&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0300577%26sid%3Dliteratum%253Aachs%26aulast%3DDaugan%26aufirst%3DA.%26aulast%3DGrondin%26aufirst%3DP.%26aulast%3DRuault%26aufirst%3DC.%26aulast%3DLe%2BMonnier%2Bde%2BGouville%26aufirst%3DA.-C.%26aulast%3DCoste%26aufirst%3DH.%26aulast%3DLinget%26aufirst%3DJ.-M.%26aulast%3DKirilovsky%26aufirst%3DJ.%26aulast%3DHyafil%26aufirst%3DF.%26aulast%3DLabaudini%25C3%25A8re%26aufirst%3DR.%26atitle%3DThe%2520discovery%2520of%2520tadalafil%253A%2520a%2520novel%2520and%2520highly%2520selective%2520PDE5%2520inhibitor.%25202%253A2%252C3%252C6%252C7%252C12%252C12a-hexahydropyrazino%255B1%25E2%2580%2599%252C2%25E2%2580%2599%253A1%252C6%255Dpyrido%255B3%252C4-b%255Dindole-1%252C4-dione%2520analogues%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D4533%26epage%3D4542%26doi%3D10.1021%2Fjm0300577" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sung, B.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, K. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeon, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heo, Y.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyun, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eum, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.-O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, J. M.</span></span> <span> </span><span class="NLM_article-title">Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>425</i></span>,  <span class="NLM_fpage">98</span>– <span class="NLM_lpage">102</span>, <span class="refDoi"> DOI: 10.1038/nature01914</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1038%2Fnature01914" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=12955149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFansrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=425&publication_year=2003&pages=98-102&author=B.-J.+Sungauthor=K.+Y.+Hwangauthor=Y.+H.+Jeonauthor=J.+I.+Leeauthor=Y.-S.+Heoauthor=J.+H.+Kimauthor=J.+Moonauthor=J.+M.+Yoonauthor=Y.-L.+Hyunauthor=E.+Kimauthor=S.+J.+Eumauthor=S.-Y.+Parkauthor=J.-O.+Leeauthor=T.+G.+Leeauthor=S.+Roauthor=J.+M.+Cho&title=Structure+of+the+catalytic+domain+of+human+phosphodiesterase+5+with+bound+drug+molecules&doi=10.1038%2Fnature01914"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Structure of the catalytic domain of human phosphodiesterase 5 with bound drug molecules</span></div><div class="casAuthors">Sung, Byung-Je; Hwang, Kwang Yeon; Jeon, Young Ho; Lee, Jae Il; Heo, Yong-Seok; Kim, Jin Hwan; Moon, Jinho; Yoon, Jung Min; Hyun, Young-Lan; Kim, Eunmi; Eum, Sung Jin; Park, Sam-Yong; Lee, Jie-Oh; Lee, Tae Gyu; Ro, Seonggu; Cho, Joong Myung</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">425</span>
        (<span class="NLM_cas:issue">6953</span>),
    <span class="NLM_cas:pages">98-102</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) are a superfamily of enzymes that degrade the intracellular second messengers cAMP and cGMP.  As essential regulators of cyclic nucleotide signaling with diverse physiol. functions, PDEs are drug targets for the treatment of various diseases, including heart failure, depression, asthma, inflammation and erectile dysfunction.  Of the 12 PDE gene families, cGMP-specific PDE5 carries out the principal cGMP-hydrolyzing activity in human corpus cavernosum tissue.  It is well known as the target of sildenafil citrate (Viagra) and other similar drugs for the treatment of erectile dysfunction.  Despite the pressing need to develop selective PDE inhibitors as therapeutic drugs, only the cAMP-specific PDE4 structures are currently available.  Here we present the three-dimensional structures of the catalytic domain (residues 537-860) of human PDE5 complexed with the three drug mols. sildenafil, tadalafil (Cialis) and vardenafil (Levitra).  These structures will provide opportunities to design potent and selective PDE inhibitors with improved pharmacol. profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr5pTrMfa72rVg90H21EOLACvtfcHk0lgrMzIm_bkKsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFansrg%253D&md5=8459333ee12ed3469f7b48d6e7f9fd5d</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1038%2Fnature01914&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature01914%26sid%3Dliteratum%253Aachs%26aulast%3DSung%26aufirst%3DB.-J.%26aulast%3DHwang%26aufirst%3DK.%2BY.%26aulast%3DJeon%26aufirst%3DY.%2BH.%26aulast%3DLee%26aufirst%3DJ.%2BI.%26aulast%3DHeo%26aufirst%3DY.-S.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DMoon%26aufirst%3DJ.%26aulast%3DYoon%26aufirst%3DJ.%2BM.%26aulast%3DHyun%26aufirst%3DY.-L.%26aulast%3DKim%26aufirst%3DE.%26aulast%3DEum%26aufirst%3DS.%2BJ.%26aulast%3DPark%26aufirst%3DS.-Y.%26aulast%3DLee%26aufirst%3DJ.-O.%26aulast%3DLee%26aufirst%3DT.%2BG.%26aulast%3DRo%26aufirst%3DS.%26aulast%3DCho%26aufirst%3DJ.%2BM.%26atitle%3DStructure%2520of%2520the%2520catalytic%2520domain%2520of%2520human%2520phosphodiesterase%25205%2520with%2520bound%2520drug%2520molecules%26jtitle%3DNature%26date%3D2003%26volume%3D425%26spage%3D98%26epage%3D102%26doi%3D10.1038%2Fnature01914" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Card, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">England, B. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fong, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Powell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizizad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gillette, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, P. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artis, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollag, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Milburn, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schlessinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, K. Y. J.</span></span> <span> </span><span class="NLM_article-title">Structural basis for the activity of drugs that inhibits phosphodiesterases</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2233</span>– <span class="NLM_lpage">2247</span>, <span class="refDoi"> DOI: 10.1016/j.str.2004.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.str.2004.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=15576036" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVClur3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=2233-2247&author=G.+L.+Cardauthor=B.+P.+Englandauthor=Y.+Suzukiauthor=D.+Fongauthor=B.+Powellauthor=B.+Leeauthor=C.+Luuauthor=M.+Tabrizizadauthor=S.+Gilletteauthor=P.+N.+Ibrahimauthor=D.+R.+Artisauthor=G.+Bollagauthor=M.+V.+Milburnauthor=S.-H.+Kimauthor=J.+Schlessingerauthor=K.+Y.+J.+Zhang&title=Structural+basis+for+the+activity+of+drugs+that+inhibits+phosphodiesterases&doi=10.1016%2Fj.str.2004.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Basis for the Activity of Drugs that Inhibit Phosphodiesterases</span></div><div class="casAuthors">Card, Graeme L.; England, Bruce P.; Suzuki, Yoshihisa; Fong, Daniel; Powell, Ben; Lee, Byunghun; Luu, Catherine; Tabrizizad, Maryam; Gillette, Sam; Ibrahim, Prabha N.; Artis, Dean R.; Bollag, Gideon; Milburn, Michael V.; Kim, Sung-Hou; Schlessinger, Joseph; Zhang, Kam Y. J.</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2233-2247</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) comprise a large family of enzymes that catalyze the hydrolysis of cAMP or cGMP and are implicated in various diseases.  The authors describe the high-resoln. crystal structures of the catalytic domains of PDE4B, PDE4D, and PDE5A with ten different inhibitors, including the drug candidates cilomilast and roflumilast, for respiratory diseases.  These cocrystal structures reveal a common scheme of inhibitor binding to the PDEs: (i) a hydrophobic clamp formed by highly conserved hydrophobic residues that sandwich the inhibitor in the active site; (ii) hydrogen bonding to an invariant glutamine that controls the orientation of inhibitor binding.  A scaffold can be readily identified for any given inhibitor based on the formation of these two types of conserved interactions.  These structural insights will enable the design of isoform-selective inhibitors with improved binding affinity and should facilitate the discovery of more potent and selective PDE inhibitors for the treatment of a variety of diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8l4KWCohSy7Vg90H21EOLACvtfcHk0lgrMzIm_bkKsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVClur3K&md5=0fa91e4b9047e3df3946c526592be396</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2004.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2004.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DCard%26aufirst%3DG.%2BL.%26aulast%3DEngland%26aufirst%3DB.%2BP.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DFong%26aufirst%3DD.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DLee%26aufirst%3DB.%26aulast%3DLuu%26aufirst%3DC.%26aulast%3DTabrizizad%26aufirst%3DM.%26aulast%3DGillette%26aufirst%3DS.%26aulast%3DIbrahim%26aufirst%3DP.%2BN.%26aulast%3DArtis%26aufirst%3DD.%2BR.%26aulast%3DBollag%26aufirst%3DG.%26aulast%3DMilburn%26aufirst%3DM.%2BV.%26aulast%3DKim%26aufirst%3DS.-H.%26aulast%3DSchlessinger%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DK.%2BY.%2BJ.%26atitle%3DStructural%2520basis%2520for%2520the%2520activity%2520of%2520drugs%2520that%2520inhibits%2520phosphodiesterases%26jtitle%3DStructure%26date%3D2004%26volume%3D12%26spage%3D2233%26epage%3D2247%26doi%3D10.1016%2Fj.str.2004.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Felding, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorensen, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Refer, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engell, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ladefoged, L. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thormann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinggaard, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegardt, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sohoel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, S. F.</span></span> <span> </span><span class="NLM_article-title">Discovery and early clinical development of 2-{6-[2-(3,5-Dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a soft-drug inhibitor of phosphodiesterase 4 for topical treatment of atopic dermatitis</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">5893</span>– <span class="NLM_lpage">5903</span>, <span class="refDoi"> DOI: 10.1021/jm500378a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm500378a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtV2jsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=5893-5903&author=J.+Feldingauthor=M.+D.+Sorensenauthor=T.+D.+Poulsenauthor=J.+Larsenauthor=C.+Anderssonauthor=P.+Referauthor=K.+Engellauthor=L.+G.+Ladefogedauthor=T.+Thormannauthor=A.+M.+Vinggaardauthor=P.+Hegardtauthor=A.+Sohoelauthor=S.+F.+Nielsen&title=Discovery+and+early+clinical+development+of+2-%7B6-%5B2-%283%2C5-Dichloro-4-pyridyl%29acetyl%5D-2%2C3-dimethoxyphenoxy%7D-N-propylacetamide+%28LEO+29102%29%2C+a+soft-drug+inhibitor+of+phosphodiesterase+4+for+topical+treatment+of+atopic+dermatitis&doi=10.1021%2Fjm500378a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Early Clinical Development of 2-{6-[2-(3,5-Dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a Soft-Drug Inhibitor of Phosphodiesterase 4 for Topical Treatment of Atopic Dermatitis</span></div><div class="casAuthors">Felding, Jakob; Soerensen, Morten D.; Poulsen, Tina D.; Larsen, Jens; Andersson, Christina; Refer, Pia; Engell, Karen; Ladefoged, Lotte G.; Thormann, Thorsten; Vinggaard, Anne Marie; Hegardt, Pontus; Soehoel, Anders; Nielsen, Simon Feldbaek</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">5893-5903</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Development of orally available phosphodiesterase 4 (PDE4) inhibitors as anti-inflammatory drugs has been going on for decades.  However, only roflumilast has received FDA approval.  One key challenge has been the low therapeutic window obsd. in the clinic for PDE4 inhibitors, primarily due to PDE4 mediated side effects.  Here we describe our approach to circumvent this issue by applying a soft-drug concept in the design of a topically acting PDE4 inhibitor for treatment of dermatol. diseases.  We used a fast follower approach, starting from piclamilast.  In particular, simultaneous introduction of 2'-alkoxy substituents and changing an amide to a keto linker proved to be beneficial when designing potential soft-drug candidates.  This effort culminated in identification of LEO 29102 (20), a potent, selective, and soft-drug PDE4 inhibitor with properties suitable for patient-friendly formulations giving efficient drug delivery to the skin.  Compd. 20 has reached phase 2 and demonstrated clin. relevant efficacy in the treatment of atopic dermatitis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq6hRC8lktjRrVg90H21EOLACvtfcHk0lh5_7Z1K57d3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtV2jsrfF&md5=9d236da8f314edec69f5b442e1a41141</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1021%2Fjm500378a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm500378a%26sid%3Dliteratum%253Aachs%26aulast%3DFelding%26aufirst%3DJ.%26aulast%3DSorensen%26aufirst%3DM.%2BD.%26aulast%3DPoulsen%26aufirst%3DT.%2BD.%26aulast%3DLarsen%26aufirst%3DJ.%26aulast%3DAndersson%26aufirst%3DC.%26aulast%3DRefer%26aufirst%3DP.%26aulast%3DEngell%26aufirst%3DK.%26aulast%3DLadefoged%26aufirst%3DL.%2BG.%26aulast%3DThormann%26aufirst%3DT.%26aulast%3DVinggaard%26aufirst%3DA.%2BM.%26aulast%3DHegardt%26aufirst%3DP.%26aulast%3DSohoel%26aufirst%3DA.%26aulast%3DNielsen%26aufirst%3DS.%2BF.%26atitle%3DDiscovery%2520and%2520early%2520clinical%2520development%2520of%25202-%257B6-%255B2-%25283%252C5-Dichloro-4-pyridyl%2529acetyl%255D-2%252C3-dimethoxyphenoxy%257D-N-propylacetamide%2520%2528LEO%252029102%2529%252C%2520a%2520soft-drug%2520inhibitor%2520of%2520phosphodiesterase%25204%2520for%2520topical%2520treatment%2520of%2520atopic%2520dermatitis%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D5893%26epage%3D5903%26doi%3D10.1021%2Fjm500378a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beghyn, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hounsou, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez, B. P.</span></span> <span> </span><span class="NLM_article-title">PDE5 inhibitors: an original access to novel potent arylated analogues of tadalafil</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">789</span>– <span class="NLM_lpage">792</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2006.10.069</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmcl.2006.10.069" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=17107795" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotFalsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=789-792&author=T.+Beghynauthor=C.+Hounsouauthor=B.+P.+Deprez&title=PDE5+inhibitors%3A+an+original+access+to+novel+potent+arylated+analogues+of+tadalafil&doi=10.1016%2Fj.bmcl.2006.10.069"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">PDE5 inhibitors: An original access to novel potent arylated analogues of tadalafil</span></div><div class="casAuthors">Beghyn, Terence; Hounsou, Candide; Deprez, Benoit P.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">789-792</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A method to access totally new analogs of tadalafil, e.g., I, was explored.  The Buchwald reaction was adapted and used to replace the Me group of tadalafil by various aryl groups.  Inhibition potencies on PDE5 of these analogs were detd. and proved to be comparable to the one of tadalafil.  Using the same route, compds. with the same level of activity but improved water soly. were produced by introducing a pyridine or a pyrimidine ring.  This original route also opens access to new unpatented compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHEuLfICWSTrVg90H21EOLACvtfcHk0lh5_7Z1K57d3A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotFalsA%253D%253D&md5=f9159ca13ab26c3d4c75cb7924bd293a</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2006.10.069&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2006.10.069%26sid%3Dliteratum%253Aachs%26aulast%3DBeghyn%26aufirst%3DT.%26aulast%3DHounsou%26aufirst%3DC.%26aulast%3DDeprez%26aufirst%3DB.%2BP.%26atitle%3DPDE5%2520inhibitors%253A%2520an%2520original%2520access%2520to%2520novel%2520potent%2520arylated%2520analogues%2520of%2520tadalafil%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D789%26epage%3D792%26doi%3D10.1016%2Fj.bmcl.2006.10.069" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maw, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allerton, C. M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gbekor, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Million, W. A.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological activity of β-carboline-based type-5 phosphodiesterase inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">1425</span>– <span class="NLM_lpage">1428</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(03)00159-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2FS0960-894X%2803%2900159-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=12668004" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3sXis1aqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=1425-1428&author=G.+N.+Mawauthor=C.+M.+N.+Allertonauthor=E.+Gbekorauthor=W.+A.+Million&title=Design%2C+synthesis+and+biological+activity+of+%CE%B2-carboline-based+type-5+phosphodiesterase+inhibitors&doi=10.1016%2FS0960-894X%2803%2900159-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological activity of β-carboline-based type-5 phosphodiesterase inhibitors</span></div><div class="casAuthors">Maw, Graham N.; Allerton, Charlotte M. N.; Gbekor, Eugene; Million, William A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1425-1428</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">The SAR of a series of β-carboline derived type 5 phosphodiesterase inhibitors has been explored and we have discovered compds. with excellent levels of PDE5 potency and selectivity over PDE6.  However, the series exhibits low levels of selectivity over PDE11, a phosphodiesterase with unknown function.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_rN-WnGiu37Vg90H21EOLACvtfcHk0lhrsjAHVQklXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXis1aqtrY%253D&md5=07f48da05629e870a75dd17f7c4922d1</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900159-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900159-8%26sid%3Dliteratum%253Aachs%26aulast%3DMaw%26aufirst%3DG.%2BN.%26aulast%3DAllerton%26aufirst%3DC.%2BM.%2BN.%26aulast%3DGbekor%26aufirst%3DE.%26aulast%3DMillion%26aufirst%3DW.%2BA.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520activity%2520of%2520%25CE%25B2-carboline-based%2520type-5%2520phosphodiesterase%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D1425%26epage%3D1428%26doi%3D10.1016%2FS0960-894X%2803%2900159-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elhady, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigler, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noureldin, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canzoneri, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span> <span> </span><span class="NLM_article-title">Structure-based design of novel tetrahydro-beta-carboline derivatives with a hydrophilic side chain as potential phosphodiesterase inhibitors</span>. <i>Sci. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>84</i></span>,  <span class="NLM_fpage">428</span>– <span class="NLM_lpage">446</span>, <span class="refDoi"> DOI: 10.3390/scipharm84030428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3390%2Fscipharm84030428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktl2msb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=84&publication_year=2016&pages=428-446&author=A.+K.+Elhadyauthor=S.+C.+Siglerauthor=N.+Noureldinauthor=J.+C.+Canzoneriauthor=N.+S.+Ahmedauthor=G.+A.+Piazzaauthor=A.+H.+Abadi&title=Structure-based+design+of+novel+tetrahydro-beta-carboline+derivatives+with+a+hydrophilic+side+chain+as+potential+phosphodiesterase+inhibitors&doi=10.3390%2Fscipharm84030428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based design of novel tetrahydro-beta-carboline derivatives with a hydrophilic side chain as potential phosphodiesterase inhibitors</span></div><div class="casAuthors">Elhady, Ahmed K.; Sigler, Sara C.; Noureldin, Nazih; Canzoneri, Joshua C.; Ahmed, Nermin S.; Piazza, Gary A.; Abadi, Ashraf H.</div><div class="citationInfo"><span class="NLM_cas:title">Scientia Pharmaceutica</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">84</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">428-446</span>CODEN:
                <span class="NLM_cas:coden">SCPHA4</span>;
        ISSN:<span class="NLM_cas:issn">2218-0532</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Tadalafil is a clin. approved phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction and pulmonary arterial hypertension.  It contains two chiral carbons, and the marketed isomer is the 6R, 12aR isomer with a Me substituent on the terminal nitrogen of the piperazinedione ring.  In this report, tadalafil analogs with an extended hydrophilic side chain on the piperazine nitrogen were designed to interact with particular hydrophilic residues in the binding pocket.  This leads to analogs with moderate inhibitory activity on phosphodiesterase-5, even for isomers in which chiral carbons are of the S configuration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAE_r8VPylXLVg90H21EOLACvtfcHk0lhrsjAHVQklXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktl2msb4%253D&md5=b400fb905bae340f81149440dc0e9799</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.3390%2Fscipharm84030428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fscipharm84030428%26sid%3Dliteratum%253Aachs%26aulast%3DElhady%26aufirst%3DA.%2BK.%26aulast%3DSigler%26aufirst%3DS.%2BC.%26aulast%3DNoureldin%26aufirst%3DN.%26aulast%3DCanzoneri%26aufirst%3DJ.%2BC.%26aulast%3DAhmed%26aufirst%3DN.%2BS.%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26atitle%3DStructure-based%2520design%2520of%2520novel%2520tetrahydro-beta-carboline%2520derivatives%2520with%2520a%2520hydrophilic%2520side%2520chain%2520as%2520potential%2520phosphodiesterase%2520inhibitors%26jtitle%3DSci.%2520Pharm.%26date%3D2016%26volume%3D84%26spage%3D428%26epage%3D446%26doi%3D10.3390%2Fscipharm84030428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beghyn, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charton, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroux, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henninot, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reboule, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deprez, B.</span></span> <span> </span><span class="NLM_article-title">Drug-to-genome-to-drug, step 2: reversing selectivity in a series of antiplasmodial compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1274</span>– <span class="NLM_lpage">1286</span>, <span class="refDoi"> DOI: 10.1021/jm201422e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201422e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs12hsL3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=1274-1286&author=T.+B.+Beghynauthor=J.+Chartonauthor=F.+Lerouxauthor=A.+Henninotauthor=I.+Rebouleauthor=P.+Cosauthor=L.+Maesauthor=B.+Deprez&title=Drug-to-genome-to-drug%2C+step+2%3A+reversing+selectivity+in+a+series+of+antiplasmodial+compounds&doi=10.1021%2Fjm201422e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Drug-to-Genome-to-Drug, Step 2: Reversing Selectivity in a Series of Antiplasmodial Compounds</span></div><div class="casAuthors">Beghyn, Terence B.; Charton, Julie; Leroux, Florence; Henninot, Antoine; Reboule, Irena; Cos, Paul; Maes, Louis; Deprez, Benoit</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1274-1286</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In a recent paper, we have described the discovery of antimalarial compds. derived from tadalafil, using a drug-to-genome-to-drug approach (J. Med. CHem. 2011, 54 (9), pp 3222-3240).  We have shown that these derivs. inhibit the phosphodiesterase activity of Plasmodium falciparum and the parasite growth in culture.  In this paper, we describe the optimization of these compds.  A direct consequence of our approach based on gene orthol. is the lack of selectivity of the compds. over the original activity on the human target.  We demonstrate here that it is possible to take advantage of subtle differences in SAR between HsPDE5 inhibition and antiplasmodial activity to improve significantly the selectivity.  In particular, the replacement of the piperonyl group in compd. I by a dimethoxyphenyl group was the best way to optimize selectivity.  This observation is consistent with the differences between human and plasmodial sequences in the Q2 pocket receiving this group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGudK7UKU_qbVg90H21EOLACvtfcHk0lhrsjAHVQklXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs12hsL3P&md5=4cafbcc78b39d613f9ef6192d93d04f8</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1021%2Fjm201422e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201422e%26sid%3Dliteratum%253Aachs%26aulast%3DBeghyn%26aufirst%3DT.%2BB.%26aulast%3DCharton%26aufirst%3DJ.%26aulast%3DLeroux%26aufirst%3DF.%26aulast%3DHenninot%26aufirst%3DA.%26aulast%3DReboule%26aufirst%3DI.%26aulast%3DCos%26aufirst%3DP.%26aulast%3DMaes%26aufirst%3DL.%26aulast%3DDeprez%26aufirst%3DB.%26atitle%3DDrug-to-genome-to-drug%252C%2520step%25202%253A%2520reversing%2520selectivity%2520in%2520a%2520series%2520of%2520antiplasmodial%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D1274%26epage%3D1286%26doi%3D10.1021%2Fjm201422e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tamiz, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whittemore, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woodward, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Upasani, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keana, J. F. W.</span></span> <span> </span><span class="NLM_article-title">Structure-activity relationship for a series of 2-substituted 1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indoles: potent subtype-selective inhibitors of N-methyl-D-aspartate (NMDA) receptors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1619</span>– <span class="NLM_lpage">1624</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(99)00248-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2FS0960-894X%2899%2900248-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10386947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK1MXjvVKisbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=1999&pages=1619-1624&author=A.+P.+Tamizauthor=E.+R.+Whittemoreauthor=R.+M.+Woodwardauthor=R.+B.+Upasaniauthor=J.+F.+W.+Keana&title=Structure-activity+relationship+for+a+series+of+2-substituted+1%2C2%2C3%2C4-tetrahydro-9H-pyrido%5B3%2C4-b%5Dindoles%3A+potent+subtype-selective+inhibitors+of+N-methyl-D-aspartate+%28NMDA%29+receptors&doi=10.1016%2FS0960-894X%2899%2900248-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship for a series of 2-substituted 1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indoles: potent subtype-selective inhibitors of N-methyl-D-aspartate (NMDA) receptors</span></div><div class="casAuthors">Tamiz, Amir P.; Whittemore, Edward R.; Woodward, Richard M.; Upasani, Ravindra B.; Keana, John F. W.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1619-1624</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A series of 2-substituted 1,2,3,4-tetrahydro-9H-pyrido[3,4-b]indoles was synthesized as potential antagonists for the NR1A/2B subtype of N-methyl-D-aspartate (NMDA) receptors.  Assayed by elec. recording under steady-state conditions, 7-hydroxy-2-(4-phenylbutyl)-1,2,3,4-tetrahydropyrido-[3,4-b]indole (30) was the most potent compd. in the series having an IC50 value of 50 nM at the NR1A/2B receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpia5hKHj6WWLVg90H21EOLACvtfcHk0ljaSYZik5Jj5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXjvVKisbo%253D&md5=51573f56e18805a8c19372ec1c331889</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2899%2900248-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252899%252900248-6%26sid%3Dliteratum%253Aachs%26aulast%3DTamiz%26aufirst%3DA.%2BP.%26aulast%3DWhittemore%26aufirst%3DE.%2BR.%26aulast%3DWoodward%26aufirst%3DR.%2BM.%26aulast%3DUpasani%26aufirst%3DR.%2BB.%26aulast%3DKeana%26aufirst%3DJ.%2BF.%2BW.%26atitle%3DStructure-activity%2520relationship%2520for%2520a%2520series%2520of%25202-substituted%25201%252C2%252C3%252C4-tetrahydro-9H-pyrido%255B3%252C4-b%255Dindoles%253A%2520potent%2520subtype-selective%2520inhibitors%2520of%2520N-methyl-D-aspartate%2520%2528NMDA%2529%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D1999%26volume%3D9%26spage%3D1619%26epage%3D1624%26doi%3D10.1016%2FS0960-894X%2899%2900248-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Espinoza-Moraga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caballero, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaube, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winckler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, L. S.</span></span> <span> </span><span class="NLM_article-title">1-Benzyl-1,2,3,4-tetrahydro-β-carboline as channel blocker of N-methyl-D-aspartate receptors</span>. <i>Chem. Biol. Drug Des.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">594</span>– <span class="NLM_lpage">599</span>, <span class="refDoi"> DOI: 10.1111/j.1747-0285.2012.01317.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1111%2Fj.1747-0285.2012.01317.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=22226015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XltVajs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2012&pages=594-599&author=M.+Espinoza-Moragaauthor=J.+Caballeroauthor=F.+Gaubeauthor=T.+Wincklerauthor=L.+S.+Santos&title=1-Benzyl-1%2C2%2C3%2C4-tetrahydro-%CE%B2-carboline+as+channel+blocker+of+N-methyl-D-aspartate+receptors&doi=10.1111%2Fj.1747-0285.2012.01317.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">1-benzyl-1,2,3,4-tetrahydro-β-carboline as channel blocker of N-methyl-D-aspartate receptors</span></div><div class="casAuthors">Espinoza-Moraga, Marlene; Caballero, Julio; Gaube, Friedemann; Winckler, Thomas; Santos, Leonardo S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Biology & Drug Design</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">594-599</span>CODEN:
                <span class="NLM_cas:coden">CBDDAL</span>;
        ISSN:<span class="NLM_cas:issn">1747-0277</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">N-methyl-D-aspartate (NMDA) receptors belong to the family of ligand-gated ion channels and are important for synaptic plasticity and memory function.  The NMDA receptor consists of a voltage-dependent channel permeable to Ca2+ and Na+.  In Alzheimer's disease, neuronal degeneration is thought to cause an excessive release of glutamate to the extracellular space, which may in turn mediate prolonged stimulation of the NMDA receptor complex and, as a consequence, excessive calcium influx into neuronal cells, leading to subsequent cell death.  This process is called glutamate-induced excitotoxicity, and its inhibition may present an effective antidementive therapy.  We found that 1-benzyl-1,2,3,4-tetrahydro-β-carboline (1a) blocked NMDA receptor-mediated, glutamate-induced excitotoxicity with an IC50 value of 27.4 μM, whereas the closely related 1-phenyl-1,2,3,4-tetrahydro-β-carboline (1b) had no effect.  The binding modes of the reported compds. were studied by in silico docking simulations.  We demonstrate that compds. (S)-1a and (R)-1a, but not (S)-1b and (R)-1b, have the same characteristics of potent NMDA receptor blockers, because they establish the main interactions inside the vestibule region of the receptor described previously for the high-affinity NMDA receptor blocker, MK-801.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpof6sldb57WrVg90H21EOLACvtfcHk0li5YWAehcLO3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XltVajs7g%253D&md5=693b4df86257261a85920cd1efb3eaa6</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1111%2Fj.1747-0285.2012.01317.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1747-0285.2012.01317.x%26sid%3Dliteratum%253Aachs%26aulast%3DEspinoza-Moraga%26aufirst%3DM.%26aulast%3DCaballero%26aufirst%3DJ.%26aulast%3DGaube%26aufirst%3DF.%26aulast%3DWinckler%26aufirst%3DT.%26aulast%3DSantos%26aufirst%3DL.%2BS.%26atitle%3D1-Benzyl-1%252C2%252C3%252C4-tetrahydro-%25CE%25B2-carboline%2520as%2520channel%2520blocker%2520of%2520N-methyl-D-aspartate%2520receptors%26jtitle%3DChem.%2520Biol.%2520Drug%2520Des.%26date%3D2012%26volume%3D79%26spage%3D594%26epage%3D599%26doi%3D10.1111%2Fj.1747-0285.2012.01317.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pereira, N. A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureda, F. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, M. M. M.</span></span> <span> </span><span class="NLM_article-title">Enantiopure indolo[2,3-a]quinolizidines: synthesis and evaluation as NMDA receptor antagonists</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">1027</span>– <span class="NLM_lpage">1038</span>, <span class="refDoi"> DOI: 10.3390/molecules21081027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3390%2Fmolecules21081027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVWktrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=1027-1038&author=N.+A.+L.+Pereiraauthor=F.+X.+Suredaauthor=M.+P%C3%A9rezauthor=M.+Amatauthor=M.+M.+M.+Santos&title=Enantiopure+indolo%5B2%2C3-a%5Dquinolizidines%3A+synthesis+and+evaluation+as+NMDA+receptor+antagonists&doi=10.3390%2Fmolecules21081027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Enantiopure indolo[2,3-a]quinolizidines: synthesis and evaluation as NMDA receptor antagonists</span></div><div class="casAuthors">Pereira, Nuno A. L.; Sureda, Francesc X.; Perez, Maria; Amat, Mercedes; Santos, Maria M. M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1027/1-1027/12</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">The development of a small library of indolo[2,3-a]quinolizidines and evaluation of their activity as N-Me D-Aspartate (NMDA) receptor antagonists was reported.  The indolo[2,3-a]quinolizidine scaffold was obtained using the following key steps: (i) a stereoselective cyclocondensation of (S)- or (R)-tryptophanol with appropriate racemic δ-oxoesters; (ii) a stereocontrolled cyclization on the indole nucleus.  The synthesized enantiopure indolo[2,3-a]quinolizidines were evaluated as NMDA receptor antagonists and one compd. was identified to be 2.9-fold more potent as NMDA receptor blocker than amantadine (used in the clinic for Parkinson's disease).  This compd. represented a hit compd. for the development of novel NMDA receptor antagonists with potential applications in neurodegenerative disorders assocd. with overactivation of NMDA receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHwN99YB2U0rVg90H21EOLACvtfcHk0li5YWAehcLO3g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVWktrnL&md5=86055090f84fd018b2d84a6be6cf99f4</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21081027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21081027%26sid%3Dliteratum%253Aachs%26aulast%3DPereira%26aufirst%3DN.%2BA.%2BL.%26aulast%3DSureda%26aufirst%3DF.%2BX.%26aulast%3DP%25C3%25A9rez%26aufirst%3DM.%26aulast%3DAmat%26aufirst%3DM.%26aulast%3DSantos%26aufirst%3DM.%2BM.%2BM.%26atitle%3DEnantiopure%2520indolo%255B2%252C3-a%255Dquinolizidines%253A%2520synthesis%2520and%2520evaluation%2520as%2520NMDA%2520receptor%2520antagonists%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D1027%26epage%3D1038%26doi%3D10.3390%2Fmolecules21081027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Neill, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Webber, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casadesus, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marlatt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raina, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perry, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, M. A.</span></span> <span> </span><span class="NLM_article-title">The role of metabotropic glutamate receptors in Alzheimer’s disease</span>. <i>Acta Neurobiol. Exp.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">98</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=15190683" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ptVGjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2004&pages=89-98&author=H.-G.+Leeauthor=X.+Zhuauthor=M.+J.+O%E2%80%99Neillauthor=K.+Webberauthor=G.+Casadesusauthor=M.+Marlattauthor=K.+R.+Rainaauthor=G.+Perryauthor=M.+A.+Smith&title=The+role+of+metabotropic+glutamate+receptors+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">The role of metabotropic glutamate receptors in Alzheimer's disease</span></div><div class="casAuthors">Lee Hyoung-gon; Zhu Xiongwei; O'Neill Michael J; Webber Kate; Casadesus Gemma; Marlatt Michael; Raina Arun K; Perry George; Smith Mark A</div><div class="citationInfo"><span class="NLM_cas:title">Acta neurobiologiae experimentalis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">64</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-98</span>
        ISSN:<span class="NLM_cas:issn">0065-1400</span>.
    </div><div class="casAbstract">While glutamatergic transmission is severely altered by early degeneration of cortico-cortical connections and hippocampal projections in Alzheimer's disease (AD), the role of glutamate receptors in the pathogenesis of AD is not yet defined clearly.  Nonetheless, as reviewed here, the topographical distribution of different types of receptors likely contributes to the regional selective nature of neuronal degeneration.  In particular, metabotropic glutamate receptors (mGluR) may contribute the pathogenesis of many neurological conditions and also regulate neuronal vulnerability against cytotoxic stress.  Thus, we here discuss the possible role of mGluR in the pathogenesis of AD based on the results from other neurodegenerative diseases that may give us clues to solve the mysterious selective neurodegeneration evident in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcR6CrmAaD06JCjiVMCqkKxVfW6udTcc2ebKRC1scnjXrrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ptVGjsA%253D%253D&md5=e3c14363b0ef8c6225a28d2acd6f0a69</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DH.-G.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DO%25E2%2580%2599Neill%26aufirst%3DM.%2BJ.%26aulast%3DWebber%26aufirst%3DK.%26aulast%3DCasadesus%26aufirst%3DG.%26aulast%3DMarlatt%26aufirst%3DM.%26aulast%3DRaina%26aufirst%3DK.%2BR.%26aulast%3DPerry%26aufirst%3DG.%26aulast%3DSmith%26aufirst%3DM.%2BA.%26atitle%3DThe%2520role%2520of%2520metabotropic%2520glutamate%2520receptors%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DActa%2520Neurobiol.%2520Exp.%26date%3D2004%26volume%3D64%26spage%3D89%26epage%3D98" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di Fabio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Micheli, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alvaro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavanni, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donati, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagliardi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fontana, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovannini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maffeis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mingardi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tranquillini, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitulli, G.</span></span> <span> </span><span class="NLM_article-title">From pyrroles to 1-oxo-2,3,4,9-tetrahydro-1H-β-carbolines: a new class of orally bioavailable mGluR1 antagonists</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2254</span>– <span class="NLM_lpage">2259</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2007.01.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmcl.2007.01.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=17276684" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvVaitrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2254-2259&author=R.+Di+Fabioauthor=F.+Micheliauthor=G.+Alvaroauthor=P.+Cavanniauthor=D.+Donatiauthor=T.+Gagliardiauthor=G.+Fontanaauthor=R.+Giovanniniauthor=M.+Maffeisauthor=A.+Mingardiauthor=M.+E.+Tranquilliniauthor=G.+Vitulli&title=From+pyrroles+to+1-oxo-2%2C3%2C4%2C9-tetrahydro-1H-%CE%B2-carbolines%3A+a+new+class+of+orally+bioavailable+mGluR1+antagonists&doi=10.1016%2Fj.bmcl.2007.01.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">From pyrroles to 1-oxo-2,3,4,9-tetrahydro-1H-β-carbolines: A new class of orally bioavailable mGluR1 antagonists</span></div><div class="casAuthors">Di Fabio, Romano; Micheli, Fabrizio; Alvaro, Giuseppe; Cavanni, Paolo; Donati, Daniele; Gagliardi, Tatiana; Fontana, Gabriele; Giovannini, Riccardo; Maffeis, Micaela; Mingardi, Anna; Tranquillini, Maria Elvira; Vitulli, Giovanni</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2254-2259</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Exploiting the SAR of the known pyrrole derivs., a new class of mGluR1 antagonists was designed by replacement of the pyrrole core with an indole scaffold and consequent cyclization of the C-2 position into a tricyclic β-carboline template.  The appropriate exploration of the position C-6 with a combination of H-bond acceptor groups coupled with bulky/lipophilic moieties led to the discovery of a new series of mGluR1 antagonists.  These compds. exhibited a noncompetitive behavior, excellent pharmacokinetic properties, and good in vivo activity in animal models of acute and chronic pain, after oral administration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoduwR7y9-xMLVg90H21EOLACvtfcHk0lh55BY3vKD-mQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvVaitrw%253D&md5=e8cc6bdbb00b35d51318efd87d1bd0fd</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.01.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.01.055%26sid%3Dliteratum%253Aachs%26aulast%3DDi%2BFabio%26aufirst%3DR.%26aulast%3DMicheli%26aufirst%3DF.%26aulast%3DAlvaro%26aufirst%3DG.%26aulast%3DCavanni%26aufirst%3DP.%26aulast%3DDonati%26aufirst%3DD.%26aulast%3DGagliardi%26aufirst%3DT.%26aulast%3DFontana%26aufirst%3DG.%26aulast%3DGiovannini%26aufirst%3DR.%26aulast%3DMaffeis%26aufirst%3DM.%26aulast%3DMingardi%26aufirst%3DA.%26aulast%3DTranquillini%26aufirst%3DM.%2BE.%26aulast%3DVitulli%26aufirst%3DG.%26atitle%3DFrom%2520pyrroles%2520to%25201-oxo-2%252C3%252C4%252C9-tetrahydro-1H-%25CE%25B2-carbolines%253A%2520a%2520new%2520class%2520of%2520orally%2520bioavailable%2520mGluR1%2520antagonists%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2254%26epage%3D2259%26doi%3D10.1016%2Fj.bmcl.2007.01.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Govindpani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calvo-Flores Guzmán, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinnakota, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldvogel, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faull, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwakowsky, A.</span></span> <span> </span><span class="NLM_article-title">Towards a better understanding of GABAergic remodeling in Alzheimer’s disease</span>. <i>Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1813</span>– <span class="NLM_lpage">1853</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3390%2Fijms18081813" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitVOmtrnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=1813-1853&author=K.+Govindpaniauthor=B.+Calvo-Flores+Guzm%C3%A1nauthor=C.+Vinnakotaauthor=H.+J.+Waldvogelauthor=R.+L.+Faullauthor=A.+Kwakowsky&title=Towards+a+better+understanding+of+GABAergic+remodeling+in+Alzheimer%E2%80%99s+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Towards a better understanding of GABAergic remodeling in Alzheimer's disease</span></div><div class="casAuthors">Govindpani, Karan; Guzman, Beatriz Calvo-Flores; Vinnakota, Chitra; Waldvogel, Henry J.; Faull, Richard L.; Kwakowsky, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1813/1-1813/41</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">γ-Aminobutyric acid (GABA) is the primary inhibitory neurotransmitter in the vertebrate brain.  In the past, there has been a major research drive focused on the dysfunction of the glutamatergic and cholinergic neurotransmitter systems in Alzheimer's disease (AD).  However, there is now growing evidence in support of a GABAergic contribution to the pathogenesis of this neurodegenerative disease.  Previous studies paint a complex, convoluted and often inconsistent picture of AD-assocd. GABAergic remodeling.  Given the importance of the GABAergic system in neuronal function and homeostasis, in the maintenance of the excitatory/inhibitory balance, and in the processes of learning and memory, such changes in GABAergic function could be an important factor in both early and later stages of AD pathogenesis.  Given the limited scope of currently available therapies in modifying the course of the disease, a better understanding of GABAergic remodeling in AD could open up innovative and novel therapeutic opportunities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDk53DIMXlE7Vg90H21EOLACvtfcHk0lijg1le_wYbJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitVOmtrnO&md5=de355673bd7876e1d6f62f5f14de954d</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.3390%2Fijms18081813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms18081813%26sid%3Dliteratum%253Aachs%26aulast%3DGovindpani%26aufirst%3DK.%26aulast%3DCalvo-Flores%2BGuzm%25C3%25A1n%26aufirst%3DB.%26aulast%3DVinnakota%26aufirst%3DC.%26aulast%3DWaldvogel%26aufirst%3DH.%2BJ.%26aulast%3DFaull%26aufirst%3DR.%2BL.%26aulast%3DKwakowsky%26aufirst%3DA.%26atitle%3DTowards%2520a%2520better%2520understanding%2520of%2520GABAergic%2520remodeling%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMol.%2520Sci.%26date%3D2017%26volume%3D18%26spage%3D1813%26epage%3D1853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Calvo-Flores Guzmán, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinnakota, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govindpani, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waldvogel, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faull, R. L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwakowsky, A.</span></span> <span> </span><span class="NLM_article-title">The GABAergic system as a therapeutic target for Alzheimer’s disease</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>146</i></span>,  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">669</span>, <span class="refDoi"> DOI: 10.1111/jnc.14345</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1111%2Fjnc.14345" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=29645219" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVeiu7%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=146&publication_year=2018&pages=649-669&author=B.+Calvo-Flores+Guzm%C3%A1nauthor=C.+Vinnakotaauthor=K.+Govindpaniauthor=H.+J.+Waldvogelauthor=R.+L.+M.+Faullauthor=A.+Kwakowsky&title=The+GABAergic+system+as+a+therapeutic+target+for+Alzheimer%E2%80%99s+disease&doi=10.1111%2Fjnc.14345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">The GABAergic system as a therapeutic target for Alzheimer's disease</span></div><div class="casAuthors">Calvo-Flores Guzman, Beatriz; Vinnakota, Chitra; Govindpani, Karan; Waldvogel, Henry J.; Faull, Richard L. M.; Kwakowsky, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">146</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">649-669</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Glutamatergic and cholinergic dysfunction are well-attested features of Alzheimer's disease (AD), progressing with other pathol. indexes of the disorder and exacerbating neuronal and network dysfunction.  However, relatively little attention has been paid to the inhibitory component of the excitatory/inhibitory (E/I) network, particularly dysfunction in the gamma-aminobutyric acid (GABA) signaling system.  There is growing evidence in support of GABAergic remodeling in the AD brain, potentially beginning in early stages of disease pathogenesis, and this could thus be a valid mol. target for drug development and pharmacol. therapies.  Several GABAergic drugs have been tested for efficacy in attenuating or reversing various features and symptoms of AD, and this could represent a novel path by which we might address the growing need for more effective and benign therapies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDgcgTZzN3mbVg90H21EOLACvtfcHk0lijg1le_wYbJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVeiu7%252FN&md5=0e3efd4ca632d4e04efdd98354eccde0</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1111%2Fjnc.14345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.14345%26sid%3Dliteratum%253Aachs%26aulast%3DCalvo-Flores%2BGuzm%25C3%25A1n%26aufirst%3DB.%26aulast%3DVinnakota%26aufirst%3DC.%26aulast%3DGovindpani%26aufirst%3DK.%26aulast%3DWaldvogel%26aufirst%3DH.%2BJ.%26aulast%3DFaull%26aufirst%3DR.%2BL.%2BM.%26aulast%3DKwakowsky%26aufirst%3DA.%26atitle%3DThe%2520GABAergic%2520system%2520as%2520a%2520therapeutic%2520target%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurochem.%26date%3D2018%26volume%3D146%26spage%3D649%26epage%3D669%26doi%3D10.1111%2Fjnc.14345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Roy, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stute, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höfling, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartlage-Rübsamen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matysik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roβner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alia, A.</span></span> <span> </span><span class="NLM_article-title">Sex- and age-specific modulation of brain GABA levels in a mouse model of Alzheimer’s disease</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">168</span>– <span class="NLM_lpage">179</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2017.10.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.neurobiolaging.2017.10.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=29154037" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslylsrrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2018&pages=168-179&author=U.+Royauthor=L.+Stuteauthor=C.+H%C3%B6flingauthor=M.+Hartlage-R%C3%BCbsamenauthor=J.+Matysikauthor=S.+Ro%CE%B2nerauthor=A.+Alia&title=Sex-+and+age-specific+modulation+of+brain+GABA+levels+in+a+mouse+model+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.neurobiolaging.2017.10.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">Sex- and age-specific modulation of brain GABA levels in a mouse model of Alzheimer's disease</span></div><div class="casAuthors">Roy, Upasana; Stute, Lara; Hoefling, Corinna; Hartlage-Ruebsamen, Maike; Matysik, Joerg; Roβner, Steffen; Alia, A.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">168-179</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Age and sex are risk factors of Alzheimer's disease (AD).  Among the neurotransmitter systems, gamma-aminobutyric acid (GABA) has been implicated in AD pathogenesis but the relevance of sex-specific GABAergic dysfunction during AD progression remains unknown.  In the present study, we utilized state-of-the-art high-resoln. magic angle spinning NMR to systematically monitor the brain region-, age-, and sex-specific modulation of GABA levels in wild-type and Tg2576 mice with amyloid pathol.  In addn., we followed the possible role of reactive astrocytes in sex-specific GABA modulation.  In female Tg2576 mice, hippocampal GABA levels were significantly elevated, along with higher no. of reactive astrocytes and amyloid deposition.  The elevated GABA was found to be produced via the monoamine oxidase-B route from putrescine in reactive astrocytes, more substantially in female than male mice, thus suggesting a role of astrocytes in memory impairment and sex-related differences in AD.  Our results paint a coherent model of memory impairment in AD and signify that dynamic changes in regional GABA may be at the root of marked sex disparities obsd. in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozCzQt3Kt4HrVg90H21EOLACvtfcHk0ljKkiNTuhNL4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslylsrrK&md5=1132e6c2251bb833736aa186995edb7d</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2017.10.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2017.10.015%26sid%3Dliteratum%253Aachs%26aulast%3DRoy%26aufirst%3DU.%26aulast%3DStute%26aufirst%3DL.%26aulast%3DH%25C3%25B6fling%26aufirst%3DC.%26aulast%3DHartlage-R%25C3%25BCbsamen%26aufirst%3DM.%26aulast%3DMatysik%26aufirst%3DJ.%26aulast%3DRo%25CE%25B2ner%26aufirst%3DS.%26aulast%3DAlia%26aufirst%3DA.%26atitle%3DSex-%2520and%2520age-specific%2520modulation%2520of%2520brain%2520GABA%2520levels%2520in%2520a%2520mouse%2520model%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DNeurobiol.%2520Aging%26date%3D2018%26volume%3D62%26spage%3D168%26epage%3D179%26doi%3D10.1016%2Fj.neurobiolaging.2017.10.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DasGupta, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, S.</span></span> <span> </span><span class="NLM_article-title">Altered neurochemistry in Alzheimer’s disease: targeting neurotransmitter receptor mechanisms and therapeutic strategy</span>. <i>Neurophysiology</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">293</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1007/s11062-019-09823-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1007%2Fs11062-019-09823-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1MXisVyktLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2019&pages=293-309&author=S.+Kaurauthor=G.+DasGuptaauthor=S.+Singh&title=Altered+neurochemistry+in+Alzheimer%E2%80%99s+disease%3A+targeting+neurotransmitter+receptor+mechanisms+and+therapeutic+strategy&doi=10.1007%2Fs11062-019-09823-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Altered Neurochemistry in Alzheimer's Disease: Targeting Neurotransmitter Receptor Mechanisms and Therapeutic Strategy</span></div><div class="casAuthors">Kaur, S.; DasGupta, G.; Singh, S.</div><div class="citationInfo"><span class="NLM_cas:title">Neurophysiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">293-309</span>CODEN:
                <span class="NLM_cas:coden">NPHYBI</span>;
        ISSN:<span class="NLM_cas:issn">0090-2977</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Alzheimer's disease (AD) is the most common form of dementia characterized by impaired cognitive functions assocd. with altered neurotransmitter levels in the brain.  In AD with advancement of age, symptoms that affect memory, learning ability, language perception, and behavior start to progress.  These shifts correlate with accumulations of amyloid beta plaques and neurofibrillary tangles.  Such pathol. changes are thought to distort synaptic neurotransmitter levels and interrupt neuron-toneuron functioning.  The current drugs in AD, like donepezil, rivastigmine, etc., rely to a significant extent on ameliorated cholinergic neurotransmission and utilization of anticholinesterase inhibitors.  The recent outbreaks in this disease also target neurotransmitters such as dopamine, serotonin, and their receptor signaling, rather than focusing on cholinergic neurotransmission.  This concept emerges due to findings of altered neurotransmitter levels in the post mortem brains of AD patients.  The current review summarizes some data underlying mechanisms targeting the role of neurotransmitters and their assocn. with AD, as well as those related to the resp. therapeutic aspects.  In addn., the review describes advances in recent drugs targeting neurotransmission preclinically and clin. for their neuroprotective role in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPlRA9o7xGJbVg90H21EOLACvtfcHk0lhCerxMKuLT7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXisVyktLrO&md5=0ff4b4e3191f08ce24c1716540068473</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1007%2Fs11062-019-09823-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11062-019-09823-7%26sid%3Dliteratum%253Aachs%26aulast%3DKaur%26aufirst%3DS.%26aulast%3DDasGupta%26aufirst%3DG.%26aulast%3DSingh%26aufirst%3DS.%26atitle%3DAltered%2520neurochemistry%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520targeting%2520neurotransmitter%2520receptor%2520mechanisms%2520and%2520therapeutic%2520strategy%26jtitle%3DNeurophysiology%26date%3D2019%26volume%3D51%26spage%3D293%26epage%3D309%26doi%3D10.1007%2Fs11062-019-09823-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Robertson, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, G. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coutts, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benderly, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Locock, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, I. L.</span></span> <span> </span><span class="NLM_article-title">Interactions of β-carbolines with the benzodiazepine receptor: structure-activity relationships</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1981</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1016/0014-2999(81)90515-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2F0014-2999%2881%2990515-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=6277646" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL38XhtlGgs7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1981&pages=281-284&author=H.+A.+Robertsonauthor=G.+B.+Bakerauthor=R.+T.+Couttsauthor=A.+Benderlyauthor=R.+A.+Locockauthor=I.+L.+Martin&title=Interactions+of+%CE%B2-carbolines+with+the+benzodiazepine+receptor%3A+structure-activity+relationships&doi=10.1016%2F0014-2999%2881%2990515-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Interactions of β-carbolines with the benzodiazepine receptor:  structure-activity relationships</span></div><div class="casAuthors">Robertson, Harold A.; Baker, Glen B.; Coutts, Ronald T.; Benderly, Avi; Locock, R. Anthony; Martin, Ian L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">1981</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">2-3</span>),
    <span class="NLM_cas:pages">281-4</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    </div><div class="casAbstract">The effects of a no. of β-carboline derivs. I (R1 = H or Me; R2 = H, or CO2Me, or CO2Et and R3 = H or OMe) and II (R1 = H or Me; R2 = H or CO2Et; R3 = H or OH or OMe; R4 = H or CH2OEt; 3,4-satd. or unsatd.) on 3H labeled flunitrazepam  [1622-62-4] binding to the benzodiazepine binding site were investigated.  In rat cortex the potency of β-carbolines at the benzodiazepine binding site appeared to be detd. largely by the aromaticity of the mol.  norharmane-3-carboxylic acid Et ester  [74214-62-3] Was considerably more potent (IC50 10 nM) than its tetrahydro-β-carboline analog (IC50 6 μM).  There is essentially no difference in potency between the (+)-  [80994-41-8] and (-)-forms  [80994-42-9] of the tetrahydro-β-carboline-3-carboxylate analogs.  Structure-activity relation are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpS0lf7Mn1dELVg90H21EOLACvtfcHk0lhCerxMKuLT7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38XhtlGgs7s%253D&md5=00cd3c7c67729cac6d1bc0a394140ba0</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1016%2F0014-2999%2881%2990515-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0014-2999%252881%252990515-X%26sid%3Dliteratum%253Aachs%26aulast%3DRobertson%26aufirst%3DH.%2BA.%26aulast%3DBaker%26aufirst%3DG.%2BB.%26aulast%3DCoutts%26aufirst%3DR.%2BT.%26aulast%3DBenderly%26aufirst%3DA.%26aulast%3DLocock%26aufirst%3DR.%2BA.%26aulast%3DMartin%26aufirst%3DI.%2BL.%26atitle%3DInteractions%2520of%2520%25CE%25B2-carbolines%2520with%2520the%2520benzodiazepine%2520receptor%253A%2520structure-activity%2520relationships%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D1981%26volume%3D76%26spage%3D281%26epage%3D284%26doi%3D10.1016%2F0014-2999%2881%2990515-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rommelspacher, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nanz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borbe, H. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fehske, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wollert, U.</span></span> <span> </span><span class="NLM_article-title">1-Methyl-β-carboline (harmane), a potent endogenous inhibitor of benzodiazepine receptor binding</span>. <i>Naunyn-Schmiedeberg's Arch. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>314</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">100</span>, <span class="refDoi"> DOI: 10.1007/BF00498436</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1007%2FBF00498436" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=6255348" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL3MXpsFOhuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=314&publication_year=1980&pages=97-100&author=H.+Rommelspacherauthor=C.+Nanzauthor=H.+O.+Borbeauthor=K.+J.+Fehskeauthor=W.+E.+M%C3%BCllerauthor=U.+Wollert&title=1-Methyl-%CE%B2-carboline+%28harmane%29%2C+a+potent+endogenous+inhibitor+of+benzodiazepine+receptor+binding&doi=10.1007%2FBF00498436"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">1-Methyl-β-carboline (harmane), a potent endogenous inhibitor of benzodiazepine receptor binding</span></div><div class="casAuthors">Rommelspacher, Hans; Nanz, Christel; Borbe, Harald O.; Fehske, Klaus J.; Mueller, Walter E.; Wollert, Uwe</div><div class="citationInfo"><span class="NLM_cas:title">Naunyn-Schmiedeberg's Archives of Pharmacology</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">314</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">97-100</span>CODEN:
                <span class="NLM_cas:coden">NSAPCC</span>;
        ISSN:<span class="NLM_cas:issn">0028-1298</span>.
    </div><div class="casAbstract">The interaction of several β-carbolines with specific [3H]flunitrazepam binding to benzodiazepine receptors in rat brain membranes was investigated.  Of the investigated compds., harmane (I)  [486-84-0] and norharmane  [244-63-3] were the most potent inhibitors of specific [3]flunitrazepam binding, with 50% inhibitory concn. values in the micromolar range.  All other derivs., including harmine  [442-51-3], harmaline  [304-21-2], and several other tetrahydro derivs., were at least 10 times less potent.  Harmane has been previously found in rat brain and human urine, so it is the most potent endogenous inhibitor of specific [3H]flunitrazepam binding known so far, with a several-hundred-fold higher affinity for the benzodiazepine receptor than inosine  [58-63-9] and hypoxanthine  [68-94-0].  Harmane or other related β-carbolines may be potential candidates as endogenous ligands of the benzodiazepine receptor.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqnJD2iKNtZPLVg90H21EOLACvtfcHk0ljpcZhYilkESg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3MXpsFOhuw%253D%253D&md5=eed009c540297d4e4c6fa539019dae47</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=10.1007%2FBF00498436&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00498436%26sid%3Dliteratum%253Aachs%26aulast%3DRommelspacher%26aufirst%3DH.%26aulast%3DNanz%26aufirst%3DC.%26aulast%3DBorbe%26aufirst%3DH.%2BO.%26aulast%3DFehske%26aufirst%3DK.%2BJ.%26aulast%3DM%25C3%25BCller%26aufirst%3DW.%2BE.%26aulast%3DWollert%26aufirst%3DU.%26atitle%3D1-Methyl-%25CE%25B2-carboline%2520%2528harmane%2529%252C%2520a%2520potent%2520endogenous%2520inhibitor%2520of%2520benzodiazepine%2520receptor%2520binding%26jtitle%3DNaunyn-Schmiedeberg%2527s%2520Arch.%2520Pharmacol.%26date%3D1980%26volume%3D314%26spage%3D97%26epage%3D100%26doi%3D10.1007%2FBF00498436" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lawson, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uyeno, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nienow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loew, G. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toll, L.</span></span> <span> </span><span class="NLM_article-title">Structure-activity studies of β-carboline analogs</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">2007</span>– <span class="NLM_lpage">2013</span>, <span class="refDoi"> DOI: 10.1016/0024-3205(84)90365-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2F0024-3205%2884%2990365-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=6328151" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL2cXktFKrs7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1984&pages=2007-2013&author=J.+A.+Lawsonauthor=E.+T.+Uyenoauthor=J.+Nienowauthor=G.+H.+Loewauthor=L.+Toll&title=Structure-activity+studies+of+%CE%B2-carboline+analogs&doi=10.1016%2F0024-3205%2884%2990365-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit117R"><div class="casContent"><span class="casTitleNuber">117</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity studies of β-carboline analogs</span></div><div class="casAuthors">Lawson, John A.; Uyeno, Edward T.; Nienow, John; Loew, Gilda H.; Toll, Lawrence</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">2007-13</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    </div><div class="casAbstract">A no. of β-carboline analogs I (R1 = H or Me; R2 = H, CN, CONH2, CO2Me, or CO2Et, R3 = H or NO2, and X = N or CH) were obtained or synthesized, and their in vitro receptor affinities and in vivo antagonist activities detd.  The choice of analogs was made in order to explore the importance of the N9-H, the arom. N and the C3-ester moiety for high-receptor affinity and antagonist activity of this class of benzodiazepine antagonist.  Among the analogs investigated, the properties of 3-cyano-β-carboline (I, R1-R3 = H, R2 = CN, X = N)  [83911-48-2], the first potent β-carboline antagonist without a carbonyl at the C3-position are described.  The results obtained indicate: (1) Specific interactions of the C3-substituent with key cationic receptor sites rather than electron-withdrawing properties are important for high-receptor affinity and antagonist activity.  (2) Specific in-plane interactions of the arom. N with a cationic receptor site, rather than stacking with neutral arom. residues of the receptor are also important for high affinity and antagonist activity.  (3) While the presence of an N9-H enhances receptor affinity, interaction with an anionic receptor site does not appear essential for antagonist activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjkP2HHeLV7bVg90H21EOLACvtfcHk0ljpcZhYilkESg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXktFKrs7g%253D&md5=40c1b4b8cb45cdd1766e9dcce42e2bf1</span></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2F0024-3205%2884%2990365-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0024-3205%252884%252990365-5%26sid%3Dliteratum%253Aachs%26aulast%3DLawson%26aufirst%3DJ.%2BA.%26aulast%3DUyeno%26aufirst%3DE.%2BT.%26aulast%3DNienow%26aufirst%3DJ.%26aulast%3DLoew%26aufirst%3DG.%2BH.%26aulast%3DToll%26aufirst%3DL.%26atitle%3DStructure-activity%2520studies%2520of%2520%25CE%25B2-carboline%2520analogs%26jtitle%3DLife%2520Sci.%26date%3D1984%26volume%3D34%26spage%3D2007%26epage%3D2013%26doi%3D10.1016%2F0024-3205%2884%2990365-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trudell, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Codding, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of novel 3-substituted β-carbolines as benzodiazepine receptor ligands: probing the benzodiazepine receptor pharmacophore</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">1854</span>– <span class="NLM_lpage">1861</span>, <span class="refDoi"> DOI: 10.1021/jm00117a029</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00117a029" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL1cXkvFartrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=1854-1861&author=M.+S.+Allenauthor=T.+J.+Hagenauthor=M.+L.+Trudellauthor=P.+W.+Coddingauthor=P.+Skolnickauthor=J.+M.+Cook&title=Synthesis+of+novel+3-substituted+%CE%B2-carbolines+as+benzodiazepine+receptor+ligands%3A+probing+the+benzodiazepine+receptor+pharmacophore&doi=10.1021%2Fjm00117a029"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit118R"><div class="casContent"><span class="casTitleNuber">118</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of novel 3-substituted β-carbolines as benzodiazepine receptor ligands:  probing the benzodiazepine receptor pharmacophore</span></div><div class="casAuthors">Allen, Michael S.; Hagen, Timothy J.; Trudell, Mark L.; Codding, Penelope W.; Skolnick, Phil; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1854-61</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">In order to det. their binding affinity for benzodiazepine receptors (BzR), the 3-substituted β-carbolines I (R = Cl, NO2, MeO, EtO, PrO, isothiocyano) were prepd. from 3-amino-β-carboline I (R = NH2) in one step via diazotization, followed by reaction with the appropriate nucleophile.  All three of the 3-alkoxy-β-carbolines I (R = MeO) (IC50 = 124 nM), I (R = EtO) (IC50 = 24 nM), and I (R = PrO) (IC50 11 nM) have high affinities for BzR.  The β-carbolines substituted with electron-withdrawing groups including I (R = Cl) (IC50 = 45 nM), I (R = NO2) (IC50 = 125 nM), I (R = isothiocyano) (IC50 = 8 nM) also had high affinities for BzR.  The affinities of I (R = Cl, NO2, MeO, isothiocyano) clearly indicate that a carbonyl moiety at position 3 of a β-carboline is not required for high-affinity binding to BzR.  These findings have led to the development of a model for the binding of ligands to an inverse agonist domain at BzR.  This model is supported by the recent synthesis of 3-ethoxy-β-carboline I (R = EtO), a potent, long-lived partial inverse agonist, and I (R = isothiocyano) an irreversible BzR ligand.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYcYWjJ8CyJrVg90H21EOLACvtfcHk0lh4P0McYVDrMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1cXkvFartrk%253D&md5=3819b32cfc302daa6077003e998cb902</span></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1021%2Fjm00117a029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00117a029%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DM.%2BS.%26aulast%3DHagen%26aufirst%3DT.%2BJ.%26aulast%3DTrudell%26aufirst%3DM.%2BL.%26aulast%3DCodding%26aufirst%3DP.%2BW.%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DSynthesis%2520of%2520novel%25203-substituted%2520%25CE%25B2-carbolines%2520as%2520benzodiazepine%2520receptor%2520ligands%253A%2520probing%2520the%2520benzodiazepine%2520receptor%2520pharmacophore%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1988%26volume%3D31%26spage%3D1854%26epage%3D1861%26doi%3D10.1021%2Fjm00117a029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, Y. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trudell, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narayanan, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schindler, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, K. F.</span></span> <span> </span><span class="NLM_article-title">Synthetic and computer-assisted analyses of the pharmacophore for the benzodiazepine receptor inverse agonist site</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">2343</span>– <span class="NLM_lpage">2357</span>, <span class="refDoi"> DOI: 10.1021/jm00171a007</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00171a007" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK3MXitVKqt7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=2343-2357&author=M.+S.+Allenauthor=Y.+C.+Tanauthor=M.+L.+Trudellauthor=K.+Narayananauthor=L.+R.+Schindlerauthor=M.+J.+Martinauthor=C.+Schultzauthor=T.+J.+Hagenauthor=K.+F.+Koehler&title=Synthetic+and+computer-assisted+analyses+of+the+pharmacophore+for+the+benzodiazepine+receptor+inverse+agonist+site&doi=10.1021%2Fjm00171a007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Synthetic and computer-assisted analyses of the pharmacophore for the benzodiazepine receptor inverse agonist site</span></div><div class="casAuthors">Allen, Michael S.; Tan, Yun C.; Trudell, Mark L.; Narayanan, Kris; Schindler, Liesl R.; Martin, Michael J.; Schultz, Christopher; Hagen, Timothy J.; Koehler, Konrad F.; et al.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2343-57</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The structural requirements for ligand binding of the benzodiazepine receptor inverse agonist site was probed through 3-substituted β-carbolines I (R = OCHMe2, OBu, COPr, Bu, CO2Me) and diindoles, e.g. II (R1-R5 = H, Me).  Based on the binding affinities of I and II the receptor is proposed to interact with the H in the 9-N position on I and with the H in the 7-N position of II; likewise a H bonding site exists for the 2-N position in I and the 5-N position in II.  I (R = OPr) was an antagonist at the benzodiazepine receptor site.  A 3D-quant. structure-activity relationship (3D-QSAR) was established.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopxj-FH5PV07Vg90H21EOLACvtfcHk0lh4P0McYVDrMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3MXitVKqt7o%253D&md5=4be24f2b84cf70eeeabfe4e9cfed967b</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1021%2Fjm00171a007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00171a007%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DM.%2BS.%26aulast%3DTan%26aufirst%3DY.%2BC.%26aulast%3DTrudell%26aufirst%3DM.%2BL.%26aulast%3DNarayanan%26aufirst%3DK.%26aulast%3DSchindler%26aufirst%3DL.%2BR.%26aulast%3DMartin%26aufirst%3DM.%2BJ.%26aulast%3DSchultz%26aufirst%3DC.%26aulast%3DHagen%26aufirst%3DT.%2BJ.%26aulast%3DKoehler%26aufirst%3DK.%2BF.%26atitle%3DSynthetic%2520and%2520computer-assisted%2520analyses%2520of%2520the%2520pharmacophore%2520for%2520the%2520benzodiazepine%2520receptor%2520inverse%2520agonist%2520site%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D2343%26epage%3D2357%26doi%3D10.1021%2Fjm00171a007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Allen, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">LaLoggia, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorn, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costantino, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koehler, K. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Predictive binding of β-carboline inverse agonists and antagonists via the CoMFA/GOLPE approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">4001</span>– <span class="NLM_lpage">4010</span>, <span class="refDoi"> DOI: 10.1021/jm00100a004</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00100a004" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK3sXmvVyq" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1992&pages=4001-4010&author=M.+S.+Allenauthor=A.+J.+LaLoggiaauthor=L.+J.+Dornauthor=M.+J.+Martinauthor=G.+Costantinoauthor=T.+J.+Hagenauthor=K.+F.+Koehlerauthor=P.+Skolnickauthor=J.+M.+Cook&title=Predictive+binding+of+%CE%B2-carboline+inverse+agonists+and+antagonists+via+the+CoMFA%2FGOLPE+approach&doi=10.1021%2Fjm00100a004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">Predictive binding of β-carboline inverse agonists and antagonists via the CoMFA/GOLPE approach</span></div><div class="casAuthors">Allen, Michael S.; LaLoggia, Anthony J.; Dorn, Linda J.; Martin, Michael J.; Costantino, Gabriele; Hagen, Timothy J.; Koehler, Konrad F.; Skolnick, Phil; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1992</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4001-10</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The synthesis and affinities of six new 3-substituted β-carbolines I (R = EtCHMeO, Me2CHCH2O, Me2CHCH2CH2O, Me3CCH2O, PhCH2O, Me3CCO) for the benzodiazepine receptor is described.  These analogs were used both to probe the dimensions of the hydrophobic pocket in the benzodiazepine receptor and to test the predictive ability of a previously reported 3D-QSAR regression model.  Of the new analogs synthesized, the γ-branched derivs. I (R = Me2CHCH2O, Me3CCH2O) display significantly higher receptor affinity than either the β-branched I (R = MeCH2CHMeO, Me3CCO or δ-branched I (R = Me2CHCH2CH2O) analogs.  An exception to this rule is the γ-branched I (R = PhCH2O) which appears to have a chain length that is too long to be accommodated by the benzodiazepine receptor.  The std. error of prediction for these six new β-carbolines using the original regression model is significantly lower than the std. error est. of the cross validation runs on the training set, hence the predictions made using this model are much better than expected.  In order to obtain more credible predictions, a new procedure called GOLPE (generating optimal linear PLS ests.) was used to eliminate irrelevant electrostatic and steric descriptors from the regression equation.  A substantial redn. in the std. error est. resulted.  The predictions from this new regression equation were somewhat less accurate than the ones obtained with the original regression equation; however the std. error of prediction and the std. error est. are in much closer agreement.  Finally, to probe the effect that the steric and electrostatic potentials have on 3D-QSAR analyses, the semiempirical MNDO//PRDDO geometries and Mulliken charges used in the original anal. were replaced with ab initio 3-21G//6-31G* geometries and electrostatic potential fit charges.  A modest decrease in the std. error est. and increase in cross validated R2 resulted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjn3YzT4pprLVg90H21EOLACvtfcHk0liPdgM7PKXRJw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXmvVyq&md5=d4ee9fa7217a9eb6b458ee3f6e79ac01</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1021%2Fjm00100a004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00100a004%26sid%3Dliteratum%253Aachs%26aulast%3DAllen%26aufirst%3DM.%2BS.%26aulast%3DLaLoggia%26aufirst%3DA.%2BJ.%26aulast%3DDorn%26aufirst%3DL.%2BJ.%26aulast%3DMartin%26aufirst%3DM.%2BJ.%26aulast%3DCostantino%26aufirst%3DG.%26aulast%3DHagen%26aufirst%3DT.%2BJ.%26aulast%3DKoehler%26aufirst%3DK.%2BF.%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DPredictive%2520binding%2520of%2520%25CE%25B2-carboline%2520inverse%2520agonists%2520and%2520antagonists%2520via%2520the%2520CoMFA%252FGOLPE%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1992%26volume%3D35%26spage%3D4001%26epage%3D4010%26doi%3D10.1021%2Fjm00100a004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larscheid, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S. M.</span></span> <span> </span><span class="NLM_article-title">Biomimetic approach to potential benzodiazepine receptor agonists and antagonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">564</span>– <span class="NLM_lpage">570</span>, <span class="refDoi"> DOI: 10.1021/jm00371a002</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00371a002" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL2cXhsFSlsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1984&pages=564-570&author=F.+Guzmanauthor=M.+Cainauthor=P.+Larscheidauthor=T.+Hagenauthor=J.+M.+Cookauthor=M.+Schweriauthor=P.+Skolnickauthor=S.+M.+Paul&title=Biomimetic+approach+to+potential+benzodiazepine+receptor+agonists+and+antagonists&doi=10.1021%2Fjm00371a002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit121R"><div class="casContent"><span class="casTitleNuber">121</span><div class="casTitle"><span class="NLM_cas:atitle">Biomimetic approach to potential benzodiazepine receptor agonists and antagonists</span></div><div class="casAuthors">Guzman, Filadelfo; Cain, Michael; Larscheid, Paul; Hagen, Tim; Cook, James M.; Schweri, Margaret; Skolnick, Phil; Paul, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">564-70</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Isoquinolines I (R1 and R2 = H or MeO; R3 = H or Me), imidazopyridines II (R1 = H or Ph; R2 = H or Me), canthinones III (R = H or CO2Me), and β-carboline-3-carboxamide (IV)  [88932-13-2] were prepd. and they and some previously prepd. analogs were evaluated for their ability to bind to benzodiazepine receptors.  Me isoquinoline-3-carboxylate (I; R1 = R2 = H, R3 = Me)  [27104-73-0] binds with moderate affinity, whereas 2-carbomethoxycanthin-6-one (III; R = CO2Me)  [84133-31-3] binds with an affinity comparable to several active benzodiazepines.  Structure-activity relations are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryQQMBerbyXbVg90H21EOLACvtfcHk0lhbUoD4c6iSJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXhsFSlsb4%253D&md5=62cde58661bf6473a2642d745397d84b</span></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1021%2Fjm00371a002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00371a002%26sid%3Dliteratum%253Aachs%26aulast%3DGuzman%26aufirst%3DF.%26aulast%3DCain%26aufirst%3DM.%26aulast%3DLarscheid%26aufirst%3DP.%26aulast%3DHagen%26aufirst%3DT.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26aulast%3DSchweri%26aufirst%3DM.%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DPaul%26aufirst%3DS.%2BM.%26atitle%3DBiomimetic%2520approach%2520to%2520potential%2520benzodiazepine%2520receptor%2520agonists%2520and%2520antagonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1984%26volume%3D27%26spage%3D564%26epage%3D570%26doi%3D10.1021%2Fjm00371a002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Braestrup, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, C. E.</span></span> <span> </span><span class="NLM_article-title">Urinary and brain β-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1980</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">2288</span>– <span class="NLM_lpage">2292</span>, <span class="refDoi"> DOI: 10.1073/pnas.77.4.2288</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1073%2Fpnas.77.4.2288" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=6246535" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL3cXks1Wjsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=1980&pages=2288-2292&author=C.+Braestrupauthor=M.+Nielsenauthor=C.+E.+Olsen&title=Urinary+and+brain+%CE%B2-carboline-3-carboxylates+as+potent+inhibitors+of+brain+benzodiazepine+receptors&doi=10.1073%2Fpnas.77.4.2288"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">Urinary and brain β-carboline-3-carboxylates as potent inhibitors of brain benzodiazepine receptors</span></div><div class="casAuthors">Braestrup, Claus; Nielsen, Mogens; Olsen, Carl Erik</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1980</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2288-92</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    </div><div class="casAbstract">In searching for possible endogenous ligands for benzodiazepine receptors, a compd. was purified 107-fold from human urine by extns., treatment with hot ethanol, and column chromatog.  The compd. was identified as β-carboline-3-carboxylic acid Et ester (I)  [74214-62-3] by mass spectrometry, NMR spectrometry, and synthesis; I was also isolated from brain tissues (20 ng/g) by similar procedures.  Very small concns. of I displaced labeled diazepam completely from specific cerebral receptors, but not from liver and kidney binding sites; the concn. causing 50% inhibition of specific diazepam binding (IC50) was 4-7 nM compared to ∼5 nM for lorazepam.  Specific binding sites for quinuclidinyl benzilate, naloxone, spiroperidol, serotonin, muscimol, and WB 4101 were not affected by I.  In contrast to benzodiazepines, I exhibits mixed-type competitive inhibition of forebrain benzodiazepine receptors.  A structure activity study showed that tetrahydro-β-carbolines were almost inactive on benzodiazepine receptors.  Esters of β-carboline-3-carboxylic acid were active.  Substitution of a Me group in the 1st position of the ring structure decreased the activity remarkably.  Endogenous ligand for I receptors may be a deriv. of β-carboline-3-carboxylic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrab1wHiZqfb7Vg90H21EOLACvtfcHk0lhbUoD4c6iSJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL3cXks1Wjsb4%253D&md5=093c92b2da5dcd0e196810231306863c</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1073%2Fpnas.77.4.2288&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.77.4.2288%26sid%3Dliteratum%253Aachs%26aulast%3DBraestrup%26aufirst%3DC.%26aulast%3DNielsen%26aufirst%3DM.%26aulast%3DOlsen%26aufirst%3DC.%2BE.%26atitle%3DUrinary%2520and%2520brain%2520%25CE%25B2-carboline-3-carboxylates%2520as%2520potent%2520inhibitors%2520of%2520brain%2520benzodiazepine%2520receptors%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1980%26volume%3D77%26spage%3D2288%26epage%3D2292%26doi%3D10.1073%2Fpnas.77.4.2288" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dorey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poissonnet, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, M.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Carvalho, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venault, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapouthier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, R. H.</span></span> <span> </span><span class="NLM_article-title">Synthesis and benzodiazepine receptor affinities of rigid analogues of 3-carboxy-β-carbolines: demonstration that the benzodiazepine receptor recognizes preferentially the s-cis conformation of the 3-carboxy group</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1799</span>– <span class="NLM_lpage">1804</span>, <span class="refDoi"> DOI: 10.1021/jm00128a023</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00128a023" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL1MXkvFOisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1989&pages=1799-1804&author=G.+Doreyauthor=G.+Poissonnetauthor=M.-C.+Potierauthor=L.+P.+de+Carvalhoauthor=P.+Venaultauthor=G.+Chapouthierauthor=J.+Rossierauthor=P.+Potierauthor=R.+H.+Dodd&title=Synthesis+and+benzodiazepine+receptor+affinities+of+rigid+analogues+of+3-carboxy-%CE%B2-carbolines%3A+demonstration+that+the+benzodiazepine+receptor+recognizes+preferentially+the+s-cis+conformation+of+the+3-carboxy+group&doi=10.1021%2Fjm00128a023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and benzodiazepine receptor affinities of rigid analogs of 3-carboxy-β-carbolines:  demonstration that the benzodiazepine receptor recognizes preferentially the s-cis conformation of the 3-carboxy group</span></div><div class="casAuthors">Dorey, Gilbert; Poissonnet, Guillaume; Potier, Marie Claude; De Carvalho, Lia Prado; Venault, Patrice; Chapouthier, Georges; Rossier, Jean; Potier, Pierre; Dodd, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1989</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1799-804</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Indolopyrido-2-penten-5-olide I (X = O; II) and indolopyridopyridinone I (X = NH), rigid analogs of Me 4-ethyl-β-carboline-3-carboxylate III (R = OMe; IV) and N-methyl-4-ethyl-β-carboline-3-carboxamide III (R = NHMe; V), resp., were synthesized and their in vitro binding affinities to the central type benzodiazepine receptors were compared.  The IC50 values of II and IV were approx. equiv. (42 and 27 nM, resp.).  The amide deriv. V, for which theor. energy calcns. indicate that the s-trans carbonyl conformation is the preferred one, displayed very low affinity (IC50 > 104 nM).  However, when the carbonyl group of V was forced to adopt the s-cis conformation as in lactam I (X = NH), binding to the benzodiazepine receptor was largely restored (IC50 = 150 nM), indicating that the s-cis carboxy conformation at C-3 of β-carbolines is preferentially recognized by this receptor.  In vivo, II showed neither convulsant, proconvulsant, nor anticonvulsant activity in mice.  Moreover, II did not antagonize Me β-carboline-3-carboxylate induced convulsions in mice.  This lack of activity of II was attributed to its inability to cross the blood-brain barrier since no significant displacement of [3H]Ro 15-1788 from mouse brain benzodiazepine receptors by II could be obsd. in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWkoHFbwHY-rVg90H21EOLACvtfcHk0lj5u-EUp-r1Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXkvFOisL8%253D&md5=41b326cecefe4f5cccbd7de45525f4d9</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1021%2Fjm00128a023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00128a023%26sid%3Dliteratum%253Aachs%26aulast%3DDorey%26aufirst%3DG.%26aulast%3DPoissonnet%26aufirst%3DG.%26aulast%3DPotier%26aufirst%3DM.-C.%26aulast%3Dde%2BCarvalho%26aufirst%3DL.%2BP.%26aulast%3DVenault%26aufirst%3DP.%26aulast%3DChapouthier%26aufirst%3DG.%26aulast%3DRossier%26aufirst%3DJ.%26aulast%3DPotier%26aufirst%3DP.%26aulast%3DDodd%26aufirst%3DR.%2BH.%26atitle%3DSynthesis%2520and%2520benzodiazepine%2520receptor%2520affinities%2520of%2520rigid%2520analogues%2520of%25203-carboxy-%25CE%25B2-carbolines%253A%2520demonstration%2520that%2520the%2520benzodiazepine%2520receptor%2520recognizes%2520preferentially%2520the%2520s-cis%2520conformation%2520of%2520the%25203-carboxy%2520group%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1989%26volume%3D32%26spage%3D1799%26epage%3D1804%26doi%3D10.1021%2Fjm00128a023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzman, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rice, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crawley, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span> <span> </span><span class="NLM_article-title">β-Carbolines: synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1081</span>– <span class="NLM_lpage">1091</span>, <span class="refDoi"> DOI: 10.1021/jm00351a015</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00351a015" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL38Xkslahtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=1982&pages=1081-1091&author=M.+Cainauthor=R.+W.+Weberauthor=F.+Guzmanauthor=J.+M.+Cookauthor=S.+A.+Barkerauthor=K.+C.+Riceauthor=J.+N.+Crawleyauthor=S.+M.+Paulauthor=P.+Skolnick&title=%CE%B2-Carbolines%3A+synthesis+and+neurochemical+and+pharmacological+actions+on+brain+benzodiazepine+receptors&doi=10.1021%2Fjm00351a015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">β-Carbolines:  synthesis and neurochemical and pharmacological actions on brain benzodiazepine receptors</span></div><div class="casAuthors">Cain, Michael; Weber, Robert W.; Guzman, Fil; Cook, James M.; Barker, Steven A.; Rice, Kenner C.; Crawley, Jacqueline N.; Paul, Steven M.; Skolnick, Phil</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1982</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1081-91</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A series of tetrahydro-β-carbolines, e.g. I, β-carbolines, e.g. II, and other nitrogen heterocycles were prepd. and evaluated in vitro with respect to their ability to bind to benzodiazepine receptors.  Thus, 5-hydroxytryptophan was cyclized with EtCHO and then esterified by methanolic hydrochloric acid to give 58% cis-I, which was dehydrogenated to give 48% II.  The fully arom. β-carbolines were more potent than their corresponding tetrahydro-β-carboline derivs.  When substituents possessing a carbonyl (CO2Me, COCH3, CHO) were introduced at the β-C-3 position the in vitro potency was augmented.  Alc. substituents (CH2OH, CHOHCH3) demonstrated decreased in vitro potency.  The importance of the carbonyl moiety was further demonstrated when β-carboline-3-carboxylic acid was shown to bind tighter to benzodiazepine receptors at lower pH.  A lower pH increases the concn. of the acid and decreases the concn. of the anion.  3-(Hydroxymethyl)-β-carboline, 3-formyl-β-carboline, and 3-acetyl-β-carboline were benzodiazepine antagonists in vivo.  Me isoquinoline-3-carboxylate also had in vitro activity.  The same structure-activity relationships seen in β-carbolines were also obsd. for isoquinolines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoOrGGXq0IFxLVg90H21EOLACvtfcHk0lj5u-EUp-r1Ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL38Xkslahtbw%253D&md5=a7a48935c6eec5eae59957270a0ddbb6</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1021%2Fjm00351a015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00351a015%26sid%3Dliteratum%253Aachs%26aulast%3DCain%26aufirst%3DM.%26aulast%3DWeber%26aufirst%3DR.%2BW.%26aulast%3DGuzman%26aufirst%3DF.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26aulast%3DBarker%26aufirst%3DS.%2BA.%26aulast%3DRice%26aufirst%3DK.%2BC.%26aulast%3DCrawley%26aufirst%3DJ.%2BN.%26aulast%3DPaul%26aufirst%3DS.%2BM.%26aulast%3DSkolnick%26aufirst%3DP.%26atitle%3D%25CE%25B2-Carbolines%253A%2520synthesis%2520and%2520neurochemical%2520and%2520pharmacological%2520actions%2520on%2520brain%2520benzodiazepine%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1982%26volume%3D25%26spage%3D1081%26epage%3D1091%26doi%3D10.1021%2Fjm00351a015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ouannès, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prado de Carvalho, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venault, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chapouthier, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potier, P.</span></span> <span> </span><span class="NLM_article-title">3-Amino-β-carboline derivatives and the benzodiazepine receptor. Synthesis of a selective antagonist of the sedative action of diazepam</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1985</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">824</span>– <span class="NLM_lpage">828</span>, <span class="refDoi"> DOI: 10.1021/jm00383a024</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00383a024" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL2MXitVerurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=1985&pages=824-828&author=R.+H.+Doddauthor=C.+Ouann%C3%A8sauthor=L.+Prado+de+Carvalhoauthor=A.+Valinauthor=P.+Venaultauthor=G.+Chapouthierauthor=J.+Rossierauthor=P.+Potier&title=3-Amino-%CE%B2-carboline+derivatives+and+the+benzodiazepine+receptor.+Synthesis+of+a+selective+antagonist+of+the+sedative+action+of+diazepam&doi=10.1021%2Fjm00383a024"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">3-Amino-β-carboline derivatives and the benzodiazepine receptor.  Synthesis of a selective antagonist of the sedative action of diazepam</span></div><div class="casAuthors">Dodd, Robert H.; Ouannes, Catherine; Prado de Carvalho, Lia; Valin, Anne; Venault, Patrice; Chapouthier, Georges; Rossier, Jean; Potier, Pierre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1985</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">824-8</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">Seven 3-N-substituted derivs. I (R = CO2Me, CO2Et, CHO, SO2Me, COMe, COCF3, Et) of 3-amino-β-carboline were synthesized from Et β-carboline-3-carboxylate and their affinities for the benzodiazepine receptor were assessed in vitro.  Two compds., 3-(ethylamino)-β-carboline and 3-(methoxycarbonylamino)-β-carboline (II), showing IC50 values of 460 and 71 nM, resp., were selected for in vivo studies.  The former compd. showed long-lasting proconvulsant activity in Papio papio baboons while II in mice selectively antagonized the sedative effects of diazepam without exhibiting convulsant, proconvulsant, or anxiogenic activity by itself.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq_nmqwK-27RbVg90H21EOLACvtfcHk0liOtsAF7dUuWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2MXitVerurc%253D&md5=225f8d20ecf42d144c3cf3eef6845fca</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Fjm00383a024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00383a024%26sid%3Dliteratum%253Aachs%26aulast%3DDodd%26aufirst%3DR.%2BH.%26aulast%3DOuann%25C3%25A8s%26aufirst%3DC.%26aulast%3DPrado%2Bde%2BCarvalho%26aufirst%3DL.%26aulast%3DValin%26aufirst%3DA.%26aulast%3DVenault%26aufirst%3DP.%26aulast%3DChapouthier%26aufirst%3DG.%26aulast%3DRossier%26aufirst%3DJ.%26aulast%3DPotier%26aufirst%3DP.%26atitle%3D3-Amino-%25CE%25B2-carboline%2520derivatives%2520and%2520the%2520benzodiazepine%2520receptor.%2520Synthesis%2520of%2520a%2520selective%2520antagonist%2520of%2520the%2520sedative%2520action%2520of%2520diazepam%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1985%26volume%3D28%26spage%3D824%26epage%3D828%26doi%3D10.1021%2Fjm00383a024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 6-substituted β-carbolines that behave as benzodiazepine receptor antagonists or inverse agonists</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">750</span>– <span class="NLM_lpage">753</span>, <span class="refDoi"> DOI: 10.1021/jm00387a033</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00387a033" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL2sXhvFKhu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=750-753&author=T.+J.+Hagenauthor=P.+Skolnickauthor=J.+M.+Cook&title=Synthesis+of+6-substituted+%CE%B2-carbolines+that+behave+as+benzodiazepine+receptor+antagonists+or+inverse+agonists&doi=10.1021%2Fjm00387a033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 6-substituted β-carbolines that behave as benzodiazepine receptor antagonists or inverse agonists</span></div><div class="casAuthors">Hagen, Timothy J.; Skolnick, Phil; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">750-3</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The synthesis of the first β-carboline (I; R = H, R1 = PhCH2) devoid of a substituent at the 3-position but capable of binding to benzodiazepine receptors with potent affinity is described.  Thus, I (R = R1 = H) was treated with KOH and BzH in MeOH and then NaBH3CN to give I (R = H, R1 = PhCH2).  I (R = H, R1 = PhCH2) proved to be a partial inverse agonist when tested in mice.  Addn. of the benzylamino group at the 6-position of the β-carboline nucleus is primarily responsible for the activity of I (R = H, R1 = PhCH2; R = HOCH2, R1 = PhCH2).  The importance of the Nb-nitrogen atom for binding affinity was also demonstrated since 3-(benzylamino)carbazole (II) exhibited little or no affinity for benzodiazepine receptors in vitro, in contrast to the activity of I (R = H, R1 = PhCH2).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3e6_cm4M8F7Vg90H21EOLACvtfcHk0liOtsAF7dUuWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhvFKhu7s%253D&md5=ca05594d001f4bd261b523675d94381c</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1021%2Fjm00387a033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00387a033%26sid%3Dliteratum%253Aachs%26aulast%3DHagen%26aufirst%3DT.%2BJ.%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DSynthesis%2520of%25206-substituted%2520%25CE%25B2-carbolines%2520that%2520behave%2520as%2520benzodiazepine%2520receptor%2520antagonists%2520or%2520inverse%2520agonists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D750%26epage%3D753%26doi%3D10.1021%2Fjm00387a033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hollinshead, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trudell, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Structural requirements for agonist actions at the benzodiazepine receptor: studies with analogues of 6-(benzyloxy)-4-(methoxymethyl)-β-carboline-3-carboxylic acid ethyl ester</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1990</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1062</span>– <span class="NLM_lpage">1069</span>, <span class="refDoi"> DOI: 10.1021/jm00165a028</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00165a028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK3cXhtFylu74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=1990&pages=1062-1069&author=S.+P.+Hollinsheadauthor=M.+L.+Trudellauthor=P.+Skolnickauthor=J.+M.+Cook&title=Structural+requirements+for+agonist+actions+at+the+benzodiazepine+receptor%3A+studies+with+analogues+of+6-%28benzyloxy%29-4-%28methoxymethyl%29-%CE%B2-carboline-3-carboxylic+acid+ethyl+ester&doi=10.1021%2Fjm00165a028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Structural requirements for agonist actions at the benzodiazepine receptor:  studies with analogs of 6-(benzyloxy)-4-(methoxymethyl)-β-carboline-3-carboxylic acid ethyl ester</span></div><div class="casAuthors">Hollinshead, Sean P.; Trudell, Mark L.; Skolnick, Phil; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1990</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1062-9</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">The β-carboline analogs I (R = H, Me; R1= H, Et, CH2OMe, R2 = H, OMe, OH, OCH2Ph) were synthesized in order to det. which functional groups are required for agonist activity exhibited by the parent compd. I ( R = H, R1 = CH2OMe, R2 = OCH2Ph)(II) at the benzodiazepine receptor (BzR).  The potencies of these compds. were evaluated in vitro and in vivo; the β-carbolines I (R = H, R1 = CH2OMe, R2 = OH, OMe, H; R1 = Et, R2 = OCH2Ph; R1 = H, R2 = CH2OPh) exhibited high affinity (0.5-22 nM) for BzR, but in vivo studies demonstrated they were not anticonvulsant while I (R = H, R1 = CH2OMe, R2 = OMe, H) antagonized the effects of diazepam.  These results are in agreement with the model proposed for the pharmacophore of the agonist site (domain) of the BzR, which requires the interaction of three sites of electron d. [N(2), C(4), and C(6)] and two of lipophilicity [C(3) and C(6)] of the ligand with the BzR protein.  The pharmacophore for the agonist site is derived from the structure-activity relationship of the benzodiazepines, pyrazoloquinolines, and II and compared to interactions required for ligand inverse agonist activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruxC6588LpNrVg90H21EOLACvtfcHk0liD5oIH03nU_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXhtFylu74%253D&md5=32734d22fa4784a12a5fdc068686eb26</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Fjm00165a028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00165a028%26sid%3Dliteratum%253Aachs%26aulast%3DHollinshead%26aufirst%3DS.%2BP.%26aulast%3DTrudell%26aufirst%3DM.%2BL.%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DStructural%2520requirements%2520for%2520agonist%2520actions%2520at%2520the%2520benzodiazepine%2520receptor%253A%2520studies%2520with%2520analogues%2520of%25206-%2528benzyloxy%2529-4-%2528methoxymethyl%2529-%25CE%25B2-carboline-3-carboxylic%2520acid%2520ethyl%2520ester%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1990%26volume%3D33%26spage%3D1062%26epage%3D1069%26doi%3D10.1021%2Fjm00165a028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diaz-Arauzo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKernan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of analogues of the partial agonist 6-(propyloxy)-4-(methoxymethyl)-β-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(benzyloxy)-4-(methoxymethyl)-β-carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2537</span>– <span class="NLM_lpage">2552</span>, <span class="refDoi"> DOI: 10.1021/jm970460b</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm970460b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK1cXkt12jt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=1998&pages=2537-2552&author=E.+D.+Coxauthor=H.+Diaz-Arauzoauthor=Q.+Huangauthor=M.+S.+Reddyauthor=C.+Maauthor=B.+Harrisauthor=R.+McKernanauthor=P.+Skolnickauthor=J.+M.+Cook&title=Synthesis+and+evaluation+of+analogues+of+the+partial+agonist+6-%28propyloxy%29-4-%28methoxymethyl%29-%CE%B2-carboline-3-carboxylic+acid+ethyl+ester+%286-PBC%29+and+the+full+agonist+6-%28benzyloxy%29-4-%28methoxymethyl%29-%CE%B2-carboline-3-carboxylic+acid+ethyl+ester+%28Zk+93423%29+at+wild+type+and+recombinant+GABAA+receptors&doi=10.1021%2Fjm970460b"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of analogs of the partial agonist 6-(Propyloxy)-4-(methoxymethyl)-β-carboline-3-carboxylic acid ethyl ester (6-PBC) and the full agonist 6-(Benzyloxy)-4-(methoxymethyl)-β- carboline-3-carboxylic acid ethyl ester (Zk 93423) at wild type and recombinant GABAA receptors</span></div><div class="casAuthors">Cox, Eric D.; Diaz-Arauzo, Hernando; Huang, Qi; Reddy, Mundla S.; Ma, Chunrong; Harris, Brad; McKernan, Ruth; Skolnick, Phil; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2537-2552</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A pharmacophore and an alignment rule have previously been reported for BzR agonist ligands.  The design and synthesis of 6-(propyloxy)-4-(methoxymethyl)-β-carboline-3-carboxylic acid Et ester (6-PBC, 24, IC50 = 8.1 nM) was based on this pharmacophore.  When evaluated in vivo this ligand exhibited anticonvulsant/anxiolytic activity but was devoid of the muscle relaxant/ataxic effects of "classical" 1,4-benzodiazepines (i.e., diazepam).  Significantly, 6-PBC 24 also reversed diazepam-induced muscle relaxation in mice.  The 3-substituted analogs of 6-PBC 24 and Zk 93423 27 (IC50 = 1 nM) were synthesized and evaluated in vitro to det. what affect these modifications would have on the binding affinity at recombinant BzR subtypes.  With the exception of the 3-amino ligands, all the β-carbolines were found to exhibit high binding affinity at BzR sites.  The 3-Pr ether deriv. was also evaluated in vivo and found to be devoid of any proconvulsant or anticonvulsant activity at doses up to 40 mg/kg.  The 6-(1-naphthylmethyloxy) and 6-octyloxy analogs of 6-PBC 24 were synthesized to further evaluate the proposed alignment of agonists vs inverse agonists in the pharmacophore of the BzR.  These and other related β-carbolines were also examd. in five recombinant GABAA receptor subtypes.  Moderate to high affinity at GABAA receptors contg. α1 subunits was obsd.  These ligands will be useful in further defining the pharmacophore at α1β3γ2 receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjRuoXhM4xcLVg90H21EOLACvtfcHk0liD5oIH03nU_A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXkt12jt7k%253D&md5=be85a0d7e1d3c5236f72d58df85cf81d</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Fjm970460b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm970460b%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DE.%2BD.%26aulast%3DDiaz-Arauzo%26aufirst%3DH.%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DReddy%26aufirst%3DM.%2BS.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DHarris%26aufirst%3DB.%26aulast%3DMcKernan%26aufirst%3DR.%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520analogues%2520of%2520the%2520partial%2520agonist%25206-%2528propyloxy%2529-4-%2528methoxymethyl%2529-%25CE%25B2-carboline-3-carboxylic%2520acid%2520ethyl%2520ester%2520%25286-PBC%2529%2520and%2520the%2520full%2520agonist%25206-%2528benzyloxy%2529-4-%2528methoxymethyl%2529-%25CE%25B2-carboline-3-carboxylic%2520acid%2520ethyl%2520ester%2520%2528Zk%252093423%2529%2520at%2520wild%2520type%2520and%2520recombinant%2520GABAA%2520receptors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1998%26volume%3D41%26spage%3D2537%26epage%3D2552%26doi%3D10.1021%2Fjm970460b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olesen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidelmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, J. B.</span></span> <span> </span><span class="NLM_article-title">Oxazolo[4,5-g]-β-carbolines and pyrazino[2,3-g]-β-carbolines. Synthesis of modulators of the GABAA/chloride channel complex</span>. <i>Heterocycles</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.3987/COM-97-7959</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3987%2FCOM-97-7959" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK1cXitFWrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=1998&pages=31-40&author=P.+H.+Olesenauthor=D.+Seidelmannauthor=J.+B.+Hansen&title=Oxazolo%5B4%2C5-g%5D-%CE%B2-carbolines+and+pyrazino%5B2%2C3-g%5D-%CE%B2-carbolines.+Synthesis+of+modulators+of+the+GABAA%2Fchloride+channel+complex&doi=10.3987%2FCOM-97-7959"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Oxazolo[4,5-g]-β-carbolines and pyrazino[2,3-g]-β-carbolines. Synthesis of modulators of the GABAA/chloride channel complex</span></div><div class="casAuthors">Olesen, Preben H.; Seidelmann, Dieter; Hansen, John Bondo</div><div class="citationInfo"><span class="NLM_cas:title">Heterocycles</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">31-40</span>CODEN:
                <span class="NLM_cas:coden">HTCYAM</span>;
        ISSN:<span class="NLM_cas:issn">0385-5414</span>.
    
            (<span class="NLM_cas:orgname">Japan Institute of Heterocyclic Chemistry</span>)
        </div><div class="casAbstract">The synthesis of oxazolo[4,5-g]-β-carbolines, e.g., I, and pyrazino[2,3-g]-β-carbolines II [R1 = R2 = H; R1R2 = (CH2)4] starting from 6-hydroxy-β-carboline III was investigated in order to prep. new ligands for the benzodiazepine site of the GABAA/chloride channel complex.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZdotE6pEBFrVg90H21EOLACvtfcHk0lh_F-kcGLcc9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXitFWrsbg%253D&md5=4b91a10b47a03486a650f2bd50ac81e3</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.3987%2FCOM-97-7959&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3987%252FCOM-97-7959%26sid%3Dliteratum%253Aachs%26aulast%3DOlesen%26aufirst%3DP.%2BH.%26aulast%3DSeidelmann%26aufirst%3DD.%26aulast%3DHansen%26aufirst%3DJ.%2BB.%26atitle%3DOxazolo%255B4%252C5-g%255D-%25CE%25B2-carbolines%2520and%2520pyrazino%255B2%252C3-g%255D-%25CE%25B2-carbolines.%2520Synthesis%2520of%2520modulators%2520of%2520the%2520GABAA%252Fchloride%2520channel%2520complex%26jtitle%3DHeterocycles%26date%3D1998%26volume%3D48%26spage%3D31%26epage%3D40%26doi%3D10.3987%2FCOM-97-7959" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honoré, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braestrup, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehr, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wachtel, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidelman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmiechen, R.</span></span> <span> </span><span class="NLM_article-title">ZK 91296, a partial agonist at benzodiazepine receptors</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">240</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1007/BF00464788</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1007%2FBF00464788" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=6089246" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL2cXltVeqtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1984&pages=240-248&author=E.+N.+Petersenauthor=L.+H.+Jensenauthor=T.+Honor%C3%A9author=C.+Braestrupauthor=W.+Kehrauthor=D.+N.+Stephensauthor=H.+Wachtelauthor=D.+Seidelmanauthor=R.+Schmiechen&title=ZK+91296%2C+a+partial+agonist+at+benzodiazepine+receptors&doi=10.1007%2FBF00464788"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">ZK 91296, a partial agonist at benzodiazepine receptors</span></div><div class="casAuthors">Petersen, Erling N.; Jensen, Leif H.; Honore, Tage; Braestrup, Claus; Kehr, Wolfgang; Stephens, David N.; Wachtel, Helmuth; Seidelman, Dieter; Schmiechen, Ralph</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">240-8</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">ZK 91296 (I)  [83910-34-3] is a potent and selective ligand for benzodiazepine (BZ) receptors.  I may be a partial agonist at BZ receptors; this may explain to some extent why I needs higher BZ receptor occupancy than diazepam for the same effect against chem. convulsants and for behavioral effects.  The lack of sedative effects and the very potent inhibition of reflex epilepsy, spontaneous epilepsy, and DMCM-induced seizures suggest, furthermore, that I may possess pharmacol. selectivity for a particular type of BZ receptor interaction, perhaps including topog. as well as receptor subtype differentiation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2e4s8TvyLJbVg90H21EOLACvtfcHk0lh_F-kcGLcc9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXltVeqtrY%253D&md5=295ca439a33e166324497cdc5d8b8a80</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1007%2FBF00464788&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00464788%26sid%3Dliteratum%253Aachs%26aulast%3DPetersen%26aufirst%3DE.%2BN.%26aulast%3DJensen%26aufirst%3DL.%2BH.%26aulast%3DHonor%25C3%25A9%26aufirst%3DT.%26aulast%3DBraestrup%26aufirst%3DC.%26aulast%3DKehr%26aufirst%3DW.%26aulast%3DStephens%26aufirst%3DD.%2BN.%26aulast%3DWachtel%26aufirst%3DH.%26aulast%3DSeidelman%26aufirst%3DD.%26aulast%3DSchmiechen%26aufirst%3DR.%26atitle%3DZK%252091296%252C%2520a%2520partial%2520agonist%2520at%2520benzodiazepine%2520receptors%26jtitle%3DPsychopharmacology%26date%3D1984%26volume%3D83%26spage%3D240%26epage%3D248%26doi%3D10.1007%2FBF00464788" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jensen, L. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petersen, E. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braestrup, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Honoré, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehr, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephens, D. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seidelmann, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmiechen, R.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the β-carboline ZK 93 426 as a benzodiazepine receptor antagonist</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">1984</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1007/BF00464789</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1007%2FBF00464789" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=6089247" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL2cXltVeqtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=1984&pages=249-256&author=L.+H.+Jensenauthor=E.+N.+Petersenauthor=C.+Braestrupauthor=T.+Honor%C3%A9author=W.+Kehrauthor=D.+N.+Stephensauthor=H.+Schneiderauthor=D.+Seidelmannauthor=R.+Schmiechen&title=Evaluation+of+the+%CE%B2-carboline+ZK+93+426+as+a+benzodiazepine+receptor+antagonist&doi=10.1007%2FBF00464789"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of the β-carboline ZK 93426 as a benzodiazepine receptor antagonist</span></div><div class="casAuthors">Jensen, Leif H.; Petersen, Erling N.; Braestrup, Claus; Honore, Tage; Kehr, Wolfgang; Stephens, David N.; Schneider, Herbert; Seidelmann, Dieter; Schmiechen, Ralph</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">1984</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-56</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    </div><div class="casAbstract">Certain biochem. effects of ZK 93426 (I)  [89592-45-0] were quite similar to those of the benzodiazepine antagonists Ro 15-1788 and CGS 8216 (e.g., [3H]flunitrazepam displacement, GABA ratio, photoshift).  In most pharmacol. tests I and Ro 15-1788 lacked overt effects; Ro 15-1788 was a weak agonist in some paradigms, whereas I exhibited a potent proconflict effect but also a weak anticonvulsant effect.  This finding with I suggests that benzodiazepine (BZ) receptor ligands may possess differential efficacy at BZ receptor subtypes.  In contrast, CGS 8216 exhibited potent proconvulsant effects in several paradigms in addn. to proconflict and pentylenetetrazole generalizing effects.  I, Ro 15-1788, and CGS 8216 were almost equally potent as antagonists of the effects of BZ receptor agonists, such as diazepam and lorazepam.  However, I was the most potent inhibitor of the convulsions produced by the BZ receptor inverse agonist DMCM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRYwTDdrU2UbVg90H21EOLACvtfcHk0lh_F-kcGLcc9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2cXltVeqtrc%253D&md5=b1510536223f22d79ad78986e033e918</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1007%2FBF00464789&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252FBF00464789%26sid%3Dliteratum%253Aachs%26aulast%3DJensen%26aufirst%3DL.%2BH.%26aulast%3DPetersen%26aufirst%3DE.%2BN.%26aulast%3DBraestrup%26aufirst%3DC.%26aulast%3DHonor%25C3%25A9%26aufirst%3DT.%26aulast%3DKehr%26aufirst%3DW.%26aulast%3DStephens%26aufirst%3DD.%2BN.%26aulast%3DSchneider%26aufirst%3DH.%26aulast%3DSeidelmann%26aufirst%3DD.%26aulast%3DSchmiechen%26aufirst%3DR.%26atitle%3DEvaluation%2520of%2520the%2520%25CE%25B2-carboline%2520ZK%252093%2520426%2520as%2520a%2520benzodiazepine%2520receptor%2520antagonist%26jtitle%3DPsychopharmacology%26date%3D1984%26volume%3D83%26spage%3D249%26epage%3D256%26doi%3D10.1007%2FBF00464789" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, H.</span></span> <span> </span><span class="NLM_article-title">Ligands of the GABAA receptor benzodiazepine binding site</span>. <i>CNS Drug Rev.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1111/j.1527-3458.1999.tb00094.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1111%2Fj.1527-3458.1999.tb00094.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK1MXmsFKku7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1999&pages=125-144&author=Q.+Wangauthor=Y.+Hanauthor=H.+Xue&title=Ligands+of+the+GABAA+receptor+benzodiazepine+binding+site&doi=10.1111%2Fj.1527-3458.1999.tb00094.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Ligands of the GABAA receptor benzodiazepine binding site</span></div><div class="casAuthors">Wang, Qinmi; Han, Yifan; Xue, Hong</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drug Reviews</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-144</span>CODEN:
                <span class="NLM_cas:coden">CDREFB</span>;
        ISSN:<span class="NLM_cas:issn">1080-563X</span>.
    
            (<span class="NLM_cas:orgname">Neva Press</span>)
        </div><div class="casAbstract">A review, with 74 refs. describing the developments related to the structure-activity and structure-efficacy relationships that surround various benzodiazepine (BZ)-binding site ligands, along with their relevant pharmacophore models.  These relationships and models can provide useful signposts for the study of the structural properties of the BZ-binding site and their assocd. interactions with ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr41-pM9vDebVg90H21EOLACvtfcHk0li8wGRXgGDIYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmsFKku7o%253D&md5=6144a6b1c9ee9099c76e7eb50c6392fc</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3458.1999.tb00094.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3458.1999.tb00094.x%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DQ.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DXue%26aufirst%3DH.%26atitle%3DLigands%2520of%2520the%2520GABAA%2520receptor%2520benzodiazepine%2520binding%2520site%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D1999%26volume%3D5%26spage%3D125%26epage%3D144%26doi%3D10.1111%2Fj.1527-3458.1999.tb00094.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, C. R.</span></span> <span> </span><span class="NLM_article-title">Functional in vivo correlates of the benzodiazepine agonist-inverse agonist continuum</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">425</span>– <span class="NLM_lpage">476</span>, <span class="refDoi"> DOI: 10.1016/0301-0082(88)90011-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2F0301-0082%2888%2990011-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=2849142" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL1MXhsl2nsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=1988&pages=425-476&author=C.+R.+Gardner&title=Functional+in+vivo+correlates+of+the+benzodiazepine+agonist-inverse+agonist+continuum&doi=10.1016%2F0301-0082%2888%2990011-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit133R"><div class="casContent"><span class="casTitleNuber">133</span><div class="casTitle"><span class="NLM_cas:atitle">Functional in vivo correlates of the benzodiazepine agonist-inverse agonist continuum</span></div><div class="casAuthors">Gardner, Colin R.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">31</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">425-76</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    </div><div class="casAbstract">A review with ∼500 refs. of benzodiazepine agonists, antagonists, and inverse agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvLHp-kxAeW7Vg90H21EOLACvtfcHk0li8wGRXgGDIYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL1MXhsl2nsg%253D%253D&md5=495191a9fc542a6af741eeda9d3b61e1</span></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1016%2F0301-0082%2888%2990011-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0301-0082%252888%252990011-1%26sid%3Dliteratum%253Aachs%26aulast%3DGardner%26aufirst%3DC.%2BR.%26atitle%3DFunctional%2520in%2520vivo%2520correlates%2520of%2520the%2520benzodiazepine%2520agonist-inverse%2520agonist%2520continuum%26jtitle%3DProg.%2520Neurobiol.%26date%3D1988%26volume%3D31%26spage%3D425%26epage%3D476%26doi%3D10.1016%2F0301-0082%2888%2990011-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gardner, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedgecock, C. J. R.</span></span> <span> </span><span class="NLM_article-title">The rapidly expanding range of neuronal benzodiazepine receptor ligands</span>. <i>Prog. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">61</span>, <span class="refDoi"> DOI: 10.1016/0301-0082(93)90047-V</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2F0301-0082%2893%2990047-V" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=8380934" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK3sXhsFOgtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1993&pages=1-61&author=C.+R.+Gardnerauthor=W.+R.+Tullyauthor=C.+J.+R.+Hedgecock&title=The+rapidly+expanding+range+of+neuronal+benzodiazepine+receptor+ligands&doi=10.1016%2F0301-0082%2893%2990047-V"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">The rapidly expanding range of neuronal benzodiazepine receptor ligands</span></div><div class="casAuthors">Gardner, Colin R.; Tully, W. Roger; Hedgecock, Charles J. R.</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Neurobiology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-61</span>CODEN:
                <span class="NLM_cas:coden">PGNBA5</span>;
        ISSN:<span class="NLM_cas:issn">0301-0082</span>.
    </div><div class="casAbstract">A review with ≈400 ref.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP17ux6SV5nrVg90H21EOLACvtfcHk0lgDyhvy8xLLlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXhsFOgtw%253D%253D&md5=4d546bf15110feb5e6f4db3800d673be</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1016%2F0301-0082%2893%2990047-V&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0301-0082%252893%252990047-V%26sid%3Dliteratum%253Aachs%26aulast%3DGardner%26aufirst%3DC.%2BR.%26aulast%3DTully%26aufirst%3DW.%2BR.%26aulast%3DHedgecock%26aufirst%3DC.%2BJ.%2BR.%26atitle%3DThe%2520rapidly%2520expanding%2520range%2520of%2520neuronal%2520benzodiazepine%2520receptor%2520ligands%26jtitle%3DProg.%2520Neurobiol.%26date%3D1993%26volume%3D40%26spage%3D1%26epage%3D61%26doi%3D10.1016%2F0301-0082%2893%2990047-V" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dayer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenger, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKernan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacophore/receptor models for GABAA/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a comprehensive ligand-mapping approach</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1021/jm990341r</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990341r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK1MXnslKgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=71-95&author=Q.+Huangauthor=X.+Heauthor=C.+Maauthor=R.+Liuauthor=S.+Yuauthor=C.+A.+Dayerauthor=G.+R.+Wengerauthor=R.+McKernanauthor=J.+M.+Cook&title=Pharmacophore%2Freceptor+models+for+GABAA%2FBzR+subtypes+%28%CE%B11%CE%B23%CE%B32%2C+%CE%B15%CE%B23%CE%B32%2C+and+%CE%B16%CE%B23%CE%B32%29+via+a+comprehensive+ligand-mapping+approach&doi=10.1021%2Fjm990341r"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacophore/receptor models for GABAA/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) via a comprehensive ligand-mapping approach</span></div><div class="casAuthors">Huang, Qi; He, Xiaohui; Ma, Chunrong; Liu, Ruiyan; Yu, Shu; Dayer, Charlotte A.; Wenger, Galen R.; McKernan, Ruth; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-95</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Pharmacophore/receptor models for three recombinant GABAA/BzR subtypes (α1β3γ2, α5β3γ2, and α6β3γ2) have been established via an SAR ligand-mapping approach.  This study was based on the affinities of 151 BzR ligands at five distinct (α1-3,5,6β3γ2) recombinant GABAA/BzR receptor subtypes from at least nine different structural families.  Examn. of the included vols. of the α1-, α5-, and α6-contg. subtypes indicated that region L2 for the α5-contg. subtype appeared to be larger in size than the analogous region of the other receptor subtypes.  Region LDi, in contrast, appeared to be larger in the α1 subtype than in the other two subtypes. Moreover, region L3 in the α6 subtype is either very small or nonexistent in this diazepam-insensitive subtype (see Figure 16 for details) as compared to the other subtypes.  Use of the pharmacophore/receptor models for these subtypes has resulted in the design of novel BzR ligands (see 27) selective for the α5β3γ2 receptor subtype. α5-Selective ligand 27 when injected directly into the hippocampus did enhance memory in one paradigm (Bailey et al., unpublished observations); however, systemic administration of either 9 or 27 into animals did not provide an observable enhancement.  This result is in complete agreement with the observation of Liu (1996).  It has been shown (Liu, 1996; Wisden et al., 1992) that in the central nervous system of the rat (as well as monkeys and pigeons) there are several native subtypes of the GABAA receptor which exhibit different functions, regional distributions, and neuronal locations.  Although 27 binds more potently at α5β3γ2 receptor subtypes and is clearly an inverse agonist (Liu et al., 1996; Liu, 1996), it is possible that this ligand acts as an agonist at one or more subtypes.  Liu (1996) clearly showed that a no. of imidazobenzodiazepines were neg. modulators at one subtype and agonists at another. Therefore, selectivity for a particular subtype at this point is not sufficient to rule out some physiol. effect at other GABAA/BzR subtypes.  The inability of 27 to potentiate memory when given systemically is again in support of this hypothesis, esp. since α1β2γ2 subtypes are distributed throughout the brain (Wisden et al., 1992).  A drug delivered systemically is far more likely to interact with all subtypes than one delivered to a specific brain region.  This observation (systemic vs intrahippocampal) provides further support for the design of more subtype-specific ligands at the BzR to accurately define their pharmacol., one key to the design of new drugs with fewer side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX43jXnLKV1rVg90H21EOLACvtfcHk0lgDyhvy8xLLlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXnslKgt7Y%253D&md5=2ff8989f0201c03ff7fd7ae64574a066</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1021%2Fjm990341r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990341r%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DQ.%26aulast%3DHe%26aufirst%3DX.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DYu%26aufirst%3DS.%26aulast%3DDayer%26aufirst%3DC.%2BA.%26aulast%3DWenger%26aufirst%3DG.%2BR.%26aulast%3DMcKernan%26aufirst%3DR.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DPharmacophore%252Freceptor%2520models%2520for%2520GABAA%252FBzR%2520subtypes%2520%2528%25CE%25B11%25CE%25B23%25CE%25B32%252C%2520%25CE%25B15%25CE%25B23%25CE%25B32%252C%2520and%2520%25CE%25B16%25CE%25B23%25CE%25B32%2529%2520via%2520a%2520comprehensive%2520ligand-mapping%2520approach%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D71%26epage%3D95%26doi%3D10.1021%2Fjm990341r" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alder, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silk, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adkins, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fletcher, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scales, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kerby, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marshall, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wafford, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKernan, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atack, J. R.</span></span> <span> </span><span class="NLM_article-title">Effect of a subunit on allosteric modulation of ion channel function in stably expressed human recombinant γ-aminobutyric acidA receptors determined using 36Cl ion flux</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1108</span>– <span class="NLM_lpage">1118</span>, <span class="refDoi"> DOI: 10.1124/mol.59.5.1108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1124%2Fmol.59.5.1108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=11306694" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjt1aqsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2001&pages=1108-1118&author=A.+J.+Smithauthor=L.+Alderauthor=J.+Silkauthor=J.+Adkinsauthor=A.+E.+Fletcherauthor=T.+Scalesauthor=J.+Kerbyauthor=G.+Marshallauthor=K.+A.+Waffordauthor=R.+M.+McKernanauthor=J.+R.+Atack&title=Effect+of+a+subunit+on+allosteric+modulation+of+ion+channel+function+in+stably+expressed+human+recombinant+%CE%B3-aminobutyric+acidA+receptors+determined+using+36Cl+ion+flux&doi=10.1124%2Fmol.59.5.1108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of α subunit on allosteric modulation of ion channel function in stably expressed human recombinant γ-aminobutyric acidA receptors determined using 36Cl ion flux</span></div><div class="casAuthors">Smith, Alison J.; Alder, Luanda; Silk, Jonathan; Adkins, Charles; Fletcher, Alan E.; Scales, Tim; Kerby, Julie; Marshall, George; Wafford, Keith A.; Mckernan, Ruth M.; Atack, John R.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1108-1118</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Inhibitory γ-aminobutyric acid (GABA)A receptors are subject to modulation at a variety of allosteric sites, with pharmacol. dependent on receptor subunit combination.  The influence of different α subunits in combination with β3γ2s was examd. in stably expressed human recombinant GABAA receptors by measuring 36Cl influx through the ion channel pore.  Muscimol and GABA exhibited similar maximal efficacy at each receptor subtype, although muscimol was more potent, with responses blocked by picrotoxin and bicuculline.  Receptors contg. the α3 subunit exhibited slightly lower potency.  The comparative pharmacol. of a range of benzodiazepine site ligands was examd., revealing a range of intrinsic efficacies at different receptor subtypes.  Of the diazepam-sensitive GABAA receptors (α1, α2, α3, α5), α5 showed the most divergence, being discriminated by zolpidem in terms of very low affinity, and CL 218872 and CGS 9895 with different efficacies.  Benzodiazepine potentiation at α3β3γ2s with nonselective agonist chlordiazepoxide was greater than at α1, α2, or α5 (P < 0.001).  The presence of an α4 subunit conferred a unique pharmacol. profile.  The partial agonist bretazenil was the most efficacious benzodiazepine, despite lower α4 affinity, and FG 8205 displayed similar efficacy.  Most striking were the lack of affinity/efficacy for classical benzodiazepines and the relatively high efficacy of Ro 15-1788 (53%), CGS 8216 (56%), CGS 9895 (65%), and the weak partial inverse agonist Ro 15-4513 (87%).  Each receptor subtype was modulated by pentobarbital, loreclezole, and 5α-pregnan-3α-ol-20-one, but the type of α subunit influenced the level of potentiation.  The maximal pentobarbital response was significantly greater at α4β3γ2s (226% increase in the EC20 response to GABA) than any other modulator.  The rank order of potentiation for pregnanolone was α5 > α2 > α3 = α4 > α1, for loreclezole α1 = α2 = α3 > α5 > α4, and for pentobarbital α4 = α5 = α2 > α1 = α3.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrqRE39F8EK9LVg90H21EOLACvtfcHk0lgC7Cr2zHXVQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjt1aqsbk%253D&md5=0294f7356c3d726a26f823e08fd8fd09</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1124%2Fmol.59.5.1108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.59.5.1108%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DA.%2BJ.%26aulast%3DAlder%26aufirst%3DL.%26aulast%3DSilk%26aufirst%3DJ.%26aulast%3DAdkins%26aufirst%3DJ.%26aulast%3DFletcher%26aufirst%3DA.%2BE.%26aulast%3DScales%26aufirst%3DT.%26aulast%3DKerby%26aufirst%3DJ.%26aulast%3DMarshall%26aufirst%3DG.%26aulast%3DWafford%26aufirst%3DK.%2BA.%26aulast%3DMcKernan%26aufirst%3DR.%2BM.%26aulast%3DAtack%26aufirst%3DJ.%2BR.%26atitle%3DEffect%2520of%2520a%2520subunit%2520on%2520allosteric%2520modulation%2520of%2520ion%2520channel%2520function%2520in%2520stably%2520expressed%2520human%2520recombinant%2520%25CE%25B3-aminobutyric%2520acidA%2520receptors%2520determined%2520using%252036Cl%2520ion%2520flux%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D59%26spage%3D1108%26epage%3D1118%26doi%3D10.1124%2Fmol.59.5.1108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banks, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wingrove, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whiting, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atack, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seabrook, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maubach, K. A.</span></span> <span> </span><span class="NLM_article-title">Role of the histidine residue at position 105 in the human α5 containing GABAA receptor on the affinity and efficacy of benzodiazepine site ligands</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">256</span>, <span class="refDoi"> DOI: 10.1038/sj.bjp.0704459</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1038%2Fsj.bjp.0704459" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=11786501" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD38XovVemsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2002&pages=248-256&author=M.+D.+Kellyauthor=A.+Smithauthor=G.+Banksauthor=P.+Wingroveauthor=P.+W.+Whitingauthor=J.+Atackauthor=G.+R.+Seabrookauthor=K.+A.+Maubach&title=Role+of+the+histidine+residue+at+position+105+in+the+human+%CE%B15+containing+GABAA+receptor+on+the+affinity+and+efficacy+of+benzodiazepine+site+ligands&doi=10.1038%2Fsj.bjp.0704459"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Role of the histidine residue at position 105 in the human α5 containing GABAA receptor on the affinity and efficacy of benzodiazepine site ligands</span></div><div class="casAuthors">Kelly, M. D.; Smith, A.; Banks, G.; Wingrove, P.; Whiting, P. W.; Atack, J.; Seabrook, G. R.; Maubach, K. A.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">135</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">248-256</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">0007-1188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A histidine residue in the N-terminal extracellular region of α1,2,3,5 subunits of the human GABAA receptor, which is replaced by an arginine in α4 and α6 subunits, is a major determinant for high affinity binding of classical benzodiazepine (BZ)-site ligands.  The effect of mutating this histidine at position 105 in the α5 subunit to an arginine (α5H105R) on BZ-site pharmacol. has been investigated using radioligand binding on HEK293 and L(tk-) cells and two electrode voltage clamp recording on Xenopus oocytes in which GABAA receptors of subtypes α5, α5H105R, α4 and α6 were co-expressed with β3γ2s.  The classical BZs, diazepam and flunitrazepam (full agonists on the α5 receptor) showed negligible affinity and therefore negligible efficacy on α5H105R receptors.  The β-carbolines DMCM and βCCE (inverse agonists on the α5 receptor) retained some affinity but did not exhibit inverse agonist efficacy at α5H105R receptors.  Therefore, the α5H105R mutation confers an α4/α6-like pharmacol. to the classical BZs and β-carbolines.  Ro 15-4513, flumazenil, bretazenil and FG 8094, which share a common imidazobenzodiazepine core structure, retained high affinity and were higher efficacy agonists on α5H105R receptors than would be predicted from an α4/α6 pharmacol. profile.  This effect was antagonized by DMCM, which competes for the BZ-site and therefore is likely to be mediated via the BZ-site.  These data indicate that the conserved histidine residue in the α subunit is not only a key determinant in the affinity of BZ-site ligands on α5 contg. GABAA receptors, but also influences ligand efficacy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx-1n2Lxv11rVg90H21EOLACvtfcHk0lgC7Cr2zHXVQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XovVemsQ%253D%253D&md5=b82b9ec52a06ed6717fa7eab22fc25b7</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjp.0704459&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjp.0704459%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DM.%2BD.%26aulast%3DSmith%26aufirst%3DA.%26aulast%3DBanks%26aufirst%3DG.%26aulast%3DWingrove%26aufirst%3DP.%26aulast%3DWhiting%26aufirst%3DP.%2BW.%26aulast%3DAtack%26aufirst%3DJ.%26aulast%3DSeabrook%26aufirst%3DG.%2BR.%26aulast%3DMaubach%26aufirst%3DK.%2BA.%26atitle%3DRole%2520of%2520the%2520histidine%2520residue%2520at%2520position%2520105%2520in%2520the%2520human%2520%25CE%25B15%2520containing%2520GABAA%2520receptor%2520on%2520the%2520affinity%2520and%2520efficacy%2520of%2520benzodiazepine%2520site%2520ligands%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2002%26volume%3D135%26spage%3D248%26epage%3D256%26doi%3D10.1038%2Fsj.bjp.0704459" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majumder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clayton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petrou, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">VanLinn, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namjoshi, O. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cromer, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roth, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Platt, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">7548</span>– <span class="NLM_lpage">7564</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.08.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmc.2010.08.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=20888240" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlSms73K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=7548-7564&author=W.+Yinauthor=S.+Majumderauthor=T.+Claytonauthor=S.+Petrouauthor=M.+L.+VanLinnauthor=O.+A.+Namjoshiauthor=C.+Maauthor=B.+A.+Cromerauthor=B.+L.+Rothauthor=D.+M.+Plattauthor=J.+M.+Cook&title=Design%2C+synthesis%2C+and+subtype+selectivity+of+3%2C6-disubstituted+%CE%B2-carbolines+at+Bz%2FGABA%28A%29ergic+receptors.+SAR+and+studies+directed+toward+agents+for+treatment+of+alcohol+abuse&doi=10.1016%2Fj.bmc.2010.08.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse</span></div><div class="casAuthors">Yin, Wenyuan; Majumder, Samarpan; Clayton, Terry; Petrou, Steven; VanLinn, Michael L.; Namjoshi, Ojas A.; Ma, Chunrong; Cromer, Brett A.; Roth, Bryan L.; Platt, Donna M.; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7548-7564</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of 3,6-disubstituted β-carbolines was synthesized and evaluated for their in vitro affinities at αxβ3γ2 GABAA/benzodiazepine receptor subtypes by radioligand binding assays in search of α1 subtype selective ligands to treat alc. abuse.  Analogs of β-carboline-3-carboxylate-t-Bu ester (βCCt, 1) were synthesized via a CDI-mediated process and the related 6-substituted β-carboline-3-carboxylates 6 including WYS8 (7) were synthesized via a Sonogashira or Stille coupling processes from 6-iodo-βCCt (5).  The bivalent ligands of βCCt (32 and 33) were also designed and prepd. via a palladium-catalyzed homocoupling process to expand the structure-activity relationships (SAR) to larger ligands.  Based on the pharmacophore/receptor model, a preliminary SAR study on 34 analogs illustrated that large substituents at position-6 of the β-carbolines were well tolerated.  As expected, these groups are proposed to project into the extracellular domain (LDi region) of GABAA/Bz receptors (see 32 and 33).  Moreover, substituents located at position-3 of the β-carboline nucleus exhibited a conserved stereo interaction in lipophilic pocket L1, while N(2) presumably underwent a hydrogen bonding interaction with H1.  Three novel β-carboline ligands (βCCt, 3PBC and WYS8), which preferentially bound to α1 BzR subtypes permitted a comparison of the pharmacol. efficacies with a range of classical BzR antagonists (flumazenil, ZK93426) from several different structural groups and indicated these β-carbolines were near GABA neutral antagonists'.  Based on the SAR, the most potent (in vitro) α1 selective ligand was the 6-substituted acetylenyl βCCt (WYS8, 7).  Earlier both βCCt and 3PBC had been shown to reduce alc. self-administration in alc. preferring (P) and high alc. drinking (HAD) rats but had little or no effect on sucrose self-administration.  Moreover, these two β-carbolines were orally active, and in addn., were anxiolytic in P rats but were only weakly anxiolytic in rodents.  These data prompted the synthesis of the β-carbolines presented here.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDob07fAiYDLVg90H21EOLACvtfcHk0ljIJeiQ-BFV2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlSms73K&md5=3339b0d8ed30c7cb64f503f61d7396bb</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.08.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.08.049%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DW.%26aulast%3DMajumder%26aufirst%3DS.%26aulast%3DClayton%26aufirst%3DT.%26aulast%3DPetrou%26aufirst%3DS.%26aulast%3DVanLinn%26aufirst%3DM.%2BL.%26aulast%3DNamjoshi%26aufirst%3DO.%2BA.%26aulast%3DMa%26aufirst%3DC.%26aulast%3DCromer%26aufirst%3DB.%2BA.%26aulast%3DRoth%26aufirst%3DB.%2BL.%26aulast%3DPlatt%26aufirst%3DD.%2BM.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520subtype%2520selectivity%2520of%25203%252C6-disubstituted%2520%25CE%25B2-carbolines%2520at%2520Bz%252FGABA%2528A%2529ergic%2520receptors.%2520SAR%2520and%2520studies%2520directed%2520toward%2520agents%2520for%2520treatment%2520of%2520alcohol%2520abuse%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D7548%26epage%3D7564%26doi%3D10.1016%2Fj.bmc.2010.08.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yin, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarma, P. V. V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of bivalent ligands of β-carboline-3-carboxylates via a palladium-catalyzed homocoupling process</span>. <i>Tetrahedron Lett.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">6363</span>– <span class="NLM_lpage">6368</span>, <span class="refDoi"> DOI: 10.1016/j.tetlet.2005.07.022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.tetlet.2005.07.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2MXns1SgsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2005&pages=6363-6368&author=W.+Yinauthor=P.+V.+V.+S.+Sarmaauthor=J.+Maauthor=D.+Hanauthor=J.+L.+Chenauthor=J.+M.+Cook&title=Synthesis+of+bivalent+ligands+of+%CE%B2-carboline-3-carboxylates+via+a+palladium-catalyzed+homocoupling+process&doi=10.1016%2Fj.tetlet.2005.07.022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of bivalent ligands of β-carboline-3-carboxylates via a palladium-catalyzed homocoupling process</span></div><div class="casAuthors">Yin, Wenyuan; Sarma, P. V. V. Srirama; Ma, Jun; Han, Dongmei; Chen, Jessica L.; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">6363-6368</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The first synthesis of bivalent ligands of β-carboline-3-carboxylates was achieved from β-carboline-3-carboxylate tert-Bu ester (βCCt) via Sonogashira and palladium-catalyzed homocoupling processes.  The Boc-protected intermediate, an iodo-β-carboline-3-carboxylate, was employed to provide a general entry into a series of bivalent ligands structurally similar to βCCt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXcwGcYMHBnLVg90H21EOLACvtfcHk0ljIJeiQ-BFV2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXns1SgsLk%253D&md5=4158e1c49fef715f2e0e5c3025d541a9</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1016%2Fj.tetlet.2005.07.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tetlet.2005.07.022%26sid%3Dliteratum%253Aachs%26aulast%3DYin%26aufirst%3DW.%26aulast%3DSarma%26aufirst%3DP.%2BV.%2BV.%2BS.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DHan%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DJ.%2BL.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DSynthesis%2520of%2520bivalent%2520ligands%2520of%2520%25CE%25B2-carboline-3-carboxylates%2520via%2520a%2520palladium-catalyzed%2520homocoupling%2520process%26jtitle%3DTetrahedron%2520Lett.%26date%3D2005%26volume%3D46%26spage%3D6363%26epage%3D6368%26doi%3D10.1016%2Fj.tetlet.2005.07.022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Griebel, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perrault, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simiand, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Granger, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Depoortere, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Françon, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avenet, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schoemaker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evanno, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sevrin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">George, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scatton, B.</span></span> <span> </span><span class="NLM_article-title">SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms</span>. <i>CNS Drug Rev.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3</span>– <span class="NLM_lpage">20</span>, <span class="refDoi"> DOI: 10.1111/j.1527-3458.2003.tb00241.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1111%2Fj.1527-3458.2003.tb00241.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=12595909" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3sXjsFyht70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2003&pages=3-20&author=G.+Griebelauthor=G.+Perraultauthor=J.+Simiandauthor=C.+Cohenauthor=P.+Grangerauthor=H.+Depoortereauthor=D.+Fran%C3%A7onauthor=P.+Avenetauthor=H.+Schoemakerauthor=Y.+Evannoauthor=M.+Sevrinauthor=P.+Georgeauthor=B.+Scatton&title=SL651498%2C+a+GABAA+receptor+agonist+with+subtype-selective+efficacy%2C+as+a+potential+treatment+for+generalized+anxiety+disorder+and+muscle+spasms&doi=10.1111%2Fj.1527-3458.2003.tb00241.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms</span></div><div class="casAuthors">Griebel, Guy; Perrault, Ghislaine; Simiand, Jacques; Cohen, Caroline; Granger, Patrick; Depoortere, Henri; Francon, Dominique; Avenet, Patrick; Schoemaker, Hans; Evanno, Yannick; Sevrin, Mireille; George, Pascal; Scatton, Bernard</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drug Reviews</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-20</span>CODEN:
                <span class="NLM_cas:coden">CDREFB</span>;
        ISSN:<span class="NLM_cas:issn">1080-563X</span>.
    
            (<span class="NLM_cas:orgname">Neva Press</span>)
        </div><div class="casAbstract">A review.  SL651498 (6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2, 9-dihydro-1H-pyrido[3,4-b]indol-1-one) was identified as a drug development candidate from a research program designed to discover subtype-selective GABAA receptor agonists for the treatment of generalized anxiety disorder and muscle spasms.  The drug displays high affinity for rat native GABAA receptors contg. α1 (Ki = 6.8 nM) and α2 (Ki = 12.3 nM) subunits, and weaker affinity for as-contg. GABAA receptors (Ki = 117 nM).  Studies on recombinant rat GABAA receptors confirm these findings and indicate intermediate affinity for the α3β2γ2 subtype.  SL651498 behaves as a full agonist at recombinant rat GABAA receptors contg. α2 and α3 subunits, and as a partial agonist at recombinant GABAA receptors expressing α1 and α5 subunits.  SL651498 produced anxiolytic-like and skeletal muscle relaxant effects qual. similar to those of benzodiazepines (BZs) [minimal ED (MED): 1 to 10 mg/kg, i.p. and 3 to 10 mg/kg, p.o.].  However, unlike these latter drugs, SL651498 induced muscle weakness, ataxia or sedation at doses much higher than those having anxiolytic-like activity (MED: 30 to 100 mg/kg, i.p. or p.o.).  Moreover, in contrast to BZs, SL651498 did not produce tolerance to its anticonvulsant activity or phys. dependence.  It was much less active than BZs in potentiating the depressant effects of ethanol or impairing cognitive processes in rodents.  The differential profile of SL651498 as compared to BZs may be related to its selective efficacy at the α2- and α3-contg. GABAA receptors.  This suggests that selectively targeting GABAA receptor subtypes can lead to drugs with increased clin. specificity.  SL651498 represents a promising alternative to agents currently used for the treatment of anxiety disorders and muscle spasms without the major side effects seen with classical BZs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxyItz_ZQayLVg90H21EOLACvtfcHk0lg_wqkq5L1I_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXjsFyht70%253D&md5=79ace63273f5be34a70bd0a6f42a95e6</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1111%2Fj.1527-3458.2003.tb00241.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1527-3458.2003.tb00241.x%26sid%3Dliteratum%253Aachs%26aulast%3DGriebel%26aufirst%3DG.%26aulast%3DPerrault%26aufirst%3DG.%26aulast%3DSimiand%26aufirst%3DJ.%26aulast%3DCohen%26aufirst%3DC.%26aulast%3DGranger%26aufirst%3DP.%26aulast%3DDepoortere%26aufirst%3DH.%26aulast%3DFran%25C3%25A7on%26aufirst%3DD.%26aulast%3DAvenet%26aufirst%3DP.%26aulast%3DSchoemaker%26aufirst%3DH.%26aulast%3DEvanno%26aufirst%3DY.%26aulast%3DSevrin%26aufirst%3DM.%26aulast%3DGeorge%26aufirst%3DP.%26aulast%3DScatton%26aufirst%3DB.%26atitle%3DSL651498%252C%2520a%2520GABAA%2520receptor%2520agonist%2520with%2520subtype-selective%2520efficacy%252C%2520as%2520a%2520potential%2520treatment%2520for%2520generalized%2520anxiety%2520disorder%2520and%2520muscle%2520spasms%26jtitle%3DCNS%2520Drug%2520Rev.%26date%3D2003%26volume%3D9%26spage%3D3%26epage%3D20%26doi%3D10.1111%2Fj.1527-3458.2003.tb00241.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trudell, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basile, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shannon, H. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnick, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. M.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 7,12-dihydropyrido[3,4-b:5,4-b’]diindoles. A novel class of rigid, planar benzodiazepine receptor ligands</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">456</span>– <span class="NLM_lpage">458</span>, <span class="refDoi"> DOI: 10.1021/jm00386a003</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm00386a003" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaL2sXhtF2ksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=1987&pages=456-458&author=M.+L.+Trudellauthor=A.+S.+Basileauthor=H.+E.+Shannonauthor=P.+Skolnickauthor=J.+M.+Cook&title=Synthesis+of+7%2C12-dihydropyrido%5B3%2C4-b%3A5%2C4-b%E2%80%99%5Ddiindoles.+A+novel+class+of+rigid%2C+planar+benzodiazepine+receptor+ligands&doi=10.1021%2Fjm00386a003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 7,12-dihydropyrido[3,2-b:5,4-b']diindoles.  A novel class of rigid, planar benzodiazepine receptor ligands</span></div><div class="casAuthors">Trudell, Mark L.; Basile, Anthony S.; Shannon, Harlan E.; Skolnick, Phil; Cook, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1987</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">456-8</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    </div><div class="casAbstract">A new series of rigid, planar compds. I (R = H, Cl, OMe), which possess a high affinity for the benzodiazepine receptor(s) based on the novel heterocyclic system, dihydropyridodiindole I (R = H) were prepd. and evaluated for biol. activity.  Substitution on the E ring had a marked effect on the intrinsic biol.  activity of these benzodiazepine receptor ligands.  The 2-substituted analogs demonstrated the greatest affinity for the benzodiazepine receptor.  I (R = H, Cl, OMe) antagonized the anticonvulsant effects of diazepam (ED53 = 5 nM) in mice; however, I (R = H, OMe) also behaved as partial inverse agonists for they possessed convulsant activity.  I (R = Cl) did not elicit convulsant activity at the highest dose tested (30 mg/Kg) even though it was the most potent antagonist of diazepam with a ED50 of 2.5 mg/Kg.  The biol. profile of these rigid, planar analogs does suggest selectivity of action when the activity of I (R = H, OMe) are compared to that of I (R = Cl).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaSm8vIdwVHbVg90H21EOLACvtfcHk0lg_wqkq5L1I_g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL2sXhtF2ksL0%253D&md5=932daa5911862564e1c7012d113b7a8f</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1021%2Fjm00386a003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm00386a003%26sid%3Dliteratum%253Aachs%26aulast%3DTrudell%26aufirst%3DM.%2BL.%26aulast%3DBasile%26aufirst%3DA.%2BS.%26aulast%3DShannon%26aufirst%3DH.%2BE.%26aulast%3DSkolnick%26aufirst%3DP.%26aulast%3DCook%26aufirst%3DJ.%2BM.%26atitle%3DSynthesis%2520of%25207%252C12-dihydropyrido%255B3%252C4-b%253A5%252C4-b%25E2%2580%2599%255Ddiindoles.%2520A%2520novel%2520class%2520of%2520rigid%252C%2520planar%2520benzodiazepine%2520receptor%2520ligands%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1987%26volume%3D30%26spage%3D456%26epage%3D458%26doi%3D10.1021%2Fjm00386a003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Geldenhuys, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Schyf, C. J.</span></span> <span> </span><span class="NLM_article-title">Role of serotonin in Alzheimer’s disease: a new therapeutic target?</span>. <i>CNS Drugs</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">765</span>– <span class="NLM_lpage">781</span>, <span class="refDoi"> DOI: 10.2165/11590190-000000000-00000</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.2165%2F11590190-000000000-00000" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=21870888" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsVWjsbrK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=765-781&author=W.+J.+Geldenhuysauthor=C.+J.+Van+der+Schyf&title=Role+of+serotonin+in+Alzheimer%E2%80%99s+disease%3A+a+new+therapeutic+target%3F&doi=10.2165%2F11590190-000000000-00000"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Role of serotonin in Alzheimer's disease: a new therapeutic target?</span></div><div class="casAuthors">Geldenhuys, Werner J.; Van der Schyf, Cornelis J.</div><div class="citationInfo"><span class="NLM_cas:title">CNS Drugs</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">765-781</span>CODEN:
                <span class="NLM_cas:coden">CNDREF</span>;
        ISSN:<span class="NLM_cas:issn">1172-7047</span>.
    
            (<span class="NLM_cas:orgname">Adis Data Information BV</span>)
        </div><div class="casAbstract">A review.  Mounting evidence accumulated over the past few years indicates that the neurotransmitter serotonin plays a significant role in cognition.  As a drug target, serotonin receptors have received notable attention due in particular to the role of several serotonin-receptor subclasses in cognition and memory.  The intimate anatomical and neurochem. assocn. of the serotonergic system with brain areas that regulate memory and learning has directed current drug discovery programs to focus on this system as a major therapeutic drug target.  Thus far, none of these programs has yielded unambiguous data that suggest that any of the new drug entities possesses disease-modifying properties, and significantly more research in this promising area of investigation is required.  Compds. are currently being investigated for activity against serotonin 5-HT1, 5-HT4 and 5-HT6 receptors.  This review concludes that most work done in the development of selective serotonin receptor ligands is in the pre-clin. or early clin. phase.  Also, while many of these compds. will likely find application as adjuvant therapy in the symptomatic treatment of Alzheimer's disease, there are currently only a few drug entities with activity against serotonin receptors that may offer the potential to alter the progression of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTAnnw7_1LMLVg90H21EOLACvtfcHk0lh3OwynacUl6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsVWjsbrK&md5=87559be5dea4eda592186e0038e1ece9</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.2165%2F11590190-000000000-00000&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2165%252F11590190-000000000-00000%26sid%3Dliteratum%253Aachs%26aulast%3DGeldenhuys%26aufirst%3DW.%2BJ.%26aulast%3DVan%2Bder%2BSchyf%26aufirst%3DC.%2BJ.%26atitle%3DRole%2520of%2520serotonin%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520a%2520new%2520therapeutic%2520target%253F%26jtitle%3DCNS%2520Drugs%26date%3D2011%26volume%3D25%26spage%3D765%26epage%3D781%26doi%3D10.2165%2F11590190-000000000-00000" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Švob Štrac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pivac, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mück-Šeler, D.</span></span> <span> </span><span class="NLM_article-title">The serotonergic system and cognitive function</span>. <i>Transl. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">35</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1515/tnsci-2016-0007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1515%2Ftnsci-2016-0007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=28123820" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADC%252BC1c7ptlOnsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=35-49&author=D.+%C5%A0vob+%C5%A0tracauthor=N.+Pivacauthor=D.+M%C3%BCck-%C5%A0eler&title=The+serotonergic+system+and+cognitive+function&doi=10.1515%2Ftnsci-2016-0007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">The serotonergic system and cognitive function</span></div><div class="casAuthors">Svob Strac Dubravka; Pivac Nela; Muck-Seler Dorotea</div><div class="citationInfo"><span class="NLM_cas:title">Translational neuroscience</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">35-49</span>
        ISSN:<span class="NLM_cas:issn">2081-3856</span>.
    </div><div class="casAbstract">Symptoms of cognitive dysfunction like memory loss, poor concentration, impaired learning and executive functions are characteristic features of both schizophrenia and Alzheimer's disease (AD).  The neurobiological mechanisms underlying cognition in healthy subjects and neuropsychiatric patients are not completely understood.  Studies have focused on serotonin (5-hydroxytryptamine, 5-HT) as one of the possible cognitionrelated biomarkers.  The aim of this review is to provide a summary of the current literature on the role of the serotonergic (5-HTergic) system in cognitive function, particularly in AD and schizophrenia.  The role of the 5-HTergic system in cognition is modulated by the activity and function of 5-HT receptors (5-HTR) classified into seven groups, which differ in structure, action, and localization.  Many 5-HTR are located in the regions linked to various cognitive processes.  Preclinical studies using animal models of learning and memory, as well as clinical in vivo (neuroimaging) and in vitro (post-mortem) studies in humans have shown that alterations in 5-HTR activity influence cognitive performance.  The current evidence implies that reduced 5-HT neurotransmission negatively influences cognitive functions and that normalization of 5-HT activity may have beneficial effects, suggesting that 5-HT and 5-HTR represent important pharmacological targets for cognition enhancement and restoration of impaired cognitive performance in neuropsychiatric disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ-nK0Ed8w9D3p3bfzSLaX5fW6udTcc2eZCV8lBGLDiUrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7ptlOnsQ%253D%253D&md5=338ed0985629c57ac200901e38001bf0</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1515%2Ftnsci-2016-0007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1515%252Ftnsci-2016-0007%26sid%3Dliteratum%253Aachs%26aulast%3D%25C5%25A0vob%2B%25C5%25A0trac%26aufirst%3DD.%26aulast%3DPivac%26aufirst%3DN.%26aulast%3DM%25C3%25BCck-%25C5%25A0eler%26aufirst%3DD.%26atitle%3DThe%2520serotonergic%2520system%2520and%2520cognitive%2520function%26jtitle%3DTransl.%2520Neurosci.%26date%3D2016%26volume%3D7%26spage%3D35%26epage%3D49%26doi%3D10.1515%2Ftnsci-2016-0007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grella, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teitler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrick-Davis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glennon, R. A.</span></span> <span> </span><span class="NLM_article-title">Investigation of hallucinogenic and related β-carbolines</span>. <i>Drug Alcohol Depend.</i> <span class="NLM_year" style="font-weight: bold;">1998</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">107</span>, <span class="refDoi"> DOI: 10.1016/S0376-8716(97)00163-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2FS0376-8716%2897%2900163-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=9649961" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK1cXjvFemur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=1998&pages=99-107&author=B.+Grellaauthor=M.+Dukatauthor=R.+Youngauthor=M.+Teitlerauthor=K.+Herrick-Davisauthor=C.+B.+Gauthierauthor=R.+A.+Glennon&title=Investigation+of+hallucinogenic+and+related+%CE%B2-carbolines&doi=10.1016%2FS0376-8716%2897%2900163-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of hallucinogenic and related β-carbolines</span></div><div class="casAuthors">Grella, Brian; Dukat, Malgorzata; Young, Richard; Teitler, Milt; Herrick-Davis, Katharine; Gauthier, Colleen B.; Glennon, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">99-107</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">Certain β-carbolines are known to be hallucinogenic in humans, and several produce stimulus effects in animals similar to those of the classical hallucinogen 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM).  Classical hallucinogens bind at 5-HT2 serotonin receptors and these receptors are thought to play a role in their mechanism of action.  In the present study, we examd. the binding of 15 β-carbolines at rat 5-HT2A and 5-HT2C receptors.  Affinities (Ki values) of the β-carbolines ranged from about 100 nM to greater than 10 000 nM depending upon the degree of satn. of the pyridyl ring, and upon the presence and location of methoxy substituents in the benzenoid ring.  In a further study, six rats were trained to discriminate the hallucinogenic β-carboline harmaline (3.0 mg/kg, i.p.) from vehicle using a VI-15s schedule of reinforcement.  This represents the first time a hallucinogenic β-carboline has been used as a training drug in a drug discrimination study.  Administration of DOM to the harmaline-trained animals resulted in 76% harmaline-appropriate responding at 1.25 mg/kg DOM and disruption of behavior at a higher dose.  Taken together, the results of the present investigation demonstrate that: (a) certain β-carbolines bind at 5-HT2 receptors; (b) that harmaline serves as a training drug at 3.0 mg/kg in drug discrimination studies with rats as subjects; and that (c) there is some similarity between the stimulus effects produced by harmaline and DOM.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoym92j5UaRtbVg90H21EOLACvtfcHk0lihMBvZE5-0SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXjvFemur4%253D&md5=cd616378c0004ab942d4fe243a48ada7</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2FS0376-8716%2897%2900163-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0376-8716%252897%252900163-4%26sid%3Dliteratum%253Aachs%26aulast%3DGrella%26aufirst%3DB.%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DYoung%26aufirst%3DR.%26aulast%3DTeitler%26aufirst%3DM.%26aulast%3DHerrick-Davis%26aufirst%3DK.%26aulast%3DGauthier%26aufirst%3DC.%2BB.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DInvestigation%2520of%2520hallucinogenic%2520and%2520related%2520%25CE%25B2-carbolines%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D1998%26volume%3D50%26spage%3D99%26epage%3D107%26doi%3D10.1016%2FS0376-8716%2897%2900163-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glennon, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grella, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Costantino, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teitler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mattson, M. V.</span></span> <span> </span><span class="NLM_article-title">Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors</span>. <i>Drug Alcohol Depend.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1016/S0376-8716(99)00148-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2FS0376-8716%2899%2900148-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10940539" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFCis70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2000&pages=121-132&author=R.+A.+Glennonauthor=M.+Dukatauthor=B.+Grellaauthor=S.-S.+Hongauthor=L.+Costantinoauthor=M.+Teitlerauthor=C.+Smithauthor=C.+Eganauthor=K.+Davisauthor=M.+V.+Mattson&title=Binding+of+%CE%B2-carbolines+and+related+agents+at+serotonin+%285-HT2+and+5-HT1A%29%2C+dopamine+%28D2%29+and+benzodiazepine+receptors&doi=10.1016%2FS0376-8716%2899%2900148-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of β-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors</span></div><div class="casAuthors">Glennon, R. A.; Dukat, M.; Grella, B.; Hong, S.-S.; Costantino, L.; Teitler, M.; Smith, C.; Egan, C.; Davis, K.; Mattson, M. V.</div><div class="citationInfo"><span class="NLM_cas:title">Drug and Alcohol Dependence</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">121-132</span>CODEN:
                <span class="NLM_cas:coden">DADEDV</span>;
        ISSN:<span class="NLM_cas:issn">0376-8716</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A large series of β-carbolines was examd. for their ability to bind at [3H]agonist-labeled 5-HT2A serotonin receptors.  Selected β-carbolines were also examd. at 5-HT2C serotonin receptors, 5-HT1A serotonin receptors, dopamine D2 receptors, and benzodiazepine receptors.  Indolealkylamines and phenylisopropylamines were also evaluated in some of these binding assays.  The β-carbolines were found to bind with modest affinity at 5-HT2A receptors, and affinity was highly dependent upon the presence of ring substituents and ring satn.  The β-carbolines displayed little to no affinity for 5-HT1A serotonin receptors, dopamine D2 receptors and, with the exception of β-CCM, for benzodiazepine receptors.  Examples of β-carbolines, indolealkylamines (i.e. N,N-dimethyltryptamine analogs), and phenylisopropylamines have been previously shown to produce common stimulus effects in animals trained to discriminate the phenyliisopropylamine hallucinogen DOM 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane from vehicle.  Although the only common receptor population that might account for this action is 5-HT2A, on the basis of a lack of enhanced affinity for agonist-labeled 5-HT2A receptors, as well as on their lack of agonist action in the PI hydrolysis assay, it is difficult to conclude that the β-carbolines behave in a manner consistent with that of other classical hallucinogens.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaypy9C8pdJrVg90H21EOLACvtfcHk0lihMBvZE5-0SA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFCis70%253D&md5=81e7b5842567ef2a43229f158112cec6</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1016%2FS0376-8716%2899%2900148-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0376-8716%252899%252900148-9%26sid%3Dliteratum%253Aachs%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26aulast%3DDukat%26aufirst%3DM.%26aulast%3DGrella%26aufirst%3DB.%26aulast%3DHong%26aufirst%3DS.-S.%26aulast%3DCostantino%26aufirst%3DL.%26aulast%3DTeitler%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DEgan%26aufirst%3DC.%26aulast%3DDavis%26aufirst%3DK.%26aulast%3DMattson%26aufirst%3DM.%2BV.%26atitle%3DBinding%2520of%2520%25CE%25B2-carbolines%2520and%2520related%2520agents%2520at%2520serotonin%2520%25285-HT2%2520and%25205-HT1A%2529%252C%2520dopamine%2520%2528D2%2529%2520and%2520benzodiazepine%2520receptors%26jtitle%3DDrug%2520Alcohol%2520Depend.%26date%3D2000%26volume%3D60%26spage%3D121%26epage%3D132%26doi%3D10.1016%2FS0376-8716%2899%2900148-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grella, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teitler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Herrick-Davis, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glennon, R. A.</span></span> <span> </span><span class="NLM_article-title">Binding of β-carbolines at 5-HT2 serotonin receptors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">4421</span>– <span class="NLM_lpage">4425</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2003.09.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmcl.2003.09.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=14643338" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3sXpt1yrur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=4421-4425&author=B.+Grellaauthor=M.+Teitlerauthor=C.+Smithauthor=K.+Herrick-Davisauthor=R.+A.+Glennon&title=Binding+of+%CE%B2-carbolines+at+5-HT2+serotonin+receptors&doi=10.1016%2Fj.bmcl.2003.09.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">Binding of β-carbolines at 5-HT2 serotonin receptors</span></div><div class="casAuthors">Grella, Brian; Teitler, Milt; Smith, Carol; Herrick-Davis, Katharine; Glennon, R. A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">4421-4425</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">A series of ring-substituted (i.e., methoxy and bromo) 3,4-dihydro- and 1,2,3,4-tetrahydro-β-carbolines was examd. at 5-HT2A and 5-HT2C serotonin receptors.  Whereas most of the methoxy-substituted derivs. typically displayed affinities similar to their unsubstituted parents, certain (particularly 8-substituted) bromo derivs. displayed enhanced affinity.  A binding profile was obtained for selected β-carbolines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOohuBjbKuCLVg90H21EOLACvtfcHk0lh4XpYC1do17Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXpt1yrur0%253D&md5=a369be6edf8222e3d1eb2bd65eebc2d0</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2003.09.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2003.09.027%26sid%3Dliteratum%253Aachs%26aulast%3DGrella%26aufirst%3DB.%26aulast%3DTeitler%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DC.%26aulast%3DHerrick-Davis%26aufirst%3DK.%26aulast%3DGlennon%26aufirst%3DR.%2BA.%26atitle%3DBinding%2520of%2520%25CE%25B2-carbolines%2520at%25205-HT2%2520serotonin%2520receptors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D4421%26epage%3D4425%26doi%3D10.1016%2Fj.bmcl.2003.09.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de la Fuente Revenga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Garcia, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso-Gil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pérez-Castillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caignard, D.-H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yañez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez-Franco, M. I.</span></span> <span> </span><span class="NLM_article-title">Neurogenic potential assessment and pharmacological characterization of 6-methoxy-1,2,3,4-tetrahydro-β-carboline (pinoline) and melatonin-pinoline hybrids</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">800</span>– <span class="NLM_lpage">810</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.5b00041</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.5b00041" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsVShsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=800-810&author=M.+de+la+Fuente+Revengaauthor=C.+P%C3%A9rezauthor=J.+A.+Morales-Garciaauthor=S.+Alonso-Gilauthor=A.+P%C3%A9rez-Castilloauthor=D.-H.+Caignardauthor=M.+Ya%C3%B1ezauthor=A.+M.+Gamoauthor=M.+I.+Rodriguez-Franco&title=Neurogenic+potential+assessment+and+pharmacological+characterization+of+6-methoxy-1%2C2%2C3%2C4-tetrahydro-%CE%B2-carboline+%28pinoline%29+and+melatonin-pinoline+hybrids&doi=10.1021%2Facschemneuro.5b00041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Neurogenic Potential Assessment and Pharmacological Characterization of 6-Methoxy-1,2,3,4-tetrahydro-β-carboline (Pinoline) and Melatonin-Pinoline Hybrids</span></div><div class="casAuthors">de la Fuente Revenga, Mario; Perez, Concepcion; Morales-Garcia, Jose A.; Alonso-Gil, Sandra; Perez-Castillo, Ana; Caignard, Daniel-Henri; Yanez, Matilde; Gamo, Ana M.; Rodriguez-Franco, Maria Isabel</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">800-810</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">6-Methoxy-1,2,3,4-tetrahydro-β-carboline (pinoline) and N-acetyl-5-methoxytryptamine (melatonin) are both structurally related to 5-hydroxytryptamine (serotonin).  Here we describe the design, synthesis, and characterization of a series of melatonin rigid analogs resulting from the hybridization of both pinoline and melatonin structures.  The pharmacol. evaluation of melatonin-pinoline hybrids comprises serotonergic and melatonergic receptors, metabolic enzymes (monoamine oxidases), antioxidant potential, the in vitro blood-brain barrier permeability, and neurogenic studies.  Pinoline at trace concns. and 2-acetyl-6-methoxy-1,2,3,4-tetrahydro-β-carboline were able to stimulate early neurogenesis and neuronal maturation in an in vitro model of neural stem cells isolated from the adult rat subventricular zone.  Such effects are presumably mediated via serotonergic and melatonergic stimulation, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKQ6b1mXG0V7Vg90H21EOLACvtfcHk0lh4XpYC1do17Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsVShsb0%253D&md5=b2cb37ef83402c47895a769035e73250</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.5b00041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.5b00041%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2Bla%2BFuente%2BRevenga%26aufirst%3DM.%26aulast%3DP%25C3%25A9rez%26aufirst%3DC.%26aulast%3DMorales-Garcia%26aufirst%3DJ.%2BA.%26aulast%3DAlonso-Gil%26aufirst%3DS.%26aulast%3DP%25C3%25A9rez-Castillo%26aufirst%3DA.%26aulast%3DCaignard%26aufirst%3DD.-H.%26aulast%3DYa%25C3%25B1ez%26aufirst%3DM.%26aulast%3DGamo%26aufirst%3DA.%2BM.%26aulast%3DRodriguez-Franco%26aufirst%3DM.%2BI.%26atitle%3DNeurogenic%2520potential%2520assessment%2520and%2520pharmacological%2520characterization%2520of%25206-methoxy-1%252C2%252C3%252C4-tetrahydro-%25CE%25B2-carboline%2520%2528pinoline%2529%2520and%2520melatonin-pinoline%2520hybrids%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2015%26volume%3D6%26spage%3D800%26epage%3D810%26doi%3D10.1021%2Facschemneuro.5b00041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Audia, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evrard, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murdoch, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Droste, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nissen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schenck, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fludzinski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucaites, V. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, M. L.</span></span> <span> </span><span class="NLM_article-title">Potent, selective tetrahydro-β-carboline antagonists of the serotonin 2B (5HT2B) contractile receptor in the rat stomach fundus</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">2773</span>– <span class="NLM_lpage">2780</span>, <span class="refDoi"> DOI: 10.1021/jm960062t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm960062t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADyaK28XjsFeqs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=1996&pages=2773-2780&author=J.+E.+Audiaauthor=D.+A.+Evrardauthor=G.+R.+Murdochauthor=J.+J.+Drosteauthor=J.+S.+Nissenauthor=K.+W.+Schenckauthor=P.+Fludzinskiauthor=V.+L.+Lucaitesauthor=D.+L.+Nelsonauthor=M.+L.+Cohen&title=Potent%2C+selective+tetrahydro-%CE%B2-carboline+antagonists+of+the+serotonin+2B+%285HT2B%29+contractile+receptor+in+the+rat+stomach+fundus&doi=10.1021%2Fjm960062t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Potent, Selective Tetrahydro-β-carboline Antagonists of the Serotonin 2B (5HT2B) Contractile Receptor in the Rat Stomach Fundus</span></div><div class="casAuthors">Audia, James E.; Evrard, Deborah A.; Murdoch, Gwyn R.; Droste, James J.; Nissen, Jeffrey S.; Schenck, Kathy W.; Fludzinski, Pawel; Lucaites, Virginia L.; Nelson, David L.; Cohen, Marlene L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2773-2780</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of potent, selective 5HT2B receptor antagonists has been identified based upon yohimbine, with SAR studies resulting in a 1000-fold increase in 5HT2B receptor affinity relative to the starting structure (-log KBs >10.0 have been obtained).  These high-affinity tetrahydro-β-carboline antagonists are able to discriminate among the 5HT2 family of serotonin receptors, with members of the series showing selectivities of more than 100-fold vs. both the 5HT2A and 5HT2C receptors based upon radioligand binding and functional assays.  As the first compds. reported with such selectivity and enhanced receptor affinity, these tetrahydro-β-carboline antagonists are useful tools for elucidating the role of serotonin acting at the 5HT2B receptor in normal and disease physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOL3gJ44WLvrVg90H21EOLACvtfcHk0li-fy__Ryr_kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjsFeqs7Y%253D&md5=8b11769eabacad2a63142e887bb7173c</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1021%2Fjm960062t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm960062t%26sid%3Dliteratum%253Aachs%26aulast%3DAudia%26aufirst%3DJ.%2BE.%26aulast%3DEvrard%26aufirst%3DD.%2BA.%26aulast%3DMurdoch%26aufirst%3DG.%2BR.%26aulast%3DDroste%26aufirst%3DJ.%2BJ.%26aulast%3DNissen%26aufirst%3DJ.%2BS.%26aulast%3DSchenck%26aufirst%3DK.%2BW.%26aulast%3DFludzinski%26aufirst%3DP.%26aulast%3DLucaites%26aufirst%3DV.%2BL.%26aulast%3DNelson%26aufirst%3DD.%2BL.%26aulast%3DCohen%26aufirst%3DM.%2BL.%26atitle%3DPotent%252C%2520selective%2520tetrahydro-%25CE%25B2-carboline%2520antagonists%2520of%2520the%2520serotonin%25202B%2520%25285HT2B%2529%2520contractile%2520receptor%2520in%2520the%2520rat%2520stomach%2520fundus%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D1996%26volume%3D39%26spage%3D2773%26epage%3D2780%26doi%3D10.1021%2Fjm960062t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Millan, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman-Tancredi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Audinot, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cussac, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lejeune, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicolas, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coge, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Galizzi, J.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boutin, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rivet, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekeyne, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gobert, A.</span></span> <span> </span><span class="NLM_article-title">Agonist and antagonist actions of yohimbine as compared to fluparoxan at α2-adrenergic receptors (AR)s, serotonin (5-HT)1A, 5-HT1B, 5-HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">79</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1002/(SICI)1098-2396(200002)35:2<79::AID-SYN1>3.0.CO;2-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1002%2F%28SICI%291098-2396%28200002%2935%3A2%3C79%3A%3AAID-SYN1%3E3.0.CO%3B2-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10611634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD3cXkt1SksA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2000&pages=79-95&author=M.+J.+Millanauthor=A.+Newman-Tancrediauthor=V.+Audinotauthor=D.+Cussacauthor=F.+Lejeuneauthor=J.-P.+Nicolasauthor=F.+Cogeauthor=J.-P.+Galizziauthor=J.+A.+Boutinauthor=J.-M.+Rivetauthor=A.+Dekeyneauthor=A.+Gobert&title=Agonist+and+antagonist+actions+of+yohimbine+as+compared+to+fluparoxan+at+%CE%B12-adrenergic+receptors+%28AR%29s%2C+serotonin+%285-HT%291A%2C+5-HT1B%2C+5-HT1D+and+dopamine+D2+and+D3+receptors.+Significance+for+the+modulation+of+frontocortical+monoaminergic+transmission+and+depressive+states&doi=10.1002%2F%28SICI%291098-2396%28200002%2935%3A2%3C79%3A%3AAID-SYN1%3E3.0.CO%3B2-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Agonist and antagonist actions of yohimbine as compared to fluparoxan at α2-adrenergic receptors (AR)s, serotonin (5-HT)1A, 5-HT1B, 5-HT1D and dopamine D2 and D3 receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states</span></div><div class="casAuthors">Millan, Mark J.; Newman-Tancredi, Adrian; Audinot, Valerie; Cussac, Didier; Lejeune, Francoise; Nicolas, Jean-Paul; Coge, Francis; Galizzi, Jean-Pierre; Boutin, Jean A.; Rivet, Jean-Michel; Dekeyne, Anne; Gobert, Alain</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (New York)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">79-95</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">Herein, we evaluate the interaction of the α2-AR antagonist, yohimbine, as compared to fluparoxan, at multiple monoaminergic receptors and examine their roles in the modulation of adrenergic, dopaminergic and serotonergic transmission in freely-moving rats.  Yohimbine displays marked affinity at human (h)α2A-, hα2B- and hα2C-ARs, significant affinity for h5-HT1A, h5-HT1B, h5-HT1D, and hD2 receptors and weak affinity for hD3 receptors.  In [35S]GTPγS binding protocols, yohimbine exerts antagonist actions at hα2A-AR, h5-HT1B, h5-HT1D, and hD2 sites, yet partial agonist actions at h5-HT1A sites.  In vivo, agonist actions of yohimbine at 5-HT1A sites are revealed by WAY100,635-reversible induction of hypothermia in the rat.  In guinea pigs, antagonist actions of yohimbine at 5-HT1B receptors are revealed by blockade of hypothermia evoked by the 5-HT1B agonist, GR46,611.  In distinction to yohimbine, fluparoxan shows only modest partial agonist actions at h5-HT1A sites vs. marked antagonist actions at hα2-ARs.  While fluparoxan selectively enhances hippocampal noradrenaline (NAD) turnover, yohimbine also enhances striatal dopamine (DA) turnover and suppresses striatal turnover of 5-HT.  Further, yohimbine decreases firing of serotonergic neurons in raphe nuclei, an action reversed by WAY100,635.  Fluparoxan increases extracellular levels of DA and NAD, but not 5-HT, in frontal cortex.  In analogy, yohimbine enhances FCX levels of DA and NAD, yet suppresses those of 5-HT, the latter effect being antagonized by WAY100,635.  The induction by fluoxetine of FCX levels of 5-HT, DA, and NAD is potentiated by fluparoxan.  Yohimbine likewise facilitates the influence of fluoxetine upon DA and NAD levels, but not those of 5-HT.  In conclusion, the α2-AR antagonist properties of yohimbine increase DA and NAD levels both alone and in assocn. with fluoxetine.  However, in contrast to the selective α2-AR antagonist, fluparoxan, the 5-HT1A agonist actions of yohimbine suppress 5-HT levels alone and underlie its inability to augment the influence of fluoxetine upon 5-HT levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqPZkgvlHjfqbVg90H21EOLACvtfcHk0li-fy__Ryr_kw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXkt1SksA%253D%253D&md5=a8b3addd5a98957ac63230b67004b37e</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1002%2F%28SICI%291098-2396%28200002%2935%3A2%3C79%3A%3AAID-SYN1%3E3.0.CO%3B2-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F%2528SICI%25291098-2396%2528200002%252935%253A2%253C79%253A%253AAID-SYN1%253E3.0.CO%253B2-X%26sid%3Dliteratum%253Aachs%26aulast%3DMillan%26aufirst%3DM.%2BJ.%26aulast%3DNewman-Tancredi%26aufirst%3DA.%26aulast%3DAudinot%26aufirst%3DV.%26aulast%3DCussac%26aufirst%3DD.%26aulast%3DLejeune%26aufirst%3DF.%26aulast%3DNicolas%26aufirst%3DJ.-P.%26aulast%3DCoge%26aufirst%3DF.%26aulast%3DGalizzi%26aufirst%3DJ.-P.%26aulast%3DBoutin%26aufirst%3DJ.%2BA.%26aulast%3DRivet%26aufirst%3DJ.-M.%26aulast%3DDekeyne%26aufirst%3DA.%26aulast%3DGobert%26aufirst%3DA.%26atitle%3DAgonist%2520and%2520antagonist%2520actions%2520of%2520yohimbine%2520as%2520compared%2520to%2520fluparoxan%2520at%2520%25CE%25B12-adrenergic%2520receptors%2520%2528AR%2529s%252C%2520serotonin%2520%25285-HT%25291A%252C%25205-HT1B%252C%25205-HT1D%2520and%2520dopamine%2520D2%2520and%2520D3%2520receptors.%2520Significance%2520for%2520the%2520modulation%2520of%2520frontocortical%2520monoaminergic%2520transmission%2520and%2520depressive%2520states%26jtitle%3DSynapse%26date%3D2000%26volume%3D35%26spage%3D79%26epage%3D95%26doi%3D10.1002%2F%28SICI%291098-2396%28200002%2935%3A2%3C79%3A%3AAID-SYN1%3E3.0.CO%3B2-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boksa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokrosz, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charakchieva-Minol, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tatarczynska, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klodzinska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wesolowska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misztal, S.</span></span> <span> </span><span class="NLM_article-title">2-H- and 2-acyl-9-{ω-[4-(2-methoxyphenyl)piperazinyl]-alkyl}-1,2,3,4-tetrahydro-β-carbolines as ligands of 5-HT1A and 5-HT2A receptors</span>. <i>Polym. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">508</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=11990069" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD38XhvFOhurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2001&pages=501-508&author=J.+Boksaauthor=M.+J.+Mokroszauthor=S.+Charakchieva-Minolauthor=E.+Tatarczynskaauthor=A.+Klodzinskaauthor=A.+Wesolowskaauthor=S.+Misztal&title=2-H-+and+2-acyl-9-%7B%CF%89-%5B4-%282-methoxyphenyl%29piperazinyl%5D-alkyl%7D-1%2C2%2C3%2C4-tetrahydro-%CE%B2-carbolines+as+ligands+of+5-HT1A+and+5-HT2A+receptors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">2-H- and 2-acyl-9-{ω-[4-(2-methoxyphenyl)piperazinyl]-alkyl} -1,2,3,4-tetrahydro-β-carbolines as ligands of 5-HT1A and 5-HT2A receptors</span></div><div class="casAuthors">Boksa, Jan; Mokrosz, Maria J.; Charakchieva-Minol, Sijka; Tatarczynska, Ewa; Klodzinska, Aleksandra; Wesolowska, Anna; Misztal, Stanislaw</div><div class="citationInfo"><span class="NLM_cas:title">Polish Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">501-508</span>CODEN:
                <span class="NLM_cas:coden">PJPAE3</span>;
        ISSN:<span class="NLM_cas:issn">1230-6002</span>.
    
            (<span class="NLM_cas:orgname">Polish Academy of Sciences, Institute of Pharmacology</span>)
        </div><div class="casAbstract">Three series of new unsubstituted or 2-acyl 1,2,3,4-tetrahydro-β-carbolines (THBC), connected to 1-(o-methoxyphenyl)piperazine by 2-, 3- or 4- -membered alkylene spacer in position 9, were synthesized and their 5-HT1A/5-HT2A receptor affinities and functional in vivo activities were investigated.  Radioligand binding studies showed that unsubstituted and acyl derivs. with prop-1,3-ylene and particularly with but-1,4-ylene (5) spacer had a high 5-HT1A receptor affinity (Ki = 30-110 nM), whereas the 5-HT1A affinity of derivs. with ethylene spacer was low.  All those compds. (except one, Ki = 44 nM) did not distinctly bind to 5-HT2A receptors.  The obtained results indicated that the length of an alkylene chain was a crucial parameter for detg. 5-HT1A receptor affinities of the tested compds., while acyl substituents in position 2 of THBC were not important for their 5-HT1A/5-HT2A activities.  It was also demonstrated that the few selected compds. with the highest affinity (Ki up to 50 nM) for 5-HT1A receptors, administered at doses of 10-20 mg/kg, behaved like antagonists of postsynaptic 5-HT1A receptors, as they reduced the 8-OH-DPAT (5-HT1A agonist)-induced lower lip retraction and behavioral syndrome in rats.  Moreover, one of compd. seemed to be an agonist of presynaptic 5-HT1A receptors, since the hypothermia induced by its administration was attenuated by WAY 100635 (5-HT1A antagonist).  One of the Compds., a 5-HT2A receptor ligand, demonstrated an antagonistic activity, as it inhibited the (±) DOI (5-HT2A agonist)-induced head twitches in mice.  The obtained results of in vivo studies suggest that introduction of different acyl substituents in position 2 of THBC with propylene or butylene spacer between tricyclous and arylpiperazine moiety is insignificant for the post-synaptic 5-HT1A receptor activity of the compds. tested in vivo.  On the other hand, only compd. with an acryloyl group and a butylene chain behaved like a 5-HT1A/5-HT2A antagonist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruUh1zNe4VbbVg90H21EOLACvtfcHk0li6GZ7-i2dcJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhvFOhurw%253D&md5=518b7b7922cd0be293af48c7e118c256</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoksa%26aufirst%3DJ.%26aulast%3DMokrosz%26aufirst%3DM.%2BJ.%26aulast%3DCharakchieva-Minol%26aufirst%3DS.%26aulast%3DTatarczynska%26aufirst%3DE.%26aulast%3DKlodzinska%26aufirst%3DA.%26aulast%3DWesolowska%26aufirst%3DA.%26aulast%3DMisztal%26aufirst%3DS.%26atitle%3D2-H-%2520and%25202-acyl-9-%257B%25CF%2589-%255B4-%25282-methoxyphenyl%2529piperazinyl%255D-alkyl%257D-1%252C2%252C3%252C4-tetrahydro-%25CE%25B2-carbolines%2520as%2520ligands%2520of%25205-HT1A%2520and%25205-HT2A%2520receptors%26jtitle%3DPolym.%2520J.%2520Pharmacol.%26date%3D2001%26volume%3D53%26spage%3D501%26epage%3D508" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foley, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Issa, Y. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiller, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulcahy, S. P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and structure-activity relationships of 1-aryl-β-carbolines as affinity probes for the 5-hydroxytryptamine receptor</span>. <i>ACS Omega</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">9807</span>– <span class="NLM_lpage">9812</span>, <span class="refDoi"> DOI: 10.1021/acsomega.9b01111</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsomega.9b01111" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtV2jsb7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2019&pages=9807-9812&author=C.+A.+Foleyauthor=Y.+A.+Al-Issaauthor=K.+P.+Hillerauthor=S.+P.+Mulcahy&title=Synthesis+and+structure-activity+relationships+of+1-aryl-%CE%B2-carbolines+as+affinity+probes+for+the+5-hydroxytryptamine+receptor&doi=10.1021%2Facsomega.9b01111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Structure-Activity Relationships of 1-Aryl-β-carbolines as Affinity Probes for the 5-Hydroxytryptamine Receptor</span></div><div class="casAuthors">Foley, Caroline A.; Al-Issa, Yazan A.; Hiller, Kathryn P.; Mulcahy, Seann P.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Omega</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">9807-9812</span>CODEN:
                <span class="NLM_cas:coden">ACSODF</span>;
        ISSN:<span class="NLM_cas:issn">2470-1343</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Simple β-carbolines have been shown to bind several protein receptors that are important for signaling in the central nervous system.  Herein, we expand our previous efforts into the synthesis and biol. activity of these heterocycles by studying their neuropharmacol. activity.  A diverse set of 1-aryl-β-carbolines has been synthesized via Suzuki cross-coupling from a common triflate precursor and several substituted aryl boronic acids.  The resulting 26-member library was subjected to primary screening at 10 μM for activity against 40 protein receptors implicated in brain signaling.  The Ki was subsequently detd. for several lead structures.  The most potent activity, as low as 100 nM, was found against the 5-hydroxytryptamine subtype-2 family of receptors.  In-depth structure-activity relationships for these synthetic β-carbolines have been developed, which point to the importance of a 3-indolyl substituent attached to the 1-position of the β-carboline and a 6-methoxy substituent on the β-carboline core.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrP9aOfqyWTsLVg90H21EOLACvtfcHk0li6GZ7-i2dcJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtV2jsb7I&md5=a8d6a31ab22a8920019da2749bda1854</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1021%2Facsomega.9b01111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsomega.9b01111%26sid%3Dliteratum%253Aachs%26aulast%3DFoley%26aufirst%3DC.%2BA.%26aulast%3DAl-Issa%26aufirst%3DY.%2BA.%26aulast%3DHiller%26aufirst%3DK.%2BP.%26aulast%3DMulcahy%26aufirst%3DS.%2BP.%26atitle%3DSynthesis%2520and%2520structure-activity%2520relationships%2520of%25201-aryl-%25CE%25B2-carbolines%2520as%2520affinity%2520probes%2520for%2520the%25205-hydroxytryptamine%2520receptor%26jtitle%3DACS%2520Omega%26date%3D2019%26volume%3D4%26spage%3D9807%26epage%3D9812%26doi%3D10.1021%2Facsomega.9b01111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.-F.</span></span> <span> </span><span class="NLM_article-title">The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer’s disease</span>. <i>Transl. Neurodegener.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">19</span>, <span class="refDoi"> DOI: 10.1186/s40035-017-0089-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1186%2Fs40035-017-0089-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=28702178" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXltlClsrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2017&pages=19&author=S.-S.+Yangauthor=R.+Zhangauthor=G.+Wangauthor=Y.-F.+Zhang&title=The+development+prospection+of+HDAC+inhibitors+as+a+potential+therapeutic+direction+in+Alzheimer%E2%80%99s+disease&doi=10.1186%2Fs40035-017-0089-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">The development prospection of HDAC inhibitors as a potential therapeutic direction in Alzheimer's disease</span></div><div class="casAuthors">Yang, Shuang-shuang; Zhang, Rui; Wang, Gang; Zhang, Yong-fang</div><div class="citationInfo"><span class="NLM_cas:title">Translational Neurodegeneration</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">19/1-19/6</span>CODEN:
                <span class="NLM_cas:coden">TNREAP</span>;
        ISSN:<span class="NLM_cas:issn">2047-9158</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a chronic neurodegenerative disease, which is assocd. with learning and memory impairment in the elderly.  Recent studies have found that treating AD in the way of chromatin remodeling via histone acetylation is a promising therapeutic regimen.  In a no. of recent studies, inhibitors of histone deacetylase (HDACs) have been found to be a novel promising therapeutic agents for neurol. disorders, particularly for AD and other neurodegenerative diseases.  Although HDAC inhibitors have the ability to ameliorate cognitive impairment, successful treatments in the classic AD animal model are rarely translated into clin. trials.  As for the redn. of unwanted side effects, the development of HDAC inhibitors with increased isoform selectivity or seeking other directions is a key issue that needs to be addressed.  The review focused on literatures on epigenetic mechanisms in recent years, esp. on histone acetylation in terms of the enhancement of specificity, efficacy and avoiding side effects for treating AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrsk05xY8AF9rVg90H21EOLACvtfcHk0lhyG_qc5zRiaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXltlClsrw%253D&md5=8fa7452c294fb986aa1033691a39f871</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1186%2Fs40035-017-0089-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40035-017-0089-1%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DS.-S.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DZhang%26aufirst%3DY.-F.%26atitle%3DThe%2520development%2520prospection%2520of%2520HDAC%2520inhibitors%2520as%2520a%2520potential%2520therapeutic%2520direction%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DTransl.%2520Neurodegener.%26date%3D2017%26volume%3D6%26spage%3D19%26doi%3D10.1186%2Fs40035-017-0089-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, X.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, H.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Z.-F.</span></span> <span> </span><span class="NLM_article-title">Targeting HDACs: a promising therapy for Alzheimer’s Disease</span>. <i>Oxid. Med. Cell. Longevity</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>2011</i></span>,  <span class="NLM_fpage">143269</span>, <span class="refDoi"> DOI: 10.1155/2011/143269</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1155%2F2011%2F143269" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=21941604" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADC%252BC3MflvVWitA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2011&publication_year=2011&pages=143269&author=K.+Xuauthor=X.-L.+Daiauthor=H.-C.+Huangauthor=Z.-F.+Jiang&title=Targeting+HDACs%3A+a+promising+therapy+for+Alzheimer%E2%80%99s+Disease&doi=10.1155%2F2011%2F143269"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting HDACs: a promising therapy for Alzheimer's disease</span></div><div class="casAuthors">Xu Ke; Dai Xue-Ling; Huang Han-Chang; Jiang Zhao-Feng</div><div class="citationInfo"><span class="NLM_cas:title">Oxidative medicine and cellular longevity</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">2011</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">143269</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Epigenetic modifications like DNA methylation and histone acetylation play an important role in a wide range of brain disorders.  Histone deacetylases (HDACs) regulate the homeostasis of histone acetylation.  Histone deacetylase inhibitors, which initially were used as anticancer drugs, are recently suggested to act as neuroprotectors by enhancing synaptic plasticity and learning and memory in a wide range of neurodegenerative and psychiatric disorders, such as Alzheimer's disease (AD) and Parkinson's disease (PD).  To reveal the physiological roles of HDACs may provide us with a new perspective to understand the mechanism of AD and to develop selective HDAC inhibitors.  This paper focuses on the recent research progresses of HDAC proteins and their inhibitors on the roles of the treatment for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRVYQlbx4kqny-c-E1v-fmfW6udTcc2ebJGstgdybhMrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MflvVWitA%253D%253D&md5=0f0bed71a4778db8838e676d9e2e81f7</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1155%2F2011%2F143269&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2011%252F143269%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DK.%26aulast%3DDai%26aufirst%3DX.-L.%26aulast%3DHuang%26aufirst%3DH.-C.%26aulast%3DJiang%26aufirst%3DZ.-F.%26atitle%3DTargeting%2520HDACs%253A%2520a%2520promising%2520therapy%2520for%2520Alzheimer%25E2%2580%2599s%2520Disease%26jtitle%3DOxid.%2520Med.%2520Cell.%2520Longevity%26date%3D2011%26volume%3D2011%26spage%3D143269%26doi%3D10.1155%2F2011%2F143269" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xue, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, X.</span></span> <span> </span><span class="NLM_article-title">Novel β-carboline/hydroxamic acid hybrids targeting both histone deacetylase and DNA display high anticancer activity via regulation of the p53 signaling pathway</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">9214</span>– <span class="NLM_lpage">9227</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01052</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01052" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVWnsb3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=9214-9227&author=Y.+Lingauthor=C.+Xuauthor=L.+Luoauthor=J.+Caoauthor=J.+Fengauthor=Y.+Xueauthor=Q.+Zhuauthor=C.+Juauthor=F.+Liauthor=Y.+Zhangauthor=Y.+Zhangauthor=X.+Ling&title=Novel+%CE%B2-carboline%2Fhydroxamic+acid+hybrids+targeting+both+histone+deacetylase+and+DNA+display+high+anticancer+activity+via+regulation+of+the+p53+signaling+pathway&doi=10.1021%2Facs.jmedchem.5b01052"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Novel β-Carboline/Hydroxamic Acid Hybrids Targeting Both Histone Deacetylase and DNA Display High Anticancer Activity via Regulation of the p53 Signaling Pathway</span></div><div class="casAuthors">Ling, Yong; Xu, Chenjun; Luo, Lin; Cao, Jingyi; Feng, Jiao; Xue, Yu; Zhu, Qing; Ju, Caoyun; Li, Fengzhi; Zhang, Yihua; Zhang, Yanan; Ling, Xiang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">23</span>),
    <span class="NLM_cas:pages">9214-9227</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of hybrids from β-carboline and hydroxamic acid were designed and synthesized.  Several compds. not only exerted significant antiproliferation activity against four human colorectal cancer (CRC) cell lines but also showed histone deacetylase inhibitory effects in vitro.  The most potent compd., I, exhibited anticancer potency sevenfold higher than that of SAHA. I triggered more significant cancer cell apoptosis than did SAHA by cleavage of both PARP and caspase 3 in a dose-dependent manner.  Furthermore, I simultaneously increased the acetylation of histone H3 and α-tubulin, enhanced expression of DNA damage markers histone H2AX phosphorylation and p-p53 (Ser15), and activated p53 signaling pathway in HCT116 cells.  Finally, I showed low acute toxicity in mice and inhibited the growth of implanted human CRC in mice more potently than did SAHA.  Together, I possessed potent antitumor activity and may be a promising candidate for the potential treatment of human CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgOotCbux7PrVg90H21EOLACvtfcHk0ljMD_-F0gZuNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVWnsb3O&md5=a7a5ce18806d731f8a5bf7d0eba63d72</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01052&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01052%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DC.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DJu%26aufirst%3DC.%26aulast%3DLi%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLing%26aufirst%3DX.%26atitle%3DNovel%2520%25CE%25B2-carboline%252Fhydroxamic%2520acid%2520hybrids%2520targeting%2520both%2520histone%2520deacetylase%2520and%2520DNA%2520display%2520high%2520anticancer%2520activity%2520via%2520regulation%2520of%2520the%2520p53%2520signaling%2520pathway%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D9214%26epage%3D9227%26doi%3D10.1021%2Facs.jmedchem.5b01052" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiong, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>144</i></span>,  <span class="NLM_fpage">398</span>– <span class="NLM_lpage">409</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.12.061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2017.12.061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=29288941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXit1Kksg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=144&publication_year=2018&pages=398-409&author=Y.+Lingauthor=J.+Guoauthor=Q.+Yangauthor=P.+Zhuauthor=J.+Miaoauthor=W.+Gaoauthor=Y.+Pengauthor=J.+Yangauthor=K.+Xuauthor=B.+Xiongauthor=G.+Liuauthor=J.+Taoauthor=L.+Luoauthor=Q.+Zhuauthor=Y.+Zhang&title=Development+of+novel+%CE%B2-carboline-based+hydroxamate+derivatives+as+HDAC+inhibitors+with+antiproliferative+and+antimetastatic+activities+in+human+cancer+cells&doi=10.1016%2Fj.ejmech.2017.12.061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with antiproliferative and antimetastatic activities in human cancer cells</span></div><div class="casAuthors">Ling, Yong; Guo, Jing; Yang, Qiuxing; Zhu, Peng; Miao, Jiefei; Gao, Weijie; Peng, Yanfu; Yang, Jiaying; Xu, Kun; Xiong, Biao; Liu, Gongqing; Tao, Jinhua; Luo, Lin; Zhu, Qing; Zhang, Yanan</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">144</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">398-409</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of novel β-carboline-based hydroxamate derivs. were designed and synthesized, and their biol. activities in a series of in vitro assays were evaluated.  Several of these β-carboline derivs. not only showed excellent HDAC1/3/6 inhibitory effects, but also displayed significant antitumor activities against five human cancer cells.  The most potent compd. I demonstrated the highest anticancer potency against cancer cell lines with IC50 values of 0.53-1.56 μM, which was considerably more potent than harmine (IC50 = 46.7-55.3 μM) and also three-to ten-fold lower than that of SAHA (IC50 = 4.48-6.26 μM).  Immunoblot anal. revealed that I dose-dependently inhibited histone H3 and α-tubulin acetylation, confirming its HDAC inhibitory effects.  Moreover, I significantly arrested HepG2 cells at G2/M phase through inhibiting cell cycle related protein CDK1 and cyclin B in a concn. dependent manner.  Interestingly, I also exerted strong anti-metastasis activity by simultaneously reducing the protein level of MMP2 and MMP9 and inhibiting MAPK signaling pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP40En19G3YrVg90H21EOLACvtfcHk0ljMD_-F0gZuNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXit1Kksg%253D%253D&md5=3f2af1df25fba676748a69d95b89feb4</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.12.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.12.061%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DY.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DQ.%26aulast%3DZhu%26aufirst%3DP.%26aulast%3DMiao%26aufirst%3DJ.%26aulast%3DGao%26aufirst%3DW.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DK.%26aulast%3DXiong%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DTao%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DZhu%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DDevelopment%2520of%2520novel%2520%25CE%25B2-carboline-based%2520hydroxamate%2520derivatives%2520as%2520HDAC%2520inhibitors%2520with%2520antiproliferative%2520and%2520antimetastatic%2520activities%2520in%2520human%2520cancer%2520cells%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D144%26spage%3D398%26epage%3D409%26doi%3D10.1016%2Fj.ejmech.2017.12.061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y.</span></span> <span> </span><span class="NLM_article-title">Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with DNA damage and apoptosis inducing abilities</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">1213</span>– <span class="NLM_lpage">1219</span>, <span class="refDoi"> DOI: 10.1039/C6MD00681G</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1039%2FC6MD00681G" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=30108831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlt12lsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=1213-1219&author=J.+Liuauthor=T.+Wangauthor=X.+Wangauthor=L.+Luoauthor=J.+Guoauthor=Y.+Pengauthor=Q.+Xuauthor=J.+Miaoauthor=Y.+Zhangauthor=Y.+Ling&title=Development+of+novel+%CE%B2-carboline-based+hydroxamate+derivatives+as+HDAC+inhibitors+with+DNA+damage+and+apoptosis+inducing+abilities&doi=10.1039%2FC6MD00681G"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Development of novel β-carboline-based hydroxamate derivatives as HDAC inhibitors with DNA damage and apoptosis inducing abilities</span></div><div class="casAuthors">Liu, Ji; Wang, Tingting; Wang, Xinyang; Luo, Lin; Guo, Jing; Peng, Yanfu; Xu, Qibing; Miao, Jiefei; Zhang, Yanan; Ling, Yong</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1213-1219</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A series of novel β-carboline-based hydroxamate derivs. (8a-n) as HDAC inhibitors have been designed and synthesized.  Most of these compds. displayed potent histone deacetylase inhibitory effects and good antiproliferative activity with IC50s in the low micromolar range.  One of the most potent compds. (8k) showed the strongest inhibition of the proliferation of human hepatocellular carcinoma (HCC) cells in vitro, with IC50 values lower than that of the currently approved HDAC inhibitor SAHA.  Compd. 8k also increased acetylation of histone H3 and α-tubulin, consistent with its potent HDAC inhibition.  Importantly, 8k induced hypochromism by electrostatic interactions with CT-DNA, suggesting potential induction of DNA damage.  Finally, 8k significantly induced HepG2 cell apoptosis by regulating apoptotic relative proteins expression.  Together, our findings suggest that these novel β-carboline-based hydroxamate derivs. may provide a new framework for the discovery of novel antitumor agents for the intervention of human carcinoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokFVfBv2K3abVg90H21EOLACvtfcHk0ljMD_-F0gZuNA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlt12lsLw%253D&md5=98a212981539adea727be3d59dd38bba</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1039%2FC6MD00681G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC6MD00681G%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DMiao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DLing%26aufirst%3DY.%26atitle%3DDevelopment%2520of%2520novel%2520%25CE%25B2-carboline-based%2520hydroxamate%2520derivatives%2520as%2520HDAC%2520inhibitors%2520with%2520DNA%2520damage%2520and%2520apoptosis%2520inducing%2520abilities%26jtitle%3DMedChemComm%26date%3D2017%26volume%3D8%26spage%3D1213%26epage%3D1219%26doi%3D10.1039%2FC6MD00681G" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ling, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of C3-substituted β-carboline-based histone deacetylase inhibitors with potent antitumor activities</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">646</span>– <span class="NLM_lpage">651</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201700133</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1002%2Fcmdc.201700133" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=28425177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmtlSgsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=646-651&author=Y.+Lingauthor=J.+Fengauthor=L.+Luoauthor=J.+Guoauthor=Y.+Pengauthor=T.+Wangauthor=X.+Geauthor=Q.+Xuauthor=X.+Wangauthor=H.+Daiauthor=Y.+Zhang&title=Design+and+synthesis+of+C3-substituted+%CE%B2-carboline-based+histone+deacetylase+inhibitors+with+potent+antitumor+activities&doi=10.1002%2Fcmdc.201700133"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of C3-Substituted β-Carboline-Based Histone Deacetylase Inhibitors with Potent Antitumor Activities</span></div><div class="casAuthors">Ling, Yong; Feng, Jiao; Luo, Lin; Guo, Jing; Peng, Yanfu; Wang, Tingting; Ge, Xiang; Xu, Qibing; Wang, Xinyang; Dai, Hong; Zhang, Yanan</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">646-651</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A series of hydroxamic acid histone deacetylase (HDAC) inhibitors in which the β-carboline motif has been incorporated were designed and synthesized.  The effect of substitution at the C3 amide on HDAC inhibition and antiproliferative activities was investigated.  Most of these compds. were found to display significant HDAC inhibitory effects and good antiproliferative activity, with IC50 values in the low-micromolar range.  In particular, the HDAC inhibition IC50 value of N-(2-(dimethylamino)ethyl)-N-(4-(hydroxylcarbamoyl)benzyl)-1-(4-methoxyphenyl)-9H-pyrido[3,4-b]indole-3-carboxamide (9 h) is five-fold lower than that of suberoylanilide hydroxamic acid (SAHA, vorinostat).  Furthermore, 9 h was found to increase the acetylation of histone H3 and α-tubulin, and to induce DNA damage as evidenced by hypochromism and enhanced phosphorylation of histone H2AX.  Compd. 9 h inhibits Stat3, Akt, and ERK signaling, important cell-growth-promoting pathways that are aberrantly activated in most cancers.  Finally, 9 h showed reasonable soly. and permeability in Caco-2 cells.  Our findings suggest that these novel β-carboline-based HDAC inhibitors may hold great promise as therapeutic agents for the treatment of human cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBREclS6eZbLVg90H21EOLACvtfcHk0lgh3wPZhQwYtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmtlSgsL0%253D&md5=4be538b8314386b032d38e9df5ab6325</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201700133&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201700133%26sid%3Dliteratum%253Aachs%26aulast%3DLing%26aufirst%3DY.%26aulast%3DFeng%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DL.%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DPeng%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DGe%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DDai%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520C3-substituted%2520%25CE%25B2-carboline-based%2520histone%2520deacetylase%2520inhibitors%2520with%2520potent%2520antitumor%2520activities%26jtitle%3DChemMedChem%26date%3D2017%26volume%3D12%26spage%3D646%26epage%3D651%26doi%3D10.1002%2Fcmdc.201700133" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brochier, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langley, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Rational design and Simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">10842</span>– <span class="NLM_lpage">10846</span>, <span class="refDoi"> DOI: 10.1021/ja102758v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja102758v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ers7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2010&pages=10842-10846&author=K.+V.+Butlerauthor=J.+Kalinauthor=C.+Brochierauthor=G.+Vistoliauthor=B.+Langleyauthor=A.+P.+Kozikowski&title=Rational+design+and+Simple+chemistry+yield+a+superior%2C+neuroprotective+HDAC6+inhibitor%2C+tubastatin+A&doi=10.1021%2Fja102758v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Rational Design and Simple Chemistry Yield a Superior, Neuroprotective HDAC6 Inhibitor, Tubastatin A</span></div><div class="casAuthors">Butler, Kyle V.; Kalin, Jay; Brochier, Camille; Vistoli, Guilio; Langley, Brett; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">10842-10846</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Structure-based drug design combined with homol. modeling techniques were used to develop potent inhibitors of HDAC6 that display superior selectivity for the HDAC6 isoenzyme compared to other inhibitors.  These inhibitors can be assembled in a few synthetic steps, and thus are readily scaled up for in vivo studies.  An optimized compd. from this series, designated Tubastatin A, was tested in primary cortical neuron cultures in which it was found to induce elevated levels of acetylated α-tubulin, but not histone, consistent with its HDAC6 selectivity.  Tubastatin A also conferred dose-dependent protection in primary cortical neuron cultures against glutathione depletion-induced oxidative stress.  Importantly, when given alone at all concns. tested, this hydroxamate-contg. HDAC6-selective compd. displayed no neuronal toxicity, thus, forecasting the potential application of this agent and its analogs to neurodegenerative conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruEaJPWQfjH7Vg90H21EOLACvtfcHk0lgh3wPZhQwYtQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ers7k%253D&md5=f0cc68bb68f94ad1ef48f88cc6b57129</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.1021%2Fja102758v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja102758v%26sid%3Dliteratum%253Aachs%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DKalin%26aufirst%3DJ.%26aulast%3DBrochier%26aufirst%3DC.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DLangley%26aufirst%3DB.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DRational%2520design%2520and%2520Simple%2520chemistry%2520yield%2520a%2520superior%252C%2520neuroprotective%2520HDAC6%2520inhibitor%252C%2520tubastatin%2520A%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2010%26volume%3D132%26spage%3D10842%26epage%3D10846%26doi%3D10.1021%2Fja102758v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kalin, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akimova, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hancock, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kozikowski, A. P.</span></span> <span> </span><span class="NLM_article-title">Second-generation histone deacetylase 6 inhibitors enhance the immunosuppressive effects of Foxp3+ T-regulatory cells</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">639</span>– <span class="NLM_lpage">651</span>, <span class="refDoi"> DOI: 10.1021/jm200773h</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm200773h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1SrtbzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=639-651&author=J.+H.+Kalinauthor=K.+V.+Butlerauthor=T.+Akimovaauthor=W.+W.+Hancockauthor=A.+P.+Kozikowski&title=Second-generation+histone+deacetylase+6+inhibitors+enhance+the+immunosuppressive+effects+of+Foxp3%2B+T-regulatory+cells&doi=10.1021%2Fjm200773h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">Second-Generation Histone Deacetylase 6 Inhibitors Enhance the Immunosuppressive Effects of Foxp3+ T-Regulatory Cells</span></div><div class="casAuthors">Kalin, Jay H.; Butler, Kyle V.; Akimova, Tatiana; Hancock, Wayne W.; Kozikowski, Alan P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">639-651</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Second-generation Tubastatin A analogs were synthesized and evaluated for their ability to inhibit selectively histone deacetylase 6 (HDAC6).  Substitutions to the carboline cap group were well-tolerated with substitution at the 2-position of both β- and γ-carbolines being optimal for HDAC6 activity and selectivity.  Some compds. in this series were detd. to have subnanomolar activity at HDAC6 with more than 7000 fold selectivity for HDAC6 vs. HDAC1.  Selected compds. were then evaluated for their ability to augment the immunosuppressive effect of Foxp3+ regulatory T cells.  All compds. tested were found to enhance the ability of regulatory T cells to inhibit the mitotic division of effector T cells both in vitro and in vivo, suggesting that further investigation into the use of these compds. for the treatment of autoimmune disorders is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzt2Rz2tD6ibVg90H21EOLACvtfcHk0li705KmF5fxEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1SrtbzM&md5=88a4f02045fdc5387970abe53ec00c7a</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1021%2Fjm200773h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200773h%26sid%3Dliteratum%253Aachs%26aulast%3DKalin%26aufirst%3DJ.%2BH.%26aulast%3DButler%26aufirst%3DK.%2BV.%26aulast%3DAkimova%26aufirst%3DT.%26aulast%3DHancock%26aufirst%3DW.%2BW.%26aulast%3DKozikowski%26aufirst%3DA.%2BP.%26atitle%3DSecond-generation%2520histone%2520deacetylase%25206%2520inhibitors%2520enhance%2520the%2520immunosuppressive%2520effects%2520of%2520Foxp3%252B%2520T-regulatory%2520cells%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D639%26epage%3D651%26doi%3D10.1021%2Fjm200773h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leonhardt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellmer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krämer, O. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dove, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kraus, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beyer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahboobi, S.</span></span> <span> </span><span class="NLM_article-title">Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">329</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.04.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2018.04.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=29738953" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXpt1agtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2018&pages=329-357&author=M.+Leonhardtauthor=A.+Sellmerauthor=O.+H.+Kr%C3%A4merauthor=S.+Doveauthor=S.+Elzauthor=B.+Krausauthor=M.+Beyerauthor=S.+Mahboobi&title=Design+and+biological+evaluation+of+tetrahydro-%CE%B2-carboline+derivatives+as+highly+potent+histone+deacetylase+6+%28HDAC6%29+inhibitors&doi=10.1016%2Fj.ejmech.2018.04.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">Design and biological evaluation of tetrahydro-β-carboline derivatives as highly potent histone deacetylase 6 (HDAC6) inhibitors</span></div><div class="casAuthors">Leonhardt, Michel; Sellmer, Andreas; Kraemer, Oliver H.; Dove, Stefan; Elz, Sigurd; Kraus, Birgit; Beyer, Mandy; Mahboobi, Siavosh</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">329-357</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Various diseases are related to epigenetic modifications.  Histone deacetylases (HDACs) and histone acetyltransferases (HATs) det. the pattern of histone acetylation, and thus are involved in the regulation of gene expression.  First generation histone deacetylase inhibitors (HDACi) are unselective, hinder all different kinds of zinc dependent HDACs and addnl. cause several side effects.  Subsequently, selective HDACi are gaining more and more interest.  Esp., selective histone deacetylase 6 inhibitors (HDAC6i) are supposed to be less toxic.  Here the authors present a successful optimization study of tubastatin A, the synthesis and biol. evaluation of new inhibitors based on hydroxamic acids linked to various tetrahydro-β-carboline derivs.  The potency of the authors' selective HDAC6 inhibitors, exhibiting IC50 values in a range of 1-10 nM towards HDAC6, was evaluated with the help of a recombinant human HDAC6 enzyme assay.  Selectivity was proofed in cellular assays by the hyperacetylation of surrogate parameter α-tubulin in the absence of acetylated histone H3 analyzed by Western Blot.  The authors show that all synthesized compds., with varies modifications of the rigid cap group, were selective and potent HDAC6 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO3jAwqO8N0LVg90H21EOLACvtfcHk0li705KmF5fxEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXpt1agtbY%253D&md5=668b7ae179e680a0ae7116589e315cb5</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.04.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.04.046%26sid%3Dliteratum%253Aachs%26aulast%3DLeonhardt%26aufirst%3DM.%26aulast%3DSellmer%26aufirst%3DA.%26aulast%3DKr%25C3%25A4mer%26aufirst%3DO.%2BH.%26aulast%3DDove%26aufirst%3DS.%26aulast%3DElz%26aufirst%3DS.%26aulast%3DKraus%26aufirst%3DB.%26aulast%3DBeyer%26aufirst%3DM.%26aulast%3DMahboobi%26aufirst%3DS.%26atitle%3DDesign%2520and%2520biological%2520evaluation%2520of%2520tetrahydro-%25CE%25B2-carboline%2520derivatives%2520as%2520highly%2520potent%2520histone%2520deacetylase%25206%2520%2528HDAC6%2529%2520inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D152%26spage%3D329%26epage%3D357%26doi%3D10.1016%2Fj.ejmech.2018.04.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grünstein, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sellmer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahboobi, S.</span></span> <span> </span><span class="NLM_article-title">Enantioselective synthesis and biological investigation of tetrahydro-β-carboline-based HDAC6 inhibitors with improved solubility</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>352</i></span>, <span class="NLM_elocation-id">e1900026</span> <span class="refDoi"> DOI: 10.1002/ardp.201900026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1002%2Fardp.201900026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=31056792" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2019&author=E.+Gr%C3%BCnsteinauthor=A.+Sellmerauthor=S.+Mahboobi&title=Enantioselective+synthesis+and+biological+investigation+of+tetrahydro-%CE%B2-carboline-based+HDAC6+inhibitors+with+improved+solubility&doi=10.1002%2Fardp.201900026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1002%2Fardp.201900026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201900026%26sid%3Dliteratum%253Aachs%26aulast%3DGr%25C3%25BCnstein%26aufirst%3DE.%26aulast%3DSellmer%26aufirst%3DA.%26aulast%3DMahboobi%26aufirst%3DS.%26atitle%3DEnantioselective%2520synthesis%2520and%2520biological%2520investigation%2520of%2520tetrahydro-%25CE%25B2-carboline-based%2520HDAC6%2520inhibitors%2520with%2520improved%2520solubility%26jtitle%3DArch.%2520Pharm.%26date%3D2019%26volume%3D352%26doi%3D10.1002%2Fardp.201900026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheng, C.</span></span> <span> </span><span class="NLM_article-title">Discovery of novel multiacting topoisomerase I/II and histone deacetylase inhibitors</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">239</span>– <span class="NLM_lpage">243</span>, <span class="refDoi"> DOI: 10.1021/ml500327q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ml500327q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2MXosVGitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=239-243&author=S.+Heauthor=G.+Dongauthor=Z.+Wangauthor=W.+Chenauthor=Y.+Huangauthor=Z.+Liauthor=Y.+Jiangauthor=N.+Liuauthor=J.+Yaoauthor=Z.+Miaoauthor=W.+Zhangauthor=C.+Sheng&title=Discovery+of+novel+multiacting+topoisomerase+I%2FII+and+histone+deacetylase+inhibitors&doi=10.1021%2Fml500327q"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase Inhibitors</span></div><div class="casAuthors">He, Shipeng; Dong, Guoqiang; Wang, Zhibin; Chen, Wei; Huang, Yahui; Li, Zhengang; Jiang, Yan; Liu, Na; Yao, Jianzhong; Miao, Zhenyuan; Zhang, Wannian; Sheng, Chunquan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">239-243</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Designing multitarget drugs remains a significant challenge in current antitumor drug discovery.  Because of the synergistic effect between topoisomerase and HDAC inhibitors, the present study reported the first-in-class triple inhibitors of topoisomerase I/II and HDAC.  On the basis of 3-amino-10-hydroxylevodiamine and SAHA, a series of hybrid mols. was successfully designed and synthesized.  In particular, compd. 8c was proven to be a potent inhibitor of topoisomerase I/II and HDAC with good antiproliferative and apoptotic activities.  This proof-of-concept study also validated the effectiveness of discovering triple topoisomerase I/II and HDAC inhibitors as novel antitumor agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNFr6sR4u6kbVg90H21EOLACvtfcHk0lhv6vvbCmfJpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXosVGitw%253D%253D&md5=9630a82acaa4df7023a07aa7ed395e86</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1021%2Fml500327q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml500327q%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DS.%26aulast%3DDong%26aufirst%3DG.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DW.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DN.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSheng%26aufirst%3DC.%26atitle%3DDiscovery%2520of%2520novel%2520multiacting%2520topoisomerase%2520I%252FII%2520and%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D6%26spage%3D239%26epage%3D243%26doi%3D10.1021%2Fml500327q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mehndiratta, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, Y.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liang, L.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, C.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liou, J.-P.</span></span> <span> </span><span class="NLM_article-title">Indole-3-ethylsulfamoylphenylacrylamides: potent histone deacetylase inhibitors with anti-inflammatory activity</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">468</span>– <span class="NLM_lpage">479</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.08.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2014.08.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=25113875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtleisr%252FE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=468-479&author=S.+Mehndirattaauthor=Y.-L.+Hsiehauthor=Y.-M.+Liuauthor=A.+W.+Wangauthor=H.-Y.+Leeauthor=L.-Y.+Liangauthor=S.+Kumarauthor=C.-M.+Tengauthor=C.-R.+Yangauthor=J.-P.+Liou&title=Indole-3-ethylsulfamoylphenylacrylamides%3A+potent+histone+deacetylase+inhibitors+with+anti-inflammatory+activity&doi=10.1016%2Fj.ejmech.2014.08.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Indole-3-ethylsulfamoylphenylacrylamides: Potent histone deacetylase inhibitors with anti-inflammatory activity</span></div><div class="casAuthors">Mehndiratta, Samir; Hsieh, Yi-Ling; Liu, Yi-Min; Wang, Amber Weiching; Lee, Hsueh-Yun; Liang, Lung-Yu; Kumar, Sunil; Teng, Che-Ming; Yang, Chia-Ron; Liou, Jing-Ping</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">468-479</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of 2-methyl-1H-indol-3-ethylsulfamoylphenylacrylamides based on the LBH589-PXD101 core have been synthesized and evaluated for their histone deacetylase (HDAC) inhibitory and anti-inflammatory activity.  In vitro, four of these compds. show 2.6-fold better HDAC inhibition and 3-fold better IL-6 suppression compared to LBH589·HCl.  Furthermore, these compds. did not show apparent cell viability suppression on macrophages while in contrast, treatment with LBH589·HCl. resulted in significant redn. in cell viability as demonstrated by an MTT assay.  Repressed expression of iNOS, COX-2 and reduced phosphorylation of p65 revealed the inhibitory effect of these analogs on inflammatory mediator release which is related to inhibited NF-kB signals.  N-Hydroxy-3-{3-[2-(2-methyl-1H-indol-3-yl)ethylsulfamoyl]phenyl}acrylamide (I) exhibited ability superior to that of LBH589·HCl. and was able to reduce carrageenan-induced acute inflammation in an animal model.  Several of these compds. have potential anti-inflammatory activity and compd. I can serve as the lead compd. for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJq3jOkXNVHrVg90H21EOLACvtfcHk0lhv6vvbCmfJpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtleisr%252FE&md5=3f5f8c998c188eb8541b7a33ce9494d7</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.08.020%26sid%3Dliteratum%253Aachs%26aulast%3DMehndiratta%26aufirst%3DS.%26aulast%3DHsieh%26aufirst%3DY.-L.%26aulast%3DLiu%26aufirst%3DY.-M.%26aulast%3DWang%26aufirst%3DA.%2BW.%26aulast%3DLee%26aufirst%3DH.-Y.%26aulast%3DLiang%26aufirst%3DL.-Y.%26aulast%3DKumar%26aufirst%3DS.%26aulast%3DTeng%26aufirst%3DC.-M.%26aulast%3DYang%26aufirst%3DC.-R.%26aulast%3DLiou%26aufirst%3DJ.-P.%26atitle%3DIndole-3-ethylsulfamoylphenylacrylamides%253A%2520potent%2520histone%2520deacetylase%2520inhibitors%2520with%2520anti-inflammatory%2520activity%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D85%26spage%3D468%26epage%3D479%26doi%3D10.1016%2Fj.ejmech.2014.08.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gong, C.-X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iqbal, K.</span></span> <span> </span><span class="NLM_article-title">Multifactorial hypothesis and multi-targets for Alzheimer’s disease</span>. <i>J. Alzheimer's Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>64</i></span>,  <span class="NLM_fpage">S107</span>– <span class="NLM_lpage">S117</span>, <span class="refDoi"> DOI: 10.3233/JAD-179921</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3233%2FJAD-179921" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=29562523" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=64&publication_year=2018&pages=S107-S117&author=C.-X.+Gongauthor=F.+Liuauthor=K.+Iqbal&title=Multifactorial+hypothesis+and+multi-targets+for+Alzheimer%E2%80%99s+disease&doi=10.3233%2FJAD-179921"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.3233%2FJAD-179921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-179921%26sid%3Dliteratum%253Aachs%26aulast%3DGong%26aufirst%3DC.-X.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DIqbal%26aufirst%3DK.%26atitle%3DMultifactorial%2520hypothesis%2520and%2520multi-targets%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Alzheimer%2527s%2520Dis.%26date%3D2018%26volume%3D64%26spage%3DS107%26epage%3DS117%26doi%3D10.3233%2FJAD-179921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Panek, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wichur, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Godyn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pasieka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Malawska, B.</span></span> <span> </span><span class="NLM_article-title">Advances toward multifunctional cholinesterase and β-amyloid aggregation inhibitors</span>. <i>Future Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1835</span>– <span class="NLM_lpage">1854</span>, <span class="refDoi"> DOI: 10.4155/fmc-2017-0094</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.4155%2Ffmc-2017-0094" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=28925729" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFylsrfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&pages=1835-1854&author=D.+Panekauthor=T.+Wichurauthor=J.+Godynauthor=A.+Pasiekaauthor=B.+Malawska&title=Advances+toward+multifunctional+cholinesterase+and+%CE%B2-amyloid+aggregation+inhibitors&doi=10.4155%2Ffmc-2017-0094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Advances toward multifunctional cholinesterase and β-amyloid aggregation inhibitors</span></div><div class="casAuthors">Panek, Dawid; Wichur, Tomasz; Godyn, Justyna; Pasieka, Anna; Malawska, Barbara</div><div class="citationInfo"><span class="NLM_cas:title">Future Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1835-1854</span>CODEN:
                <span class="NLM_cas:coden">FMCUA7</span>;
        ISSN:<span class="NLM_cas:issn">1756-8919</span>.
    
            (<span class="NLM_cas:orgname">Future Science Ltd.</span>)
        </div><div class="casAbstract">The emergence of a multitarget design approach in the development of new potential anti-Alzheimer's disease agents has resulted in the discovery of many multifunctional compds. focusing on various targets.  Among them the largest group comprises inhibitors of both cholinesterases, with addnl. anti-β-amyloid aggregation activity.  This review describes recent advances in this research area and presents the most interesting compds. reported over a 2-yr span (2015-2016).  The majority of hybrids possess heterodimeric structures obtained by linking structurally active fragments interacting with different targets.  Multipotent cholinesterase inhibitors with β-amyloid antiaggregating activity may addnl. possess antioxidative, neuroprotective or metal-chelating properties or less common features such as anti-β-secretase or τ-antiaggregation activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoxd2zZfQmQp7Vg90H21EOLACvtfcHk0lhv6vvbCmfJpw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFylsrfN&md5=5ea0721d2c8568c41567dd950c1e1aeb</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.4155%2Ffmc-2017-0094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4155%252Ffmc-2017-0094%26sid%3Dliteratum%253Aachs%26aulast%3DPanek%26aufirst%3DD.%26aulast%3DWichur%26aufirst%3DT.%26aulast%3DGodyn%26aufirst%3DJ.%26aulast%3DPasieka%26aufirst%3DA.%26aulast%3DMalawska%26aufirst%3DB.%26atitle%3DAdvances%2520toward%2520multifunctional%2520cholinesterase%2520and%2520%25CE%25B2-amyloid%2520aggregation%2520inhibitors%26jtitle%3DFuture%2520Med.%2520Chem.%26date%3D2017%26volume%3D9%26spage%3D1835%26epage%3D1854%26doi%3D10.4155%2Ffmc-2017-0094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, P.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, S.-L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, J.-T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, L.-Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Z.-S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">299</span>– <span class="NLM_lpage">312</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2013.02.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2013.02.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=23501115" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC3sXovFejs7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2013&pages=299-312&author=Y.+Heauthor=P.-F.+Yaoauthor=S.+Chenauthor=Z.+Huangauthor=S.-L.+Huangauthor=J.-T.+Tanauthor=D.+Liauthor=L.-Q.+Guauthor=Z.-S.+Huang&title=Synthesis+and+evaluation+of+7%2C8-dehydrorutaecarpine+derivatives+as+potential+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2013.02.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and evaluation of 7,8-dehydrorutaecarpine derivatives as potential multifunctional agents for the treatment of Alzheimer's disease</span></div><div class="casAuthors">He, Yan; Yao, Pei-Fen; Chen, Shuo-bin; Huang, Zhi-hong; Huang, Shi-Liang; Tan, Jia-Heng; Li, Ding; Gu, Lian-Quan; Huang, Zhi-Shu</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">299-312</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of 7,8-dehydrorutaecarpine derivs. were synthesized and characterized as potential multifunctional agents for treatment of Alzheimer's disease (AD).  All of these synthetic compds. showed high acetylcholinesterase (AChE) inhibitory activity with IC50 values ranged from 0.60 to 196.7 nM, and good selectivity for AChE over butyrylcholinesterase (BuChE) (125- to 3225-fold).  A Lineweaver-Burk plot and mol. modeling study indicated these compds. could bind to both catalytic active site and the peripheral anionic site of AChE.  Besides, compds. showed higher activity of inhibiting AChE-induced amyloid-beta (Aβ) aggregation than curcumin, higher anti-oxidative activity than Trolox, and could also be good metal chelators.  Considering their low cytotoxicity, our results indicated that these derivs. provide good templates for developing new multifunctional agents for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqV3tzQW7M0x7Vg90H21EOLACvtfcHk0lin9Dnn8u2ogQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXovFejs7Y%253D&md5=c977a85f61bed7ae0b705d6cb1ebcad9</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2013.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2013.02.014%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DY.%26aulast%3DYao%26aufirst%3DP.-F.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DS.-L.%26aulast%3DTan%26aufirst%3DJ.-T.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DGu%26aufirst%3DL.-Q.%26aulast%3DHuang%26aufirst%3DZ.-S.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%25207%252C8-dehydrorutaecarpine%2520derivatives%2520as%2520potential%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2013%26volume%3D63%26spage%3D299%26epage%3D312%26doi%3D10.1016%2Fj.ejmech.2013.02.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer’s disease</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">198</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.05.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.ejmech.2019.05.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=31136894" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVOjsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2019&pages=198-211&author=M.+Wuauthor=J.+Maauthor=L.+Jiauthor=M.+Wangauthor=J.+Hanauthor=Z.+Li&title=Design%2C+synthesis%2C+and+biological+evaluation+of+rutacecarpine+derivatives+as+multitarget-directed+ligands+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.ejmech.2019.05.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of rutacecarpine derivatives as multitarget-directed ligands for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Wu, Mingfei; Ma, Jie; Ji, Lijun; Wang, Min; Han, Jianfei; Li, Zeng</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">198-211</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A series of 3-amino-substituted rutacecarpine derivs. were synthesized to identify novel multitarget-directed ligands (MTDLs) for the treatment of Alzheimer's disease (AD).  Biol. evaluation showed that most of the synthesized compds. inhibited butyrylcholinesterase (BuChE) and exerted antioxidant effects.  Among the synthesized compds., I was subjected to further biol. evaluation.  Lineweaver-Burk plotting and mol. modeling illustrated that I bound simultaneously to the peripheral anionic site (PAS) and catalytic sites (CAS) of BuChE.  Furthermore, I modulated Aβ aggregation; chelated biometals; presented good absorption, distribution, metab., excretion, and toxicity properties; and showed remarkable neuroprotective activity.  Previous research has shown that the optimized compd. I has considerable potential for development as an MTDL for the treatment of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoB6vo8fb0dxLVg90H21EOLACvtfcHk0lin9Dnn8u2ogQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVOjsrbM&md5=f1b51d7c2a192cddc8520ac045e7fa09</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.05.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.05.055%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DJi%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DZ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520rutacecarpine%2520derivatives%2520as%2520multitarget-directed%2520ligands%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D177%26spage%3D198%26epage%3D211%26doi%3D10.1016%2Fj.ejmech.2019.05.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, S.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, L.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.-B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, L.-Y.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer’s disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">6089</span>– <span class="NLM_lpage">6104</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.08.035</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmc.2014.08.035" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=25282654" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFCnsbnJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=6089-6104&author=J.-S.+Lanauthor=S.-S.+Xieauthor=S.-Y.+Liauthor=L.-F.+Panauthor=X.-B.+Wangauthor=L.-Y.+Kong&title=Design%2C+synthesis+and+evaluation+of+novel+tacrine-%28%CE%B2-carboline%29+hybrids+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2014.08.035"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of novel tacrine-(β-carboline) hybrids as multifunctional agents for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Lan, Jin-Shuai; Xie, Sai-Sai; Li, Su-Yi; Pan, Long-Fei; Wang, Xiao-Bing; Kong, Ling-Yi</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6089-6104</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of tacrine-(β-carboline) hybrids were designed, synthesized and evaluated as multifunctional cholinesterase inhibitors against Alzheimer's disease.  In vitro studies showed that most of them exhibited significant potency to inhibit acetylcholinesterase (AChE and hAChE), butyrylcholinesterase (BuChE) and self-induced β-amyloid (Aβ) aggregation, Cu2+-induced Aβ (1-42) aggregation, and to chelate metal ions.  Compd. I had the greatest ability to inhibit cholinesterase (IC50, 21.6 nM for AChE, 63.2 nM for hAChE and 39.8 nM for BuChE), good inhibition of Aβ aggregation (65.8% at 20 μM) and good antioxidant activity (1.57 trolox equiv.).  Kinetic and mol. modeling studies indicated that I was a mixed-type inhibitor, binding simultaneously to the catalytic anionic site and the peripheral anionic site of AChE.  In addn., I could chelate metal ions, reduce PC12 cells death induced by oxidative stress and penetrate the blood-brain barrier.  These results suggested that I might be an excellent multifunctional agent for AD treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonc2vpVkzQn7Vg90H21EOLACvtfcHk0lgHpF7Fcx-6IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFCnsbnJ&md5=e13e874f9adb8855952c19fdcafce8ab</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.08.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.08.035%26sid%3Dliteratum%253Aachs%26aulast%3DLan%26aufirst%3DJ.-S.%26aulast%3DXie%26aufirst%3DS.-S.%26aulast%3DLi%26aufirst%3DS.-Y.%26aulast%3DPan%26aufirst%3DL.-F.%26aulast%3DWang%26aufirst%3DX.-B.%26aulast%3DKong%26aufirst%3DL.-Y.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520novel%2520tacrine-%2528%25CE%25B2-carboline%2529%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D6089%26epage%3D6104%26doi%3D10.1016%2Fj.bmc.2014.08.035" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and evaluation of novel bivalent β-carboline derivatives as multifunctional agents for the treatment of Alzheimer’s disease</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">3812</span>– <span class="NLM_lpage">3824</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2018.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmc.2018.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=29960728" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXht1agsbzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2018&pages=3812-3824&author=Y.+Zhaoauthor=F.+Yeauthor=J.+Xuauthor=Q.+Liaoauthor=L.+Chenauthor=W.+Zhangauthor=H.+Sunauthor=W.+Liuauthor=F.+Fengauthor=W.+Qu&title=Design%2C+synthesis+and+evaluation+of+novel+bivalent+%CE%B2-carboline+derivatives+as+multifunctional+agents+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bmc.2018.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and evaluation of novel bivalent β-carboline derivatives as multifunctional agents for the treatment of Alzheimer's disease</span></div><div class="casAuthors">Zhao, Yifan; Ye, Feng; Xu, Jian; Liao, Qinghong; Chen, Lei; Zhang, Weijia; Sun, Haopeng; Liu, Wenyuan; Feng, Feng; Qu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">3812-3824</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">To develop potent multi-target ligands against Alzheimer's disease (AD), a series of novel bivalent β-carboline derivs. were designed, synthesized, and evaluated.  In vitro studies revealed these compds. exhibited good multifunctional activities.  In particular, compds. 8f (N,N'-dimethyl-bis(1-(1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid Me ester) propan-1-one)ethylenediamine) and 8g (bis(1-(1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid Me ester) butan-1-one)piperazine) showed the good selectivity potency on BuChE inhibition (IC50 = 1.7 and 2.7 μM, resp.), Aβ1-42 disaggregation and neuroprotection.  Compared with the pos. control resveratrol, 8f and 8g showed better activity in inhibiting Aβ1-42 aggregation, with inhibitory rate 82.7% and 85.7% at 25 μM, resp.  Moreover, compds. 8e (bis(1-(1-methyl-1,2,3,4-tetrahydro-β-carboline-3-carboxylic acid Me ester) propan-1-one)piperazine), 8f and 8g displayed excellent neuroprotective activity by ameliorating the impairment induced by H2O2, okadaic acid (OA) and Aβ1-42 without cytotoxicity in SH-SY5Y cells.  Thus, the present study evidently showed that compds. 8f and 8g are potent multifunctional agents against AD and might serve as promising lead candidates for further development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJbHSYxu1u3rVg90H21EOLACvtfcHk0lgHpF7Fcx-6IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXht1agsbzO&md5=ef847d15386e4344139c1ee653a2f13b</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2018.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2018.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DYe%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DQ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DQu%26aufirst%3DW.%26atitle%3DDesign%252C%2520synthesis%2520and%2520evaluation%2520of%2520novel%2520bivalent%2520%25CE%25B2-carboline%2520derivatives%2520as%2520multifunctional%2520agents%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2018%26volume%3D26%26spage%3D3812%26epage%3D3824%26doi%3D10.1016%2Fj.bmc.2018.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liao, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qu, W.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis and biological evaluation of novel carboline-cinnamic acid hybrids as multifunctional agents for treatment of Alzheimer’s disease</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>99</i></span>,  <span class="NLM_fpage">103844</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103844</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bioorg.2020.103844" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=32325336" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BB3cXos1Sitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=99&publication_year=2020&pages=103844&author=Q.+Liaoauthor=Q.+Liauthor=Y.+Zhaoauthor=P.+Jiangauthor=Y.+Yanauthor=H.+Sunauthor=W.+Liuauthor=F.+Fengauthor=W.+Qu&title=Design%2C+synthesis+and+biological+evaluation+of+novel+carboline-cinnamic+acid+hybrids+as+multifunctional+agents+for+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.bioorg.2020.103844"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis and biological evaluation of novel carboline-cinnamic acid hybrids as multifunctional agents for treatment of Alzheimer's disease</span></div><div class="casAuthors">Liao, Qinghong; Li, Qi; Zhao, Yifan; Jiang, Pan; Yan, Yuhui; Sun, Haopeng; Liu, Wenyuan; Feng, Feng; Qu, Wei</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">99</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103844</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Herein, a series of carboline-cinnamic acid hybrids, compds. I [R1 = H, MeO; R2 = 4-OH, 3,4-(OMe)2, etc.] was designed and synthesized to obtain new multifunctional mols. with low toxicity and good physicochem. properties.  In particular, compds. I [R1 = H, MeO; R2 = 3,4-(OH)2] exhibited significant inhibition of Aβ aggregation (inhibitory rate at 25μM: 65% and 72% resp.), moderate BuChE inhibition, excellent neuroprotective effects and low neurotoxicity.  Furthermore, in the AD mice model, compds. I [R1 = H, MeO; R2 = 3,4-(OH)2] could restore learning and memory function to a comparable level to that of the control and did not exhibit any acute toxicity in vivo at a relatively high dose of 600 mg/kg.  Thus, these new compds. can be further studied as multifunctional mols. for AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprFmQxWhmearVg90H21EOLACvtfcHk0lgHpF7Fcx-6IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXos1Sitrc%253D&md5=f0625bc4e4ae931dbf7cbed012574c9e</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103844&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103844%26sid%3Dliteratum%253Aachs%26aulast%3DLiao%26aufirst%3DQ.%26aulast%3DLi%26aufirst%3DQ.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DP.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DFeng%26aufirst%3DF.%26aulast%3DQu%26aufirst%3DW.%26atitle%3DDesign%252C%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520carboline-cinnamic%2520acid%2520hybrids%2520as%2520multifunctional%2520agents%2520for%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D99%26spage%3D103844%26doi%3D10.1016%2Fj.bioorg.2020.103844" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiaranaikulwanitch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govitrapong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fokin, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajragupta, O.</span></span> <span> </span><span class="NLM_article-title">From BACE1 inhibitor to multifunctionality tryptoline and tryptamine triazole derivatives for Alzheimer’s disease</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">8312</span>– <span class="NLM_lpage">8333</span>, <span class="refDoi"> DOI: 10.3390/molecules17078312</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.3390%2Fmolecules17078312" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=22781443" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtV2mtr3M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2012&pages=8312-8333&author=J.+Jiaranaikulwanitchauthor=P.+Govitrapongauthor=V.+V.+Fokinauthor=O.+Vajragupta&title=From+BACE1+inhibitor+to+multifunctionality+tryptoline+and+tryptamine+triazole+derivatives+for+Alzheimer%E2%80%99s+disease&doi=10.3390%2Fmolecules17078312"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">From BACE1 inhibitor to multifunctionality of tryptoline and tryptamine triazole derivatives for Alzheimer's disease</span></div><div class="casAuthors">Jiaranaikulwanitch, Jutamas; Govitrapong, Piyarat; Fokin, Valery V.; Vajragupta, Opa</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">8312-8333</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Efforts to discover new drugs for Alzheimer's disease emphasizing multiple targets was conducted seeking to inhibit amyloid oligomer formation and to prevent radical formation.  The tryptoline and tryptamine cores of BACE1 inhibitors previously identified by virtual screening were modified in silico for addnl. modes of action.  These core structures were readily linked to different side chains using 1,2,3-triazole rings as bridges by copper catalyzed azide-alkyne cycloaddn. reactions.  Three compds. among the sixteen designed compds. exerted multifunctional activities including β-secretase inhibitory action, anti-amyloid aggregation, metal chelating and antioxidant effects at micromolar levels.  The neuroprotective effects of several multifunctional compds. induced neuronal cell death at 1 μM were significantly greater than those of the potent single target compd., a known BACE1 inhibitor and were comparable to curcumin.  The obsd. synergistic effect resulting from the redn. of the Aβ1-42 neurotoxicity cascade substantiates the validity of our multifunctional strategy in drug discovery for Alzheimer's disease.  The title compds. thus formed included (3S)-2,3,4,9-tetrahydro-3-[[4-(6-methoxy-2-naphthalenyl)-1H-1,2,3-triazol-1-yl]methyl]-1H-pyrido[3,4-b]indole (I) and related substances.  The synthesis of the target compds. was achieved by a cycloaddn. of (αS)-α-(azidomethyl)-1H-indole-3-ethanamine or (3S)-3-(azidomethyl)-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole with alkyne derivs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryOpIFtfQsLLVg90H21EOLACvtfcHk0ljuu_w3ol3sSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtV2mtr3M&md5=7b4eedc2212e7ce15a001fdb760c198b</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.3390%2Fmolecules17078312&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules17078312%26sid%3Dliteratum%253Aachs%26aulast%3DJiaranaikulwanitch%26aufirst%3DJ.%26aulast%3DGovitrapong%26aufirst%3DP.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DVajragupta%26aufirst%3DO.%26atitle%3DFrom%2520BACE1%2520inhibitor%2520to%2520multifunctionality%2520tryptoline%2520and%2520tryptamine%2520triazole%2520derivatives%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DMolecules%26date%3D2012%26volume%3D17%26spage%3D8312%26epage%3D8333%26doi%3D10.3390%2Fmolecules17078312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jiaranaikulwanitch, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tadtong, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Govitrapong, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fokin, V. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajragupta, O.</span></span> <span> </span><span class="NLM_article-title">Neuritogenic activity of bi-functional bis-tryptoline triazole</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1201</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bmc.2016.12.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=28043778" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXit12mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2017&pages=1195-1201&author=J.+Jiaranaikulwanitchauthor=S.+Tadtongauthor=P.+Govitrapongauthor=V.+V.+Fokinauthor=O.+Vajragupta&title=Neuritogenic+activity+of+bi-functional+bis-tryptoline+triazole&doi=10.1016%2Fj.bmc.2016.12.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Neuritogenic activity of bi-functional bis-tryptoline triazole</span></div><div class="casAuthors">Jiaranaikulwanitch, Jutamas; Tadtong, Sarin; Govitrapong, Piyarat; Fokin, Valery V.; Vajragupta, Opa</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1195-1201</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a common neurodegenerative disorder, one of the hallmarks of which is the deposition of aggregated β-amyloid peptides (Aβ40,42) as plaques in the brain.  Oligomers of these peptides have been reported to be toxic and to inhibit neurite outgrowth, as evidenced by neurite dystrophy and significant loss of synaptic connectivity of neurons in the AD brain resulting in cognitive decline.  These peptides also react with biol. metal in the brain to generate free radicals, thereby aggravating neuronal cell injury and death.  Herein, multifunctional triazole-based compds. acting on multiple targets, namely β-secretase (BACE1), β-amyloid peptides (Aβ) as well as those possessing metal chelation and antioxidant properties, were developed and evaluated for neuritogenic activity in P19-derived neurons.  At the non-cytotoxic concn. (1 nM), all multifunctional compds. significantly enhanced neurite outgrowth.  New bis-tryptoline triazole (BTT) increased the neurite length and neurite no., by 93.25% and 136.09% over the control, resp.  This finding demonstrates the ability of multifunctional compds. targeting Aβ to enhance neurite outgrowth in addn. to their neuroprotective action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo0ZMBuiD49HbVg90H21EOLACvtfcHk0ljuu_w3ol3sSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXit12mtQ%253D%253D&md5=f98199404e438be0db02d1009af5e1b6</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DJiaranaikulwanitch%26aufirst%3DJ.%26aulast%3DTadtong%26aufirst%3DS.%26aulast%3DGovitrapong%26aufirst%3DP.%26aulast%3DFokin%26aufirst%3DV.%2BV.%26aulast%3DVajragupta%26aufirst%3DO.%26atitle%3DNeuritogenic%2520activity%2520of%2520bi-functional%2520bis-tryptoline%2520triazole%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2017%26volume%3D25%26spage%3D1195%26epage%3D1201%26doi%3D10.1016%2Fj.bmc.2016.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Staay, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Vente, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span> <span> </span><span class="NLM_article-title">Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">381</span>– <span class="NLM_lpage">390</span>, <span class="refDoi"> DOI: 10.1007/s00213-004-1967-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1007%2Fs00213-004-1967-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=15630588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BD2MXkslCi" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2005&pages=381-390&author=J.+Prickaertsauthor=A.+Sikauthor=F.+J.+van+der%0AStaayauthor=J.+de+Venteauthor=A.+Blokland&title=Dissociable+effects+of+acetylcholinesterase+inhibitors+and+phosphodiesterase+type+5+inhibitors+on+object+recognition+memory%3A+acquisition+versus+consolidation&doi=10.1007%2Fs00213-004-1967-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">Dissociable effects of acetylcholinesterase inhibitors and phosphodiesterase type 5 inhibitors on object recognition memory: acquisition versus consolidation</span></div><div class="casAuthors">Prickaerts, Jos; Sik, Ayhan; Staay, Franz Josef; Vente, Jan; Blokland, Arjan</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">381-390</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">Phosphodiesterase enzyme type 5 (PDE5) inhibitors and acetylcholinesterase (AChE) inhibitors have cognition-enhancing properties.  However, it is not known whether these drug classes affect the same memory processes.  The authors investigated the memory-enhancing effects of the PDE5 inhibitor sildenafil and AChE inhibitors metrifonate and donepezil in the object recognition task to find out whether acquisition or consolidation processes were affected by these drugs.  The object recognition task measures whether rats remembered an object they have explored in a previous learning trial.  All drugs were given orally 30 min before or immediately after learning to study acquisition and consolidation, resp.  Sildenafil given immediately after the 1st trial improved the memory performance after 24 h and resulted in an inverted U-shaped dose-effect curve with the peak dose at 3 mg/kg.  When given before the 1st trial, sildenafil also improved the memory performance.  However, the dose needed for the best performance under this condition was 10 mg/kg, suggesting that the dose-effect curve shifted to the right.  This can be explained by the metabolic clearance of the high dose of sildenafil.  Donepezil had no memory improving effect when given after the 1st trial.  However, when given before the 1st trial, a gradually increasing dose-effect curve was found which had its max. effect at the highest dose tested (1 mg/kg).  Likewise, only when metrifonate (30 mg/kg) was given before the 1st trial did rats show an improved memory performance.  The authors' data strongly suggest that PDE5 inhibitors improve processes of consolidation of object information, whereas AChE inhibitors improve processes of acquisition of object information.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcXq9JR0IqT7Vg90H21EOLACvtfcHk0ljuu_w3ol3sSA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXkslCi&md5=d60e39add7d18b9338b2a7e5a17ffb37</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1007%2Fs00213-004-1967-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-004-1967-7%26sid%3Dliteratum%253Aachs%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DSik%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BStaay%26aufirst%3DF.%2BJ.%26aulast%3Dde%2BVente%26aufirst%3DJ.%26aulast%3DBlokland%26aufirst%3DA.%26atitle%3DDissociable%2520effects%2520of%2520acetylcholinesterase%2520inhibitors%2520and%2520phosphodiesterase%2520type%25205%2520inhibitors%2520on%2520object%2520recognition%2520memory%253A%2520acquisition%2520versus%2520consolidation%26jtitle%3DPsychopharmacology%26date%3D2005%26volume%3D177%26spage%3D381%26epage%3D390%26doi%3D10.1007%2Fs00213-004-1967-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ni, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of orally available first-generation dual-target selective inhibitors of acetylcholinesterase (AChE) and phosphodiesterase 5 (PDE5) for the treatment of Alzheimer’s disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">328</span>– <span class="NLM_lpage">345</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.7b00345</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.7b00345" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWrs7rF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=328-345&author=F.+Maoauthor=H.+Wangauthor=W.+Niauthor=X.+Zhengauthor=M.+Wangauthor=K.+Baoauthor=D.+Lingauthor=X.+Liauthor=Y.+Xuauthor=H.+Zhangauthor=J.+Li&title=Design%2C+synthesis%2C+and+biological+evaluation+of+orally+available+first-generation+dual-target+selective+inhibitors+of+acetylcholinesterase+%28AChE%29+and+phosphodiesterase+5+%28PDE5%29+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facschemneuro.7b00345"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Biological Evaluation of Orally Available First-Generation Dual-Target Selective Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5) for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Mao, Fei; Wang, Huan; Ni, Wei; Zheng, Xinyu; Wang, Manjiong; Bao, Keting; Ling, Dazheng; Li, Xiaokang; Xu, Yixiang; Zhang, Haiyan; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">328-345</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Through drug discovery strategies of repurposing and redeveloping existing drugs, a series of novel tadalafil derivs. were rationally designed, synthesized, and evaluated to seek dual-target AChE/PDE5 inhibitors as good candidate drugs for Alzheimer's disease (AD).  Among these derivs., (6R,12aR)-6-(benzo[d][1,3]dioxol-5-yl)-2-(2-(1-benzylpiperidin-4yl)ethyl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione (1p, I) and (6R,12aS)-6-(benzo[d][1,3]dioxol-5-yl)-2-(2-(1-benzylpiperidin-4yl)ethyl)-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione (1w, II) exhibited excellent selective dual-target AChE/PDE5 inhibitory activities and improved blood-brain barrier (BBB) penetrability.  Importantly, II·Cit (citrate of II) could reverse the cognitive dysfunction of scopolamine-induced AD mice and exhibited an excellent effect on enhancing cAMP response element-binding protein (CREB) phosphorylation in vivo, a crucial factor in memory formation and synaptic plasticity.  Moreover, the mol. docking simulations of II with hAChE and hPDE5A confirmed that the design strategy was rational.  In summary, the research provides a potential selective dual-target AChE/PDE5 inhibitor as a good candidate drug for the treatment of AD, and it could also be regarded as a small mol. probe to validate the novel AD therapeutic approach in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoThEyISqB-vrVg90H21EOLACvtfcHk0liNmWBhHZk7Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWrs7rF&md5=f681ad7b8ce0bf011d30d36a869eedd0</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.7b00345&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.7b00345%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DNi%26aufirst%3DW.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DBao%26aufirst%3DK.%26aulast%3DLing%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520orally%2520available%2520first-generation%2520dual-target%2520selective%2520inhibitors%2520of%2520acetylcholinesterase%2520%2528AChE%2529%2520and%2520phosphodiesterase%25205%2520%2528PDE5%2529%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26spage%3D328%26epage%3D345%26doi%3D10.1021%2Facschemneuro.7b00345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ni, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span> <span> </span><span class="NLM_article-title">Novel tadalafil derivatives ameliorates scopolamine-induced cognitive impairment in mice via inhibition of acetylcholinesterase (AChE) and phosphodiesterase 5 (PDE5)</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1625</span>– <span class="NLM_lpage">1636</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00014</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00014" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXmvFansbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2018&pages=1625-1636&author=W.+Niauthor=H.+Wangauthor=X.+Liauthor=X.+Zhengauthor=M.+Wangauthor=J.+Zhangauthor=Q.+Gongauthor=D.+Lingauthor=F.+Maoauthor=H.+Zhangauthor=J.+Li&title=Novel+tadalafil+derivatives+ameliorates+scopolamine-induced+cognitive+impairment+in+mice+via+inhibition+of+acetylcholinesterase+%28AChE%29+and+phosphodiesterase+5+%28PDE5%29&doi=10.1021%2Facschemneuro.8b00014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Tadalafil Derivatives Ameliorates Scopolamine-Induced Cognitive Impairment in Mice via Inhibition of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5)</span></div><div class="casAuthors">Ni, Wei; Wang, Huan; Li, Xiaokang; Zheng, Xinyu; Wang, Manjiong; Zhang, Jian; Gong, Qi; Ling, Dazheng; Mao, Fei; Zhang, Haiyan; Li, Jian</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1625-1636</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of the drug-repositioning and redeveloping strategy, first-generation dual-target inhibitors of acetylcholinesterase (AChE) and phosphodiesterase 5 (PDE5) have been recently reported as a potentially novel therapeutic method for the treatment of Alzheimer's disease (AD), and the lead compd. 2 has proven this method was feasible in AD mouse models.  In this study, our work focused on exploring alternative novel tadalafil derivs. (3a-s).  Among the 19 analogs, compd. I exhibited good selective dual-target AChE/PDE5 inhibition and good blood-brain barrier (BBB) permeability.  Moreover, its citrate (3c·Cit) possessed improved water soly. and good effects against scopolamine-induced cognitive impairment with inhibition of cortical AChE activities and enhancement of cAMP response element-binding protein (CREB) phosphorylation ex vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGYmE-ZOSvnLVg90H21EOLACvtfcHk0liNmWBhHZk7Dw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXmvFansbY%253D&md5=4bcd7bac48de27c00afbea39949d331c</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00014%26sid%3Dliteratum%253Aachs%26aulast%3DNi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DZheng%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DJ.%26aulast%3DGong%26aufirst%3DQ.%26aulast%3DLing%26aufirst%3DD.%26aulast%3DMao%26aufirst%3DF.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DNovel%2520tadalafil%2520derivatives%2520ameliorates%2520scopolamine-induced%2520cognitive%2520impairment%2520in%2520mice%2520via%2520inhibition%2520of%2520acetylcholinesterase%2520%2528AChE%2529%2520and%2520phosphodiesterase%25205%2520%2528PDE5%2529%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2018%26volume%3D9%26spage%3D1625%26epage%3D1636%26doi%3D10.1021%2Facschemneuro.8b00014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Otto, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Penzis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gaube, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adolph, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Föhr, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warncke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robaa, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appenroth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleck, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enzensperger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehmann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winckler, T.</span></span> <span> </span><span class="NLM_article-title">Evaluation of homobivalent carbolines as designed multiple ligands for the treatment of neurodegenerative disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">6710</span>– <span class="NLM_lpage">6715</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b00958</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b00958" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlequ7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=6710-6715&author=R.+Ottoauthor=R.+Penzisauthor=F.+Gaubeauthor=O.+Adolphauthor=K.+J.+F%C3%B6hrauthor=P.+Warnckeauthor=D.+Robaaauthor=D.+Appenrothauthor=C.+Fleckauthor=C.+Enzenspergerauthor=J.+Lehmannauthor=T.+Winckler&title=Evaluation+of+homobivalent+carbolines+as+designed+multiple+ligands+for+the+treatment+of+neurodegenerative+disorders&doi=10.1021%2Facs.jmedchem.5b00958"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of Homobivalent Carbolines as Designed Multiple Ligands for the Treatment of Neurodegenerative Disorders</span></div><div class="casAuthors">Otto, Robert; Penzis, Robert; Gaube, Friedemann; Adolph, Oliver; Foehr, Karl J.; Warncke, Paul; Robaa, Dina; Appenroth, Dorothea; Fleck, Christian; Enzensperger, Christoph; Lehmann, Jochen; Winckler, Thomas</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">6710-6715</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurodegenerative diseases represent a challenge for biomedical research due to their high prevalence and lack of mechanism-based treatments.  Because of the complex pathol. of neurodegenerative disorders, multifunctional drugs have been increasingly recognized as potential treatments.  We identified homobivalent γ-carbolinium salts as potent inhibitors of both cholinesterases, N-methyl-D-aspartate receptors, and monoamine oxidases.  Homobivalent γ-carbolines displayed similar structure-activity relationships on all tested targets and may present promising designed multiple ligands for the treatment of neurodegenerative disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoggGUTF85gz7Vg90H21EOLACvtfcHk0lh3oK_fM-DF5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlequ7fP&md5=ccd884b3ed035287c7bbfd5bf17582c8</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b00958&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b00958%26sid%3Dliteratum%253Aachs%26aulast%3DOtto%26aufirst%3DR.%26aulast%3DPenzis%26aufirst%3DR.%26aulast%3DGaube%26aufirst%3DF.%26aulast%3DAdolph%26aufirst%3DO.%26aulast%3DF%25C3%25B6hr%26aufirst%3DK.%2BJ.%26aulast%3DWarncke%26aufirst%3DP.%26aulast%3DRobaa%26aufirst%3DD.%26aulast%3DAppenroth%26aufirst%3DD.%26aulast%3DFleck%26aufirst%3DC.%26aulast%3DEnzensperger%26aufirst%3DC.%26aulast%3DLehmann%26aufirst%3DJ.%26aulast%3DWinckler%26aufirst%3DT.%26atitle%3DEvaluation%2520of%2520homobivalent%2520carbolines%2520as%2520designed%2520multiple%2520ligands%2520for%2520the%2520treatment%2520of%2520neurodegenerative%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2015%26volume%3D58%26spage%3D6710%26epage%3D6715%26doi%3D10.1021%2Facs.jmedchem.5b00958" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Arias, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Miguel, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Gonzalez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espelosin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haizhong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span> <span> </span><span class="NLM_article-title">Impact of scaffold exploration on novel dual-acting histone deacetylases and phosphodiesterase 5 inhibitors for the treatment of Alzheimer’s disease</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">638</span>– <span class="NLM_lpage">661</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.6b00370</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.6b00370" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVKqtL3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=638-661&author=J.+A.+Sanchez-Ariasauthor=O.+Rabalauthor=M.+Cuadrado-Tejedorauthor=I.+de+Miguelauthor=M.+Perez-Gonzalezauthor=A.+Ugarteauthor=E.+Saezauthor=M.+Espelosinauthor=S.+Ursuaauthor=T.+Haizhongauthor=W.+Weiauthor=X.+Mushengauthor=A.+Garcia-Ostaauthor=J.+Oyarzabal&title=Impact+of+scaffold+exploration+on+novel+dual-acting+histone+deacetylases+and+phosphodiesterase+5+inhibitors+for+the+treatment+of+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facschemneuro.6b00370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Impact of Scaffold Exploration on Novel Dual-Acting Histone Deacetylases and Phosphodiesterase 5 Inhibitors for the Treatment of Alzheimer's Disease</span></div><div class="casAuthors">Sanchez-Arias, Juan A.; Rabal, Obdulia; Cuadrado-Tejedor, Mar; de Miguel, Irene; Perez-Gonzalez, Marta; Ugarte, Ana; Saez, Elena; Espelosin, Maria; Ursua, Susana; Haizhong, Tan; Wei, Wu; Musheng, Xu; Garcia-Osta, Ana; Oyarzabal, Julen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">638-661</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel systems therapeutics approach, involving simultaneous inhibition of phosphodiesterase 5 (PDE5) and histone deacetylase (HDAC), has been validated as a potentially novel therapeutic strategy for the treatment of Alzheimer's disease (AD).  First-in-class dual inhibitors bearing a sildenafil core have been very recently reported, and the lead mol. CM-414 has proven this strategy in AD animal models.  Because scaffolds may play a crit. role in primary activities and ADME-Tox profiling as well as on intellectual property, the authors have explored alternative scaffolds (vardenafil- and tadalafil-based cores) and evaluated their impact on crit. parameters such as primary activities, permeability, toxicity, and in vivo (pharmacokinetics and functional response in hippocampus) to identify a potential alternative lead mol. bearing a different chemotype for in vivo testing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKdULOaIw0N7Vg90H21EOLACvtfcHk0lh3oK_fM-DF5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVKqtL3F&md5=ac897538f818e202a961eb7c74acd8f5</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.6b00370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.6b00370%26sid%3Dliteratum%253Aachs%26aulast%3DSanchez-Arias%26aufirst%3DJ.%2BA.%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3Dde%2BMiguel%26aufirst%3DI.%26aulast%3DPerez-Gonzalez%26aufirst%3DM.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3DSaez%26aufirst%3DE.%26aulast%3DEspelosin%26aufirst%3DM.%26aulast%3DUrsua%26aufirst%3DS.%26aulast%3DHaizhong%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DMusheng%26aufirst%3DX.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26aulast%3DOyarzabal%26aufirst%3DJ.%26atitle%3DImpact%2520of%2520scaffold%2520exploration%2520on%2520novel%2520dual-acting%2520histone%2520deacetylases%2520and%2520phosphodiesterase%25205%2520inhibitors%2520for%2520the%2520treatment%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2017%26volume%3D8%26spage%3D638%26epage%3D661%26doi%3D10.1021%2Facschemneuro.6b00370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rabal, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanchez-Arias, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Miguel, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Gonzalez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estella-Hermoso de Mendoza, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Espelosin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ursua, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haizhong, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span> <span> </span><span class="NLM_article-title">Discovery of in vivo chemical probes for treating Alzheimer’s disease: dual phosphodiesterase 5 (PDE5) and class I histone deacetylase selective inhibitors</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">1765</span>– <span class="NLM_lpage">1782</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.8b00648</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.8b00648" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVKjtLvF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=1765-1782&author=O.+Rabalauthor=J.+A.+Sanchez-Ariasauthor=M.+Cuadrado-Tejedorauthor=I.+de+Miguelauthor=M.+Perez-Gonzalezauthor=C.+Garcia-Barrosoauthor=A.+Ugarteauthor=A.+Estella-Hermoso+de+Mendozaauthor=E.+Saezauthor=M.+Espelosinauthor=S.+Ursuaauthor=T.+Haizhongauthor=W.+Weiauthor=X.+Mushengauthor=A.+Garcia-Ostaauthor=J.+Oyarzabal&title=Discovery+of+in+vivo+chemical+probes+for+treating+Alzheimer%E2%80%99s+disease%3A+dual+phosphodiesterase+5+%28PDE5%29+and+class+I+histone+deacetylase+selective+inhibitors&doi=10.1021%2Facschemneuro.8b00648"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of in Vivo Chemical Probes for Treating Alzheimer's Disease: Dual Phosphodiesterase 5 (PDE5) and Class I Histone Deacetylase Selective Inhibitors</span></div><div class="casAuthors">Rabal, Obdulia; Sanchez-Arias, Juan A.; Cuadrado-Tejedor, Mar; de Miguel, Irene; Perez-Gonzalez, Marta; Garcia-Barroso, Carolina; Ugarte, Ana; Estella-Hermoso de Mendoza, Ander; Saez, Elena; Espelosin, Maria; Ursua, Susana; Haizhong, Tan; Wei, Wu; Musheng, Xu; Garcia-Osta, Ana; Oyarzabal, Julen</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1765-1782</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In order to det. the contributions of histone deacetylase (HDAC) isoforms to the beneficial effects of dual phosphodiesterase 5 (PDE5) and pan-HDAC inhibitors on in vivo models of Alzheimer's disease (AD), we have designed, synthesized, and tested novel chem. probes with the desired target compd. profile of PDE5 and class I HDAC selective inhibitors.  Compared to previous hydroxamate-based series, these mols. exhibit longer residence times on HDACs.  In this scenario, shorter or longer preincubation times may have a significant impact on the IC50 values of these compds. and therefore on their corresponding selectivity profiles on the different HDAC isoforms.  On the other hand, different chem. series have been explored and, as expected, some pairwise comparisons show a clear impact of the scaffold on biol. responses.  The lead identification process led to compd. I, which shows an adequate ADME-Tox profile and in vivo target engagement (histone acetylation and cAMP/cGMP response element-binding (CREB) phosphorylation) in the central nervous system (CNS), suggesting that this compd. represents an optimized chem. probe; thus, I has been assayed in a mouse model of AD (Tg2576).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpMx-DcLUAMrVg90H21EOLACvtfcHk0lh3oK_fM-DF5A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVKjtLvF&md5=d3d13a9121111b166ea69c09106eb3c5</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.8b00648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.8b00648%26sid%3Dliteratum%253Aachs%26aulast%3DRabal%26aufirst%3DO.%26aulast%3DSanchez-Arias%26aufirst%3DJ.%2BA.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3Dde%2BMiguel%26aufirst%3DI.%26aulast%3DPerez-Gonzalez%26aufirst%3DM.%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3DEstella-Hermoso%2Bde%2BMendoza%26aufirst%3DA.%26aulast%3DSaez%26aufirst%3DE.%26aulast%3DEspelosin%26aufirst%3DM.%26aulast%3DUrsua%26aufirst%3DS.%26aulast%3DHaizhong%26aufirst%3DT.%26aulast%3DWei%26aufirst%3DW.%26aulast%3DMusheng%26aufirst%3DX.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26aulast%3DOyarzabal%26aufirst%3DJ.%26atitle%3DDiscovery%2520of%2520in%2520vivo%2520chemical%2520probes%2520for%2520treating%2520Alzheimer%25E2%2580%2599s%2520disease%253A%2520dual%2520phosphodiesterase%25205%2520%2528PDE5%2529%2520and%2520class%2520I%2520histone%2520deacetylase%2520selective%2520inhibitors%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2019%26volume%3D10%26spage%3D1765%26epage%3D1782%26doi%3D10.1021%2Facschemneuro.8b00648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">ElHady, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shih, S.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.-C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeton, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abadi, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Halim, M.</span></span> <span> </span><span class="NLM_article-title">Extending the use of tadalafil scaffold: Development of novel selective phosphodiesterase 5 inhibitors and histone deacetylase inhibitors</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">103742</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2020.103742</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=10.1016%2Fj.bioorg.2020.103742" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=32199305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;key=1%3ACAS%3A280%3ADC%252BB383mtFGhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2020&pages=103742&author=A.+K.+ElHadyauthor=S.-P.+Shihauthor=Y.-C.+Chenauthor=Y.-C.+Liuauthor=N.+S.+Ahmedauthor=A.+B.+Keetonauthor=G.+A.+Piazzaauthor=M.+Engelauthor=A.+H.+Abadiauthor=M.+Abdel-Halim&title=Extending+the+use+of+tadalafil+scaffold%3A+Development+of+novel+selective+phosphodiesterase+5+inhibitors+and+histone+deacetylase+inhibitors&doi=10.1016%2Fj.bioorg.2020.103742"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">Extending the use of tadalafil scaffold: Development of novel selective phosphodiesterase 5 inhibitors and histone deacetylase inhibitors</span></div><div class="casAuthors">ElHady Ahmed K; Ahmed Nermin S; Abadi Ashraf H; Shih Shou-Ping; Chen Yu-Cheng; Liu Yi-Chang; Keeton Adam B; Piazza Gary A; Engel Matthias; Abdel-Halim Mohammad</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">103742</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Herein we present the synthesis and characterization of a novel chemical series of tadalafil analogues that display different pharmacological profiles.  Compounds that have the 6R, 12aR configuration and terminal carboxylic acid group at the side chain arising from the piperazinedione nitrogen were potent PDE5 inhibitors, with compound 11 having almost equal potency to tadalafil and superior selectivity over PDE11, the most common off-target for tadalafil.  Modifying the stereochemistry into 6S, 12aS configuration and adopting the hydroxamic acid moiety as a terminal group gave rise to compounds that only inhibited HDAC.  Dual PDE5/HDAC inhibition could be achieved with compounds having 6R, 12aR configuration and hydroxamic acid moiety as a terminal group.  The anticancer activity of the synthesized compounds was evaluated against a diverse number of cell lines of different origin.  The compounds elicited anticancer activity against cell lines belonging to lymphoproliferative cancer as well as solid tumors.  Despite the previous reports suggesting anticancer activity of PDE5 inhibitors, the growth inhibitory activity of the compounds seemed to be solely dependent on HDAC inhibition.  Compound 26 (pan HDAC IC50 = 14 nM, PDE5 IC50 = 46 nM) displayed the most potent anticancer activity in the present series and was shown to induce apoptosis in Molt-4 cells.  HDAC isoform selectivity testing for compound 26 showed that it is more selective for HDAC6 and 8 over HDAC1 by more than 20-fold.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSKSTByA9pE9wHqQV89nF-2fW6udTcc2ebnB4RiBCOpe7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB383mtFGhsg%253D%253D&md5=ebfd14af9b97a2e0b7782878622a7062</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2020.103742&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2020.103742%26sid%3Dliteratum%253Aachs%26aulast%3DElHady%26aufirst%3DA.%2BK.%26aulast%3DShih%26aufirst%3DS.-P.%26aulast%3DChen%26aufirst%3DY.-C.%26aulast%3DLiu%26aufirst%3DY.-C.%26aulast%3DAhmed%26aufirst%3DN.%2BS.%26aulast%3DKeeton%26aufirst%3DA.%2BB.%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26aulast%3DEngel%26aufirst%3DM.%26aulast%3DAbadi%26aufirst%3DA.%2BH.%26aulast%3DAbdel-Halim%26aufirst%3DM.%26atitle%3DExtending%2520the%2520use%2520of%2520tadalafil%2520scaffold%253A%2520Development%2520of%2520novel%2520selective%2520phosphodiesterase%25205%2520inhibitors%2520and%2520histone%2520deacetylase%2520inhibitors%26jtitle%3DBioorg.%2520Chem.%26date%3D2020%26volume%3D98%26spage%3D103742%26doi%3D10.1016%2Fj.bioorg.2020.103742" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ANR" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3ANR','PDB','3ANR'); return false;">PDB: 3ANR</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UWY" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6UWY','PDB','6UWY'); return false;">PDB: 6UWY</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YU2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4YU2','PDB','4YU2'); return false;">PDB: 4YU2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YTG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6YTG','PDB','6YTG'); return false;">PDB: 6YTG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z5X" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2Z5X','PDB','2Z5X'); return false;">PDB: 2Z5X</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OJ9" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1OJ9','PDB','1OJ9'); return false;">PDB: 1OJ9</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UDU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1UDU','PDB','1UDU'); return false;">PDB: 1UDU</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WCU" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4WCU','PDB','4WCU'); return false;">PDB: 4WCU</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c01887&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-3%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c01887" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c01887" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                8MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67991a7cbe023c7c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
